NCT Number,Study Title,Study URL,Study Status,Conditions,Interventions,Sponsor,Collaborators,Sex,Age,Phases,Study Type,Locations
NCT00726505,Renal Mechanism of Action/Splay vs. TmG,https://clinicaltrials.gov/study/NCT00726505,TERMINATED,"Diabetes, NOS",DRUG: Dapagliflozin,AstraZeneca,Bristol-Myers Squibb,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"University Of Texas Health Center At San Antonio, San Antonio, Texas, 78229, United States"
NCT03731637,A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort,https://clinicaltrials.gov/study/NCT03731637,TERMINATED,Diabetes|Type2 Diabetes|Diabetes Mellitus,,Fred Hutchinson Cancer Center,M.D. Anderson Cancer Center|National Cancer Institute (NCI)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Alliance for Clinical Trials in Oncology,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Kaiser Permanente Southern California, Los Angeles, California, 90027, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|Greater Los Angeles Veterans Affairs Medical Center, Los Angeles, California, 90073, United States|Kaiser Permanente Northern California, Oakland, California, 94612, United States|Stanford University Medical Center, Palo Alto, California, 94605, United States|University of Florida, Gainesville, Florida, 32608, United States|Advent Health Translational Research Institute, Orlando, Florida, 32804, United States|Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Univeristy Hospital, Indiana University Health, Indianapolis, Indiana, 46202, United States|Ochsner Medical Center, New Orleans, Louisiana, 70121, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Trinity Health Ann Arbor Hospital, Ypsilanti, Michigan, 48197, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, 43210, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States|Gibbs Cancer Center & Research Institute, Spartanburg, South Carolina, 29303, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|Marshfield Clinic Health System, Marshfield, Wisconsin, 54449, United States"
NCT04650945,"In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part A",https://clinicaltrials.gov/study/NCT04650945,TERMINATED,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus|Diabetes Mellitus,OTHER: isCGM group,University of Aarhus,Aarhus University Hospital,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Aarhus university hospital, Aarhus, 8200, Denmark"
NCT04630925,"In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part B",https://clinicaltrials.gov/study/NCT04630925,TERMINATED,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus|Diabetes Mellitus,OTHER: isCGM,University of Aarhus,Aarhus University Hospital,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Aarhus university hospital, Aarhus, 8200, Denmark"
NCT01172743,Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar),https://clinicaltrials.gov/study/NCT01172743,TERMINATED,Diabetes Mellitus|Type 2 Diabetes Mellitus,,Weill Medical College of Cornell University,Weill Cornell Medical College in Qatar|Hamad Medical Corporation,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Hamad Medical Corporation, Doha, Qatar"
NCT00762190,Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00762190,TERMINATED,Diabetes Mellitus,DRUG: TAK-559 and insulin|DRUG: Insulin,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02681185,Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02681185,TERMINATED,Diabetes Mellitus,OTHER: Virtual Care|OTHER: Standard of Care,Endocrine Research Society,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Endocrine Research Society, Vancouver, British Columbia, V6J4Y3, Canada"
NCT00762112,Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00762112,TERMINATED,Diabetes Mellitus,DRUG: TAK-559,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02660476,Qatar Universal Diabetes Outcomes (QUDOS) Study,https://clinicaltrials.gov/study/NCT02660476,TERMINATED,Diabetes Mellitus|Type 2 Diabetes Mellitus,,Weill Cornell Medical College in Qatar,Hamad Medical Corporation,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Weill Cornell Medicine Qatar, Doha, Qatar"
NCT02040025,"Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus",https://clinicaltrials.gov/study/NCT02040025,TERMINATED,Diabetes Mellitus,,David Grant U.S. Air Force Medical Center,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"David Grant USAF Medical Center, Travis Air Force Base, California, 94535, United States"
NCT00762684,Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00762684,TERMINATED,Diabetes Mellitus,DRUG: TAK-559|DRUG: Placebo,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT05840250,Continuous Glucose Monitoring and Diabetes,https://clinicaltrials.gov/study/NCT05840250,TERMINATED,Diabetes,OTHER: Continuous Glucose Monitoring and Education Support,Hackensack Meridian Health,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hackensack Univeristy Medical Center, Hackensack, New Jersey, 07601, United States"
NCT00762957,Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.,https://clinicaltrials.gov/study/NCT00762957,TERMINATED,Diabetes Mellitus,DRUG: TAK-559 and metformin|DRUG: TAK-559 and metformin|DRUG: Metformin,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00759720,Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.,https://clinicaltrials.gov/study/NCT00759720,TERMINATED,Diabetes Mellitus,DRUG: TAK-559 and glyburide|DRUG: TAK-559 and glyburide|DRUG: Glyburide,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02439177,Evaluating System Accuracy and User Performance of Omnitest® Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02439177,TERMINATED,Diabetes,DEVICE: Blood glucose monitoring system (Omnitest 3)|DEVICE: Blood glucose monitoring system (Omnitest 5),B. Braun Melsungen AG,Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany"
NCT01755442,Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects,https://clinicaltrials.gov/study/NCT01755442,TERMINATED,Diabetes Mellitus,OTHER: Placebo|DRUG: AMG 151,Amgen,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Research Site, San Diego, California, 92161, United States"
NCT04089202,Diabetes eConsult Non-Inferiority Study,https://clinicaltrials.gov/study/NCT04089202,TERMINATED,Diabetes,OTHER: eConsult|OTHER: Standard of care,Boston Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Boston Medical Center, Boston, Massachusetts, 02118, United States"
NCT05003908,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes,https://clinicaltrials.gov/study/NCT05003908,TERMINATED,Diabetes,BIOLOGICAL: AlloRx,The Foundation for Orthopaedics and Regenerative Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Medical Surgical Associates Center, St. John's, Antigua and Barbuda|Center for Investigation in Tissue Engineering and Cellular Therapy, Buenos Aires, Argentina"
NCT03077997,Internet Intervention for Diabetes Distress,https://clinicaltrials.gov/study/NCT03077997,TERMINATED,Diabetes,BEHAVIORAL: Space from Diabetes,Derek Richards,"Silver Cloud Health|University of Dublin, Trinity College",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Barnet, Enfield, and Haringey Mental Health Trust, Enfield, EN2 0JB, United Kingdom"
NCT00722917,Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00722917,TERMINATED,Diabetes Mellitus,DRUG: TAK-379|DRUG: TAK-379|DRUG: TAK-379|DRUG: Pioglitazone|DRUG: Placebo,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Artesia, California, United States|Norwalk, California, United States|Santa Ana, California, United States|Santa Monica, California, United States|Panama City, Florida, United States|Cranston, Rhode Island, United States|Dallas, Texas, United States|Houston, Texas, United States"
NCT00763347,Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00763347,TERMINATED,Diabetes Mellitus,DRUG: SYR-619|DRUG: SYR-619|DRUG: SYR-619|DRUG: SYR-619|DRUG: Placebo|DRUG: Alogliptin,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT01511042,Vascular Dysfunction in Diabetes: Genes and Hormones,https://clinicaltrials.gov/study/NCT01511042,TERMINATED,Diabetes Mellitus,DRUG: Para-aminohippuric Acid|DRUG: Angiotensin II|DRUG: Norepinephrine,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Brigham and Women's Hospital- 221 Longwood Avenue, Boston, Massachusetts, 02115, United States"
NCT03830216,Connected Pens for Diabetes Study,https://clinicaltrials.gov/study/NCT03830216,TERMINATED,Diabetes Mellitus,DEVICE: Connected insulin pen and smartphone app|DEVICE: Inactive connected insulin pen without smartphone app,"Companion Medical, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92663, United States"
NCT02230488,Intensive Case Diabetes Management (ICDM) to Prevent Readmission,https://clinicaltrials.gov/study/NCT02230488,TERMINATED,Diabetes,OTHER: Intensive Diabetes Case Management,Washington University School of Medicine,Barnes-Jewish Hospital,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Barnes-Jewish Hospital, St. Louis, Missouri, 63110, United States"
NCT03258723,Diabetes Prevention With Lifestyle Intervention and Metformin Escalation,https://clinicaltrials.gov/study/NCT03258723,TERMINATED,Diabetes,BEHAVIORAL: Lifestyle Intervention|DRUG: Metformin,Yale University,"National Heart, Lung, and Blood Institute (NHLBI)|National Institute on Minority Health and Health Disparities (NIMHD)",ALL,ADULT,PHASE4,INTERVENTIONAL,"University of the West Indies, Cavehill and Barbados Ministry of Health Polyclinics, Bridgetown, Barbados|Internal Medicine Clinic at the University of Puerto Rico Hospital, Carolina, 00984, Puerto Rico|Southwest Regional Health Authority, La Romaine Health Center, San Fernando, Trinidad and Tobago|Ministry of Health Clinics, Charlotte Amalie, Virgin Islands (U.S.)"
NCT04819256,Primary Care Based Integrated Community Care Team Intervention,https://clinicaltrials.gov/study/NCT04819256,TERMINATED,"Diabetes|Diabetes Mellitus|Diabetes Mellitus, Type 2|Diabetes type2",OTHER: PACE-It mobile application,SingHealth Polyclinics,"Ministry of Health, Singapore|Agency for Integrated Care, Singapore|SingHealth Regional Health System",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"SingHealth Polyclinics - Marine Parade, 80 Marine Parade Central, #01-792, Singapore, 440080, Singapore"
NCT03708380,Diabetes Prevention for Black Men,https://clinicaltrials.gov/study/NCT03708380,TERMINATED,Diabetes,BEHAVIORAL: Dietary intervention,NYU Langone Health,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"New York University School of Medicine, New York, New York, 10016, United States"
NCT03946631,GDM Post Partum Screening,https://clinicaltrials.gov/study/NCT03946631,TERMINATED,"Diabetes|Gestational Diabetes|Diabetes Mellitus, Type 2",DIAGNOSTIC_TEST: 2 hour glucose tolerance test using 75g glucose drink,Pediatrix,Banner University Medical Center,FEMALE,ADULT,,OBSERVATIONAL,"Banner - University Medical Center Phoenix, Phoenix, Arizona, 85006, United States"
NCT01963728,Comparison of Insulin Therapy in Treating Post-Transplant Diabetes,https://clinicaltrials.gov/study/NCT01963728,TERMINATED,Diabetes Mellitus,"DRUG: Insulin, Isophane|DRUG: insulin glargine",Inova Health Care Services,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Inova Fairfax Hospital, Falls Church, Virginia, 22042, United States"
NCT01029444,Effects of Pulsed Intravenous (IV) Insulin on Brittle and Uncontrolled Diabetes,https://clinicaltrials.gov/study/NCT01029444,TERMINATED,Diabetes Mellitus,"PROCEDURE: Pulsatile Intravenous Insulin Therapy (Humulin, Humulog, Novolog )",Florida Atlantic University,Advanced Diabetes Treatment Centers,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Florida Atlantic University, Boca Raton, Florida, 33421, United States"
NCT00701935,Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin,https://clinicaltrials.gov/study/NCT00701935,TERMINATED,Diabetes Mellitus,DRUG: placebo|DRUG: exenatide,AstraZeneca,Eli Lilly and Company,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Temple, Arizona, United States|Research Site, Colorado Springs, Colorado, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Bellevue, Nebraska, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Calgary, Alberta, Canada|Research Site, Vancouver, British Columbia, Canada|Research Site, Victoria, British Columbia, Canada|Research Site, Winnipeg, Manitoba, Canada|Research Site, Saint John, New Brunswick, Canada|Research Site, Brampton, Ontario, Canada|Research Site, London, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Chicoutimi, Quebec, Canada|Research Site, Pointe-Claire, Quebec, Canada|Research Site, Quebec, Canada"
NCT00437164,A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00437164,TERMINATED,"Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2",DRUG: Insulin|DRUG: Oral GW677954 Capsules (15 mg),GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"GSK Investigational Site, Beverly Hills, California, 90211, United States"
NCT03460964,Measuring Sweat Glucose of Patients With Diabetes - The ENGAGE Study,https://clinicaltrials.gov/study/NCT03460964,TERMINATED,Diabetes Mellitus,DEVICE: Adhesive glucose sensor|DRUG: Pilocarpine,"University of California, San Diego",National Institutes of Health (NIH),ALL,ADULT,,INTERVENTIONAL,"UCSD Altman Clinical and Translational Research Institute, San Diego, California, 92161, United States|UCSD, San Diego, California, 92161, United States"
NCT01302743,"Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.",https://clinicaltrials.gov/study/NCT01302743,TERMINATED,Diabetes,DRUG: Group 1: Metformin|DIETARY_SUPPLEMENT: Group 2: Cinnamon Bark|DIETARY_SUPPLEMENT: Group 3: Cinnulin PF,Mike O'Callaghan Military Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Mike O'Callaghan Federal Hospital, Nellis Air Force Base, Nevada, 89191, United States"
NCT00521820,Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure,https://clinicaltrials.gov/study/NCT00521820,TERMINATED,Diabetes Mellitus,DRUG: Pioglitazone|DRUG: Glyburide,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02748122,CSII Pilot in Adolescents With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02748122,TERMINATED,Diabetes,OTHER: MMT 723,NYU Langone Health,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"New York University Langone Medical Center, New York, New York, 10016, United States"
NCT01906294,IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01906294,TERMINATED,Type 2 Diabetes Mellitus,DRUG: antidiabetic treatment (ATC A10B),IMS HEALTH GmbH & Co. OHG,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Praxis Dr. med. Birgit Böttger, Frankfurt am Main, 60325, Germany"
NCT02287506,StartRIGHT: A Pilot Research Study About Diabetes Diagnosis & Treatment,https://clinicaltrials.gov/study/NCT02287506,TERMINATED,Diabetes,OTHER: Optimised Diagnostic Strategy,Royal Devon and Exeter NHS Foundation Trust,,ALL,ADULT,,INTERVENTIONAL,
NCT01856881,Multiple Ascending Dose Study in Subjects With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01856881,TERMINATED,Diabetes Mellitus,DRUG: AMG 876,Amgen,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Research Site, Chula Vista, California, 91911, United States|Research Site, Miramar, Florida, 33025, United States|Research Site, Overland Park, Kansas, 66212, United States|Research Site, Cincinnati, Ohio, 45255, United States|Research Site, San Antonio, Texas, 78209, United States|Research Site, Renton, Washington, 98057, United States"
NCT00143247,Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00143247,TERMINATED,Diabetes Mellitus,DRUG: Exubera® (inhaled insulin),Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Pfizer Investigational Site, San Diego, California, 92123, United States|Pfizer Investigational Site, New Haven, Connecticut, 06504, United States|Pfizer Investigational Site, Miami, Florida, 33136, United States|Pfizer Investigational Site, Chicago, Illinois, 60610, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87131-5666, United States|Pfizer Investigational Site, Durham, North Carolina, 27710, United States|Pfizer Investigational Site, Winston Salem, North Carolina, 27157, United States|Pfizer Investigational Site, Austin, Texas, 78752, United States|Pfizer Investigational Site, Austin, Texas, 78758, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75243, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States"
NCT00896610,Natural History of Autoimmune Diabetes and Its Complications,https://clinicaltrials.gov/study/NCT00896610,TERMINATED,Diabetes Mellitus Type 1|Diabetes Mellitus Type 2,,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT00527397,"Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes",https://clinicaltrials.gov/study/NCT00527397,TERMINATED,"Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1","DRUG: CP-464,005|DRUG: CP-464,005|DRUG: CP-464,005",Pfizer,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Nagoya-shi, Aichi, Japan|Pfizer Investigational Site, Yokohama-shi, Kanagawa, Japan|Pfizer Investigational Site, Tenri-shi, Nara, Japan|Pfizer Investigational Site, Takatsuki-shi, Oosaka, Japan|Pfizer Investigational Site, Bunkyo-ku, Tokyo, Japan|Pfizer Investigational Site, Meguro-ku, Tokyo, Japan|Pfizer Investigational Site, Toyama-shi, Toyama, Japan|Pfizer Investigational Site, Kyoto, Japan|Pfizer Investigational Site, Osaka, Japan|Pfizer Investigational Site, Tokyo, Japan"
NCT00228878,Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes,https://clinicaltrials.gov/study/NCT00228878,TERMINATED,Diabetes Mellitus,PROCEDURE: Effects of Pulsatile IV insulin on Diabetic Quality of Life,Florida Atlantic University,Advanced Diabetes Treatment Centers,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Florida Atlantic University, Boca Raton, Florida, 33487, United States"
NCT01492465,Single Ascending Dose Trial in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01492465,TERMINATED,Diabetes Mellitus,DRUG: AMG 876,Amgen,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Research Site, Omaha, Nebraska, 68154, United States|Research Site, San Antonio, Texas, 78209, United States|San Antonio, Texas, 78209, United States"
NCT00326573,Trial of Motivational Interviewing in Adolescents With Diabetes,https://clinicaltrials.gov/study/NCT00326573,TERMINATED,Diabetes Mellitus,BEHAVIORAL: Motivational Interviewing,Cardiff University,Diabetes UK,ALL,CHILD,PHASE1|PHASE2,INTERVENTIONAL,"Dept of Child Health, UHW, Cardiff, South Glamorgan, CF14 4XN, United Kingdom"
NCT00425919,Study Evaluating PPM-204 In Subjects With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00425919,TERMINATED,Diabetes Mellitus,DRUG: PPM-204,Wyeth is now a wholly owned subsidiary of Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Artesia, California, 90701, United States|Los Angeles, California, 90057, United States|Chipley, Florida, 32428, United States|Destin, Florida, 32541, United States|Marianna, Florida, 32446, United States|West Palm Beach, Florida, 33401, United States|Omaha, Nebraska, 68131, United States|New York, New York, 10032, United States|Austin, Texas, 78705, United States|Richmond, Virginia, 23249, United States|Tacoma, Washington, 98405, United States|Buenos Aires, C1117ABH, Argentina|Corrientes, 3400, Argentina|La Plata, 1900, Argentina|Mar del Plata Pcia de Bs. As, 7600, Argentina|Ramos Mejia, Pcia de Bs., 1704, Argentina|Daws Park, South Australia, 5041, Australia|Keswick, South Australia, 5035, Australia|Box Hill, Victoria, 3128, Australia|Vila Clementino - Sao Paulo, 04020-060, Brazil|Edmonton, Alberta, T5G 3G6, Canada|Toronto, Ontario, M9W 4L6, Canada|Charlottetown, Prince Edward Island, C1E 1J7, Canada|Laval, Quebec, H7P 2P5, Canada|Saint-Janvier, Quebec, J7J 2K8, Canada|Beijing, 100730, China|Beijing, 100853, China|Krapinske Toplice, 49000, Croatia|Rijeka, 51000, Croatia|Zagreb, 10000, Croatia|Belgrade, 11000, Former Serbia and Montenegro|Athens, 115 21, Greece|Thessaloniki, 56429, Greece|Wanchai, Hong Kong|Bangalore, Karnataka, 560043, India|Cochin, Kerala, 682 026, India|Pune, Maharashtra, 411001, India|Chennai, Tamil nadu, 600 013, India|Vellore, Tamil Nadu, 632004, India|Catanzaro, 88100, Italy|Pisa, 56124, Italy|Aguascalientes, 20230, Mexico|Mexico D.F., 11650, Mexico|Mexico DF, 14000, Mexico|Miguel Hidalgo, 11550, Mexico|Monterrey N.L, 64410, Mexico|Tlapan, 14080, Mexico|Bucuresti, 10825, Romania|Bucuresti, 20475, Romania|Cluj-Napoca, 400006, Romania|Moscow, 117036, Russian Federation|Moscow, 117292, Russian Federation|Moscow, 123154, Russian Federation|Moscow, 125315, Russian Federation|St. Petersburg, 194044, Russian Federation|St. Petersburg, 194354, Russian Federation|Port Elizabeth, Eastern Cape, 6014, South Africa|Benoni, Gauteng, 1501, South Africa|Pretoria, Gauteng, 0002, South Africa|Pretoria, Gauteng, 39, South Africa|Temba, North West Province, 400, South Africa|Kharkiv, 61070, Ukraine|Kyiv, 02175, Ukraine|Poltava, 36024, Ukraine|Uzhgorod, 80312, Ukraine|Dundee, DD1 9SY, United Kingdom|Edinburgh, EH4 2XU, United Kingdom|Livingston, EH54 6PP, United Kingdom"
NCT02800044,Studying the Effectiveness of Non-Invasive Glucose Sensors in Patients With Diabetes: The SENSOR Study,https://clinicaltrials.gov/study/NCT02800044,TERMINATED,Diabetes Mellitus,DEVICE: Wearing a non-invasive glucose sensor,"University of California, San Diego",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"UCSD, San Diego, California, 92161, United States"
NCT01820169,Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG,https://clinicaltrials.gov/study/NCT01820169,TERMINATED,Diabetes,DEVICE: ;Accu-Chek Compact Plus LCM bulk Japan,Hoffmann-La Roche,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Kyoto, 612-8555, Japan"
NCT00629434,A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person,https://clinicaltrials.gov/study/NCT00629434,TERMINATED,Diabetes Mellitus,OTHER: diabetes education via telemedicine|OTHER: diabetes education in-person,State University of New York - Upstate Medical University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Joslin Diabetes Center Affiliate at SUNY Upstate Medical University, Syracuse, New York, 13214, United States"
NCT02887677,Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.,https://clinicaltrials.gov/study/NCT02887677,TERMINATED,Diabetes Mellitus,DRUG: Dapagliflozin|DRUG: Placebo,Hellenic Society for Medical Education,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Ahepa Hospital, Thessaloniki, 54621, Greece|Hippokrateio Hospital, Thessaloniki, 54642, Greece|Papageorgiou Hospital, Thessaloniki, 56429, Greece"
NCT01069965,Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01069965,TERMINATED,Diabetes Mellitus,DRUG: BGP-15 100 mg QD|DRUG: BGP-15 100 mg BID|DRUG: Placebo BID|DRUG: BGP-15 200 mg QD|DRUG: BGP-15 200 mg BID|DRUG: BGP-15 400 mg QD,"N-Gene Research Laboratories, Inc.","Integrium|Msource Medical Development GmbH|Kinexum LLC|Thermo Fisher Scientific, Inc|Haupt Pharma Wülfing GmbH|Barc NV",ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Andrew J. Lewin Medical Corporation DBA National Research Institute, Los Angeles, California, 90057, United States|Center for Clinical Trials, LLC., Paramount, California, 90723, United States|Orange County Research Center, Tustin, California, 92780, United States|Creekside Endocrine Associates PC, Denver, Colorado, 80209, United States|Clinical Research of South Florida, Coral Gables, Florida, 33134, United States|Metabolic Research Institute, Inc., West Palm Beach, Florida, 33401, United States|Atlanta Pharmaceutical Research, Decatur, Georgia, 30033, United States|ICCT Research International, Inc., Chicago, Illinois, 60611, United States|Medstar Health Research Institute, Hyattsville, Maryland, 20782, United States|The Center for Pharmaceutical Research, P.C., Kansas City, Missouri, 64114, United States|Nevada Alliance Against Diabetes, Las Vegas, Nevada, 89101, United States|New Hanover Medical Research, Wilmington, North Carolina, 28401, United States|Piedmont Medical Research, LLC., Winston-Salem, North Carolina, 27103, United States|Upstate Pharmaceutical Research, Greenville, South Carolina, 29615, United States|Mountain View Clinical Research, Greer, South Carolina, 29651, United States|Southeastern Research Associates, Inc., Taylors, South Carolina, 29687, United States|Athens Medical Group, Athens, Tennessee, 37303, United States|Juno Research, LLC., Houston, Texas, 77074, United States|Juno Research, LLC., Katy, Texas, 77451, United States|Cetero Research-San Antonio, San Antonio, Texas, 78229, United States|Diabetespraxis Bad Mergentheim, Bad Mergentheim, 97980, Germany|Praxis Dr. Schätzl, Großheirath-Rossach, 96269, Germany|Universitätsklinikum Köln, Köln, 50937, Germany|Schwerpunktpraxis Diabetes, Neuwied, 56564, Germany|Diabetologische Schwerpunktpraxis, Siegen, 57072, Germany|DRUG Research Center Hungary Kft., Balatonfüred, 8230, Hungary|Semmelweis University 2nd Clinic for Internal Medicine, Budapest, 1088, Hungary|Petz Aladar Country Teaching Hospital, Dept of Diabetology and Metabolism, Győr, 9024, Hungary|Dr. Bugyi Istvan Hospital, Diabetology Outpatient Clinic, Szentes, 6600, Hungary|Zala County Hospital Department of Diabetology, Zalaegerszeg, 8900, Hungary"
NCT01829464,TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01829464,TERMINATED,Diabetes,DRUG: Placebo|DRUG: TAK-875|DRUG: TAK-875,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Birmingham, Alabama, United States|Dothan, Alabama, United States|Muscle Shoals, Alabama, United States|Phoenix, Arizona, United States|Anaheim, California, United States|El Cajon, California, United States|Long Beach, California, United States|Modesto, California, United States|North Hollywood, California, United States|Norwalk, California, United States|Pismo Beach, California, United States|San Diego, California, United States|Vista, California, United States|West Hills, California, United States|Boca Raton, Florida, United States|Boynton Beach, Florida, United States|Bradenton, Florida, United States|Clearwater, Florida, United States|Cocoa, Florida, United States|Doral, Florida, United States|Miami, Florida, United States|North Miami, Florida, United States|Pembroke Pines, Florida, United States|Port Orange, Florida, United States|Tampa, Florida, United States|West Palm Beach, Florida, United States|Atlanta, Georgia, United States|Savannah, Georgia, United States|Woodstock, Georgia, United States|Boise, Idaho, United States|Meridian, Idaho, United States|Apex Medical Research, MI, Inc, Chicago, Illinois, 60616, United States|Chicago, Illinois, United States|Avon, Indiana, United States|Greenfield, Indiana, United States|Muncie, Indiana, United States|Council Bluffs, Iowa, United States|Topeka, Kansas, United States|Owensboro, Kentucky, United States|Oxon Hill, Maryland, United States|Fall River, Massachusetts, United States|St. Louis, Missouri, United States|Washington, Missouri, United States|Omaha, Nebraska, United States|Nashua, New Hampshire, United States|Elizabeth, New Jersey, United States|Haddon Heights, New Jersey, United States|Albany, New York, United States|Rosedale, New York, United States|Calabash, North Carolina, United States|Charlotte, North Carolina, United States|Greensboro, North Carolina, United States|Morganton, North Carolina, United States|Winston-Salem, North Carolina, United States|Dayton, Ohio, United States|Maumee, Ohio, United States|Norman, Oklahoma, United States|Oklahoma City, Oklahoma, United States|Feasterville, Pennsylvania, United States|Harleysville, Pennsylvania, United States|Levittown, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Fort Mill, South Carolina, United States|Greer, South Carolina, United States|Spartanburg, South Carolina, United States|Crossville, Tennessee, United States|Knoxville, Tennessee, United States|Carrollton, Texas, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Irving, Texas, United States|Katy, Texas, United States|Lewisville, Texas, United States|McKinney, Texas, United States|New Braunfels, Texas, United States|Plano, Texas, United States|San Antonio, Texas, United States|Tomball, Texas, United States|Salt Lake City, Utah, United States|Burke, Virginia, United States|Manassas, Virginia, United States|Rosario, Santa Fe, Argentina|Ciudad Autonoma Buenos Aires, Argentina|Salta, Argentina|Lima, Peru"
NCT00136916,Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00136916,TERMINATED,Diabetes Mellitus,DRUG: Inhaled Insulin|DRUG: Subcutaneous insulin,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Phoenix, Arizona, 85016, United States|Pfizer Investigational Site, Tucson, Arizona, 85715, United States|Pfizer Investigational Site, Fresno, California, 93720, United States|Pfizer Investigational Site, Greenbrae, California, 94904, United States|Pfizer Investigational Site, Los Angeles, California, 90073, United States|Pfizer Investigational Site, Sacramento, California, 95816, United States|Pfizer Investigational Site, San Diego, California, 92103, United States|Pfizer Investigational Site, San Diego, California, 92108, United States|Pfizer Investigational Site, San Luis Obispo, California, 93401, United States|Pfizer Investigational Site, Tustin, California, 92780, United States|Pfizer Investigational Site, Walnut Creek, California, 94598, United States|Pfizer Investigational Site, Denver, Colorado, 80209, United States|Pfizer Investigational Site, Hamden, Connecticut, 06518, United States|Pfizer Investigational Site, Madison, Connecticut, 06443, United States|Pfizer Investigational Site, New Britain, Connecticut, 06050, United States|Pfizer Investigational Site, Waterbury, Connecticut, 06708, United States|Pfizer Investigational Site, Chiefland, Florida, 32626, United States|Pfizer Investigational Site, Clearwater, Florida, 33761, United States|Pfizer Investigational Site, Fort Myers, Florida, 33901, United States|Pfizer Investigational Site, Hollywood, Florida, 33021, United States|Pfizer Investigational Site, Miami, Florida, 33156, United States|Pfizer Investigational Site, Ocala, Florida, 34471, United States|Pfizer Investigational Site, Palm Harbor, Florida, 34684, United States|Pfizer Investigational Site, Tallahassee, Florida, 32308, United States|Pfizer Investigational Site, West Palm Beach, Florida, 33401, United States|Pfizer Investigational Site, Honolulu, Hawaii, 96813, United States|Pfizer Investigational Site, Honolulu, Hawaii, 96814, United States|Pfizer Investigational Site, Chicago, Illinois, 60602, United States|Pfizer Investigational Site, Chicago, Illinois, 60607, United States|Pfizer Investigational Site, Chicago, Illinois, 60610, United States|Pfizer Investigational Site, Springfield, Illinois, 62704, United States|Pfizer Investigational Site, Wilmette, Illinois, 60091, United States|Pfizer Investigational Site, New Orleans, Louisiana, 70112, United States|Pfizer Investigational Site, Bethesda, Maryland, 20817, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Ann Arbor, Michigan, 48106, United States|Pfizer Investigational Site, Bloomfield Hills, Michigan, 48302, United States|Pfizer Investigational Site, Plymouth, Michigan, 48170, United States|Pfizer Investigational Site, Royal Oak, Michigan, 48073, United States|Pfizer Investigational Site, Southfield, Michigan, 48034, United States|Pfizer Investigational Site, Chesterfield, Missouri, 63017, United States|Pfizer Investigational Site, St. Louis, Missouri, 63141, United States|Pfizer Investigational Site, Butte, Montana, 59701, United States|Pfizer Investigational Site, Lincoln, Nebraska, 68521, United States|Pfizer Investigational Site, Henderson, Nevada, 89014, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87108, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87109, United States|Pfizer Investigational Site, Mineola, New York, 11501, United States|Pfizer Investigational Site, New Hyde Park, New York, 11042, United States|Pfizer Investigational Site, Rochester, New York, 14609, United States|Pfizer Investigational Site, Durham, North Carolina, 27713, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 27103, United States|Pfizer Investigational Site, Mansfield, Ohio, 44903, United States|Pfizer Investigational Site, Tulsa, Oklahoma, 74104, United States|Pfizer Investigational Site, Warwick, Rhode Island, 02886, United States|Pfizer Investigational Site, Beaumont, Texas, 77701, United States|Pfizer Investigational Site, Beaumont, Texas, 77706, United States|Pfizer Investigational Site, Corpus Christi, Texas, 78411, United States|Pfizer Investigational Site, Corpus Christi, Texas, 78412, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75231, United States|Pfizer Investigational Site, Dallas, Texas, 75246, United States|Pfizer Investigational Site, Houston, Texas, 77079, United States|Pfizer Investigational Site, Irving, Texas, 75061, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Burlington, Vermont, 05401, United States|Pfizer Investigational Site, Richmond, Virginia, 23225, United States|Pfizer Investigational Site, Renton, Washington, 98055, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53209, United States|Pfizer Investigational Site, Porto Alegre, RS, 90035-170, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 01244-030, Brazil|Pfizer Investigational Site, Calgary, Alberta, T2T 5C7, Canada|Pfizer Investigational Site, Calgary, Alberta, T3B 0M3, Canada|Pfizer Investigational Site, Red Deer, Alberta, T4N 6V7, Canada|Pfizer Investigational Site, Victoria, British Columbia, V8R 1J8, Canada|Pfizer Investigational Site, Winnepeg, Manitoba, R3A 1R9, Canada|Pfizer Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, B3H 1V7, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, B3H 2Y9, Canada|Pfizer Investigational Site, London, Ontario, N6A 4V2, Canada|Pfizer Investigational Site, Ottawa, Ontario, K1H 1A2, Canada|Pfizer Investigational Site, Toronto, Ontario, M4N-3M5, Canada|Pfizer Investigational Site, Toronto, Ontario, M5G 1X5, Canada|Pfizer Investigational Site, Laval, Quebec, H7T 2P5, Canada|Pfizer Investigational Site, Montreal, Quebec, H1T 2M4, Canada|Pfizer Investigational Site, Montreal, Quebec, H3A 1A1, Canada|Pfizer Investigational Site, Saskatoon, Saskatchewan, S7N 0W8, Canada|Pfizer Investigational Site, Aguas Buenas, 00703, Puerto Rico|Pfizer Investigational Site, Anasco, 00610, Puerto Rico|Pfizer Investigational Site, Cabo Rojo, 00623, Puerto Rico|Pfizer Investigational Site, San Juan, 00909, Puerto Rico|Pfizer Investigational Site, San Juan, 00921, Puerto Rico"
NCT02806960,A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes,https://clinicaltrials.gov/study/NCT02806960,TERMINATED,"Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2",DRUG: Nasal Glucagon,Eli Lilly and Company,Locemia Solutions ULC,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mount-Royal, Quebec, H3P 3P1, Canada"
NCT00332826,Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma,https://clinicaltrials.gov/study/NCT00332826,TERMINATED,"Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Asthma",DRUG: Technosphere Insulin,Mannkind Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Arizona Research Center, Phoenix, Arizona, 85023, United States|Northwest Medical Center, Phoenix, Arizona, 85029, United States|Premiere Pharmaceutical Research LLC, Tempe, Arizona, 85282, United States|Canyon Internal Medicine, Tucson, Arizona, 85712, United States|Associated Pharmaceutical Research Center Inc, Buena Park, California, 90620, United States|Family Medical Center, Foothill Ranch, California, 92610, United States|Health Care Partners Medical Group, Long Beach, California, 90806, United States|Golden Pine Clinical Research, Long Beach, California, 90807, United States|Keck USC School of Medicine, Los Angeles, California, 90033, United States|Pinaccle Trials Inc (SMO), Atlanta, Georgia, 30329, United States|Executive Health and Research Associates Inc, Atlanta, Georgia, 30342, United States|Atlanta Pharmaceutical Research Center, Dunwoody, Georgia, 30338, United States|Southeastern Endocrine & Diabetes, Roswell, Georgia, 30076, United States|Cedar-Crosse Research Center, Chicago, Illinois, 60607, United States|Franklin Square Hospital, Baltimore, Maryland, 21237, United States|Healthcare Research, Florissant, Missouri, 63031, United States|MedEx Healthcare Research Inc(009), St Louis, Missouri, 63117, United States|Billings Clinic Research Division, Billings, Montana, 59101, United States|Your Doctors Care, Hillsborough, New Jersey, 08844, United States|Hopewell Valley Family Medicine PA, Trenton, New Jersey, 08618, United States|Eastside Comprehensive Medical Center, New York, New York, 10021, United States|Carolinas Research, Concord, North Carolina, 28025, United States|Cleveland Clinic Dept of Endocrinology, Cleveland, Ohio, 44195, United States|Diabetes & Glandular Disease Research Assoc PA, San Antonio, Texas, 78229, United States|McLennan County Medical Education and Research Foundation, Waco, Texas, 76707, United States|DIM (Clinica Privada), Buenos Aires, 1704, Argentina|Ins De Inv Cardiovascular La Plata, La Plata, Argentina|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, 90035-903, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, 90035-070, Brazil|Hospital Sao Lucas - PUCRS (Fritscher), Porto Alegre, 90610-000, Brazil|Hospital Nossa Senhora da Conceicao, Porto Alegre, 91350-200, Brazil|Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda, Rio de Janeiro, 22271-100, Brazil|CPClin-Centro de Pesquisas Clinicas, Sao Paulo, 01244-030, Brazil|Clinica de Endocrinologia, Sao Paulo, 01323-001, Brazil|Finchlea Medical Group, Brampton, Ontario, L6T 3J1, Canada|Courtice Health Centre, Courtice, Ontario, L1E 3C3, Canada|Parkwood Hospital, London, Ontario, N6C 5J1, Canada|The London Road Diagnostic Clinic and Medical Centre, Sarnia, Ontario, N7T 4X3, Canada|Albany Medical Center, Toronto, Ontario, M4K 1N5, Canada|Windsor Professional Research, Windsor, Ontario, N8X 3V6, Canada|Surgery of Diabetology, Melnik, CZE, 276 01, Czech Republic|Interni oddeleni nemocnice Na Homolce, Praha 5, CZE, 15031, Czech Republic|Diabetologicka Outpatient Surgery of Diabetology, Slany, CZE, 274 01, Czech Republic|InternÃ- a diabetologickÃ¡ Outpatient, Ostrava, 70900, Czech Republic|I InternÃ- klinika, Ostrava, 728 80, Czech Republic|Hospital Angeles Mocel, Mexico City, DF, 06726, Mexico|Mexican Institute of Clinical Research, Mexico City, MX, 06700, Mexico|Nuevo Sanatorio Durango, Delegacion Cuauhtemoc, 6700, Mexico|Hospital Angeles de las Lomas, Huixquilucan, 52760, Mexico|Klinika Endocrinologii Diabetologii I, Bialystock, POL, 15-276, Poland|NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny, Bialystok, POL, 15-435, Poland|Dzial Badan Klinicznych Malopoiskie, Krakow, POL, 30 510, Poland|III Oddzial Chorob Wewnetrznych Szpital, Krakow, POL, 31121, Poland|Oddzial Chorob Wewnetrznych Wojewodzki, Lodz, Zgierz, 95-100, Poland|Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego, Lodz, 90-153, Poland|NHI Kemerovo Regional Clinical Hospital, Kemerovo, RUS, 650061, Russian Federation|NI Principal Military Clinical Hospital n a academician N.N. Burdenko, Moscow, RUS, 105229, Russian Federation|Moscow State Medico-Stomatological University City Hospital # 23, Moscow, RUS, 109240, Russian Federation|Smolensk Medical Academy Smolensk Regional Clinical Hospital, Smolensk, RUS, 214018, Russian Federation|Central Medical Sanitary Unit #122, St Petersburg, RUS, 194291, Russian Federation|City Hospital # 2 Endocrinology Department, St. Petersburg, RUS, 194354, Russian Federation|Yaroslavl Municipal Health Care Institution Clinical Hospital for Emergency Care na NV Soloviev, Yaroslavl, RUS, 150003, Russian Federation|Federal State Institution Pulmonology Research Institute of Federal Agency of HC&SD, Moscow, 105077, Russian Federation|City Clinical Hospital #64 Center of Applied Clinical Paharmacology Friendship University, Moscow, 117 198, Russian Federation|Central Clinical Hospital of Russian Science Academy, Moscow, 117 593, Russian Federation|City Clinical Hospital # 61, Moscow, 119 048, Russian Federation|Russian Scientific Center of Restoration Medicine & Balneology, Moscow, 121069, Russian Federation|St Petersburg Medical Academy (Ilkovich), St Petersburg, Russian Federation|Hospital 2 de Maig, Barcelona, 30108025, Spain|Donetsk State Medical University, Donetsk, UKR, 83003, Ukraine|Donetsk State Medical University, Donetsk, UKR, 83009, Ukraine|Railway Clinical Hospital on Donetsk Station, Donetsk, UKR, 83114, Ukraine|Chair Family Med of National Med University, Kiev, UKR, 04050, Ukraine|Institute of Endocrinology and Metabolism, Kiev, UKR, 04114, Ukraine|Clinical Research Centre The Royal London Hospital, London, GBR, E1 2AT, United Kingdom|Northern General Hospital, Sheffield, GBR, S5 7AU, United Kingdom|Birmingham Heartland Hospital, West Midlands, GBR, B9 5SS, United Kingdom|Addenbrooke's Hospital Department of Medicine, Cambridge, CB2 2QQ, United Kingdom"
NCT04570111,MOD Diet in Gestational Diabetes Mellitus,https://clinicaltrials.gov/study/NCT04570111,TERMINATED,Gestational Diabetes,OTHER: MOD Diet|OTHER: Standard Care Diet,University of Kansas Medical Center,,FEMALE,ADULT,,INTERVENTIONAL,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States"
NCT01876992,Metformin at the Cellular Level and Dosing for Diabetes Mellitus (DM),https://clinicaltrials.gov/study/NCT01876992,TERMINATED,Diabetes|Pre-diabetes|Obesity,DRUG: Metformin,Johns Hopkins University,,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Johns Hopkins University, Baltimore, Maryland, 21287, United States"
NCT00155610,The Relationship Between Voiding Dysfunction and Intravesical Sensory Threshold in Diabetes Women,https://clinicaltrials.gov/study/NCT00155610,TERMINATED,Diabetes Mellitus,DEVICE: intravesical current perception test,National Taiwan University Hospital,,FEMALE,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT00361907,Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes,https://clinicaltrials.gov/study/NCT00361907,TERMINATED,Diabetes Mellitus,PROCEDURE: Effect of Pulsatile IV insulin on diabetic pt blood markers|PROCEDURE: Effect of Pulsatile IV Insulin on blood markers|PROCEDURE: Effect of Pulsatile IV insulin on diabetic pt blood markers,Florida Atlantic University,Advanced Diabetes Treatment Centers,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Florida Atlantic University Center for Complex Systems and Brain Sciences, Boca Raton, Florida, 33431, United States"
NCT03428945,Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT03428945,TERMINATED,Type1 Diabetes Mellitus,DRUG: Hydroxychloroquine|DRUG: Placebo,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),Juvenile Diabetes Research Foundation,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|University of California - San Francisco, San Francisco, California, 94143, United States|Stanford University, Stanford, California, 94305, United States|Barbara Davis Center, Aurora, Colorado, 80045, United States|Yale University School of Medicine, New Haven, Connecticut, 06519, United States|University of Florida, Gainesville, Florida, 32610, United States|University of Miami, Miami, Florida, 33136, United States|USF Diabetes Center, Tampa, Florida, 33612, United States|Emory Children's Center, Atlanta, Georgia, 30322, United States|St. Luke's Humphreys Diabetes Center, Boise, Idaho, 83702, United States|Rocky Mountain Clinical Research, Idaho Falls, Idaho, 83404, United States|University of Chicago, Chicago, Illinois, 60637, United States|Indiana University - Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|University of Iowa, Iowa City, Iowa, 52242, United States|University of Kentucky/UK Healthcare, Lexington, Kentucky, 40504, United States|University of Louisville Pediatric Endocrinology, Louisville, Kentucky, 40202, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|University of Michigan Health System, Ann Arbor, Michigan, 48109, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|The Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Palm Research Center, Inc., Las Vegas, Nevada, 89148, United States|UBMD Pediatrics, Buffalo, New York, 14203, United States|Columbia University, New York, New York, 10032, United States|Joslin Center at SUNY Upstate Medical University, Syracuse, New York, 13210, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|The University of Oklahoma, Oklahoma City, Oklahoma, 73104, United States|Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104-4399, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15224, United States|Endocrinology Specialist / Greenville Health System, Greenville, South Carolina, 29605, United States|GHS - Pediatric Endocrinology, Greenville, South Carolina, 29615, United States|Sanford Children's Specialty Clinic, Sioux Falls, South Dakota, 57105, United States|Vanderbilt Eskind Diabetes Clinic, Nashville, Tennessee, 37232, United States|University of Texas Southwestern, Dallas, Texas, 75390, United States|University of Utah, Salt Lake City, Utah, 84132, United States|University of Virginia Health System, Charlottesville, Virginia, 22908, United States|Benaroya Research Institute, Seattle, Washington, 98101, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Royal North Shore Hospital, St. Leonards, New South Wales, 2065, Australia|Women's and Children's Hospital, Adelaide, North Adelaide, South Australia, 5006, Australia|Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, 3052, Australia|Perth Children's Hospital, Perth, Western Australia, 6840, Australia|Children's Hospital of Eastern Ontario, Ottawa, Ontario, K1H8L1, Canada|The Hospital For Sick Kids, Toronto, Ontario, M5G-1X8, Canada|IWK Health Center, Halifax, NS B3K 6R8, Canada|San Raffaele Hospital, Milan, 20132, Italy|Skane University Hospital, Malmö, 20502, Sweden|Royal Devon and Exeter Hospital, Exeter, Devon, EX2 5DW, United Kingdom|Plymouth Diabetes Clinical Research Unit, Plymouth, Devon, PLG8BX, United Kingdom|Harrogate and District NHS Foundation Trust, Harrogate, North Yorkshire, HG2 7SX, United Kingdom|University of Bristol, Bristol, UK, BS10 5NB, United Kingdom|Nottingham University Hospitals, Nottingham, NG7 2UH, United Kingdom"
NCT02767596,Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog,https://clinicaltrials.gov/study/NCT02767596,TERMINATED,Diabetes Mellitus Type 2,DRUG: Lixisenatide|DRUG: Basal insulins,Laniado Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Bildirici Diabetes Center, Laniado Hospital, Netanya, 42150, Israel"
NCT02478762,Glycemic Objectives of Women With Gestational Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02478762,TERMINATED,Gestational Diabetes Mellitus,PROCEDURE: Normal glycemic control|PROCEDURE: Low glycemic control,Université de Sherbrooke,,FEMALE,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, J1H5N4, Canada"
NCT01792635,A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01792635,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: PF-05175157|DRUG: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Profil Institute for Clinical Research, Inc., Chula Vista, California, 91911, United States"
NCT01197963,A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2,https://clinicaltrials.gov/study/NCT01197963,TERMINATED,Type 2 Diabetes Mellitus,PROCEDURE: Sleeve Gastrectomy and Ileal transposition|DIETARY_SUPPLEMENT: dietary and medical management,"The University of Texas Health Science Center, Houston",,ALL,ADULT,,INTERVENTIONAL,"The University of Texas, Bellaire, Texas, 77494, United States"
NCT02382757,Changing Diabetes in Children,https://clinicaltrials.gov/study/NCT02382757,TERMINATED,"Diabetes|Diabetes Mellitus, Type 1",DRUG: insulin human,Novo Nordisk A/S,,ALL,"CHILD, ADULT",,OBSERVATIONAL,"Bangalore, 560001, India"
NCT00287066,A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition,https://clinicaltrials.gov/study/NCT00287066,TERMINATED,Diabetes Mellitus,DRUG: Inhaled Human Insulin|DRUG: Regular Human Insulin,Pfizer,,ALL,ADULT,PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Pittsburgh, Pennsylvania, United States"
NCT02044848,Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02044848,TERMINATED,Type 1 Diabetes Mellitus,DRUG: Secukinumab|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,ADULT,PHASE2,INTERVENTIONAL,"Novartis Investigative Site, New York City, New York, 10032, United States|Novartis Investigative Site, Seattle, Washington, 98122, United States"
NCT02786979,Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients,https://clinicaltrials.gov/study/NCT02786979,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Beraprost|DRUG: Aspirin,Astellas Pharma Inc,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Site CN00001, Beijing, Beijing, China|Site CN00002, Beijing, Beijing, China|Site CN00004, Guangzhou, Guangdong, China|Site CN00003, Shanghai, Shanghai, China|Site CN00005, Chengdu, Sichuan, China|Site CN00006, Tianjin, Tianjin, China"
NCT00203632,Glitazones and Endothelial Function (GATE),https://clinicaltrials.gov/study/NCT00203632,TERMINATED,Diabetes Mellitus,DRUG: rosiglitazone/placebo,University of Calgary,GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Foothills Medical Centre, Calgary, Alberta, T2N 2T9, Canada"
NCT05169034,Feasibility Study of Blood Glucose Monitoring With the Non-invasive Medical Device D-Base,https://clinicaltrials.gov/study/NCT05169034,TERMINATED,"Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2",,Diamontech AG,Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Baden-Württemberg, 89081, Germany"
NCT04169243,Randomized Controlled Trial Intervention With New Nordic DIet in Women With GestatiOnal Diabetes Mellitus: iNDIGO,https://clinicaltrials.gov/study/NCT04169243,TERMINATED,Gestational Diabetes Mellitus,BEHAVIORAL: New Nordic Diet|OTHER: Control,Göteborg University,Swedish Council for Working Life and Social Research,FEMALE,ADULT,,INTERVENTIONAL,"Antenatal care, Göteborg, S-41650, Sweden|Region Stockholm, Stockholm, Sweden|Region Västerbotten, Umeå, 90185, Sweden"
NCT02839031,Cognitive-Behavioral Therapy (CBT) in Children With Diabetes,https://clinicaltrials.gov/study/NCT02839031,TERMINATED,"Diabetes Mellitus, Type 1","BEHAVIORAL: ""CBT"" (Cognitive-Behavioral Therapy)|BEHAVIORAL: Control (telephonic support without CBT content)","University Hospital, Montpellier",,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Montpellier University Hospital, Montpellier, 34295, France"
NCT00437398,Islet Transplantation for Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00437398,TERMINATED,Type 1 Diabetes Mellitus,BIOLOGICAL: Islet Transplant,Mayo Clinic,National Center for Research Resources (NCRR),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Mayo Clinic, Rochester, Minnesota, 55905, United States"
NCT00430742,An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED),https://clinicaltrials.gov/study/NCT00430742,TERMINATED,Obesity Type 2 Diabetes Mellitus|Type 2 Diabetes Mellitus,DRUG: Taranabant|DRUG: Comparator: Placebo,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00689026,Efficacy of Lubiprostone in Combination With Standard PEG Preparation,https://clinicaltrials.gov/study/NCT00689026,TERMINATED,"Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2",DRUG: Lubiprostone|OTHER: Polyethylene glycol with electrolytes,Augusta University,"Takeda Pharmaceuticals North America, Inc.",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Medical College of Georgia, Augusta, Georgia, 30912, United States"
NCT01222078,Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01222078,TERMINATED,"Diabetes Mellitus, Type 1",BIOLOGICAL: otelixizumab,GlaxoSmithKline,,ALL,ADULT,PHASE2,INTERVENTIONAL,"GSK Investigational Site, Paris Cedex 18, 75877, France|GSK Investigational Site, Leipzig, Sachsen, 04103, Germany"
NCT02158078,A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02158078,TERMINATED,Type 2 Diabetes Mellitus,DEVICE: PaQ® Insulin Delivery Device,CeQur Corporation,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Medical University of Graz, Graz, A-8036, Austria"
NCT02750930,"Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects",https://clinicaltrials.gov/study/NCT02750930,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Albiglutide|DEVICE: Auto-injector,GlaxoSmithKline,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"GSK Investigational Site, Phoenix, Arizona, 85018, United States|GSK Investigational Site, Fresno, California, 93720, United States|GSK Investigational Site, Lomita, California, 90717, United States|GSK Investigational Site, Sacramento, California, 95831, United States|GSK Investigational Site, Spring Valley, California, 91978, United States|GSK Investigational Site, Tustin, California, 92780, United States|GSK Investigational Site, West Hills, California, 91307, United States|GSK Investigational Site, Littleton, Colorado, 80128, United States|GSK Investigational Site, Bradenton, Florida, 34201, United States|GSK Investigational Site, Clearwater, Florida, 33765, United States|GSK Investigational Site, Hallandale Beach, Florida, 33009, United States|GSK Investigational Site, Miami, Florida, 33156, United States|GSK Investigational Site, Miami, Florida, 33176, United States|GSK Investigational Site, Orlando, Florida, 32825, United States|GSK Investigational Site, Conyers, Georgia, 30094, United States|GSK Investigational Site, Evansville, Indiana, 47714, United States|GSK Investigational Site, Kalamazoo, Michigan, 49009, United States|GSK Investigational Site, Chesterfield, Missouri, 63017, United States|GSK Investigational Site, Columbia, North Carolina, 28150, United States|GSK Investigational Site, Columbus, Ohio, 43201, United States|GSK Investigational Site, Columbia, South Carolina, 29204, United States|GSK Investigational Site, Arlington, Texas, 76012, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Houston, Texas, 77036, United States|GSK Investigational Site, Houston, Texas, 77058, United States|GSK Investigational Site, Schertz, Texas, 782154, United States|GSK Investigational Site, Shavano Prk, Texas, 78231, United States"
NCT00228865,Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1,https://clinicaltrials.gov/study/NCT00228865,TERMINATED,Diabetes Mellitus,PROCEDURE: Pulsatile IV insulin therapy|PROCEDURE: Effects of Pulsatile IV Insulin on Cognitive functions,Florida Atlantic University,Advanced Diabetes Treatment Centers,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Florida Atlantic University, Boca Raton, Florida, 33431, United States"
NCT03118713,"A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria",https://clinicaltrials.gov/study/NCT03118713,TERMINATED,Type 2 Diabetes Mellitus,DRUG: metformin|DRUG: ipragliflozin|DRUG: glimepiride,"Astellas Pharma Korea, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Site 13, Busan, Korea, Republic of|Site 02, Deagu, Korea, Republic of|Site 11, Guri-si, Korea, Republic of|Site 01, Seoul, Korea, Republic of|Site 05, Seoul, Korea, Republic of|Site 07, Seoul, Korea, Republic of|Site 09, Seoul, Korea, Republic of|Site 12, Suwon-si, Korea, Republic of"
NCT02605564,Effects of Gluten Free Diet on Type 1 Diabetes Mellitus in Children,https://clinicaltrials.gov/study/NCT02605564,TERMINATED,Type 1 Diabetes Mellitus,OTHER: Gluten Free Diet|OTHER: Placebo,Loma Linda University,,ALL,CHILD,,INTERVENTIONAL,
NCT02549924,Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02549924,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Resveratrol|DRUG: Placebo,University of Guadalajara,,ALL,ADULT,PHASE2,INTERVENTIONAL,"Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, 44340, Mexico"
NCT02793154,An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects,https://clinicaltrials.gov/study/NCT02793154,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Exenatide|DRUG: Albiglutide,GlaxoSmithKline,Wake Forrest Baptist Health,ALL,ADULT,PHASE4,INTERVENTIONAL,"GSK Investigational Site, Louisville, Kentucky, 40213, United States|GSK Investigational Site, Dallas, Texas, 75230, United States"
NCT00554697,Diabetes Mellitus Type II and Tissue Oxygenation,https://clinicaltrials.gov/study/NCT00554697,TERMINATED,"Diabetes Mellitus, Type II",,The Cleveland Clinic,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT03332836,Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT03332836,TERMINATED,Type 2 Diabetes Mellitus,BIOLOGICAL: HM12460A,Hanmi Pharmaceutical Company Limited,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Hanmi Investigative Site, Chula Vista, California, 91911, United States"
NCT00242645,Computer-Assisted Cancer Risk Behavior Counseling,https://clinicaltrials.gov/study/NCT00242645,TERMINATED,Diabetes|Diabetes Mellitus|Hypertension,BEHAVIORAL: Health Information|BEHAVIORAL: Preventive Services|BEHAVIORAL: Computer tailored information,Thomas Jefferson University,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,
NCT01244646,Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.,https://clinicaltrials.gov/study/NCT01244646,TERMINATED,Diabetes Mellitus Type 2,,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Research Site, Alkmaar, Netherlands|Research Site, Den Haag, Netherlands|Research Site, Edam, Netherlands|Research Site, Gorinchem, Netherlands|Research Site, Heerhugowaard, Netherlands|Research Site, Heiloo, Netherlands|Research Site, Hoogvliet, Netherlands|Research Site, Lichtenvoorde, Netherlands|Research Site, Limmen, Netherlands|Research Site, Maasbracht, Netherlands|Research Site, Noord-Scharwoude, Netherlands|Research Site, Poortvliet, Netherlands|Research Site, Rotterdam, Netherlands|Research Site, Spijkenisse, Netherlands|Research Site, Tuitjenhorn, Netherlands|Research Site, Vaassen, Netherlands|Research Site, Valkenswaard, Netherlands|Research Site, Voerendaal, Netherlands|Research Site, Volendam, Netherlands|Research Site, Wamel, Netherlands|Research Site, Zuid-Scharwoude, Netherlands|Research Site, Zutphen, Netherlands"
NCT00451321,TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM),https://clinicaltrials.gov/study/NCT00451321,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: Otelixizumab,GlaxoSmithKline,Juvenile Diabetes Research Foundation,ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"GSK Investigational Site, Birmingham, Alabama, 35294, United States|GSK Investigational Site, Walnut Creek, California, 94598, United States|GSK Investigational Site, Aurora, Colorado, 80045, United States|GSK Investigational Site, Washington, D.C., District of Columbia, 20037, United States|GSK Investigational Site, Jacksonville, Florida, 32207, United States|GSK Investigational Site, Pinellas Park, Florida, 33781, United States|GSK Investigational Site, Chicago, Illinois, 60637, United States|GSK Investigational Site, Baltimore, Maryland, 21201, United States|GSK Investigational Site, Worcester, Massachusetts, 1655, United States|GSK Investigational Site, Kalamazoo, Michigan, 49048, United States|GSK Investigational Site, Minneapolis, Minnesota, 55455, United States|GSK Investigational Site, Gulfport, Mississippi, 39501, United States|GSK Investigational Site, Omaha, Nebraska, 68131, United States|GSK Investigational Site, Mentor, Ohio, 44060, United States|GSK Investigational Site, Rapid City, South Dakota, 57701, United States|GSK Investigational Site, San Antonio, Texas, 78229-4801, United States|GSK Investigational Site, Toronto, Ontario, M4G 3E8, Canada"
NCT02749435,A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02749435,TERMINATED,Type II Diabetes Mellitus,OTHER: Use of digital disease management tool in participants with T2DM,AstraZeneca,Parexel,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Research Site, Dundee, Angus, United Kingdom|Research Site, Cardiff, Cardiff [Caerdydd GB-CRD], United Kingdom|Research Site, Muirhead, Dundee City, United Kingdom|Research Site, Flintshire, Flintshire [Sir y Fflint GB-FF, United Kingdom|Research Site, London, Harrow, United Kingdom|Research Site, Manchester, Lancashire, United Kingdom|Research Site, Oldham, Manchester, United Kingdom|Research Site, Bonnyrigg, Midlothian, United Kingdom|Research Site, Edinburgh, Midlothian, United Kingdom|Research Site, Fife, United Kingdom|Research Site, Leicester, United Kingdom|Research Site, London, United Kingdom|Research Site, Mid Glamorgan, United Kingdom|Research Site, Stockport, United Kingdom"
NCT04007003,An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform,https://clinicaltrials.gov/study/NCT04007003,TERMINATED,"Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1",BEHAVIORAL: training in optimal insulin injection technique,"Becton, Dickinson and Company",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Universitair Ziekenhuis Antwerpen, Antwerpen, Belgium|Imeldaziekenhuis, Bonheiden, Belgium|Universitair Ziekenhuis Brussel, Brussel, Belgium|UZ Gent, Gent, Belgium|Virga Jesse Ziekenhuis, Hasselt, Belgium|AZ Groeninge, Kortrijk, Belgium|AZ Nikolaas, Sint-Niklaas, Belgium|AZ Turnhout, Turnhout, Belgium|AZ Jan Portaels, Vilvoorde, Belgium"
NCT05579977,Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity,https://clinicaltrials.gov/study/NCT05579977,TERMINATED,Diabetes Mellitus|Obesity,DRUG: PF-07081532|OTHER: Placebo|DRUG: Rybelsus,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Trinity Clinical Research, Centreville, Alabama, 35042, United States|Anaheim Clinical Trials, LLC, Anaheim, California, 92801, United States|San Fernando Valley Health Institute, Canoga Park, California, 91304, United States|Catalina Research Institute, LLC, Montclair, California, 91763, United States|Empire Clinical Research, Pomona, California, 91767, United States|University Clinical Investigators, Inc., Tustin, California, 92780, United States|Diablo Clinical Research, Inc., Walnut Creek, California, 94598, United States|Innovative Research of West Florida, Clearwater, Florida, 33756, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, 32216, United States|Adult Medicine of Lake County, Mount Dora, Florida, 32757, United States|Endocrine Research Solutions, Inc., Roswell, Georgia, 30076, United States|Cedar Crosse Research Center, Chicago, Illinois, 60607, United States|Evanston Premier Healthcare Research LLC, Skokie, Illinois, 60077, United States|Iowa Diabetes and Endocrinology Research Center, West Des Moines, Iowa, 50265, United States|Anderson Medical Research, Fort Washington, Maryland, 20744, United States|StudyMetrix Research, Saint Peters, Missouri, 63303, United States|Mercury Street Medical Group, PLLC, Butte, Montana, 59701, United States|Hassman Research Institute, Berlin, New Jersey, 08009, United States|Premier Research, Trenton, New Jersey, 08611, United States|Medication Management, Greensboro, North Carolina, 27405, United States|Meridian Clinical Research, LLC, Cincinnati, Ohio, 45219, United States|Alliance for Multispecialty Research, LLC, Norman, Oklahoma, 73069, United States|Heritage Valley Multispecialty Group, Inc, Beaver, Pennsylvania, 15009, United States|Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18), Pittsburgh, Pennsylvania, 15236, United States|Preferred Primary Care Physicians, Uniontown, Pennsylvania, 15401, United States|Velocity Clinical Research, Providence, East Greenwich, Rhode Island, 02818, United States|HealthStar Physicians, P.C., Morristown, Tennessee, 37813, United States|Healthstar Physicians, Morristown, Tennessee, 37813, United States|Elligo Clinical Research Center, Austin, Texas, 78738, United States|Velocity Clinical Research, Dallas, Dallas, Texas, 75230, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|Medical Colleagues of Texas, LLP, Katy, Texas, 77450, United States|Tapia Internal Medicine Clinic, Paris, Texas, 75462, United States|Northeast Clinical Research of San Antonio, San Antonio, Texas, 78233, United States|Consano Clinical Research, LLC, Shavano Park, Texas, 78231, United States|Sugar Lakes Family Practice, Sugar Land, Texas, 77479, United States|Chrysalis Clinical Research, Saint George, Utah, 84790, United States|Southwest Internal Medicine, Saint George, Utah, 84790, United States|Manassas Clinical Research Center, Manassas, Virginia, 20110, United States|Medical Centre ""Asklepiy"", Dupnitsa, Kyustendil, 2600, Bulgaria|Diagnostic Consultative Center Aleksandrovska, Sofia, Sofia (stolitsa), 1431, Bulgaria|MHAT Botevgrad, Botevgrad, Sofia, 2140, Bulgaria|Medical Center Zdrave 1, Kozloduy, Vratsa, 3320, Bulgaria|""Prevencia - 2000 - Medical Center for Prehospital Medical Care"" OOD, Stara Zagora, 6000, Bulgaria|Dr. M.B. Jones Inc., Victoria, British Columbia, V8V 4A1, Canada|G A Research Associates, Moncton, New Brunswick, E1G 1A7, Canada|Aggarwal and Associates Limited, Brampton, Ontario, L6T 0G1, Canada|Dawson Clinical Research, Guelph, Ontario, N1H 1B1, Canada|Milestone Research Inc., London, Ontario, N5W 6A2, Canada|Bluewater Clinical Research Group Inc., Sarnia, Ontario, N7T 4X3, Canada|LMC Clinical Research Inc. (Bayview), Toronto, Ontario, M4G 3E8, Canada|Manna Research Mirabel, Mirabel, Quebec, J7J 2K8, Canada|Diex Recherche Victoriavile Inc., Victoriaville, Quebec, G6P 6P6, Canada|Diex Recherche Quebec Inc., Quebec, G1V 4T3, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|MUDr. Alena Vachova, Ceske Budejovice, Jihočeský KRAJ, 37011, Czechia|EDUMED s.r.o., Broumov, Kralovehradecky KRAY, 550 01, Czechia|Kardiologicka a Angiologicka Ambulance, Ostrava, Ostrava Město, 700 30, Czechia|Clinical Trials Service s.r.o., Uherské Hradiště, Zlínský KRAJ, 686 01, Czechia|Agentura Science Pro, Olomouc, 779 00, Czechia|Private Practice - Dr. Tomáš Brychta, Olomouc, 779 00, Czechia|EUC Klinika Praha, Prague, 150 00, Czechia|Clinical Trials Service s.r.o., Uherske Hradiste, Czechia|Belinus Orvosi és Számitástechnikai Bt, Debrecen, Hajdú-bihar, 4025, Hungary|Borbánya Praxis, Nyíregyháza, Borbánya, Szabolcs-szatmár-bereg, 4405, Hungary|CLINFAN Szolgáltató Kft, Szekszárd, Tolna, 7100, Hungary|DRC Gyógyszervizsgáló Központ, Balatonfüred, Veszprém, 8230, Hungary|ClinDiab Kft., Budapest, 1089, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 04032, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 4032, Hungary|Nakakinen clinic, Naka, Ibaraki, 311-0113, Japan|Yokohama Minoru Clinic, Yokohama, Kanagawa, 232-0064, Japan|Shiraiwa Medical Clinic, Kashiwara, Osaka, 582-0005, Japan|Medical Corporation Heishinkai OCROM Clinic, Suita-shi, Osaka, 565-0853, Japan|Seiwa Clinic, Adachi-ku, Tokyo, 120-0011, Japan|Seiwa Clinic, Adachi-ku, Tokyo, 123-0845, Japan|Tokyo-Eki Center-building Clinic, Chuo-ku, Tokyo, 103-0027, Japan|Medical Corporation Chiseikai Tokyo Center Clinic, Chuo-ku, Tokyo, 103-0028, Japan|Fukuwa Clinic, Chuo-ku, Tokyo, 104-0031, Japan|Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku, Tokyo, 160-0008, Japan|Yokohama Minoru Clinic, Yokohama, 232-0064, Japan|KO-MED Centra Kliniczne Pulawy, Pulawy, Lubelskie, 24-100, Poland|Oświęcimskie Centrum Badań Klinicznych, Oświęcim, Małopolskie, 32-600, Poland|Zdrowie Osteo-Medic, Bialystok, Podlaskie, 15-351, Poland|Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk, Pomorskie, 80-546, Poland|Centrum Zdrowia Metabolicznego Pawel Bogdanski, Poznan, 60-589, Poland|Gabinet Lekarski Małgorzata Jadwiga Saryusz-Wolska, Łódź, 90-132, Poland|NZOZ Przychodnia Specjalistyczna Andrzej Wittek, Henryk Rudzki, Ruda Slaska, Śląskie, 41-709, Poland|Latin Clinical Trial Center, San Juan, 00909, Puerto Rico|GCM Medical Group, PSC - Hato Rey Site, San Juan, 00917, Puerto Rico"
NCT03001323,Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis,https://clinicaltrials.gov/study/NCT03001323,TERMINATED,Diabetes Mellitus,DRUG: Degludec|DRUG: Standard long-acting,Hennepin Healthcare Research Institute,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States"
NCT01201928,"Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166",https://clinicaltrials.gov/study/NCT01201928,TERMINATED,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,DRUG: Comparator administered in parent trial|DRUG: Technosphere Insulin Inhalation Powder,Mannkind Corporation,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Valley Research, Fresno, California, 93720, United States|Health Care Partners Medical Group, Long Beach, California, 90806, United States|Laureate Clinical Research Group, Atlanta, Georgia, 30308, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|Alta Pharmaceutical Research Center, Dunwoody, Georgia, 30338, United States|LaPorte County Institute for Clinical Research Inc., Michigan City, Indiana, 46360, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|Billings Clinic Research Center, Billings, Montana, 59101, United States|Winthrop University Hospital, Mineola, New York, 11501, United States|North Shore Diabetes and Endocrine Associates, New Hyde Park, New York, 11042, United States|Endocrine Research Physicians East PA, Greenville, North Carolina, 27834, United States|Israel Hartman MD, Arlington, Texas, 76014, United States|Dallas Diabetes & Endocrine Center, Dallas, Texas, 75230, United States|SAM Clinical Research Center, San Antonio, Texas, 78229, United States"
NCT04155996,Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT04155996,TERMINATED,Type2 Diabetes,DEVICE: data collection,ValoTec,APHP,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"GH Pitié Salpêtrière Charles Foix, Paris, Ile De France, 75013, France"
NCT03651531,Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus,https://clinicaltrials.gov/study/NCT03651531,TERMINATED,Gestational Diabetes,DRUG: Insulin|DRUG: Metformin,Women and Infants Hospital of Rhode Island,,FEMALE,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Women & Infants Hospital, Providence, Rhode Island, 02905, United States"
NCT01826370,Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01826370,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Linagliptin,Boehringer Ingelheim,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Boehringer Ingelheim Investigational Site 43, Agoo, La Union, Philippines|Boehringer Ingelheim Investigational Site 40, Angeles City, Pampanga, Philippines|Boehringer Ingelheim Investigational Site 31, Angono, Rizal, Philippines|Boehringer Ingelheim Investigational Site 32, Antipolo, Rizal, Philippines|Boehringer Ingelheim Investigational Site 27, Aparri, Cagayan, Philippines|Boehringer Ingelheim Investigational Site 4, Batangas, Philippines|Boehringer Ingelheim Investigational Site 48, Butuan City, Agusan del Norte, Philippines|Boehringer Ingelheim Investigational Site 12, Cabanatuan, Nueva Ecija, Philippines|Boehringer Ingelheim Investigational Site 23, Cagayan de Oro, Philippines|Boehringer Ingelheim Investigational Site 3, Caloocan, Philippines|Boehringer Ingelheim Investigational Site 42, Cardona, Rizal, Philippines|Boehringer Ingelheim Investigational Site 25, Cebu, Philippines|Boehringer Ingelheim Investigational Site 44, Dagupan, Pangasinan, Philippines|Boehringer Ingelheim Investigational Site 49, Iligan City, Lanao del Norte, Philippines|Boehringer Ingelheim Investigational Site 2, Iloilo, Philippines|Boehringer Ingelheim Investigational Site 45, Iriga City, Camarines Sur, Philippines|Boehringer Ingelheim Investigational Site 20, Laoag, Ilocos Norte, Philippines|Boehringer Ingelheim Investigational Site 24, Las Pinas, Philippines|Boehringer Ingelheim Investigational Site 7, Legazpi, Albay, Philippines|Boehringer Ingelheim Investigational Site 35, Lucena, Quezon, Philippines|Boehringer Ingelheim Investigational Site 1, Makati, Philippines|Boehringer Ingelheim Investigational Site 39, Malolos, Bulacan, Philippines|Boehringer Ingelheim Investigational Site 37, Mandaluyong City, Philippines|Boehringer Ingelheim Investigational Site 28, Manila, Philippines|Boehringer Ingelheim Investigational Site 5, Marikina, Philippines|Boehringer Ingelheim Investigational Site 16, Meycauyan, Bulacan, Philippines|Boehringer Ingelheim Investigational Site 47, Naga City, Camarines Sur, Philippines|Boehringer Ingelheim Investigational Site 15, Olongapo, Philippines|Boehringer Ingelheim Investigational Site 10, Pampanga, Philippines|Boehringer Ingelheim Investigational Site 19, Paranaque, Philippines|Boehringer Ingelheim Investigational Site 51, Pasay City, Philippines|Boehringer Ingelheim Investigational Site 30, Pasig, Philippines|Boehringer Ingelheim Investigational Site 34, Puerto Princesa, Palawan, Philippines|Boehringer Ingelheim Investigational Site 26, Quezon City, Philippines|Boehringer Ingelheim Investigational Site 11, Rosales, Pangasinan, Philippines|Boehringer Ingelheim Investigational Site 21, San Fernando, La Union, Philippines|Boehringer Ingelheim Investigational Site 9, San Fernando, Pampanga, Philippines|Boehringer Ingelheim Investigational Site 13, San Jose, Nueva Ecija, Philippines|Boehringer Ingelheim Investigational Site 29, San Juan, Philippines|Boehringer Ingelheim Investigational Site 8, San Pablo, Laguna, Philippines|Boehringer Ingelheim Investigational Site 50, San Pedro, Laguna, Philippines|Boehringer Ingelheim Investigational Site 41, Santiago city, Isabela, Philippines|Boehringer Ingelheim Investigational Site 36, Sogod, Southern Leyte, Philippines|Boehringer Ingelheim Investigational Site 38, Sta.Maria, Bulacan, Philippines|Boehringer Ingelheim Investigational Site 6, Tacloban, Philippines|Boehringer Ingelheim Investigational Site 33, Tagbilaran, Bohol, Philippines|Boehringer Ingelheim Investigational Site 14, Tuguegarao, Cagayan, Philippines|Boehringer Ingelheim Investigational Site 18, Urdaneta, Pangasinan, Philippines|Boehringer Ingelheim Investigational Site 46, Valencia City Bukidnon, Philippines|Boehringer Ingelheim Investigational Site 17, Valenzuela, Bulacan, Philippines|Boehringer Ingelheim Investigational Site 22, Zamboanga, Philippines"
NCT05088616,Native American Diabetes Project,https://clinicaltrials.gov/study/NCT05088616,TERMINATED,"Diabetes|Diabete Type 2|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Diabetes Type 1|Diabetes Mellitus",BEHAVIORAL: Virtual Diabetes Wellness Classes and Medically Tailored Meals,University of Southern California,"Project Angel Food|United American Indian Involvement, Inc.",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Southern California, Los Angeles, California, 90032, United States"
NCT03278704,Concurrent Training in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT03278704,TERMINATED,Type 2 Diabetes Mellitus,OTHER: RE only|OTHER: RE + HIIT,University of Birmingham,"Loughborough University|Metabolic Fitness Association, Italy|Università degli studi di Roma Foro Italico",MALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, United Kingdom"
NCT02072096,A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM),https://clinicaltrials.gov/study/NCT02072096,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Glimepiride|DRUG: Metformin|DRUG: Pioglitazone|DRUG: Acarbose|DRUG: Linagliptin|DRUG: Sitagliptin|DRUG: Liraglutide|DRUG: Insulin Glargine|DRUG: Exenatide once weekly (QW)|DRUG: Exenatide twice daily (BID),Eli Lilly and Company,,ALL,OLDER_ADULT,PHASE4,INTERVENTIONAL,"Suncoast Research Group, LLC, Miami, Florida, 33135, United States|New Horizon Research Center, Miami, Florida, 33175, United States|Suncoast Clinical Research, New Port Richey, Florida, 34652, United States|Florida Hospital, Orlando, Florida, 32804, United States|Athens Primary Care, Athens, Georgia, 30606, United States|Herman Clinical Research, LLC, Suwanee, Georgia, 30024, United States|Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, 83404, United States|Iderc, P.L.C., Des Moines, Iowa, 50314, United States|Cotton O'Neil Clinic, Topeka, Kansas, 66606, United States|Mercy Health Research, Saint Louis, Missouri, 63141, United States|Southern New Hampshire Diabetes and Endocrinology, Nashua, New Hampshire, 03063, United States|Heritage Valley Medical Group, Inc., Beaver, Pennsylvania, 15009, United States|Family Medical Associates, Levittown, Pennsylvania, 19056, United States|Carolina Health Specialists, Myrtle Beach, South Carolina, 29572, United States|Dallas Diabetes Endocrine Center, Dallas, Texas, 75230, United States|Rockwood Clinic Research Center, Spokane, Washington, 99202, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Saint Stefan Ob Stainz, A-8511, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Salzburg, 5026, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Vienna, A-1060, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Wien, A 1210, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Berlin, 10409, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dortmund, 44137, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hamburg, 22607, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mainz, 55116, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Münster, 48145, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Neuwied, 56564, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Stuttgart, 70378, Germany|Manati Medical Center, Manati, 00674, Puerto Rico|American Telemedicine Center, San Juan, 00917-3104, Puerto Rico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Salford, Manchester, M6 8HD, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dundee, Scotland, DD1 9SY, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sheffield, South Yorkshire, S5 7AU, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ipswich, Suffolk, IP4 5PD, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Manchester, M41 5SL, United Kingdom"
NCT02111096,A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02111096,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: LY2409021|DRUG: Sitagliptin|DRUG: Placebo|DRUG: Metformin|DRUG: Sulfonylurea,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"John Muir Health Network - The Osteoporosis Center, Concord, California, 94520, United States|Valley Endocrine, Fresno, Fresno, California, 93720, United States|National Research Institute, Los Angeles, California, 90057, United States|Suncoast Research Group, LLC, Miami, Florida, 33135, United States|New Horizon Research Center, Miami, Florida, 33175, United States|Clinical Research of West Florida, Inc., Tampa, Florida, 33603, United States|University of Hawaii, Honolulu, Hawaii, 96813, United States|East West Medical Institute, Honolulu, Hawaii, 96814, United States|Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, 83404, United States|Cedar-Crosse Research Center, Chicago, Illinois, 60607, United States|Midwest CRC, Crystal Lake, Illinois, 60012, United States|Iderc, P.L.C., Des Moines, Iowa, 50314, United States|Cotton O'Neil Clinic, Topeka, Kansas, 66606, United States|Centex Studies, Inc, Lake Charles, Louisiana, 70601, United States|Cosmopolitan International Diabetes Center, Columbia, Missouri, 65212, United States|Mercy Medical Research Institute, Springfield, Missouri, 65807, United States|Palm Research Center, Las Vegas, Nevada, 89148, United States|SHS Clinical Research Group, Toms River, New Jersey, 08753, United States|Office:Alwine,Lk, Downingtown, Pennsylvania, 19335, United States|University Diabetes and Endocrine Consultants, Chattanooga, Tennessee, 37411, United States|Dallas Diabetes Endocrine Center, Dallas, Texas, 75230, United States|Galenos Research, Dallas, Texas, 75251, United States|San Gabriel Clinical Research, Georgetown, Texas, 78626, United States|Oakwell Clinical Research, San Antonio, Texas, 78218, United States|Victorium Clinical Research, San Antonio, Texas, 78240, United States|Polyclinic, Seattle, Washington, 98104, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Athens, 11527, Greece|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Thessaloniki, 54636, Greece|PRADNET, Inc. Centro Especializado de Nutricion y Bariatria, Hato Rey, 00917, Puerto Rico|American Telemedicine Center, San Juan, 00917-3104, Puerto Rico|GCM Medical Group PSC, San Juan, 909, Puerto Rico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Changhua, 500, Taiwan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Yong Kung City, 71004, Taiwan"
NCT02093221,Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02093221,TERMINATED,Type 1 Diabetes Mellitus,BIOLOGICAL: 180 mg/kg Alpha1-PI|BIOLOGICAL: 90 mg/kg Alpha1-PI|BIOLOGICAL: Placebo,Grifols Therapeutics LLC,,ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"University of Arizona, Tucson, Arizona, 85724, United States|Clinica Medica San Miguel, Los Angeles, California, 90015, United States|Diabetes Associates Medical Group, Orange, California, 92868, United States|Rady Children's Hospital San Diego, San Diego, California, 92123, United States|Metabolic Institute of America, Tarzana, California, 91356, United States|Ronald H Chochinov MD, Ventura, California, 93003, United States|Yale New Haven Hospital, New Haven, Connecticut, 06511, United States|Christiana Care Health Services, Newark, Delaware, 19713, United States|Solutions Through Advanced Research Inc., Jacksonville, Florida, 32258, United States|CCM Clinical Research, Miami, Florida, 33133, United States|Advanced Pharma CR LLC, Miami, Florida, 33136, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, 83404, United States|Cook County Hospital, Chicago, Illinois, 60612, United States|Methodist Research Institute, Indianapolis, Indiana, 46202, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Barry J. Reiner MD, LLC., Baltimore, Maryland, 21229, United States|UMass Memorial Medical Center, Worcester, Massachusetts, 01655, United States|Wayne State University, Detroit, Michigan, 48201, United States|Children's Hospitals and Clinics of Minnesota, Saint Paul, Minnesota, 55102, United States|Morristown Medical Center, Morristown, New Jersey, 07962, United States|University of New Mexico, Health Sciences Center, Albuquerque, New Mexico, 87131-0001, United States|Women and Children's Hospital, Buffalo, New York, 14222, United States|WakeMed Children's Hospital, Raleigh, North Carolina, 27610, United States|Endocrinology Associates Inc, Columbus, Ohio, 43201, United States|Ohio State University, Columbus, Ohio, 43210, United States|Pediatric Endocrinology, Genetics & Metabolism, Oklahoma City, Oklahoma, 73112, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19106, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15224, United States|Rapid City Regional Hospital/Health Clinical Research, Rapid City, South Dakota, 57701, United States|Research Institute of Dallas, Dallas, Texas, 75231, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Northeast Clinical Research of San Antonio LLC, San Antonio, Texas, 78154, United States|University of Texas Health Science Center, San Antonio, Texas, 78229, United States|Consano Clinical Research, San Antonio, Texas, 78232, United States"
NCT00747006,Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake,https://clinicaltrials.gov/study/NCT00747006,TERMINATED,"Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1",DRUG: TI Inhalation Powder and Humalog (Amendment 1)|DRUG: TI Inhalation Powder (original protocol),Mannkind Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Sansum Medical Research Institute, Santa Barbara, California, 93105, United States"
NCT01206101,Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation,https://clinicaltrials.gov/study/NCT01206101,TERMINATED,"Diabetes|Diabetes Mellitus, Type 1",DRUG: liraglutide|DRUG: placebo,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Novo Nordisk Investigational Site, Duarte, California, 91010, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60612, United States|Novo Nordisk Investigational Site, Boston, Massachusetts, 02114, United States|Novo Nordisk Investigational Site, Madison, Wisconsin, 53792-0001, United States|Novo Nordisk Investigational Site, Edmonton, Alberta, T6G 2C8, Canada|Novo Nordisk Investigational Site, Vancouver, British Columbia, V5Z 1M9, Canada|Novo Nordisk Investigational Site, Besancon, 25030, France|Novo Nordisk Investigational Site, Grenoble, 38043, France|Novo Nordisk Investigational Site, Lille, 59037, France|Novo Nordisk Investigational Site, MONTPELLIER cedex 5, 34295, France|Novo Nordisk Investigational Site, Strasbourg, 67091, France|Novo Nordisk Investigational Site, Dresden, 01307, Germany|Novo Nordisk Investigational Site, Genève 14, 1211, Switzerland|Novo Nordisk Investigational Site, Zürich, 8091, Switzerland|Novo Nordisk Investigational Site, Headington, OX3 7LE, United Kingdom|Novo Nordisk Investigational Site, London, SE5 9RS, United Kingdom"
NCT01286090,An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01286090,TERMINATED,Gastroparesis|Diabetes Mellitus,DRUG: Cisapride|DRUG: Placebo,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT02889172,Intervention for Reducing Psychiatric Symptoms and Metabolic Variables in Patients With Diabetes Mellitus (DM),https://clinicaltrials.gov/study/NCT02889172,TERMINATED,"Diabetes Mellitus, Type 2",BEHAVIORAL: Problem Solving Therapy,Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente,Universidad Nacional Autonoma de Mexico,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente, Mexico city, 14370, Mexico"
NCT01467414,A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01467414,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: insulin degludec,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Neuss, 41460, Germany"
NCT01183468,A Research Trial of Aralast in New Onset Diabetes (RETAIN),https://clinicaltrials.gov/study/NCT01183468,TERMINATED,"Diabetes Mellitus, Type 1",BIOLOGICAL: Aralast NP 45 mg dose|BIOLOGICAL: Aralast NP 90 mg dose|BIOLOGICAL: Aralast NP 180 mg dose,National Institute of Allergy and Infectious Diseases (NIAID),Immune Tolerance Network (ITN)|Juvenile Diabetes Research Foundation,ALL,"CHILD, ADULT",PHASE1,INTERVENTIONAL,"RADY Children's Hospital (University of California, San Diego), San Diego, California, 92093, United States|Barbara Davis Center (University of Colorado), Aurora, Colorado, 80045, United States|Yale University, New Haven, Connecticut, 06520, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|Children's Hospital of Atlanta (Emory University), Atlanta, Georgia, 30322, United States|University of Iowa Children's Hospital, Iowa City, Iowa, 52242, United States|University of Maryland Medical Center, Baltimore, Maryland, 21201, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, 01655, United States|Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Naomi Berrie Diabetes Center (Columbia University), New York, New York, 10032, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Pacific Northwest Research Institute-University of Washington, Seattle, Washington, 98122, United States"
NCT04769765,Feasability of a Care Pathway Integrating Collaborative Tele-expertise to Prevent Recurring Hospitalisations for Diabetic Patients,https://clinicaltrials.gov/study/NCT04769765,TERMINATED,Diabetes Mellitus,OTHER: Definition of the Individualized Care Pathway,Centre Hospitalier Universitaire de Nīmes,"University Hospital, Montpellier|Alès Hospital|Bagnols sur Cèze Hospital|Sète Hospital|Narbonne Hospital|Béziers Hospital|Perpignan Hospital",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Centre Hospitalier d'Alès, Alès, 30100, France|CH de Bagnols sur Cèze, Bagnols-sur-Cèze, France|CH de Beziers, Béziers, 34525, France|Centre Hospitalier Universitaire de Montpellier, Montpellier, France|CH de Narbonne HÔTEL DIEU, Narbonne cedex, 11108, France|Centre Hospitalier Saint Jean, Perpignan, 66000, France|Hopital St Clair Hbt Sete, Sète, 34207, France"
NCT04871958,"Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward",https://clinicaltrials.gov/study/NCT04871958,TERMINATED,Diabetes Mellitus|Covid19,"DEVICE: Continuous glucose monitoring (CGM, Dexcom G6)",Federico II University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Federico II University Hospital, Naples, 80131, Italy"
NCT01101945,Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01101945,TERMINATED,Type 2 Diabetes Mellitus,DRUG: dutogliptin,Phenomix,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Fullerton, California, United States|Long Beach, California, United States|Orange, California, United States|San Diego, California, United States|Kissimmee, Florida, United States|Melbourne, Florida, United States|New Port Richey, Florida, United States|Gurnee, Illinois, United States|Wichita, Kansas, United States|Kansas City, Missouri, United States|Henderson, Nevada, United States|Las Vegas, Nevada, United States|Berlin, New Jersey, United States|Margate City, New Jersey, United States|Trenton, New Jersey, United States|Charlotte, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnati, Ohio, United States|Oklahoma City, Oklahoma, United States|Medford, Oregon, United States|Warminster, Pennsylvania, United States|Columbia, South Carolina, United States|Greer, South Carolina, United States|Dallas, Texas, United States|San Antonio, Texas, United States|Salt Lake City, Utah, United States|Norfolk, Virginia, United States|Cuidad Autonoma de Buenos Aires, Buenos Aires, Argentina|La Plata, Buenos Aires, Argentina|Lanus Este, Buenos Aires, Argentina|Moron, Buenos Aires, Argentina|Quilmes, Buenos Aires, Argentina|Corrientes, Argentina|Calgary, Alberta, Canada|Red Deer, Alberta, Canada|Mount Pearl, Newfoundland and Labrador, Canada|St. John's, Newfoundland and Labrador, Canada|Etobicoke, Ontario, Canada|London, Ontario, Canada|Samia, Ontario, Canada|Toronto, Ontario, Canada|Cornwall, Prince Edward Island, Canada|Mirabel, Quebec, Canada|Montreal, Quebec, Canada|Ellisbridge, Ahmedabad, India|Banjara Hills, Hyderabad, India|Punjagutta, Hyderabad, India|Pune, Maharashtra, India|Tardeo, Mumbai, India|Dhantoli, Nagpur, India|Chennai, Tamilnadu, India|Mexico City, Distrito Federal, Mexico|Guadalajara, Jalisco, Mexico|Morelia, Michoacan, Mexico|Monterrey N. L., Nuevo Leon, Mexico"
NCT02370719,Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02370719,TERMINATED,Type 2 Diabetes Mellitus,BEHAVIORAL: Mobile application for diabetes self-management,"University Health Network, Toronto",MOUNT SINAI HOSPITAL|University of Toronto|Canadian Institutes of Health Research (CIHR),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Mount Sinai Hospital, Toronto, Ontario, M5T3L9, Canada"
NCT02862431,"Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM)",https://clinicaltrials.gov/study/NCT02862431,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: JNJ-64565111|DRUG: Placebo,"Janssen Research & Development, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Neuss, Germany"
NCT01189422,Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT01189422,TERMINATED,Type 1 Diabetes Mellitus,DRUG: teplizumab or placebo,MacroGenics,Eli Lilly and Company,ALL,ADULT,PHASE1,INTERVENTIONAL,
NCT03684642,Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin,https://clinicaltrials.gov/study/NCT03684642,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Efpeglenatide|DRUG: Dulaglutide|DRUG: Background therapy Metformin,Sanofi,Hanmi Pharmaceutical Company Limited,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8400038, Birmingham, Alabama, 35211, United States|Investigational Site Number 8400035, Chandler, Arizona, 85224, United States|Investigational Site Number 8400005, Glendale, Arizona, 85306, United States|Investigational Site Number 8400054, Peoria, Arizona, 85381, United States|Investigational Site Number 8400057, Huntington Park, California, 90255, United States|Investigational Site Number 8400009, Los Angeles, California, 90057, United States|Investigational Site Number 8400007, San Diego, California, 92120, United States|Investigational Site Number 8400045, Spring Valley, California, 91978, United States|Investigational Site Number 8400040, Tustin, California, 92780, United States|Investigational Site Number 8400026, Van Nuys, California, 91405, United States|Investigational Site Number 8400050, Waterbury, Connecticut, 06708, United States|Investigational Site Number 8400055, Orlando, Florida, 32825, United States|Investigational Site Number 8400041, Pembroke Pines, Florida, 33026, United States|Investigational Site Number 8400025, Lawrenceville, Georgia, 30044, United States|Investigational Site Number 8400060, Meridian, Idaho, 83642, United States|Investigational Site Number 8400059, Skokie, Illinois, 60077, United States|Investigational Site Number 8400044, Lexington, Kentucky, 40503, United States|Investigational Site Number 8400061, Boston, Massachusetts, 02115, United States|Investigational Site Number 8400001, Bridgeton, New Jersey, 08302, United States|Investigational Site Number 8400039, New Windsor, New York, 12553, United States|Investigational Site Number 8400028, Burlington, North Carolina, 27215, United States|Investigational Site Number 8400036, Morehead City, North Carolina, 28557, United States|Investigational Site Number 8400013, Maumee, Ohio, 43537, United States|Investigational Site Number 8400014, Goose Creek, South Carolina, 29445, United States|Investigational Site Number 8400030, Dallas, Texas, 75230, United States|Investigational Site Number 8400020, San Antonio, Texas, 78218, United States|Investigational Site Number 8400043, San Antonio, Texas, 78229, United States|Investigational Site Number 8400053, San Antonio, Texas, 78258, United States|Investigational Site Number 8400037, Layton, Utah, 84041, United States|Investigational Site Number 8400049, Manassas, Virginia, 20110, United States|Investigational Site Number 3480004, Budapest, 1036, Hungary|Investigational Site Number 3480003, Debrecen, 4025, Hungary|Investigational Site Number 3480001, Gyula, 5700, Hungary|Investigational Site Number 3480005, Hatvan, 3000, Hungary|Investigational Site Number 3480002, Nyíregyháza, 4400, Hungary|Investigational Site Number 6160008, Gdansk, 80-382, Poland|Investigational Site Number 6160004, Gdynia, 81-537, Poland|Investigational Site Number 6160010, Katowice, 40-040, Poland|Investigational Site Number 6160009, Poznan, 60-702, Poland|Investigational Site Number 6160003, Warszawa, 01-192, Poland|Investigational Site Number 6160001, Wroclaw, 50-381, Poland|Investigational Site Number 8040003, Kyiv, 02002, Ukraine|Investigational Site Number 8040001, Kyiv, 03037, Ukraine|Investigational Site Number 8040002, Kyiv, 03049, Ukraine|Investigational Site Number 8040004, Vinnytsia, 21050, Ukraine"
NCT00998686,Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin,https://clinicaltrials.gov/study/NCT00998686,TERMINATED,Type 2 Diabetes Mellitus,DRUG: dutogliptin|DRUG: sitagliptin,Phenomix,Forest Laboratories,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Phenomix Investigational Site 105, Montgomery, Alabama, United States|Phenomix Investigational Site 121, Tempe, Arizona, United States|Phenomix Investigational Site 137, Tempe, Arizona, United States|Phenomix Investigational Site 105, Anaheim, California, United States|Phenomix Investigational Site 103, Long Beach, California, United States|Phenomix Investigational Site 106, Los Angeles, California, United States|Phenomix Investigational Site 143, Coral Gables, Florida, United States|Phenomix Investigational Site 142, Hialeah, Florida, United States|Phenomix Investigational Site 133, Kissimmee, Florida, United States|Phenomix Investigational Site 101, Honolulu, Hawaii, United States|Phenomix Investigational Site 135, Chicago, Illinois, United States|Phenomix Investigational Site 124, Indianapolis, Indiana, United States|Phenomix Investigational Site 136, Brockton, Massachusetts, United States|Phenomix Investigational Site 138, Biloxi, Mississippi, United States|Phenomix Investigational Site 122, Las Vegas, Nevada, United States|Phenomix Investigational Site 140, Las Vegas, Nevada, United States|Phenomix Investigational Site 110, Trenton, New Jersey, United States|Phenomix Investigational Site 116, Albuquerque, New Mexico, United States|Phenomix Investigational Site 107, Winston-Salem, North Carolina, United States|Phenomix Investigational Site 112, Greenville, South Carolina, United States|Phenomix Investigational Site 102, Dallas, Texas, United States|Phenomix Investigational Site 104, San Antonio, Texas, United States|Phenomix Investigational Site 100, Kenosha, Wisconsin, United States|Phenomix Investigational Site 402, Buenos Aires, Argentina|Phenomix Investigational Site 408, Buenos Aires, Argentina|Phenomix Investigational Site 410, Mendoza, Argentina|Phenomix Investigational Site 208, Praha 10, Czech Republic|Phenomix Investigational Site 209, Praha 4 Chodov, Czech Republic|Phenomix Investigational Site 207, Unicov, Czech Republic|Phenomix Investigational Site 707, Shastrinagar, Jaipur, India|Phenomix Investigational Site 701, Bangalore, Karnataka, India|Phenomix Investigational Site 705, Trivandrum, Kerala, India|Phenomix Investigational Site 706, Indore, Madhya Pradesh, India|Phenomix Investigational Site 711, Mumbai, Maharashtra, India|Phenomix Investigational Site 607, Arequipa, Peru|Phenomix Investigational Site 601, Ica, Peru|Phenomix Investigational Site 604, Lima, Peru|Phenomix Investigational Site 610, Lima, Peru|Phenomix Investigational Site 300, Gdansk, Poland|Phenomix Investigational Site 309, Karkow, Poland|Phenomix Investigational Site 303, Katowice, Poland|Phenomix Investigational Site 306, Pulawy, Poland|Phenomix Investigational Site 305, Warszawa, Poland|Phenomix Investigational Site 302, Wroclaw, Poland"
NCT03260868,Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy),https://clinicaltrials.gov/study/NCT03260868,TERMINATED,Type 1 Diabetes Mellitus,"DRUG: Insulin glargine, 300 units per milliliter (U/mL)|DRUG: Background therapy: Rapid Acting meal time insulin analogs (Humalog, Novolog or Apidra)",Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Investigational Site Number 8400002, West Des Moines, Iowa, 50265, United States|Investigational Site Number 8400004, Houston, Texas, 77043, United States|Investigational Site Number 8400003, Bridgeport, West Virginia, 26330, United States|Investigational Site Number 1240001, Barrie, L4M 7G1, Canada|Investigational Site Number 1240003, Oakville, L6M 1M1, Canada|Investigational Site Number 1240002, Thornhill, L4J 8L7, Canada"
NCT05833100,Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System,https://clinicaltrials.gov/study/NCT05833100,TERMINATED,Diabetes,DEVICE: CareSens PRO GK Blood Glucose/b-Ketone Monitoring system,"i-SENS, Inc.",Avania|Rainier Clinical Research Center,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Rainier Clinical Research Center, Renton, Washington, 98057, United States"
NCT00850239,Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin,https://clinicaltrials.gov/study/NCT00850239,TERMINATED,Type 2 Diabetes Mellitus,DRUG: dutogliptin|DRUG: placebo,Phenomix,Forest Laboratories,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Phenomix Investigational Site 115, Montgomery, Alabama, United States|Phenomix Investigational Site 121, Tempe, Arizona, United States|Phenomix Investigational Site 137, Tempe, Arizona, United States|Phenomix Investigational Site 105, Anaheim, California, United States|Phenomix Investigational Site 123, Chico, California, United States|Phenomix Investigational Site 134, Escondido, California, United States|Phenomix Investigational Site 103, Long Beach, California, United States|Phenomix Investigational Site 106, Los Angeles, California, United States|Phenomix Investigational Site 143, Coral Gables, Florida, United States|Phenomix Investigational Site 142, Hialeah, Florida, United States|Phenomix Investigational Site 119, Jacksonville, Florida, United States|Phenomix Investigational Site 133, Kissimmee, Florida, United States|Phenomix Investigational Site 141, Dunwoody, Georgia, United States|Phenomix Investigational Site 101, Honolulu, Hawaii, United States|Phenomix Investigational Site 135, Chicago, Illinois, United States|Phenomix Investigational Site 124, Indianapolis, Indiana, United States|Phenomix Investigational Site 127, Indianapolis, Indiana, United States|Phenomix Investigational Site 136, Brockton, Massachusetts, United States|Phenomix Investigational Site 125, Kalamazoo, Michigan, United States|Phenomix Investigational Site 138, Biloxi, Mississippi, United States|Phenomix Investigational Site 122, Las Vegas, Nevada, United States|Phenomix Investigational Site 140, Las Vegas, Nevada, United States|Phenomix Investigational Site 131, Brick, New Jersey, United States|Phenomix Investigational Site 110, Trenton, New Jersey, United States|Phenomix Investigational Site 116, Albuquerque, New Mexico, United States|Phenomix Investigational Site 107, Winston-Salem, North Carolina, United States|Phenomix Investigational Site 130, Cincinnati, Ohio, United States|Phenomix Investigational Site 118, Cuyahoga Falls, Ohio, United States|Phenomix Investigational Site 112, Greenville, South Carolina, United States|Phenomix Investigational Site 102, Dallas, Texas, United States|Phenomix Investigational Site 139, Dallas, Texas, United States|Phenomix Investigational Site 126, El Paso, Texas, United States|Phenomix Investigational Site 104, San Antonio, Texas, United States|Phenomix Investigational Site 100, Kenosha, Wisconsin, United States|Phenomix Investigational Site 401, Buenos Aires, Argentina|Phenomix Investigational Site 402, Buenos Aires, Argentina|Phenomix Investigational Site 404, Buenos Aires, Argentina|Phenomix Investigational Site 405, Buenos Aires, Argentina|Phenomix Investigational Site 406, Buenos Aires, Argentina|Phenomix Investigational Site 407, Buenos Aires, Argentina|Phenomix Investigational Site 408, Buenos Aires, Argentina|Phenomix Investigational Site 409, Buenos Aires, Argentina|Phenomix Investigational Site 411, Buenos Aires, Argentina|Phenomix Investigational Site 403, Corrientes, Argentina|Phenomix Investigational Site 410, Mendoza, Argentina|Phenomix Investigational Site 400, Rosario, Argentina|Phenomix Investigational Site 502, Santiago, Chile|Phenomix Investigational Site 504, Santiago, Chile|Phenomix Investigational Site 505, Santiago, Chile|Phenomix Investigational Site 500, Temuco, Chile|Phenomix Investigational Site 501, Temuco, Chile|Phenomix Investigational Site 209, Chodov, Czech Republic|Phenomix Investigational Site 205, Havířov-Město, Czech Republic|Phenomix Investigational Site 204, Liberec, Czech Republic|Phenomix Investigational Site 202, Olomouc, Czech Republic|Phenomix Investigational Site 206, Ostrava Kunčice, Czech Republic|Phenomix Investigational Site 208, Praha, Czech Republic|Phenomix Investigational Site 203, Prostějov, Czech Republic|Phenomix Investigational Site 207, Uničov, Czech Republic|Phenomix Investigational Site 201, Valašské Klobouky, Czech Republic|Phenomix Investigational Site 703, Hyderabad, Andhara Pradesh, India|Phenomix Investigational Site 704, Visakhapatanam, Andhra Pradesh, India|Phenomix Investigational Site 709, Gopalapuram, Chennai, India|Phenomix Investigational Site 707, Shastrinagar, Jaipur, India|Phenomix Investigational Site 701, Bangalore, Karnataka, India|Phenomix Investigational Site 702, Bangalore, Karnataka, India|Phenomix Investigational Site 705, Trivandrum, Kerala, India|Phenomix Investigational Site 706, Indore, Madhya Pradesh, India|Phenomix Investigational Site 700, Nashik, Maharashtra, India|Phenomix Investigational Site 710, Navi Mumbai, Maharashtra, India|Phenomix Investigational Site 711, Mumbai, Maharastra, India|Phenomix Investigational Site 708, Chennai, India|Phenomix Investigational Site 607, Arequipa, Peru|Phenomix Investigational Site 605, Cercado de Lima, Peru|Phenomix Investigational Site 601, Ica, Peru|Phenomix Investigational Site 600, Lima, Peru|Phenomix Investigational Site 603, Lima, Peru|Phenomix Investigational Site 604, Lima, Peru|Phenomix Investigational Site 608, Lima, Peru|Phenomix Investigational Site 610, Lima, Peru|Phenomix Investigational Site 606, Piura, Peru|Phenomix Investigational Site 602, Trujillo, Peru|Phenomix Investigational Site 609, Wanchaq Cusco, Peru|Phenomix Investigational Site 300, Gdańsk, Poland|Phenomix Investigational Site 301, Gdańsk, Poland|Phenomix Investigational Site 303, Katowice, Poland|Phenomix Investigational Site 312, Katowice, Poland|Phenomix Investigational Site 309, Kraków, Poland|Phenomix Investigational Site 313, Kraków, Poland|Phenomix Investigational Site 308, Lublin, Poland|Phenomix Investigational Site 310, Poznan, Poland|Phenomix Investigational Site 306, Puławy, Poland|Phenomix Investigational Site 304, Szczecin, Poland|Phenomix Investigational Site 305, Warszawa, Poland|Phenomix Investigational Site 307, Warszawa, Poland|Phenomix Investigational Site 311, Warszawa, Poland|Phenomix Investigational Site 302, Wrocław, Poland"
NCT00637338,Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00637338,TERMINATED,"Diabetes Mellitus, Type 2",BIOLOGICAL: PF-04603629|BIOLOGICAL: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Pfizer Investigational Site, Phoenix, Arizona, 85013, United States|Pfizer Investigational Site, Miami, Florida, 33169, United States|Pfizer Investigational Site, Wichita, Kansas, 67214, United States|Pfizer Investigational Site, Portland, Oregon, 97239, United States"
NCT03547427,Glucagon Counterregulation in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03547427,TERMINATED,Type 1 Diabetes Mellitus,OTHER: Basal insulin alone|OTHER: Basal pramlintide and reduced basal insulin|OTHER: CGM|OTHER: Acetaminophen test|OTHER: Insulin-induced hypoglycemia|OTHER: Exercise-induced hypoglycemia,University of Virginia,,ALL,ADULT,,INTERVENTIONAL,"University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, 22903, United States"
NCT03617146,Coaching and Education for Diabetes Distress,https://clinicaltrials.gov/study/NCT03617146,TERMINATED,Diabetes Distress,BEHAVIORAL: Health coaching|OTHER: Diabetes Distress-specific Education,Baylor College of Medicine,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Baylor Family Medicine, Houston, Texas, 77098, United States"
NCT04524949,IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study),https://clinicaltrials.gov/study/NCT04524949,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: IMCY-0098 450 μg|DRUG: IMCY-0098 1350 μg|DRUG: Placebo,Imcyse SA,,ALL,ADULT,PHASE2,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35205, United States|Barbara Davis Center, Aurora, Colorado, 80045, United States|University of Chicago, Chicago, Illinois, 60637, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|Princess Alexandra Hospital, Brisbane, Australia|Royal Melbourne Hospital, Melbourne, Australia|St. Vincent's Hospital, Melbourne, Australia|Royal North Shore Hospital, Sydney, Australia|Université Libre de Bruxelles - Hôpital Erasme - ULB, Brussels, Belgium|UZ Brussels, Brussels, Belgium|Katholieke Universiteit Leuven UZ Gasthuisberg, Leuven, Belgium|Ospedale San Raffaele S.r.l., Milan, Italy|AOU Pisana - Ospedale Cisanello, Pisa, Italy|Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania|Klaipeda university hospital, Klaipeda, Lithuania|Vilnius university hospital Santaros klinikos, Vilnius, Lithuania|UMC - University Children's Hospital, Ljubljana, Slovenia|Department of clinical sciences, CRC/Malmö, Lund University, Lund, Sweden|Addenbrooke's Hospital, Cambridge, United Kingdom|University Hospital of Wales, Cardiff, United Kingdom|Royal Infirmary of Edinburgh, Edinburgh, United Kingdom|Royal Devon and Exeter Hospital, Exeter, United Kingdom|St James´s University Hospital, Leeds, United Kingdom|Leicester General Hospital, Leicester, United Kingdom|Guy's and St Thomas' Hospital, London, United Kingdom|Royal London Hospital, London, United Kingdom|St George's Hospital, London, United Kingdom|Royal Victoria Infirmary, Newcastle, United Kingdom|Churchill Hospital, Oxford, United Kingdom"
NCT02339311,Zuni Health Initiative - Chronic Disease Education,https://clinicaltrials.gov/study/NCT02339311,TERMINATED,Diabetes,OTHER: Educational intervention of Lifestyle and patient activation in diabetics,University of New Mexico,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT00469586,Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00469586,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: inhaled human insulin|DRUG: metformin|DRUG: glimepiride|DRUG: inhaled human insulin,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Buenos Aires, B1636DSU, Argentina|Novo Nordisk Investigational Site, Buenos Aires, C1425AGC, Argentina|Novo Nordisk Investigational Site, Ciudad de Mendoza, 5500, Argentina|Novo Nordisk Investigational Site, Mar del Plata, B7600FZN, Argentina|Novo Nordisk Investigational Site, Ebreichsdorf, 2483, Austria|Novo Nordisk Investigational Site, Kittsee, A 2421, Austria|Novo Nordisk Investigational Site, Salzburg, 5020, Austria|Novo Nordisk Investigational Site, Wien, 1130, Austria|Novo Nordisk Investigational Site, Wien, A 1160, Austria|Novo Nordisk Investigational Site, Arlon, 6700, Belgium|Novo Nordisk Investigational Site, Bonheiden, 2820, Belgium|Novo Nordisk Investigational Site, Borsbeek, 2150, Belgium|Novo Nordisk Investigational Site, Gent, 9000, Belgium|Novo Nordisk Investigational Site, Huy, 4500, Belgium|Novo Nordisk Investigational Site, Leuven, 3000, Belgium|Novo Nordisk Investigational Site, Sofia, 1431, Bulgaria|Novo Nordisk Investigational Site, Sofia, 1606, Bulgaria|Novo Nordisk Investigational Site, Edmonton, Alberta, T5J 3N4, Canada|Novo Nordisk Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|Novo Nordisk Investigational Site, Halifax, Nova Scotia, B3H 2Y9, Canada|Novo Nordisk Investigational Site, Hamilton, Ontario, L8L 2X2, Canada|Novo Nordisk Investigational Site, Smiths Falls, Ontario, K7A 4W8, Canada|Novo Nordisk Investigational Site, Laval, Quebec, H7T 2P5, Canada|Novo Nordisk Investigational Site, Sherbrooke, Quebec, J1H 5N4, Canada|Novo Nordisk Investigational Site, Mississauga, L5M 2V8, Canada|Novo Nordisk Investigational Site, Oshawa, L1J 2K1, Canada|Novo Nordisk Investigational Site, Saskatoon, S7N 0W8, Canada|Novo Nordisk Investigational Site, Trois-Rivieres, G8T 7A1, Canada|Novo Nordisk Investigational Site, Corbeil Essonnes, 91106, France|Novo Nordisk Investigational Site, Nantes, 44093, France|Novo Nordisk Investigational Site, Narbonne, 11108, France|Novo Nordisk Investigational Site, NEVERS cedex, 58033, France|Novo Nordisk Investigational Site, Paris, 75877, France|Novo Nordisk Investigational Site, Roubaix, 59100, France|Novo Nordisk Investigational Site, Indore, Madhya Pradesh, 452010, India|Novo Nordisk Investigational Site, Bangalore, 560041, India|Novo Nordisk Investigational Site, Coimbatore, 641002, India|Novo Nordisk Investigational Site, Hyderabad, 600034, India|Novo Nordisk Investigational Site, Thriruvananthapuram, 695 032, India|Novo Nordisk Investigational Site, Beer Sheva, 84101, Israel|Novo Nordisk Investigational Site, Holon, 58100, Israel|Novo Nordisk Investigational Site, Jerusalem, 91120, Israel|Novo Nordisk Investigational Site, Mexico City, México, D.F., 14000, Mexico|Novo Nordisk Investigational Site, Monterrey, Nuevo León, 64460, Mexico|Novo Nordisk Investigational Site, Guadalajara, 44600, Mexico|Novo Nordisk Investigational Site, Mexico city, 03100, Mexico|Novo Nordisk Investigational Site, Mexico city, 11650, Mexico|Novo Nordisk Investigational Site, Gdansk, 80-858, Poland|Novo Nordisk Investigational Site, Lodz, 90-030, Poland|Novo Nordisk Investigational Site, Lublin, 20-044, Poland|Novo Nordisk Investigational Site, Lublin, 20-538, Poland|Novo Nordisk Investigational Site, Mazowieckie, 09-400, Poland|Novo Nordisk Investigational Site, Rawa Mazowiecka, 96-200, Poland|Novo Nordisk Investigational Site, Warszawa, 02-097, Poland|Novo Nordisk Investigational Site, Zabrze, 41-800, Poland|Novo Nordisk Investigational Site, Istanbul, 34093, Turkey|Novo Nordisk Investigational Site, Istanbul, 34371, Turkey|Novo Nordisk Investigational Site, Istanbul, 34718, Turkey|Novo Nordisk Investigational Site, Konya, 42001, Turkey"
NCT05297045,A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT05297045,TERMINATED,Type 2 Diabetes Mellitus,DRUG: RGT001-075|OTHER: Placebo,Regor Pharmaceuticals Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Axon Clinical Research, Doral, Florida, 33166, United States"
NCT00506662,Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00506662,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: insulin detemir|DRUG: insulin NPH,Novo Nordisk A/S,,ALL,OLDER_ADULT,PHASE4,INTERVENTIONAL,"Paris La Défense, 92936, France|Cambridge, CB2 2QQ, United Kingdom"
NCT01603121,Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01603121,TERMINATED,Type 1 Diabetes Mellitus,DRUG: Lisofylline,Eastern Virginia Medical School,,ALL,ADULT,PHASE1|PHASE2,INTERVENTIONAL,"Eastern Virginia Medical School Strelitz Diabetes Center, Norfolk, Virginia, 23510, United States"
NCT00348712,Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00348712,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: rosiglitazone|DRUG: inhaled human insulin|DRUG: metformin,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Ebreichsdorf, 2483, Austria|Novo Nordisk Investigational Site, Wien, 1030, Austria|Novo Nordisk Investigational Site, Wien, 1090, Austria|Novo Nordisk Investigational Site, Joensuu, 80130, Finland|Novo Nordisk Investigational Site, Kirkkonummi, 02400, Finland|Novo Nordisk Investigational Site, Turku, FI-20520, Finland|Novo Nordisk Investigational Site, Corbeil Essonnes, 91106, France|Novo Nordisk Investigational Site, LA ROCHELLE cedex, 17019, France|Novo Nordisk Investigational Site, Mougins, 06250, France|Novo Nordisk Investigational Site, Nanterre, 92014, France|Novo Nordisk Investigational Site, Narbonne, 11108, France|Novo Nordisk Investigational Site, NEVERS cedex, 58033, France|Novo Nordisk Investigational Site, Pessac, 33600, France|Novo Nordisk Investigational Site, Pointe à Pitre, 97159, France|Novo Nordisk Investigational Site, Roubaix, 59100, France|Novo Nordisk Investigational Site, Tours, 37044, France|Novo Nordisk Investigational Site, Venissieux, 69200, France|Novo Nordisk Investigational Site, Aschaffenburg, 63739, Germany|Novo Nordisk Investigational Site, Augsburg, 86150, Germany|Novo Nordisk Investigational Site, Bad Mergentheim, 97980, Germany|Novo Nordisk Investigational Site, Berlin, 13355, Germany|Novo Nordisk Investigational Site, Darmstadt, 64283, Germany|Novo Nordisk Investigational Site, Dormagen, 41539, Germany|Novo Nordisk Investigational Site, Dresden, 01307, Germany|Novo Nordisk Investigational Site, Duisburg, 47051, Germany|Novo Nordisk Investigational Site, Flörsheim, 65439, Germany|Novo Nordisk Investigational Site, Frankfurt, 60590, Germany|Novo Nordisk Investigational Site, Fulda, 36037, Germany|Novo Nordisk Investigational Site, Genthin, 39307, Germany|Novo Nordisk Investigational Site, Hermaringen, 89568, Germany|Novo Nordisk Investigational Site, Kutenholz-Mulsum, 27449, Germany|Novo Nordisk Investigational Site, Münster, 48145, Germany|Novo Nordisk Investigational Site, Pirna, 01796, Germany|Novo Nordisk Investigational Site, Schkeuditz, 04435, Germany|Novo Nordisk Investigational Site, Wangen, 88239, Germany|Novo Nordisk Investigational Site, Wiesbaden, 65191, Germany|Novo Nordisk Investigational Site, Dublin, DUBLIN 7, Ireland|Novo Nordisk Investigational Site, Dublin, DUBLIN 8, Ireland|Novo Nordisk Investigational Site, Waterford, Ireland|Novo Nordisk Investigational Site, Delft, 2625 AD, Netherlands|Novo Nordisk Investigational Site, Den Haag, 2582 LJ, Netherlands|Novo Nordisk Investigational Site, Den Haag, 2597 AX, Netherlands|Novo Nordisk Investigational Site, Drachten, 9202 NN, Netherlands|Novo Nordisk Investigational Site, Rijswijk, 2281 AK, Netherlands|Novo Nordisk Investigational Site, Roelofarendsveen, 2371 RB, Netherlands|Novo Nordisk Investigational Site, Vlodrop, 6063 DA, Netherlands|Novo Nordisk Investigational Site, Zwijndrecht, 3331 LZ, Netherlands|Novo Nordisk Investigational Site, Alcira, 46600, Spain|Novo Nordisk Investigational Site, Barcelona, 08035, Spain|Novo Nordisk Investigational Site, Gijón, 33206, Spain|Novo Nordisk Investigational Site, Majadahonda, 28222, Spain|Novo Nordisk Investigational Site, Palma de Mallorca, 07010, Spain|Novo Nordisk Investigational Site, Partida de Bacarot, 03114, Spain|Novo Nordisk Investigational Site, Pontevedra, 36071, Spain|Novo Nordisk Investigational Site, Reus, 43201, Spain|Novo Nordisk Investigational Site, San Juan, 03550, Spain|Novo Nordisk Investigational Site, Sevilla, 41009, Spain|Novo Nordisk Investigational Site, Interlaken-Unterseen, 3800, Switzerland|Novo Nordisk Investigational Site, Olten, 4600, Switzerland|Novo Nordisk Investigational Site, Zürich, 8032, Switzerland|Novo Nordisk Investigational Site, Aberdeen, AB25 1LD, United Kingdom|Novo Nordisk Investigational Site, Bath, BA1 2SR, United Kingdom|Novo Nordisk Investigational Site, Belfast, BT12 6BA, United Kingdom|Novo Nordisk Investigational Site, Birmingham, B9 5SS, United Kingdom|Novo Nordisk Investigational Site, Bradford-on-Avon, BA15 1DQ, United Kingdom|Novo Nordisk Investigational Site, Guildford, GU2 7XX, United Kingdom|Novo Nordisk Investigational Site, Hull, HU3 2JZ, United Kingdom|Novo Nordisk Investigational Site, Northampton, NN1 5BD, United Kingdom|Novo Nordisk Investigational Site, Salford, M6 8HD, United Kingdom|Novo Nordisk Investigational Site, Swansea, SA6 6NL, United Kingdom|Novo Nordisk Investigational Site, Trowbridge, BA14 8QA, United Kingdom|Novo Nordisk Investigational Site, Trowbridge, BA14 9AR, United Kingdom|Novo Nordisk Investigational Site, Wirral, Merseyside, CH63 4JY, United Kingdom|Novo Nordisk Investigational Site, York, YO3 7HE, United Kingdom"
NCT00343980,Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00343980,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: rosiglitazone|DRUG: inhaled human insulin|DRUG: glimepiride,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, St Leonards, New South Wales, 2065, Australia|Novo Nordisk Investigational Site, Wollongong, New South Wales, 2500, Australia|Novo Nordisk Investigational Site, Garran, 2605, Australia|Novo Nordisk Investigational Site, Kingswood, 2747, Australia|Novo Nordisk Investigational Site, Osijek, 31 000, Croatia|Novo Nordisk Investigational Site, Zagreb, 10 000, Croatia|Novo Nordisk Investigational Site, Chennai, Tamil Nadu, 600086, India|Novo Nordisk Investigational Site, Vellore, Tamil Nadu, 632004, India|Novo Nordisk Investigational Site, Bangalore, 560010, India|Novo Nordisk Investigational Site, Chennai, 600020, India|Novo Nordisk Investigational Site, Coimbatore, 641002, India|Novo Nordisk Investigational Site, Skopje, 1000, Macedonia, The Former Yugoslav Republic of|Novo Nordisk Investigational Site, Cebu City, 6000, Philippines|Novo Nordisk Investigational Site, Makati City, 1200, Philippines|Novo Nordisk Investigational Site, Manila, 1000, Philippines|Novo Nordisk Investigational Site, Moscow, 119034, Russian Federation|Novo Nordisk Investigational Site, Moscow, 121356, Russian Federation|Novo Nordisk Investigational Site, Moscow, 127486, Russian Federation|Novo Nordisk Investigational Site, Moscow, 127644, Russian Federation|Novo Nordisk Investigational Site, Saint-Petersburg, 194354, Russian Federation|Novo Nordisk Investigational Site, Saint-Petersburg, 198013, Russian Federation|Novo Nordisk Investigational Site, Bornova-IZMIR, 35100, Turkey|Novo Nordisk Investigational Site, Bursa, 16059, Turkey|Novo Nordisk Investigational Site, Istanbul, 34098, Turkey|Novo Nordisk Investigational Site, Istanbul, 34390, Turkey|Novo Nordisk Investigational Site, Istanbul, 34718, Turkey"
NCT01862263,Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes,https://clinicaltrials.gov/study/NCT01862263,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Vildagliptin|DRUG: Insulin|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Novartis Investigative Site, Mexico, Distrito Federal, 06700, Mexico|Novartis Investigative Site, Mexico, Distrito Federal, 07300, Mexico|Novartis Investigative Site, Mexico, Distrito Federal, 14050, Mexico|Novartis Investigative Site, Metepec, Estado De México, 52140, Mexico|Novartis Investigative Site, Celaya, Guanajuato, 38000, Mexico|Novartis Investigative Site, Guadalajara, Jalisco, 44150, Mexico|Novartis Investigative Site, Guadalajara, Jalisco, 44600, Mexico|Novartis Investigative Site, Guadalajara, Jalisco, 44670, Mexico|Novartis Investigative Site, Monterrey, Nuevo Leon, 64710, Mexico|Novartis Investigative Site, Monterrey, Nuevo León, 64020, Mexico|Novartis Investigative Site, Cancun, Quintana Roo, 77500, Mexico|Novartis Investigative Site, Culiacán, Sinaloa, 80000, Mexico|Novartis Investigative Site, Puebla, 72190, Mexico"
NCT03592784,Food Order Intervention for Gestational Diabetes,https://clinicaltrials.gov/study/NCT03592784,TERMINATED,Gestational Diabetes,BEHAVIORAL: Food Order Therapy|BEHAVIORAL: Medical Nutrition Therapy,Weill Medical College of Cornell University,,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Materal-Fetal Medicine of Weill Cornell Medicine, New York, New York, 10065, United States"
NCT05330208,"Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects",https://clinicaltrials.gov/study/NCT05330208,TERMINATED,Diabetes,DRUG: SHR-1816|DRUG: Placebo,"Beijing Suncadia Pharmaceuticals Co., Ltd",,ALL,ADULT,PHASE1,INTERVENTIONAL,"The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266003, China"
NCT05787457,Comparative Metabolomics in Diabetes Patients From Sri Lanka and Switzerland,https://clinicaltrials.gov/study/NCT05787457,TERMINATED,"Diabetes Mellitus, Type 2",OTHER: Clinical examination|OTHER: Blood testing|OTHER: MRI,"Insel Gruppe AG, University Hospital Bern",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"University Hospital Inselspital, Berne, Bern, 3011, Switzerland"
NCT01674348,"A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes",https://clinicaltrials.gov/study/NCT01674348,TERMINATED,Type 2 Diabetes Mellitus,DRUG: P2202|DRUG: Placebo,Piramal Enterprises Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"LMC Endocrinolgy Centres Ltd, Toronto, Ontario, M4G 3E8, Canada"
NCT02348099,Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes,https://clinicaltrials.gov/study/NCT02348099,TERMINATED,Diabetes|Lipohypertrophy,OTHER: Ultrasound,University of British Columbia,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Vancouver General Hospital, Vancouver, British Columbia, V5Z 1M9, Canada"
NCT00411892,Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00411892,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: pioglitazone|DRUG: inhaled human insulin,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Ozark, Alabama, 36360, United States|Novo Nordisk Investigational Site, Tuscaloosa, Alabama, 35406, United States|Novo Nordisk Investigational Site, Vestavia Hills, Alabama, 35209, United States|Novo Nordisk Investigational Site, Tucson, Arizona, 85741, United States|Novo Nordisk Investigational Site, Little Rock, Arkansas, 72204, United States|Novo Nordisk Investigational Site, Bermuda Dunes, California, 92203, United States|Novo Nordisk Investigational Site, Escondido, California, 92025, United States|Novo Nordisk Investigational Site, Fresno, California, 93720, United States|Novo Nordisk Investigational Site, Huntington Beach, California, 92646, United States|Novo Nordisk Investigational Site, La Jolla, California, 92037, United States|Novo Nordisk Investigational Site, Northridge, California, 91325, United States|Novo Nordisk Investigational Site, Orange, California, 92868, United States|Novo Nordisk Investigational Site, Orange, California, 92869, United States|Novo Nordisk Investigational Site, Poway, California, 92064, United States|Novo Nordisk Investigational Site, Roseville, California, 95661, United States|Novo Nordisk Investigational Site, Sacramento, California, 95821, United States|Novo Nordisk Investigational Site, San Diego, California, 92103-620, United States|Novo Nordisk Investigational Site, Santa Barbara, California, 93105, United States|Novo Nordisk Investigational Site, Temecula, California, 92591, United States|Novo Nordisk Investigational Site, Tustin, California, 92780, United States|Novo Nordisk Investigational Site, Walnut Creek, California, 94598, United States|Novo Nordisk Investigational Site, Arvada, Colorado, 80005, United States|Novo Nordisk Investigational Site, Colorado Springs, Colorado, 80904, United States|Novo Nordisk Investigational Site, Beverly Hills, Florida, 34465, United States|Novo Nordisk Investigational Site, Boca Raton, Florida, 33433, United States|Novo Nordisk Investigational Site, Clearwater, Florida, 33759, United States|Novo Nordisk Investigational Site, Hialeah, Florida, 33010, United States|Novo Nordisk Investigational Site, Hollywood, Florida, 33021, United States|Novo Nordisk Investigational Site, Lake Mary, Florida, 32746, United States|Novo Nordisk Investigational Site, Marianna, Florida, 32446, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32901, United States|Novo Nordisk Investigational Site, Miami, Florida, 33136, United States|Novo Nordisk Investigational Site, Niceville, Florida, 32578, United States|Novo Nordisk Investigational Site, Palm Harbor, Florida, 34684, United States|Novo Nordisk Investigational Site, Panama City, Florida, 32401, United States|Novo Nordisk Investigational Site, Pembroke Pines, Florida, 33029, United States|Novo Nordisk Investigational Site, Saint Petersburg, Florida, 33709, United States|Novo Nordisk Investigational Site, Tallahassee, Florida, 32308, United States|Novo Nordisk Investigational Site, Vero Beach, Florida, 32960, United States|Novo Nordisk Investigational Site, West Palm Beach, Florida, 33401, United States|Novo Nordisk Investigational Site, Athens, Georgia, 30606, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30342, United States|Novo Nordisk Investigational Site, Blue Ridge, Georgia, 30513, United States|Novo Nordisk Investigational Site, Dunwoody, Georgia, 30338, United States|Novo Nordisk Investigational Site, Powder Springs, Georgia, 30127, United States|Novo Nordisk Investigational Site, Roswell, Georgia, 30076, United States|Novo Nordisk Investigational Site, Sandy Springs, Georgia, 30328, United States|Novo Nordisk Investigational Site, Suwanee, Georgia, 30024, United States|Novo Nordisk Investigational Site, Tucker, Georgia, 30084, United States|Novo Nordisk Investigational Site, Honolulu, Hawaii, 96814, United States|Novo Nordisk Investigational Site, Boise, Idaho, 83702, United States|Novo Nordisk Investigational Site, Avon, Illinois, 46123, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60611, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60612, United States|Novo Nordisk Investigational Site, Peoria, Illinois, 61615, United States|Novo Nordisk Investigational Site, Lafayette, Indiana, 47904, United States|Novo Nordisk Investigational Site, Des Moines, Iowa, 50314, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Wichita, Kansas, 67205, United States|Novo Nordisk Investigational Site, Lexington, Kentucky, 40503, United States|Novo Nordisk Investigational Site, Baltimore, Maryland, 21201, United States|Novo Nordisk Investigational Site, Prince Frederick, Maryland, 20678, United States|Novo Nordisk Investigational Site, Marlborough, Massachusetts, 01752, United States|Novo Nordisk Investigational Site, Waltham, Massachusetts, 02453, United States|Novo Nordisk Investigational Site, Bloomington, Minnesota, 55420, United States|Novo Nordisk Investigational Site, Jackson, Mississippi, 39216, United States|Novo Nordisk Investigational Site, Chesterfield, Missouri, 63017, United States|Novo Nordisk Investigational Site, Jefferson City, Missouri, 65109, United States|Novo Nordisk Investigational Site, Kansas City, Missouri, 64111, United States|Novo Nordisk Investigational Site, Saint Louis, Missouri, 63141, United States|Novo Nordisk Investigational Site, Billings, Montana, 59102, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89109, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89128, United States|Novo Nordisk Investigational Site, Syracuse, New York, 13210, United States|Novo Nordisk Investigational Site, Charlotte, North Carolina, 28209, United States|Novo Nordisk Investigational Site, High Point, North Carolina, 27262, United States|Novo Nordisk Investigational Site, Raleigh, North Carolina, 27612, United States|Novo Nordisk Investigational Site, Winston-Salem, North Carolina, 27103, United States|Novo Nordisk Investigational Site, Bismarck, North Dakota, 58501, United States|Novo Nordisk Investigational Site, Canal Fulton, Ohio, 44614, United States|Novo Nordisk Investigational Site, Cincinnati, Ohio, 45224, United States|Novo Nordisk Investigational Site, Cincinnati, Ohio, 45245, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44115, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44122, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45439, United States|Novo Nordisk Investigational Site, Clinton, Oklahoma, 73601, United States|Novo Nordisk Investigational Site, Oklahoma City, Oklahoma, 73104-5020, United States|Novo Nordisk Investigational Site, Medford, Oregon, 97504-8491, United States|Novo Nordisk Investigational Site, Altoona, Pennsylvania, 16602, United States|Novo Nordisk Investigational Site, Beaver, Pennsylvania, 15009, United States|Novo Nordisk Investigational Site, Bensalem, Pennsylvania, 19020, United States|Novo Nordisk Investigational Site, Hershey, Pennsylvania, 17033, United States|Novo Nordisk Investigational Site, Norristown, Pennsylvania, 19401, United States|Novo Nordisk Investigational Site, Greer, South Carolina, 29651, United States|Novo Nordisk Investigational Site, Clarksville, Tennessee, 37043, United States|Novo Nordisk Investigational Site, Kingsport, Tennessee, 37660, United States|Novo Nordisk Investigational Site, Arlington, Texas, 76014, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75251, United States|Novo Nordisk Investigational Site, Houston, Texas, 77024, United States|Novo Nordisk Investigational Site, Houston, Texas, 77030, United States|Novo Nordisk Investigational Site, Lewisville, Texas, 75067, United States|Novo Nordisk Investigational Site, Plano, Texas, 75093, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Saint George, Utah, 84790, United States|Novo Nordisk Investigational Site, Arlington, Virginia, 22204, United States|Novo Nordisk Investigational Site, Norfolk, Virginia, 23502, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23249, United States|Novo Nordisk Investigational Site, Warrenton, Virginia, 20186, United States|Novo Nordisk Investigational Site, Tacoma, Washington, 98405, United States"
NCT04591925,SteadiSet™ Pilot Study (SteP Study),https://clinicaltrials.gov/study/NCT04591925,TERMINATED,"Diabetes Mellitus, Type I|IDDM|Diabetes Mellitus, Insulin-Dependent, 1|Type 1 Diabetes|Type 1 Diabetes Mellitus",DEVICE: Control Device insulin infusion devcie|DEVICE: Investigative insulin infusion devcie,"Capillary Biomedical, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Medizinische Universität Graz, Graz, 8036, Austria"
NCT03770728,Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea,https://clinicaltrials.gov/study/NCT03770728,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Efpeglenatide SAR439977|DRUG: Placebo|DRUG: Background therapy: Metformin alone or in combination with SU,Sanofi,Hanmi Pharmaceutical Company Limited,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8400038, Birmingham, Alabama, 35211, United States|Investigational Site Number 8400035, Chandler, Arizona, 85224, United States|Investigational Site Number 8400005, Glendale, Arizona, 85306, United States|Investigational Site Number 8400042, Mesa, Arizona, 85206, United States|Investigational Site Number 8400051, Phoenix, Arizona, 85020, United States|Investigational Site Number 8400056, Tucson, Arizona, 85741, United States|Investigational Site Number 8400057, Huntington Park, California, 90255, United States|Investigational Site Number 8400009, Los Angeles, California, 90057, United States|Investigational Site Number 8400045, Spring Valley, California, 91978, United States|Investigational Site Number 8400040, Tustin, California, 92780, United States|Investigational Site Number 8400047, Colorado Springs, Colorado, 80909, United States|Investigational Site Number 8400046, Coral Gables, Florida, 33134, United States|Investigational Site Number 8400041, Pembroke Pines, Florida, 33026, United States|Investigational Site Number 8400025, Lawrenceville, Georgia, 30044, United States|Investigational Site Number 8400044, Lexington, Kentucky, 40503, United States|Investigational Site Number 8400001, Bridgeton, New Jersey, 08302, United States|Investigational Site Number 8400039, New Windsor, New York, 12553, United States|Investigational Site Number 8400036, Morehead City, North Carolina, 28557, United States|Investigational Site Number 8400013, Maumee, Ohio, 43537, United States|Investigational Site Number 8400048, Oklahoma City, Oklahoma, 73111, United States|Investigational Site Number 8400030, Dallas, Texas, 75230, United States|Investigational Site Number 8400043, San Antonio, Texas, 78229, United States|Investigational Site Number 8400037, Layton, Utah, 84041, United States|Investigational Site Number 1560005, Baotou, 014010, China|Investigational Site Number 1560042, Beijing, 101199, China|Investigational Site Number 1560053, Hangzhou, 310009, China|Investigational Site Number 1560051, Hefei, 210011, China|Investigational Site Number 1560011, Hunan, 411100, China|Investigational Site Number 1560025, Meihekou, 135000, China|Investigational Site Number 1560055, Nanchang, 330006, China|Investigational Site Number 1560024, Nanjing, 210011, China|Investigational Site Number 1560020, Pingxiang, 337055, China|Investigational Site Number 1560031, Shandong, 250013, China|Investigational Site Number 1560030, Shandong, 250031, China|Investigational Site Number 1560012, Shanghai, 200040, China|Investigational Site Number 1560013, Shanghai, 200040, China|Investigational Site Number 1560004, Shanghai, 200065, China|Investigational Site Number 1560022, Shanghai, 200090, China|Investigational Site Number 1560041, Tianjin, 300052, China|Investigational Site Number 1560010, Wenzhou, 325027, China|Investigational Site Number 1560052, Wuhu, 241001, China|Investigational Site Number 1560034, Wuxi, 214000, China|Investigational Site Number 1560026, Xuzhou, 221006, China|Investigational Site Number 1560044, Yichun, 336000, China|Investigational Site Number 1560003, Zhengzhou, 450003, China|Investigational Site Number 1580006, Kaohsiung, 83301, Taiwan|Investigational Site Number 1580003, Taichung, 40705, Taiwan|Investigational Site Number 1580002, Taipei, 11217, Taiwan"
NCT01514838,A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01514838,TERMINATED,Type II Diabetes Mellitus,DRUG: ASP1941|DRUG: acarbose|DRUG: Placebo,Astellas Pharma Inc,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Busan, Korea, Republic of|Daegu, Korea, Republic of|Daejeon, Korea, Republic of|Gwangju, Korea, Republic of|Incheon, Korea, Republic of|Seongnam, Korea, Republic of|Seoul, Korea, Republic of|Wonju, Korea, Republic of|Changha, Taiwan|Chiayi, Taiwan|Kaohsiung, Taiwan|Taichung, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Taoyuan, Taiwan"
NCT01703208,A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018),https://clinicaltrials.gov/study/NCT01703208,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Omarigliptin|DRUG: Placebo,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00427154,Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00427154,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: rosiglitazone|DRUG: inhaled human insulin|DRUG: metformin|DRUG: glimepiride,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Hueytown, Alabama, 35023, United States|Novo Nordisk Investigational Site, Ozark, Alabama, 36360, United States|Novo Nordisk Investigational Site, Tuscaloosa, Alabama, 35406, United States|Novo Nordisk Investigational Site, Vestavia Hills, Alabama, 35209, United States|Novo Nordisk Investigational Site, Tucson, Arizona, 85741, United States|Novo Nordisk Investigational Site, Concord, California, 94520, United States|Novo Nordisk Investigational Site, Escondido, California, 92025, United States|Novo Nordisk Investigational Site, Fresno, California, 93720, United States|Novo Nordisk Investigational Site, Huntington Beach, California, 92646, United States|Novo Nordisk Investigational Site, La Jolla, California, 92037, United States|Novo Nordisk Investigational Site, Orange, California, 92869, United States|Novo Nordisk Investigational Site, Poway, California, 92064, United States|Novo Nordisk Investigational Site, Roseville, California, 95661, United States|Novo Nordisk Investigational Site, Sacramento, California, 95821, United States|Novo Nordisk Investigational Site, San Diego, California, 92103, United States|Novo Nordisk Investigational Site, Santa Barbara, California, 93105, United States|Novo Nordisk Investigational Site, Temecula, California, 92591, United States|Novo Nordisk Investigational Site, Walnut Creek, California, 94598, United States|Novo Nordisk Investigational Site, Colorado Springs, Colorado, 80904, United States|Novo Nordisk Investigational Site, Waterbury, Connecticut, 06708, United States|Novo Nordisk Investigational Site, Boca Raton, Florida, 33433, United States|Novo Nordisk Investigational Site, Clearwater, Florida, 33759, United States|Novo Nordisk Investigational Site, Hialeah, Florida, 33010, United States|Novo Nordisk Investigational Site, Hollywood, Florida, 33021, United States|Novo Nordisk Investigational Site, Lake Mary, Florida, 32746, United States|Novo Nordisk Investigational Site, Marianna, Florida, 32446, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32901, United States|Novo Nordisk Investigational Site, Merritt Island, Florida, 32953, United States|Novo Nordisk Investigational Site, Miami, Florida, 33136, United States|Novo Nordisk Investigational Site, Palm Harbor, Florida, 34684, United States|Novo Nordisk Investigational Site, Pembroke Pines, Florida, 33029, United States|Novo Nordisk Investigational Site, Vero Beach, Florida, 32960, United States|Novo Nordisk Investigational Site, West Palm Beach, Florida, 33401, United States|Novo Nordisk Investigational Site, Athens, Georgia, 30606, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30318, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30342, United States|Novo Nordisk Investigational Site, Augusta, Georgia, 30912-3152, United States|Novo Nordisk Investigational Site, Dunwoody, Georgia, 30338, United States|Novo Nordisk Investigational Site, Powder Springs, Georgia, 30127, United States|Novo Nordisk Investigational Site, Roswell, Georgia, 30076, United States|Novo Nordisk Investigational Site, Suwanee, Georgia, 30024, United States|Novo Nordisk Investigational Site, Tucker, Georgia, 30084, United States|Novo Nordisk Investigational Site, Honolulu, Hawaii, 96814, United States|Novo Nordisk Investigational Site, Boise, Idaho, 83702, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Peoria, Illinois, 61615, United States|Novo Nordisk Investigational Site, Springfield, Illinois, 62711, United States|Novo Nordisk Investigational Site, Lafayette, Indiana, 47904, United States|Novo Nordisk Investigational Site, Des Moines, Iowa, 50314, United States|Novo Nordisk Investigational Site, Shawnee Mission, Kansas, 66204, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Wichita, Kansas, 67205, United States|Novo Nordisk Investigational Site, Lexington, Kentucky, 40503, United States|Novo Nordisk Investigational Site, Scarborough, Maine, 04074, United States|Novo Nordisk Investigational Site, Baltimore, Maryland, 21201, United States|Novo Nordisk Investigational Site, Marlborough, Massachusetts, 01752, United States|Novo Nordisk Investigational Site, Springfield, Massachusetts, 01199, United States|Novo Nordisk Investigational Site, Jackson, Mississippi, 39216, United States|Novo Nordisk Investigational Site, Chesterfield, Missouri, 63017, United States|Novo Nordisk Investigational Site, Jefferson City, Missouri, 65109, United States|Novo Nordisk Investigational Site, Kansas City, Missouri, 64111, United States|Novo Nordisk Investigational Site, Saint Louis, Missouri, 63141, United States|Novo Nordisk Investigational Site, Billings, Montana, 59101, United States|Novo Nordisk Investigational Site, Omaha, Nebraska, 68114, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89109, United States|Novo Nordisk Investigational Site, Berlin, New Jersey, 08009, United States|Novo Nordisk Investigational Site, Cherry Hill, New Jersey, 08034, United States|Novo Nordisk Investigational Site, Lawrenceville, New Jersey, 08648, United States|Novo Nordisk Investigational Site, Staten Island, New York, 10301, United States|Novo Nordisk Investigational Site, Syracuse, New York, 13210, United States|Novo Nordisk Investigational Site, Asheville, North Carolina, 28803, United States|Novo Nordisk Investigational Site, Charlotte, North Carolina, 28209, United States|Novo Nordisk Investigational Site, Greenville, North Carolina, 27834, United States|Novo Nordisk Investigational Site, High Point, North Carolina, 27262, United States|Novo Nordisk Investigational Site, Cincinnati, Ohio, 45245, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44115, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44122, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45406, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45439, United States|Novo Nordisk Investigational Site, Clinton, Oklahoma, 73601, United States|Novo Nordisk Investigational Site, Oklahoma City, Oklahoma, 73104-5020, United States|Novo Nordisk Investigational Site, Medford, Oregon, 97504-8491, United States|Novo Nordisk Investigational Site, Altoona, Pennsylvania, 16602, United States|Novo Nordisk Investigational Site, Beaver, Pennsylvania, 15009, United States|Novo Nordisk Investigational Site, Norristown, Pennsylvania, 19401, United States|Novo Nordisk Investigational Site, Greer, South Carolina, 29651, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37404, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37411, United States|Novo Nordisk Investigational Site, Clarksville, Tennessee, 37043, United States|Novo Nordisk Investigational Site, Kingsport, Tennessee, 37660, United States|Novo Nordisk Investigational Site, Arlington, Texas, 76014, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75230, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75231, United States|Novo Nordisk Investigational Site, Houston, Texas, 77030, United States|Novo Nordisk Investigational Site, Hurst, Texas, 76054, United States|Novo Nordisk Investigational Site, Lewisville, Texas, 75067, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Arlington, Virginia, 22204, United States|Novo Nordisk Investigational Site, Norfolk, Virginia, 23502, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23249, United States|Novo Nordisk Investigational Site, Warrenton, Virginia, 20186, United States|Novo Nordisk Investigational Site, Renton, Washington, 98057, United States|Novo Nordisk Investigational Site, Tacoma, Washington, 98405, United States"
NCT06052371,Project VerioVue Enhancements - Neonate Study,https://clinicaltrials.gov/study/NCT06052371,TERMINATED,Diabetes Mellitus,DEVICE: VerioVue (Enhancements) blood glucose monitoring system,LifeScan Scotland Ltd,,ALL,CHILD,,OBSERVATIONAL,"Whipps Cross University Hospital (Barts Health NHS Trust), London, E1 1FR,, United Kingdom|Queens Hospital Romford (BHRUT), London, RM7 0AG, United Kingdom|The Royal Oldham Hospital (Northern Care Alliance NHS Foundation Trust), Manchester, OL1 2JH, United Kingdom"
NCT05962710,FreeStyle Libre 3 Continuous Glucose Monitoring System,https://clinicaltrials.gov/study/NCT05962710,TERMINATED,Diabetes Mellitus,DEVICE: FreeStyle Libre 3,Abbott Diabetes Care,,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"Sansum Diabetes Research Institute, Santa Barbara, California, 93105, United States|Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls, Idaho, 83404, United States|Diabetes and Glandular Disease Clinic, San Antonio, Texas, 78229, United States|Rainier Clinical Research Center, Renton, Washington, 98057, United States"
NCT00723411,A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU),https://clinicaltrials.gov/study/NCT00723411,TERMINATED,Type 1 Diabetes Mellitus,DRUG: rhGAD65|DRUG: rhGAD65|DRUG: Placebo,Diamyd Therapeutics AB,,ALL,"CHILD, ADULT",PHASE3,INTERVENTIONAL,"Helsingin yliopistollinen keskussairaala, Lasten ja nuorten sairaala, Helsinki, FI-00029, Finland|Kuopion yliopistollinen sairaala, Lasten klinikka, Kuopio, FI-70211, Finland|Oulun yliopistollinen sairaala, Lasten ja nuorten klinikka, Oulu, FI-90029, Finland|Seinäjoen keskussairaala, Lastentautien poliklinikka, Seinäjoki, FI-60220, Finland|Tampereen yliopistollinen sairaala, Lasten klinikka, Tampere, FI-33521, Finland|Turun yliopistollinen keskussairaala, Lastentautien Klinikka, Turku, FI-20521, Finland|Medecine B, Angers, 49033, France|Centre Hospitalier Universitaire de Besançon, Besançon, 25030, France|Hôpital Pellegrin Enfants, Service d'endocrinologie pédiatrique, Bordeaux, 33076, France|Hôpital Jeanne de Flandre Sce Pédiatrie, Lille, 59037, France|CHU Timone Enfants, Service de pédiatrie multidisciplinaire, Marseilles, 13385, France|CHU Montpellier Hôpital Arnaud de Villeneuve, Service de Pédiatrie 1, Montpellier, 34295, France|C.H.U.Serv.Pediatrie, Nantes, 44093, France|Hopital Robert Debré, Service d'Endocrinologie, Paris, 3319, France|Hôpital Necker, Clinique Robert Debré, Diabète de l'Enfant et de l'Adolescent,, Paris, 75743, France|CHU Rennes, Rennes, 35000, France|Hôpital des Enfants, Gastroentero-nutrition-diabétologie pédiatrique, Toulouse, 70034, France|Charité Campus Virchow Childrens Hospital, Berlin, 13353, Germany|DRK Kliniken Westend, Berlin, 14050, Germany|KHK Wilhelmstift, Hamburg-Rahlstedt, 22149, Germany|Hannover Kinderkrankenhaus auf der Bult, Hannover, 30173, Germany|Klinik und Poliklinik fȕr Kinder und Jugendliche der Universität Leipzig, Leipzig, 04103, Germany|Klinik fȕr Kinder- und Jugendmedizin, Mȕnchen, 80804, Germany|Universitätsklinik fȕr Kinder- und Jugendmedizin, Tȕbingen, Tȕbingen, 72076, Germany|Unità Operativa di Pediatria, Policlinico, Bologna, 40138, Italy|Struttura Complessa di Diabetologia, Ospedale S. Michele, Cagliari, 09134, Italy|S.S. Annunziata, Clinica Pediatrica, Chieti, 66013, Italy|Clinica Pediatrica, Università di Genova, Genova, 16147, Italy|Reparto di Pediatria, Ospedale S. Raffaele, Milano, 20132, Italy|Diabetologia - Dipartimento Clinica Pediatrica, Ospedale Luigi Sacco, Milano, 20157, Italy|Azienda Ospedaliero, Universitaria di Parma, Pediatria, Parma, 43100, Italy|Campus Bio-Medico, Dipartimento di Diabetologia e Endocrinologia, Roma, 00128, Italy|Diabetologia - Dipartimento Scienze Pediatriche, Ospedale Infantile, Regina Margherita, Torino, 10126, Italy|Meander Medisch Centrum, Lokatie Elisabeth, Amersfoort, 3816 CP, Netherlands|Haga Ziekenhuis, Lokatie Juliana Kinderziekenhuis, Den Haag, 2566 MJ, Netherlands|Diabeter, Rotterdam, 3011 TG, Netherlands|Orbis Medisch Centrum, Sittard-Geleen, 6162, Netherlands|University Medical Centre Ljubljana, Department of Pediatric Endocrinology, Ljubljana, 1525, Slovenia|Hospital Materno-Infantil Vall Hebrón, Barcelona, 08035, Spain|Hospital Materno-Infantil de Cruces, Cruces / Barakaldo, 48903, Spain|Hospital Materno-Infantil Ramón y Cajal, Madrid, 28034, Spain|Hospital Materno-Infantil La Paz, Madrid, 28046, Spain|Hospital Materno-Infantil Carlos Haya, Málaga, 29011, Spain|Hospital Materno-Infantil Vírgen del Camino, Pamplona, 31008, Spain|Hospital Materno-Infantil Vírgen del Rocío, Sevilla, 41013, Spain|Hospital Materno-Infantil Clínico de Valencia, Valencia, 46010, Spain|Hospital Materno-Infantil Miguel Servet, Zaragoza, 50009, Spain|Barn- och ungdomskliniken, Lasarettet, Borås, SE-501 82, Sweden|Barn- och ungdomskliniken, Länssjukhuset, Gävle, SE-801 87, Sweden|Drottning Silvias Barnsjukhus, Barn- och ungdomssjukvården, Göteborg, SE-416 85, Sweden|Barn- och ungdomskliniken, Länssjukhuset, Halmstad, SE-301 85, Sweden|Barn- och ungdomsmedicin, Lasarettet, Helsingborg, SE-251 87, Sweden|Barnkliniken, Hudiksvalls Sjukhus, Hudiksvall, SE-824 81, Sweden|Barn- och ungdomskliniken, Länssjukhuset Ryhov, Jönköping, SE-551 85, Sweden|Barn- och ungdomskliniken, Lasarettet, Kalmar, SE-391 85, Sweden|Barn- och ungdomskliniken, Centralsjukhuset, Karlstad, SE-651 85, Sweden|Barn och ungdomsmedicinska kliniken, Centralsjukhuset, Kristianstad, SE-291 33, Sweden|Barn- och ungdomskliniken, Universitetssjukhuset, Linköping, SE-581 85, Sweden|Barn- och ungdomskliniken, Universitetssjukhuset, Lund, SE-221 85, Sweden|Barn- och ungdomscentrum, Universitetssjukhuset MAS, Malmö, SE-205 02, Sweden|Barn- och ungdomskliniken, Vrinnevi sjukhus, Norrköping, SE-601 83, Sweden|Sachsska Barnsjukhuset, Södersjukhuset, Stockholm, SE-118 83, Sweden|Barn- och ungdomskliniken, NU-sjukvården/NÄL, Trollhättan, SE-461 85, Sweden|Barn- och ungdomskliniken, Uddevalla Sjukhus, Uddevalla, SE-451 80, Sweden|Barn- och ungdomskliniken, Centrallasarettet, Västerås, SE-721 89, Sweden|Barn- och ungdomskliniken, Centrallasarettet, Växjö, SE-351 85, Sweden|Barn- och ungdomskliniken, Universitetssjukhuset, Örebro, SE-701 85, Sweden|Maternal & Child Health Sciences, University of Dundee, Dundee, DD1 9SY, United Kingdom|Children's Admin Centre, Leicester, LE1 5WW, United Kingdom|Centre for Diabetes and Metabolic Medicine (DMM), Barts and The London School of Medicine and Dentistry, London, E1 2AT, United Kingdom"
NCT01029795,A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01029795,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: LY2599506|DRUG: Glyburide|DRUG: Placebo,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Elizabeth Vale, South Australia, 5112, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., East Ringwood, Victoria, 3135, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Victoria, 3081, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Vienna, 1090, Austria|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Holesov, 769 01, Czech Republic|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Prague, 140 59, Czech Republic|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mainz, 55116, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Neuss, D-41460, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Jerusalem, 91120, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nahariya, 22100, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Rostov-On-Don, 344022, Russian Federation|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Saint Petersburg, 191126, Russian Federation|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, 08022, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cordoba, 14004, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dos Hermanas, 41014, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Teruel, 44002, Spain"
NCT02239354,"A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus",https://clinicaltrials.gov/study/NCT02239354,TERMINATED,Type 1 Diabetes Mellitus,COMBINATION_PRODUCT: VC-01™ Combination Product,ViaCyte,California Institute for Regenerative Medicine (CIRM),ALL,ADULT,PHASE1|PHASE2,INTERVENTIONAL,"University of California at San Diego, San Diego, California, United States|University of Alberta Hospital, Edmonton, Alberta, T6G 2B7, Canada"
NCT00509925,Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00509925,TERMINATED,"Diabetes|Diabetes Mellitus, Type 1",DRUG: insulin detemir|DRUG: insulin NPH|DRUG: insulin aspart,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Novo Nordisk Investigational Site, Guildford, GU2 7XX, United Kingdom"
NCT00751842,A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT,https://clinicaltrials.gov/study/NCT00751842,TERMINATED,Type 1 Diabetes Mellitus,DRUG: rhGAD65|DRUG: rhGAD65|DRUG: Placebo,Diamyd Therapeutics AB,,ALL,"CHILD, ADULT",PHASE3,INTERVENTIONAL,"University of Arizona, Tucson, Arizona, 85724, United States|Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, 72202, United States|Alex Endocrine Associates, Rogers, Arkansas, 72758, United States|Children's Hospital Orange County, Orange, California, 92868, United States|Rady Children's Hospital, San Diego, California, 92123, United States|Stanford University Medical Center, Stanford, California, 94305, United States|Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, 80045, United States|Christina Care Research institute, Newark, Delaware, 19713, United States|University of Florida, Gainsville, Florida, 32610, United States|Nemours Children's Clinic, Jacksonville, Florida, 32207, United States|Miami Children's Hospital Research Institute, Miami, Florida, 33155, United States|University of South Florida, Tampa, Florida, 33606, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, 83404, United States|University of Iowa Hospitals and Clinicals, Iowa City, Iowa, 52242, United States|Mid America Diabetes Associates, Wichita, Kansas, 67211, United States|University of Kentucky College of Medicine, Lexington, Kentucky, 40536, United States|University of Louisville Research Foundation, Louisville, Kentucky, 40202, United States|Children's Hospital, New Orleans, Louisiana, 70118, United States|University of Maryland Medical Center, Baltimore, Maryland, 21201, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|UMass Memorial Medical Center, Worcester, Massachusetts, 01655, United States|University of Michigan Health System, Ann Arbor, Michigan, 48109, United States|Alzohaili Medical Consultants, Dearborn, Michigan, 48126, United States|The Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|St. Louis Children's Hospital, St. Louis, Missouri, 63110, United States|Creighton Diabetes Center, Omaha, Nebraska, 68131, United States|Kathryn Eckert, Reno, Nevada, 89502, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Morristown Memorial Hospital, Morristown, New Jersey, 07962, United States|Winthrop University Hospital, Mineola, New York, 11501, United States|Naomi Berrie Diabetes Center of Columbia University, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|SUNY Institute for Human Performance, Syracuse, New York, 13210, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, 44308, United States|University of Oklahoma, Schustermann Center Clinic, Tulsa, Oklahoma, 74135, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Regional Medical Clinic - Endocrinology, Rapid City, South Dakota, 57701, United States|LeBonheur Children's Medical Center, Memphis, Tennessee, 38103, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|CHRISTUS Santa Rosa Children's Hospital, San Antonio, Texas, 78207, United States|Virginia Commonwealth University, Richmond, Virginia, 23219, United States|Benaroya Research Institute, Seattle, Washington, 98101, United States"
NCT00331604,Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00331604,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: inhaled human insulin|DRUG: insulin detemir|DRUG: insulin aspart|DRUG: insulin aspart,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Campinas, 13083-900, Brazil|Novo Nordisk Investigational Site, Higienopolis, 01244-030, Brazil|Novo Nordisk Investigational Site, Porto Alegre, 90035-170, Brazil|Novo Nordisk Investigational Site, Sao Paulo, 04022-001, Brazil|Novo Nordisk Investigational Site, Hillerød, 3400, Denmark|Novo Nordisk Investigational Site, Hvidovre, 2650, Denmark|Novo Nordisk Investigational Site, Århus C, 8000, Denmark|Novo Nordisk Investigational Site, Brest, 29200, France|Novo Nordisk Investigational Site, GRENOBLE cedex, 38043, France|Novo Nordisk Investigational Site, LA ROCHELLE cedex, 17019, France|Novo Nordisk Investigational Site, Nanterre, 92014, France|Novo Nordisk Investigational Site, Narbonne, 11108, France|Novo Nordisk Investigational Site, NEVERS cedex, 58033, France|Novo Nordisk Investigational Site, Strasbourg, 67091, France|Novo Nordisk Investigational Site, TOULOUSE cedex, 31054, France|Novo Nordisk Investigational Site, Bad Harzburg, 38667, Germany|Novo Nordisk Investigational Site, Bad Kreuznach, 55545, Germany|Novo Nordisk Investigational Site, Bad Lauterberg, 37431, Germany|Novo Nordisk Investigational Site, Dresden, 01219, Germany|Novo Nordisk Investigational Site, Dresden, 01307, Germany|Novo Nordisk Investigational Site, Friedrichsthal, 66299, Germany|Novo Nordisk Investigational Site, Hamburg, 21073, Germany|Novo Nordisk Investigational Site, Hamburg, 22607, Germany|Novo Nordisk Investigational Site, Herrenberg, 71083, Germany|Novo Nordisk Investigational Site, Hohenmölsen, 06679, Germany|Novo Nordisk Investigational Site, Neumünster, 24534, Germany|Novo Nordisk Investigational Site, Neuwied, 56564, Germany|Novo Nordisk Investigational Site, Schkeuditz, 04435, Germany|Novo Nordisk Investigational Site, Speyer, 67346, Germany|Novo Nordisk Investigational Site, St. Ingbert, 66386, Germany|Novo Nordisk Investigational Site, Völklingen, 66333, Germany|Novo Nordisk Investigational Site, Warburg, 34414, Germany|Novo Nordisk Investigational Site, Shatin, New Territories, Hong Kong|Novo Nordisk Investigational Site, Beer Sheva, 84101, Israel|Novo Nordisk Investigational Site, Holon, 58100, Israel|Novo Nordisk Investigational Site, Jerusalem, 91120, Israel|Novo Nordisk Investigational Site, Bari, 70124, Italy|Novo Nordisk Investigational Site, Catania, 95122, Italy|Novo Nordisk Investigational Site, Catanzaro, 88100, Italy|Novo Nordisk Investigational Site, Milano, 20132, Italy|Novo Nordisk Investigational Site, Perugia, 06126, Italy|Novo Nordisk Investigational Site, Pescara, 65124, Italy|Novo Nordisk Investigational Site, Pisa, 56100, Italy|Novo Nordisk Investigational Site, Roma, 00133, Italy|Novo Nordisk Investigational Site, Roma, 00168, Italy|Novo Nordisk Investigational Site, San Giovanni Rotondo, 71013, Italy|Novo Nordisk Investigational Site, Verona, 37126, Italy|Novo Nordisk Investigational Site, Singapore, 119074, Singapore|Novo Nordisk Investigational Site, Singapore, 159964, Singapore|Novo Nordisk Investigational Site, Almería, 04001, Spain|Novo Nordisk Investigational Site, Cáceres, 10004, Spain|Novo Nordisk Investigational Site, Elche, 3203, Spain|Novo Nordisk Investigational Site, Granada, 18012, Spain|Novo Nordisk Investigational Site, Lugo, 27004, Spain|Novo Nordisk Investigational Site, Mostoles - Madrid -, 28935, Spain|Novo Nordisk Investigational Site, Sevilla, 41014, Spain|Novo Nordisk Investigational Site, Valladolid, 47011, Spain|Novo Nordisk Investigational Site, Xátiva, 46800, Spain|Novo Nordisk Investigational Site, Taichung City, 407, Taiwan|Novo Nordisk Investigational Site, Taipei, 100, Taiwan|Novo Nordisk Investigational Site, Taipei, 114, Taiwan|Novo Nordisk Investigational Site, Aberdeen, AB25 1LD, United Kingdom|Novo Nordisk Investigational Site, Ayr, KA6 6DX, United Kingdom|Novo Nordisk Investigational Site, Bristol, BS10 5NB, United Kingdom|Novo Nordisk Investigational Site, Cosham, PO6 3LY, United Kingdom|Novo Nordisk Investigational Site, Edgbaston, Birmingham, B15 2TH, United Kingdom|Novo Nordisk Investigational Site, Edinburgh, EH16 4SA, United Kingdom|Novo Nordisk Investigational Site, Livingstone, EH54 6PP, United Kingdom|Novo Nordisk Investigational Site, Nottingham, NG7 2UH, United Kingdom|Novo Nordisk Investigational Site, Plymouth, PL6 8BQ, United Kingdom|Novo Nordisk Investigational Site, Salford, M6 8HD, United Kingdom|Novo Nordisk Investigational Site, Sheffield, S5 7AU, United Kingdom|Novo Nordisk Investigational Site, Wirral, Merseyside, CH63 4JY, United Kingdom"
NCT00370942,GW823093C For The Treatment Of Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00370942,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: GW823093C A|DRUG: GW823093C B|DRUG: GW823093C C,GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"GSK Investigational Site, Hokkaido, 051-0005, Japan|GSK Investigational Site, Miyagi, 985-0852, Japan|GSK Investigational Site, Tokyo, 130-0004, Japan|GSK Investigational Site, Tokyo, 160-0017, Japan|GSK Investigational Site"
NCT00322257,Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00322257,TERMINATED,"Diabetes|Diabetes Mellitus, Type 1",DRUG: inhaled human insulin|DRUG: insulin detemir|DRUG: insulin aspart,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Birmingham, Alabama, 35294, United States|Novo Nordisk Investigational Site, Tuscaloosa, Alabama, 35406, United States|Novo Nordisk Investigational Site, Concord, California, 94520, United States|Novo Nordisk Investigational Site, Encino, California, 91436, United States|Novo Nordisk Investigational Site, Escondido, California, 92025, United States|Novo Nordisk Investigational Site, Fresno, California, 93720, United States|Novo Nordisk Investigational Site, Inglewood, California, 90301, United States|Novo Nordisk Investigational Site, La Jolla, California, 92037, United States|Novo Nordisk Investigational Site, Mission Viejo, California, 92691, United States|Novo Nordisk Investigational Site, Poway, California, 92064, United States|Novo Nordisk Investigational Site, San Mateo, California, 94401, United States|Novo Nordisk Investigational Site, Santa Barbara, California, 93105, United States|Novo Nordisk Investigational Site, Tustin, California, 92780, United States|Novo Nordisk Investigational Site, Vista, California, 92084, United States|Novo Nordisk Investigational Site, Walnut Creek, California, 94598, United States|Novo Nordisk Investigational Site, Aurora, Colorado, 80045, United States|Novo Nordisk Investigational Site, Colorado Springs, Colorado, 80909, United States|Novo Nordisk Investigational Site, New Britain, Connecticut, 06050, United States|Novo Nordisk Investigational Site, Norwalk, Connecticut, 06851, United States|Novo Nordisk Investigational Site, Waterbury, Connecticut, 06708, United States|Novo Nordisk Investigational Site, Boca Raton, Florida, 33433, United States|Novo Nordisk Investigational Site, Hollywood, Florida, 33021, United States|Novo Nordisk Investigational Site, Lake Mary, Florida, 32746, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32901, United States|Novo Nordisk Investigational Site, Merritt Island, Florida, 32953, United States|Novo Nordisk Investigational Site, Miami, Florida, 33136, United States|Novo Nordisk Investigational Site, West Palm Beach, Florida, 33401, United States|Novo Nordisk Investigational Site, Athens, Georgia, 30606, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30318, United States|Novo Nordisk Investigational Site, Savannah, Georgia, 31406, United States|Novo Nordisk Investigational Site, Honolulu, Hawaii, 96813, United States|Novo Nordisk Investigational Site, Honolulu, Hawaii, 96814, United States|Novo Nordisk Investigational Site, Idaho Falls, Idaho, 83404-7596, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Peoria, Illinois, 61615, United States|Novo Nordisk Investigational Site, Springfield, Illinois, 62711, United States|Novo Nordisk Investigational Site, Lafayette, Indiana, 47904, United States|Novo Nordisk Investigational Site, New Albany, Indiana, 47150, United States|Novo Nordisk Investigational Site, Des Moines, Iowa, 50314, United States|Novo Nordisk Investigational Site, Shawnee Mission, Kansas, 66204, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Lexington, Kentucky, 40503, United States|Novo Nordisk Investigational Site, Baton Rouge, Louisiana, 70808, United States|Novo Nordisk Investigational Site, Scarborough, Maine, 04074, United States|Novo Nordisk Investigational Site, Hyattsville, Maryland, 20782, United States|Novo Nordisk Investigational Site, Springfield, Massachusetts, 01199, United States|Novo Nordisk Investigational Site, Waltham, Massachusetts, 02453, United States|Novo Nordisk Investigational Site, Bloomington, Minnesota, 55420, United States|Novo Nordisk Investigational Site, Duluth, Minnesota, 55805, United States|Novo Nordisk Investigational Site, Minneapolis, Minnesota, 55416-2699, United States|Novo Nordisk Investigational Site, Tupelo, Mississippi, 38801, United States|Novo Nordisk Investigational Site, Jefferson City, Missouri, 65109, United States|Novo Nordisk Investigational Site, Kansas City, Missouri, 64114, United States|Novo Nordisk Investigational Site, Saint Louis, Missouri, 63141, United States|Novo Nordisk Investigational Site, Butte, Montana, 59701, United States|Novo Nordisk Investigational Site, Omaha, Nebraska, 68114, United States|Novo Nordisk Investigational Site, Dover, New Hampshire, 03820, United States|Novo Nordisk Investigational Site, Hampton, New Hampshire, 03842, United States|Novo Nordisk Investigational Site, Lawrenceville, New Jersey, 08648, United States|Novo Nordisk Investigational Site, Albany, New York, 12206, United States|Novo Nordisk Investigational Site, New Hyde Park, New York, 11042, United States|Novo Nordisk Investigational Site, Rochester, New York, 14642, United States|Novo Nordisk Investigational Site, Asheville, North Carolina, 28803, United States|Novo Nordisk Investigational Site, Greenville, North Carolina, 27834, United States|Novo Nordisk Investigational Site, Cincinnati, Ohio, 45267, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44122, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45406, United States|Novo Nordisk Investigational Site, Kettering, Ohio, 45429, United States|Novo Nordisk Investigational Site, Mentor, Ohio, 44060, United States|Novo Nordisk Investigational Site, Medford, Oregon, 97504, United States|Novo Nordisk Investigational Site, Hershey, Pennsylvania, 17033, United States|Novo Nordisk Investigational Site, Norristown, Pennsylvania, 19401, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37404, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37411, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75230, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75231, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75246, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75390-8858, United States|Novo Nordisk Investigational Site, Midland, Texas, 79707, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Ogden, Utah, 84403, United States|Novo Nordisk Investigational Site, Olympia, Washington, 98502, United States|Novo Nordisk Investigational Site, Renton, Washington, 98057, United States|Novo Nordisk Investigational Site, Spokane, Washington, 99208, United States|Novo Nordisk Investigational Site, Milwaukee, Wisconsin, 53209, United States|Novo Nordisk Investigational Site, Victoria, British Columbia, V8R 1J8, Canada|Novo Nordisk Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|Novo Nordisk Investigational Site, Laval, Quebec, H7T 2P5, Canada|Novo Nordisk Investigational Site, Montreal, Quebec, H2W 1T8, Canada|Novo Nordisk Investigational Site, Gatineau, J8T 8M1, Canada|Novo Nordisk Investigational Site, Mississauga, L5M 2V8, Canada|Novo Nordisk Investigational Site, Penticton, V2A 5C8, Canada|Novo Nordisk Investigational Site, Red Deer, T4N 6V7, Canada|Novo Nordisk Investigational Site, St John's, A1B 3V6, Canada|Novo Nordisk Investigational Site, Vancouver, V5Z 1C6, Canada"
NCT00267683,Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00267683,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: insulin aspart|DRUG: glibenclamide,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00571519,"Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus",https://clinicaltrials.gov/study/NCT00571519,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Rivoglitazone HCl|DRUG: rivoglitazone HCl|DRUG: rivoglitazone HCl|DRUG: placebo|DRUG: pioglitazone HCl|DRUG: pioglitazone HCl|DRUG: pioglitazone HCl 45 mg|DRUG: placebo|DRUG: metformin,Daiichi Sankyo,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Huntsville, Alabama, 35801, United States|Huntsville, Alabama, 35802, United States|San Diego, California, 92128, United States|San Francisco, California, 94115, United States|Ridgefield, Connecticut, 06877, United States|Fort Lauderdale, Florida, 33308, United States|Pembroke Pines, Florida, 33026, United States|Port Gibson, Mississippi, 39150, United States|Las Vegas, Nevada, 89119, United States|Albuquerque, New Mexico, 87109, United States|Kettering, Ohio, 45429, United States|Fleetwood, Pennsylvania, 19522, United States|Harrisburg, Pennsylvania, 17112, United States|Simpsonville, South Carolina, 29681, United States|Daingerfield, Texas, 75638, United States|Dallas, Texas, 75216, United States|Plano, Texas, 75093, United States|San Antonio, Texas, 78205, United States"
NCT00282971,A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00282971,TERMINATED,Diabetes Mellitus Type 2,DRUG: Inhaled Insulin (Exubera)|OTHER: Standard of Care,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Gain Medical Center, Coquitlam, British Columbia, V3K 3P4, Canada|Misericordia Health Centre, Winnipeg, Manitoba, R3C 1A2, Canada|Maritime Research Center, Bathurst, New Brunswick, E2A 4X7, Canada|Office of Dr. Salim Sunderji, London, Ontario, N6P 1A9, Canada|Orillia Soldier's Memorial Hospital, Orillia, Ontario, L3V 2Z6, Canada|Douglas Tweel M.D. Professional Corporation, Charlottetown, Prince Edward Island, C1A 1L2, Canada|Laboratoire Sante Le Gaspesien Inc., Bonaventure, Quebec, G0C 1E0, Canada|Centre de santé et de services sociaux de Chicoutimi, Centre de médecine genique communataire, Chicoutimi, Quebec, G7H 5H6, Canada|Rhodin Recherche Clinique, Drummondville, Quebec, J2B 1H8, Canada|Q & T Research Outaouais Inc., Gatineau, Quebec, J8Y 6S9, Canada|Hopital Charles LeMoyne, Greenfield Park, Quebec, J4V2H1, Canada|Hopital Laval, Saint-Foy, Quebec, G1V 4G5, Canada|Centre Medical des Carrieres, St-Marc-des-Carrieres, Quebec, G0A 4B0, Canada|CIC Mauricie Inc., Trois-Rivières, Quebec, G8T 7A1, Canada|Hotel Dieu CHU, Clinique d´Endocrinologie, Maladie Metaboliques, Nutrition, Nantes, Cedex 01, F-44035, France|Groupe Hospitalier Sud/Service d'Endocrinologie, Amiens cedex 1, 80094, France|Private Practise, Armentieres, 59427, France|Service d'Endocrinologie-, Bondy Cedex, 93143, France|Hopital LA Cavale Blanche, Service de Diabetologie, Brest CEDEX, 29609, France|CHU Cote de Nacre, Service d'Endocrinologie, Cean Cedex, 14033, France|Private Practise, Chartres, 28000, France|Office of Antoine Lemaire, MD, Lille, 59000, France|Centre Hospitalier Bretagne Sud, Lorient Cedex, 56322, France|Hopital Lapeyronnie Sce des Maladies, Montpellier CEDEX 5, 34295, France|Hopital Bichat, Service d'Endocrinology, Paris Cedex 18, 75877, France|Hopital Saint Michel, Paris, 75015, France|Hopital Robert Debre, Reims, 51100, France|C.H. Sud, Diabetologie, Rennes, 35056, France|Centre Hospitalier Victor Provo, Roubaix, 59100, France|Hôpital Jeanne d'Arc - Dommartin les Toul, Toul Cedex, 54201, France|General Hospital of Athens ""Laikon"", 1st Propedeutic University Internal Medicine Clinic, Athens, 11527, Greece|""Hygeia"" Diagnostic and Therapeutic Center of Athens, Diabetes Clinic, Athens, 151 23, Greece|""ATTIKON"" University General Hospital, 2nd Propedeutic University Internal Medicine Clinic, Haidari, 124 62, Greece|Peripheral General Hospital of Nikaia ""Ag. Panteleimon"", Internal Medicine Department, Pireaus, 18454, Greece|University General Hospital of Thessaloniki ""A.H.E.P.A."" 1st Propedeutic University Internal Medicin, Thessaloniki, 546 36, Greece|Hospital Infante D. Pedro, Aveiro, 3814-096, Portugal|Hospitais da Universidade de Coimbra, Coimbra, 3000-075, Portugal|Associação Protectora dos Diabéticos de Portugal, Lisboa, 1250-203, Portugal|Serviço de Endocrinologia - Hospital de Egas Moniz, Lisboa, 1300, Portugal|Hospital Geral de Santo António, Porto, 4099-001, Portugal|Centro Hospitalar de Torres Vedras, Torres Vedras, 2560-324, Portugal|Hospital Clinico Universitario de Santiago, Santiago de Compostela, A Coruña, 15706, Spain|Hospital de Conxo, Santiago de Compostela, A Coruña, 15706, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, 33006, Spain|Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Mutua de Terrassa, Terrassa, Barcelona, 08221, Spain|Clinica Universitaria de Navarra, Pamplona, Navarra, 31008, Spain|Hospital General Universitario de Alicante, Alicante, 03010, Spain|Hospital de La Santa Creu I Sant Pau, Barcelona, 08025, Spain|Hospital General Universitario Valle de Hebron, Barcelona, 08035, Spain|Hospital Universitario Puerta de Hierro, Madrid, 28035, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Hospital de Mostoles, Madrid, 28935, Spain|Complejo Hospitalario Carlos Haya Hospital Civil - Pabellon C, Malaga, 29009, Spain|Hospital Montecelo, Pontevedra, 36071, Spain|Hospital Universitario La Fe, Valencia, 46009, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Hospital Clinico Universitario Lozano Blesa, Zaragoza, 50009, Spain|Sodersjukhuset, Stockholm, 118 83, Sweden|Karolinska US Huddinge, Stockholm, 141 86, Sweden|Ängelholms sjukhus, Ängelholm, 262 81, Sweden|Hacettepe University Medical School Department of Endocrinology, Anakara, Turkey|Istanbul University Istanbul Medical School, Department of Endocrinology, Istanbul, 34390, Turkey|Dokuz Eylul University Medical School, Department of Endocrinology, Izmir, 35340, Turkey"
NCT00737633,Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults,https://clinicaltrials.gov/study/NCT00737633,TERMINATED,Diabetes,DRUG: VI-0521,VIVUS LLC,"Synteract, Inc.|Sentrx",ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Birmingham, Alabama, United States|Research Site, Los Angeles, California, United States|Research Site, San Francisco, California, United States|Research Site, Spring Valley, California, United States|Research Site, Walnut Creek, California, United States|Research Site, Bethesda, Maryland, United States|Research Site, Austin, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Richmond, Virginia, United States"
NCT03544242,Nitrite Infusion in Islet Cell Transplantation,https://clinicaltrials.gov/study/NCT03544242,TERMINATED,Diabetes,OTHER: Control|DRUG: Pre-Isolation Infusion|DRUG: Post-Isolation Infusion,University of Alabama at Birmingham,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States"
NCT03713684,Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s),https://clinicaltrials.gov/study/NCT03713684,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Efpeglenatide SAR439977|DRUG: Placebo|DRUG: Background therapy,Sanofi,Hanmi Pharmaceutical Company Limited,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8400038, Birmingham, Alabama, 35211, United States|Investigational Site Number 8400035, Chandler, Arizona, 85224, United States|Investigational Site Number 8400005, Glendale, Arizona, 85306, United States|Investigational Site Number 8400057, Huntington Park, California, 90255, United States|Investigational Site Number 8400058, La Jolla, California, 92037, United States|Investigational Site Number 8400009, Los Angeles, California, 90057, United States|Investigational Site Number 8400045, Spring Valley, California, 91978, United States|Investigational Site Number 8400040, Tustin, California, 92780, United States|Investigational Site Number 8400026, Van Nuys, California, 91405, United States|Investigational Site Number 8400055, Orlando, Florida, 32825, United States|Investigational Site Number 8400041, Pembroke Pines, Florida, 33026, United States|Investigational Site Number 8400025, Lawrenceville, Georgia, 30044, United States|Investigational Site Number 8400052, West Des Moines, Iowa, 50265, United States|Investigational Site Number 8400044, Lexington, Kentucky, 40503, United States|Investigational Site Number 8400001, Bridgeton, New Jersey, 08302, United States|Investigational Site Number 8400039, New Windsor, New York, 12553, United States|Investigational Site Number 8400036, Morehead City, North Carolina, 28557, United States|Investigational Site Number 8400013, Maumee, Ohio, 43537, United States|Investigational Site Number 8400030, Dallas, Texas, 75230, United States|Investigational Site Number 8400063, Dallas, Texas, 75390-9302, United States|Investigational Site Number 8400043, San Antonio, Texas, 78229, United States|Investigational Site Number 8400037, Layton, Utah, 84041, United States|Investigational Site Number 1560005, Baotou, 014010, China|Investigational Site Number 1560017, Beijing, 100730, China|Investigational Site Number 1560006, Changsha, 410013, China|Investigational Site Number 1560001, Chengdu, 610083, China|Investigational Site Number 1560004, Shanghai, 014010, China|Investigational Site Number 1560036, Shanghai, 200032, China|Investigational Site Number 1560012, Shanghai, 200040, China|Investigational Site Number 1560013, Shanghai, 200040, China|Investigational Site Number 1560003, Zhengzhou, 450003, China|Investigational Site Number 4100009, Busan, 49241, Korea, Republic of|Investigational Site Number 4100001, Daejeon, 35233, Korea, Republic of|Investigational Site Number 4100016, Gwangju, 501757, Korea, Republic of|Investigational Site Number 4100010, Gwangju, 61453, Korea, Republic of|Investigational Site Number 4100013, Gyeonggi-do, 11765, Korea, Republic of|Investigational Site Number 4100015, Incheon, 21565, Korea, Republic of|Investigational Site Number 4100014, Jeonju, 54907, Korea, Republic of|Investigational Site Number 4100007, Seongnam-Si, 13620, Korea, Republic of|Investigational Site Number 4100008, Seoul, 02447, Korea, Republic of|Investigational Site Number 4100002, Seoul, 03080, Korea, Republic of|Investigational Site Number 4100005, Seoul, 03722, Korea, Republic of|Investigational Site Number 4100004, Seoul, 05278, Korea, Republic of|Investigational Site Number 4100003, Seoul, 06351, Korea, Republic of|Investigational Site Number 4100011, Seoul, 07345, Korea, Republic of|Investigational Site Number 4100006, Seoul, 14647, Korea, Republic of|Investigational Site Number 4100012, Suwon, 16247, Korea, Republic of"
NCT01477853,A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211),https://clinicaltrials.gov/study/NCT01477853,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Sitagliptin|DRUG: Atorvastatin|OTHER: Placebo to sitagliptin|OTHER: Placebo to atorvastatin|DRUG: Metformin (open-label)|DRUG: Glimepiride (open-label)|DRUG: Glimepiride (double-blind)|DRUG: Placebo to glimepiride,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT01213563,Management of Type 2 Diabetes After Gastric Bypass Surgery,https://clinicaltrials.gov/study/NCT01213563,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Actrapid insulin+Gloucose|DRUG: Actrapid insulin,Imperial College London,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Imperial College London, Charing Cross Hospital, London, W68NA, United Kingdom"
NCT03386344,Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control,https://clinicaltrials.gov/study/NCT03386344,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Sotagliflozin|DRUG: Placebo,Lexicon Pharmaceuticals,Sanofi,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8409009, Escondido, California, 92025, United States|Investigational Site Number 8409010, Greenbrae, California, 94904, United States|Investigational Site Number 8409005, Walnut Creek, California, 94598, United States|Investigational Site Number 8409012, Columbus, Georgia, 31904, United States|Investigational Site Number 8409011, Evansville, Indiana, 47714-8011, United States|Investigational Site Number 8409014, Wichita, Kansas, 67205-1138, United States|Investigational Site Number 8409015, Albuquerque, New Mexico, 87106, United States|Investigational Site Number 8409002, Chapel Hill, North Carolina, 27517, United States|Investigational Site Number 8409001, Wilmington, North Carolina, 28401-6638, United States|Investigational Site Number 8409008, Dayton, Ohio, 45419-4336, United States|Investigational Site Number 8409004, Chattanooga, Tennessee, 37404, United States|Investigational Site Number 8409013, Austin, Texas, 78749, United States|Investigational Site Number 8409003, Dallas, Texas, 75230, United States|Investigational Site Number 8409007, Katy, Texas, 77450, United States|Investigational Site Number 0369003, Fremantle, 6160, Australia|Investigational Site Number 0369002, Merewether, 2291, Australia|Investigational Site Number 0369004, Parkville, 3050, Australia|Investigational Site Number 1249003, Brampton, L6S 0C6, Canada|Investigational Site Number 1249008, Etobicoke, M9R 4E1, Canada|Investigational Site Number 1249005, Pointe-Claire, H9R 4S3, Canada|Investigational Site Number 1249006, Thornhill, L4J 1W3, Canada|Investigational Site Number 1249004, Thornhill, L4J 8L7, Canada|Investigational Site Number 1249007, Vancouver, V5Y 3W2, Canada|Investigational Site Number 1249002, Victoriaville, G6P 6P6, Canada|Investigational Site Number 4109006, Daejeon, 35233, Korea, Republic of|Investigational Site Number 4109005, Guri-Si, Gyeonggi-Do, 11923, Korea, Republic of|Investigational Site Number 4109003, Gyeonggi-Do, 13620, Korea, Republic of|Investigational Site Number 4109004, Seoul, 03722, Korea, Republic of|Investigational Site Number 4109001, Seoul, 1830, Korea, Republic of|Investigational Site Number 4849006, Aguascalientes, Aguascalientes, 20230, Mexico|Investigational Site Number 4849001, Aguascalientes, 20129, Mexico|Investigational Site Number 4849003, Cuernavaca, 62250, Mexico|Investigational Site Number 4849002, Guadalajara Jalisco, 44130, Mexico|Investigational Site Number 4849004, Monterrey, 64460, Mexico|Investigational Site Number 4849005, Xalapa, 91020, Mexico|Investigational Site Number 5549004, Auckland, 1309, New Zealand|Investigational Site Number 5549003, Christchurch, 8011, New Zealand|Investigational Site Number 5549001, Rotorua, 3010, New Zealand|Investigational Site Number 5549002, Wellington, 6021, New Zealand|Investigational Site Number 6439007, Kemerovo, 650002, Russian Federation|Investigational Site Number 6439005, Novosibirsk, 630091, Russian Federation|Investigational Site Number 6439002, Saint-Petersburg, 195213, Russian Federation|Investigational Site Number 6439003, Saint-Petersburg, 196601, Russian Federation|Investigational Site Number 6439001, St. Petersburg, 194358, Russian Federation|Investigational Site Number 6439006, Yaroslavl, 150003, Russian Federation|Investigational Site Number 1589005, Changhua, 500, Taiwan|Investigational Site Number 1589008, New Taipei City, 220, Taiwan|Investigational Site Number 1589006, Taichung, 402, Taiwan|Investigational Site Number 1589007, Taichung, 43303, Taiwan|Investigational Site Number 1589001, Tainan, 710, Taiwan|Investigational Site Number 1589002, Tainan, Taiwan|Investigational Site Number 1589004, Taipei, 100, Taiwan|Investigational Site Number 1589003, Taipei, 11217, Taiwan"
NCT04269655,Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM),https://clinicaltrials.gov/study/NCT04269655,TERMINATED,"Diabetes Mellitus, Type 2",DEVICE: Cloud-Based Continuous Glucose Monitoring,Scripps Whittier Diabetes Institute,"DexCom, Inc.",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Scripps Whittier Diabetes Institute, La Jolla, California, 92037, United States"
NCT03181737,Psychological Online-training to Optimize Adherence in Patients With Type-II Diabetes,https://clinicaltrials.gov/study/NCT03181737,TERMINATED,Diabetes Mellitus Type 2,BEHAVIORAL: Covivio/Relaxio,Philipps University Marburg,Prof. Dr. Yvonne Nestoriuc|Gaia AG,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Psychology, Philipps University Marburg, Marburg, Hessen, 35032, Germany"
NCT01787214,Walnuts and Glucose Variability,https://clinicaltrials.gov/study/NCT01787214,TERMINATED,Type-2 Diabetes,DIETARY_SUPPLEMENT: Full dose|DIETARY_SUPPLEMENT: Half dose|DIETARY_SUPPLEMENT: Control,Loma Linda University,California Walnut Commission,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Loma Linda University, Nichol Hall, Loma Linda, California, 92350, United States"
NCT02053103,A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin,https://clinicaltrials.gov/study/NCT02053103,TERMINATED,Type 2 Diabetes Mellitus,DRUG: PF-05175157|DRUG: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Pfizer Investigational Site, Orlando, Florida, 32809, United States"
NCT03434119,Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents,https://clinicaltrials.gov/study/NCT03434119,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Insulin glargine/Lixisenatide|DRUG: Insulin glargine (HOE901)|DRUG: Background therapy,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8400072, Montgomery, Alabama, 36106, United States|Investigational Site Number 8400077, Little Rock, Arkansas, 72204, United States|Investigational Site Number 8400095, Little Rock, Arkansas, 72205, United States|Investigational Site Number 8400013, Little Rock, Arkansas, 72211, United States|Investigational Site Number 8400076, Anaheim, California, 92801-4123, United States|Investigational Site Number 8400052, Anaheim, California, 92801, United States|Investigational Site Number 8400069, Anaheim, California, 92805, United States|Investigational Site Number 8400060, Burbank, California, 91505, United States|Investigational Site Number 8400049, Cerritos, California, 90703, United States|Investigational Site Number 8400078, Chula Vista, California, 91910, United States|Investigational Site Number 8400047, Escondido, California, 92025, United States|Investigational Site Number 8400066, Fountain Valley, California, 92708, United States|Investigational Site Number 8400050, Greenbrae, California, 94904, United States|Investigational Site Number 8400092, Huntington Park, California, 90255, United States|Investigational Site Number 8400015, Los Angeles, California, 90017, United States|Investigational Site Number 8400011, Los Angeles, California, 90057, United States|Investigational Site Number 8400301, Los Angeles, California, 90094, United States|Investigational Site Number 8400302, Los Angeles, California, 90094, United States|Investigational Site Number 8400303, Los Angeles, California, 90094, United States|Investigational Site Number 8400304, Los Angeles, California, 90094, United States|Investigational Site Number 8400006, Los Gatos, California, 95032, United States|Investigational Site Number 8400048, Oakland, California, 94612, United States|Investigational Site Number 8400053, Orange, California, 92868, United States|Investigational Site Number 8400084, Pomona, California, 91766, United States|Investigational Site Number 8400081, Pomona, California, 91767, United States|Investigational Site Number 8400042, Rancho Cucamonga, California, 91730, United States|Investigational Site Number 8400063, San Carlos, California, 94070, United States|Investigational Site Number 8400091, San Diego, California, 92114, United States|Investigational Site Number 8400086, San Jose, California, 95148, United States|Investigational Site Number 8400074, Santa Ana, California, 92701, United States|Investigational Site Number 8400037, Temecula, California, 92591, United States|Investigational Site Number 8400087, Vallejo, California, 94592, United States|Investigational Site Number 8400024, Van Nuys, California, 91405, United States|Investigational Site Number 8400007, Ventura, California, 93003, United States|Investigational Site Number 8400054, Englewood, Colorado, 80113, United States|Investigational Site Number 8400023, Hamden, Connecticut, 06517, United States|Investigational Site Number 8400041, Gainesville, Florida, 32653, United States|Investigational Site Number 8400075, Jacksonville, Florida, 32204, United States|Investigational Site Number 8400016, Miami Lakes, Florida, 33014, United States|Investigational Site Number 8400036, Miami, Florida, 33144, United States|Investigational Site Number 8400017, Miami, Florida, 33176, United States|Investigational Site Number 8400014, Ocoee, Florida, 34761, United States|Investigational Site Number 8400028, Port Charlotte, Florida, 33952, United States|Investigational Site Number 8400097, Saint Petersburg, Florida, 00000, United States|Investigational Site Number 8400035, Saint Petersburg, Florida, 33713, United States|Investigational Site Number 8400094, Tampa, Florida, 33634, United States|Investigational Site Number 8400025, Atlanta, Georgia, 30303, United States|Investigational Site Number 8400051, Atlanta, Georgia, 30310, United States|Investigational Site Number 8400093, Atlanta, Georgia, 30318, United States|Investigational Site Number 8400005, Savannah, Georgia, 31406-2675, United States|Investigational Site Number 8400038, Chicago, Illinois, 60607, United States|Investigational Site Number 8400088, Chicago, Illinois, 60607, United States|Investigational Site Number 8400031, Des Plaines, Illinois, 60018, United States|Investigational Site Number 8400064, Evanston, Illinois, 60201, United States|Investigational Site Number 8400057, Gurnee, Illinois, 60031, United States|Investigational Site Number 8400030, Gretna, Louisiana, 70053, United States|Investigational Site Number 8400009, New Orleans, Louisiana, 70124, United States|Investigational Site Number 8400065, Baltimore, Maryland, 21237, United States|Investigational Site Number 8400061, Rockville, Maryland, 20852, United States|Investigational Site Number 8400079, Chelsea, Michigan, 48118, United States|Investigational Site Number 8400001, Flint, Michigan, 48504, United States|Investigational Site Number 8400012, Flint, Michigan, 48532-3447, United States|Investigational Site Number 8400090, Las Vegas, Nevada, 89117, United States|Investigational Site Number 8400082, Las Vegas, Nevada, 89148, United States|Investigational Site Number 8400018, Linden, New Jersey, 07036, United States|Investigational Site Number 8400003, Bronx, New York, 10455, United States|Investigational Site Number 8400062, Philadelphia, Pennsylvania, 19107, United States|Investigational Site Number 8400043, Columbia, South Carolina, 29204, United States|Investigational Site Number 8400021, Dallas, Texas, 75230, United States|Investigational Site Number 8400040, Fort Worth, Texas, 76132, United States|Investigational Site Number 8400045, Houston, Texas, 77089, United States|Investigational Site Number 8400002, Humble, Texas, 77338, United States|Investigational Site Number 8400039, Kerrville, Texas, 78028, United States|Investigational Site Number 8400096, Lufkin, Texas, 75904, United States|Investigational Site Number 8400027, San Antonio, Texas, 78228, United States|Investigational Site Number 8400083, San Antonio, Texas, 78230, United States|Investigational Site Number 8400008, Splendora, Texas, 77372, United States|Investigational Site Number 8400055, Spring, Texas, 77379, United States|Investigational Site Number 8400070, Sugar Land, Texas, 77478, United States|Investigational Site Number 8400085, Sugar Land, Texas, 77479, United States|Investigational Site Number 8400059, Webster, Texas, 77598, United States|Investigational Site Number 8400044, Manassas, Virginia, 20110, United States|Investigational Site Number 8400068, Norfolk, Virginia, 23510, United States|Investigational Site Number 8400033, Richmond, Virginia, 23219, United States|Investigational Site Number 8400029, Richland, Washington, 99352, United States"
NCT00229710,GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00229710,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Tesaglitazar,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Birmingham, Alabama, United States|Research Site, Phoenix, Arizona, United States|Research Site, Tucson, Arizona, United States|Research Site, Fresno, California, United States|Research Site, Greenbrae, California, United States|Research Site, La Jolla, California, United States|Research Site, Northridge, California, United States|Research Site, Riverside, California, United States|Research Site, San Diego, California, United States|Research Site, Santa Monica, California, United States|Research Site, Spring Valley, California, United States|Research Site, Walnut Creek, California, United States|Research Site, West Hills, California, United States|Research Site, Waterbury, Connecticut, United States|Research Site, Washington, District of Columbia, United States|Research Site, Gainesville, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Palm Harbor, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Augusta, Georgia, United States|Research Site, Dunwoody, Georgia, United States|Research Site, Boise, Idaho, United States|Research Site, Chicago Heights, Illinois, United States|Research Site, Chicago, Illinois, United States|Research Site, Gurnee, Illinois, United States|Research Site, Springfield, Illinois, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Wichita, Kansas, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Baltimore, Maryland, United States|Research Site, Cadillac, Michigan, United States|Research Site, Richmond Heights, Missouri, United States|Research Site, St. Louis, Missouri, United States|Research Site, Omaha, Nebraska, United States|Research Site, North Las Vegas, Nevada, United States|Research Site, Pahrump, Nevada, United States|Research Site, Dover, New Hampshire, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Brooklyn, New York, United States|Research Site, New Hyde Park, New York, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Wilmington, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Kettering, Ohio, United States|Research Site, Toledo, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Medford, Oregon, United States|Research Site, Portland, Oregon, United States|Research Site, Altoona, Pennsylvania, United States|Research Site, Cheswick, Pennsylvania, United States|Research Site, Erie, Pennsylvania, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Columbia, South Carolina, United States|Research Site, Greer, South Carolina, United States|Research Site, Corpus Christi, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Fort Worth, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Roseland, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Richmond, Virginia, United States|Research Site, Bellevue, Washington, United States|Research Site, Renton, Washington, United States|Research Site, Spokane, Washington, United States|Research Site, Tacoma, Washington, United States|Research Site, Madison, Wisconsin, United States"
NCT01486966,Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01486966,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: insulin detemir|DRUG: insulin aspart|DRUG: insulin NPH|DRUG: human soluble insulin|DRUG: metformin,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Novo Nordisk Investigational Site, Beijing, Beijing, 100034, China|Novo Nordisk Investigational Site, Chongqing, Chongqing, 400016, China|Novo Nordisk Investigational Site, Wuxi, Jiangsu, 214023, China|Novo Nordisk Investigational Site, Nanchang, Jiangxi, 330006, China|Novo Nordisk Investigational Site, Shanghai, Shanghai, 200003, China|Novo Nordisk Investigational Site, Shanghai, Shanghai, 200072, China"
NCT01829061,Reproducibility and Method Comparison Studies of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver Study of the Quo-Test™ A1C System,https://clinicaltrials.gov/study/NCT01829061,TERMINATED,Diabetes,,Quotient Diagnostics Limited,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"AMCR Institute, Escondido, California, 92026, United States|Ridgeview Research, Chaska, Minnesota, 55318, United States|University of Missouri, Columbia, Missouri, 65212, United States"
NCT00427401,A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks,https://clinicaltrials.gov/study/NCT00427401,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: PF-00915275,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Pfizer Investigational Site, Bruxelles, 1070, Belgium"
NCT02131272,A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin,https://clinicaltrials.gov/study/NCT02131272,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: Insulin detemir|DRUG: Insulin NPH|BEHAVIORAL: Diet/exercise,Novo Nordisk A/S,,ALL,"CHILD, ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Tucson, Arizona, 85724, United States|Novo Nordisk Investigational Site, Los Angeles, California, 90027, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32207, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32256, United States|Novo Nordisk Investigational Site, Pembroke Pines, Florida, 33026, United States|Novo Nordisk Investigational Site, Tallahassee, Florida, 32308, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30322, United States|Novo Nordisk Investigational Site, Silver Spring, Maryland, 20910, United States|Novo Nordisk Investigational Site, Washington, Maryland, 20011, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89148, United States|Novo Nordisk Investigational Site, Buffalo, New York, 14203, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44195-0001, United States|Novo Nordisk Investigational Site, Toledo, Ohio, 43606, United States|Novo Nordisk Investigational Site, Hershey, Pennsylvania, 17033, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19104, United States|Novo Nordisk Investigational Site, Pittsburgh, Pennsylvania, 15224, United States|Novo Nordisk Investigational Site, Providence, Rhode Island, 02903, United States|Novo Nordisk Investigational Site, Columbia, South Carolina, 29203, United States|Novo Nordisk Investigational Site, Memphis, Tennessee, 38119, United States|Novo Nordisk Investigational Site, Amarillo, Texas, 79106, United States|Novo Nordisk Investigational Site, Edinburg, Texas, 78539, United States|Novo Nordisk Investigational Site, Norfolk, Virginia, 23507, United States|Novo Nordisk Investigational Site, Milwaukee, Wisconsin, 53226, United States|Novo Nordisk Investigational Site, Caba, C1425DUC, Argentina|Novo Nordisk Investigational Site, Aparecida de Goiania, Goias, 74935-530, Brazil|Novo Nordisk Investigational Site, Porto Alegre, Rio Grande Do Sul, 91350-250, Brazil|Novo Nordisk Investigational Site, São Paulo, Sao Paulo, 01223-001, Brazil|Novo Nordisk Investigational Site, São Paulo, Sao Paulo, 01228-000, Brazil|Novo Nordisk Investigational Site, Zagreb, 10000, Croatia|Novo Nordisk Investigational Site, Alexandria, 21131, Egypt|Novo Nordisk Investigational Site, Cairo, 11562, Egypt|Novo Nordisk Investigational Site, Cairo, 11628, Egypt|Novo Nordisk Investigational Site, Ludwigshafen, 67059, Germany|Novo Nordisk Investigational Site, Neuwied, 56564, Germany|Novo Nordisk Investigational Site, Goudi/ Athens, GR-11527, Greece|Novo Nordisk Investigational Site, Thessaloniki, GR 54642, Greece|Novo Nordisk Investigational Site, Budapest, 1023, Hungary|Novo Nordisk Investigational Site, Budapest, 1083, Hungary|Novo Nordisk Investigational Site, Miskolc, 3501, Hungary|Novo Nordisk Investigational Site, Hyderabad, Andhra Pradesh, 500072, India|Novo Nordisk Investigational Site, Hyderabad, Andhra Pradesh, 500082, India|Novo Nordisk Investigational Site, Ahmedabad, Gujarat, 380007, India|Novo Nordisk Investigational Site, Bangalore, Karnataka, 560002, India|Novo Nordisk Investigational Site, Bangalore, Karnataka, 560034, India|Novo Nordisk Investigational Site, Bangalore, Karnataka, 560045, India|Novo Nordisk Investigational Site, Chennai, Tamil Nadu, 600 013, India|Novo Nordisk Investigational Site, Kolkata, West Bengal, 700032, India|Novo Nordisk Investigational Site, Beer Sheva, 84101, Israel|Novo Nordisk Investigational Site, Haifa, 31096, Israel|Novo Nordisk Investigational Site, Ancona, 60123, Italy|Novo Nordisk Investigational Site, Firenze, 50139, Italy|Novo Nordisk Investigational Site, Seoul, 05030, Korea, Republic of|Novo Nordisk Investigational Site, Seoul, 135-720, Korea, Republic of|Novo Nordisk Investigational Site, Beirut, Lebanon|Novo Nordisk Investigational Site, Hazmieh, 9615, Lebanon|Novo Nordisk Investigational Site, Lebanon - Beirut, 9611, Lebanon|Novo Nordisk Investigational Site, Kota Kinabalu, 88996, Malaysia|Novo Nordisk Investigational Site, Kuala Lumpur, 59100, Malaysia|Novo Nordisk Investigational Site, Seremban, 70300, Malaysia|Novo Nordisk Investigational Site, Seri Manjung, 32040, Malaysia|Novo Nordisk Investigational Site, Puebla, 72190, Mexico|Novo Nordisk Investigational Site, Casablanca, 20000, Morocco|Novo Nordisk Investigational Site, Fès, 30000, Morocco|Novo Nordisk Investigational Site, Marrakech, 40000, Morocco|Novo Nordisk Investigational Site, Rabat, 10000, Morocco|Novo Nordisk Investigational Site, Wroclaw, 50-311, Poland|Novo Nordisk Investigational Site, Lisboa, 1250-230, Portugal|Novo Nordisk Investigational Site, Izhevsk, 426009, Russian Federation|Novo Nordisk Investigational Site, Stavropol, 355017, Russian Federation|Novo Nordisk Investigational Site, Tomsk, 634034, Russian Federation|Novo Nordisk Investigational Site, Nis, 18 000, Serbia|Novo Nordisk Investigational Site, Lenasia, Gauteng, 1827, South Africa|Novo Nordisk Investigational Site, Pretoria, Gauteng, 0181, South Africa|Novo Nordisk Investigational Site, Observatory, Western Cape, 7925, South Africa|Novo Nordisk Investigational Site, Esplugues Llobregat(Barcelona), 08950, Spain|Novo Nordisk Investigational Site, Taichung, 404, Taiwan|Novo Nordisk Investigational Site, Taoyuan, 333, Taiwan|Novo Nordisk Investigational Site, Adana, 01130, Turkey|Novo Nordisk Investigational Site, Ankara, 06100, Turkey|Novo Nordisk Investigational Site, Istanbul, 34093, Turkey|Novo Nordisk Investigational Site, Istanbul, 34890, Turkey|Novo Nordisk Investigational Site, Kayseri, 38010, Turkey"
NCT03116009,Randomization of Early Diabetes Screening Among Obese Pregnant Women.,https://clinicaltrials.gov/study/NCT03116009,TERMINATED,Gestational Diabetes,DRUG: Screening for diabetes with 1-hour GCT and HbA1,University of Illinois at Chicago,,FEMALE,ADULT,PHASE3,INTERVENTIONAL,"University of Illinois at Chicago, Chicago, Illinois, 60612, United States"
NCT00707590,Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM),https://clinicaltrials.gov/study/NCT00707590,TERMINATED,Type 2 Diabetes Mellitus,DRUG: BMS-767778 or Placebo,Bristol-Myers Squibb,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Local Institution, Quebec, G1P 0A2, Canada"
NCT03660553,Simplified Insulin Regimen for the Elderly,https://clinicaltrials.gov/study/NCT03660553,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Insulin Glargine|DRUG: Insulin Glargine|DRUG: Insulin Aspart|DRUG: Insulin Lispro,University of Miami,,ALL,OLDER_ADULT,PHASE4,INTERVENTIONAL,"University of Miami, South Miami, Florida, 33143, United States"
NCT00568854,Immunobiology of Diabetes and Tuberculosis,https://clinicaltrials.gov/study/NCT00568854,TERMINATED,Tuberculosis|Diabetes Mellitus,BIOLOGICAL: BCG,Stanford University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Stanford University School of Medicine, Stanford, California, 94305, United States"
NCT03938441,"Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study",https://clinicaltrials.gov/study/NCT03938441,TERMINATED,Diabetes Type 2|Pre-diabetes,OTHER: Intermittent Fasting,gino gaddini,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Mike O'Callaghan Military Medical Center, Nellis Air Force Base, Nevada, 89191, United States"
NCT00868790,A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009),https://clinicaltrials.gov/study/NCT00868790,TERMINATED,Type 2 Diabetes Mellitus,DRUG: MK-3577|DRUG: Placebo to MK-3577|DRUG: Metformin|DRUG: Placebo to Metformin,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00226330,GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00226330,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Tesaglitazar|DRUG: Pioglitazone,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Birmingham, Alabama, United States|Research Site, Columbiana, Alabama, United States|Research Site, Mobile, Alabama, United States|Research Site, Chandler, Arizona, United States|Research Site, Mesa, Arizona, United States|Research Site, Phoenix, Arizona, United States|Research Site, Sierra Vista, Arizona, United States|Research Site, Tucson, Arizona, United States|Research Site, Jonesboro, Arkansas, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Searcy, Arkansas, United States|Research Site, Anaheim, California, United States|Research Site, Carmichael, California, United States|Research Site, Dinuba, California, United States|Research Site, Elk Grove, California, United States|Research Site, Encinitas, California, United States|Research Site, Encino, California, United States|Research Site, Fresno, California, United States|Research Site, Greenbrae, California, United States|Research Site, Loma Linda, California, United States|Research Site, Long Beach, California, United States|Research Site, Los Angeles, California, United States|Research Site, Mission Viejo, California, United States|Research Site, Northridge, California, United States|Research Site, Pasadena, California, United States|Research Site, Redondo Beach, California, United States|Research Site, Riverside, California, United States|Research Site, Sacramento, California, United States|Research Site, Santa Ana, California, United States|Research Site, Santa Monica, California, United States|Research Site, Spring Valley, California, United States|Research Site, Tustin, California, United States|Research Site, Walnut Creek, California, United States|Research Site, West Hills, California, United States|Research Site, Newark, Delaware, United States|Research Site, Washington, District of Columbia, United States|Research Site, Brandon, Florida, United States|Research Site, Cooper City, Florida, United States|Research Site, Delray Beach, Florida, United States|Research Site, Gainesville, Florida, United States|Research Site, Hialeah, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Melbourne, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Ocoee, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Plantation, Florida, United States|Research Site, W. Palm Beach, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Augusta, Georgia, United States|Research Site, Columbus, Georgia, United States|Research Site, Dunwoody, Georgia, United States|Research Site, Berwyn, Illinois, United States|Research Site, Chicago, Illinois, United States|Research Site, Elk Grove Village, Illinois, United States|Research Site, Gurnee, Illinois, United States|Research Site, Melrose Park, Illinois, United States|Research Site, North Chicago, Illinois, United States|Research Site, Peoria, Illinois, United States|Research Site, Sterling, Illinois, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Des Moines, Iowa, United States|Research Site, Waterloo, Iowa, United States|Research Site, Topeka, Kansas, United States|Research Site, Witchita, Kansas, United States|Research Site, Lexington, Kentucky, United States|Research Site, Louisville, Kentucky, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Slidell, Louisiana, United States|Research Site, Baltimore, Maryland, United States|Research Site, Columbia, Maryland, United States|Research Site, Haverhill, Massachusetts, United States|Research Site, Petoskey, Michigan, United States|Research Site, Excelsior Springs, Missouri, United States|Research Site, Richmond Heights, Missouri, United States|Research Site, Rolla, Missouri, United States|Research Site, Las Vegas, Nevada, United States|Research Site, North Las Vegas, Nevada, United States|Research Site, Pahrump, Nevada, United States|Research Site, Reno, Nevada, United States|Research Site, Pleasantville, New Jersey, United States|Research Site, Manlius, New York, United States|Research Site, New York, New York, United States|Research Site, Olean, New York, United States|Research Site, Staten Island, New York, United States|Research Site, Asheville, North Carolina, United States|Research Site, Winston-Salem, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Lakewood, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Medford, Oregon, United States|Research Site, Portland, Oregon, United States|Research Site, Altoona, Pennsylvania, United States|Research Site, Erie, Pennsylvania, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Reading, Pennsylvania, United States|Research Site, Warminster, Pennsylvania, United States|Research Site, West Chester, Pennsylvania, United States|Research Site, Columbia, South Carolina, United States|Research Site, Memphis, Tennessee, United States|Research Site, Carrollton, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, North Richland Hills, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Salt Lake City, Utah, United States|Research Site, Norfolk, Virginia, United States|Research Site, Virginia Beach, Virginia, United States|Research Site, Gig Harbor, Washington, United States|Research Site, Huntington, West Virginia, United States|Research Site, Moron, Buenos Aires, Argentina|Research Site, Quilmes, Buenos Aires, Argentina|Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Córdoba - Córdoba, Argentina|Research Site, Rosario, Argentina|Research Site, Salta - Salta, Argentina|Research Site, Curitiba, Brazil|Research Site, Fortaleza, Brazil|Research Site, Goiânia, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, São Paulo, Brazil|Research Site, Edmonton, Alberta, Canada|Research Site, Abbotsford, British Columbia, Canada|Research Site, Chilliwack, British Columbia, Canada|Research Site, Vancouver, British Columbia, Canada|Research Site, Victoria, British Columbia, Canada|Research Site, St. John's, Newfoundland and Labrador, Canada|Research Site, Dartmouth, Nova Scotia, Canada|Research Site, Halifax, Nova Scotia, Canada|Research Site, Truro, Nova Scotia, Canada|Research Site, Windsor, Nova Scotia, Canada|Research Site, Brampton, Ontario, Canada|Research Site, Etobicoke, Ontario, Canada|Research Site, Kingston, Ontario, Canada|Research Site, Niagara Falls, Ontario, Canada|Research Site, Oshawa, Ontario, Canada|Research Site, Scarborough, Ontario, Canada|Research Site, St. Catharines, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Chicoutimi, Quebec, Canada|Research Site, Longueuil, Quebec, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Trois-Rivières, Quebec, Canada|Research Site, Helsinki, Finland|Research Site, Kauniainen, Finland|Research Site, Kuopio, Finland|Research Site, Pietarsaari, Finland|Research Site, Pori, Finland|Research Site, Tampere, Finland|Research Site, Guadalajara, Jalisco., Mexico|Research Site, México, D.F., Mexico|Research Site, Nuevo León, Monterrey, Mexico|Research Site, Puebla, Mexico, Mexico|Research Site, Torreon, Mexico|Research Site, Zapopan, Mexico|Research Site, Belfast, United Kingdom|Research Site, Cardiff, United Kingdom|Research Site, Co Antrim N Ireland, United Kingdom|Research Site, Co. Wexford, Ireland, United Kingdom|Research Site, Dublin, United Kingdom|Research Site, Edinburgh, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Kent, United Kingdom|Research Site, Leeds, United Kingdom|Research Site, Mid Glamorgan, United Kingdom|Research Site, Pembrokeshire, United Kingdom|Research Site, Plymouth, United Kingdom|Research Site, Reading, United Kingdom|Research Site, Surrey, United Kingdom|Research Site, Wiltshire, United Kingdom"
NCT00970424,Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone,https://clinicaltrials.gov/study/NCT00970424,TERMINATED,"Diabetes Mellitus, Type II",DRUG: Placebo|DRUG: Dutogliptin,Forest Laboratories,Phenomix,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Forest Investigative Site 064, Birmingham, Alabama, 35205, United States|Forest Investigative Site 020, Birmingham, Alabama, 35235, United States|Forest Investigative Site 059, Chandler, Arizona, 85225, United States|Forest Investigative Site 096, Litchfield, Arizona, 85340, United States|Forest Investigative Site 098, Phoenix, Arizona, 85020, United States|Forest Investigative Site 044, Scottsdale, Arizona, 85254, United States|Forest Investigative Site 087, Tucson, Arizona, 85741, United States|Forest Investigative Site 061, Anaheim, California, 92801, United States|Forest Investigative Site 041, Chula Vista, California, 91911, United States|Forest Investigative Site 049, Encinitas, California, 92024, United States|Forest Investigative Site 022, Greenbrae, California, 94904, United States|Forest Investigative Site 047, Harbor City, California, 90710, United States|Forest Investigative Site 010, Huntington Park, California, 90255, United States|Forest Investigative Site 111, Northridge, California, 91325, United States|Forest Investigative Site 031, Riverside, California, 92506, United States|Forest Investigative Site 091, Roseville, California, 95661, United States|Forest Investigative Site 067, Sacramento, California, 95821, United States|Forest Investigative Site 112, Santa Ana, California, 92701, United States|Forest Investigative Site 011, Walnut Creek, California, 94598, United States|Forest Investigative Site 063, West Hills, California, 91307, United States|Forest Investigative Site 115, Colorado Springs, Colorado, 80910, United States|Forest Investigative Site 073, Clearwater, Florida, 33765, United States|Forest Investigative Site 004, Daytona Beach, Florida, 32117, United States|Forest Investigative Site 052, DeLand, Florida, 32720, United States|Forest Investigative Site 062, Jacksonville, Florida, 32205, United States|Forest Investigative Site 021, Miami, Florida, 33169, United States|Forest Investigative Site 050, Miami, Florida, 33183, United States|Forest Investigative Site 122, Miami, Florida, 33186, United States|Forest Investigative Site 015, Orlando, Florida, 32806, United States|Forest Investigative Site 018, Sarasota, Florida, 34239, United States|Forest Investigative Site 075, St. Petersburg, Florida, 33716, United States|Forest Investigative Site 026, West Palm Beach, Florida, 33401, United States|Forest Investigative Site 045, Atlanta, Georgia, 30338, United States|Forest Investigative Site 079, Augusta, Georgia, 30909, United States|Forest Investigative Site 009, Meridian, Idaho, 83646, United States|Forest Investigative Site 60, Melrose Park, Illinois, 60160, United States|Forest Investigative Site 030, Peoria, Illinois, 61614, United States|Forest Investigative Site 100, Evansville, Indiana, 47710, United States|Forest Investigative Site 097, Evansville, Indiana, 47713, United States|Forest Investigative Site 053, Kansas City, Kansas, 66160, United States|Forest Investigative Site 008, Wichita, Kansas, 67203, United States|Forest Investigative Site 078, Erlanger, Kentucky, 41018, United States|Forest Investigative Site 024, Madisonville, Kentucky, 42431, United States|Forest Investigative Site 034, Covington, Louisiana, 70433, United States|Forest Investigative Site 035, Baltimore, Maryland, 21204, United States|Forest Investigative Site 046, Oxon Hill, Maryland, 20745, United States|Forest Investigative Site 118, New Bedford, Massachusetts, 02740, United States|Forest Investigative Site 007, Waltham, Massachusetts, 02453, United States|Forest Investigative Site 002, Dearborn, Michigan, 48126, United States|Forest Investigative Site 029, St. Clair Shores, Michigan, 48081, United States|Forest Investigative Site 054, Edina, Minnesota, 55435, United States|Forest Investigative Site 013, Grand Island, Nebraska, 68803, United States|Forest Investigative Site 072, Las Vegas, Nevada, 89101, United States|Forest Investigative Site 065, Las Vegas, Nevada, 89117, United States|Forest Investigative Site 081, New Hyde Park, New York, 11042, United States|Forest Investigative Site 016, New York, New York, 10019, United States|Forest Investigative Site 094, Charlotte, North Carolina, 28204, United States|Forest Investigative Site 051, Charlotte, North Carolina, 28209, United States|Forest Investigative Site 117, Charlotte, North Carolina, 28277, United States|Forest Investigative Site 058, Lenoir, North Carolina, 28645, United States|Forest Investigative Site 038, Morehead City, North Carolina, 28557, United States|Forest Investigative Site 040, Salisbury, North Carolina, 28144, United States|Forest Investigative Site 039, Akron, Ohio, 44311, United States|Forest Investigative Site 023, Cincinnati, Ohio, 45242, United States|Forest Investigative Site 043, Columbus, Ohio, 43201, United States|Forest Investigative Site 057, Dayton, Ohio, 45406, United States|Forest Investigative Site 032, Kettering, Ohio, 45429, United States|Forest Investigative Site 149, Norman, Oklahoma, 73069, United States|Forest Investigative Site 102, Ashland, Oregon, 97520, United States|Forest Investigative Site 005, Eugene, Oregon, 97404, United States|Forest Investigative Site 037, Harleysville, Pennsylvania, 19438, United States|Forest Investigative Site 066, Philadelphia, Pennsylvania, 19152, United States|Forest Investigative Site 036, Tipton, Pennsylvania, 16684, United States|Forest Investigative Site 103, Greer, South Carolina, 29651, United States|Forest Investigative Site 090, Manning, South Carolina, 29102, United States|Forest Investigative Site 033, Pelzer, South Carolina, 29669, United States|Forest Investigative Site 114, Chattanooga, Tennessee, 37404, United States|Forest Investigative Site 104, Chattanooga, Tennessee, 37421, United States|Forest Investigative Site 099, Arlington, Texas, 76014, United States|Forest Investigative Site 056, Corpus Christi, Texas, 78404, United States|Forest Investigative Site 017, Dallas, Texas, 75235, United States|Forest Investigative Site 124, Dallas, Texas, 75251, United States|Forest Investigative Site 106, Houston, Texas, 77079, United States|Forest Investigative Site 014, Irving, Texas, 75039, United States|Forest Investigative Site 109, San Antonio, Texas, 78229, United States|Forest Investigative Site 076, Salt Lake City, Utah, 84107, United States|Forest Investigative Site 028, Virginia Beach, Virginia, 23454, United States|Forest Investigative Site 092, Spokane, Washington, 99207, United States|Forest Investigative Site 027, Milwaukee, Wisconsin, 53209, United States|Forest Investigative Site 209, Mogilev, 212030, Belarus|Forest Investigative Site 401, Dresden, 01099, Germany|Forest Investigative Site 402, Dresden, 01307, Germany|Forest Investigative Site 403, Mainz, 55116, Germany|Forest Investigative Site 614, Vijayawada, Andhra Pradesh, 520002, India|Forest Investigative Site 618, Ahmedabad, Gujarat, 380015, India|Forest Investigative Site 620, Haryana, Karnal, 132001, India|Forest Investigative Site 607, Bangalore, Karnataka, 560003, India|Forest Investigative Site 606, Bangalore, Karnataka, 560010, India|Forest Investigative Site 602, Bangalore, Karnataka, 560043, India|Forest Investigative Site 604, Bangalore, Karnataka, 560092, India|Forest Investigative Site 601, Mangalore, Karnataka, 575003, India|Forest Investigative Site 616, Nagpur, Maharashtra, 440012, India|Forest Investigative Site 617, Nasik, Maharashtra, 380015, India|Forest Investigative Site 612, Pune, Maharashtra, 411037, India|Forest Investigative Site 603, Channi, Tamil Nadu, 600020, India|Forest Investigative Site 613, Chennai, Tamil Nadu, 600013, India|Forest Investigative Site 615, Vellore, Tamil Nadu, 632009, India|Forest Investigative Site 702, Kaunas, Lithunia, 48259, Lithuania|Forest Investigative Site 703, Kaunas, Lithunia, 49456, Lithuania|Forest Investigative Site 704, Klaipeda, Lithunia, 92288, Lithuania|Forest Investigative Site 705, Vilnius, Lithunia, 09112, Lithuania|Forest Investigative Site 909, Bacau, 600164, Romania|Forest Investigative Site 906, Bucuresti, 010584, Romania|Forest Investigative Site 908, Bucuresti, 020725, Romania|Forest Investigative Site 903, Satu Mare, 440055, Romania|Forest Investigative Site 901, Sibiu, 550245, Romania|Forest Investigative Site 905 Romania, Tg Mures, 540142, Romania|Forest Investigative Site 902, Timisoara, 300736, Romania"
NCT02053116,A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin,https://clinicaltrials.gov/study/NCT02053116,TERMINATED,Type 2 Diabetes Mellitus,DRUG: PF-05175157|DRUG: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Pfizer Investigational Site, DeLand, Florida, 32720, United States"
NCT01939834,Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes,https://clinicaltrials.gov/study/NCT01939834,TERMINATED,Type 1 Diabetes Mellitus,DEVICE: Overnight CLC|DEVICE: Sensor-Augmented Pump Therapy (SAP),Sue Brown,"DexCom, Inc.|Roche Diagnostics GmbH",ALL,ADULT,,INTERVENTIONAL,"University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, 22903, United States"
NCT00315614,Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00315614,TERMINATED,Type 1 Diabetes Mellitus,BIOLOGICAL: Islet Transplantation and Bone Marrow,University of Miami,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Diabetes Research Institute Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Diabetes Research Institute, Miami, Florida, 33136, United States"
NCT02333851,Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study),https://clinicaltrials.gov/study/NCT02333851,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Mixtard 30:70 Novonordisk® twice daily|DRUG: Lantus® once daily and Apidra® before meals,Hospital Universitario Central de Asturias,Sanofi,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT00995540,"Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults",https://clinicaltrials.gov/study/NCT00995540,TERMINATED,Type 1 Diabetes Mellitus,DRUG: INGAP Peptide|DRUG: INGAP Peptide|DRUG: Placebo,Exsulin Corporation,,ALL,ADULT,PHASE2,INTERVENTIONAL,"Mayo Clinic, Rochester, Minnesota, 55905, United States|McGill University - Montreal General Hospital, Montreal, Quebec, H3G 1A4, Canada"
NCT01614782,"A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)",https://clinicaltrials.gov/study/NCT01614782,TERMINATED,Type 2 Diabetes Mellitus,DRUG: MK-5823|OTHER: Placebo,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,
NCT03537131,Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia,https://clinicaltrials.gov/study/NCT03537131,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: Dapagliflozin 10 MG Oral Tablet,University of Oxford,The Leona M. and Harry B. Helmsley Charitable Trust|Oxford Brookes University,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Clinical Research Unit, OCDEM, Churchill Hospital, Oxford, Oxfordshire, OX3 7LE, United Kingdom"
NCT01961401,Acute Effects of Moderate Versus High Intensity Exercise on Insulin Sensitivity in Gestational Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01961401,TERMINATED,"Diabetes, Gestational",BEHAVIORAL: exercise,Norwegian University of Science and Technology,St. Olavs Hospital,FEMALE,ADULT,,INTERVENTIONAL,"Department of circulation and medical imaging, Trondheim, Norway"
NCT04577976,FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG,https://clinicaltrials.gov/study/NCT04577976,TERMINATED,Diabetes Mellitus,DEVICE: SMBG,Abbott Diabetes Care,,ALL,CHILD,,OBSERVATIONAL,"Florida Institute, Orlando, Florida, 32825, United States|The DOCS, Las Vegas, Nevada, 89113, United States"
NCT01863667,A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027),https://clinicaltrials.gov/study/NCT01863667,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Omarigliptin|DRUG: Glimepiride|DRUG: Omarigliptin Placebo|DRUG: Glimepiride Placebo,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT04624672,Treatment of GLP-1 for Diabetic Bariatric Patients,https://clinicaltrials.gov/study/NCT04624672,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Semaglutide (1 Mg Dose)|DRUG: Placebo,Geisinger Clinic,Novo Nordisk A/S,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Geisinger Medical Center, Danville, Pennsylvania, 17822, United States"
NCT04090242,Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes,https://clinicaltrials.gov/study/NCT04090242,TERMINATED,"Diabetes Mellitus, Type 2",DEVICE: BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle,"Becton, Dickinson and Company",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Mills Pennisula Medical Center-Diabetes Research Institute, San Mateo, California, 94401, United States|Metabolic Research Institute, West Palm Beach, Florida, 33401, United States|East West Medical Research Institute, Honolulu, Hawaii, 96814, United States|Texas Diabetes and Endocrinology, Austin, Texas, 78749, United States"
NCT03368209,Noninvasive Glucose Measurements - Database and Calibration Compilation,https://clinicaltrials.gov/study/NCT03368209,TERMINATED,Diabetes,DEVICE: WM3.4,RSP Systems A/S,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Endocrinology M, Odense University Hospital, Odense, 5000, Denmark"
NCT05168306,T2 FSL2 Weight Loss,https://clinicaltrials.gov/study/NCT05168306,TERMINATED,"Diabetes Mellitus, Type 2",DEVICE: FreeStyle Libre 2 Flash Glucose Monitoring System,Abbott Diabetes Care,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Rainier Clinical Research Center, Renton, Washington, 98057, United States"
NCT00920582,Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00920582,TERMINATED,Type 1 Diabetes Mellitus,BIOLOGICAL: Teplizumab Herold Regimen|DRUG: Placebo|BIOLOGICAL: Teplizumab 33.3% Herold Regimen|BIOLOGICAL: Teplizumab Curtailed Herold Regimen,MacroGenics,Eli Lilly and Company,ALL,"CHILD, ADULT",PHASE3,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|NEA Clinic, Jonesboro, Arkansas, 72401, United States|Arkansas Children's Hospital, Little Rock, Arkansas, 72272, United States|Clinical Innovations Inc. Research Facility, Costa Mesa, California, 92626, United States|Axis Clinical Trials, Los Angeles, California, 90036, United States|Diabetes Associates Medical Group, Inc, Orange, California, 92868, United States|Clinical Innovations, Inc., Riverside, California, 92506, United States|San Diego Clinical Trials, San Diego, California, 92120, United States|Ronald Chochinov Md Inc, Ventura, California, 93003, United States|Yale University, New Haven, Connecticut, 06519, United States|Christiana Care Research Institute, Newark, Delaware, 19713, United States|Richard Hays, MD, Wellington, Florida, 33414, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|John H Stoger Jr. Hospital of Cook County, Cook County Hospital, Chicago, Illinois, 60612, United States|Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States|University of Iowa Children's Hospital, Iowa City, Iowa, 52242-1083, United States|Mid-America Diabetes Associates, Wichita, Kansas, 67211, United States|St. Agnes Hospital, Baltimore, Maryland, 21229, United States|Maryland Diabetes & Endocrine Associates, Rockville, Maryland, 20852, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Alzohaili Medical Consultants, Dearborn, Michigan, 48126, United States|Children's Hospitals and Clinics of Minnesota, Saint Paul, Minnesota, 55102, United States|University of Missouri - Columbia, Cosmopolitan Diabetes and Endocrinology, Columbia, Missouri, 65212, United States|The Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Saint Barnabas Medical Center, Livingston, New Jersey, 07039, United States|Albany Medical College, Albany, New York, 12208, United States|Bassett Healthcare, Cooperstown, New York, 13326, United States|East Carolina University, Brody School of Medicine, Greenville, North Carolina, 27834, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|GHS Pediatric Endocrinology, Greenville, South Carolina, 29615, United States|AM Diabetes & Endocrinology Center, Bartlett, Tennessee, 38133, United States|University Diabetes & Endocrine Consultants, Chattanooga, Tennessee, 37403, United States|LeBonheur Children's Medical Center, Memphis, Tennessee, 38103, United States|Research Institute of Dallas, Dallas, Texas, 75231, United States|Southwest Clinical Trials, Houston, Texas, 77074, United States|Houston Center for Clinical Research, Houston, Texas, 77081, United States|Medical & Surgical Clinic of Irving, Irving, Texas, 75061, United States|InVisions Consultants, LLC, San Antonio, Texas, 78217, United States|Diabetes and Glandular Disease Research Associates, PA, San Antonio, Texas, 78229, United States|Endocrine Research Specialists, Ogden, Utah, 84403, United States|Virginia Commonwealth University-Division of Pediatric Endocrinology & Metabolism, Richmond, Virginia, 23219, United States|University of Washington, Seattle, Washington, 98122, United States|Universitair Ziekenhuis Antwerpen, Edegem, Antwerp, 2650, Belgium|Cliniques du Sud Luxembourg - Vivalia, Arlon, 6700, Belgium|I. Detska interni klinika,Fakultni nemocnice Brno Detska nemocnice, Brno, 62500, Czechia|Klinika deti a dorostu FN Kralovske Vinohrady, Praha, 10034, Czechia|Centrum diabetologie, Institut klinicke a experimentalni mediciny, Praha, 14021, Czechia|Pediatricka klinika UK 2.LF a FN Motol, Fakultni nemocnice v Motole, Praha, 15006, Czechia|Detska klinika, Masarykova nemocnice v Usti nad Labem, o.z., Usti nad Labem, 40113, Czechia|Kuopio University Hospital, Kuopio, 70210, Finland|Central Hospital of Mikkeli, Mikkeli, 50100, Finland|Oulu University Hospital, Oulu, 90029, Finland|CHU de Besançon, Besançon, 25030, France|CHU de Brest Hôpital de la Cavale Blanche, Brest, 29609, France|Centre Hospitalier Sud Francilien, Corbeil-Essonnes, 91106, France|CHU de Bordeaux, Pessac, 33604, France|CHU de Reims, Reims, 51092, France|Hôpitaux Universitaires de Strasbourg Hôpital Civil, Strasbourg, 67091, France|Diabetes-Klinik Bad Nauheim GmbH, Bad Nauheim, 61231, Germany|Herz und Diabeteszentrum Nordrhein-Westfallen, Bad Oeynhausen, 32545, Germany|Charite, Campus Benjamin Franklin, Berlin, 12200, Germany|Universitätsklinikum Düsseldorf, Düsseldorf, 20225, Germany|Universitatsklinik Giessen, Giessen, 35392, Germany|Asklepios Westklinikum Hamburg, Hamburg, 22559, Germany|Kinderkrankenhaus auf der Bult, Hannover, 30173, Germany|Universitatsklinikum Heidelberg, Heidelberg, 69120, Germany|Medwin Hospitals, Hyderabad, Andhra Pradesh, 500001, India|King George Hospital, Visakhapatnam, Andhra Pradesh, 530002, India|Maulana Azad Medical College and Associated Hospitals, New Delhi, Delhi, 110002, India|DHL Research Centre, Ahmedabad, Gujarat, 380015, India|Bangalore Diabetes Centre, Bangalore, Karnataka, 560043, India|Health & Research Centre, Trivandrum, Kerala, 695011, India|Gandhi's Research Institute, Nagpur, Maharashtra, 440010, India|Grant Medical Foundation, Pune, Maharashtra, 411001, India|KEM Hospital Research Center, Pune, Maharashtra, 411011, India|Kalinga Hospital Limited, Bhubaneswar, Orissa, 751023, India|Diabetes-Thyroid-Hormone Research Institute Pvt. Ltd., Madhya, Pradesh, 452001, India|Dayanand Medical College and Hospital, Ludhiana, Punjab, 141001, India|Fortis Escorts Hospital, Jaipur, Rajasthan, 302017, India|Hormone Care & Research Center, Ghaziabad, Uttar Pradesh, 201002, India|B. P. Poddar Hospital & Medical Research Limited, Kolkata, West Bengal, 700053, India|Apollo Glenagles Hospital, Kolkata, West Bengal, 700054, India|Hillel Yaffe Medical Center, Hadera, 38100, Israel|Mayer Children's Hospital of Haifa, Haifa, 31096, Israel|The E. Wolfson Medical Center, Holon, 58100, Israel|Schneider Children's Medical, Petach-Tikva, 49202, Israel|The Safra Children's Hospital, The Chaim Sheba Medical Center, Ramat-Gan, 52621, Israel|Struttura Complessa di Pediatria, Azienda Ospedaliero-Universitaria di Modena,, Modena, 41124, Italy|U.O. di Malattie del Metabolismo, Pisa, 16132, Italy|U.O. di Malattie Metaboliche e Diabetologia, Pisa, 56124, Italy|Hospital y Clinica OCA / Monterrey International Research Center, Monterrey, Nuevo León, 64000, Mexico|Medical Care & Research, Merida, Yucatan, 97070, Mexico|Centro Especializado en Diabetes, Obesidad y Prevención de Enfermedades Cardiovasculares, S.C., Mexico, Distrito Federal, 11650, Mexico|Stichting Diabeter, Rotterdam, 3011 TG, Netherlands|Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, 15-276, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-952, Poland|Wojewódzki Specjalistyczny Szpital Dzieciecy, Kielce, 25-734, Poland|Samodzielny Publiczny Dzieciecy Szpital Kliniczny w Warszawie-Filia, Warszawa, 01-184, Poland|Samodzielny Publiczny Szpital Kliniczny Nr1 we Wroclawiu, Wroclaw, 50-376, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny Nr 4, Łódź, 91-738, Poland|S.C. Minimed S.R.L., Bacau, 600164, Romania|Institutul National De Diabet, Nutritie si Boli Metabolice, Bucuresti, 020045, Romania|Spitalul Judetean de Urgenta Satu Mare, Satu-Mare, 440055, Romania|Hospital Universitario Principe de Asturias, Alcala de Henares, 28805, Spain|Hospital Dr. Josep Trueta, Girona, 17007, Spain|Donetsk Regional Children Clinical Hospital, Donetsk, 83052, Ukraine|Ivano-Frankivsk Regional Clinical Hospital, Ivano-Frankivsk, 76008, Ukraine|Ivano-Frankivsk State Regional Pediatric Clinical Hospital, Ivano-Frankivsk, 76014, Ukraine|Kharkiv Regional Clinical Children Hospital, Department of Endocrinology, Kharkiv, 61093, Ukraine|Ukrainian Children Specialized Clinical Hospital, Kyiv, 01135, Ukraine|Institute of Endocrinology and Metabolism named after V.Komisarenko of AMS Ukraine, Kyiv, 04114, Ukraine|Regional Clinical Endocrinology Dispensary of MoH Ukraine, Vinnitsa, 21010, Ukraine|George Eliot Hospital NHS Trust, Nuneaton, Warwickshire, CV10 7DJ, United Kingdom|University of Bristol Henery Wellcome laboratories for Integrative Neuroscience and Endocrinology,, Bristol, BS1 3NY, United Kingdom|Aintree University Hospitals NHS Foundation Trust, Liverpool, L9 7AL, United Kingdom|Kings College, Clinical Research Unit, Department of Diabetes and Endocrinology, London, SE1 9RT, United Kingdom|Queens Medical Centre, Diabetes and Endocrinology Unit, Nottingham, NG7 2UH, United Kingdom|Sheffield Children's Hospital NHS Foundation Trust, Sheffield, S10 2IH, United Kingdom"
NCT00294723,To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c,https://clinicaltrials.gov/study/NCT00294723,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: liraglutide|DRUG: glimepiride|DRUG: liraglutide|DRUG: placebo|DRUG: placebo|DRUG: placebo,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Concord, California, 94520, United States|Novo Nordisk Investigational Site, Escondido, California, 92025, United States|Novo Nordisk Investigational Site, Fullerton, California, 92835, United States|Novo Nordisk Investigational Site, Inglewood, California, 90301, United States|Novo Nordisk Investigational Site, Mission Viejo, California, 92691, United States|Novo Nordisk Investigational Site, Orange, California, 92869, United States|Novo Nordisk Investigational Site, Santa Barbara, California, 93105, United States|Novo Nordisk Investigational Site, Spring Valley, California, 91978, United States|Novo Nordisk Investigational Site, Vista, California, 92084, United States|Novo Nordisk Investigational Site, Walnut Creek, California, 94598, United States|Novo Nordisk Investigational Site, Daytona Beach, Florida, 32117, United States|Novo Nordisk Investigational Site, Delray Beach, Florida, 33484, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32205, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32216, United States|Novo Nordisk Investigational Site, Longwood, Florida, 32779, United States|Novo Nordisk Investigational Site, Ocala, Florida, 34471, United States|Novo Nordisk Investigational Site, St. Cloud, Florida, 34769, United States|Novo Nordisk Investigational Site, Athens, Georgia, 30606, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30032, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30034, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30318, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30339, United States|Novo Nordisk Investigational Site, Blue Ridge, Georgia, 30513, United States|Novo Nordisk Investigational Site, Columbus, Georgia, 31904, United States|Novo Nordisk Investigational Site, Marietta, Georgia, 30060, United States|Novo Nordisk Investigational Site, Powder Springs, Georgia, 30127, United States|Novo Nordisk Investigational Site, Tucker, Georgia, 30084, United States|Novo Nordisk Investigational Site, Honolulu, Hawaii, 96813, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60611, United States|Novo Nordisk Investigational Site, Maywood, Illinois, 60153, United States|Novo Nordisk Investigational Site, Indianapolis, Indiana, 46202, United States|Novo Nordisk Investigational Site, Des Moines, Iowa, 50314, United States|Novo Nordisk Investigational Site, Shawnee Mission, Kansas, 66204, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Lexington, Kentucky, 40503, United States|Novo Nordisk Investigational Site, Lexington, Kentucky, 40536, United States|Novo Nordisk Investigational Site, New Orleans, Louisiana, 70121, United States|Novo Nordisk Investigational Site, Baltimore, Maryland, 21218, United States|Novo Nordisk Investigational Site, Hyattsville, Maryland, 20782, United States|Novo Nordisk Investigational Site, Minneapolis, Minnesota, 55407, United States|Novo Nordisk Investigational Site, St. Paul, Minnesota, 55108, United States|Novo Nordisk Investigational Site, Jackson, Mississippi, 39216, United States|Novo Nordisk Investigational Site, Tupelo, Mississippi, 38801, United States|Novo Nordisk Investigational Site, Chesterfield, Missouri, 63017, United States|Novo Nordisk Investigational Site, St. Louis, Missouri, 63104, United States|Novo Nordisk Investigational Site, St. Louis, Missouri, 63110, United States|Novo Nordisk Investigational Site, St. Peters, Missouri, 63376, United States|Novo Nordisk Investigational Site, Butte, Montana, 59701, United States|Novo Nordisk Investigational Site, Omaha, Nebraska, 68114, United States|Novo Nordisk Investigational Site, Reno, Nevada, 89502, United States|Novo Nordisk Investigational Site, Berlin, New Jersey, 08009, United States|Novo Nordisk Investigational Site, Lawrenceville, New Jersey, 08648, United States|Novo Nordisk Investigational Site, Plainsboro, New Jersey, 08536, United States|Novo Nordisk Investigational Site, Albany, New York, 12206, United States|Novo Nordisk Investigational Site, Lewiston, New York, 14092, United States|Novo Nordisk Investigational Site, New York, New York, 10023, United States|Novo Nordisk Investigational Site, Northport, New York, 11768, United States|Novo Nordisk Investigational Site, Staten Island, New York, 10301, United States|Novo Nordisk Investigational Site, Syracuse, New York, 13210, United States|Novo Nordisk Investigational Site, West Seneca, New York, 14224, United States|Novo Nordisk Investigational Site, Asheville, North Carolina, 28803, United States|Novo Nordisk Investigational Site, Charlotte, North Carolina, 28277, United States|Novo Nordisk Investigational Site, Durham, North Carolina, 27710, United States|Novo Nordisk Investigational Site, Greensboro, North Carolina, 27408, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44195, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45439, United States|Novo Nordisk Investigational Site, Mentor, Ohio, 44060, United States|Novo Nordisk Investigational Site, Oklahoma City, Oklahoma, 73103, United States|Novo Nordisk Investigational Site, Oklahoma City, Oklahoma, 73104, United States|Novo Nordisk Investigational Site, Tulsa, Oklahoma, 74104, United States|Novo Nordisk Investigational Site, Bend, Oregon, 97710, United States|Novo Nordisk Investigational Site, Eugene, Oregon, 97401, United States|Novo Nordisk Investigational Site, Medford, Oregon, 97504-8491, United States|Novo Nordisk Investigational Site, Medford, Oregon, 97504, United States|Novo Nordisk Investigational Site, Lancaster, Pennsylvania, 17601, United States|Novo Nordisk Investigational Site, Norristown, Pennsylvania, 19401, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Novo Nordisk Investigational Site, East Providence, Rhode Island, 02914, United States|Novo Nordisk Investigational Site, Greer, South Carolina, 29651, United States|Novo Nordisk Investigational Site, Spartanburg, South Carolina, 29303, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37411, United States|Novo Nordisk Investigational Site, Arlington, Texas, 76014, United States|Novo Nordisk Investigational Site, Corpus Christi, Texas, 78412, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75208, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75224, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75230, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75231, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75246, United States|Novo Nordisk Investigational Site, Houston, Texas, 77024, United States|Novo Nordisk Investigational Site, Houston, Texas, 77025, United States|Novo Nordisk Investigational Site, Houston, Texas, 77030, United States|Novo Nordisk Investigational Site, Houston, Texas, 77074, United States|Novo Nordisk Investigational Site, Midland, Texas, 79707, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Salt Lake City, Utah, 84132, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23249, United States|Novo Nordisk Investigational Site, Edmonds, Washington, 98026-7610, United States|Novo Nordisk Investigational Site, Olympia, Washington, 98502, United States|Novo Nordisk Investigational Site, Renton, Washington, 98057, United States|Novo Nordisk Investigational Site, Spokane, Washington, 99218, United States|Novo Nordisk Investigational Site, Tacoma, Washington, 98405, United States|Novo Nordisk Investigational Site, Guadalajara, Jalisco, 44650, Mexico|Novo Nordisk Investigational Site, Cuernavaca, Morelos, 62250, Mexico|Novo Nordisk Investigational Site, Monterrey, Nuevo León, 64460, Mexico|Novo Nordisk Investigational Site, Chihuahua, Chih, 31000, Mexico|Novo Nordisk Investigational Site, Ciudad de México, D.F., 06100, Mexico|Novo Nordisk Investigational Site, Ciudad de México, D.F., 14050, Mexico|Novo Nordisk Investigational Site, Guadalajara, 44600, Mexico|Novo Nordisk Investigational Site, Hermosillo, Son., 83000, Mexico|Novo Nordisk Investigational Site, Mexico D.F., 06700, Mexico|Novo Nordisk Investigational Site, Mexico, D.F., 01120, Mexico|Novo Nordisk Investigational Site, Monterrey, N.L., 64000, Mexico|Novo Nordisk Investigational Site, Monterrey, NL, 66260, Mexico|Novo Nordisk Investigational Site, Santiago de Querétaro, Qro., 76178, Mexico|Novo Nordisk Investigational Site, Tampico, 80109, Mexico|Novo Nordisk Investigational Site, Rio Piedras, 00921, Puerto Rico"
NCT06414824,The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes,https://clinicaltrials.gov/study/NCT06414824,TERMINATED,"Diabetes Mellitus, Type 1",DEVICE: Intermittently Scanned Continuous Glucose Monitoring|DEVICE: Standard Blood Glucose Monitoring,Jagiellonian University,Diabetes Poland,ALL,ADULT,,INTERVENTIONAL,"Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland|Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland|Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland|Department of Internal Medicine, Diabetology, and Cardiometabolic Disorders, Medical University of Silesia in Katowice, Zabrze, Poland"
NCT03562767,Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes,https://clinicaltrials.gov/study/NCT03562767,TERMINATED,"Diabetes Mellitus, Type 2",BEHAVIORAL: Group-based Cognitive Behavioral Intervention|BEHAVIORAL: Web-based Cognitive Behavioral Intervention|BEHAVIORAL: Usual Care,Emory University,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Emory Dunwoody Clinic, Atlanta, Georgia, 30338, United States"
NCT00950534,Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care,https://clinicaltrials.gov/study/NCT00950534,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: INSULIN GLARGINE (HOE901)|DRUG: Oral Anti Diabetics (OAD),Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Macquarie Park, Australia"
NCT01333514,Carbohydrate Consumption as a Factor in Aspart Dosing,https://clinicaltrials.gov/study/NCT01333514,TERMINATED,Diabetes,DRUG: aspart|DRUG: aspart- Insulin,Rush University Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Rush University Medical Center, Chicago, Illinois, 60612, United States"
NCT00846391,A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2),https://clinicaltrials.gov/study/NCT00846391,TERMINATED,Type 2 Diabetes Mellitus,DRUG: MK8245 5 mg (twice a day) b.i.d.|DRUG: MK8245 50 mg b.i.d.|DRUG: Placebo,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00767000,Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED),https://clinicaltrials.gov/study/NCT00767000,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK-0941|DRUG: Comparator: Placebo|BIOLOGICAL: Lantus|DRUG: Metformin,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00878605,Development of A Novel Anti-Hyperglycemic Agent,https://clinicaltrials.gov/study/NCT00878605,TERMINATED,Diabetes,DRUG: Cyclo-Z|DRUG: Placebo,VA Office of Research and Development,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, 90073, United States"
NCT04107935,"Telemedicine for Reach, Education, Access and Treatment-ongoing",https://clinicaltrials.gov/study/NCT04107935,TERMINATED,Diabetes Mellitus,BEHAVIORAL: TREAT-ON|BEHAVIORAL: Usual Care,University of Pittsburgh,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States"
NCT03760965,Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise,https://clinicaltrials.gov/study/NCT03760965,TERMINATED,Type 2 Diabetes Mellitus,DRUG: sotagliflozin (SAR439954)|DRUG: placebo,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 1560001, Beijing, 100044, China|Investigational Site Number 1560003, Beijing, 100730, China|Investigational Site Number 1560004, Beijing, 100730, China|Investigational Site Number 1560002, Beijing, 101200, China|Investigational Site Number 1560007, Changchun, 130021, China|Investigational Site Number 1560008, Changchun, 130041, China|Investigational Site Number 1560024, Chongqing, 400010, China|Investigational Site Number 1560022, Guangzhou, 510120, China|Investigational Site Number 1560033, Guangzhou, 510150, China|Investigational Site Number 1560021, Guangzhou, China|Investigational Site Number 1560029, Harbin, 150001, China|Investigational Site Number 1560009, Hohhot, 010017, China|Investigational Site Number 1560014, Huai'An, 223300, China|Investigational Site Number 1560019, Huzhou, China|Investigational Site Number 1560025, Jining, China|Investigational Site Number 1560027, Jining, China|Investigational Site Number 1560012, Luoyang, China|Investigational Site Number 1560013, Pingxiang, 337055, China|Investigational Site Number 1560034, Qingdao, 266011, China|Investigational Site Number 1560026, Qingdao, 266042, China|Investigational Site Number 1560017, Shanghai, 200040, China|Investigational Site Number 1560016, Shanghai, China|Investigational Site Number 1560006, Shijiazhuang, China|Investigational Site Number 1560005, Tianjin, 300211, China|Investigational Site Number 1560035, Wuhan, 430000, China|Investigational Site Number 1560023, Xuzhou, 221006, China|Investigational Site Number 1560028, Yinchuan, 750004, China|Investigational Site Number 1560032, Yuncheng, 044000, China|Investigational Site Number 1560015, Zhuzhou, 412007, China"
NCT00947557,Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin,https://clinicaltrials.gov/study/NCT00947557,TERMINATED,"Diabetes Mellitus, Type II",DRUG: Dutogliptin|DRUG: Placebo,Forest Laboratories,Phenomix,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Forest Investigative Site 064, Birmingham, Alabama, 35205, United States|Forest Investigative Site 020, Birmingham, Alabama, 35235, United States|Forest Investigative Site 025, Muscle Shoals, Alabama, 35661, United States|Forest Investigative Site 059, Chandler, Arizona, 85225, United States|Forest Investigative Site 113, Gilbert, Arizona, 85295, United States|Forest Investigative Site 096, Litchfield, Arizona, 85340, United States|Forest Investigative Site 080, Peoria, Arizona, 85381, United States|Forest Investigative Site 098, Phoenix, Arizona, 85020, United States|Forest Investigative Site 044, Scottsdale, Arizona, 85254, United States|Forest Investigative Site 061, Anaheim, California, 92801, United States|Forest Investigative Site 041, Chula Vista, California, 91911, United States|Forest Investigative Site 049, Encinitas, California, 92024, United States|Forest Investigative Site 022, Greenbrae, California, 94904, United States|Forest Investigative Site 047, Harbor City, California, 90710, United States|Forest Investigative Site 010, Huntington Park, California, 90255, United States|Forest Investigative Site 070, Los Angeles, California, 90057, United States|Forest Investigative Site 111, Northridge, California, 91325, United States|Forest Investigative Site 031, Riverside, California, 92506, United States|Forest Investigative Site 091, Roseville, California, 95661, United States|Forest Investigative Site 067, Sacramento, California, 95821, United States|Forest Investigative Site 112, Santa Ana, California, 92701, United States|Forest Investigative Site 011, Walnut Creek, California, 94598, United States|Forest Investigative Site 063, West Hills, California, 91307, United States|Forest Investigative Site 088, Denver, Colorado, 80239, United States|Forest Investigative Site 156, Boca Raton, Florida, 33432, United States|Forest Investigative Site 004, Daytona Beach, Florida, 32117, United States|Forest Investigative Site 052, DeLand, Florida, 32720, United States|Forest Investigative Site 129, Hollywood, Florida, 33021, United States|Forest Investigative Site 062, Jacksonville, Florida, 32205, United States|Forest Investigative Site 125, Miami Lakes, Florida, 33014, United States|Forest Investigative Site 050, Miami, Florida, 33156, United States|Forest Investigative Site 021, Miami, Florida, 33169, United States|Forest Investigative Site 122, Miami, Florida, 33186, United States|Forest Investigative Site 069, New Port Richey, Florida, 34652, United States|Forest Investigative Site 012, Ocala, Florida, 34471, United States|Forest Investigative Site 015, Orlando, Florida, 32806, United States|Forest Investigative Site 131, Ormond Beach, Florida, 32174, United States|Forest Investigative Site 127, Pembroke Pines, Florida, 33028, United States|Forest Investigative Site 018, Sarasota, Florida, 34239, United States|Forest Investigative Site 075, St. Petersburg, Florida, 33716, United States|Forest Investigative Site 026, West Palm Beach, Florida, 33401, United States|Forest Investigative Site 045, Atlanta, Georgia, 30338, United States|Forest Investigative Site 079, Augusta, Georgia, 30909, United States|Forest Investigative Site 084, Roswell, Georgia, 30076, United States|Forest Investigative Site 132, Roswell, Georgia, 30076, United States|Forest Investigative Site 009, Meridian, Idaho, 83646, United States|Forest Investigative Site 030, Peoria, Illinois, 61614, United States|Forest Investigative Site 100, Evansville, Indiana, 47710, United States|Forest Investigative Site 097, Evansville, Indiana, 47713, United States|Forest Investigative Site 053, Kansas City, Kansas, 66160, United States|Forest Investigative Site 008, Wichita, Kansas, 67203, United States|Forest Investigative Site 107, Lexington, Kentucky, 40504, United States|Forest Investigative Site 034, Covington, Louisiana, 70433, United States|Forest Investigative Site 035, Baltimore, Maryland, 21204, United States|Forest Investigative Site 046, Oxon Hill, Maryland, 20745, United States|Forest Investigative Site 003, Brockton, Massachusetts, 02301, United States|Forest Investigative Site 055, Brockton, Massachusetts, 23301, United States|Forest Investigative Site 118, New Bedford, Massachusetts, 02740, United States|Forest Investigative Site 007, Waltham, Massachusetts, 24453, United States|Forest Investigative Site 002, Dearborn, Michigan, 48126, United States|Forest Investigative Site 029, St. Clair Shores, Michigan, 48081, United States|Forest Investigative Site 054, Edina, Minnesota, 55435, United States|Forest Investigative Site 072, Las Vegas, Nevada, 89101, United States|Forest Investigative Site 065, Las Vegas, Nevada, 89117, United States|Forest Investigative Site 101, Albuquerque, New Mexico, 87108, United States|Forest Investigative Site 081, New Hyde Park, New York, 11042, United States|Forest Investigative Site 016, New York, New York, 10019, United States|Forest Investigative Site 094, Charlotte, North Carolina, 28204, United States|Forest Investigative Site 051, Charlotte, North Carolina, 28209, United States|Forest Investigative Site 058, Lenoir, North Carolina, 28645, United States|Forest Investigative Site 038, Morehead City, North Carolina, 28557, United States|Forest Investigative Site 040, Salisbury, North Carolina, 28144, United States|Forest Investigative Site 082, Winston-Salem, North Carolina, 27103, United States|Forest Investigative Site 039, Akron, Ohio, 44311, United States|Forest Investigative Site 023, Cincinnati, Ohio, 45242, United States|Forest Investigative Site 043, Columbus, Ohio, 43201, United States|Forest Investigative Site 057, Dayton, Ohio, 45406, United States|Forest Investigative Site 032, Kettering, Ohio, 45429, United States|Forest Investigative Site 083, Bethany, Oklahoma, 73008, United States|Forest Investigative Site 005, Eugene, Oregon, 97404, United States|Forest Investigative Site 001, Medford, Oregon, 97504, United States|Forest Investigative Site 126, Jenkintown, Pennsylvania, 19046, United States|Forest Investigative Site 066, Philadelphia, Pennsylvania, 19152, United States|Forest Investigative Site 036, Tipton, Pennsylvania, 16684, United States|Forest Investigative Site 103, Greer, South Carolina, 29651, United States|Forest Investigative Site 033, Pelzer, South Carolina, 29669, United States|Forest Investigative Site 114, Chattanooga, Tennessee, 37404, United States|Forest Investigative Site 104, Chattanooga, Tennessee, 37421, United States|Forest Investigative Site 099, Arlington, Texas, 76014, United States|Forest Investigative Site 056, Corpus Christi, Texas, 78404, United States|Forest Investigative Site 071, Dallas, Texas, 75230, United States|Forest Investigative Site 017, Dallas, Texas, 75235, United States|Forest Investigative Site 014, Irving, Texas, 75039, United States|Forest Investigative Site 109, San Antonio, Texas, 78229, United States|Forest Investigative Site 119, San Antonio, Texas, 78258, United States|Forest Investigative Site 076, Salt Lake City, Utah, 84107, United States|Forest Investigative Site 028, Virginia Beach, Virginia, 23454, United States|Forest Investigative Site 068, Renton, Washington, 98057, United States|Forest Investigative Site 202, Gomel, 236029, Belarus|Forest Investigative Site 208, Grodno, 230015, Belarus|Forest Investigative Site 207, Minsk, 220114, Belarus|Forest Investigative Site 209, Mogilev, 212030, Belarus|Forest Investigative Site 206, Vitebsk, 210037, Belarus|Forest Investigative Site 302, Medellin, Antioquia, Colombia|Forest Investigative Site 506, Budapest, H-1083, Hungary|Forest Investigative Site 504, Szentes, H-6600, Hungary|Forest Investigative Site 621, Hyderabad, Andhra Pradesh, 500034, India|Forest Investigative Site 614, Vijayawada, Andhra Pradesh, 520002, India|Forest Investigative Site 610, Visakhapatanam, Andhra Pradesh, 530002, India|Forest Investigative Site 609, Mapusa, Goa, 403507, India|Forest Investigative Site 618, Ahmedabad, Gujarat, 380015, India|Forest Investigative Site 620, Haryana, Karnal, 132001, India|Forest Investigative Site 607, Bangalore, Karnataka, 560003, India|Forest Investigative Site 606, Bangalore, Karnataka, 560010, India|Forest Investigative Site 602, Bangalore, Karnataka, 560043, India|Forest Investigative Site 604, Bangalore, Karnataka, 560092, India|Forest Investigative Site 601, Mangalore, Karnataka, 575003, India|Forest Investigative Site 619, Palakkad, Kerala, 678013, India|Forest Investigative Site 616, Nagpur, Maharashtra, 440012, India|Forest Investigative Site 617, Nasik, Maharashtra, 380015, India|Forest Investigative Site 612, Pune, Maharashtra, 411037, India|Forest Investigative Site 603, Channi, Tamil Nadu, 600020, India|Forest Investigative Site 613, Chennai, Tamil Nadu, 600013, India|Forest Investigative Site 615, Vellore, Tamil Nadu, 632009, India|Forest Investigative Site 702, Kaunas, 48259, Lithuania|Forest Investigative Site 703, Kaunas, 49456, Lithuania|Forest Investigative Site 701, Kaunas, 51270, Lithuania|Forest Investigative Site 704, Klaipeda, 92288, Lithuania|Forest Investigative Site 705, Vilnius, 09112, Lithuania|Forest Investigative Site 812, Trujillo, La Libertad, Peru|Forest Investigative Site 811, Chiclayo, Lambayeque, Peru|Forest Investigative Site 804, Arequipa, 804, Peru|Forest Investigative Site 803, Arequipa, Peru|Forest Investigative Site 805, Lima, Lima 14, Peru|Forest Investigative Site 813, Lima, Lima 17, Peru|Forest Investigative Site 801, Lima, Lima 27, Peru|Forest Investigative Site 807, Lima, Lima 27, Peru|Forest Investigative Site 809, Lima, Lima 33, Peru|Forest Investigative Site 808, Lima, Lima 41, Peru|Forest Investigative Site 802, Piura, Peru|Forest Investigative Site 909, Bacau, 600164, Romania|Forest Investigative Site 906, Bucuresti, 010584, Romania|Forest Investigative Site 908, Bucuresti, 020725, Romania|Forest Investigative Site 903, Satu Mare, 440055, Romania|Forest Investigative Site 901, Sibiu, 550245, Romania|Forest Investigative Site 905, Tg Mures, 540142, Romania|Forest Investigative Site 902, Timisoara, 300736, Romania"
NCT04606576,Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT04606576,TERMINATED,Type 2 Diabetes Mellitus,OTHER: Placebo|DRUG: ORMD-0801 QD|DRUG: ORMD-0801 BD,"Oramed, Ltd.",Integrium,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Orange County Research Center (OCRC) 14351 Myford Rd., Suite B, Tustin, CA 92780, Tustin, California, 92780, United States"
NCT02120976,"Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252",https://clinicaltrials.gov/study/NCT02120976,TERMINATED,Diabetes Mellitus,DRUG: JTT-252 or Placebo|DRUG: JTT-252,Akros Pharma Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Overland Park, Kansas, United States|Austin, Texas, United States"
NCT02020616,A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02020616,TERMINATED,Type 2 Diabetes Mellitus,DRUG: LY3053102|DRUG: Exenatide ER|DRUG: Placebo|DRUG: Metformin,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Orange County Research Center, Orange, California, 92868, United States|Miami Research Associates, Miami, Florida, 33143, United States|Compass Research, Orlando, Florida, 32806, United States|Clinilabs, Inc (New York), New York, New York, 10019, United States|Dallas Diabetes Endocrine Center, Dallas, Texas, 75230, United States"
NCT03544892,"The Effects of a Low Carbohydrate, Non-Ketogenic Diet Versus Standard Diabetes Diet on Glycemic Control in Type 1 Diabetes",https://clinicaltrials.gov/study/NCT03544892,TERMINATED,"Diabetes Mellitus, Type 1",OTHER: Low carbohydrate diet|OTHER: Standard of care diet,University of Oklahoma,,ALL,ADULT,,INTERVENTIONAL,"University of Oklahoma Harold Hamm Diabetes Center, Tulsa, Oklahoma, 74135, United States"
NCT03889496,Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin,https://clinicaltrials.gov/study/NCT03889496,TERMINATED,Diabetes Mellitus,RADIATION: indium-111-exendin SPECT/CT,Radboud University Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Radboud university medical center, Nijmegen, Gelderland, 6525 GA, Netherlands"
NCT00887445,First in Man Study With SLV341,https://clinicaltrials.gov/study/NCT00887445,TERMINATED,Diabetes,DRUG: SLV341|DRUG: placebo,Solvay Pharmaceuticals,"Quintiles, Inc.",MALE,ADULT,PHASE1,INTERVENTIONAL,"S341.1.001 Site #, London, United Kingdom"
NCT03761134,Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea,https://clinicaltrials.gov/study/NCT03761134,TERMINATED,Type 2 Diabetes Mellitus,DRUG: sotagliflozin (SAR439954)|DRUG: placebo|DRUG: metformin|DRUG: sulfonylurea,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 1560039, Baotou, 014010, China|Investigational Site Number 1560040, Baotou, 014010, China|Investigational Site Number 1560001, Beijing, 100029, China|Investigational Site Number 1560038, Beijing, 100191, China|Investigational Site Number 1560035, Cangzhou, 061000, China|Investigational Site Number 1560020, Changchun, 130033, China|Investigational Site Number 1560012, Changchun, 130041, China|Investigational Site Number 1560011, Changsha, 410011, China|Investigational Site Number 1560021, Changzhou, 213003, China|Investigational Site Number 1560024, Chongqing, 400010, China|Investigational Site Number 1560028, Dalian, 116011, China|Investigational Site Number 1560010, Dalian, 116033, China|Investigational Site Number 1560036, Dalian, China|Investigational Site Number 1560030, Fuzhou, 354200, China|Investigational Site Number 1560032, Guangzhou, 510080, China|Investigational Site Number 1560027, Guangzhou, 510180, China|Investigational Site Number 1560041, Hangzhou, China|Investigational Site Number 1560046, Harbin, 150001, China|Investigational Site Number 1560009, Hefei, 230001, China|Investigational Site Number 1560025, Hohhot, 010017, China|Investigational Site Number 1560026, Huai'An, 223300, China|Investigational Site Number 1560006, Jinan, 250013, China|Investigational Site Number 1560033, Kunming, China|Investigational Site Number 1560034, Luoyang, China|Investigational Site Number 1560014, Nanjing, 210011, China|Investigational Site Number 1560018, Pingxiang, 337055, China|Investigational Site Number 1560003, Shanghai, 200072, China|Investigational Site Number 1560004, Shanghai, 201700, China|Investigational Site Number 1560013, Shanghai, China|Investigational Site Number 1560005, Shenyang, 110004, China|Investigational Site Number 1560019, Shijiazhuang, China|Investigational Site Number 1560017, Suzhou, 215004, China|Investigational Site Number 1560022, Wuhan, 430014, China|Investigational Site Number 1560023, Wuxi, 214023, China|Investigational Site Number 1560015, Xiangtan, China|Investigational Site Number 1560043, Yuncheng, 044000, China|Investigational Site Number 1560042, Zhengzhou, 450003, China|Investigational Site Number 1560007, Zhenjiang, 212001, China|Investigational Site Number 1560037, Zhongshan, China|Investigational Site Number 1560016, Zhuzhou, 412007, China"
NCT04507438,The Effect of Donepezil on Glycemic Control in Type II Diabetics,https://clinicaltrials.gov/study/NCT04507438,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Donepezil 5-10 Mg Oral Tablet|DRUG: Placebo Oral Tablet,"University of Maryland, Baltimore",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Maryland Shore Regional Health, Easton, Maryland, 21601, United States"
NCT03593694,Technology Delivered Diabetes-Modified Behavioral Activation Treatment,https://clinicaltrials.gov/study/NCT03593694,TERMINATED,"Diabetes Mellitus, Type 2",BEHAVIORAL: TECH DM-BAT|BEHAVIORAL: TECH DMBAT Active Comparator|BEHAVIORAL: TECH DMBAT Other,State University of New York at Buffalo,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States"
NCT00946972,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus",https://clinicaltrials.gov/study/NCT00946972,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: JNJ-38431055; Placebo,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",,ALL,ADULT,PHASE1,INTERVENTIONAL,
NCT03881995,Effects of Insulin Glargine and Lixisenatide on the Brain,https://clinicaltrials.gov/study/NCT03881995,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: IGlarLixi|DRUG: Insulin Glargine 100 UNT/ML,University Hospital Tuebingen,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Tuebingen, Department of Internal Medicine IV, Tübingen, 72076, Germany"
NCT03353792,Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients,https://clinicaltrials.gov/study/NCT03353792,TERMINATED,Type1 Diabetes Mellitus,DEVICE: CL/AP system|DEVICE: usual diabetic care,Yale University,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Yale New Haven Hospital, New Haven, Connecticut, 06510, United States"
NCT02373865,Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02373865,TERMINATED,Diabetes Mellitus Type 2,DRUG: Sitagliptin|DRUG: Glimepiride|DRUG: Sitagliptin-Placebo|DRUG: Glimepiride-Placebo,GWT-TUD GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"GWT-TUD GmbH / Studienzentrum Hanefeld, Dresden, 01307, Germany"
NCT00215735,Effect of Platelet Concentrate in Treatment of Diabetic Ulcers,https://clinicaltrials.gov/study/NCT00215735,TERMINATED,Diabetes,"DEVICE: debridement, dressing, and APC",Harvest Technologies,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Washington Regional Medical Center, Fayetteville, Alaska, 72703, United States|Lucerne Hospital, Orlando, Florida, 32806, United States|Bay Pines V.A. Medical Center, St. Petersburg, Florida, 33708, United States|New England Medical Center Hospital, Boston, Massachusetts, 02111, United States|Traveling Medical Services, Southfield, Michigan, 48075, United States|Blair Medical Associates, Altoona, Pennsylvania, 16602, United States|Roger Williams Hospital, Providence, Rhode Island, 02908, United States|Tennessee Christian Hospital, Madison, Tennessee, 37115, United States|St. Luke's Medical Ctr, Milwaukee, Wisconsin, 53215, United States"
NCT03448367,FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients,https://clinicaltrials.gov/study/NCT03448367,TERMINATED,Diabetes Mellitus,DEVICE: FreeStyle Libre Flash Glucose Monitoring System,Abbott Diabetes Care,,ALL,CHILD,,OBSERVATIONAL,"Sansum Diabetes Research Institute, Santa Barbara, California, 93105, United States|Barbara Davis Center for Diabetes, Aurora, Colorado, 80045, United States|Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls, Idaho, 83404, United States|Albuquerque Neuroscience Inc., Albuquerque, New Mexico, 87109, United States"
NCT04504045,Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT04504045,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Metformin|DRUG: Caffeine|DRUG: Efavirenz|DRUG: Losartan|DRUG: Omeprazol|DRUG: Metoprolol|DRUG: Midazolam,University of Southern Denmark,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"University of Southern Denmark, Odense, Region Of Southern Denmark, 5000, Denmark"
NCT02504086,Online Support for Diabetes Self-Management,https://clinicaltrials.gov/study/NCT02504086,TERMINATED,Diabetes Mellitus Type 2,BEHAVIORAL: Online Support,University of British Columbia,University of Minnesota,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Vancouver primary care offices, Vancouver, British Columbia, V6T 2B5, Canada"
NCT00598871,A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds,https://clinicaltrials.gov/study/NCT00598871,TERMINATED,Diabetes,DRUG: Thymosin Beta 4 (Tβ4)|OTHER: Placebo,"ReGenTree, LLC","PPD DEVELOPMENT, LP",ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"United Medical Research Institute, Inglewood, California, 90301, United States|Doheny Eye Institute, Los Angeles, California, 90033, United States|Magruder Eye Institue, Orlando, Florida, 32803, United States|Southeast Retina Center, Augusta, Georgia, 30909, United States|Western Carolina Retinal Associates, PA, Asheville, North Carolina, 28803, United States"
NCT02236364,Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye,https://clinicaltrials.gov/study/NCT02236364,TERMINATED,Diabetes,"DEVICE: Contour, Bayer Healthcare, LLC",University of Toledo Health Science Campus,University of Toledo,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Toledo, Health Science Campus, Toledo, Ohio, 43614, United States"
NCT04612257,Assessing Closed-loop Insulin Delivery in Children With Type 1 Diabetes.,https://clinicaltrials.gov/study/NCT04612257,TERMINATED,"Diabetes Mellitus, Type 1",OTHER: Insulin-alone closed-loop,McGill University,Eli Lilly and Company,ALL,CHILD,,INTERVENTIONAL,"McGill University Health Centre Research Institute, Montréal, Quebec, H4A 3J1, Canada"
NCT04068805,Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II),https://clinicaltrials.gov/study/NCT04068805,TERMINATED,"Diabetes Mellitus, Type 2",BEHAVIORAL: Happify,Happify Inc.,Northwestern University,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Happify (an online platform -- study is entirely online), New York, New York, 10012, United States"
NCT03907202,"A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM",https://clinicaltrials.gov/study/NCT03907202,TERMINATED,Type II Diabetes Mellitus,DRUG: Daily injection of KBP/placebo for up to 28 days,KeyBioscience AG,Eli Lilly and Company|Nordic Bioscience A/S|Profil Institut für Stoffwechselforschung GmbH,ALL,ADULT,PHASE1,INTERVENTIONAL,"Profil Institut für Stoffwechselforschung GmbH, Neuss, D-41460, Germany"
NCT02492763,A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004),https://clinicaltrials.gov/study/NCT02492763,TERMINATED,Type II Diabetes Mellitus,DRUG: MK-8521|DRUG: Placebo|DRUG: Liraglutide|DRUG: Metformin,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00799448,Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00799448,TERMINATED,"Diabetes|Diabetes Mellitus, Type 2",DRUG: repaglinide|DRUG: biphasic human insulin 30|DRUG: insulin NPH,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Novo Nordisk Investigational Site, Athens, 15127, Greece"
NCT01374568,Changes in Bone Turnover With Increased Incretin Hormone Exposure,https://clinicaltrials.gov/study/NCT01374568,TERMINATED,Type 2 Diabetes Mellitus,DRUG: sitagliptin|OTHER: Placebo,University of Alabama at Birmingham,,FEMALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States"
NCT02284425,Study of REGN1193 in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02284425,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: REGN1193|DRUG: Placebo,Regeneron Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Miami, Florida, United States|Atlanta, Georgia, United States|Knoxville, Tennessee, United States"
NCT02460354,Metformin and Congenital Nephrogenic Diabetes Insipidus,https://clinicaltrials.gov/study/NCT02460354,TERMINATED,Diabetes Insipidus,DRUG: Metformin,Emory University,,MALE,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Childen's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Emory University Hospital - Atlanta Clinical and Translational Science Institute (ACTSI), Atlanta, Georgia, 30322, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States"
NCT00806572,Treatment With hOKT3gamma1(Ala-Ala) in T1DM,https://clinicaltrials.gov/study/NCT00806572,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: hOKT3gamma1(Ala-Ala),National Institute of Allergy and Infectious Diseases (NIAID),Immune Tolerance Network (ITN),ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"University of California San Francisco, San Francisco, California, 94143, United States|Naomie Berrie Diabetes Center, Columbia University, New York, New York, 10032, United States|Benaroya Research Institute, Seattle, Washington, 98101, United States"
NCT03785275,Beta Cell Imaging in T1D Patients With a Different Glycemic Control,https://clinicaltrials.gov/study/NCT03785275,TERMINATED,Type 1 Diabetes Mellitus,RADIATION: gallium-68-exendin PET/CT,Radboud University Medical Center,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Radboudumc, Nijmegen, Gelderland, 6525 GA, Netherlands"
NCT03682250,Electrocardiographic Modifications and Spontaneous Hypoglycemic Episodes in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03682250,TERMINATED,Type 1 Diabetes Mellitus,DEVICE: FreeStyle Libre Pro|DEVICE: Holter monitor,Institut de Recherches Cliniques de Montreal,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Institut de recherches cliniques de Montréal, Montreal, Quebec, H2W 1R7, Canada"
NCT02588950,A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02588950,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: U-500R,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Profil Institute for Clinical Research, Chula Vista, California, 91911, United States"
NCT00925119,Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00925119,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Atenolol,"University of Maryland, Baltimore","National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Maryland, Baltimore, Maryland, 21201, United States"
NCT01089790,Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone,https://clinicaltrials.gov/study/NCT01089790,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Dutogliptin|DRUG: Sitagliptin,Forest Laboratories,Phenomix,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Forest Investigative Site 064, Birmingham, Alabama, 35205, United States|Forest Investigative Site 020, Birmingham, Alabama, 35235, United States|Forest Investigative Site 025, Muscle Shoals, Alabama, 35661, United States|Forest Investigative Site 059, Chandler, Arizona, 85225, United States|Forest Investigative Site 113, Gilbert, Arizona, 85295, United States|Forest Investigative Site 096, Goodyear, Arizona, 85395, United States|Forest Investigative Site 080, Peoria, Arizona, 85381, United States|Forest Investigative Site 098, Phoenix, Arizona, 85020, United States|Forest Investigative Site 133, Phoenix, Arizona, 85023, United States|Forest Investigative Site 044, Scottsdale, Arizona, 85254, United States|Forest Investigative Site 087, Tucson, Arizona, 85741, United States|Forest Investigative Site 061, Anaheim, California, 92801, United States|Forest Investigative Site 152, Anaheim, California, 92804, United States|Forest Investigative Site 041, Chula Vista, California, 91911, United States|Forest Investigative Site 049, Encinitas, California, 92024, United States|Forest Investigative Site 022, Greenbrae, California, 94904, United States|Forest Investigative Site 047, Harbor City, California, 90710, United States|Forest Investigative Site 010, Huntington Park, California, 90255, United States|Forest Investigative Site 070, Los Angeles, California, 90057, United States|Forest Investigative Site 111, Northridge, California, 91325, United States|Forest Investigative Site 031, Riverside, California, 92506, United States|Forest Investigative Site 091, Roseville, California, 95661, United States|Forest Investigative Site 140, Sacramento, California, 95816, United States|Forest Investigative Site 067, Sacramento, California, 95821, United States|Forest Investigative Site 145, San Mateo, California, 94401, United States|Forest Investigative Site 112, Santa Ana, California, 92701, United States|Forest Investigative Site 128, Tustin, California, 92780, United States|Forest Investigative Site 011, Walnut Creek, California, 94598, United States|Forest Investigative Site 063, West Hills, California, 91307, United States|Forest Investigative Site 115, Colorado Springs, Colorado, 80910, United States|Forest Investigative Site 088, Denver, Colorado, 80239, United States|Forest Investigative Site 156, Boca Raton, Florida, 33432, United States|Forest Investigative Site 148, Brandenton, Florida, 34205, United States|Forest Investigative Site 073, Clearwater, Florida, 33765, United States|Forest Investigative Site 004, Daytona Beach, Florida, 32117, United States|Forest Investigative Site 052, DeLand, Florida, 32720, United States|Forest Investigative Site 144, Hialeah, Florida, 33012, United States|Forest Investigative Site 129, Hollywood, Florida, 33021, United States|Forest Investigative Site 062, Jacksonville, Florida, 32205, United States|Forest Investigative Site 125, Miami Lakes, Florida, 33014, United States|Forest Investigative Site 161, Miami, Florida, 33136, United States|Forest Investigative Site 157, Miami, Florida, 33143, United States|Forest Investigative Site 154, Miami, Florida, 33175, United States|Forest Investigative Site 050, Miami, Florida, 33183, United States|Forest Investigative Site 122, Miami, Florida, 33186, United States|Forest Investigative Site 069, New Port Richey, Florida, 34652, United States|Forest Investigative Site 012, Ocala, Florida, 34471, United States|Forest Investigative Site 015, Orlando, Florida, 32806, United States|Forest Investigative Site 131, Ormond Beach, Florida, 32174, United States|Forest Investigative Site 127, Pembroke Pines, Florida, 33028, United States|Forest Investigative Site 018, Sarasota, Florida, 34239, United States|Forest Investigative Site 075, St Petersburg, Florida, 33716, United States|Forest Investigative Site 138, Tamarac, Florida, 33319, United States|Forest Investigative Site 026, West Palm Beach, Florida, 33401, United States|Forest Investigative Site 045, Atlanta, Georgia, 30338, United States|Forest Investigative Site 079, Augusta, Georgia, 30909, United States|Forest Investigative Site 077, Decatur, Georgia, 30035, United States|Forest Investigative Site 042, Dunwoody, Georgia, 30338, United States|Forest Investigative Site 084, Roswell, Georgia, 30076, United States|Forest Investigative Site 132, Roswell, Georgia, 30076, United States|Forest Investigative Site 009, Meridian, Idaho, 83646, United States|Forest Investigative Site 030, Peoria, Illinois, 61614, United States|Forest Investigative Site 123, Springfield, Illinois, 62704, United States|Forest Investigative Site 100, Evansville, Indiana, 47710, United States|Forest Investigative Site 097, Evansville, Indiana, 47713, United States|Forest Investigative Site 053, Kansas City, Kansas, 66160, United States|Forest Investigative Site 008, Wichita, Kansas, 67203, United States|Forest Investigative Site 078, Erlanger, Kentucky, 41018, United States|Forest Investigative Site 107, Lexington, Kentucky, 40504, United States|Forest Investigative Site 024, Madisonville, Kentucky, 42431, United States|Forest Investigative Site 034, Covington, Louisiana, 70433, United States|Forest Investigative Site 035, Baltimore, Maryland, 21204, United States|Forest Investigative Site 046, Oxon Hill, Maryland, 20745, United States|Forest Investigative Site 165, Rockville, Maryland, 20852, United States|Forest Investigative Site 003, Brockton, Massachusetts, 02301, United States|Forest Investigative Site 055, Brockton, Massachusetts, 02301, United States|Forest Investigative Site 118, New Bedford, Massachusetts, 02740, United States|Forest Investigative Site 007, Waltham, Massachusetts, 02453, United States|Forest Investigative Site 163, Cadillac, Michigan, 49601, United States|Forest Investigative Site 002, Dearborn, Michigan, 48126, United States|Forest Investigative Site 029, St. Clair Shores, Michigan, 48081, United States|Forest Investigative Site 054, Edina, Minnesota, 55435, United States|Forest Investigative Site 142, St. Louis, Missouri, 63110, United States|Forest Investigative Site 143, St. Louis, Missouri, 63110, United States|Forest Investigative Site 013, Grand Island, Nebraska, 68803, United States|Forest Investigative Site 150, Omaha, Nebraska, 68114, United States|Forest Investigative Site 072, Las Vegas, Nevada, 89101, United States|Forest Investigative Site 065, Las Vegas, Nevada, 89117, United States|Forest Investigative Site 147, Berkeley Heights, New Jersey, 07922, United States|Forest Investigative Site 137, Albuquerque, New Mexico, 87102, United States|Forest Investigative Site 101, Albuquerque, New Mexico, 87108, United States|Forest Investigative Site 006, Albany, New York, 12206, United States|Forest Investigative Site 081, New Hyde Park, New York, 11042, United States|Forest Investigative Site 016, New York, New York, 10019, United States|Forest Investigative Site 151, New York, New York, 10032, United States|Forest Investigative Site 155, Asheboro, North Carolina, 27203, United States|Forest Investigative Site 094, Charlotte, North Carolina, 28204, United States|Forest Investigative Site 051, Charlotte, North Carolina, 28209, United States|Forest Investigative Site 117, Charlotte, North Carolina, 28277, United States|Forest Investigative Site 135, Durham, North Carolina, 27704, United States|Forest Investigative Site 058, Lenoir, North Carolina, 28645, United States|Forest Investigative Site 038, Morehead City, North Carolina, 28557, United States|Forest Investigative Site 040, Salisbury, North Carolina, 28144, United States|Forest Investigative Site 082, Winston-Salem, North Carolina, 27103, United States|Forest Investigative Site 039, Akron, Ohio, 44311, United States|Forest Investigative Site 023, Cincinnati, Ohio, 45242, United States|Forest Investigative Site 043, Columbus, Ohio, 43201, United States|Forest Investigative Site 057, Dayton, Ohio, 45406, United States|Forest Investigative Site 032, Kettering, Ohio, 45429, United States|Forest Investigative Site 141, Marion, Ohio, 43302, United States|Forest Investigative Site 159, Marion, Ohio, 43302, United States|Forest Investigative Site 153, Zanesville, Ohio, 43701, United States|Forest Investigative Site 083, Bethany, Oklahoma, 73008, United States|Forest Investigative Site 149, Norman, Oklahoma, 73069, United States|Forest Investigative Site 102, Ashland, Oregon, 97520, United States|Forest Investigative Site 005, Eugene, Oregon, 97404, United States|Forest Investigative Site 001, Medford, Oregon, 97504, United States|Forest Investigative Site 130, Bensalem, Pennsylvania, 19020, United States|Forest Investigative Site 037, Harleysville, Pennsylvania, 19438, United States|Forest Investigative Site 126, Jenkintown, Pennsylvania, 19046, United States|Forest Investigative Site 158, Morrisville, Pennsylvania, 19067, United States|Forest Investigative Site 066, Philadelphia, Pennsylvania, 19152, United States|Forest Investigative Site 036, Tipton, Pennsylvania, 16684, United States|Forest Investigative Site 103, Greer, South Carolina, 29651, United States|Forest Investigative Site 090, Manning, South Carolina, 29102, United States|Forest Investigative Site 033, Pelzer, South Carolina, 29669, United States|Forest Investigative Site 048, Bristol, Tennessee, 37620, United States|Forest Investigative Site 114, Chattanooga, Tennessee, 37404, United States|Forest Investigative Site 104, Chattanooga, Tennessee, 37421, United States|Forest Investigative Site 099, Arlington, Texas, 76014, United States|Forest Investigative Site 056, Corpus Christi, Texas, 78404, United States|Forest Investigative Site 071, Dallas, Texas, 75230, United States|Forest Investigative Site 017, Dallas, Texas, 75235, United States|Forest Investigative Site 124, Dallas, Texas, 75251, United States|Forest Investigative Site 162, Desoto, Texas, 75115, United States|Forest Investigative Site 136, Houston, Texas, 77002, United States|Forest Investigative Site 106, Houston, Texas, 77079, United States|Forest Investigative Site 014, Irving, Texas, 75039, United States|Forest Investigative Site 139, Irving, Texas, 75039, United States|Forest Investigative Site 160, New Braunfels, Texas, 78130, United States|Forest Investigative Site 146, San Antonio, Texas, 78205, United States|Forest Investigative Site 109, San Antonio, Texas, 78229, United States|Forest Investigative Site 119, San Antonio, Texas, 78258, United States|Forest Investigative Site 076, Salt Lake City, Utah, 84107, United States|Forest Investigative Site 121, Arlington, Virginia, 22204, United States|Forest Investigative Site 028, Virginia Beach, Virginia, 23454, United States|Forest Investigative Site 068, Renton, Washington, 98057, United States|Forest Investigative Site 092, Spokane, Washington, 99207, United States|Forest Investigative Site 027, Milwaukee, Wisconsin, 53209, United States"
NCT02013557,Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes,https://clinicaltrials.gov/study/NCT02013557,TERMINATED,"Diabetes, Gestational",BEHAVIORAL: Text-message reminder,University of South Florida,,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Tampa General Hospital, Tampa, Florida, 33606, United States"
NCT02802514,A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects,https://clinicaltrials.gov/study/NCT02802514,TERMINATED,Diabetes Mellitus,DRUG: Albiglutide 50mg|DRUG: Albiglutide matching placebo|DRUG: Exenatide 10microgram|DRUG: Exenatide placebo (saline),GlaxoSmithKline,The General Hospital Corporation d/b/a Massachusetts General Hospital,ALL,ADULT,PHASE4,INTERVENTIONAL,"GSK Investigational Site, Boston, Massachusetts, 02114, United States"
NCT03017287,Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI,https://clinicaltrials.gov/study/NCT03017287,TERMINATED,"Diabetes Mellitus, Type 1 or 2",DEVICE: GlucoMe App,GlucoMe,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Diabitic Unit of the Wolfson Medical Center, Holon, Israel"
NCT01678820,A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266),https://clinicaltrials.gov/study/NCT01678820,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Sitagliptin/Simvastatin FDC|DRUG: Sitagliptin|DRUG: Simvastatin|DRUG: Placebo to sitagliptin|DRUG: Placebo to simvastatin|DRUG: Placebo to Sitagliptin/Simvastatin FDC|DRUG: Metformin|DRUG: Glimepiride,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT03496298,Effect of Efpeglenatide on Cardiovascular Outcomes,https://clinicaltrials.gov/study/NCT03496298,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Efpeglenatide (SAR439977)|DRUG: Placebo,Sanofi,Hanmi Pharmaceutical Company Limited,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8400032, Sheffield, Alabama, 35660, United States|Investigational Site Number 8400014, Gilbert, Arizona, 85295, United States|Investigational Site Number 8400012, Surprise, Arizona, 85374, United States|Investigational Site Number 8400046, Tucson, Arizona, 85745, United States|Investigational Site Number 8400022, Beverly Hills, California, 90211, United States|Investigational Site Number 8400065, Concord, California, 94520, United States|Investigational Site Number 8400060, Greenbrae, California, 94904, United States|Investigational Site Number 8400084, Long Beach, California, 90807, United States|Investigational Site Number 8400002, Los Gatos, California, 95032, United States|Investigational Site Number 8400085, Northridge, California, 91325, United States|Investigational Site Number 8400082, Pomona, California, 91767, United States|Investigational Site Number 8400025, Sacramento, California, 95821, United States|Investigational Site Number 8400064, Englewood, Colorado, 80113, United States|Investigational Site Number 8400019, Hamden, Connecticut, 06517, United States|Investigational Site Number 8400023, Waterbury, Connecticut, 06708-3346, United States|Investigational Site Number 8400091, Hialeah, Florida, 33012, United States|Investigational Site Number 8400040, Hollywood, Florida, 33024, United States|Investigational Site Number 8400073, Hudson, Florida, 34667, United States|Investigational Site Number 8400011, Jacksonville, Florida, 32204, United States|Investigational Site Number 8400017, Jacksonville, Florida, 32204, United States|Investigational Site Number 8400042, Jacksonville, Florida, 32277, United States|Investigational Site Number 8400027, Miami, Florida, 33126, United States|Investigational Site Number 8400051, Miami, Florida, 33136, United States|Investigational Site Number 8400041, New Port Richey, Florida, 34652, United States|Investigational Site Number 8400059, Ormond Beach, Florida, 32174, United States|Investigational Site Number 8400006, Macon, Georgia, 31210-1359, United States|Investigational Site Number 8400008, Roswell, Georgia, 30076, United States|Investigational Site Number 8400081, Idaho Falls, Idaho, 83404, United States|Investigational Site Number 8400095, Arlington Heights, Illinois, 60005, United States|Investigational Site Number 8400070, Chicago, Illinois, 60607, United States|Investigational Site Number 8400036, Crystal Lake, Illinois, 60012, United States|Investigational Site Number 8400030, New Albany, Indiana, 46113, United States|Investigational Site Number 8400074, Topeka, Kansas, 66606, United States|Investigational Site Number 8400077, Owensboro, Kentucky, 42303, United States|Investigational Site Number 8400043, Paris, Kentucky, 40361, United States|Investigational Site Number 8400034, Alexandria, Louisiana, 71301, United States|Investigational Site Number 8400079, Monroe, Louisiana, 71203, United States|Investigational Site Number 8400013, New Orleans, Louisiana, 70112, United States|Investigational Site Number 8400047, Oxon Hill, Maryland, 20745, United States|Investigational Site Number 8400001, Flint, Michigan, 48504, United States|Investigational Site Number 8400061, Flint, Michigan, 48532-3447, United States|Investigational Site Number 8400010, Troy, Michigan, 48085, United States|Investigational Site Number 8400005, Troy, Michigan, 48098, United States|Investigational Site Number 8400024, Saint Paul, Minnesota, 55102, United States|Investigational Site Number 8400045, Saint Louis, Missouri, 63136, United States|Investigational Site Number 8400071, Billings, Montana, 59103, United States|Investigational Site Number 8400028, Great Falls, Montana, 59405-4507, United States|Investigational Site Number 8400086, Kalispell, Montana, 59901, United States|Investigational Site Number 8400037, Las Vegas, Nevada, 89128, United States|Investigational Site Number 8400087, Raritan, New Jersey, 08869, United States|Investigational Site Number 8400018, Bronx, New York, 00000, United States|Investigational Site Number 8400056, Staten Island, New York, 10301, United States|Investigational Site Number 8400076, Greenville, North Carolina, 27834-5704, United States|Investigational Site Number 8400007, Morehead City, North Carolina, 28557, United States|Investigational Site Number 8400093, Morehead City, North Carolina, 28557, United States|Investigational Site Number 8400094, Morganton, North Carolina, 28655, United States|Investigational Site Number 8400029, Fargo, North Dakota, 58104, United States|Investigational Site Number 8400031, Columbus, Ohio, 43203, United States|Investigational Site Number 8400078, Lorain, Ohio, 44053, United States|Investigational Site Number 8400072, Bend, Oregon, 97702, United States|Investigational Site Number 8400067, Beaver, Pennsylvania, 15009-1957, United States|Investigational Site Number 8400096, Philadelphia, Pennsylvania, 19107, United States|Investigational Site Number 8400021, Pittsburgh, Pennsylvania, 15212, United States|Investigational Site Number 8400015, Greer, South Carolina, 29651, United States|Investigational Site Number 8400063, Murrells Inlet, South Carolina, 29576, United States|Investigational Site Number 8400044, Rapid City, South Dakota, 57702, United States|Investigational Site Number 8400016, Memphis, Tennessee, 38163, United States|Investigational Site Number 8400009, Nashville, Tennessee, 37203, United States|Investigational Site Number 8400055, Corpus Christi, Texas, 78814, United States|Investigational Site Number 8400097, Dallas, Texas, 75230, United States|Investigational Site Number 8400088, El Paso, Texas, 79935, United States|Investigational Site Number 8400058, Fort Worth, Texas, 76132, United States|Investigational Site Number 8400069, Houston, Texas, 77004, United States|Investigational Site Number 8400089, Houston, Texas, 77030, United States|Investigational Site Number 8400092, Richmond, Texas, 77469, United States|Investigational Site Number 8400033, Waco, Texas, 76710, United States|Investigational Site Number 8400039, Salt Lake City, Utah, 84102, United States|Investigational Site Number 8400052, Norfolk, Virginia, 23510, United States|Investigational Site Number 8400049, Manitowoc, Wisconsin, 54220, United States|Investigational Site Number 0320009, Buenos Aires, 1430, Argentina|Investigational Site Number 0320002, Caba, 1120, Argentina|Investigational Site Number 0320013, Caba, 1425DES, Argentina|Investigational Site Number 0320010, Caba, 1425, Argentina|Investigational Site Number 0320005, Caba, C1119ACN, Argentina|Investigational Site Number 0320008, Capital Federal, C1056ABJ, Argentina|Investigational Site Number 0320001, Capital Federal, C1179AAB, Argentina|Investigational Site Number 0320004, Corrientes, W3400AMZ, Argentina|Investigational Site Number 0320012, Corrientes, W3410AVV, Argentina|Investigational Site Number 0320011, Godoy Cruz, M5501ARP, Argentina|Investigational Site Number 0320007, Mar Del Plata, B7600FZN, Argentina|Investigational Site Number 0320006, Merlo, B1722COV, Argentina|Investigational Site Number 0320015, Rosario, 2000, Argentina|Investigational Site Number 0320017, Rosario, S2002OJP, Argentina|Investigational Site Number 0320003, Salta, 4400, Argentina|Investigational Site Number 0320018, Salta, 4400, Argentina|Investigational Site Number 0320016, San Isidro, B1642DCB, Argentina|Investigational Site Number 0320014, Santa Rosa, Argentina|Investigational Site Number 1000011, Blagoevgrad, 2700, Bulgaria|Investigational Site Number 1000014, Dimitrovgrad, Bulgaria|Investigational Site Number 1000017, Gabrovo, 5300, Bulgaria|Investigational Site Number 1000007, Kazanlak, 6100, Bulgaria|Investigational Site Number 1000013, Kyustendil, Bulgaria|Investigational Site Number 1000010, Lovech, 5500, Bulgaria|Investigational Site Number 1000008, Plovdiv, 4000, Bulgaria|Investigational Site Number 1000002, Plovdiv, 4002, Bulgaria|Investigational Site Number 1000012, Ruse, 7002, Bulgaria|Investigational Site Number 1000003, Sofia, 1233, Bulgaria|Investigational Site Number 1000001, Sofia, 1431, Bulgaria|Investigational Site Number 1000005, Sofia, 1750, Bulgaria|Investigational Site Number 1000006, Stara Zagora, 6000, Bulgaria|Investigational Site Number 1000009, Varna, 9000, Bulgaria|Investigational Site Number 1000016, Yambol, 8600, Bulgaria|Investigational Site Number 1240001, Barrie, L4N 7L3, Canada|Investigational Site Number 1240002, Brampton, L6S 0C6, Canada|Investigational Site Number 1240018, Burlington, L7M 1K9, Canada|Investigational Site Number 1240021, Burlington, L7R 1E2, Canada|Investigational Site Number 1240007, Calgary, T2H 2G4, Canada|Investigational Site Number 1240020, Calgary, T2V 4J2, Canada|Investigational Site Number 1240024, Chicoutimi, G7H 7K9, Canada|Investigational Site Number 1240004, Concord, L4K 4M2, Canada|Investigational Site Number 1240005, Etobicoke, M9R 4E1, Canada|Investigational Site Number 1240011, Levis, G6W 0M5, Canada|Investigational Site Number 1240025, London, N5W 6A2, Canada|Investigational Site Number 1240028, London, N6A 5R8, Canada|Investigational Site Number 1240029, Mirabel, J7J 2K8, Canada|Investigational Site Number 1240008, Montreal, H1M 1B1, Canada|Investigational Site Number 1240031, Montreal, H1T 1C8, Canada|Investigational Site Number 1240014, Montreal, H4A 2C6, Canada|Investigational Site Number 1240023, Montreal, H4A 3T2, Canada|Investigational Site Number 1240017, Montreal, H4N 2W2, Canada|Investigational Site Number 1240015, Oakville, L6M 1M1, Canada|Investigational Site Number 1240012, Oshawa, L1J 2K1, Canada|Investigational Site Number 1240030, Ottawa, K2J 0V2, Canada|Investigational Site Number 1240027, Peterborough, K9J 0B2, Canada|Investigational Site Number 1240016, Pointe-Claire, H9R 4S3, Canada|Investigational Site Number 1240010, Quebec, G1N 4V3, Canada|Investigational Site Number 1240019, Red Deer, T4N 6V7, Canada|Investigational Site Number 1240006, Sherbrooke, J1L 0H8, Canada|Investigational Site Number 1240022, Sudbury, P3E 4H5, Canada|Investigational Site Number 1240013, Toronto, M4G 3E8, Canada|Investigational Site Number 1240003, Vancouver, V5Y 3W2, Canada|Investigational Site Number 1240009, Victoriaville, G6P 6P6, Canada|Investigational Site Number 1240026, Victoria, V8V 4A1, Canada|Investigational Site Number 1520012, Antofagasta, 1270013, Chile|Investigational Site Number 1520008, Concepción, 4070566, Chile|Investigational Site Number 1520013, Santiago, 7500571, Chile|Investigational Site Number 1520002, Santiago, 7500710, Chile|Investigational Site Number 1520007, Santiago, 7500710, Chile|Investigational Site Number 1520011, Santiago, 7770086, Chile|Investigational Site Number 1520010, Santiago, 8053095, Chile|Investigational Site Number 1520001, Santiago, 8330336, Chile|Investigational Site Number 1520003, Santiago, 8380456, Chile|Investigational Site Number 1520014, Santiago, 8900132, Chile|Investigational Site Number 1520005, Santiago, Chile|Investigational Site Number 1520006, Temuco, 4813299, Chile|Investigational Site Number 1520004, Viña Del Mar, Chile|Investigational Site Number 2080004, Aarhus N, 8200, Denmark|Investigational Site Number 2080005, Esbjerg, 6700, Denmark|Investigational Site Number 2080001, Hellerup, 2900, Denmark|Investigational Site Number 2080003, Hvidovre, 2650, Denmark|Investigational Site Number 2080002, København Nv, 2400, Denmark|Investigational Site Number 2330002, Pärnu, 80018, Estonia|Investigational Site Number 2330001, Tallinn, 13419, Estonia|Investigational Site Number 2330003, Viljandi, 71024, Estonia|Investigational Site Number 2460002, Helsinki, 00100, Finland|Investigational Site Number 2460001, Jyväskylä, 40620, Finland|Investigational Site Number 2460003, Kuopio, 70100, Finland|Investigational Site Number 2460004, Oulu, 90220, Finland|Investigational Site Number 2760006, Berlin, 10437, Germany|Investigational Site Number 2760009, Berlin, 12627, Germany|Investigational Site Number 2760004, Essen, 45355, Germany|Investigational Site Number 2760008, Frankfurt Am Main, 60313, Germany|Investigational Site Number 2760005, Münster, 48145, Germany|Investigational Site Number 2760003, Oldenburg In Holstein, 23758, Germany|Investigational Site Number 2760002, Pirna, 01796, Germany|Investigational Site Number 2760007, Rotenburg An Der Fulda, 36199, Germany|Investigational Site Number 3480012, Balatonfüred, 8230, Hungary|Investigational Site Number 3480011, Budapest, 1036, Hungary|Investigational Site Number 3480003, Budapest, 1042, Hungary|Investigational Site Number 3480005, Budapest, 1106, Hungary|Investigational Site Number 3480001, Budapest, 1122, Hungary|Investigational Site Number 3480006, Budapest, 1134, Hungary|Investigational Site Number 3480002, Debrecen, 4032, Hungary|Investigational Site Number 3480009, Komárom, 2900, Hungary|Investigational Site Number 3480008, Mosonmagyaróvár, 9200, Hungary|Investigational Site Number 3480007, Székesfehérvár, 8000, Hungary|Investigational Site Number 3480004, Zalaegerszeg, 8900, Hungary|Investigational Site Number 3560001, Belgaum, 590010, India|Investigational Site Number 3560002, Gurgaon, 122001, India|Investigational Site Number 3560007, Kolkata, 700073, India|Investigational Site Number 3560006, Lucknow, 226002, India|Investigational Site Number 3560003, New Delhi, 110 029, India|Investigational Site Number 3560009, New Delhi, 110060, India|Investigational Site Number 3560010, Pune, 411001, India|Investigational Site Number 3560005, Pune, 411010, India|Investigational Site Number 3560004, Vellore, 632004, India|Investigational Site Number 3800006, Catania, 95123, Italy|Investigational Site Number 3800003, Catanzaro, 88100, Italy|Investigational Site Number 3800005, Catanzaro, 88100, Italy|Investigational Site Number 3800002, Chieti, 66013, Italy|Investigational Site Number 3800001, Milano, 20132, Italy|Investigational Site Number 3800004, Roma, 00133, Italy|Investigational Site Number 4100006, Guri-si, Gyeonggi-Do, 11923, Korea, Republic of|Investigational Site Number 4100007, Busan, 49241, Korea, Republic of|Investigational Site Number 4100005, Seoul, 02841, Korea, Republic of|Investigational Site Number 4100002, Seoul, 03080, Korea, Republic of|Investigational Site Number 4100009, Seoul, 03181, Korea, Republic of|Investigational Site Number 4100001, Seoul, 03722, Korea, Republic of|Investigational Site Number 4100011, Seoul, 06351, Korea, Republic of|Investigational Site Number 4100003, Seoul, 06591, Korea, Republic of|Investigational Site Number 4100010, Seoul, 08308, Korea, Republic of|Investigational Site Number 4100008, Wonju, 26426, Korea, Republic of|Investigational Site Number 4280004, Daugavpils, LV-5417, Latvia|Investigational Site Number 4280002, Liepāja, LV3414, Latvia|Investigational Site Number 4280001, Riga, LV-1011, Latvia|Investigational Site Number 4280003, Sigulda, LV-2150, Latvia|Investigational Site Number 4400001, Kaunas, 49449, Lithuania|Investigational Site Number 4400002, Kaunas, 50161, Lithuania|Investigational Site Number 4400003, Klaipeda, 92111, Lithuania|Investigational Site Number 4400004, Vilnius, 08661, Lithuania|Investigational Site Number 4840004, Actopan, 42500, Mexico|Investigational Site Number 4840007, Aguascalientes, 20230, Mexico|Investigational Site Number 4840009, Aguascalientes, 20230, Mexico|Investigational Site Number 4840013, Aguascalientes, 20230, Mexico|Investigational Site Number 4840014, Chihuahua, 31000, Mexico|Investigational Site Number 4840002, Cuernavaca, 62250, Mexico|Investigational Site Number 4840016, Durango, 34000, Mexico|Investigational Site Number 4840015, Durango, 34080, Mexico|Investigational Site Number 4840006, Guadalajara, 44210, Mexico|Investigational Site Number 4840003, Guadalajara, 44600, Mexico|Investigational Site Number 4840005, Guadalajara, 44650, Mexico|Investigational Site Number 4840011, Monterrey, 64020, Mexico|Investigational Site Number 4840010, Monterrey, 64060, Mexico|Investigational Site Number 4840001, Monterrey, 64460, Mexico|Investigational Site Number 5780002, Hamar, 2317, Norway|Investigational Site Number 5780001, Oslo, Norway|Investigational Site Number 5780003, Stavanger, 4011, Norway|Investigational Site Number 6040007, Lima, LIMA 01, Peru|Investigational Site Number 6040004, Lima, LIMA 11, Peru|Investigational Site Number 6040003, Lima, LIMA 27, Peru|Investigational Site Number 6040006, Lima, LIMA 31, Peru|Investigational Site Number 6040001, Lima, Peru|Investigational Site Number 6040005, Lima, Peru|Investigational Site Number 6040002, Piura, 20000, Peru|Investigational Site Number 6160017, Bialystok, 15-404, Poland|Investigational Site Number 6160018, Bydgoszcz, 80-095, Poland|Investigational Site Number 6160015, Bydgoszcz, 85-090, Poland|Investigational Site Number 6160016, Gdansk, 80-546, Poland|Investigational Site Number 6160012, Gdansk, 80-858, Poland|Investigational Site Number 6160005, Katowice, 40-530, Poland|Investigational Site Number 6160006, Plock, 09-402, Poland|Investigational Site Number 6160011, Skierniewice, 96-100, Poland|Investigational Site Number 6160013, Skorzewo, 60-185, Poland|Investigational Site Number 6160010, Szczecin, 70-506, Poland|Investigational Site Number 6160007, Torun, 87-100, Poland|Investigational Site Number 6160009, Torun, 87-100, Poland|Investigational Site Number 6160014, Tychy, 43-100, Poland|Investigational Site Number 6160002, Warszawa, 02-507, Poland|Investigational Site Number 6160004, Wroclaw, 50-315, Poland|Investigational Site Number 6420007, Bacau, 600154, Romania|Investigational Site Number 6420001, Brasov, 500097, Romania|Investigational Site Number 6420011, Brasov, 500365, Romania|Investigational Site Number 6420009, Bucuresti, 020475, Romania|Investigational Site Number 6420012, Oradea, 410151, Romania|Investigational Site Number 6420005, Oradea, 410159, Romania|Investigational Site Number 6420010, Oradea, 410169, Romania|Investigational Site Number 6420008, Ploiesti, 100561, Romania|Investigational Site Number 6420002, Târgu-Mureş, 540142, Romania|Investigational Site Number 6420003, Târgu-Mureş, 540142, Romania|Investigational Site Number 6430018, Kaliningrad, 236035, Russian Federation|Investigational Site Number 6430014, Kazan, 420087, Russian Federation|Investigational Site Number 6430001, Kemerovo, 650002, Russian Federation|Investigational Site Number 6430017, Krasnogorsk, 143408, Russian Federation|Investigational Site Number 6430004, Moscow, 111539, Russian Federation|Investigational Site Number 6430005, Moscow, 117292, Russian Federation|Investigational Site Number 6430002, Moscow, 121374, Russian Federation|Investigational Site Number 6430015, Moscow, 121552, Russian Federation|Investigational Site Number 6430009, Novosibirsk, 630055, Russian Federation|Investigational Site Number 6430019, Novosibirsk, 630087, Russian Federation|Investigational Site Number 6430006, Saint-Petersburg, 190013, Russian Federation|Investigational Site Number 6430012, Saint-Petersburg, 198205, Russian Federation|Investigational Site Number 6430003, Saratov, 410028, Russian Federation|Investigational Site Number 6430020, Saratov, 410039, Russian Federation|Investigational Site Number 6430010, St-Petersburg, 193312, Russian Federation|Investigational Site Number 6430011, St-Petersburg, 193312, Russian Federation|Investigational Site Number 6430013, St. Petersburg, 194156, Russian Federation|Investigational Site Number 6430016, St. Petersburg, 195067, Russian Federation|Investigational Site Number 6880001, Belgrade, 11000, Serbia|Investigational Site Number 6880002, Belgrade, 11000, Serbia|Investigational Site Number 6880003, Belgrade, 11050, Serbia|Investigational Site Number 6880005, Belgrade, 11050, Serbia|Investigational Site Number 6880004, Kragujevac, 34000, Serbia|Investigational Site Number 6880006, Novi Sad, 21000, Serbia|Investigational Site Number 7030007, Bratislava, 85101, Slovakia|Investigational Site Number 7030001, Kosice, 040 01, Slovakia|Investigational Site Number 7030004, Kosice, 040 01, Slovakia|Investigational Site Number 7030003, Kralovsky Chlmec, 077 01, Slovakia|Investigational Site Number 7030009, Moldava Nad Bodvou, 04525, Slovakia|Investigational Site Number 7030010, Pezinok, 90201, Slovakia|Investigational Site Number 7030006, Povazska Bystrica, 01701, Slovakia|Investigational Site Number 7030005, Presov, 080 01, Slovakia|Investigational Site Number 7030008, Roznava, 04801, Slovakia|Investigational Site Number 7030011, Sturovo, 943 01, Slovakia|Investigational Site Number 7030002, Trebisov, 075 01, Slovakia|Investigational Site Number 7030012, Trencin, 91101, Slovakia|Investigational Site Number 7100007, Bloemfontein, 9301, South Africa|Investigational Site Number 7100005, Cape Town, 7130, South Africa|Investigational Site Number 7100006, Cape Town, South Africa|Investigational Site Number 7100003, Johannesburg, 1752, South Africa|Investigational Site Number 7100001, Johannesburg, 2198, South Africa|Investigational Site Number 7100002, Parow, 7500, South Africa|Investigational Site Number 7100004, Rivonia, 2128, South Africa|Investigational Site Number 7100008, Umhlanga Rocks Suburb, South Africa|Investigational Site Number 7240008, Alcorcón, 28922, Spain|Investigational Site Number 7240002, Barcelona, 08035, Spain|Investigational Site Number 7240009, Barcelona, 08041, Spain|Investigational Site Number 7240007, Granada, 18014, Spain|Investigational Site Number 7240010, Madrid, 28023, Spain|Investigational Site Number 7240001, Madrid, 28040, Spain|Investigational Site Number 7240006, Majadahonda, 28222, Spain|Investigational Site Number 7240011, Málaga, 29010, Spain|Investigational Site Number 7240005, Olot, 17800, Spain|Investigational Site Number 7240003, San Sebastián De Los Reyes, 28702, Spain|Investigational Site Number 7240013, Sevilla, 41014, Spain|Investigational Site Number 7240004, Valencia, 46010, Spain|Investigational Site Number 7240014, Valencia, 46026, Spain|Investigational Site Number 7520006, Goteborg, 41345, Sweden|Investigational Site Number 7520003, Helsingborg, 252 20, Sweden|Investigational Site Number 7520004, Kristianstad, 291 85, Sweden|Investigational Site Number 7520002, Malmö, 211 52, Sweden|Investigational Site Number 7520005, Skövde, 541 40, Sweden|Investigational Site Number 7520001, Stockholm, 171 76, Sweden|Investigational Site Number 7920005, Adana, 01250, Turkey|Investigational Site Number 7920010, Ankara, 06490, Turkey|Investigational Site Number 7920012, Antalya, 07070, Turkey|Investigational Site Number 7920015, Aydin, 09100, Turkey|Investigational Site Number 7920002, Bursa, 16059, Turkey|Investigational Site Number 7920013, Eskisehir, 26040, Turkey|Investigational Site Number 7920001, Istanbul, 34393, Turkey|Investigational Site Number 7920006, Istanbul, 34843, Turkey|Investigational Site Number 7920011, Izmit, 41380, Turkey|Investigational Site Number 7920014, Kutahya, 43040, Turkey|Investigational Site Number 7920007, Samsun, 55139, Turkey|Investigational Site Number 7920009, Sivas, 58140, Turkey|Investigational Site Number 8040006, Dnipro, 49005, Ukraine|Investigational Site Number 8040009, Ivano-Frankivsk, 76008, Ukraine|Investigational Site Number 8040001, Ivano-Frankivsk, 76018, Ukraine|Investigational Site Number 8040003, Kharkiv, 61124, Ukraine|Investigational Site Number 8040002, Kharkiv, 61166, Ukraine|Investigational Site Number 8040007, Kiev, 02091, Ukraine|Investigational Site Number 8040008, Kyiv, 01004, Ukraine|Investigational Site Number 8040004, Ternopil, 46000, Ukraine|Investigational Site Number 8040005, Vinnytsya, 21001, Ukraine"
NCT00543959,Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005),https://clinicaltrials.gov/study/NCT00543959,TERMINATED,Diabetes Mellitus Type 2,DRUG: MK0533|DRUG: Comparator: Placebo (unspecified)|DRUG: Comparator: pioglitazone,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT01627899,One Touch VerioIQ US Clinical Outcomes Study,https://clinicaltrials.gov/study/NCT01627899,TERMINATED,Diabetes,DEVICE: One Touch VerioIQ Blood Glucose Monitor,LifeScan,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT00303134,Islet Cell Transplants for Diabetes,https://clinicaltrials.gov/study/NCT00303134,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: Islet Cell Transplantation,Weill Medical College of Cornell University,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"New York Presbyterian Hospital - Weill Cornell Medical Center, New York, New York, 10021, United States"
NCT04158921,Control:Diabetes Pilot Study I,https://clinicaltrials.gov/study/NCT04158921,TERMINATED,"Insulin Treated Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 1",OTHER: Control:Diabetes mobile app,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States"
NCT00449605,A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00449605,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Rimonabant|DRUG: Glimepiride|DRUG: Metformin,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, 08807, United States|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-aventis adminsitrative office, Santiago, Chile|Sanofi-Aventis Administrative Office, Horsholm, Denmark|Sanofi-Aventis Administrative Office, Helsinki, Finland|Sanofi-Aventis Administrative Office, Budapest, Hungary|Sanofi-Aventis Administrative Office, Mumbai, India|Sanofi-Aventis Administrative Office, Milan, Italy|Sanofi-Aventis Administrative Office, Seoul, Korea, Republic of|Sanofi-Aventis Administrative Office, Mexico, Mexico|Sanofi-Aventis Administrative Office, Puerto Rico, Puerto Rico|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Moscow, Russian Federation|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Bromma, Sweden"
NCT03534193,Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03534193,TERMINATED,Type 1 Diabetes Mellitus,OTHER: Molly Center Diabetes Care Guide (Paper-based)|OTHER: Tablet based interactive diabetes education modules,Hackensack Meridian Health,Verizon Foundation,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, 07601, United States"
NCT02915263,The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes,https://clinicaltrials.gov/study/NCT02915263,TERMINATED,Diabetes Complications|Diabetes Mellitus|Diabetic Neuropathies,DRUG: IGIV-C|DRUG: 0.9% Sodium Chloride,Beth Israel Deaconess Medical Center,"Grifols Biologicals, LLC",ALL,ADULT,PHASE2,INTERVENTIONAL,"Beth Israel Deaconness Medical Center, Boston, Massachusetts, 02215, United States"
NCT00456963,Prevention of Diabetes and Hypertension,https://clinicaltrials.gov/study/NCT00456963,TERMINATED,Diabetes Mellitus|Hypertension,BEHAVIORAL: Diet|BEHAVIORAL: Moderate exercise|DRUG: enalapril tablets|DRUG: placebo tablets|DRUG: Losartan Tablets,Istituto Auxologico Italiano,Italian Society of Hypertension|Italian Society of General Practitioners|Yghea,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Istituto Auxologico Italiano., Milan, 20145, Italy"
NCT01024244,A Study of LY2599506 in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01024244,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Placebo|DRUG: LY2599506,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Topeka, Kansas, 66606, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Toms River, New Jersey, 08753, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Syracuse, New York, 13210, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., St. Leonards, New South Wales, 2065, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daw Park, South Australia, 5041, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Box Hill, Victoria, 3128, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Manati, 00674, Puerto Rico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Juan, 00907, Puerto Rico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Arkhangelsk, 163045, Russian Federation|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Moscow, 119435, Russian Federation|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Rostov-On-Don, 344022, Russian Federation|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Saint Petersburg, 194354, Russian Federation|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Alcira, 46600, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Alicante, 03114, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dos Hermanas, 41014, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Santa Cruz De Tenerife, 38320, Spain"
NCT00633997,Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00633997,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Vildagliptin|DRUG: Vildagliptin,Novartis,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Novartis Investigator Site, Baltimore, Maryland, 21225, United States"
NCT02231658,"Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion",https://clinicaltrials.gov/study/NCT02231658,TERMINATED,Diabetes Mellitus,DRUG: Liraglutide|DRUG: Lixisenatide,Profil Institut für Stoffwechselforschung GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"St. Josef-Hospital, Universitätsklinik, Bochum, 44791, Germany|Profil Institut für Stoffwechselforschung GmbH, Neuss, 41460, Germany"
NCT01516476,Study of RO6807952 in Patients With Diabetes Mellitus Type 2,https://clinicaltrials.gov/study/NCT01516476,TERMINATED,Diabetes Mellitus Type 2,DRUG: Placebo|DRUG: RO6807952|DRUG: RO6807952|DRUG: liraglutide,Hoffmann-La Roche,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Cincinnati, Ohio, 45227, United States"
NCT01035801,"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients",https://clinicaltrials.gov/study/NCT01035801,TERMINATED,Type 1 Diabetes Mellitus,DRUG: IN-105|DRUG: Insulin Lispro Injection,Biocon Limited,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Care Hospital, Hyderabad, Andhra Pradesh, 500034, India|Bharti Research Institute of Diabetes and Endocrinology, Karnal, Hariyana, 132001, India|Diacon Hospital,(Diabetes Care and Research Centre), Bangalore, Karnataka, 560010, India|Bangalore Diabetes Hospital, Bangalore, Karnataka, 560052, India|Belgaum Diabetic Centre, Belgaum, Karnataka, 590001, India"
NCT03161964,Propranolol in Treating Hypoglycemia Unawareness,https://clinicaltrials.gov/study/NCT03161964,TERMINATED,Type 1 Diabetes Mellitus,"DRUG: Propranolol 80 Mg Oral Capsule, Extended Release|DRUG: Placebo oral capsule",Anu Sharma,,ALL,ADULT,PHASE2,INTERVENTIONAL,"University of Utah, Salt Lake City, Utah, 84132, United States"
NCT00870818,Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01),https://clinicaltrials.gov/study/NCT00870818,TERMINATED,Type 1 Diabetes Mellitus,DIAGNOSTIC_TEST: Blood samples for safety|BEHAVIORAL: Patient reported outcome questionnaires|DIAGNOSTIC_TEST: Analysis of T-cell subsets,MacroGenics,Eli Lilly and Company,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States"
NCT02998008,Effects of Acute High Intensity Exercise Training on Cardiac Function in Type II Diabetes,https://clinicaltrials.gov/study/NCT02998008,TERMINATED,"Diabetes Mellitus, Type 2",BEHAVIORAL: high intensity interval training,Norwegian University of Science and Technology,St. Olavs Hospital|Helse Nord-Trøndelag HF,ALL,ADULT,,INTERVENTIONAL,"Department of Circulation and Medical Imaging, NTNU, Trondheim, Norway"
NCT04277780,Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital Discharge,https://clinicaltrials.gov/study/NCT04277780,TERMINATED,Type 2 Diabetes Mellitus,DEVICE: Continuous Glucose Monitoring Sensor|OTHER: Diabetes Management Instructions,Albert Einstein Healthcare Network,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Albert Einstein Medical Center, Philadelphia, Pennsylvania, 19141, United States"
NCT03060980,"Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin",https://clinicaltrials.gov/study/NCT03060980,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: ITCA 650 20/60 mcg/day|DRUG: Empagliflozin (oral)|DRUG: Glimepiride (oral),Intarcia Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Fountain Hills Family Practice, P.C., Fountain Hills, Arizona, 85268, United States|Thomas C. Lenzmeier, M.D., P.C., Glendale, Arizona, 85308, United States|Family Practice Specialists, Phoenix, Arizona, 85018, United States|Central Phoenix Medical Center, Phoenix, Arizona, 85020, United States|Fiel Family and Sports Medicine, Tempe, Arizona, 85283, United States|Arizona Community Physicians, Tucson, Arizona, 85712, United States|Orange Grove Family Practice, Tucson, Arizona, 85741, United States|Anaheim Clinical Trials, Anaheim, California, 92801, United States|Radiant Research, Carlsbad, California, 92008, United States|Research Center of Fresno, Inc., Fresno, California, 93726, United States|Marin Endocrine Care and Research, Inc., Greenbrae, California, 94904, United States|National Research Institute, Huntington Park, California, 90255, United States|National Research Institute, Los Angeles, California, 91402, United States|Catalina Research Institute, Montclair, California, 91710, United States|Providence Clinical Research, North Hollywood, California, 91606, United States|Center for Clinical Trials of Sacramento, Inc., Sacramento, California, 95816, United States|Denver VA Medical Center, Aurora, Colorado, 80045, United States|Radiant Research, Centennial, Colorado, 75115, United States|Colorado Springs Health Partners - East, Colorado Springs, Colorado, 80922, United States|Columbine Family Practice, Littleton, Colorado, 80128, United States|Nature Coast Clinical Reseaerch - Crystal River, Crystal River, Florida, 34429, United States|Indago Research and Health Center, Inc., Hialeah, Florida, 33012, United States|Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, 32256, United States|Research Institure of South Florida, Miami, Florida, 33173, United States|Clinical Neuroscience Solutions, Inc., Orlando, Florida, 32801, United States|Palm Harbor Medical Associates, Palm Harbor, Florida, 34684, United States|Andres Patron, D.O., P.A, Pembroke Pines, Florida, 33026, United States|South Broward Research, Pembroke Pines, Florida, 33027, United States|Primary Care Research Group, Atlanta, Georgia, 30312, United States|Atlanta Center for Medical Research, Atlanta, Georgia, 30331, United States|Solaris Clinical Research, Meridian, Idaho, 83646, United States|Michigan Avenue Internists, Chicago, Illinois, 60604, United States|Medical and Procedural Specialists, Skokie, Illinois, 60077, United States|HSHS Medical Group DIabetes Research, Springfield, Illinois, 62711, United States|Community Hospital of Anderson and Madison County, Inc., Anderson, Indiana, 46011, United States|Clinical Research Advantage, Evansville, Indiana, 47225, United States|American Health Network of Indiana, LLC, Franklin, Indiana, 46131, United States|American Health Network of Indiana, LLC, New Albany, Indiana, 47150, United States|Heartland Research Associates, LLC, Augusta, Kansas, 67010, United States|Overland Park Surgical Specialists, LLL dba College Park Family Care Center, Overland Park, Kansas, 66210, United States|Cotton O'Neil Clinical Research Center, Topeka, Kansas, 66606, United States|Heartland Research Associates, LLC, Wichita, Kansas, 67205, United States|Heartland Research Associates, LLC, Wichita, Kansas, 67207, United States|Pennington Biomedical Research Center, Baton Rouge, Louisiana, 70808, United States|Maine Research Associates, Auburn, Maine, 04210, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|Radiant Research, Inc., Edina, Minnesota, 55435, United States|Ehrhardt Clinical Research, LLC, Belton, Missouri, 64012, United States|HealthCare Research Network, Hazelwood, Missouri, 63042, United States|Mercury Street Medical Group, Butte, Montana, 59701, United States|Skyline Medical Center, Elkhorn, Nebraska, 68022, United States|Nevada Family Care, Henderson, Nevada, 89047, United States|Palm Research Center, Inc., Las Vegas, Nevada, 89148, United States|Albany Medical College, Albany, New York, 12208, United States|Scott Research Center, Laurelton, New York, 11413, United States|American Health Research, Charlotte, North Carolina, 28207, United States|Medication Management, LLC, Greensboro, North Carolina, 27408, United States|Down East Medical Associates, PA, Morehead City, North Carolina, 28557, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28401, United States|Radiant Research, Akron, Ohio, 44311, United States|Sentral Clinical Research Services, LLC, Cincinnati, Ohio, 45236, United States|Canyon Medical Center, LLC, Columbus, Ohio, 43213, United States|Aventiv Research, Columbus, Ohio, 43231, United States|Prestige Clinical Research, Franklin, Ohio, 45005, United States|Wells Institute for Health Awareness, Kettering, Ohio, 45429, United States|University of Toledo, Toledo, Ohio, 43614, United States|Oklahoma City Clinic - Midwest City, Midwest City, Oklahoma, 73110, United States|Intend Research, Norman, Oklahoma, 73069, United States|Oklahoma City Clinic - Central, Oklahoma City, Oklahoma, 73104, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, 73112, United States|Clinical Research Institute of Southern Oregon, PC, Medford, Oregon, 97504, United States|Harleysville Medical Associates, Harleysville, Pennsylvania, 19438, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|Preferred Primary Care Phys Inc, Pittsburgh, Pennsylvania, 15243, United States|Preferred Primary Care Physicians, Uniontown, Pennsylvania, 15401, United States|Clinical Research of Rock Hill, Rock Hill, South Carolina, 29732, United States|Spartanburg Medical Research, Spartanburg, South Carolina, 29303, United States|Holston Medical Group, P.C., Kingsport, Tennessee, 37660, United States|Clinical Neuroscience Solutions, Inc., Memphis, Tennessee, 38119, United States|DCT-AACT, LLC dba Discovery Clinical Trials, Austin, Texas, 78758, United States|Dallas Diabetes and Endocrine Center, Dallas, Texas, 75230, United States|Research Institute of Dallas, Dallas, Texas, 75231, United States|Global Medical Research, DeSoto, Texas, 75115, United States|Juno Research, Houston, Texas, 77004, United States|PCP for Life - -Tidwell, Houston, Texas, 77093, United States|Sante Clinical Research, Kerrville, Texas, 78028, United States|Health Texas Research Institute, San Angelo, Texas, 78228, United States|Panacea Clinical Research, San Antonio, Texas, 78228, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, 78229, United States|Victorium Clinical Research Ltd., San Antonio, Texas, 78230, United States|MacGregor Medical Center, San Antonio, Texas, 78240, United States|Crossroads Clinical Research, LLC, Victoria, Texas, 77901, United States|Ericksen Research and Development, LLC, Clinton, Utah, 84015, United States|Radiant Research, Murray, Utah, 84123, United States|Advanced Clinical Research, West Jordan, Utah, 84088, United States|Sound Healthcare, Port Orchard, Washington, 98366, United States|Bailey Clinic, Red Deer, Alberta, T466V7, Canada|CookMed Research, Victoria, British Columbia, V8V 4A1, Canada|Milestone Research, London, Ontario, N5W 6A2, Canada|Bluewater Clinical Research Group, Sarnia, Ontario, N7T 4X3, Canada|Dr. Anil K. Gupta Medicine Professional Corporation, Toronto, Ontario, M9V 4B4, Canada"
NCT00878891,Real-time Continuous Glucose Monitoring in Diabetic Cardiothoracic Surgery Patients,https://clinicaltrials.gov/study/NCT00878891,TERMINATED,Diabetes,DEVICE: Continuous glucose monitoring for immediate correction of abnormal glycemia,"University Hospital, Bordeaux",Menarini Group,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Service d'endocrinologie-Diabétologie - Hôpital Haut-Lévêque - CHU de Bordeaux, Pessac, 33604, France"
NCT05094401,Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT05094401,TERMINATED,Type2 Diabetes,DEVICE: BT-001,Better Therapeutics,Catalyst Health Network,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Catalyst Health Network, Plano, Texas, 75024, United States"
NCT01514149,Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy,https://clinicaltrials.gov/study/NCT01514149,TERMINATED,Type 2 Diabetes Mellitus (T2DM),DRUG: CJC-1134-PC Injection|DRUG: Weekly placebo for CJC-1134-PC Injection,ConjuChem,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Phoenix, Arizona, 85018, United States|Research Site, Inglewood, California, 90301, United States|Research Site, Tarzana, California, 91356, United States|Research Site, Ventura, California, 93003, United States|Research Site, Wellington, Florida, 33414, United States|Research Site, Idaho Falls, Idaho, 83404, United States|Research Site, Lexington, Kentucky, 40504, United States|Research Site, Brighton, Massachusetts, 02135, United States|Research Site, Greensboro, North Carolina, 27405, United States|Research Site, Eugene, Oregon, 97401, United States|Research Site, Altoona, Pennsylvania, 16602, United States|Research Site, East Providence, Rhode Island, 02915, United States|Research Site, Charleston, South Carolina, 29407, United States|Research Site, Taylors, South Carolina, 29687, United States|Research Site, Austin, Texas, 78758, United States|Research Site, Dallas, Texas, 75231, United States|Research Site, San Antonio, Texas, 78249, United States|Research Site, Salt Lake City, Utah, 84107, United States|Research Site, Henrico, Virginia, 23233, United States|Research Site, Vancouver, British Columbia, Canada|Research Site, Smiths Falls, Ontario, Canada|Research Site, Toronto, Ontario, Canada"
NCT02763007,An Extension Study of PEAK Trial,https://clinicaltrials.gov/study/NCT02763007,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: alogliptin+pioglitazone|DRUG: alogliptin|DRUG: pioglitazone,Kun-Ho Yoon,Takeda,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, 137-701, Korea, Republic of"
NCT00770679,Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging,https://clinicaltrials.gov/study/NCT00770679,TERMINATED,Diabetes,DRUG: lipitor,Johns Hopkins University,Pfizer,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Harry SIlber, MD, Baltimore, Maryland, 21224, United States"
NCT00837759,Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00837759,TERMINATED,Diabetes Mellitus Type 1|Autoimmune Diabetes,DRUG: Insulin|DRUG: Lansoprazole|DRUG: Sitagliptin|BIOLOGICAL: Diamyd|DRUG: GAD65 (Diamyd),National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),,ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT00707434,Continuous Glucose Monitoring in Critically Ill,https://clinicaltrials.gov/study/NCT00707434,TERMINATED,Diabetes,DEVICE: Guardian® blood-sugar monitoring device,M.D. Anderson Cancer Center,Medtronic,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, 77555, United States|University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|University of Texas Health Science Center at Tyler, Tyler, Texas, 75708, United States"
NCT01987674,Pre-meal Protein Drink Improve Glycemic Regulation,https://clinicaltrials.gov/study/NCT01987674,TERMINATED,Type 2 Diabetes Mellitus,DIETARY_SUPPLEMENT: Pre-meal protein drink|OTHER: Water drink,Lund University,Landstinget i Kalmar Län,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Lindsdals hälsocentral, Kalmar, 39365, Sweden"
NCT00865592,Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00865592,TERMINATED,Type 2 Diabetes Mellitus|Type 2 Diabetes,DRUG: dutogliptin,Phenomix,Forest Laboratories,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Norwalk, California, United States|Orange, California, United States|Santa Ana, California, United States|Daytona Beach, Florida, United States|Kissimmee, Florida, United States|Atlanta, Georgia, United States|Phenomix Investigational Site 663, Honolulu, Hawaii, United States|Brockton, Massachusetts, United States|St. Louis, Missouri, United States|Cincinnati, Ohio, United States|El Paso, Texas, United States|San Antonio, Texas, United States|Norfolk, Virginia, United States|Phenomix Investigational Site 103, Buenos Aires, Argentina|Phenomix Investigational Site 110, Buenos Aires, Argentina|Phenomix Investigational Site 111, Buenos Aires, Argentina|Phenomix Investigational Site 106, Caba, Argentina|Phenomix Investigational Site 112, Corrientes, Argentina|Phenomix Investigational Site 102, Paraná, Argentina|Bangalore, Karnataka, India|Chennai, Tamil Nadu, India|Gulbarga, Karnataka, India|Hyderabad, Andhara Pradesh, India|Mumbai, Maharashtra, India|Nagpur, Maharashtra, India|Nashik, Maharashtra, India|Navi Mumbai, Maharashtra, India|Pune, Maharashtra, India|Phenomix Investigational Site 403, Kuching, Sarawak, Malaysia|Kelantan, Malaysia|Kuala Lumpur, Malaysia|Perak, Malaysia|Phenomix Investigational Site 404, Putrajaya, Malaysia|Sarawak, Malaysia|Phenomix Investigational Site 604, Arequipa, Peru|Phenomix Investigational Site 606, Lambayeque, Peru|Phenomix Investigational Site 600, Lima, Peru|Phenomix Investigational Site 601, Lima, Peru|Phenomix Investigational Site 602, Lima, Peru|Phenomix Investigational Site 609, Lima, Peru|Phenomix Investigational Site 703, Cebu City, Philippines|Manila, NCR, Philippines|Quezon City, NCR, Philippines|San Juan, NCR, Philippines|Phenomix Investigational Site 802, Brasov, Romania|Phenomix Investigational Site 806, Brasov, Romania|Phenomix Investigational Site 800, Bucharest, Romania|Phenomix Investigational Site 803, Bucharest, Romania|Phenomix Investigational Site 805, Bucharest, Romania|Phenomix Investigational Site 807, Bucharest, Romania|Phenomix Investigational Site 804, Galati, Romania|Phenomix Investigational Site 801, Ploieşti, Romania|Phenomix Investigational Site 808, Sibiu, Romania|Phenomix Investigational Site 551, Ivano-Frankivsk, Ukraine|Phenomix Investigational Site 557, Kharkiv, Ukraine|Phenomix Investigational Site 564, Kharkiv, Ukraine|Phenomix Investigational Site 550, Kharkov, Ukraine|Phenomix Investigational Site 555, Kiev, Ukraine|Phenomix Investigational Site 556, Kiev, Ukraine|Phenomix Investigational Site 562, Kiev, Ukraine|Phenomix Investigational Site 563, Kiev, Ukraine|Phenomix Investigational Site 554, Kylv, Ukraine|Phenomix Investigational Site 565, Lutsk, Ukraine|Phenomix Investigational Site 553, Lviv, Ukraine|Phenomix Investigational Site 561, Poltava, Ukraine|Phenomix Investigational Site 560, Simferopol, Ukraine|Phenomix Investigational Site 559, Vinnitsa, Ukraine|Phenomix Investigational Site 552, Zaporzhzhia, Ukraine"
NCT00214565,GALLANT 6 Tesaglitazar vs. Pioglitazone,https://clinicaltrials.gov/study/NCT00214565,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Galida,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Altoona, Pennsylvania, United States|Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Córdoba, Argentina|Research Site, Moron- Buenos Aires, Argentina|Research Sites, Quilmes - Buenos Aires, Argentina|Research Site, Rosario, Argentina|Research Site, Salta, Argentina|Research Site, Curitiba, Brazil|Research Site, Edmonton, Alberta, Canada|Research Site, Abbotsford, British Columbia, Canada|Research Site, Chilliwack, British Columbia, Canada|Research Site, Vancouver, British Columbia, Canada|Research Site, Victoria, British Columbia, Canada|Research Site, Dartmouth, Nova Scotia, Canada|Research Site, Halifax, Nova Scotia, Canada|Research Site, Truro, Nova Scotia, Canada|Research Site, Windsor, Nova Scotia, Canada|Research Site, Brampton, Ontario, Canada|Research Site, Etobicoke, Ontario, Canada|Research Site, Kingston, Ontario, Canada|Research Site, Niagara Falls, Ontario, Canada|Research Site, Oshawa, Ontario, Canada|Research Site, Scarborough, Ontario, Canada|Research Site, St. Catharines, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Windsor, Ontario, Canada|Research Site, Trois-Rivières, Quebec, Canada|Research Site, Chicoutimi, Canada|Research Site, Longueuil, Canada|Research Site, Montreal, Canada|Research Site, St. John's, Canada|Research Site, Espoo, Finland|Research Site, Helsinki, Finland|Research Site, Kuopio, Finland|Research Site, Pietarsaar, Finland|Research Site, Pori, Finland|Research Site, Tampere, Finland|Research Site, Guadalajara Jalisco, Mexico|Research Site, Mexico City, Mexico|Research Site, Mexico, Mexico|Research Site, Nuevo Leon, Mexico|Research Site, Puebla, Mexico|Research Site, Torreon, Mexico|Research Site, Zapopan, Mexico|Research Site, Bergen, Norway|Research Site, Elvernum, Norway|Research Site, Hamar, Norway|Research Site, Horten, Norway|Research Site, Kongsberg, Norway|Research Site, Lena, Norway|Research Site, Loeten, Norway|Research Site, Lysaker, Norway|Research Site, Oslo, Norway|Research Site, Osteraas, Norway|Research Site, Skedsmokorset, Norway|Research Site, Straume, Norway|Research Site, Toensberg, Norway|Research Site, Tronheim, Norway|Research Site, Ås, Norway|Research Site, Dublin, Ireland, United Kingdom|Research Site, Wexford, Ireland, United Kingdom|Research Site, Antrim, NI, United Kingdom|Research Site, Belfast, United Kingdom|Research Site, Cardiff, United Kingdom|Research Site, Edinburgh, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Kent, United Kingdom|Research Site, Leeds, United Kingdom|Research Site, Mid Glamorgan, United Kingdom|Research Site, Pembrokeshire, United Kingdom|Research Site, Plymouth, United Kingdom|Research SIte, Reading, United Kingdom|Research Site, Surrey, United Kingdom|Research Site, Wiltshire, United Kingdom"
NCT00349986,LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00349986,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Insuline glargine,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Sanofi-Aventis, Budapest, Hungary"
NCT02925676,Evaluation of the Hypoglycaemia Notification Device Hyposafe H02,https://clinicaltrials.gov/study/NCT02925676,TERMINATED,"Diabetes Mellitus, Type 1",DEVICE: hyposafe H02,UNEEG Medical A/S,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"North Zealand Hospital, Hillerød, Denmark|Odense University Hospital, Odense, 5000, Denmark"
NCT00214591,GALLANT 5 Tesaglitazar Versus Metformin,https://clinicaltrials.gov/study/NCT00214591,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: GALIDA,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Birmingham, Alabama, United States|Research Site, Columbiana, Alabama, United States|Research Site, Mobile, Alabama, United States|Research Site, Carlisle, Arizona, United States|Research Center, Sherwood, Arizona, United States|Research Site, Chula Vista, California, United States|Research Site, Escondido, California, United States|Research Site, Huntington Beach, California, United States|Research Site, Los Angeles, California, United States|Research Site, Mission Viejo, California, United States|Research Site, Orange, California, United States|Research Site, Pasadena, California, United States|Research Site, Pomona, California, United States|Research Site, Redondo Beach, California, United States|Research Site, Sacramento, California, United States|Research Site, Colorado Springs, Colorado, United States|Research Site, Wheat Ridge, Colorado, United States|Research Site, Clearwater, Florida, United States|Research Site, Gainesville, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Miami, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Brunswick, Georgia, United States|Research Site, Carollton, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Boise, Idaho, United States|Research Site, Evansville, Indiana, United States|Research Site, Kansas City, Kansas, United States|Research Site, Overland Park, Kansas, United States|Research Site, Witchita, Kansas, United States|Research Site, Bossier City, Louisiana, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Baltimore, Maryland, United States|Research Site, Kalamazoo, Missouri, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Hamilton, New Jersey, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Albany, New York, United States|Research Site, Bronx, New York, United States|Research Site, New York, New York, United States|Research Site, Pahrump, New York, United States|Research Site, Rochester, New York, United States|Research Site, White Plains, New York, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Dayton, Ohio, United States|Research Site, Kettering, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Medford, Oregon, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Simpsonville, South Carolina, United States|Research Site, Morristown, Tennessee, United States|Research Site, Corpus Christi, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Lubbock, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Burke, Virginia, United States|Research Site, Norfolk, Virginia, United States|Research Site, Richmond, Virginia, United States|Research Site, Tacoma, Washington, United States|Research Site, Menomonee Falls, Wisconsin, United States|Research Site, Milwaukee, Wisconsin, United States|Research Site, Helsinki, Finland|Research Site, Hämeenlinna, Finland|Research Site, Joensuu, Finland|Research Site, Kouvola, Finland|Research Site, Kuopio, Finland|Research Site, Mikkeli, Finland|Research Site, Oulu, Finland|Research Site, Salo, Finland|Research Site, Tampere, Finland|Research Site, Vantaa, Finland|Research Site, Aschaffenburg, Germany|Research Site, Bad Segeberg, Germany|Research Site, Beckum, Germany|Research Site, Berlin, Germany|Research Site, Dresden, Germany|Research Site, Ehrenberg, Germany|Research Site, Essen, Germany|Research Site, Feldafing, Germany|Research Site, Hamburg, Germany|Research Site, Hannover, Germany|Research Site, Hermaringen, Germany|Research Site, Künzing, Germany|Research Site, Langen, Germany|Research Site, Mannheim, Germany|Research Site, Marl, Germany|Research Site, Nürnberg, Germany|Research Site, Pirna, Germany|Research Site, Rotenburg/Fulda, Germany|Research Site, Ashkelon, Israel|Research Site, Haifa, Israel|Research Site, Holon, Israel|Research Site, Jerusalem, Israel|Research Site, Rishon-Lezion, Israel|Research Site, Tel Aviv, Israel|Research Site, Zefat, Israel|Research Site, Beek en Donk, Netherlands|Research Site, Bennebroe, Netherlands|Research Site, Den Haag, Netherlands|Research Site, Deurne, Netherlands|Research Site, Huizen, Netherlands|Research Site, Losser, Netherlands|Research Site, Nijverdal, Netherlands|Research Site, Rijswijk, Netherlands|Research Site, Roelofarendsveen, Netherlands|Research Site, Rotterdam, Netherlands|Research Site, Bergen, Norway|Research Site, Oslo, Norway|Research Site, Østerås, Norway|Research Site, San Vicente de Raspeig, Alicante, Spain|Research Site, Villar del Arzobispo, Valencia, Spain|Research Site, Alzira (Valencia), Spain|Research Site, Barcelona, Spain|Research Site, Begonte (Lugo), Spain|Research Site, Madrid, Spain|Research Site, Sevilla, Spain|Research Site, Aberdeen, United Kingdom|Research Site, Ayr, United Kingdom|Research Site, Bath, United Kingdom|Research Site, Berks, United Kingdom|Research Site, Bucks, United Kingdom|Research Site, Coventry, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Manchester, United Kingdom|Research Sites, Northampton, United Kingdom|Research Site, Wiltshire, United Kingdom"
NCT05761301,A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM,https://clinicaltrials.gov/study/NCT05761301,TERMINATED,Type 2 Diabetes Mellitus (T2DM),DRUG: ALN-KHK|DRUG: Placebo,Alnylam Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Clinical Trial Site, Phoenix, Arizona, 85020, United States|Clinical Trial Site, Vista, California, 92083, United States|Clinical Trial Site, Lake Worth, Florida, 33461, United States|Clinical Trial Site, Orlando, Florida, 32806, United States|Clinical Trial Site, Atlanta, Georgia, 30342, United States|Clinical Trial Site, Berlin, New Jersey, 08009, United States|Clinical Trial Site, Monroe, North Carolina, 28110, United States|Clinical Trial Site, Oklahoma City, Oklahoma, 73112, United States|Clinical Trial Site, Dallas, Texas, 75234, United States|Clinical Trial Site, Houston, Texas, 77036, United States|Clinical Trial Site, San Antonio, Texas, 78229, United States|Clinical Trial Site, Sarnia, Ontario, Canada|Clinical Trial Site, Montréal, Quebec, Canada|Clinical Trial Site, Victoriaville, Quebec, Canada|Clinical Trial Site, Toronto, Canada"
NCT04047537,Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT04047537,TERMINATED,Type 2 Diabetes Mellitus,OTHER: Medical Food Formulation 1|OTHER: Medical Food Formulation 2|OTHER: Placebo,Pendulum Therapeutics,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Atlantia Food Clinical Trials, 1st Floor, Block C, Heron House, Blackpool Retail Park, Cork, Ireland"
NCT00543556,MK0767 in Type 2 Diabetes (0767-012),https://clinicaltrials.gov/study/NCT00543556,TERMINATED,Type 2 Diabetes Mellitus,DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT03080337,Group vs. Traditional Diabetes Prenatal Care,https://clinicaltrials.gov/study/NCT03080337,TERMINATED,Pregnancy|Diabetes,OTHER: Group Care,"University of Wisconsin, Madison",Akron Children's Hospital,FEMALE,ADULT,,INTERVENTIONAL,"UnityPoint Health- Meriter Hospital, Madison, Wisconsin, 53715, United States"
NCT02726490,Glyburide vs Glucovance in the Treatment of GDM,https://clinicaltrials.gov/study/NCT02726490,TERMINATED,Gestational Diabetes,DRUG: Glyburide|DRUG: Glucovance,"Texas Tech University Health Sciences Center, El Paso",,FEMALE,"ADULT, OLDER_ADULT",EARLY_PHASE1,INTERVENTIONAL,"TTUHSC El Paso, El Paso, Texas, 79905, United States"
NCT02728453,SGLT2 Inhibition and Left Ventricular Mass,https://clinicaltrials.gov/study/NCT02728453,TERMINATED,Diabetes Mellitus Type 2,DRUG: Empagliflozin|DRUG: Glimepiride,Hannover Medical School,Boehringer Ingelheim,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Hannover Medical School, Hannover, 30625, Germany"
NCT00242372,GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin,https://clinicaltrials.gov/study/NCT00242372,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Tesaglitazar 0.5|DRUG: Insulin at least 30 units/day,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Birmingham, Alabama, United States|Research Site, Phoenix, Arizona, United States|Research Site, Tuscson, Arizona, United States|Research Site, Fresno, California, United States|Research Site, Greenbrae, California, United States|Research Site, La Jolla, California, United States|Research Site, Northridge, California, United States|Research Site, Riverside, California, United States|Research Site, San Diego, California, United States|Research Site, Santa Monica, California, United States|Research Site, Spring Valley, California, United States|Research Site, Walnut Creek, California, United States|Research Site, West Hills, California, United States|Research Site, Waterbury, Connecticut, United States|Research Site, Washington, District of Columbia, United States|Research Site, Gainesville, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Palm Harbor, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Augusta, Georgia, United States|Research Site, Dunwoody, Georgia, United States|Research Site, Boise, Idaho, United States|Research Site, Chicago Heights, Illinois, United States|Research Site, Chicago, Illinois, United States|Research Site, Gurnee, Illinois, United States|Research Site, Maywood, Illinois, United States|Research Site, Springfield, Illinois, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Wichita, Kansas, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Cadillac, Michigan, United States|Research Site, Richmond Heights, Missouri, United States|Research Site, St Louis, Missouri, United States|Research Site, Omaha, Nebraska, United States|Research Site, North Las Vegas, Nevada, United States|Research Site, Pahrump, Nevada, United States|Research Site, Dover, New Hampshire, United States|Research Site, Roseland, New Jersey, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Brooklyn, New York, United States|Research Site, New Hyde Park, New York, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Wilmington, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Kettering, Ohio, United States|Research Site, Toledo, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Medford, Oregon, United States|Research Site, Portland, Oregon, United States|Research Site, Altoona, Pennsylvania, United States|Research Site, Cheswick, Pennsylvania, United States|Research Site, Erie, Pennsylvania, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Columbia, South Carolina, United States|Research Site, Greer, South Carolina, United States|Research Site, Corpus Christie, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Fort Worth, Texas, United States|Research Site, Houston, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Richmond, Virginia, United States|Research Site, Bellevue, Washington, United States|Research Site, Renton, Washington, United States|Research Site, Spokane, Washington, United States|Research Site, Tacoma, Washington, United States|Research Site, Madison, Wisconsin, United States"
NCT03053518,Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes,https://clinicaltrials.gov/study/NCT03053518,TERMINATED,Type2 Diabetes,DEVICE: Abbott Freestyle Libre Pro|BEHAVIORAL: LifeStyle,NYU Langone Health,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"New York University School of Medicine, New York, New York, 10016, United States"
NCT01124656,Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01124656,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Pioglitazone-Azilsartan,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00814372,Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin,https://clinicaltrials.gov/study/NCT00814372,TERMINATED,Type 2 Diabetes Mellitus,DRUG: MBX-102|DRUG: Placebo|DRUG: Actos|DRUG: Metformin,Gilead Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Providence Clinical Research, Burbank, California, 91505, United States|American Institute of Research, Los Angeles, California, 90017, United States|Nevada Alliance Against Diabetes, Las Vegas, Nevada, 89101, United States|Piedmont Medical Research Associates, Winston-Salem, North Carolina, 27103, United States|DGD Research, Inc., San Antonio, Texas, 78229, United States|Kamineni Hospitals Pvt, Ltd., Hyderabad, Andhra Pradesh, 50008, India|Bangalore Diabetes Centre, Bangalore, India|Diacon Hospital Diabetes & Research Centre, Bangalore, India|M. S. Ramaiah Memorial Hospital, Bangalore, India|St. John's Medical College & Hospital, Bangalore, India|Dr. V. Seshiah Diabetes Care & Research Institute, Chennai, India|Mediciti Hospital, Hyderabad, India|Medwin Hospital, Hyderabad, India|Diabetes Thyroid Hormone Research Institute Pvt. Ltd., Indore, India|Fortis Hospital, Jaipur, India|Bharti Research Institute of Diabetes & Endocrinology, Karnal, India|Amrita Institute of Medical Sciences, Kochi, India|Diabetes Action Centre, Mumbai, 400067, India|BYL Nair Hospital, Mumbai, India|PD Hindhuja National Hospital, Mumbai, India|Gandhi Endocrinology & Diabetes Centre, Nagpur, India|All India Institute of Medical Sciences, New Delhi, India|Deenanath Mangeshkar Hospital & Research Centre, Pune, India|Diabetes Care & Research Centre, Pune, India|Health & Research Centre, Trivendrum, India|Christian Medical College, Vellore, India"
NCT04180813,Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose,https://clinicaltrials.gov/study/NCT04180813,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Linagliptin|DRUG: Acarbose,Boehringer Ingelheim,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"No.731 Hospital of China Aerospace Science & Industry Corp., Beijing, 100074, China|Affiliated Hospital of Chengdu University, Chengdu, 610081, China|ChongQing The Fourth Hospital, Chongqing, 400014, China|Dongying People's Hospital, Dongying, 257000, China|Huai'an first people's hospital, Huai'an, 223300, China|Nanjing Drum Tower Hospital, Nanjing, 210008, China|Zhongda Hospital Southeast University, Nanjing, 210009, China|Shanghai TCM-Integrated Hospital, Shanghai, 200000, China|Southern Medical University Shenzhen Hospital, Shenzhen, 518110, China|Zhangjiagang First People Hospital, Suzhou, 215699, China"
NCT02026232,Metabolic Effects of Hydroxychloroquine,https://clinicaltrials.gov/study/NCT02026232,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Hydroxychloroquine|OTHER: Hydroxychloroquine Placebo,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Washington University, Saint Louis, Missouri, 63110, United States"
NCT01982253,Fasiglifam 25 mg BID vs 50 mg QD,https://clinicaltrials.gov/study/NCT01982253,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Fasiglifam|DRUG: Placebo to fasiglifam,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Goodyear, Arizona, United States|Long Beach, California, United States|Los Angeles, California, United States|North Hollywood, California, United States|Norwalk, California, United States|Tustin, California, United States|Boynton Beach, Florida, United States|Coral Gables, Florida, United States|Miami, Florida, United States|Orlando, Florida, United States|Pembroke Pines, Florida, United States|Decatur, Georgia, United States|Chicago, Illinois, United States|Avon, Indiana, United States|Franklin, Indiana, United States|Greenfield, Indiana, United States|Muncie, Indiana, United States|Council Bluffs, Iowa, United States|Topeka, Kansas, United States|Lexington, Kentucky, United States|Metairie, Louisiana, United States|Flint, Michigan, United States|Albuquerque, New Mexico, United States|Charlotte, North Carolina, United States|Greensboro, North Carolina, United States|Mooresville, North Carolina, United States|Morganton, North Carolina, United States|Salisbury, North Carolina, United States|Maumee, Ohio, United States|Norman, Oklahoma, United States|Corvallis, Oregon, United States|Portland, Oregon, United States|Harleysville, Pennsylvania, United States|Levittown, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Greer, South Carolina, United States|Carrollton, Texas, United States|Dallas, Texas, United States|Edinburg, Texas, United States|Houstan, Texas, United States|Houston, Texas, United States|New Braunfels, Texas, United States|San Antonio, Texas, United States|Spring, Texas, United States|Salt Lake City, Utah, United States|Burke, Virginia, United States|Manassas, Virginia, United States|Byala, Bulgaria|Pleven, Bulgaria|Plovdiv, Bulgaria|Ruse, Bulgaria|Sevlievo, Bulgaria|Sofia, Bulgaria|Varna, Bulgaria|Lodz, Poland|Oswiecim, Poland|Poznan, Poland|Rzeszow, Poland|Sobotka, Poland|Torun, Poland|Zgierz, Poland|Baia Mare, Romania|Bucuresti, Romania|Cluj-Napoca, Romania|Iasi, Romania|Oradea, Romania|Ploiesti, Romania|Bardejov, Slovakia|Bratislava, Slovakia|Dolny Kubin, Slovakia|Komarno, Slovakia|Levice, Slovakia|Lucenec, Slovakia|Nitra, Slovakia|Pezinok, Slovakia|Sabinov, Slovakia|Stropkov, Slovakia|Sturovo, Slovakia|Svidnik, Slovakia|Kaohsiung, Taiwan|Taichung, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Kharkiv, Ukraine|Kyiv, Ukraine|Simferopol, Ukraine|Ternopil, Ukraine|Vinnytsia, Ukraine"
NCT03262116,Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas,https://clinicaltrials.gov/study/NCT03262116,TERMINATED,Type 1 Diabetes Mellitus,DRUG: Humalog|DRUG: Novolog|DRUG: BC222 insulin lispro|DEVICE: Bionic Pancreas,Massachusetts General Hospital,Boston University,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States"
NCT01453049,An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients,https://clinicaltrials.gov/study/NCT01453049,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: rosiglitazone/glimepiride fix dose combination|DRUG: glimepiride,GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"GSK Investigational Site, Wuhan, Hubei, 430030, China|GSK Investigational Site, Suzhou, Jiangsu, 215004, China|GSK Investigational Site, Dalian, Liaoning, 116027, China|GSK Investigational Site, Hangzhou, Zhejiang, 310003, China|GSK Investigational Site, Hangzhou, Zhejiang, 310009, China|GSK Investigational Site, Beijing, 100029, China|GSK Investigational Site, Beijing, 100730, China|GSK Investigational Site, Chongqing, 400016, China|GSK Investigational Site, Shanghai, 200080, China|GSK Investigational Site, Shenyang, 110003, China|GSK Investigational Site, Tianjin, 300052, China|GSK Investigational Site, Wuhan, 430022, China"
NCT00229684,ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR),https://clinicaltrials.gov/study/NCT00229684,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Tesaglitazar|DRUG: pioglitazone,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Pasadena, California, United States|Research Site, Washington, District of Columbia, United States|Research Site, Gainesville, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Augusta, Georgia, United States|Research Site, Columbus, Georgia, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Reno, Nevada, United States|Research Site, Flushing, New York, United States|Research Site, Durham, North Carolina, United States|Research Site, Cleveland, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Tulsa, Oklahoma, United States|Research Site, Cheswick, Pennsylvania, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Nashville, Tennessee, United States|Research Site, Midland, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Gig Harbor, Washington, United States|Research Site, Seattle, Washington, United States"
NCT03217175,Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise,https://clinicaltrials.gov/study/NCT03217175,TERMINATED,Type 1 Diabetes Mellitus,DEVICE: Bihormonal Bionic Pancreas|DEVICE: Insulin Only Bionic Pancreas|DRUG: Glucagon|DRUG: Placebo,Massachusetts General Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"MGH Diabetes Research Center, Boston, Massachusetts, 02114, United States"
NCT01275235,Exposure to Type II Diabetes for Two Siblings With the Same Parents,https://clinicaltrials.gov/study/NCT01275235,TERMINATED,Type 2 Diabetes Mellitus,,Pennington Biomedical Research Center,,ALL,ADULT,,OBSERVATIONAL,"Pennington Biomedical Research Center, Baton Rouge, Louisiana, 70808, United States"
NCT02057211,Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study,https://clinicaltrials.gov/study/NCT02057211,TERMINATED,Type 1 Diabetes Mellitus,BIOLOGICAL: autologous mesenchymal stem cell transplantation|PROCEDURE: sham transplantation of mesenchymal stem cells,Uppsala University Hospital,,ALL,ADULT,PHASE2,INTERVENTIONAL,"Uppsala University Hospital, Uppsala, SE-75185, Sweden"
NCT00789282,Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00789282,TERMINATED,"Diabetes Mellitus, Type 2",OTHER: multidisciplinary approach|OTHER: multifactorial approach - for enhanced care group|OTHER: reflects current patterns of care,University of Alberta,Alberta Heritage Foundation for Medical Research,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Alberta, Dept of Family Medicicne, Edmonton, Alberta, T6G - 2C8, Canada"
NCT00543816,MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030),https://clinicaltrials.gov/study/NCT00543816,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00543738,MK0767 and Metformin Combination Study (0767-028),https://clinicaltrials.gov/study/NCT00543738,TERMINATED,Diabetes Mellitus,DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00464854,Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward,https://clinicaltrials.gov/study/NCT00464854,TERMINATED,Diabetes Mellitus,DRUG: Glargine and insulin aspart or lispro,Assaf-Harofeh Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Assaf Harofe Medical Center, Zerifin, 70300, Israel"
NCT02282423,PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes,https://clinicaltrials.gov/study/NCT02282423,TERMINATED,Diabetes|Obesity,BEHAVIORAL: Pre-study dietary and exercise instruction.|PROCEDURE: Screening examination and oral glucose tolerance test|PROCEDURE: Euglycemic clamp|PROCEDURE: VO2max.|BEHAVIORAL: Acute exercise bout|PROCEDURE: Percutaneous needle muscle biopsies,Mayo Clinic,Arizona State University,ALL,ADULT,,INTERVENTIONAL,"Mayo Clinic, Scottsdale, Arizona, 85259, United States"
NCT00514618,Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics,https://clinicaltrials.gov/study/NCT00514618,TERMINATED,"Diabetes, Gestational",DRUG: Misoprostol|DIETARY_SUPPLEMENT: Placebo,MemorialCare Health System,Long Beach Memorial Medical Center,FEMALE,ADULT,,INTERVENTIONAL,"Long Beach Memorial Medical Center, Long Beach, California, 90806, United States"
NCT02791867,"Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake",https://clinicaltrials.gov/study/NCT02791867,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: AphoelineBrake,Dasman Diabetes Institute,University at Buffalo,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Dasman DIabetes Institute, Kuwait, Kuwait"
NCT02443532,Effects of Structured Group Education on Quality of Life and Glycemic Control in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT02443532,TERMINATED,"Diabetes Mellitus, Type 1",BEHAVIORAL: Structured group education|BEHAVIORAL: Individual education,Azienda Ospedaliero-Universitaria Careggi,,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT00135070,Hospital In-Patient Insulin Study,https://clinicaltrials.gov/study/NCT00135070,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Detemir,The Royal Bournemouth Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"The Royal Bournemouth Hospital, Bournemouth, Dorset, BH7 7DW, United Kingdom"
NCT01315808,Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM,https://clinicaltrials.gov/study/NCT01315808,TERMINATED,Diabetes Mellitus Type 2,,Wyckoff Heights Medical Center,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Wyckoff Heights Medical Center, Brooklyn, New York, 11237, United States"
NCT00543751,Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025),https://clinicaltrials.gov/study/NCT00543751,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00137046,Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00137046,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: Subcutaneous Insulin|DRUG: Inhaled Insulin,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Fullerton, California, 92835, United States|Pfizer Investigational Site, Long Beach, California, 90806, United States|Pfizer Investigational Site, Sacramento, California, 95816, United States|Pfizer Investigational Site, San Diego, California, 92103, United States|Pfizer Investigational Site, Santa Barbara, California, 93105, United States|Pfizer Investigational Site, Santa Rosa, California, 95405, United States|Pfizer Investigational Site, Tustin, California, 92780, United States|Pfizer Investigational Site, Walnut Creek, California, 94598, United States|Pfizer Investigational Site, Denver, Colorado, 80220, United States|Pfizer Investigational Site, Longmont, Colorado, 80501, United States|Pfizer Investigational Site, Hamden, Connecticut, 06518, United States|Pfizer Investigational Site, Madison, Connecticut, 06443, United States|Pfizer Investigational Site, Newark, Delaware, 19713, United States|Pfizer Investigational Site, Coral Gables, Florida, 33134, United States|Pfizer Investigational Site, Hollywood, Florida, 33021, United States|Pfizer Investigational Site, Miami, Florida, 33136, United States|Pfizer Investigational Site, Tallahassee, Florida, 32308, United States|Pfizer Investigational Site, West Palm Beach, Florida, 33401, United States|Pfizer Investigational Site, Winter Park, Florida, 32789, United States|Pfizer Investigational Site, Chicago, Illinois, 60602, United States|Pfizer Investigational Site, Chicago, Illinois, 60610, United States|Pfizer Investigational Site, Wilmette, Illinois, 60091, United States|Pfizer Investigational Site, Bethesda, Maryland, 20817, United States|Pfizer Investigational Site, St. Louis, Missouri, 63141, United States|Pfizer Investigational Site, Butte, Montana, 59701, United States|Pfizer Investigational Site, New Hyde Park, New York, 11042, United States|Pfizer Investigational Site, Durham, North Carolina, 27713, United States|Pfizer Investigational Site, Portland, Oregon, 97210, United States|Pfizer Investigational Site, Lansdale, Pennsylvania, 19446, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75246, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, Burlington, Vermont, 05401, United States|Pfizer Investigational Site, Richmond, Virginia, 23225, United States|Pfizer Investigational Site, Renton, Washington, 98057, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53209, United States|Pfizer Investigational Site, Capital Federal, Buenos Aires, C1120 AAF, Argentina|Pfizer Investigational Site, Capital Federal, Buenos Aires, C1181 ACH, Argentina|Pfizer Investigational Site, Capital Federal, Buenos Aires, C1405 DCS, Argentina|Pfizer Investigational Site, Capital Federal, Buenos Aires, C1427 AQR, Argentina|Pfizer Investigational Site, Belo Horizonte, MG, 30150-221, Brazil|Pfizer Investigational Site, Curitiba, PR, 80420-011, Brazil|Pfizer Investigational Site, Porto Alegre, RS, 90035-170, Brazil|Pfizer Investigational Site, Porto Alegre, RS, 90035-903, Brazil|Pfizer Investigational Site, Campinas, SP, 13083-900, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 01244-030, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 04231-030, Brazil|Pfizer Investigational Site, São Paulo, SP, 04020-041, Brazil|Pfizer Investigational Site, Calgary, Alberta, T2T 5C7, Canada|Pfizer Investigational Site, Calgary, Alberta, T3B 0M3, Canada|Pfizer Investigational Site, Edmonton, Alberta, T5J 3N4, Canada|Pfizer Investigational Site, Edmonton, Alberta, T6G 2C8, Canada|Pfizer Investigational Site, Victoria, British Columbia, V8R 1J8, Canada|Pfizer Investigational Site, Winnepeg, Manitoba, R3A 1R9, Canada|Pfizer Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, B3H 1V7, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, B3H 2Y9, Canada|Pfizer Investigational Site, Kingston, Ontario, K7L 2V7, Canada|Pfizer Investigational Site, London, Ontario, N6A 4V2, Canada|Pfizer Investigational Site, Mississauga, Ontario, L5M 2V8, Canada|Pfizer Investigational Site, Oakville, Ontario, L6H 3P1, Canada|Pfizer Investigational Site, Ottawa, Ontario, K1H 1A2, Canada|Pfizer Investigational Site, Thornhill, Ontario, L4J 8L7, Canada|Pfizer Investigational Site, Toronto, Ontario, M4R 2G4, Canada|Pfizer Investigational Site, Laval, Quebec, H7T 2P5, Canada|Pfizer Investigational Site, Montreal, Quebec, H1T 2M4, Canada|Pfizer Investigational Site, Montreal, Quebec, H3A 1A1, Canada|Pfizer Investigational Site, Sherbrooke, Quebec, J1H 5N4, Canada|Pfizer Investigational Site, Saskatoon, Saskatchewan, S7N 0W8, Canada|Pfizer Investigational Site, Mexico Df, Col Las Americas, 01120, Mexico|Pfizer Investigational Site, Mexico, DF, 02990, Mexico|Pfizer Investigational Site, Mexico, DF, 14000, Mexico|Pfizer Investigational Site, Monterrey, Nuevo Leon, 64060, Mexico"
NCT03344341,A Phase IV Study in Drug-Naive Patients With T2DM in China,https://clinicaltrials.gov/study/NCT03344341,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Dapagliflozin|DRUG: Acarbose,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Research Site, Beijing, 100020, China|Research Site, Beijing, 100730, China|Research Site, Changsha, 410013, China|Research Site, Chengdu, 610041, China|Research Site, Chongqing, 400016, China|Research Site, Guangzhou, 510280, China|Research Site, Hangzhou, 310014, China|Research Site, Hangzhou, 310016, China|Research Site, Hefei, 230022, China|Research Site, Jinan, 250012, China|Research Site, Nanjing, 2100008, China|Research Site, Qingdao, 266003, China|Research Site, Qingdao, China|Research Site, Shanghai, 200233, China|Research Site, Shanghai, CN-200120, China|Research Site, Shenyang, 100003, China|Research Site, Suzhou, 215004, China|Research Site, Tianjin, CN-300070, China|Research Site, Xi'an, 710061, China|Research Site, Yinchuan, 750004, China"
NCT00738088,Variation in Sulphonylurea Response in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00738088,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: gliclazide,NHS Tayside,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"NHS Tayside, Dundee, DD1 9SY, United Kingdom"
NCT00766441,Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan,https://clinicaltrials.gov/study/NCT00766441,TERMINATED,Diabetes|Hypoglycemia,DRUG: Sitagliptin|DRUG: sulphonylurea,University of Manchester,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Wellcome Trust Clinical Research Facility, Manchester, M13 9NT, United Kingdom"
NCT00280085,The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.,https://clinicaltrials.gov/study/NCT00280085,TERMINATED,Diabetes Mellitus,PROCEDURE: MR imaging|PROCEDURE: Glucose clamp|DRUG: Arginine,Pfizer,Yale University,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Pfizer Investigational Site, New Haven, Connecticut, 06510, United States"
NCT03608358,Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin,https://clinicaltrials.gov/study/NCT03608358,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Dapagliflozin 10 mg|DRUG: Dapagliflozin 5 mg|DRUG: Dapagliflozin 10 mg placebo to match|DRUG: Dapagliflozin 5 mg placebo to match|DRUG: Saxagliptin 5 mg|DRUG: Metformin,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Bangkok, 10330, Thailand|Research Site, Bangkok, 10400, Thailand|Research Site, Ho Chi Minh, 10000, Vietnam|Research Site, Ho Chi Minh, 700000, Vietnam"
NCT03349840,Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan,https://clinicaltrials.gov/study/NCT03349840,TERMINATED,Type2 Diabetes,DRUG: Insulin Degludec U100|DRUG: Insulin Glargine,Weill Cornell Medical College in Qatar,Novo Nordisk A/S,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Hamad Medical Corporation, Doha, 3050, Qatar"
NCT00997152,Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT00997152,TERMINATED,Type II Diabetes Mellitus,DRUG: JTT-654|DRUG: JTT-654 Placebo,Akros Pharma Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Birmingham, Alabama, United States|Chandler, Arizona, United States|Phoenix, Arizona, United States|Tempe, Arizona, United States|Chino, California, United States|Greenbrae, California, United States|Huntington Park, California, United States|Los Angeles, California, United States|Paramount, California, United States|Sacramento, California, United States|Walnut Creek, California, United States|West Covina, California, United States|Deland, Florida, United States|Hialeah, Florida, United States|Hollywood, Florida, United States|Jacksonville, Florida, United States|Miami, Florida, United States|Port Orange, Florida, United States|Marietta, Georgia, United States|Addison, Illinois, United States|Chicago, Illinois, United States|Indianapolis, Indiana, United States|Oxon Hill, Maryland, United States|New Bedford, Massachusetts, United States|Great Falls, Montana, United States|Charlotte, North Carolina, United States|Morehead City, North Carolina, United States|Cincinnati, Ohio, United States|Marion, Ohio, United States|Oklahoma City, Oklahoma, United States|Lansdale, Pennsylvania, United States|Bristol, Tennessee, United States|Carrollton, Texas, United States|Corpus Christi, Texas, United States|Dallas, Texas, United States|Houston, Texas, United States|Katy, Texas, United States|San Antonio, Texas, United States|Sugar Land, Texas, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Virginia Beach, Virginia, United States"
NCT02595580,The GlucoPred Investigation II,https://clinicaltrials.gov/study/NCT02595580,TERMINATED,"Diabetes Mellitus, Type 1",DEVICE: Glucopred,Norwegian University of Science and Technology,St. Olavs Hospital|Sykehuset Ostfold,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Sykehuset Østvold, Frederikstad, Norway|St Olavs Hospital, Trondheim, Norway"
NCT00202670,Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients,https://clinicaltrials.gov/study/NCT00202670,TERMINATED,Diabetes Mellitus,,Société Française de Cardiologie,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Pitie Salpetriere, Paris, 75013, France|Service de diabétologie - Pitié Salpêtrière, Paris, 75013, France"
NCT00177138,Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation,https://clinicaltrials.gov/study/NCT00177138,TERMINATED,Diabetes Mellitus,DRUG: Tacrolimus|DRUG: Alemtuzumab,University of Minnesota,"Bayer|Gruessner, Rainer, MD",ALL,ADULT,PHASE4,INTERVENTIONAL,"University of Minnesota-Fairview, Minneapolis, Minnesota, 55414, United States"
NCT02189395,Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting,https://clinicaltrials.gov/study/NCT02189395,TERMINATED,Type 2 Diabetes Mellitus,DRUG: NPH and regular insulin|DRUG: glargine and humalog,Riverside University Health System Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Riverside County Regional Medical Center, Moreno Valley, California, 92555, United States"
NCT00128089,Trial of New Dietary Treatment of Diabetes,https://clinicaltrials.gov/study/NCT00128089,TERMINATED,"Diabetes Mellitus, Type 2",BEHAVIORAL: Dietary treatment,Manassas Internal Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Manassas Internal Medicine, Manassas, Virginia, 20110, United States"
NCT01638260,GLP-1 and Non-exercise Activity Thermogenesis in RHZ,https://clinicaltrials.gov/study/NCT01638260,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Liraglutide|BEHAVIORAL: NEAT,Maastricht University Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Maastricht University Medical Center, Maastricht, 6229HX, Netherlands"
NCT00640549,Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00640549,TERMINATED,"Hyperlipidemia|Diabetes Mellitus, Type 2|Non-Insulin Dependent Diabetes Mellitus",DRUG: Atorvastatin|DRUG: Placebo,Pfizer's Upjohn has merged with Mylan to form Viatris Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Pfizer Investigational Site, BAD Muenster AM Stein, 55583, Germany|Pfizer Investigational Site, Bosenheim, 55545, Germany|Pfizer Investigational Site, Bretten, 75015, Germany|Pfizer Investigational Site, Dresden, 01307, Germany|Pfizer Investigational Site, Duisburg, 47199, Germany|Pfizer Investigational Site, Essen, 45217, Germany|Pfizer Investigational Site, Goch, 47574, Germany|Pfizer Investigational Site, Heidelberg, 69120, Germany|Pfizer Investigational Site, Kuenzing, 94550, Germany|Pfizer Investigational Site, Offenbach, 63067, Germany|Pfizer Investigational Site, Offenbach, 63071, Germany|Pfizer Investigational Site, Offenbach, 63073, Germany|Pfizer Investigational Site, Rain, 94369, Germany|Pfizer Investigational Site, Schwabenheim, 55270, Germany"
NCT05392959,Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT05392959,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Dapagliflozin 10 mg Tab|DRUG: Placebo,Centre Hospitalier Universitaire Saint Pierre,AstraZeneca,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"CHU Saint Pierre, Brussels, Bruxelles-Capitale, Région de;Brussels Hoofdstedelijk Gewest, 1000, Belgium"
NCT02932475,Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD),https://clinicaltrials.gov/study/NCT02932475,TERMINATED,Diabetes|Pregnancy,DRUG: Metformin|DRUG: Placebo,"University of North Carolina, Chapel Hill",Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),FEMALE,ADULT,PHASE3,INTERVENTIONAL,"University of Alabama, Birmingham, Alabama, 35294, United States|University of California - San Diego, San Diego, California, 92093, United States|University of Mississippi, Jackson, Mississippi, 38677, United States|Columbia University, New York, New York, 10027, United States|University of North Carolina, Chapel Hill, North Carolina, 27599, United States|Ohio State University, Columbus, Ohio, 43210, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Texas Medical Branch, Galveston, Texas, 77555, United States|University of Texas - Houston, Houston, Texas, 77030, United States|University of Utah, Salt Lake City, Utah, 84112, United States"
NCT03867851,Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation,https://clinicaltrials.gov/study/NCT03867851,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: IBsolvMIR|DRUG: Heparin,TikoMed AB,,ALL,ADULT,PHASE2,INTERVENTIONAL,"Leiden University Medical Center, Leiden, Zuid-Holland, 2300 RC, Netherlands|Oslo Universitetssykehus HF, Oslo, Norway|Sahlgrenska sjukhuset, Göteborg, Sweden|Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden|Akademiska sjukhuset, Uppsala, Sweden"
NCT00639600,Transplantation of Pancreatic Islets in Patients With Type 1 Diabetes Mellitus and Functional Kidney Graft,https://clinicaltrials.gov/study/NCT00639600,TERMINATED,Type 1 Diabetes Mellitus,PROCEDURE: human pancreatic islet transplantation,"University Hospital, Grenoble",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"University Hospital, Besancon, 25000, France|University Hospital, Department of Endocrinology, Grenoble, 38043, France|University Hospital, Department of Endocrinology, Lyon, 69000, France|University Hospital, Department of Endocrinology, Montpellier, 34000, France|University Hospital, Department of Endocrinology, Nancy, 54000, France|University Hospital, Department of Endocrinology, Strasbourg, 66000, France|University Hospital, Department of Surgery, Geneva, 1211, Switzerland"
NCT01223456,Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use,https://clinicaltrials.gov/study/NCT01223456,TERMINATED,Type 2 Diabetes Mellitus,,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Research Site, Batangas City, Batangas, Philippines|Research Site, Cebu City, Cebu, Philippines|Research Site, Davao City, Davao, Philippines|Research Site, Iloilo City, Iloilo, Philippines|Research Site, Las Pinas City, Manila, Philippines|Research Site, Makati, Manila, Philippines|Research Site, Pasig, Manila, Philippines|Research Site, Quezon City, Manila, Philippines|Research Site, Mabalacat, Pampanga, Philippines|Research Site, Manila, Philippines"
NCT03785236,Visualizing Beta Cells After Islet Transplantation,https://clinicaltrials.gov/study/NCT03785236,TERMINATED,Type 1 Diabetes Mellitus,RADIATION: 68Ga-NODAGA-exendin PET/CT,Radboud University Medical Center,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Radboud university medical center, Nijmegen, Gelderland, 6525 GA, Netherlands|Uppsala University Hospital, Uppsala, SE-751 85, Sweden"
NCT03740698,The Bio-Inspired Artificial Pancreas for the Home,https://clinicaltrials.gov/study/NCT03740698,TERMINATED,"Diabetes Mellitus, Type 1",DEVICE: BiAP|DEVICE: ABC4D,Imperial College London,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Imperial College Clinical Research Facility, London, United Kingdom"
NCT01334606,Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units,https://clinicaltrials.gov/study/NCT01334606,TERMINATED,"Diabetes Mellitus, Type 2",DEVICE: 4 mm x 32G pen needle (Nano)|DEVICE: 8mm x 31G pen needle (Short),"Becton, Dickinson and Company",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"International Diabetes Center (IDC), Minneapolis, Minnesota, 55416, United States|Comprehensive Clinical Research, Berlin, New Jersey, 08009, United States|BioPharma Services Inc., Toronto, Ontario, M9L 3A2, Canada"
NCT00900146,"Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients",https://clinicaltrials.gov/study/NCT00900146,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Canakinumab|DRUG: Metformin|DRUG: Placebo,Novartis,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Anasazi Internal Medicine, Phoenix, Arizona, United States|Whittier Institute of Diabetes, La Jolla, California, United States|Novartis Investigative Site, Los Gatos, California, United States|Novartis Investigative Site, Santa Monica, California, 90404, United States|Orange County Research Center, Tustin, California, United States|Novartis Investigative Site, Atlanta, Georgia, United States|Deaconess Clinic, Evansville, Indiana, United States|Novartis Investigative Site, Jackson, Mississippi, United States|Novartis Investigative Site, Picayune, Mississippi, United States|Novartis Investigative Site, Trenton, New Jersey, United States|Diabetes Research Center, Columbus, Ohio, United States|Tri-State Medical Group, Beaver, Pennsylvania, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States|Novartis Investigative Site, Columbia, South Carolina, United States|R/D Clinical Research, Lake Jackson, Texas, United States|Novartis Investigative Site, Pasadena, Texas, United States|Novartis Investigative Site, San Antonio, Texas, United States|Medical Research Initiatives Inc, Virginia Beach, Virginia, United States|Clinica de Fracturas y Ortopedia, Mar del Plata, Buenos Aires, C1100ABB, Argentina|DIM Clinica Privada, Buenos Aires, B1704ETD, Argentina|Centro Medico Viamonte, Buenos Aires, C1120AAC, Argentina|Consultorios Asociados de Endocrinologia, Buenos Aires, C1425AGC, Argentina|Hospital Juan Ramon Vidal, Corrientes, W3410AVV, Argentina|Novartis Investigative Site, Rosario Santa Fe, S2000AII, Argentina|Instituto de Investigaciones Biomedicas, Santa Fe, S3000FNF, Argentina|Centro de Investigaciones Clinicas del Litoral, Santa Fe, S3000FWO, Argentina|Private Practice - DEMEULEMEESTER, Gozée, Belgium|Novartis Investigative Site, Heist-op-den-berg, Belgium|UZ Brussel, Jette, Belgium|Novartis Investigative Site, Hong Kong, China|Praxis F. Franzmann, Bad Oeynhausen, 32549, Germany|emovis GmbH, Berlin, 10629, Germany|Praxis Dr. Stütz, Bretten, 75015, Germany|GWT-TUB GmbH, Dresden, 01307, Germany|Gemeinschaftspraxis und Dialysezentrum Karlstraße, Düsseldorf, Germany|Asklepios Klinik St. Georg, Hamburg, 20099, Germany|Städt. Kankenhaus Nordstadt, Hannover, 30167, Germany|Diabeteszentrum Hohenmölsen, Hohenmölsen, 06679, Germany|Johannes Gutenberg-Universität Mainz, Mainz, 55101, Germany|Zentrum für Klinische Forschung Neuwied (ZKSN), Neuwied, 56564, Germany|Praxis Dr. Wunderer, Nürnberg, 90489, Germany|Praxis Dr. Kosch, Pirna, 01796, Germany|Praxis Dr. Alawi, Saarlouis, 66740, Germany|Praxis Dr. Klein, Schenklengsfeld, 36277, Germany|Forschungszentrum Ruhr, KliFoCenter GmbH, Witten, 58455, Germany|Fővárosi Önkormányzat Péterfy Sándor Utcai Kórház - Rendelőintézet és Baleseti Központ, Budapest, Hungary|Sandor Karolyi Hospital, Budapest, Hungary|Semmelweiss Medical University, Budapest, Hungary|Kenezy Gyula Korhaz, Debrecen, Hungary|Szegedi Egyetem, Szeged, Hungary|Zala Megyei Korhaz, Zalaegerszeg, Hungary|Gokula Metropolis Clinical Research Centre, Bangalore-, India|Bangalore Diabetes Hospital, Bangalore, India|Jnana Sanjeevini Medical Center, Bangalore, India|SAMATVAM, Bangalore, India|Madras Diabetes Reasearch Foundation, Chennai, India|Amrita Institute of Medical Sciences and Research Center, Cochin, India|Nizam's Institute of Medical Sciences, Hyderabaad, India|Diabetes Thyroid Hormone Research Institute Pvt. Ltd., Indore, India|S R Kalla Memorial Gastro & General Hospital, Jaipur, India|Pitale Diabetes & Hormone Centre, Nagpur, India|Health and Research Centre, Trivandrum, India|King George Hospital, Visakhapatnam, India|National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, 460-0001, Japan|Kyushu Rosai Hospital, Kitakyushu, Fukuoka, 800-0296, Japan|NHO Yokohama Medical Center, Yokohama, Kanagawa, 245-8575, Japan|Musashikoganei Clinic, Koganei-city, Tokyo, 184-0004, Japan|Novartis Investigative Site, Minato-ku, Tokyo, Japan|Fujikoshi Hospital, Toyama-city, Toyama, 930-0964, Japan|Saiseikai Fukuoka General Hospital, Fukuoka, 810-0001, Japan|Kokura Medical Center, Kitakyusyu, Japan|Seino Internal Medicine Clinic, Koriyama, Japan|Geriatrics Research Institute Hospital, Maebashi, Japan|Takagi Hospital, Ohkawa, Japan|Sakai Hospital Kinki University School of Medicine, Sakai, Japan|Novartis Investigative Site, Pusan, 614-735, Korea, Republic of|Novartis Investigative Site, Seoul, 135-710, Korea, Republic of|Novartis Investigative Site, Seoul, 135-720, Korea, Republic of|Novartis Investigative Site, Seoul, 139-872, Korea, Republic of|Novartis Investigative Site, Suwon, 442-721, Korea, Republic of|Instituto Delgado de Investigacion Medica, Arequipa, Peru|Clinica Chiclayo, Chiclayo, Peru|Hospital Nacional Cayetano Heredia, San Martin de Porres, Peru|Centro de Investigacion Clinica Trujillo, Trujillo, Peru|Ambulatory of Institute of Nutrition Diseases and Diabetes, Bucharest, Romania|Medical Centre ""Sanatatea ta"", Bucuresti, Romania|Novartis Investigative Site, Bucuresti, Romania|Policlinica Dr. Citu Timisoara, Timisoara, Romania|203 Maxwell Centre, Durban, South Africa|Parklands Medical Centre, Durban, South Africa|St Augustines Medical Centre, Durban, South Africa|Synapta Clinical Research Centre, Durban, South Africa|Drs Essack and Mitha, Johannesburg, South Africa|PE Greenacres Hospital, Port Elizabeth, South Africa|26 Daffodil Street, Stanger, South Africa|Ankara Ataturk Training and Research Hospital, Ankara, Turkey|Gulhane Askeri Tip Akademisi, Ankara, Turkey|Hacettepe University Medical Faculty, Ankara, Turkey|S.B. Yildirim Beyazit Training and Research Hospital, Ankara, Turkey|Istanbul University Cardiology Institute, Istanbul, Turkey|Ege University Medical Faculty, Izmir, Turkey|Hayat Tip Merkezi (Hayat Medical Center) Deapartment of Internal Diseases, Karabuk, Turkey|Morriston Hospital, Swansea, England, SA6 6NL, United Kingdom|Birmingham Heartlands Hospital, Birmingham, United Kingdom|Royal Bournemouth Hospital, Bournemouth, United Kingdom|Rowden Medical Partnership, Wiltshire, United Kingdom"
NCT04141423,"Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil",https://clinicaltrials.gov/study/NCT04141423,TERMINATED,Type 1 Diabetes Mellitus (T1DM),DRUG: Tregopil,Biocon Limited,Profil Institut für Stoffwechselforschung GmbH|Juvenile Diabetes Research Foundation,ALL,ADULT,PHASE1,INTERVENTIONAL,"Profil Mainz GmbH & Co. KG Malakoff-Passage,Rheinstraße 4C D-55116, Mainz, Germany"
NCT02989649,Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice,https://clinicaltrials.gov/study/NCT02989649,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Alogliptin|DRUG: Alogliptin FDC With Pioglitazone|DRUG: Alogliptin FDC With Metformin,Takeda,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Beijing, Beijing, China|Wuhan, Hubei, China|Dalian, Liaoning, China|Shenyang, Liaoning, China|Jinan, Shandong, China|Qingdao, Shandong, China|Tai'an, Shandong, China|Taian, Shandong, China|Tianjin, Tianjin, China|Sai Ying Pun, Hong Kong|Sha Tin, Hong Kong"
NCT02779816,Adaptive Device for Insulin Pens for Arthritic Patients,https://clinicaltrials.gov/study/NCT02779816,TERMINATED,Diabetes Mellitus|Arthritis,DEVICE: Pen device,"Levenson, David I., M.D.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"East Coast Medical Associates, Boca Raton, Florida, 33433, United States"
NCT00879970,Thiazolidinedione Intervention With Vitamin D Evaluation,https://clinicaltrials.gov/study/NCT00879970,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: pioglitazone|DRUG: rosiglitazone|DRUG: placebo|DIETARY_SUPPLEMENT: Vitamin D|DIETARY_SUPPLEMENT: Placebo,GlaxoSmithKline,Population Health Research Institute,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"GSK Investigational Site, Long Beach, California, 90822, United States|GSK Investigational Site, Los Angeles, California, 90033, United States|GSK Investigational Site, Northridge, California, 91324, United States|GSK Investigational Site, San Diego, California, 92109, United States|GSK Investigational Site, Decatur, Georgia, 30033, United States|GSK Investigational Site, Tucker, Georgia, 30084, United States|GSK Investigational Site, Pocatella, Idaho, 83209, United States|GSK Investigational Site, Pocatello, Idaho, 83201, United States|GSK Investigational Site, New Orleans, Louisiana, 70112, United States|GSK Investigational Site, Haverhill, Massachusetts, 1830, United States|GSK Investigational Site, Minneapolis, Minnesota, 55454, United States|GSK Investigational Site, St. Louis, Missouri, 63106, United States|GSK Investigational Site, Kalispell, Montana, 59901, United States|GSK Investigational Site, Westfield, New York, 14787, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Cleveland, Ohio, 44195, United States|GSK Investigational Site, Portland, Oregon, 97216, United States|GSK Investigational Site, Portland, Oregon, 97239, United States|GSK Investigational Site, Kingsport, Tennessee, 37660, United States|GSK Investigational Site, Memphis, Tennessee, 38104, United States|GSK Investigational Site, Dallas, Texas, 75246, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Temple, Texas, 76508, United States|GSK Investigational Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, 1090, Argentina|GSK Investigational Site, Coronel Suarez, Buenos Aires, Argentina|GSK Investigational Site, Mar del Plata, Buenos Aires, 7600, Argentina|GSK Investigational Site, San Nicolas, Buenos Aires, B2900DMH, Argentina|GSK Investigational Site, Buenos Aires, 1405, Argentina|GSK Investigational Site, Salta, 4400, Argentina|GSK Investigational Site, San Miguel de Tucuman, 4000, Argentina|GSK Investigational Site, Zárate, B2800DGH, Argentina|GSK Investigational Site, Calgary, Alberta, T2T 5C7, Canada|GSK Investigational Site, Calgary, Alberta, T3S OM3, Canada|GSK Investigational Site, Edmonton, Alberta, T5A 4L8, Canada|GSK Investigational Site, Surrey, British Columbia, V3R 3P1, Canada|GSK Investigational Site, Vancouver, British Columbia, V6H 3X8, Canada|GSK Investigational Site, Winnipeg, Manitoba, R2H 0R8, Canada|GSK Investigational Site, Winnipeg, Manitoba, R2V 4W3, Canada|GSK Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|GSK Investigational Site, Saint John's, Newfoundland and Labrador, A1B 3V6, Canada|GSK Investigational Site, Halifax, Nova Scotia, B3H 2Y9, Canada|GSK Investigational Site, Barrie, Ontario, L4M 7G1, Canada|GSK Investigational Site, Brampton, Ontario, L6Z 4N5, Canada|GSK Investigational Site, Cambridge, Ontario, N1R 7L6, Canada|GSK Investigational Site, Hamilton., Ontario, L8N 3X5, Canada|GSK Investigational Site, Hamilton, Ontario, L8L 2X2, Canada|GSK Investigational Site, Hamilton, Ontario, L8N 3Z5, Canada|GSK Investigational Site, London, Ontario, N6A 4V2, Canada|GSK Investigational Site, Mississauga, Ontario, L5M 2V8, Canada|GSK Investigational Site, Ohsweken, Ontario, N0A 1M0, Canada|GSK Investigational Site, Oshawa, Ontario, L1J 2K1, Canada|GSK Investigational Site, Ottawa, Ontario, K1C 1S6, Canada|GSK Investigational Site, Ottawa, Ontario, K1H 1A2, Canada|GSK Investigational Site, Thornhill, Ontario, L4J 8L7, Canada|GSK Investigational Site, Toronto, Ontario, M4R 2G4, Canada|GSK Investigational Site, Toronto, Ontario, M5C 2T2, Canada|GSK Investigational Site, Toronto, Ontario, M9L 1W9, Canada|GSK Investigational Site, Laval, Quebec, H7T 2P5, Canada|GSK Investigational Site, Montreal, Quebec, H2W 1R7, Canada|GSK Investigational Site, Quebec City, Quebec, G1J 1Z6, Canada|GSK Investigational Site, Quebec City, Quebec, G1L 3L5, Canada|GSK Investigational Site, Quebec City, Quebec, G1V 4G5, Canada|GSK Investigational Site, Rimouski, Quebec, G5L 5T1, Canada|GSK Investigational Site, Saint-Georges, Quebec, G5Y 4T8, Canada|GSK Investigational Site, Sainte-Foy, Quebec, G1V 4G2, Canada|GSK Investigational Site, Sherbrooke, Quebec, J1H 5N4, Canada|GSK Investigational Site, Temuco, Región De La Araucania, Chile|GSK Investigational Site, Santiago, Región Metro De Santiago, 8330024, Chile|GSK Investigational Site, Santiago, Región Metro De Santiago, 8331143, Chile|GSK Investigational Site, Santiago, Región Metro De Santiago, Chile|GSK Investigational Site, Osorno, Chile|GSK Investigational Site, Valdivia, Chile|GSK Investigational Site, Victoria, Chile|GSK Investigational Site, Armenia, Colombia|GSK Investigational Site, Barrangquilla, Colombia|GSK Investigational Site, Barranquilla, Colombia|GSK Investigational Site, Bogotac, 83012, Colombia|GSK Investigational Site, Bogota, Colombia|GSK Investigational Site, Cali, Colombia|GSK Investigational Site, Cartagena, 71 31-315, Colombia|GSK Investigational Site, Cartagena, Colombia|GSK Investigational Site, Espinal, Colombia|GSK Investigational Site, Floridablanca, Colombia|GSK Investigational Site, Manizales, Colombia|GSK Investigational Site, Medellín, Colombia|GSK Investigational Site, Pereira, Colombia|GSK Investigational Site, Havirov, 736 01, Czech Republic|GSK Investigational Site, Jihlava, 586 01, Czech Republic|GSK Investigational Site, Mestec Kralove, 289 03, Czech Republic|GSK Investigational Site, Ostrava, 70030, Czech Republic|GSK Investigational Site, Prague, 181 00, Czech Republic|GSK Investigational Site, Praha 4, 140 21, Czech Republic|GSK Investigational Site, Praha 5, 150 00, Czech Republic|GSK Investigational Site, Praha 5, 158 00, Czech Republic|GSK Investigational Site, Praha 6, 160 00, Czech Republic|GSK Investigational Site, Praha, 102 00, Czech Republic|GSK Investigational Site, Pribram 8, 261 01, Czech Republic|GSK Investigational Site, Rakovnik, 269 01, Czech Republic|GSK Investigational Site, Uherske Hradiste, 68601, Czech Republic|GSK Investigational Site, Aarhus-N, 8200, Denmark|GSK Investigational Site, Frederiksberg, 2000, Denmark|GSK Investigational Site, Glostrup, 2600, Denmark|GSK Investigational Site, Hellerup, 2900, Denmark|GSK Investigational Site, Herlev, DK-2730, Denmark|GSK Investigational Site, Koebenhavn, 2300, Denmark|GSK Investigational Site, København NV, 2400, Denmark|GSK Investigational Site, Odense C, 5000, Denmark|GSK Investigational Site, Viborg, 8800, Denmark|GSK Investigational Site, Helsinski, 00260, Finland|GSK Investigational Site, Kuopio, 70210, Finland|GSK Investigational Site, Oulu, 90100, Finland|GSK Investigational Site, Deggingen, Baden-Wuerttemberg, 73326, Germany|GSK Investigational Site, Villingen-Schwenningen, Baden-Wuerttemberg, 78048, Germany|GSK Investigational Site, Wangen, Baden-Wuerttemberg, 88239, Germany|GSK Investigational Site, Weinheim, Baden-Wuerttemberg, 69469, Germany|GSK Investigational Site, Augsburg, Bayern, 86150, Germany|GSK Investigational Site, Gars am Inn, Bayern, 83536, Germany|GSK Investigational Site, Haag, Bayern, 83527, Germany|GSK Investigational Site, Kuenzing, Bayern, 94550, Germany|GSK Investigational Site, Muenchen, Bayern, 80339, Germany|GSK Investigational Site, Muenchen, Bayern, 80809, Germany|GSK Investigational Site, Vilshofen, Bayern, 94474, Germany|GSK Investigational Site, Wallerfing, Bayern, 94574, Germany|GSK Investigational Site, Angermuende, Brandenburg, 16278, Germany|GSK Investigational Site, Elsterwerda, Brandenburg, 04910, Germany|GSK Investigational Site, Potsdam, Brandenburg, 14469, Germany|GSK Investigational Site, Grossalmerode, Hessen, 37247, Germany|GSK Investigational Site, Kelkheim, Hessen, 65779, Germany|GSK Investigational Site, Winsen/Lohe, Niedersachsen, 21423, Germany|GSK Investigational Site, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany|GSK Investigational Site, Bergkamen, Nordrhein-Westfalen, 59192, Germany|GSK Investigational Site, Dorsten, Nordrhein-Westfalen, 46282, Germany|GSK Investigational Site, Eschweiler, Nordrhein-Westfalen, 52249, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, 45329, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, 45355, Germany|GSK Investigational Site, Goch, Nordrhein-Westfalen, 47574, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50823, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 51069, Germany|GSK Investigational Site, Witten, Nordrhein-Westfalen, 58455, Germany|GSK Investigational Site, Ingelheim, Rheinland-Pfalz, 55218, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, 55116, Germany|GSK Investigational Site, Rhaunen, Rheinland-Pfalz, 55624, Germany|GSK Investigational Site, Neunkirchen, Saarland, 66539, Germany|GSK Investigational Site, Koethen, Sachsen-Anhalt, 06366, Germany|GSK Investigational Site, Schoenebeck, Sachsen-Anhalt, 39218, Germany|GSK Investigational Site, Wolmirstedt, Sachsen-Anhalt, 39326, Germany|GSK Investigational Site, Zerbst, Sachsen-Anhalt, 39261, Germany|GSK Investigational Site, Borna, Sachsen, 04552, Germany|GSK Investigational Site, Delitzsch, Sachsen, 04509, Germany|GSK Investigational Site, Dresden, Sachsen, 01099, Germany|GSK Investigational Site, Dresden, Sachsen, 01307, Germany|GSK Investigational Site, Leipzg, Sachsen, 04109, Germany|GSK Investigational Site, Leipzig, Sachsen, 04103, Germany|GSK Investigational Site, Oschatz, Sachsen, 04758, Germany|GSK Investigational Site, Pirna, Sachsen, 01796, Germany|GSK Investigational Site, Berlin, 10367, Germany|GSK Investigational Site, Berlin, 10629, Germany|GSK Investigational Site, Berlin, 10787, Germany|GSK Investigational Site, Berlin, 13125, Germany|GSK Investigational Site, Berlin, 13158, Germany|GSK Investigational Site, Hamburg, 22177, Germany|GSK Investigational Site, Ahmedabad, 380006, India|GSK Investigational Site, Bangalore, 560 010, India|GSK Investigational Site, Bangalore, 560034, India|GSK Investigational Site, Banjara Hills PO, Hyderabad, 500 034, India|GSK Investigational Site, Belgaum, 590001, India|GSK Investigational Site, Chennai, 600 008, India|GSK Investigational Site, Chennai, 600 028, India|GSK Investigational Site, Cochin, 683572, India|GSK Investigational Site, Hyderabad, 500034, India|GSK Investigational Site, Karnal, 132001, India|GSK Investigational Site, Kerala, 688 524, India|GSK Investigational Site, Kochi, 682 040, India|GSK Investigational Site, Kochi, 682026, India|GSK Investigational Site, Kottyam, 686 027, India|GSK Investigational Site, Mumbai, 400007, India|GSK Investigational Site, Nasik, 422013, India|GSK Investigational Site, Nellore, 524001, India|GSK Investigational Site, Pune, 411004, India|GSK Investigational Site, Tamil Nadu, Trichy - 620 018, India|GSK Investigational Site, Trivandrum, 695607, India|GSK Investigational Site, Vijayawada, 520008, India|GSK Investigational Site, Milano (Milan), Lombardia, 20132, Italy|GSK Investigational Site, Sesto San Giovanni (MI), Lombardia, 20099, Italy|GSK Investigational Site, Pozzilli (IS), Molise, 86077, Italy|GSK Investigational Site, Chieri (Torino), 10023, Italy|GSK Investigational Site, Cesis, LV4100, Latvia|GSK Investigational Site, Daugavpils, LV5417, Latvia|GSK Investigational Site, Jekabpils, LV5201, Latvia|GSK Investigational Site, Liepaja, LV3401, Latvia|GSK Investigational Site, Riga, LV 1002, Latvia|GSK Investigational Site, Riga, LV 1011, Latvia|GSK Investigational Site, Riga, LV1024, Latvia|GSK Investigational Site, Tukums, LV 3100, Latvia|GSK Investigational Site, Tijuana, Baja California Norte, 22010, Mexico|GSK Investigational Site, Guadalajara, Jalisco, 44150, Mexico|GSK Investigational Site, Guadalajara, Jalisco, 44380, Mexico|GSK Investigational Site, Guadalajara, Jalisco, 44600, Mexico|GSK Investigational Site, Guadalajara, Jalisco, CP 44340, Mexico|GSK Investigational Site, Zapopan, Jalisco, 45200, Mexico|GSK Investigational Site, Morelia, Michoacán, Mexico|GSK Investigational Site, San Luis Potosi, San Luis Potosí, 78200, Mexico|GSK Investigational Site, Aguascalientes, 20230, Mexico|GSK Investigational Site, Guadalajara, Mexico|GSK Investigational Site, Tampico, Mexico|GSK Investigational Site, Amsterdam, 1061 AE, Netherlands|GSK Investigational Site, Heerlen, 6419 PC, Netherlands|GSK Investigational Site, Hoofddorp, 2134, Netherlands|GSK Investigational Site, Rotterdam, 3015 CE, Netherlands|GSK Investigational Site, Rotterdam, 3045 PM, Netherlands|GSK Investigational Site, Bodø, 8005, Norway|GSK Investigational Site, Hoenefoss, 3513, Norway|GSK Investigational Site, Kløfta, 2040, Norway|GSK Investigational Site, Oslo, 0160, Norway|GSK Investigational Site, Oslo, 0319, Norway|GSK Investigational Site, Oslo, 0514, Norway|GSK Investigational Site, Skedsmokorset, N-2020, Norway|GSK Investigational Site, Stavanger, 4005, Norway|GSK Investigational Site, Tromsø, 9038, Norway|GSK Investigational Site, Trondheim, 7212, Norway|GSK Investigational Site, Faisalabad, 37250, Pakistan|GSK Investigational Site, Islamabad, 44000, Pakistan|GSK Investigational Site, Lahore, 54000, Pakistan|GSK Investigational Site, Arequipa, 54, Peru|GSK Investigational Site, Laoag City, 2900, Philippines|GSK Investigational Site, Bacau, 600114, Romania|GSK Investigational Site, Baia Mare, 435400, Romania|GSK Investigational Site, Bistrita, 420016, Romania|GSK Investigational Site, Brasov, 500365, Romania|GSK Investigational Site, Bucuresti, 020475, Romania|GSK Investigational Site, Buzau, 120203, Romania|GSK Investigational Site, Deva, 330084, Romania|GSK Investigational Site, Iasi, 700547, Romania|GSK Investigational Site, Oradea, 410469, Romania|GSK Investigational Site, Pitesti, 110084, Romania|GSK Investigational Site, Sibiu, 550245, Romania|GSK Investigational Site, Arkhangelsk, 163045, Russian Federation|GSK Investigational Site, Barnaul, 656 045, Russian Federation|GSK Investigational Site, Barnaul, 656038, Russian Federation|GSK Investigational Site, Barnaul, 656055, Russian Federation|GSK Investigational Site, Ivanovo, 153012, Russian Federation|GSK Investigational Site, Ivanovo, 153462, Russian Federation|GSK Investigational Site, Kazan, 420012, Russian Federation|GSK Investigational Site, Kazan, 420033, Russian Federation|GSK Investigational Site, Kemerovo, 650000, Russian Federation|GSK Investigational Site, Kemerovo, 650002, Russian Federation|GSK Investigational Site, Kemerovo, 650036, Russian Federation|GSK Investigational Site, Kirov, 610030, Russian Federation|GSK Investigational Site, Kursk, 305035, Russian Federation|GSK Investigational Site, Moscow, 111539, Russian Federation|GSK Investigational Site, Moscow, 115487, Russian Federation|GSK Investigational Site, Moscow, 117 036, Russian Federation|GSK Investigational Site, Moscow, 117556, Russian Federation|GSK Investigational Site, Moscow, 121 552, Russian Federation|GSK Investigational Site, Moscow, 121552, Russian Federation|GSK Investigational Site, Moscow, 123448, Russian Federation|GSK Investigational Site, Moscow, 125367, Russian Federation|GSK Investigational Site, Moscow, 129110, Russian Federation|GSK Investigational Site, Nizhniy Novgorod, 603076, Russian Federation|GSK Investigational Site, Nizhniy Novgorod, 603126, Russian Federation|GSK Investigational Site, Nizhny Novgorod, 603003, Russian Federation|GSK Investigational Site, Ryazan, 390026, Russian Federation|GSK Investigational Site, Saint-Petersburg, 197341, Russian Federation|GSK Investigational Site, Saint-Petersburg, 198260, Russian Federation|GSK Investigational Site, Saratov, 410031, Russian Federation|GSK Investigational Site, Smolensk, 214 019, Russian Federation|GSK Investigational Site, St Pertersburg, 196247, Russian Federation|GSK Investigational Site, St Petersberg, 192288, Russian Federation|GSK Investigational Site, St'Petersburg, 194156, Russian Federation|GSK Investigational Site, St'Petersburg, 197110, Russian Federation|GSK Investigational Site, St-Petersburg, 193312, Russian Federation|GSK Investigational Site, St-Petersburg, 194017, Russian Federation|GSK Investigational Site, St-Petersburg, 195067, Russian Federation|GSK Investigational Site, St-Petersburg, 195197, Russian Federation|GSK Investigational Site, St. Petersburg, 197758, Russian Federation|GSK Investigational Site, St. Petersburg, 198205, Russian Federation|GSK Investigational Site, Syktyvkar, 167 981, Russian Federation|GSK Investigational Site, Tomsk, 634012, Russian Federation|GSK Investigational Site, Tomsk, 634050, Russian Federation|GSK Investigational Site, Tomsk, 634063, Russian Federation|GSK Investigational Site, Vladivostok, 690034, Russian Federation|GSK Investigational Site, Vladivostok, 690105, Russian Federation|GSK Investigational Site, Volgograd, 400008, Russian Federation|GSK Investigational Site, Voronezh, 394018, Russian Federation|GSK Investigational Site, Yaroslavl, 150003, Russian Federation|GSK Investigational Site, Bratislava, 826 06, Slovakia|GSK Investigational Site, Bratislava, 831 01, Slovakia|GSK Investigational Site, Nitra, 949 11, Slovakia|GSK Investigational Site, Port Elizabeth, Eastern Cape, 6014, South Africa|GSK Investigational Site, Meyerspark, Gauteng, 0184, South Africa|GSK Investigational Site, Parktown, Gauteng, 2193, South Africa|GSK Investigational Site, Chatsworth, KwaZulu- Natal, 4092, South Africa|GSK Investigational Site, Umhlanga Rocks, KwaZulu- Natal, 4320, South Africa|GSK Investigational Site, Bellville, 7531, South Africa|GSK Investigational Site, Benoni, 1501, South Africa|GSK Investigational Site, Bloemfontein, 9301, South Africa|GSK Investigational Site, Cape Town, 7500, South Africa|GSK Investigational Site, Cape Town, 7800, South Africa|GSK Investigational Site, Durban, 4001, South Africa|GSK Investigational Site, Newton, 2113, South Africa|GSK Investigational Site, Observatory, 7925, South Africa|GSK Investigational Site, Parktown, 2193, South Africa|GSK Investigational Site, Pretoria, 0002, South Africa|GSK Investigational Site, Somerset West, 7130, South Africa|GSK Investigational Site, Soweto, 1111, South Africa|GSK Investigational Site, Soweto, 2013, South Africa|GSK Investigational Site, Worcester, 6850, South Africa|GSK Investigational Site, Eksjö, SE-575 36, Sweden|GSK Investigational Site, Göteborg, SE-413 45, Sweden|GSK Investigational Site, Göteborg, SE-416 85, Sweden|GSK Investigational Site, Göteborg, SE-417 17, Sweden|GSK Investigational Site, Härnösand, SE-871 82, Sweden|GSK Investigational Site, Karlshamn, SE-374 80, Sweden|GSK Investigational Site, Kristianstad, SE-291 85, Sweden|GSK Investigational Site, Ljungby, SE-341 82, Sweden|GSK Investigational Site, Malmö, SE-205 02, Sweden|GSK Investigational Site, Malmö, SE-214 22, Sweden|GSK Investigational Site, Oskarshamn, SE-572 28, Sweden|GSK Investigational Site, Skene, SE-511 62, Sweden|GSK Investigational Site, Stockholm, SE-111 57, Sweden|GSK Investigational Site, Stockholm, SE-171 76, Sweden|GSK Investigational Site, Vällingby, SE-162 68, Sweden|GSK Investigational Site, Växjö, SE-351 85, Sweden|GSK Investigational Site, Bangkok, 10400, Thailand|GSK Investigational Site, Bath, Somerset, BA1 3NG, United Kingdom|GSK Investigational Site, Chippenham, SN15 2SB, United Kingdom|GSK Investigational Site, Doncaster, DN9 1EP, United Kingdom|GSK Investigational Site, Harrogate, HG1 5JP, United Kingdom|GSK Investigational Site, London, E1 1BB, United Kingdom|GSK Investigational Site, Manchester, M13 9Wl, United Kingdom|GSK Investigational Site, Sheffield, S10 2RX, United Kingdom"
NCT01817777,An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes,https://clinicaltrials.gov/study/NCT01817777,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Metformin Small Pack|DRUG: Metformin Large Pack,GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"GSK Investigational Site, Correintes, Argentina|GSK Investigational Site, Corrientes, Argentina|GSK Investigational Site, Mendoza, 5515, Argentina|GSK Investigational Site, Mendoza, 5539, Argentina|GSK Investigational Site, Mendoza, Argentina|GSK Investigational Site, Provincia de Buenos Aires, 1754, Argentina|GSK Investigational Site, Tucumán, T 4000IOE, Argentina"
NCT03380546,Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.,https://clinicaltrials.gov/study/NCT03380546,TERMINATED,Gestational Diabetes Mellitus in Pregnancy,DRUG: Acarbose|DRUG: Prandial insulin,Assistance Publique - Hôpitaux de Paris,,FEMALE,ADULT,PHASE3,INTERVENTIONAL,"Jean Verdier Hospital, Bondy, 93140, France"
NCT06868043,A Study to Investigate a Transdermal Continuous Glucose Monitoring System in Diabetic Patients for a Period of 28 Days,https://clinicaltrials.gov/study/NCT06868043,TERMINATED,Diabetes (DM),DEVICE: FiberSense System,EyeSense GmbH,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Diabetes Instiut Heidelberg, Heidelberg, 69115, Germany"
NCT00687453,Insulin Glargine Versus Twice-Daily NPH,https://clinicaltrials.gov/study/NCT00687453,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Insulin glargine at bedtime instead of NPH|DRUG: NPH twice-daily,Charles Drew University of Medicine and Science,National Center for Research Resources (NCRR),ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Charles Drew University of Medicine and Science, Los Angeles, California, 90059, United States"
NCT01829477,Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01829477,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: TAK-875|DRUG: TAK-875 Placebo|DRUG: Glimepiride,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Muscle Shoals, Alabama, United States|Phoenix, Arizona, United States|Fresno, California, United States|Long Beach, California, United States|National City, California, United States|North Hollywood, California, United States|Pismo Beach, California, United States|Lakewood, Colorado, United States|Boynton Beach, Florida, United States|Bradenton, Florida, United States|Coral Gables, Florida, United States|Miami, Florida, United States|North Miami Beach, Florida, United States|Orlando, Florida, United States|Pembroke Pines, Florida, United States|Tampa, Florida, United States|Augusta, Georgia, United States|Conyers, Georgia, United States|Chicago, Illinois, United States|Lexington, Kentucky, United States|Oxon Hill, Maryland, United States|Flint, Michigan, United States|Omaha, Nebraska, United States|Las Vegas, Nevada, United States|Nashua, New Hampshire, United States|Haddon Heights, New Jersey, United States|Rosedale, New York, United States|Morehead City, North Carolina, United States|Morganton, North Carolina, United States|Maumee, Ohio, United States|Hanleysville, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Laurens, South Carolina, United States|Houston, Texas, United States|San Antonio, Texas, United States|Spring, Texas, United States|Tomball, Texas, United States|Manassas, Virginia, United States|Gabrovo, Bulgaria|Plovdiv, Bulgaria|Sofia, Bulgaria|Oakville, Ontario, Canada|Thornhill, Ontario, Canada|Toronto, Ontario, Canada|Budapest, Hungary|Godollo, Hungary|Kistelek, Hungary|Komarom, Hungary|Zalaegerszeg, Hungary|Bialystok, Poland|Gdansk, Poland|Grodzisk Mazowiecki, Poland|Kamieniec Zabkowicki, Poland|Lodz, Poland|Oswiecim, Poland|Poznan, Poland|Pulawy, Poland|Rzeszow, Poland|Zgierz, Poland|Baia Mare, Romania|Ploiesti, Romania|Timisoara, Romania|Banska Bystrica, Slovakia|Bratislava, Slovakia|Dolny Kubin, Slovakia|Levice, Slovakia|Lucenec, Slovakia|Pezinok, Slovakia|Svidnik, Slovakia"
NCT01834274,Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01834274,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Fasiglifam (TAK-875)|DRUG: Fasiglifam (TAK-875) Placebo|DRUG: Sitagliptin|DRUG: Sitagliptin Placebo|DRUG: Metformin,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Huntsville, Alabama, United States|Chandler, Arizona, United States|Glendale, Arizona, United States|Little Rock, Arkansas, United States|Fresno, California, United States|Garden Grove, California, United States|Modesto, California, United States|San Diego, California, United States|Thousand Oaks, California, United States|Lakewood, Colorado, United States|Hallandale Beach, Florida, United States|Hialeah, Florida, United States|Miami Lakes, Florida, United States|Miami, Florida, United States|North Miami Beach, Florida, United States|North Miami, Florida, United States|Pembroke Pines, Florida, United States|Sanford, Florida, United States|Atlanta, Georgia, United States|Conyers, Georgia, United States|Evans, Georgia, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Evanston, Illinois, United States|Council Bluffs, Iowa, United States|Augusta, Kansas, United States|Omaha, Nebraska, United States|New York, New York, United States|Durham, North Carolina, United States|Greensboro, North Carolina, United States|Hickory, North Carolina, United States|Carlisle, Ohio, United States|Oklahoma City, Oklahoma, United States|Medford, Oregon, United States|Fort Mill, South Carolina, United States|Laurens, South Carolina, United States|Spartanburg, South Carolina, United States|Knoxville, Tennessee, United States|Austin, Texas, United States|Odessa, Texas, United States|San Antonio, Texas, United States|Sugar Land, Texas, United States|Victoria, Texas, United States|Salt Lake City, Utah, United States|Coronel Suarez, Buenos Aires, Argentina|Rosario, Santa Fe, Argentina|Ciudad Autonoma Buenos Aires, Argentina|Calgary, Alberta, Canada|Red Deer, Alberta, Canada|Vancouver, British Columbia, Canada|Victoria, British Columbia, Canada|Winnipeg, Manitoba, Canada|Etobicoke, Ontario, Canada|London, Ontario, Canada|Toronto, Ontario, Canada|Karlovac, Croatia|Krapinske Toplice, Croatia|Slavonski Brod, Croatia|Virovitica, Croatia|Zagreb, Croatia|Budapest, Hungary|Godollo, Hungary|Kistarcsa, Hungary|Satoraljaujhely, Hungary|Szeged, Hungary|Seri Manjung, Perak, Malaysia|Taiping, Perak, Perak, Malaysia|Taiping, Perak, Malaysia|Putrajaya, Selangor, Malaysia|Kelantan, Malaysia|Kuala Lumpur, Malaysia|Ica, Peru|Lima, Peru|Cebu City, Philippines|Iloilo City, Philippines|Marikina City, Philippines|Pasig, Philippines|Quezon City, Philippines|West Fairview, Quezon City, Philippines|Gdansk, Poland|Lodz, Poland|Oswiecim, Poland|Rzeszow, Poland|Sobotka, Poland|Wroclaw, Poland|Zgierz, Poland|Barnaul, Russian Federation|Kemerovo, Russian Federation|Novosibirsk, Russian Federation|St. Petersburg, Russian Federation|Bloemfontein, Free State, South Africa|Pretoria, Gauteng, South Africa|Durban, KwaZulu-Natal, South Africa|Cape Town, Western Cape, South Africa|Bangkoknoi, Bangkok, Thailand|Rajathevee, Bangkok, Thailand|Muang, Khon Kaen, Thailand|Klongluang, Pathum Thani, Thailand|Hat Yai, Songkhla, Thailand|Ivano-Frankivsk, Ukraine|Kharkiv, Ukraine|Kyiv, Ukraine|Lviv, Ukraine|Vinnytsia, Ukraine"
NCT01081938,Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition,https://clinicaltrials.gov/study/NCT01081938,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: INSULIN GLARGINE|DRUG: INSULIN GLULISINE,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Sanofi-Aventis Investigational Site Number 076-007, Belo Horizonte, 30150-120, Brazil|Sanofi-Aventis Investigational Site Number 076-011, Curitiba, 80420-011, Brazil|Sanofi-Aventis Investigational Site Number 076-005, Joinville, Brazil|Sanofi-Aventis Investigational Site Number 076-001, Porto Alegre, 90035-001, Brazil|Sanofi-Aventis Investigational Site Number 076-004, Porto Alegre, 90035-003, Brazil|Sanofi-Aventis Investigational Site Number 076-006, São José do Rio Preto, 15090-000, Brazil|Sanofi-Aventis Investigational Site Number 076-010, São Paulo, 01232-010, Brazil|Sanofi-Aventis Investigational Site Number 076-008, São Paulo, 01308-050, Brazil|Sanofi-Aventis Investigational Site Number 076-003, São Paulo, 01323-020, Brazil|Sanofi-Aventis Investigational Site Number 076-009, São Paulo, 01323-900, Brazil"
NCT00282945,Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone,https://clinicaltrials.gov/study/NCT00282945,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Rosiglitazone|DRUG: Metformin,Pfizer,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Pfizer Investigational Site, Holon, 58100, Israel|Pfizer Investigational Site, Jerusalem, 91120, Israel"
NCT02377362,"A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01",https://clinicaltrials.gov/study/NCT02377362,TERMINATED,"Diabetes Mellitus, Type 2","DRUG: GLWL-01, Part A|DRUG: Placebo, Part A|DRUG: GLWL-01, Part B|DRUG: Placebo, Part B|DRUG: GLWL-01, Part C|DRUG: Placebo, Part C",GLWL Research Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Celerion, Tempe, Arizona, 85283, United States|Profil Institute for Clinical Research, Inc., Chula Vista, California, 91911, United States|Clinical Pharmacology of Miami, Inc., Miami, Florida, 33014, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, 78229, United States"
NCT00260234,Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients,https://clinicaltrials.gov/study/NCT00260234,TERMINATED,"Diabetes Mellitus, Type 1",BIOLOGICAL: Allogeneic Cultured Islet Cells (human); Encapsulated,Novocell,"Diabetes & Glandular Disease Research Associates, P.A., San Antonio, TX|CHRISTUS Health",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"CHRISTUS Santa Rosa Transplant Institute, San Antonio, Texas, 78229, United States|Diabetes & Glandular Disease Research Associates, P.A., San Antonio, Texas, 78229, United States"
NCT00743756,Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM),https://clinicaltrials.gov/study/NCT00743756,TERMINATED,Obesity|Diabetes,DIETARY_SUPPLEMENT: home-delivered meals|DIETARY_SUPPLEMENT: home-delivered meals|BEHAVIORAL: diabetes education for 12 months,Emory University,,ALL,OLDER_ADULT,,INTERVENTIONAL,"Grady Health System, Atlanta, Georgia, 30303, United States"
NCT00753766,Multifactorial Pre-operative Intervention in Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00753766,TERMINATED,"Diabetes Mellitus|Surgical Procedure, Unspecified",OTHER: Multifactorial Intervention,VA Office of Research and Development,,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT02744820,Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics,https://clinicaltrials.gov/study/NCT02744820,TERMINATED,Healthy|Type 2 Diabetes Mellitus,DRUG: GMC-252-L-Lysine Salt|OTHER: Placebo,Genmedica Therapeutics S.L.,Simbec Research,MALE,ADULT,PHASE1,INTERVENTIONAL,"BioKinetic Europe Ltd., Belfast, BT2 7BA, United Kingdom|Simbec Research Ltd, Merthyr Tydfil, CF48 4DR, United Kingdom"
NCT00943371,A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002),https://clinicaltrials.gov/study/NCT00943371,TERMINATED,Type 2 Diabetes Mellitus,DRUG: MK6349|DRUG: Comparator: Placebo to MK6349,Merck Sharp & Dohme LLC,,ALL,ADULT,PHASE1,INTERVENTIONAL,
NCT01268644,Effects of Metreleptin in Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01268644,TERMINATED,Type 1 Diabetes,DRUG: Leptin,University of Texas Southwestern Medical Center,"Juvenile Diabetes Research Foundation|Amylin Pharmaceuticals, LLC.",ALL,ADULT,PHASE1,INTERVENTIONAL,"UT Southwestern Medical Center, Dallas, Texas, 75390, United States"
NCT02274740,Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT02274740,TERMINATED,Type II Diabetes Mellitus,DRUG: LIXISENATIDE AVE0010|DRUG: metformin,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00523042,Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma,https://clinicaltrials.gov/study/NCT00523042,TERMINATED,"Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Asthma",DRUG: insulin aspart|DRUG: inhaled human insulin,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Fresno, California, 93720, United States|Novo Nordisk Investigational Site, New Orleans, Louisiana, 70112, United States|Novo Nordisk Investigational Site, Kansas City, Missouri, 64108, United States|Novo Nordisk Investigational Site, Columbus, Ohio, 43210, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Novo Nordisk Investigational Site, Pittsburgh, Pennsylvania, 15213, United States|Novo Nordisk Investigational Site, Houston, Texas, 77030, United States|Novo Nordisk Investigational Site, Ogden, Utah, 84403, United States|Novo Nordisk Investigational Site, Spokane, Washington, 99208, United States|Novo Nordisk Investigational Site, Broadmeadow, New South Wales, 2292, Australia|Novo Nordisk Investigational Site, Camperdown, New South Wales, 2050, Australia|Novo Nordisk Investigational Site, Keswick, South Australia, 5035, Australia|Novo Nordisk Investigational Site, Box Hill, Victoria, 3128, Australia|Novo Nordisk Investigational Site, East Ringwood, Victoria, 3135, Australia|Novo Nordisk Investigational Site, Parkville, Victoria, 3052, Australia|Novo Nordisk Investigational Site, Auchenflower, 4066, Australia|Novo Nordisk Investigational Site, Kippa Ring, 4021, Australia|Novo Nordisk Investigational Site, Belgrade, 11000, Former Serbia and Montenegro|Novo Nordisk Investigational Site, Chandigarh, Punjab, 160012, India|Novo Nordisk Investigational Site, Vellore, Tamil Nadu, 632004, India|Novo Nordisk Investigational Site, Kolkata, West Bengal, 700020, India|Novo Nordisk Investigational Site, Hyderabad, 600034, India|Novo Nordisk Investigational Site, Mumbai, 400 067, India|Novo Nordisk Investigational Site, Pune, 411011, India|Novo Nordisk Investigational Site, Cheras, 56000, Malaysia|Novo Nordisk Investigational Site, Kota Bharu, Kelantan, 16150, Malaysia|Novo Nordisk Investigational Site, Pulau Pinang, 10990, Malaysia|Novo Nordisk Investigational Site, Kosice, 04190, Slovakia|Novo Nordisk Investigational Site, Lubochna, 03491, Slovakia|Novo Nordisk Investigational Site, Moldava nad Bodvou, 045 01, Slovakia|Novo Nordisk Investigational Site, Zilina, 01001, Slovakia|Novo Nordisk Investigational Site, Zilina, 01207, Slovakia"
NCT01496430,Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes,https://clinicaltrials.gov/study/NCT01496430,TERMINATED,Hypertension|Diabetes,DRUG: Placebo|DRUG: Azilsartan medoxomil|DRUG: Azilsartan medoxomil,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Birmingham, Alabama, United States|Green Valley, Arizona, United States|Tempe, Arizona, United States|Tucson, Arizona, United States|Buena Park, California, United States|Hawaiian Gardens, California, United States|Norwalk, California, United States|Paramount, California, United States|Rancho Cucamonga, California, United States|Sacramento, California, United States|San Diego, California, United States|Tustin, California, United States|Denver, Colorado, United States|Bradenton, Florida, United States|Brooksville, Florida, United States|Hallandale Beach, Florida, United States|Jupiter, Florida, United States|Miami, Florida, United States|Orlando, Florida, United States|Pembroke Pines, Florida, United States|St Petersburg, Florida, United States|Tampa, Florida, United States|Winter Park, Florida, United States|Roswell, Georgia, United States|Chicago, Illinois, United States|Evergreen Park, Illinois, United States|Gurnee, Illinois, United States|Avon, Indiana, United States|Greenfield, Indiana, United States|Lexington, Kentucky, United States|Paducah, Kentucky, United States|Baltimore, Maryland, United States|Columbia, Missouri, United States|Omaha, Nebraska, United States|Las Vegas, Nevada, United States|Margate, New Jersey, United States|Albuquerque, New Mexico, United States|Brooklyn, New York, United States|Calabash, North Carolina, United States|Greensboro, North Carolina, United States|Lenoir, North Carolina, United States|Morehead City, North Carolina, United States|Salisbury, North Carolina, United States|Wilmington, North Carolina, United States|Winston-Salem, North Carolina, United States|Centerville, Ohio, United States|Cincinnati, Ohio, United States|Oklahoma City, Oklahoma, United States|Downingtown, Pennsylvania, United States|Fleetwood, Pennsylvania, United States|Reading, Pennsylvania, United States|Providence, Rhode Island, United States|Anderson, South Carolina, United States|Chattanooga, Tennessee, United States|Kingsport, Tennessee, United States|Nashville, Tennessee, United States|Dallas, Texas, United States|Houston, Texas, United States|Irving, Texas, United States|North Richland Hills, Texas, United States|Pearland, Texas, United States|San Antonio, Texas, United States|Salt Lake City, Utah, United States|Burke, Virginia, United States|Manassas, Virginia, United States|Richmond, Virginia, United States|Virginia Beach, Virginia, United States|Wauwatosa, Wisconsin, United States"
NCT01481116,Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01481116,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: TAK-875|DRUG: TAK-875|DRUG: Glimepiride,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Dothan, Alabama, United States|Muscle Shoals, Alabama, United States|Goodyear, Arizona, United States|Phoenix, Arizona, United States|Tempe, Arizona, United States|Long Beach, California, United States|Mission Hills, California, United States|North Hollywood, California, United States|Norwalk, California, United States|Pismo Beach, California, United States|Bradenton, Florida, United States|Clearwater, Florida, United States|Coral Gables, Florida, United States|Hialeah, Florida, United States|Orlando, Florida, United States|Pembroke Pines, Florida, United States|Decatur, Georgia, United States|Avon, Indiana, United States|Topeka, Kansas, United States|Oxon Hill, Maryland, United States|Flint, Michigan, United States|Jackson, Mississippi, United States|Omaha, Nebraska, United States|Elizabeth, New Jersey, United States|Calabash, North Carolina, United States|Charlotte, North Carolina, United States|Greensboro, North Carolina, United States|Mooresville, North Carolina, United States|Morganton, North Carolina, United States|Raleigh, North Carolina, United States|Maumee, Ohio, United States|Oklahoma City, Oklahoma, United States|Greer, South Carolina, United States|Spartanburg, South Carolina, United States|Dallas, Texas, United States|El Paso, Texas, United States|Ft. Worth, Texas, United States|Houston, Texas, United States|New Braunfels, Texas, United States|San Antonio, Texas, United States|Spring, Texas, United States|Tomball, Texas, United States|Salt Lake City, Utah, United States|Burke, Virginia, United States|Hampton, Virginia, United States|Manassas, Virginia, United States|Ciudad Autonoma de Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina|Rosario, Santa Fe, Argentina|Ciudad Autonoma Buenos Aires, Argentina|Cordoba, Argentina|Corrientes, Argentina|Canberra, Australian Capital Territory, Australia|Brookvale, New South Wales, Australia|Mosman, New South Wales, Australia|Woy Woy, New South Wales, Australia|Canberra, Australia|Blagoevgrad, Bulgaria|Gabrovo, Bulgaria|Pleven, Bulgaria|Plovdiv, Bulgaria|Sevlievo, Bulgaria|Sofia, Bulgaria|Stara Zagora, Bulgaria|Varna, Bulgaria|Victoria, British Columbia, Canada|Oakville, Ontario, Canada|Ottawa, Ontario, Canada|Thornhill, Ontario, Canada|Toronto, Ontario, Canada|Laval, Quebec, Canada|Longueuil, Quebec, Canada|Mirabel, Quebec, Canada|Pointe Claire, Quebec, Canada|Ville Saint-Laurent, Quebec, Canada|Bogota, Colombia|Medellin, Colombia|Benatky nad Jizerou, Czech Republic|Brno, Czech Republic|Ceske Budejovice, Czech Republic|Chocen, Czech Republic|Jindrichuv Hradec, Czech Republic|Marianske Lazne, Czech Republic|Olomouc, Czech Republic|Ostrava - Moravska Ostrava, Czech Republic|Ostrava - Vitkovice, Czech Republic|Ostrava, Czech Republic|Prague 10, Czech Republic|Praha 10, Czech Republic|Praha 4 - Krc, Czech Republic|Praha 5, Czech Republic|Praha 8, Czech Republic|Znojmo, Czech Republic|Paide, Estonia|Rakvere, Estonia|Saku, Estonia|Tallinn, Estonia|Tartu, Estonia|Võru, Estonia|Hong Kong, Hong Kong|New Territories, Hong Kong|Ashkelon, Israel|Beer Sheva, Israel|Beer Yaakov, Israel|Beer-Sheva, Israel|Givataim, Israel|Hadera, Israel|Haifa, Israel|Holon, Israel|Jerusalem, Israel|Kfar-Saba, Israel|Nahariya, Israel|Petach Tikva, Israel|Petach Tikwa, Israel|Raanana, Israel|Ramat Gan, Israel|Ramat-Gan, Israel|Rechovot, Israel|Rishon le Zion, Israel|Tel Aviv, Israel|Tel-Aviv, Israel|Zefat, Israel|Jelgava, Latvia|Limbazi, Latvia|Ogre, Latvia|Riga, Latvia|Talsi, Latvia|Valmiera, Latvia|Alytus, Lithuania|Kaunas, Lithuania|Klaipeda, Lithuania|Vilnius, Lithuania|Ipoh, Perak, Malaysia|Taiping, Perak, Perak, Malaysia|Taiping, Perak, Malaysia|Petaling Jaya, Selangor, Malaysia|Kuala Lumpur, Malaysia|Melaka, Malaysia|Putrajaya, Malaysia|Terengganu, Malaysia|Mexico, Distrito Federal, Mexico|Cuernavaca, Morelos, Mexico|Auckland, New Zealand|Christchurch, New Zealand|Hamilton, New Zealand|Palmerston North, New Zealand|Rotorua, New Zealand|Tauranga, New Zealand|Wellington, New Zealand|Cebu City, Philippines|Davao City, Philippines|Iloilo City, Philippines|Lipa City, Philippines|Quezon City, Philippines|Tarlac, Philippines|Taytay, Philippines|Bialystok, Poland|Bydgoszcz, Poland|Gdansk, Poland|Grodzisk Mazowiecki, Poland|Kamieniec Zabkowicki, Poland|Katowice, Poland|Leczyca, Poland|Lodz, Poland|Lublin, Poland|Oswiecim, Poland|Parczew, Poland|Plock, Poland|Poznan, Poland|Pulawy, Poland|Ruda Slaska, Poland|Rzeszow, Poland|Sopot, Poland|Torun, Poland|Wroclaw, Poland|Zgierz, Poland|Bacau, Romania|Baia Mare, Romania|Bucuresti, Romania|Constanta, Romania|Iasi, Romania|Oradea, Romania|Ploiesti, Romania|Targu Mures, Romania|Timisoara, Romania|Kazan, Russian Federation|Kemerovo, Russian Federation|Krasnoyarsk, Russian Federation|Moscow, Russian Federation|Novosibirsk, Russian Federation|St. Petersburg, Russian Federation|Yaroslavl, Russian Federation|Port Elizabeth, Eastern Cape, South Africa|Bloemfontein, Free State, South Africa|Johannesburg, Gauteng, South Africa|Kempton Park, Gauteng, South Africa|Krugersdorp, Gauteng, South Africa|Pretoria, Gauteng, South Africa|Durban, KwaZulu-Natal, South Africa|Middelburg, Mpumalanga, South Africa|Cape Town, Western Cape, South Africa|Somerset West, Western Cape, South Africa|Stellenbosch, Western Cape, South Africa|Worcester, Western Cape, South Africa|Chia-Yi City, Taiwan|New Taipei City, Taiwan|Taichung, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Dnipropetrovsk, Ukraine|Ivano-Frankivsk, Ukraine|Kharkiv, Ukraine|Kiev, Ukraine|Kyiv, Ukraine|Lugansk, Ukraine|Lviv, Ukraine|Mykolayiv, Ukraine|Poltava, Ukraine|Ternopil, Ukraine|Vinnytsia, Ukraine|Zaporizhzhia, Ukraine|Cheadle, Cheshire, United Kingdom|Plymouth, Devon, United Kingdom|Hull, East Riding of Yorkshire, United Kingdom|Bexhill on Sea, East Sussex, United Kingdom|Watford, Hertfordshire, United Kingdom|Thornton-Cleveleys, Lancashire, United Kingdom|Liverpool, Merseyside, United Kingdom|Northwood, Middlesex, United Kingdom|Bath, Somerset, United Kingdom|Swansea, South Glamorgan, United Kingdom|Cardiff, United Kingdom"
NCT02240381,Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant,https://clinicaltrials.gov/study/NCT02240381,TERMINATED,Diabetes Mellitus|Malignant Neoplasm,PROCEDURE: assessment of therapy complications|PROCEDURE: assessment of therapy complications|OTHER: laboratory biomarker analysis,Vanderbilt-Ingram Cancer Center,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232, United States"
NCT01647542,Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01647542,TERMINATED,Type 2 Diabetes Mellitus,DRUG: TAK-875|DRUG: TAK-875 Placebo,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Brookvale, New South Wales, Australia|Maroubra, New South Wales, Australia|Mosman, New South Wales, Australia|Woy Woy, New South Wales, Australia|Elizabeth Vale, South Australia, Australia|Hefei, Anhui, China|Beijing,P.R., Beijing, China|Beijing, Beijing, China|Chongqing, Chongqing, China|Fuzhou, Fujian, China|Xiamen, Fujian, China|Guangzhou, Guangdong, China|Guiyang, Guizhou, China|Shijiazhuang, Hebei, China|Harbin, Heilongjiang, China|Wuhan, Hubei, China|Changsha, Hunan, China|Chenzhou, Hunan, China|Nanjing, Jiangsu, China|Suzhou City, Jiangsu, China|Suzhou, Jiangsu, China|Changchun City, Jilin Province, Jilin, China|Changchun, Jilin, China|Xi'an, Shaanxi, China|Shanghai, Shanghai, China|Xi'an, Shanxi, China|Chengdu, Sichuan, China|Tianjin, Tianjin, China|Beijing, China|Chongqing, China|Guangzhou, China|Guiyang, China|Heilongjiang, China|Nanjing, China|Shanghai, China|Tianjin, China|Goyang-si, Gyeonggi-do, Korea, Republic of|Seongnam-si, Gyeonggi-do, Korea, Republic of|Suwon, Gyeonggi-do, Korea, Republic of|Gyeonggi, Korea, Republic of|Incheon, Korea, Republic of|Seoul, Korea, Republic of|Auckland, New Zealand|Hamilton, New Zealand|Rotorua, New Zealand|Tauranga, New Zealand|Wellington, New Zealand|Kaohsiung, Taiwan|New Taipei City, Taiwan|Taichung, Taiwan|Tainan, Taiwan|Taipei City, Taiwan|Taipei, Taiwan"
NCT00690456,Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00690456,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Rimonabant|DRUG: Placebo (for Rimonabant)|DRUG: Metformin,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, 08807, United States|Sanofi-Aventis Administrative Office, Jakarta, Indonesia|Sanofi-Aventis Administrative Office, Vilnius, Lithuania|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Mexico, Mexico|Sanofi-Aventis Administrative Office, Makati City, Philippines|Sanofi-Aventis Administrative Office, Warszawa, Poland|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Moscow, Russian Federation|Sanofi-Aventis Administrative Office, Brastislava, Slovakia|Sanofi-Aventis Administrative Office, Taipei, Taiwan|Sanofi-Aventis Administrative Office, Bangkok, Thailand|Sanofi-Aventis Administrative Office, Kiev, Ukraine"
NCT02029846,Glycemia in Diabetic Elders Trial,https://clinicaltrials.gov/study/NCT02029846,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Standard Treatment|DRUG: Incretin-Based Treatment,Johns Hopkins University,,ALL,OLDER_ADULT,PHASE4,INTERVENTIONAL,"Bay West Endocrinology Associates, Baltimore, Maryland, 21204, United States"
NCT02701257,"The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas",https://clinicaltrials.gov/study/NCT02701257,TERMINATED,Diabetes Mellitus Type 1,DEVICE: iPhone bionic pancreas|DEVICE: iLet bionic pancreas|DRUG: Xeris Xerisol glucagon|DRUG: Lilly glucagon|DEVICE: iLet infusion set|DEVICE: Contact Detach infusion set,Massachusetts General Hospital,Boston University,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"MGH Diabetes Research Center, Boston, Massachusetts, 02114, United States"
NCT01051011,A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy,https://clinicaltrials.gov/study/NCT01051011,TERMINATED,Diabetes Mellitus Type 2,DRUG: insulin glargine|DRUG: metformin|DRUG: taspoglutide|DRUG: taspoglutide,Hoffmann-La Roche,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Beijing, 10029, China|Beijing, 100730, China|Beijing, 100853, China|Beijng, 100700, China|Chengdu, 610041, China|Chongqing, 400010, China|Guangzhou, 510120, China|Hangzhou, 310003, China|Hefei, 230022, China|Nanjing, 210006, China|Nanjing, 210036, China|Nanning, 530021, China|Shanghai, 200080, China|Shi Jiazhuang, 050051, China|Tianjin (天津), 300052, China|Tianjin, 201203, China|Hong Kong, Hong Kong|Busan, 614-735, Korea, Republic of|Daegu, 42472, Korea, Republic of|Daegu, 705-717, Korea, Republic of|Gyeonggi-do, 410-773, Korea, Republic of|Gyeonggi-do, 443-380, Korea, Republic of|Gyeonggi-do, 463-712, Korea, Republic of|Incheon, 405-760, Korea, Republic of|Kangwon-do, 220-701, Korea, Republic of|Kyounggi-do, 420-717, Korea, Republic of|Seoul, 0, Korea, Republic of|Seoul, 110-746, Korea, Republic of|Seoul, 130-702, Korea, Republic of|Seoul, 134-701, Korea, Republic of|Seoul, 135-720, Korea, Republic of|Seoul, 137-701, Korea, Republic of|Seoul, 139-872, Korea, Republic of|Johor Bahru, 80200, Malaysia|Kelantan, 16150, Malaysia|Kuala Lumpur, 50586, Malaysia|Kuala Lumpur, 50603, Malaysia|Penang, 10450, Malaysia|Putrajaya, 62250, Malaysia|Selangor, Malaysia|Cebu, 6000, Philippines|Iloilo, 5000, Philippines|Manila, 1000, Philippines|Manila, 1357, Philippines|Manila, 1503, Philippines|Pasig, 1605, Philippines|Chia-Yi City, 60002, Taiwan|Taichung, 404, Taiwan|Tainan, 710, Taiwan|Taipei, 00112, Taiwan|Taipei, 220, Taiwan|Taoyuan County, 333, Taiwan|Bangkok, 10330, Thailand|Bangkok, 10400, Thailand|Chiang Mai, 50200, Thailand|Nakhonratchasima, 30000, Thailand"
NCT01910441,Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT01910441,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Vildagliptin|DRUG: Glimepiride|DRUG: Metformin,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT02608905,Effect of Dapagliflozin on Inflammation and Endothelial Function,https://clinicaltrials.gov/study/NCT02608905,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Dapagliflozin|DRUG: Placebo,Baylor College of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Baylor College of Medicine, Houston, Texas, 77030, United States"
NCT00130806,An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065),https://clinicaltrials.gov/study/NCT00130806,TERMINATED,Type 2 Diabetes Mellitus,DRUG: MK0478 (muraglitazar)|DRUG: Comparator: placebo,Merck Sharp & Dohme LLC,Bristol-Myers Squibb,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT01434862,Pramlintide Combined With Model Predictive Control Algorithm,https://clinicaltrials.gov/study/NCT01434862,TERMINATED,Type 1 Diabetes Mellitus,DRUG: Closed loop with pramlintide|DEVICE: Closed loop without pramlintide|DRUG: Open loop with pramlintide,University of Virginia,The Paul Manning Foundation,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Virginia, Center for Diabetes Technology, Charlottesville, Virginia, 22903, United States"
NCT02212925,"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes",https://clinicaltrials.gov/study/NCT02212925,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: BI 14332 CL|DRUG: Placebo,Boehringer Ingelheim,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,
NCT02671136,Hyperbaric Oxygen Therapy as Adjunctive Therapy to Scaling and Root-planing in the Management of Periodontitis in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02671136,TERMINATED,Diabetes|Periodontitis,DEVICE: Hyperbaric Oxygen therapy|OTHER: Conventional Wound Therapies,Loma Linda University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Loma Linda University, Loma Linda, California, 92346, United States"
NCT00479466,Dose-Range Finding Study for MK0893 (0893-008),https://clinicaltrials.gov/study/NCT00479466,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK0893|DRUG: Metformin|DRUG: Placebo to MK0893|DRUG: Placebo to Metformin,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT01923389,Multiple Dose Study Of PF-05231023 In Obese Adult Subjects,https://clinicaltrials.gov/study/NCT01923389,TERMINATED,Type 2 Diabetes Mellitus (T2DM),OTHER: Placebo|DRUG: 100 mg PF-05231023,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Pfizer Investigational Site, Orlando, Florida, 32803, United States|Pfizer Investigational Site, Orlando, Florida, 32804, United States"
NCT00428207,Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy,https://clinicaltrials.gov/study/NCT00428207,TERMINATED,Type 1 Diabetes Mellitus,DRUG: Insulin Aspart versus Insulin Lispro|DRUG: Insulin Lispro versus Insulin Aspart,Joslin Diabetes Center,Novo Nordisk A/S,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Joslin Diabetes Center, Boston, Massachusetts, 02215, United States"
NCT00437606,A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.,https://clinicaltrials.gov/study/NCT00437606,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: GK Activator (2)|DRUG: Ethanol,Hoffmann-La Roche,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Berlin, Germany|Kiel, Germany|Bratislava, Slovakia"
NCT00382473,Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise,https://clinicaltrials.gov/study/NCT00382473,TERMINATED,"Diabetes Mellitus, Type 2|Overweight",BEHAVIORAL: Aerobic exercise program - 8 weeks,University of Pittsburgh,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,ADULT,,INTERVENTIONAL,"University of Pittsburgh, Montefiore Hospital, Pittsburgh, Pennsylvania, 15213, United States"
NCT01372163,A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients,https://clinicaltrials.gov/study/NCT01372163,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: PF-05190457 or Placebo|DRUG: PF-05190457 or Placebo|DRUG: PF-05190457 or Placebo|DRUG: PF-05190457 or Placebo|DRUG: PF-05190457 or Placebo|DRUG: PF-05190457 or Placebo|DRUG: PF-05190457 or Placebo,Pfizer,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Pfizer Investigational Site, New Haven, Connecticut, 06511, United States"
NCT01357148,A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235),https://clinicaltrials.gov/study/NCT01357148,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Sitagliptin Phosphate/Metformin HCl (JANUMET®),Merck Sharp & Dohme LLC,,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT01303315,TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy,https://clinicaltrials.gov/study/NCT01303315,TERMINATED,"Diabetes Mellitus, Type 2",DEVICE: TANTALUS System,"MetaCure (USA), Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Fakultni Nemocnice U SV. Anny V Brne, Brno, 656 91, Czech Republic|Klinika gerontologická a metabolická,, Hradec Kralove, 500 05, Czech Republic|General University Hospital,, Prague, 128 08, Czech Republic|Prednosta OB Kliniky a.s.,, Prague, 130 00, Czech Republic|Diabetes Zentrum, Bad Mergentheim, Germany|Asklepios Klinik St. Georg, Hamburg, 20099, Germany|Diabetes-Praxis Muenster, Münster, 48153, Germany|'N. Paulescu' National Institute of Diabetes, Nutrition and Metabolic Diseases, Bucharest, 79811, Romania|CMI Dr Busegeanu Mihaela Magdalena-Ploiesti, Bucharest, A, Romania|Fundeni Hospital - Surgical, Bucharest, A, Romania|Sanatatea Ta Medical Center, Bucharest, A, Romania|Sf. Ioan Hospital - Surgical, Bucharest, A, Romania|Spitalul Pelican, Orada, Bucharest, A, Romania"
NCT01725672,Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers,https://clinicaltrials.gov/study/NCT01725672,TERMINATED,"Diabetes Mellitus, Type 2","DRUG: Metformin, 500 mg extended release tablet|DRUG: Metformin, 1000 mg extended release tablet|DRUG: Glimepiride, 1 mg immediate release tablet|DRUG: Glimepiride, 2 mg immediate release tablet|DRUG: Metformin, 500 mg and Glimepiride, 1 mg extended release film coated tablet containing release controlling polymers|DRUG: Metformin, 1000 mg and Glimepiride, 2 mg extended release film coated tablet containing release controlling polymers|DRUG: Metformin, 500 mg and Glimepiride, 1 mg extended release tablet coated with release controlling polymers|DRUG: Metformin, 1000 mg and Glimepiride, 2 mg extended release tablet coated with release controlling polymers",GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"GSK Investigational Site, Randwick, New South Wales, 2031, Australia"
NCT01525225,"Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM",https://clinicaltrials.gov/study/NCT01525225,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Metformin immediate release (IR)|DRUG: Saxagliptin|DRUG: Metformin IR|DRUG: Saxagliptin/Metformin XR FDC|DRUG: Metformin XR,AstraZeneca,,ALL,CHILD,PHASE1,INTERVENTIONAL,"Osborne Research Center, Little Rock, Arkansas, 72201, United States|Axis Clinical Trials, Los Angeles, California, 90036, United States|Kosair Charities Pediatric Clinical Research Unit, Louisville, Kentucky, 40202, United States|The Children'S Mercy Hospital And Clinics, Kansas City, Missouri, 64108, United States|Promedica Toledo Children'S Hospital, Toledo, Ohio, 43606, United States|Promedica Toledo Childrens Hospital, Toledo, Ohio, 43606, United States|Childrens Hospital Of Pittsburgh Of Upmc, Pittsburgh, Pennsylvania, 15224, United States"
NCT01202266,A Multiple Dose Study Of PF-05161704 In Healthy Volunteers,https://clinicaltrials.gov/study/NCT01202266,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: PF-05161704 or Placebo|DRUG: PF-05161704 or Placebo|DRUG: PF-05161704 or Placebo|DRUG: PF-05161704 or Placebo|DRUG: PF-05161704 or Placebo|DRUG: PF-05161704 or Placebo|DRUG: PF-05161704 or Placebo|DRUG: PF-05161704 or Placebo,Pfizer,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Pfizer Investigational Site, New Haven, Connecticut, 06511, United States"
NCT01170468,Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals,https://clinicaltrials.gov/study/NCT01170468,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Vitamin D3|DRUG: Placebo,King Faisal Specialist Hospital & Research Center,,ALL,ADULT,PHASE3,INTERVENTIONAL,"King Faisal Specialist Hospital & Research Center, Riyadh, 11211, Saudi Arabia"
NCT01144520,Leukocyte Dysfunction in Diabetic Patients.,https://clinicaltrials.gov/study/NCT01144520,TERMINATED,"Diabetes Mellitus, Type 2",,Sashwati Roy,,ALL,ADULT,,OBSERVATIONAL,"Ohio State University Comprehensive Wound Center, Columbus, Ohio, 43221, United States"
NCT01095068,Effects of Physical Exercise in Type 2 Diabetics,https://clinicaltrials.gov/study/NCT01095068,TERMINATED,Type 2 Diabetes Mellitus,BEHAVIORAL: Physical exercise,"University Hospital, Strasbourg, France",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Médecine Interne et Nutrition, Hôpital Civil, Hôpitaux universitaires de Strasbourg, Strasbourg, 67091, France|Service de Physiologie et d'Explorations Fonctionnelles, Nouvel Hôpital Civil, Hôpitaux universitaires de Strasbourg, Strasbourg, 67091, France|Service de Médecine Interne et Nutrition, Hôpital de Hautepierre, Hôpitaux universitaires de Strasbourg, Strasbourg, 67098, France"
NCT01079364,Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting,https://clinicaltrials.gov/study/NCT01079364,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Insulin glulisine|DRUG: Insulin glargine|DRUG: Premixed insulin (Insulin Aspart 30/70 ),Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Gouda, Netherlands"
NCT01068756,Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects,https://clinicaltrials.gov/study/NCT01068756,TERMINATED,Type 2 Diabetes Mellitus,DRUG: Dapagliflozin|DRUG: Rifampin,AstraZeneca,Bristol-Myers Squibb,ALL,ADULT,PHASE1,INTERVENTIONAL,"Ppd Development, Austin, Texas, 78744, United States"
NCT00283049,"Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control",https://clinicaltrials.gov/study/NCT00283049,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Insulin Glargine|DRUG: Insulin Glulisine,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"sanofi-aventis, US, Bridgewater, New Jersey, 08807, United States"
NCT01010594,Two Pieces of Fruit to Type 2 Diabetics?,https://clinicaltrials.gov/study/NCT01010594,TERMINATED,"Diabetes Mellitus, Type 2",BEHAVIORAL: dietary treatment|BEHAVIORAL: dietary treatment,Hospitalsenheden Vest,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of nutrition, Regional Hospital West Jutland, Holstebro, 7500, Denmark"
NCT00356421,A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®,https://clinicaltrials.gov/study/NCT00356421,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: Inhaled Human Insulin (Exubera®)|DRUG: Insulin lispro (Humalog),Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Pfizer Investigational Site, Hamilton, New Jersey, 08610, United States|Pfizer Investigational Site, New Brunswick, New Jersey, 08903, United States|Pfizer Investigational Site, Vienna, A-1030, Austria|Pfizer Investigational Site, Vienna, A-1130, Austria|Pfizer Investigational Site, Edegem, 2650, Belgium|Pfizer Investigational Site, Genk, 3600, Belgium|Pfizer Investigational Site, Leuven, 3000, Belgium|Pfizer Investigational Site, Aarhus, 8000, Denmark|Pfizer Investigational Site, Kuopio, 70211, Finland|Pfizer Investigational Site, Brest CEDEX, 29609, France|Pfizer Investigational Site, Corbeil Essonnes Cedex, 91106, France|Pfizer Investigational Site, Strasbourg Cedex, 67091, France|Pfizer Investigational Site, Waterford, Ireland|Pfizer Investigational Site, Amsterdam, NL-1105 AZ, Netherlands|Pfizer Investigational Site, Stavanger, 4095, Norway|Pfizer Investigational Site, Lisboa, 1349-019, Portugal|Pfizer Investigational Site, Las Palmas, Las Palmas de Gran Canaria, 35016, Spain|Pfizer Investigational Site, Valencia, 46010, Spain|Pfizer Investigational Site, Stockholm, 171 76, Sweden|Pfizer Investigational Site, Stockholm, 182 88, Sweden|Pfizer Investigational Site, Bournemouth, Dorset, BH7 7DW, United Kingdom|Pfizer Investigational Site, Dundee, Tayside, DD1 9SY, United Kingdom|Pfizer Investigational Site, Birmingham, West Midlands, B9 5SS, United Kingdom"
NCT00939939,Effect of Sitagliptin on Postprandial Lipoprotein Metabolism,https://clinicaltrials.gov/study/NCT00939939,TERMINATED,Diabetes Mellitus Type 2,DRUG: sitagliptin|DRUG: glimepiride,Ludwig-Maximilians - University of Munich,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Medical Dept. 2, Grosshadern, University Munich, Munich, 81377, Germany"
NCT01021930,Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT,https://clinicaltrials.gov/study/NCT01021930,TERMINATED,Coronary Heart Disease|Diabetes Mellitus,DEVICE: Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent),Harbin Medical University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"The second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150081, China"
NCT00762242,Metabolomic Profiling of Novel Mediators of Vascular Function,https://clinicaltrials.gov/study/NCT00762242,TERMINATED,Type 2 Diabetes Mellitus,PROCEDURE: blood sampling and brachial artery ultrasound,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States"
NCT02985242,Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT02985242,TERMINATED,"Diabetes Mellitus, Type II",DRUG: Empagliflozin|DRUG: Glimepiride|DRUG: Empagliflozin placebo|DRUG: Glimepiride placebo,Hannover Medical School,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Hannover Medical School, University Eye Hospital and CRC Core Facility Hannover, Hanover, Lower Saxony, 30625, Germany"
NCT01767831,Evaluation of a Simulation-Based Educational Tool for Personalized Feedback in Insulin Therapy Management,https://clinicaltrials.gov/study/NCT01767831,TERMINATED,Type 1 Diabetes Mellitus,BEHAVIORAL: iBOLUSED,University of Virginia,National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, 22904, United States"
NCT00479258,Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents,https://clinicaltrials.gov/study/NCT00479258,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: Inhaled insulin (Exubera)|DRUG: Subcutaneous Insulin (subject's prescribed),Pfizer,,ALL,CHILD,PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Buffalo, New York, 14222, United States"
NCT05397028,Weight Management for the Remission of Type 2 Diabetes Using a Proprietary Meal Replacement System- Diabetes Remission Study (DRS),https://clinicaltrials.gov/study/NCT05397028,TERMINATED,"Obesity|Diabetes Mellitus, Type 2",DIETARY_SUPPLEMENT: Meal replacement system|BEHAVIORAL: Intensive lifestyle Intervention,Loma Linda University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Loma Linda University Health, Loma Linda, California, 92350, United States"
NCT00543517,Study A - MK0767 Monotherapy Study,https://clinicaltrials.gov/study/NCT00543517,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00543491,MK0767 and Sulfonylurea Combination Study (0767-027),https://clinicaltrials.gov/study/NCT00543491,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00543361,Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020),https://clinicaltrials.gov/study/NCT00543361,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK0767|DRUG: Comparator: placebo (unspecified)|DRUG: Comparator: metformin,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00543010,MK0767 Glipizide Comparator Cardiac Safety Study (0767-018),https://clinicaltrials.gov/study/NCT00543010,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00330200,"Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics",https://clinicaltrials.gov/study/NCT00330200,TERMINATED,Type 2 Diabetes Mellitus,DRUG: ISIS 113715,"Ionis Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Yale - New Haven Hospital, New Haven, Connecticut, 06511, United States"
NCT01023919,Assessment of Surface Coverage of Two Types of Drug-eluting Stent in Diabetes Mellitus and Non-Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01023919,TERMINATED,Coronary Artery Disease|Diabetes Mellitus,DEVICE: Device: Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent),Harbin Medical University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"The second Affiliated Hospital of Harbin Medical University, Harbin, Heilong Jiang, 150081, China"
NCT00412178,Effect of Mobile Communication With a Cellular Phone With a Glucometer on Glucose Control in Type 2 Diabetic Patients,https://clinicaltrials.gov/study/NCT00412178,TERMINATED,Type 2 Diabetes Mellitus,DEVICE: telecommunication based glucose monitoring system,The Catholic University of Korea,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Kangnam St. Mary's Hospital, The Catholic University of Korea, Seoul, 137-040, Korea, Republic of"
NCT01223651,Performance of Continuous Glucose Monitoring Systems at Altitude,https://clinicaltrials.gov/study/NCT01223651,TERMINATED,"Diabetes Mellitus, Type 1",PROCEDURE: two step hyperinsulinaemic glucose clamp study.,The Royal Bournemouth Hospital,,ALL,ADULT,,INTERVENTIONAL,"Royal Airforce Base Henlow, Henlow, Bedfordshire, SG16 6DN, United Kingdom|Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, Dorset, BH7 7DW, United Kingdom"
NCT00437489,A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.,https://clinicaltrials.gov/study/NCT00437489,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Inhaled Human Insulin (Exubera)|DRUG: Inhaled Human Insulin (Exubera),Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Pfizer Investigational Site, Hong Kong, Hong Kong|Pfizer Investigational Site, Karachi, Sindh, 74600, Pakistan|Pfizer Investigational Site, Makati, 1218, Philippines|Pfizer Investigational Site, Marikina City, 1810, Philippines|Pfizer Investigational Site, Pasay City, 1300, Philippines|Pfizer Investigational Site, Pasig City, 1605, Philippines|Pfizer Investigational Site, Quezon City, 1102, Philippines|Pfizer Investigational Site, Singapore, 119074, Singapore|Pfizer Investigational Site, Singapore, 159964, Singapore"
NCT00791076,The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients,https://clinicaltrials.gov/study/NCT00791076,TERMINATED,"Diabetes Mellitus, Type 1",DRUG: Placebo|DRUG: Pancreatic Polypeptide (PP),Johns Hopkins University,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Johns Hopkins Bayview Medical Center, Baltimore, Maryland, 21224, United States"
NCT01748305,Moderate-to-vigorous Physical Activity for Glycemic Control in Patients With Gestational Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01748305,TERMINATED,Gestational Diabetes Mellitus|Exercise,BEHAVIORAL: Moderate-to-vigorous intensity exercise,Oregon Health and Science University,,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Oregon Health & Science University, Portland, Oregon, 97239, United States"
NCT00231634,"A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy",https://clinicaltrials.gov/study/NCT00231634,TERMINATED,"Obesity|Diabetes Mellitus, Type 2|Diabetes Mellitus, Adult-Onset",DRUG: topiramate,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00656422,"Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine",https://clinicaltrials.gov/study/NCT00656422,TERMINATED,Diabetes|Obesity,DRUG: insulin Levemir|DRUG: insulin Lantus,University Hospital Tuebingen,Medical University of Vienna|University of Bern|CenTrial GmbH,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Medical University Graz, Graz, 8036, Austria|University Hospital Graz, Graz, 8036, Austria|Medical University Vienna, Vienna, 1090, Austria|University Hospital of Tübingen, Tübingen, 72076, Germany|University Hospital, Bern, 3010, Switzerland"
NCT00468442,B-Lymphocyte Immunotherapy in Islet Transplantation,https://clinicaltrials.gov/study/NCT00468442,TERMINATED,Type 1 Diabetes Mellitus,BIOLOGICAL: Allogeneic Pancreatic Islet Cells|BIOLOGICAL: Antithymocyte globulin|BIOLOGICAL: Daclizumab|BIOLOGICAL: Rituximab|DRUG: Sirolimus,National Institute of Allergy and Infectious Diseases (NIAID),National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Pennsylvania, Philadelphia, Pennsylvania, United States"
NCT00453817,Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging,https://clinicaltrials.gov/study/NCT00453817,TERMINATED,Type 1 Diabetes Mellitus,DRUG: ferucarbotran (iron-based MRI contrast agent)|PROCEDURE: Islet transplantation|PROCEDURE: Magnetic resonance imaging,"University Hospital, Geneva",,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Geneva University Hospitals Department of Surgery, Geneva, 1211, Switzerland"
NCT00607867,LoBAG30 Diet in Patients on Metformin,https://clinicaltrials.gov/study/NCT00607867,TERMINATED,Diabetes Mellitus|Diet,OTHER: LoBAG30 diet|OTHER: Control Diet,US Department of Veterans Affairs,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"VA Medical Center, Minneapolis, Minneapolis, Minnesota, 55417, United States"
NCT00439985,Improving Metabolic Control in Diabetic Young Children,https://clinicaltrials.gov/study/NCT00439985,TERMINATED,Type 1 Diabetes Mellitus,BEHAVIORAL: Cognitive Behavioral Therapy,Icahn School of Medicine at Mount Sinai,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,CHILD,,INTERVENTIONAL,"Mount Sinai School of Medicine, New York, New York, 10029-6574, United States"
NCT04858386,The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance,https://clinicaltrials.gov/study/NCT04858386,TERMINATED,Gestational Diabetes,,Belfast Health and Social Care Trust,"Queen's University, Belfast",FEMALE,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Royal Jubilee Maternity Service, Belfast, Northern Ireland, BT12 6BA, United Kingdom"
NCT03751813,Baby Bump Lifestyle Intervention Supplement Study,https://clinicaltrials.gov/study/NCT03751813,TERMINATED,Gestational Diabetes,DIETARY_SUPPLEMENT: Supplement,State University of New York at Buffalo,,FEMALE,ADULT,,INTERVENTIONAL,"SUNY Buffalo, Buffalo, New York, 14214, United States"
NCT03749889,Low Carb vs Normal Carb in Pregnancy,https://clinicaltrials.gov/study/NCT03749889,TERMINATED,Gestational Diabetes,OTHER: 100 g carbs|OTHER: MyPlate,State University of New York at Buffalo,,FEMALE,ADULT,,INTERVENTIONAL,"SUNY Buffalo, Buffalo, New York, 14214, United States"
NCT03726008,The Effect of a Perinatal Health Promotion Program on the Different Levels of Gestational Hyperglycemic Women,https://clinicaltrials.gov/study/NCT03726008,TERMINATED,Gestational Diabetes,BEHAVIORAL: Perinatal health promotion program and regular prenatal care,Kaohsiung Medical University Chung-Ho Memorial Hospital,,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Sanmin Dist, 807, Taiwan"
NCT02225951,Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.,https://clinicaltrials.gov/study/NCT02225951,TERMINATED,Gestational Diabetes Mellitus in Pregnancy,DIETARY_SUPPLEMENT: Nutritional product|OTHER: Standard breakfast according to ADA recommendations,"Danone Asia Pacific Holdings Pte, Ltd.",Nutricia Research,ALL,ADULT,,INTERVENTIONAL,"KK Women's and Children's Hospital, Singapore, 229899, Singapore"
NCT01440517,Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction,https://clinicaltrials.gov/study/NCT01440517,TERMINATED,Diabetes Mellitus|Heart Failure,DRUG: Tc99m-Maraciclatide,GE Healthcare,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"GE Healthcare, Princeton, New Jersey, 08540, United States"
NCT04938388,Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care,https://clinicaltrials.gov/study/NCT04938388,TERMINATED,"Diabetes Mellitus, Type 2|Glucose Metabolism Disorders (Including Diabetes Mellitus)",DRUG: Semaglutide Pill|DIETARY_SUPPLEMENT: Fresh organic vegetables,Sansum Diabetes Research Institute,Novo Nordisk A/S,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Sansum Diabetes Research Institute, Santa Barbara, California, 93105, United States"
NCT00225225,Rosiglitazone-Induced Weight Gain,https://clinicaltrials.gov/study/NCT00225225,TERMINATED,"Diabetes Mellitus, Type 2",DRUG: Rosiglitazone|BEHAVIORAL: dietary recommendation for weight maintenance,Stanford University,GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Stanford University School of Medicine, Stanford, California, 94305, United States"
NCT04678557,"A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus",https://clinicaltrials.gov/study/NCT04678557,TERMINATED,Type 1 Diabetes,COMBINATION_PRODUCT: VC-01 Combination Product,ViaCyte,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"AMCR Institute, Escondido, California, 92025, United States|Diablo Clinical Research, Walnut Creek, California, 94598, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30318, United States|Texas Diabetes & Endocrinology, Austin, Texas, 78731, United States"
NCT03925909,Supplementation of Eriocitrin in Intestinal Microbiota,https://clinicaltrials.gov/study/NCT03925909,TERMINATED,Pre Diabetes,DIETARY_SUPPLEMENT: Eriocitrin,São Paulo State University,,ALL,ADULT,,INTERVENTIONAL,"Sao Paulo State University ""Julio de Mesquita Filho"", Araraquara, SP, 14800-903, Brazil"
NCT00058981,"Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)",https://clinicaltrials.gov/study/NCT00058981,TERMINATED,"Diabetes, Autoimmune",DRUG: DiaPep277,"DeveloGen Israel, Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Alabama at Birmingham Endocrinology Department, Birmingham, Alabama, 35294, United States|University of Colorado Hospital Endocrinology Practice, Aurora, Colorado, 80010, United States|University of Kentucky Department of Internal Medicine, Lexington, Kentucky, 40536, United States|Washington University School of Medicine Endocrinology/Metabolic Dept, Saint Louis, Missouri, 63110, United States|North Shore Diabetes and Endocrine Associates, New Hyde Park, New York, 11042, United States|Diabetes & Glandular Disease Research Associates, San Antonio, Texas, 78229-4801, United States|DVA Puget Sound Health Care System Endocrinology (III) Department, Seattle, Washington, 98108, United States"
NCT03052400,Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT03052400,TERMINATED,Type 2 Diabetes Mellitus|Insulin Resistance,DRUG: Mifepristone 600 mg daily|DRUG: Placebo,Charles Drew University of Medicine and Science,,MALE,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Charles Drew University of Medicine and Science, Los Angeles, California, 90059, United States"
NCT03626623,Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care,https://clinicaltrials.gov/study/NCT03626623,TERMINATED,"Diabetes|Diabetic Foot|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1",DEVICE: Cytal Wound Matrix 1-Layer|OTHER: Standard of Care (SOC),Integra LifeSciences Corporation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Limb Preservation Platform, Inc., Fresno, California, 93710, United States|Louisiana State University Health Science Center (LSUHSC), New Orleans, Louisiana, 70112, United States|MedStar Health Research Institute, Hyattsville, Maryland, 20782, United States"
NCT03457818,Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab,https://clinicaltrials.gov/study/NCT03457818,TERMINATED,"Diabetes Mellitus, Type 2|Osteoporosis",DRUG: Denosumab 60 mg/ml [Prolia]|OTHER: Placebo,Mishaela Rubin,,FEMALE,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Columbia University Irving Medical Center - Harkness Pavillion, New York, New York, 10032, United States"
NCT01393873,Progression of Diabetic Retinopathy Post Bariatric Surgery (BS),https://clinicaltrials.gov/study/NCT01393873,TERMINATED,Obesity|Diabetes Mellitus,,NYU Langone Health,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"NYU SOM, New York, New York, 10016, United States"
NCT03325114,Safety and Efficacy of Chlorthalidone in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03325114,TERMINATED,Type 1 Diabetes Mellitus|Hypercalciuria,DRUG: Chlorthalidone,University of Rochester,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"University of Rochester, Rochester, New York, 14642, United States"
NCT06057805,The PPCGMS Intervention After GDM Trial,https://clinicaltrials.gov/study/NCT06057805,TERMINATED,Postpartum Gestational Diabetes Mellitus,DEVICE: Blinded Dexcom G7 CGM,Woman's,"DexCom, Inc.",FEMALE,ADULT,,INTERVENTIONAL,"Karen Elkind-Hirsch, Baton Rouge, Louisiana, 70817, United States"
NCT00441363,Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin,https://clinicaltrials.gov/study/NCT00441363,TERMINATED,Type 2 Diabetes,DRUG: Bromocriptine Mesylate,VeroScience,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT04468243,Pilot RCT Feasibility Study: Cancer and T2D,https://clinicaltrials.gov/study/NCT04468243,TERMINATED,"Diabetes Mellitus, Type 2|Cancer",OTHER: Nurse-led diabetes care,University of Florida,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Florida, Gainesville, Florida, 32610, United States"
NCT00212004,Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study),https://clinicaltrials.gov/study/NCT00212004,TERMINATED,Diabetes Mellitus|Myocardial Infarction,DRUG: pioglitazone|OTHER: control,"National Cerebral and Cardiovascular Center, Japan",Japan Heart Foundation,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"National Cardiovascular Center, Suita, Osaka, 565-8565, Japan"
NCT00539409,Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00539409,TERMINATED,"Diabetes Mellitus, With Complications","PROCEDURE: Pulsatile Intravenous Insulin Therapy (Humulin R, Novolog)",Florida Atlantic University,Advanced Diabetes Treatment Centers,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Florida Atlantic University, Boca Raton, Florida, 33431, United States"
NCT01631929,Two Bag System for Hydration in Diabetes,https://clinicaltrials.gov/study/NCT01631929,TERMINATED,Diabetes|Ketoacidosis,OTHER: One bag|OTHER: Two bags,Hospital General de Niños Pedro de Elizalde,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Hospital General de NIños Pedro de Elizalde, Buenos Aires, C1270AAN, Argentina"
NCT04754334,A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT04754334,TERMINATED,T2DM (Type 2 Diabetes Mellitus),DRUG: ORMD-0801|OTHER: Placebo,"Oramed, Ltd.",Integrium,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Institute of South Florida, Inc. (PHARMASEEK), Coral Gables, Florida, 33124, United States"
NCT04234581,The Effect of Lysulin on Glycemic Control and Advanced Glycation,https://clinicaltrials.gov/study/NCT04234581,TERMINATED,Type 2 Diabetes,DIETARY_SUPPLEMENT: Lysulin,Juraj Koska,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Phoenix VA Healthcare System, Phoenix, Arizona, 85012, United States|Phoenix VA Medical Center, Phoenix, Arizona, 85012, United States"
NCT02906891,A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion,https://clinicaltrials.gov/study/NCT02906891,TERMINATED,"Hypoglycemia|Diabetes Mellitus, Type 1",DEVICE: Vigilant Diabetes Management Application,"InSpark Technologies, Inc.",East Carolina University,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"East Carolina University, Greenville, North Carolina, 27834, United States"
NCT00965302,Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients,https://clinicaltrials.gov/study/NCT00965302,TERMINATED,"Diabetes Mellitus, Type 2|Obesity",PROCEDURE: Laparoscopic sleeve gastrectomy|BEHAVIORAL: Intensive medical management,59th Medical Wing,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Wilford Hall Medical Center, San Antonio, Texas, 78236, United States"
NCT00832624,The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118),https://clinicaltrials.gov/study/NCT00832624,TERMINATED,Diabetes Mellitus Non-insulin-dependent,DRUG: sitagliptin,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT02682940,T1 Diabetes Hypoglycemia Prevention Pilot,https://clinicaltrials.gov/study/NCT02682940,TERMINATED,"Diabetes Mellitus, Type 1|Hypoglycemia",DEVICE: Vigilant Diabetes Management Application,"InSpark Technologies, Inc.",Atlanta Diabetes Associates,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Atlanta Diabetes Associates, Atlanta, Georgia, 30318, United States"
NCT02730962,Interventional Bioremediation of Microbiota in Metabolic Syndrome,https://clinicaltrials.gov/study/NCT02730962,TERMINATED,Pre-Diabetes,DRUG: Vancomycin|OTHER: Placebo|DRUG: Neomycin|DRUG: Clindamycin|PROCEDURE: Fecal Microbiota Transplantation,University of Minnesota,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Minnesota Medical Center, Minneapolis, Minnesota, 55455, United States"
NCT00453934,Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device,https://clinicaltrials.gov/study/NCT00453934,TERMINATED,Type 1 Diabetes|Type 2 Diabetes,DEVICE: h-Patch,"Valeritas, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Diabetes and Glandular Research, San Antonio, Texas, 78229, United States"
NCT01855386,The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes,https://clinicaltrials.gov/study/NCT01855386,TERMINATED,Gestational Diabetes Mellitus in Pregnancy,OTHER: Subjects with Gestational Diabetes|OTHER: Controls without Gestational Diabetes,University of Florida,,FEMALE,ADULT,,OBSERVATIONAL,"Shands Medical Plaza, Gainesville, Florida, 32608, United States"
NCT04229667,Community Models for Hypertension and Diabetes Care for Refugees,https://clinicaltrials.gov/study/NCT04229667,TERMINATED,"Hypertension|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Comorbidities and Coexisting Conditions",OTHER: Improved Community Health Volunteer (CHV) program,International Rescue Committee,University of Southern California|Jordan University of Science and Technology,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"International Rescue Committee, New York, New York, 10168, United States"
NCT01515384,A Trial of 18F-AV-133 Positron Emission Tomography (PET),https://clinicaltrials.gov/study/NCT01515384,TERMINATED,Type 1 Diabetes|Type 2 Diabetes,DRUG: 18F-AV-133,Avid Radiopharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Research Site, New York, New York, 10027, United States"
NCT00974740,DIATOR-Diabetes Intervention With Atorvastatin,https://clinicaltrials.gov/study/NCT00974740,TERMINATED,Type 1 Diabetes,DRUG: Atorvastatin|DRUG: atorvastatin matching placebo,Profil Institut für Stoffwechselforschung GmbH,Pfizer,ALL,ADULT,PHASE1,INTERVENTIONAL,"Diabetes-Zentrum Mergentheim, Bad Mergentheim, 97980, Germany|Gemeinschaftskrankenhaus Havelhöhe, Berlin, 14089, Germany|Helios Klinikum Emil von Behring, Berlin, 14165, Germany|Praxis Dr. Friedhelm Schmitten, Bestwig-Ramsbeck, 59909, Germany|DDZ Deutsches Diabetes Zentrum, Düsseldorf, 40221, Germany|St. Josefs Krankenhaus, Heidelberg, 69115, Germany|St. Antonius Krankenhaus, Med. Klinik, Köln, 50968, Germany|Praxisklinik Leipzig, Leipzig, 04103, Germany|Praxis Dr. Gerhard Willms, Leverkusen, 51373, Germany|Praxis Dr. Heinz-Georg Ley, Marl, 45770, Germany|Diabetologische Schwerpunktpraxis, Angiologie, Münster, 48145, Germany|Praxis Dr. Werner Stürmer, Würzburg, 97070, Germany"
NCT00491400,Effect of a Fibrate and a Statin on Endothelial Dysfunction,https://clinicaltrials.gov/study/NCT00491400,TERMINATED,Diabetes Mellitus|Metabolic Syndrome,DRUG: Fenofibrate|DRUG: Atorvastatin,Boston University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Boston Medical Center, Boston, Massachusetts, 02118, United States"
NCT02064023,Comparison of Insulin Pump and MDI for Pregestational Diabetes During Pregnancy,https://clinicaltrials.gov/study/NCT02064023,TERMINATED,Type 1 Diabetes|Type 2 Diabetes|Pregnancy,DEVICE: insulin pump|OTHER: multiple daily insulin injection,University of British Columbia,,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Jim Pattison Outpatient Care and Surgery Centre, Surrey, British Columbia, V3T 0G9, Canada|B.C. Women's Hospital, Vancouver, British Columbia, Canada"
NCT00579371,Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00579371,TERMINATED,"Islets of Langerhans Transplantation|Diabetes Mellitus, Type 1",DRUG: Islets of Langerhans,University of Nebraska,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"The Nebraska Medical Center, Omaha, Nebraska, 68198, United States"
NCT03582956,Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03582956,TERMINATED,Type1 Diabetes Mellitus|Adiposity,PROCEDURE: Euglycemic hyperinsulinemic clamp with tracer enhancement|PROCEDURE: Euglycemic hyperinsulinemic clamp with tracer enhancement,Yale University,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"CHILD, ADULT",,INTERVENTIONAL,"Yale Pediatric Diabetes Research Program, New Haven, Connecticut, 06511, United States"
NCT02912455,CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02912455,TERMINATED,"Diabetes Mellitus, Type 2|Obesity",DRUG: canagliflozin|DRUG: Placebo (for canagliflozin),The Cleveland Clinic,"Janssen Scientific Affairs, LLC",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cleveland Clinic, Cleveland, Ohio, 44195, United States"
NCT05267925,CuraLin Herbal Supplement for Type 2 Diabetes,https://clinicaltrials.gov/study/NCT05267925,TERMINATED,Type 2 Diabetes,DIETARY_SUPPLEMENT: CuraLin,National University of Natural Medicine,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"National University of Natural Medicine, Portland, Oregon, 97201, United States|Institute of Complementary Medicine, Seattle, Washington, 98122, United States"
NCT00622089,Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients,https://clinicaltrials.gov/study/NCT00622089,TERMINATED,Type 2 Diabetes,DRUG: DIO-902|DRUG: DIO-902|DRUG: DIO-902,DiObex,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Dr. Terence Hart, Muscle Shoals, Alabama, 35662, United States|Genova Research, Tucson, Arizona, 85741, United States|Research Solutions, Jonesboro, Arkansas, 72401, United States|Arkansas Primary Care Clinic, Little Rock, Arkansas, 72211, United States|Advanced Medical Research, Lakewood, California, 90712, United States|Mills-Peninsula Helath Services, San Mateo, California, 94401, United States|Diabetes Research Goup University of Hawaii at Manoa, Honolulu, Hawaii, 96813, United States|Creighton Diabetes Center, Omaha, Nebraska, 68131, United States|AHS Oklahoma Physician Group, Tulsa, Oklahoma, 74104, United States|Covance Clinical Research Unit - Dr. Andrew Ahmann, Portland, Oregon, 927239, United States|Covance CRU, Austin, Texas, 78752, United States|Diabetes Glandular Disease Research Associates, San Antonio, Texas, 78229, United States|Flinders Medical Centre, Adelaide, South Australia, Australia|Lyell McEwin Hospital, North Western Adelaide, South Australia, Australia|ECRU, Box Hill, Melbourne, Victoria, Australia|School of Medicine and Pharmacology, Fremantle, Western Australia, 6160, Australia|Keough Institute, Nedands, Western Australia, 6009, Australia|Endocrinology Research Unit, Herston Road, QLD 4029, Australia|Endocrinology Department, St Leonards, NSW 2065, Australia|Royal Melbourn Hospital, Victoria, Australia|Middlemore Hospital, Otahuhu, Auckland, New Zealand|Lipid and Diabetes Research, Christchurch, New Zealand|Waikaito Hospital, Hamilton, New Zealand|Diabetes Centre, Wellington, New Zealand"
NCT05368402,Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.,https://clinicaltrials.gov/study/NCT05368402,TERMINATED,Type 1 Diabetes,DRUG: Ladarixin|OTHER: Placebo,Dompé Farmaceutici S.p.A,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Ospedale F. Spaziani Frosinone, Frosinone, 03100, Italy|Università Campus Bio-Medico di Roma (UCBM) Policlinico Universitario, Rome, 00128, Italy"
NCT01341587,Smart Glucose Meter Project,https://clinicaltrials.gov/study/NCT01341587,TERMINATED,Type 1 Diabetes|Type 2 Diabetes,DEVICE: Telcare Blood Glucose Meter (BGM),"University of Maryland, Baltimore","Maryland Industrial Partnerships|Telcare, Inc",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Maryland, Baltimore, Maryland, 21201, United States"
NCT00547482,The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study,https://clinicaltrials.gov/study/NCT00547482,TERMINATED,Type 2 Diabetes Mellitus|Overweight,DEVICE: TANTALUS(TM) System,"MetaCure (USA), Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Scripps Clinic Del Mar, La Jolla / San Diego, California, 92130, United States|Cedars Sinai, Los Angeles, California, 90048, United States|University of Colorado at Denver Health Sciences Center, Denver, Colorado, 80262, United States|Washington University School of Medicine in St. Louis, St. Louis, Missouri, 63110, United States|Kaleida Health, Diabetes-Endocrinology Center of Western New York, Buffalo, New York, 14209, United States|Comprehensive Weight Control Program Cornell Medical Center, New York, New York, 10021, United States|Mt. Sinai School of Medicine, NY, New York, 10029-6574, United States|University of Pennsylvania, Pennsylvania, Pennsylvania, 19104-3309, United States|Vanderbilt University School of Medicine, Nashville, Tennessee, 37232, United States|Diabetes and Glandular Disease Clinic (DGD), San Antonio, Texas, 78229, United States"
NCT01970462,Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery,https://clinicaltrials.gov/study/NCT01970462,TERMINATED,"Diabetes Mellitus, Type 2|Hyperglycemia",DRUG: Sitagliptin|DRUG: Placebo,Kathleen Dungan,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"The Ohio State University Wexner Medical Center, Columbus, Ohio, 43203, United States"
NCT04190277,Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy (DIABELOOP SP8),https://clinicaltrials.gov/study/NCT04190277,TERMINATED,"Diabetes Mellitus, Type 1|Closed-Loop",DEVICE: Open-loop condition|DEVICE: Closed-loop condition,Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète,,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Caen University Hospital, Caen, 14033, France|Sud Francilien Hospital, Corbeil-Essonnes, 91058, France|Grenoble University Hospital, Grenoble, 38043, France|Marseille - La Conception University Hospital, Marseille, 13005, France|Necker-Enfants Malades University Hospital, Paris, 75015, France|Reims University Hospital, Reims, 51092, France|Strasbourg University Hospital, Strasbourg, 67000, France|Toulouse - Purpan University Hospital, Toulouse, 31059, France|Toulouse - Rangueil University Hospital, Toulouse, 31059, France"
NCT03426345,Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02,https://clinicaltrials.gov/study/NCT03426345,TERMINATED,Gastroparesis|Diabetes Mellitus,DRUG: Placebo|DRUG: Relamorelin,Allergan,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"North Alabama Research Center, LLC, Athens, Alabama, 35611, United States|Synexus Clinical Research US - Simon Williamson Clinic, Birmingham, Alabama, 35211, United States|G & L Research, LLC, Foley, Alabama, 36535, United States|Alabama Medical Group, PC, Mobile, Alabama, 36608, United States|Synexus Clinical Research US, Inc., Tucson, Arizona, 85741, United States|Applied Research Center of Arkansas, Little Rock, Arkansas, 72212, United States|Unity Health - Searcy Medical Center, Searcy, Arkansas, 72143, United States|GW Research Inc., Chula Vista, California, 91910, United States|Diagnamics Inc., Encinitas, California, 92024, United States|Fresno Clinical Research Center, Fresno, California, 93720, United States|Torrance Clinical Research Institute, Inc., Lomita, California, 90717, United States|Tibor Rubin VA Medical Center, Long Beach, California, 90822, United States|Angel City Research Inc., Los Angeles, California, 90026, United States|Facey Medical Foundation, Mission Hills, California, 91345, United States|United Medical Doctors, Murrieta, California, 92563, United States|Stanford Hospital, Digestive Health Clinic, Palo Alto, California, 94304, United States|TriWest Research Associates, Poway, California, 92064, United States|Optimal Research California, San Diego, California, 92108, United States|Syrentis Clinical Research, Santa Ana, California, 92705, United States|New Hope Research Development, Whittier, California, 90603, United States|Synexus Clinical Research US, Inc. - Colorado Springs Family Practice, Colorado Springs, Colorado, 80909, United States|Gastroenterology Associates of Fairfield County, P.C., Bridgeport, Connecticut, 06824, United States|Visionary Investigators Network, Aventura, Florida, 33180, United States|Clinical Research of West Florida, Clearwater, Florida, 33765, United States|ALL Medical Research LLC, Cooper City, Florida, 33024, United States|Palmetto Research, LLC, Hialeah, Florida, 33016, United States|Vida Clinical Trials, Homestead, Florida, 33030, United States|Sanchez Clinical Research, Inc., Miami, Florida, 33157, United States|Gastroenterology Group of Naples, Naples, Florida, 34102, United States|Synexus, Pinellas Park, Florida, 33781, United States|Cleveland Clinic Florida - Weston, Weston, Florida, 33331, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30318, United States|Emory University, Atlanta, Georgia, 30322, United States|River Birch Research Alliance, LLC, Blue Ridge, Georgia, 30513, United States|Gwinnett Research Institute, LLC, Buford, Georgia, 30519, United States|iResearch Atlanta LLC, Decatur, Georgia, 30030, United States|Clinical Research Consultants of Atlanta, Suwanee, Georgia, 30024, United States|Rocky Mountain Diabetes and Osteoporosis Center, PA, Idaho Falls, Idaho, 83404-7596, United States|Synexus Clinical Research US, Inc., Chicago, Illinois, 60602, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|North Shore University Health System, Evanston, Illinois, 60201, United States|American Research, LLC, Jeffersonville, Indiana, 47130, United States|Gastroenterology of Southern Indiana, New Albany, Indiana, 47150, United States|Health Science Research Center, Pratt, Kansas, 67124, United States|WestGlen Gastrointestinal Consultants, Shawnee Mission, Kansas, 67214, United States|Kansas Medical Clinic, Topeka, Kansas, 66606, United States|Professional Research Network of Kansas, LLC, Wichita, Kansas, 67205, United States|Via Christi Clinic, PA, Wichita, Kansas, 67208, United States|Tri-State Gastroenterology, Crestview Hills, Kentucky, 41017, United States|WK Physicians Network, Bossier City, Louisiana, 71111, United States|Avant Research Associates LLC, Crowley, Louisiana, 70526, United States|Clinical Trials of SWLA, LLC, Lake Charles, Louisiana, 70601, United States|Tandem Clinical Research, Marrero, Louisiana, 70072, United States|Clinical Trials of America, Inc., West Monroe, Louisiana, 71291, United States|Trialspark - Sood, Bowie, Maryland, 20716, United States|Capital Diabetes and Endocrine Associates, Camp Springs, Maryland, 20746, United States|Metropolitan Gastroenterology Group PC, Chevy Chase Clinical Research, Chevy Chase, Maryland, 20815, United States|Woodholme Gastroenterology Associates, P.A., Glen Burnie, Maryland, 21061, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, 21742, United States|Meridian Clinical Research, LLC, Rockville, Maryland, 20854, United States|Commonwealth Clinical Studies, PLLC., Brockton, Massachusetts, 02302, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, 48047, United States|Aa Mrc Llc, Flint, Michigan, 48504, United States|Washington University in St. Louis, Saint Louis, Missouri, 63110, United States|Synexus Clinical Research US, Inc, Saint Louis, Missouri, 63141, United States|Heartland Clinical Research, Inc, Omaha, Nebraska, 68134, United States|USMA Clinical Research, LLC, Elizabeth, New Jersey, 07201, United States|Lovelace Scientific Resources, Inc., Albuquerque, New Mexico, 87108, United States|Synexus Clinical Research US, Inc., Jamaica, New York, 11432, United States|Winthrop-University Hospital, Mineola, New York, 11501, United States|Carolina Digestive Health Associates, PA, Davidson, North Carolina, 28036, United States|Kinston Medical Specialists, P.A., Kinston, North Carolina, 28501, United States|Diabetes and Endocrinology Consultants, PC, Morehead City, North Carolina, 28557, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28401, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, 27103, United States|Synexus Clinical Research US, Inc., Akron, Ohio, 44311, United States|Diabetes & Endocrinology Associates of Stark County, Inc., Canton, Ohio, 44718, United States|Synexus Clinical Research US - Cincinnati, Cincinnati, Ohio, 45236, United States|Synexus Clinical Research US, Inc, Cincinnati, Ohio, 45249, United States|The MetroHealth System MHS, Cleveland, Ohio, 44109-1998, United States|Digestive Disease & Surgery Institute, Cleveland, Ohio, 44195, United States|The Ohio State University, Wexner Medical Center, Columbus, Ohio, 43203, United States|Aventiv Research, Inc., Columbus, Ohio, 43213, United States|CIC America Clinical Inquest Center Ltd., Dayton, Ohio, 45409, United States|Hometown Urgent Care and Research, Dayton, Ohio, 45424, United States|Centennial Health-Synexus, Oklahoma City, Oklahoma, 73111, United States|Options Health Research, LLC, Tulsa, Oklahoma, 74104, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Allegheny Endocrinology Associates, Pittsburgh, Pennsylvania, 15212, United States|Guthrie Clinical Research, Sayre, Pennsylvania, 18840, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, 15478, United States|Preferred Primary Care Physicians, Uniontown, Pennsylvania, 15401, United States|Care Access Research, Warwick, Rhode Island, 02886, United States|Synexus Clinical Research US, Inc., Anderson, South Carolina, 29621, United States|Clinical Trials of South Carolina, Charleston, South Carolina, 29406, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|Clinsearch, Chattanooga, Tennessee, 37421, United States|Gastro One, Germantown, Tennessee, 38138, United States|East Tennessee Research Institute, Johnson City, Tennessee, 37604, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, 76012, United States|ClinRx Research, LLC, Carrollton, Texas, 75007, United States|Baylor College of Medicine Medical Center, Houston, Texas, 77030, United States|Biopharma Informatic Inc., Research Center, Houston, Texas, 77043, United States|Houston Endoscopy and Research Center, Inc., Houston, Texas, 77079, United States|Rodriguez Clinical Trials, Houston, Texas, 77083, United States|Sante Clinical Research, Kerrville, Texas, 78028, United States|Pinnacle Clinical Research, San Antonio, Texas, 78215, United States|Synexus Clinical Research US, Inc., San Antonio, Texas, 78229, United States|Digestive & Liver Disease Center of San Antonio, PLLC, San Antonio, Texas, 78233, United States|Dwayne O. Williams MD, Sugar Land, Texas, 77479, United States|Blue Ridge Medical Research, Lynchburg, Virginia, 24502, United States|Manassas Clinical Research Centre, Manassas, Virginia, 20110, United States|VA Medical Center McGuire VAMC, Richmond, Virginia, 23249, United States|Washington Gastroenterology PLLC, Tacoma, Washington, 98405, United States|Maffei Centro Medico-Investigacion Clinica Aplicada, C.a.b.a., Buenos Aires Province, C1425AGC, Argentina|Hospital Sirio Libanes, Caba, Buenos Aires Province, C1419AHN, Argentina|Centro de Investigaciones Medicas Mar del Plata SRL, Mar del Plata, Buenos Aires Province, B7600FYK, Argentina|Instituto Privado de Investigaciones Clínicas de Córdoba, Córdoba, Cordoba, X5000AAW, Argentina|Instituto de Investigaciones Clinicas de Rosario, Rosario, Santa Fe, 2000, Argentina|Instituto de Hematologia y Medicina Clinica Dr. Ruben Davoli, Rosario, Santa Fe, S200CFK, Argentina|Clinica Mayo - Infectious DiseasesClínica Mayo de Urgencias, San Miguel de Tucuman, Tucuman, 4000, Argentina|CIPREC, Ciudad Autonoma de Buenos Aires, 1119, Argentina|Centro Universitario de Investigacion en Farmacologia Clinic, Corrientes, W3410AVV, Argentina|CIDIM - Centro Integral de Diagnóstico por Imágenes Marchegian, Córdoba, X5000BNB, Argentina|Ordination, Sankt Stefan, Steiermark, 8511, Austria|VIVIT Institute, am LKH Feldkirch, Feldkirch, Vorarlberg, 6807, Austria|Privatklinik Wehrle-Diakonissen, Salzburg, 5020, Austria|Oö. Gesundheits- und Spitals-AG/LKH Steyr, Steyr, 4400, Austria|AZ Sint Lucas Brugge, Brugge, Antwerpen, 2650, Belgium|Universitair Ziekenhuis Antwerpen, Gastro-Enterologie,, Edegem, Antwerp, 2650, Belgium|UZ Brussel, Jette, Brussel, 1090, Belgium|Hospital Universitario Walter Cantidio, Fortaleza, Ceara, 60430-372, Brazil|Centro de Pesquisa Clinica do Brasil, Brasilia, Distrito Federal, 71625175, Brazil|Hospital Universitario Joao de Barros Barreto, Belem, Para, 66073-000, Brazil|Núcleo de Pesquisa Clínica do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, 90430-001, Brazil|Instituto Catarinense de Endocrinologia e Diabetes (ICED), Joinville, Santa Catarina, 89201-260, Brazil|Scentryphar Pesquisa Clinica Ltda, Campinas, Sao Paulo, 13020-431, Brazil|Instituto de Pesquisa Clinica em Campinas, Campinas, Sao Paulo, 13060-080, Brazil|CPQuali Pesquisa Clinica Ltda, Santa Cecília, Sao Paulo, 01228-000, Brazil|Instituto de Estudos E Persquisas Clinicas do Ceará - IEP/CE - Oncology, Fortaleza, 60160-230, Brazil|Instituto de Pesquisa ClÍnica e Medicina AvanCada Ltda, SÃo Paulo, 01223-001, Brazil|University of Calgary, Calgary, Alberta, T2N 2T9, Canada|Alberta Diabetes Institute, Edmonton, Alberta, T6G 2E1, Canada|Gordon and Leslie Diamond Health Care Centre, Vancouver, British Columbia, V5Z1M9, Canada|Eastern Health, St. John's, Newfoundland and Labrador, A1B 3V6, Canada|South Shore Medical Arts, Bridgewater, Nova Scotia, B4V 2V6, Canada|The Ottawa Hospital, Ottawa, Ontario, K1H 7W9, Canada|Sunnybrook Health Science Centre, Toronto, Ontario, M4N 3M5, Canada|Toronto Western Hospital, University Health Network, Toronto, Ontario, M5T 2S8, Canada|Toronto Liver Centre, Toronto, Ontario, M6H 3M1, Canada|Toronto Digestive Disease Associates, Vaughan, Ontario, L4L 4YZ, Canada|CISSS de la Monteregie-Centre, Greenfield Park, Quebec, J4V 2H1, Canada|Recherche GCP Research, Montreal, Quebec, H1M 1B1, Canada|Centre Hospitalier de l'Universite de Montreal - CHUM, Montreal, Quebec, H2X 0A9, Canada|Central Alberta Research Centre, Red Deer, T4N 6V7, Canada|Centro Cardiovascular Colombiano Clínica Santa María, Medellin, Antioquia, 050034, Colombia|Rodrigo Botero S.A.S., Medellin, Antioquia, 50030, Colombia|Centro Cardiovascular y de Diabetes, Barranquilla, Atlantico, 080020, Colombia|Fundacion Bios, Barranquilla, Atlantico, 080020, Colombia|Asociación Colombiana de Diabetes, Bogotá, Cundinamarca, 111311, Colombia|Healthy Medical Center, Zipaquira, Cundinamarca, 250252, Colombia|Medplus Mp, Bogota, Distrito Capital De Bogotá, 110221, Colombia|Endocare Ltda., Bogota, Distrito Capital De Bogotá, 111111, Colombia|Fundacion Centro de Investigaciones Clinicas CARDIOMET, Pereira, Risaralda, 660002, Colombia|IPS Centro Medico Julian Coronel S.A, Cali, Valle Del Cauca, 760035, Colombia|Centro Medico Imbanaco de Cali S.A., Cali, Valle Del Cauca, 760042, Colombia|Gastroenheden, Hvidovre hospital, Hvidovre, Copenhagen, 2605, Denmark|Endocrinology, Aalborg University Hospital, Aalborg, DK-9000, Denmark|Center for Clinical Metabolic Research, Hellerup, 2900, Denmark|Klinische Forschung Karlsruhe GmbH, Karlsruhe, Baden-SWÃƒÂ¼rttemberg, 76199, Germany|Studienzentrum Schwittay, Böhlen, Saxony, 4564, Germany|Klinische Forschung Dresden GmbH, Dresden, Saxony, 1309, Germany|Clinical Research Unit, Giessen, 32392, Germany|Clinical Research Hamburg, Hamburg, 22143, Germany|Israelitisches Krankenhaus, Hamburg, 22297, Germany|KRH Klinikum Siloah, Hannover, 30459, Germany|Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger, Heves, H-3300, Hungary|BKS Research Kft Synexus AS, Hatvan, Heves, 3000, Hungary|Hetenyi Geza Hospital, Szolnok, Jász-Nagykun-Szolnok, H-5004, Hungary|Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, Zala, H-8900, Hungary|Synexus Budapest DRS, Budapest, 1036, Hungary|Strázsahegy Gyógyszertár Medicina, Budapest, H1171, Hungary|SYNEXUS Magyarorszag Kft Debrecen A.S., Debrecen, 4025, Hungary|Synexus Magyarország kft. Gyula DRS, Gyula, 5700, Hungary|Szegedi Tudomanyegyetem, Szeged, H-6720, Hungary|Synexus Magyarorszag Kft, Zalaegerszeg, 8900, Hungary|Polana-D, Daugavpils, 5401, Latvia|Kraslava Hospital, Kraslava, 5601, Latvia|Pauls Stradins Clinical University Hospital, Endokrinologijas nodala, Riga, 1002, Latvia|Digestive Diseases Centre GASTRO, Riga, 1006, Latvia|Medical and Nutritional Trials, Cuauhtemoc, Cdmx, 06700, Mexico|Centro Especializado en Diabetes, Obesidad y Prevencion de E - Endocrinology, Mexico, Distrito Federal, 11650, Mexico|Centro de Atención e Investigación en Factores de Riesgo Car, Mexico, Distrito Federal, 14000, Mexico|Clinicos Asociados BOCM SC, Portales, Distrito Federal, 03300, Mexico|Unidad de Investigacion Clinica Cardiometabolica de Occidente, Guadalajara, Jalisco, 44150, Mexico|Consultorio Medico, Guadalajara, Jalisco, C.P. 44210, Mexico|Unidad de Investigación Clínica en Medicina S.C., Guadalajara, Jalisco, C.P. 44670, Mexico|Centro de Desarrollo Biomedico S.C.P., Mérida, Yucatan, 97070, Mexico|Centro de Investigacion Cardiometabolica de Aguascalientes SA de CV, Aguascalientes, 20230, Mexico|Hospital Cardiologica Aguascalientes, Aguascalientes, 20230, Mexico|Dioderm Instituto de Investigacion, Durango, 34060, Mexico|Sociedad de Metabolismo y Corazon, S.C., Veracruz, C.P. 91900, Mexico|Saint-Petersburg City Pokrovskaya Hospital, St-Petersburg, Leningrad Region, 199106, Russian Federation|Scientific Institute of Clinical and Experimental Lymphology, Novosibirsk, Novosibirsk Oblast, 630117, Russian Federation|GUZ Saratov City Clinical Hospital 9, Saratov, Saratov Region, 410030, Russian Federation|Nizhegorodsky Regional Clinical Hospital named after N. A. Semashko, Nizhny Novgorod, Volga, 603126, Russian Federation|Kazan State Medical University, Kazan, 420012, Russian Federation|FSBI National medical endocrinology research centre, Moscow, 117036, Russian Federation|Moscow Regional Research Clinical Institute named by MF Vladimirski, Moscow, 129110, Russian Federation|Rostov on Don, Rostov on Don, 344019, Russian Federation|Rostov State Medical University, Rostov-on-Don, 344022, Russian Federation|North-Western State Medical University named after I. I. Mechnikov, Saint-Petersburg, 191015, Russian Federation|Saratov City Clinical Hospital 12, Saratov, 410039, Russian Federation|FARMOVS, Bloemfontein, Free State, 9301, South Africa|Wits Clinical Research, Johannesburg, Gauteng, 2193, South Africa|Synexus Stanza Clinical Research Centre, Pretoria, Gauteng, 0122, South Africa|Watermeyer Clinical Research Site, Silverton, Gauteng, 184, South Africa|Synexus Helderberg Clinical Research Centre, Cape Town, Western Cape, 7130, South Africa|TREAD Research, Cape Town, 7500, South Africa|MAC Clinical Research Manchester, Manchester, Greater Manchester, M13 9NQ, United Kingdom|Synexus Lancashire Dedicated Research Centre, Chorley, Lancashire, PR7 7NA, United Kingdom|Royal Oldham Hospital, Oldham, Lancashire, OL1 2JH, United Kingdom|MAC Research, Exchange House, Cannock, Staffordshire, WS11 0BH, United Kingdom|University Hospitals of North Midlands, Stoke on Trent, Staffordshire, ST6 8DG, United Kingdom|Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands, WV10 0QP, United Kingdom|MAC Clinical Research, Monarch House, Leeds, West Yorkshire, LS10 1DU, United Kingdom|MAC Research, Barnsley, S75 3DL, United Kingdom|MAC Clinical Research, Blackpool, FY2 0JH, United Kingdom|Synexus Wales Clinical Research Centre, Cardiff, CF15 9SS, United Kingdom|Mid Essex Hospital Services NHS Trust Broomfield Hospital, Chelmsford, CM1 7ET, United Kingdom|Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|Synexus Merseyside Dedicated Research Centre, Liverpool, L22 0LG, United Kingdom|MAC Clinical Research, Liverpool, L34 1BH, United Kingdom|Wingate Institute of Neurogastroenterology and Barts Health Trust and the Royal London Hospital, London, E1 2AJ, United Kingdom|MAC Clinical Research, GAC House, Manchester, M13 9NQ, United Kingdom|Synexus Manchester Clinical Research Centre, Manchester, M15 6SX, United Kingdom|Royal Victoria Infirmary: Clinical Research Facility, Newcastle upon Tyne, NE7 7DN, United Kingdom|Biomedical Research Centre, Nottingham, NG7 2UH, United Kingdom|Synexus Hexham Dedicated Research Centre, Stockton-on-Tees, TS19 8PE, United Kingdom|Synexus North Tees Clinical Research Centre, Stockton-on-Tees, TS19 8PE, United Kingdom"
NCT02745821,Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02745821,TERMINATED,Diabetes Mellitus|Coronary Artery Disease,"DEVICE: Pressure Wire Certus, St. Jude Medical, USA",Ottawa Heart Institute Research Corporation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada"
NCT03420781,A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03,https://clinicaltrials.gov/study/NCT03420781,TERMINATED,Gastroparesis|Diabetes Mellitus,DRUG: Placebo|DRUG: Relamorelin,Allergan,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"North Alabama Research Center, LLC, Athens, Alabama, 35611, United States|Digestive Health Specialist of the South East, Dothan, Alabama, 36305, United States|G & L Research, LLC, Foley, Alabama, 36535, United States|Alabama Medical Group, PC, Mobile, Alabama, 36608, United States|Del Sol Research Management, LLC, Chandler, Arizona, 85224, United States|Phoenix Clinical LLC., Phoenix, Arizona, 85014, United States|Del Sol Research Management, LLC, Tucson, Arizona, 85712, United States|Preferred Research Partners, Inc., Little Rock, Arkansas, 72211, United States|Applied Research Center of Arkansas, Little Rock, Arkansas, 72212, United States|Arkansas Gastroenterology, North Little Rock, Arkansas, 72117, United States|Unity Health - Searcy Medical Center, Searcy, Arkansas, 72143, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|GW Research Inc, Chula Vista, California, 91910, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, 92879, United States|Aurora Care Clinic, LLC, Costa Mesa, California, 92627, United States|Diagnamics Inc., Encinitas, California, 92024, United States|VVCRD Research, Garden Grove, California, 92845, United States|University of California San Diego, La Jolla, California, 92037, United States|Om Research LLC, Lancaster, California, 93534, United States|Torrance Clinical Research Institute, Inc., Lomita, California, 90717, United States|Angel City Research Inc., Los Angeles, California, 90026, United States|TriWest Research Associates, Poway, California, 92064, United States|Medical Associates Research Group, Inc, San Diego, California, 92123, United States|Syrentis Clinical Research, Santa Ana, California, 92705, United States|Upland Clinical Research, Upland, California, 91786, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, 80907, United States|Synexus Clinical Research US, Inc. - Colorado Springs Family Practice, Colorado Springs, Colorado, 80909, United States|Gastroenterology Associates of Fairfield County, P.C., Bridgeport, Connecticut, 06606, United States|TrialSpark, Inc., Washington, District of Columbia, 20017, United States|Innovative Research of West FL, Inc., Clearwater, Florida, 33756, United States|West Central Gastroenterology, Clearwater, Florida, 33756, United States|Clinical Research of West Florida, Clearwater, Florida, 33765, United States|ALL Medical Research LLC, Cooper City, Florida, 33024, United States|Top Medical Research, Cutler Bay, Florida, 33189, United States|Palmetto Research, LLC, Hialeah, Florida, 33016, United States|Vida Clinical Trials, Homestead, Florida, 33030, United States|Nature Coast Clinical Research, Inverness, Florida, 34452, United States|Panax Clinical Research, LLC., Miami Lakes, Florida, 33014, United States|Savin Medical Group LLC, Miami Lakes, Florida, 33014, United States|APF Research LLC, Miami, Florida, 33134, United States|AMPM Research Clinic, Miami, Florida, 33169, United States|Advanced Medical Research Institute, Miami, Florida, 33174, United States|Florida Research Center, Inc., Miami, Florida, 33174, United States|American Research Institute, Inc, Miami, Florida, 33175, United States|Synexus, Pinellas Park, Florida, 33781, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30318, United States|Emory University, Atlanta, Georgia, 30322, United States|River Birch Research Alliance, LLC, Blue Ridge, Georgia, 30513, United States|Gwinnett Research Institute, LLC, Buford, Georgia, 30519, United States|Summit Clinical Research, LLC., Carnesville, Georgia, 30521, United States|iResearch Atlanta LLC, Decatur, Georgia, 30030, United States|Infinite Clinical Trials, Riverdale, Georgia, 30274, United States|Clinical Research Consultants of Atlanta, Suwanee, Georgia, 30024, United States|Rocky Mountain Diabetes and Osteoporosis Center, PA, Idaho Falls, Idaho, 83404-7596, United States|Southwest Gastroenterology, Oak Lawn, Illinois, 60453, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, 47714, United States|American Research, LLC, Jeffersonville, Indiana, 47130, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|Health Science Research Center, Pratt, Kansas, 67124, United States|WestGlen Gastrointestinal Consultants, Shawnee Mission, Kansas, 67214, United States|Cotton-O'Neil Clinical Research Center - Digestive Health, Topeka, Kansas, 66606, United States|Kansas Medical Clinic, Topeka, Kansas, 66606, United States|Professional Research Network of Kansas, LLC, Wichita, Kansas, 67205, United States|Via Christi Clinic, PA, Wichita, Kansas, 67208, United States|Tri-State Gastroenterology, Crestview Hills, Kentucky, 41017, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Delta Research Partners, Bastrop, Louisiana, 71220, United States|WK Physicians Network, Bossier City, Louisiana, 71111, United States|Avant Research Associates LLC, Crowley, Louisiana, 70526, United States|Cronola LLC, Houma, Louisiana, 70360, United States|Clinical Trials of SWLA, LLC, Lake Charles, Louisiana, 70601, United States|Tandem Clinical Research, Marrero, Louisiana, 70072, United States|New Orleans Research Institute - Metropolitan Gastroenterology Associates, Metairie, Louisiana, 70006, United States|Clinical Trials of America, Inc., West Monroe, Louisiana, 71291, United States|Trialspark - Silverman, Bowie, Maryland, 20716, United States|Gastro Center of Maryland, Columbia, Maryland, 21045, United States|Frederick Gastroenterology Associates, PA an Elligo Health Research Site, Frederick, Maryland, 21701, United States|Woodholme Gastroenterology Associates, P.A., Glen Burnie, Maryland, 21061, United States|Meridian Clinical Research, LLC, Rockville, Maryland, 20854, United States|Commonwealth Clinical Studies, PLLC., Brockton, Massachusetts, 02302, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, 48047, United States|Vida Clinical Studies, Dearborn, Michigan, 48124, United States|Aa Mrc Llc, Flint, Michigan, 48504, United States|National Clinical, LLC, Hamtramck, Michigan, 48212, United States|Gastroenterology Associates of Western Michigan, Wyoming, Michigan, 49519, United States|Minnesota Gastroenterology, P.A., Coon Rapids, Minnesota, 55446, United States|Montana Medical Research, Missoula, Montana, 59808, United States|Methodist Physicians Clinic Diabetes and Endocrine Specialists, Omaha, Nebraska, 68114, United States|Heartland Clinical Research, Inc, Omaha, Nebraska, 68134, United States|Excel Clinical Research, Las Vegas, Nevada, 89109, United States|Clinical Research of South Nevada, Las Vegas, Nevada, 89121, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, 89123, United States|Digestive Disease Specialists, Las Vegas, Nevada, 89128, United States|Palm Research Center, Las Vegas, Nevada, 89148, United States|Garden State Endocrinology, Brick, New Jersey, 08723, United States|AGA Clinical Research Associates LLC, Egg Harbor Township, New Jersey, 08234, United States|Lovelace Scientific Resources, Inc., Albuquerque, New Mexico, 87108, United States|Long Island Gastrointestinal Research Group LLP, Great Neck, New York, 11023, United States|Synexus Clinical Research US, Inc., Jamaica, New York, 11432, United States|United Health Services Hospitals, Inc., Johnson City, New York, 13790, United States|Asheville Gastroenterology Associates, Asheville, North Carolina, 28801, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7080, United States|Carolina Digestive Health Associates, PA, Concord, North Carolina, 28025, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, 28304, United States|Triad Clinical Trials, Greensboro, North Carolina, 27410, United States|Vidant Multispeciality Clinic - Kinston, Kinston, North Carolina, 28501, United States|Diabetes and Endocrinology Consultants, PC, Morehead City, North Carolina, 28557, United States|PMG Research Salisbury, Salisbury, North Carolina, 28144, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28401, United States|Trial Management Associates, LLC, Wilmington, North Carolina, 28403, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, 27103, United States|The Center for Clinical Research, Winston-Salem, North Carolina, 27103, United States|Dayton Gastroenterology, Inc., Beavercreek, Ohio, 45440, United States|Diabetes & Endocrinology Associates of Stark County, Inc., Canton, Ohio, 44718, United States|Synexus Clinical Research US - Cincinnati, Cincinnati, Ohio, 45236, United States|Endocrinology Research Associates, Inc., Columbus, Ohio, 43201, United States|The Ohio State University, Wexner Medical Center, Columbus, Ohio, 43203, United States|Aventiv Research, Inc., Columbus, Ohio, 43213, United States|Hometown Urgent Care and Research, Columbus, Ohio, 43214, United States|CIC America Clinical Inquest Center Ltd., Dayton, Ohio, 45409, United States|Hometown Urgent Care and Research, Dayton, Ohio, 45424, United States|Premier Clinical Research d.b.a. STAT Research, Franklin, Ohio, 45005, United States|Family Practice Center of Wadsworth, Inc. DBA New Venture Medical Research, Wadsworth, Ohio, 44281, United States|Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, 73112, United States|Memorial Clinical Research, Oklahoma City, Oklahoma, 73120, United States|Options Health Research, LLC, Tulsa, Oklahoma, 74104, United States|Northwest Gastroenterology Clinic, LLC, Portland, Oregon, 97210, United States|Family Medical Associates, Research Department, Levittown, Pennsylvania, 19056, United States|Allegheny Endocrinology Associates, Pittsburgh, Pennsylvania, 15212, United States|Preferred Primary Care Physicians, Inc., Pittsburgh, Pennsylvania, 15236, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, 15478, United States|Montgomery Medical, Inc., Smithfield, Pennsylvania, 15478, United States|Preferred Primary Care Physicians, Uniontown, Pennsylvania, 15401, United States|Synexus Clinical Research US, Inc., Anderson, South Carolina, 29621, United States|Synexus Clinical Research US, Inc, Anderson, South Carolina, 29621, United States|Clinical Trials of South Carolina, Charleston, South Carolina, 29406, United States|Gastroenterology Associates, PA, Greenville, South Carolina, 29615, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|Clinsearch, Chattanooga, Tennessee, 37421, United States|Gastro One, Germantown, Tennessee, 38138, United States|Quality Medical Research, Nashville, Tennessee, 37211, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, 76012, United States|Avant Research Associates,LLC, Austin, Texas, 78704, United States|ClinRx Research, LLC, Carrollton, Texas, 75007, United States|Synexus Clinical Research US, Inc., Dallas, Texas, 75234, United States|Biopharma Informatic Inc., Research Center, Houston, Texas, 77043, United States|Rodriguez Clinical Trials, Houston, Texas, 77083, United States|Amir Ali Hassan, MD, PA, Houston, Texas, 77089, United States|Sante Clinical Research, Kerrville, Texas, 78028, United States|Pinnacle Clinical Research, San Antonio, Texas, 78215, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, 78229, United States|Southern Star Research Institute, LLC, San Antonio, Texas, 78229, United States|Synexus Clinical Research US, Inc., San Antonio, Texas, 78229, United States|Advanced Research Institute, Inc., Ogden, Utah, 84405, United States|Advanced Clinical Research, West Jordan, Utah, 84088, United States|Verity Research Inc., Fairfax, Virginia, 22031, United States|Manassas Clinical Research Centre, Manassas, Virginia, 20110, United States|Cardinal Internal Medicine Associates, PC, Woodbridge, Virginia, 22192, United States|Washington Gastroenterology PLLC, Tacoma, Washington, 98405, United States|West Virginia University, Morgantown, West Virginia, 26506, United States|Maffei Centro Medico-Investigacion Clinica Aplicada, C.a.b.a., Buenos Aires Province, C1425AGC, Argentina|Hospital Sirio Libanes, Caba, Buenos Aires Province, C1419AHN, Argentina|Centro de Investigaciones Medicas Mar del Plata, Mar del Plata, Buenos Aires Province, B7600FYK, Argentina|Instituto Privado de Investigaciones Clínicas de Córdoba, Córdoba, Cordoba, X5000AAW, Argentina|Instituto de Investigaciones Clinicas de Rosario, Rosario, Santa Fe, 2000, Argentina|Instituto de Hematologia y Medicina Clinica Dr. Ruben Davoli, Rosario, Santa Fe, S200CFK, Argentina|Clinica Mayo de Urgencias Medicas Cruz Blanca SRL, San Miguel de Tucuman, Tucuman, 4000, Argentina|CIPREC, Ciudad Autonoma de Buenos Aires, 1119, Argentina|Centro Universitario de Investigacion en Farmacologia Clinic, Corrientes, W3410AVV, Argentina|Nepean Hospital, Kingswood, New South Wales, 2747, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Ordination, Sankt Stefan ob Stainz, Styria, 8511, Austria|VIVIT Institute, am LKH Feldkirch, Feldkirch', Vorarlberg, 6807, Austria|Privatklinik Wehrle-Diakonissen, Salzburg, 5020, Austria|Landeskrankenhaus Steyr, Steyr, 4400, Austria|Universitair Ziekenhuis Antwerpen, Gastro-Enterologie,, Edegem, Antwerp, 2650, Belgium|UZ Brussel, Jette, Brussel, 1090, Belgium|AZ Sint Lucas Brugge, Brugge, West-Vlaanderen, 8310, Belgium|Hospital Universitário Walter Cantídio, Fortaleza, Ceara, 60430-370, Brazil|Instituto de Estudos e Pesquisas Clinicas do Ceará IEP/CE - Oncology, Fortaleza, Ceará, 60160-230, Brazil|Centro de Pesquisa Clinica do Brasil, Brasilia, Distrito Federal, 71625175, Brazil|Núcleo de Pesquisa Clínica do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, 90430-001, Brazil|Instituto Catarinense de Endocrinologia e Diabetes (ICED), Joinville, Santa Catarina, 89201-260, Brazil|Scentryphar Pesquisa Clinica Ltda, Campinas, Sao Paulo, 13020-431, Brazil|Instituto de Pesquisa Clinica de Campinas, Campinas, Sao Paulo, 13060904, Brazil|CPQuali Pesquisa Clinica Ltda, Santa Cecília, São Paulo, 01228-000, Brazil|Hospital Universitário João de Barros Barreto, Belém, 66073-000, Brazil|IPEC-Instituto de Pesquisa Clinica, Sao Paulo, 01223-001, Brazil|MHAT Yuliya Vrevska Byala, Byala, Ruse, 7100, Bulgaria|UMHAT - Kaspela- EOOD, Plovdiv, 4002, Bulgaria|University of Calgary, Calgary, Alberta, T2N 2T9, Canada|Alberta Diabetes Institute, Edmonton, Alberta, T6G 2E1, Canada|Central Alberta Research Centre, Red Deer, Alberta, T4N 6V7, Canada|Vancouver General Hospital, Vancouver, British Columbia, V5Z 1M9, Canada|South Shore Medical Arts, Bridgewater, Nova Scotia, B4V 2V6, Canada|The Ottawa Hospital, Ottawa, Ontario, K1H 7W9, Canada|Toronto Digestive Disease Associates, Vaughan, Ontario, L4L 4YZ, Canada|Recherche GCP Research, Montreal, Quebec, H1M 1B1, Canada|Centro Cardiovascular Colombiano Clínica Santa María, Medellin, Antioquia, 050034, Colombia|Rodrigo Botero S.A.S., Medellín, Antioquia, 050030, Colombia|Centro Cardiovascular y de Diabetes, Barranquilla, Atlantico, 080020, Colombia|Fundacion BIOS, Barranquilla, Atlantico, 080020, Colombia|Endocare Ltda., Bogotá, Cundinamarca, 111111, Colombia|Healthy Medical Center, Zipaquirá, Cundinamarca, 250252, Colombia|Medplus Medicina Prepagada, Bogota, Distrito Capital De Bogota, 110221, Colombia|Asociación Colombiana de Diabetes, Teusaquillo, Distrito Capital De Bogotá, 111311, Colombia|Fundacion Centro de Investigaciones Clinicas CARDIOMET, Pereira, Risaralda, 660002, Colombia|Centro Medico Imbanaco de Cali S.A., Cali, Valle Del Cauca, 760001, Colombia|IPS Centro Medico Julian Coronel S.A, Cali, Valle Del Cauca, 760035, Colombia|Gentofte Hospital, Hellerup, Copenhagen, 2900, Denmark|Gastroenheden, Hvidovre hospital, Hvidovre, Copenhagen, 2650, Denmark|Klinische Forschung Karlsruhe GmbH, Karlsruhe, Baden-Wuertemberg, 76137, Germany|Studienzentrum Schwittay, Böhlen, Saxony, 4564, Germany|Klinische Forschung Dresden GmbH, Dresden, Saxony, 1309, Germany|Clinical Research Hamburg, Hamburg, 22143, Germany|Israelitisches Krankenhaus, Hamburg, 22297, Germany|KRH Klinikum Siloah, Hannover, 30459, Germany|First Department of Medicine, University of Szeged, Szeged, CsonfrÃ¡d, 6720, Hungary|Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger, Heves, H-3300, Hungary|Hetenyi Geza Hospital, Tószeg, Jász-Nagykun-Szolnok, H-5004, Hungary|Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, Zala, H-8900, Hungary|Synexus Budapest DRS, Budapest, 1036, Hungary|Strázsahegy Gyógyszertár Medicina, Budapest, H1171, Hungary|Kumudini Devi Diabetes Research Center; Ramdevrao Hospital, Hyderabad, Andhra Pradesh, 500072, India|King George Hospital, Visakhapatnam, Andhra Pradesh, 530002, India|Dr. Jivraj Mehta Smarak Health Foundation, Bakeri Medical Research Centre, Ahmedabad, Gujarat, 380007, India|Victoria Hospital, Bangalore, Karnataka, 560002, India|Life Care Hospital & Research Centre, Bangalore, Karnataka, 560092, India|Diacon Hospital and research Center - Diabetology, Bengaluru, Karnataka, 359-360, India|Rajalakshmi Hospital, Bengaluru, Karnataka, 560097, India|Vinaya Hospital & Research Centre, Mangalore, Karnataka, 575003, India|Bhatia Hospital, Mumbai, Maharashtra, 400007, India|B. J. Government Medical College and Sassoon General Hospitals, Pune, Maharashtra, 411001, India|Universal Hospital, Pune, Maharashtra, 411011, India|Noble Hospital, Pune, Maharashtra, 411013, India|S.R. Kalla (SRK) Memorial Gastro & General Hospital, Jaipur, Rajasthan, 302001, India|Diabetic Thyroid and Endocrine Centre, Jaipur, Rajasthan, 302006, India|Marudhar Hospital, Jaipur, Rajasthan, 302012, India|Eternal Hospital - Diabetology, Jaipur, Rajasthan, 302017, India|SMS Hospital, Jaipur, Rajasthan, 302017, India|Kovai Diabetes Speciality Centre, Coimbatore, Tamil Nadu, 641009, India|Arthur Asirvatham Hospital, Madurai, Tamil Nadu, 625020, India|M. V Hospital & Research Centre, Lucknow, Uttar Prandesh, 226003, India|Sir Ganga Ram Hospital, New Delhi, 110060, India|Bnai Zion Medical Center, Haifa, 31048, Israel|Endocrinology & Diabetes Center, Safed, 13100, Israel|Chonbuk National University Hospital, Jeonju, Jeollabuk-Do, 561-712, Korea, Republic of|Diabetes Center, Seoul, Nowon-gu, 01757, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Kraslava Hospital, Kraslava, Kraslavas Nov., 5601, Latvia|Polana-D, Daugavpils, LV5401, Latvia|Pauls Stradins Clinical University Hospital, Endokrinologijas nodala, Riga, 1002, Latvia|Digestive Diseases Centre GASTRO, Riga, 1006, Latvia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, 5460, Malaysia|Universiti Sains Malaysia, Kubang Kerian, 16150, Malaysia|Hospital Taiping, Taiping, 34000, Malaysia|Mentrials SA DE CV, Cuauhtemoc, Cdmx, 06700, Mexico|Clinicos Asociados BOCM SC, Mexico, Distrito Federal, 03300, Mexico|Centro Especializado en Diabetes, Obesidad y Prevencion de E - Endocrinology, Mexico, Distrito Federal, 11650, Mexico|Centro de Investigación y Atención de Diabetes - Endocrinología y Nutrición, Durango, Guillermina, 34270, Mexico|Unidad de Investigacion Clinica Cardiometabolica de Occidente, S.C., Guadalajara, Jalisco, 44150, Mexico|Consultorio Medico, Guadalajara, Jalisco, C.P. 44210, Mexico|Unidad de Investigación Clínica en Medicina S.C., Guadalajara, Jalisco, C.P. 44670, Mexico|Centro de Atención e Investigación en Factores de Riesgo Car, Mexico, Mexico DF, 14000, Mexico|Centro de Desarrollo Biomédico S.C.P, Mérida, Yucatán, 97070, Mexico|Centro de Investigacion Cardiometabolica de Aguascalientes SA de CV, Aguascalientes, 20230, Mexico|Hospital Cardiologica Aguascalientes, Aguascalientes, 20230, Mexico|Dioderm Instituto de Investigacion, Durango, 34060, Mexico|Sociedad de Metabolismo y Corazon, S.C., Veracruz, 91900, Mexico|West Visayas State University Medical Center, IloIlo City, IloIlo, 5000, Philippines|St. Luke's Medical Center, Quezon City, Metro Manila, 1100, Philippines|Cardinal Santos Medical Center, San Juan City, Metro Manila, 1502, Philippines|Manila Doctors Hospital, Ermita, Manila, Metropolitan Manila, 1000, Philippines|San Juan De Dios Educational Foundation, Inc., Pasay, Metropolitan Manila, 1300, Philippines|Ospital ng Makati, Makati City, NCR, 1218, Philippines|Perpetual Succor Hospital, Cebu City, 6000, Philippines|NZOZ Vita Diabetica - Malgorzata Buraczyk, Bialystok, Podlaski, 15-798, Poland|Endoskopia Sp. Z O.O., Sopot, Pomorskie, 81-756, Poland|Centrum Medyczne Lukamed, Chojnice, 89-600, Poland|Specjalistyczny Gabinet Neurologiczny Marta Banach, Krakow, 30-539, Poland|Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska, Wroclaw, 51-162, Poland|Saint-Petersburg City Pokrovskaya Hospital, St-Petersburg, Leningrad Region, 199106, Russian Federation|Scientific Institute of Clinical and Experimental Lymphology, Novosibirsk, Novosibirskaya Oblast, 630117, Russian Federation|North-Western State Medical University named after I. I. Mechnikov, Saint-Petersburg, Sankt-Peterburg, 191015, Russian Federation|Nizhegorodsky Regional Clinical Hospital named after N. A. Semashko, Nizhny Novgorod, Volga, 603126, Russian Federation|Kazan State Medical University, Kazan, 420100, Russian Federation|FSBI National medical endocrinology research centre, Moscow, 117036, Russian Federation|Moscow Regional Research Clinical Institute named by MF Vladimirski, Moscow, 129110, Russian Federation|Rostov on Don, Rostov on Don, 344019, Russian Federation|Rostov State Medical University, Rostov-on-Don, 344022, Russian Federation|GUZ Saratov City Clinical Hospital 9, Saratov, 410030, Russian Federation|Saratov City Clinical Hospital 12, Saratov, 410039, Russian Federation|National University Hospital, Singapore, 119228, Singapore|Singapore General Hospital, Singapore, 169856, Singapore|Changi General Hospital, Singapore, 529889, Singapore|FARMOVS, Bloemfontein, Free State, 9301, South Africa|Wits Clinical Research, Johannesburg, Gauteng, 2193, South Africa|Synexus Stanza Clincal Reaserch Centre, Pretoria, Gauteng, 0122, South Africa|Watermeyer Clinical Research Site, Pretoria, Gauteng, 0184, South Africa|Synexus Helderberg Clinical Research Centre, Cape Town, Western Cape, 7130, South Africa|Phramongkutklao Hospital, Bangkok, 10400, Thailand|Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand|Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, 50200, Thailand|Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76008, Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine|Regional muniRegional municipal institution ""Chernivtsi's regional clinical hospital"", gastroenterological department, Higher state educational establishment of Ukraine ""Bukovinian state medical university"", department of internal medicine and infectious, Chernivtsi, 58001, Ukraine|Regional Public Organization ""Chernivtsi Regional Endocrinology Center"", Chernivtsi, 58022, Ukraine|State Institution Ukrainian State Research Institute of Medical and Social Problems of Disability of the Ministry of Health of Ukraine, Dnipro, 49027, Ukraine|Municipal nonprofit entity of Kharkiv municipal council, Kharkiv, 61037, Ukraine|L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine, Kharkiv, 61039, Ukraine|Clinical Endocrinology of SI ""V.Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine"", Kharkiv, 61070, Ukraine|Communal Institution Kherson City Clinical Hospital, Kherson, 73000, Ukraine|Limited Liability Company ""Medical and Diagnostic Center ""ADONIS Plus"", outpatient department, c. Kyiv, Kyiv, 2002, Ukraine|Kyiv clinical hospital on railway transport #2 of the ""Healthcare Centre"" branch of JSC ""Ukrainian Railway"", Kyiv, 3049, Ukraine|Medical Center Universal Clinic Oberig, Kyiv, 3057, Ukraine|Polyclinic of medical services and rehabilitation department of State Joint-Stock Holding Company Artem, day-patient unit, Kyiv, 4050, Ukraine|Odessa Railway Clinical Hospital of Branch of HC JSC Ukrzaliznytsia, Odessa National Medical University, Odesa, 65010, Ukraine|Communal Institution ""Odesa Regional Clinical Hospital"", Out-patient department, Odesa, 65025, Ukraine|Poltava Regional Clinical Hospital, Poltava, 36011, Ukraine|Ternopil University Hospital, Ternopil, 46000, Ukraine|Private Small-Scale Enterprise Medical Centre Pulse, Vinnytsia, 21001, Ukraine|Vinnytsia Regional Clinical highly specialized Endocrinology Centre, Vinnytsia, 21010, Ukraine|Municipal nonprofit entity ""Vinnytsia's city clinical hospital #1"", c. Vinnytsia, Vinnytsia, 21029, Ukraine|6th City Clinical Hospital, c. Zaporizhzhia, Zaporizhzhia, 69035, Ukraine|Municipal Institution, City Hospital #7, Zaporizhzhia, 69600, Ukraine|Biomedical Research Centre, Nottingham, East Midland, NG7 2UH, United Kingdom|MAC Clinical Research Manchester, Manchester, Greater Manchester, M13 9NQ, United Kingdom|Royal Oldham Hospital, Oldham, Lancashire, OL1 2JH, United Kingdom|MAC Research, Exchange House, Cannock, Staffordshire, WS11 0BH, United Kingdom|MAC Clinical Research, Monarch House, Leeds, West Yorkshire, LS10 1DU, United Kingdom|MAC Research, Barnsley, S75 3DL, United Kingdom|MAC Clinical Research, Kaman Court, Blackpool, FY2 0JH, United Kingdom|Mid Essex Hospital Services NHS Trust Broomfield Hospital, Chelmsford, CM1 7ET, United Kingdom|MAC Clinical Research, Liverpool, L34 1BH, United Kingdom|MAC Clinical Research, GAC House, Stockton-on-Tees, TS17 6EW, United Kingdom"
NCT02772887,Nutraceutical Citrulline in Pregnancy,https://clinicaltrials.gov/study/NCT02772887,TERMINATED,Type 2 Diabetes,DIETARY_SUPPLEMENT: L-Citrulline|OTHER: Placebo,University of Pittsburgh,,FEMALE,"CHILD, ADULT",,INTERVENTIONAL,"Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, 15213, United States"
NCT03383146,A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04,https://clinicaltrials.gov/study/NCT03383146,TERMINATED,Gastroparesis|Diabetes Mellitus,DRUG: Placebo|DRUG: Relamorelin,Allergan,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Pinnacle Research Group, Anniston, Alabama, 36207, United States|North Alabama Research Center, LLC, Athens, Alabama, 35611, United States|Simon Williamson Clinic, Birmingham, Alabama, 35211, United States|Digestive Health Specialist of the South East, Dothan, Alabama, 36305, United States|G & L Research, LLC, Foley, Alabama, 36535, United States|Avant Research Associates, Huntsville, Alabama, 35801, United States|Alabama Medical Group, PC, Mobile, Alabama, 36608, United States|Phoenix Clinical LLC., Phoenix, Arizona, 85014, United States|Del Sol Research Management, LLC, Tucson, Arizona, 85710, United States|Del Sol Research Management, LLC, Tucson, Arizona, 85712, United States|Synexus Clinical Research US, Inc., Tucson, Arizona, 85741, United States|Preferred Research Partners, Inc., Little Rock, Arkansas, 72211, United States|Applied Research Center of Arkansas, Little Rock, Arkansas, 72212, United States|Arkansas Gastroenterology, North Little Rock, Arkansas, 72117, United States|Unity Health - Searcy Medical Center, Searcy, Arkansas, 72143, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|GW Research Inc, Chula Vista, California, 91910, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, 92879, United States|Aurora Care Clinic, LLC, Costa Mesa, California, 92627, United States|TriWest Research Associates, El Cajon, California, 92020, United States|Diagnamics Inc., Encinitas, California, 92024, United States|VVCRD Research, Garden Grove, California, 92845, United States|University of California San Diego, La Jolla, California, 92037, United States|Om Research LLC, Lancaster, California, 93534, United States|Torrance Clinical Research Institute, Inc., Lomita, California, 90717, United States|Angel City Research Inc., Los Angeles, California, 90057, United States|Stanford Hospital, Palo Alto, California, 94304, United States|Optimal Research California, San Diego, California, 92108, United States|Medical Associates Research Group, Inc, San Diego, California, 92123, United States|Syrentis Clinical Research, Santa Ana, California, 92705, United States|Upland Clinical Research, Upland, California, 91786, United States|Synexus Clinical Research US, Inc., Vista, California, 92083, United States|New Hope Research Development, Whittier, California, 90603, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, 80907, United States|Synexus, Colorado Springs, Colorado, 80909, United States|Gastroenterology Associates of Fairfield County, P.C., Bridgeport, Connecticut, 06606, United States|Medical Research Center of Connecticut, LLC, Hamden, Connecticut, 06518, United States|Innovative Research of West FL, Inc., Clearwater, Florida, 33756, United States|Clinical Research of West Florida, Clearwater, Florida, 33765, United States|ALL Medical Research, LLC, Cooper City, Florida, 33024, United States|Top Medical Research, Cutler Bay, Florida, 33189, United States|Palmetto Research, LLC, Hialeah, Florida, 33016, United States|Vida Clinical Trials, Homestead, Florida, 33030, United States|Nature Coast Clinical Research, Inverness, Florida, 34452, United States|Savin Medical Group LLC, Miami Lakes, Florida, 33014, United States|APF Research LLC, Miami, Florida, 33134, United States|AMPM Research Clinic, Miami, Florida, 33169, United States|Advanced Medical Research Institute, Miami, Florida, 33174, United States|Florida Research Center, Inc., Miami, Florida, 33174, United States|American Research Institute, Inc, Miami, Florida, 33175, United States|Gastroenterology Group of Naples, Naples, Florida, 34102, United States|Sensible Healthcare, Ocoee, Florida, 34761, United States|Synexus, Pinellas Park, Florida, 33781, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30318, United States|River Birch Research Alliance, LLC, Blue Ridge, Georgia, 30513, United States|Gwinnett Research Institute, LLC, Buford, Georgia, 30519, United States|Summit Clinical Research, LLC., Carnesville, Georgia, 30521, United States|iResearch Atlanta LLC, Decatur, Georgia, 30030, United States|Infinite Clinical Trials, Riverdale, Georgia, 30274, United States|Clinical Research Consultants of Atlanta, Suwanee, Georgia, 30024, United States|Rocky Mountain Diabetes and Osteoporosis Center, PA, Idaho Falls, Idaho, 83404-7596, United States|North Shore University Health System, Evanston, Illinois, 60201, United States|Southwest Gastroenterology, Oak Lawn, Illinois, 60453, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, 47714, United States|Synexus Clinical Research US, Inc., Evansville, Indiana, 47714, United States|American Research, LLC, Jeffersonville, Indiana, 47130, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|Health Science Research Center, Pratt, Kansas, 67124, United States|WestGlen Gastrointestinal Consultants, Shawnee Mission, Kansas, 66217, United States|Cotton-O'Neil Clinical Research Center - Digestive Health, Topeka, Kansas, 66606, United States|Kansas Medical Clinic, Topeka, Kansas, 66606, United States|Professional Research Network of Kansas, LLC, Wichita, Kansas, 67205, United States|Via Christi Clinic, PA, Wichita, Kansas, 67208, United States|St. Elizabeth Healthcare â€"" Clinical Research Institute, Erlanger, Kentucky, 41018, United States|University of Louisville, Louisville, Kentucky, 40202, United States|WK Physicians Network, Bossier City, Louisiana, 71111, United States|Avant Research Associates LLC, Crowley, Louisiana, 70526, United States|Cronola LLC, Houma, Louisiana, 70360, United States|Clinical Trials of SWLA, LLC, Lake Charles, Louisiana, 70601, United States|Tandem Clinical Research, Marrero, Louisiana, 70072, United States|Clinical Trials of America, Inc., West Monroe, Louisiana, 71291, United States|Metropolitan Gastroenterology Group PC, Chevy Chase Clinical Research, Chevy Chase, Maryland, 20815, United States|Gastro Center of Maryland, Columbia, Maryland, 21045, United States|Frederick Gastroenterology Associates, PA an Elligo Health Research Site, Frederick, Maryland, 21701, United States|Woodholme Gastroenterology Associates, P.A., Glen Burnie, Maryland, 21061, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, 21742, United States|Meridian Clinical Research, LLC, Rockville, Maryland, 20854, United States|Clinical Research Institute of Michigan, Chesterfield, Michigan, 48047, United States|Vida Clinical Studies, Dearborn, Michigan, 48124, United States|Aa Mrc, Llc, Flint, Michigan, 48504, United States|National Clinical, LLC, Hamtramck, Michigan, 48212, United States|Gastroenterology Associates of Western Michigan, West Michigan Clinical Research Center, Wyoming, Michigan, 49519, United States|MNGI Digestive Health, Coon Rapids, Minnesota, 55446, United States|Synexus Clinical Research US, Inc., Richfield, Minnesota, 55423, United States|Synexus Clinical Research US, Inc, Saint Louis, Missouri, 63141, United States|Montana Medical Research, Missoula, Montana, 59808, United States|Diabetes and Endocrine Associates, P.C., Omaha, Nebraska, 68114, United States|Heartland Clinical Research, Inc, Omaha, Nebraska, 68134, United States|Excel Clinical Research, Las Vegas, Nevada, 89109, United States|Clinical Research of South Nevada - CROSN, Las Vegas, Nevada, 89121, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, 89123, United States|Digestive Disease Specialists, Las Vegas, Nevada, 89128, United States|Palm Research Center, Las Vegas, Nevada, 89135, United States|Garden State Endocrinology LLC, Brick, New Jersey, 08723, United States|Synexus Clinical Research US, Inc., Bridgeton, New Jersey, 08302, United States|AGA Clinical Research Associates, LLC, Egg Harbor Township, New Jersey, 08234, United States|Lovelace Scientific Resources, Inc., Albuquerque, New Mexico, 87108, United States|CHEAR Center LLC, Bronx, New York, 10455, United States|Long Island Gastrointestinal Research Group LLP, Great Neck, New York, 11023, United States|United Health Services Hospitals, Inc., Johnson City, New York, 13790, United States|Asheville Gastroenterology Associates, Asheville, North Carolina, 28801, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7080, United States|Carolinas Healthcare-Charlotte, Charlotte, North Carolina, 28204, United States|Carolina Digestive Health Associates, PA, Concord, North Carolina, 28025, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, 28304, United States|Triad Clinical Trials, Greensboro, North Carolina, 27410, United States|Vidant Multispeciality Clinic - Kinston, Kinston, North Carolina, 28501, United States|Diabetes and Endocrinology Consultants, PC, Morehead City, North Carolina, 28557, United States|PMG Research Salisbury, Salisbury, North Carolina, 28144, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28401, United States|Trial Management Associates, LLC, Wilmington, North Carolina, 28403, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, 27103, United States|The Center for Clinical Research, Winston-Salem, North Carolina, 27103, United States|Synexus Clinical Research US, Inc., Akron, Ohio, 44311, United States|Dayton Gastroenterology,Inc., Beavercreek, Ohio, 45440, United States|Diabetes & Endocrinology Associates of Stark County, Inc., Canton, Ohio, 44718, United States|Synexus Clinical Research US - Cincinnati, Cincinnati, Ohio, 45236, United States|Synexus Clinical Research US, Inc, Cincinnati, Ohio, 45249, United States|Endocrinology Research Associates, Inc., Columbus, Ohio, 43201, United States|The Ohio State University, Wexner Medical Center, Columbus, Ohio, 43203, United States|Aventiv Research, Inc., Columbus, Ohio, 43213, United States|Hometown Urgent Care and Research, Columbus, Ohio, 43214, United States|CIC America Clinical Inquest Center Ltd., Dayton, Ohio, 45409, United States|Hometown Urgent Care and Research, Dayton, Ohio, 45424, United States|Premier Clinical Research d.b.a. STAT Research, Franklin, Ohio, 45005, United States|Family Practice Center of Wadsworth, Inc., Wadsworth, Ohio, 44281, United States|Centennial Health-Synexus, Oklahoma City, Oklahoma, 73111, United States|Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, 73112, United States|Memorial Clinical Research, Oklahoma City, Oklahoma, 73120, United States|Options Health Research, LLC, Tulsa, Oklahoma, 74104, United States|Northwest Gastroenterology Clinic, LLC, Portland, Oregon, 97210, United States|Family Medical Associates, Research Department, Levittown, Pennsylvania, 19056, United States|Allegheny Endocrinology Associates, Pittsburgh, Pennsylvania, 15212, United States|Preferred Primary Care Physicians, Inc., Pittsburgh, Pennsylvania, 15236, United States|Guthrie Clinical Research, Sayre, Pennsylvania, 18840, United States|Frontier Clinical Research, LLC, Scottdale, Pennsylvania, 15683, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, 15478, United States|Preferred Primary Care Physicians, Uniontown, Pennsylvania, 15401, United States|Synexus Clinical Research US, Inc., Anderson, South Carolina, 29621, United States|Synexus Clinical Research US, Inc, Anderson, South Carolina, 29621, United States|Clinical Trials of South Carolina, Charleston, South Carolina, 29406, United States|Carolina Medical Research, Clinton, South Carolina, 29325, United States|Gastroenterology Associates, PA, Greenville, South Carolina, 29615, United States|Synexus Clinical Research, Greer, South Carolina, 29650, United States|Health Concepts, Rapid City, South Dakota, 57702, United States|Clinsearch, Chattanooga, Tennessee, 37421, United States|Gastroenterology Centers of the Midsouth, Germantown, Tennessee, 38138, United States|East Tennessee Research Institute, Johnson City, Tennessee, 37604, United States|Quality Medical Research, Nashville, Tennessee, 37211, United States|Texas Clinical Research Institute, LLC, Arlington, Texas, 76012, United States|DiscoveResearch, Inc., Beaumont, Texas, 77701, United States|ClinRx Research, LLC, Carrollton, Texas, 75007, United States|Baylor College of Medicine Medical Center, Houston, Texas, 77030, United States|Biopharma Informatic Inc., Research Center, Houston, Texas, 77043, United States|Houston Endoscopy and Research Center, Inc., Houston, Texas, 77079, United States|Rodriguez Clinical Trials, Houston, Texas, 77083, United States|Amir Hassan, MD, PA, Houston, Texas, 77089, United States|Sante Clinical Research, Kerrville, Texas, 78028, United States|Pinnacle Clinical Research, San Antonio, Texas, 78215, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, 78229, United States|Sagact Pllc., San Antonio, Texas, 78229, United States|Synexus Clinical Research US, Inc., San Antonio, Texas, 78229, United States|Synexus Clinical Research US, Inc., Layton, Utah, 84041, United States|Synexus Clinical Research US, Inc., Murray, Utah, 84123, United States|Advanced Research Institute, Inc., Ogden, Utah, 84405, United States|Advanced Clinical Research, West Jordan, Utah, 84088, United States|Verity Research Inc., Fairfax, Virginia, 22031, United States|Blue Ridge Medical Research, Lynchburg, Virginia, 24502, United States|Manassas Clinical Research Centre, Manassas, Virginia, 20110, United States|VA Medical Center McGuire VAMC, Richmond, Virginia, 23249, United States|Washington Gastroenterology PLLC, Tacoma, Washington, 98405, United States|West Virginia University, Morgantown, West Virginia, 26506, United States|Consultorios Asociados de Endocrinologia e InvestigaciÃ³n Cl, Buenos Aires, Buenos Aires Province, C1425AGC, Argentina|Hospital Sirio Libanes, Caba, Buenos Aires Province, C1419AHN, Argentina|Centro de Investigaciones Medicas Mar del Plata SRL, Mar del Plata, Buenos Aires, B7600FYK, Argentina|CIPREC, Buenos Aires, Ciudad Autonoma deBuenos Aires, 1119, Argentina|Instituto de Investigaciones Clinicas de Rosario, Rosario, Santa Fe, S2000BIE, Argentina|Instituto Medico Catamarca-I.ME.C, Rosario, Santa Fe, S200CFK, Argentina|Clinica Mayo de Urgencias Medicas Cruz Blanca SRL, San Miguel de Tucuman, Tucuman, 4000, Argentina|CIDIM - Centro Integral de Diagnóstico por Imágenes Marchegian, Cordoba, X5000BNB, Argentina|Centro Universitario de Investigacion en Farmacologia Clinic, Corrientes, W3410AVV, Argentina|Instituto Privado de Investigaciones Clinicas de Cordoba, Córdoba, X5000AAW, Argentina|Nepean Hospital, Kingswood, New South Wales, 2747, Australia|Royal Adelaide Hospital - Central Adelaide Local Health Network Incorporated, Adelaide, South Australia, 5000, Australia|Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Ordination, Osterreicher, Steiermark, 8511, Austria|VIVIT Institute, am LKH Feldkirch, Feldkirch, Vorarlberg, 6807, Austria|Privatklinik wehlre-Diakonissen, Salzburg, 5020, Austria|Oö. Gesundheits- und Spitals-AG/LKH Steyr, Steyr, 4400, Austria|Universitair Ziekenhuis Antwerpen, Gastro-Enterologie,, Edegem, Antwerp, 2650, Belgium|UZ Brussel, Jette, Brussel, 1090, Belgium|AZ Sint Lucas Brugge, Brugge, West-Vlaanderen, 8310, Belgium|Hospital Universitário Walter Cantídio, Fortaleza, CE, 60430-270, Brazil|Centro de Pesquisa Clinica do Brasil, Brasilia, Distrito Federal, 71625175, Brazil|Hospital Universitário João de Barros Barreto - UFPA, Belem, PA, 66073-005, Brazil|Núcleo de Pesquisa Clínica do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, 90430-001, Brazil|Instituto Catarinense de Endocrinologia e Diabetes (ICED), Joinville, Santa Catarina, 89201-260, Brazil|Scentryphar Pesquisa Clínica Ltda, Campinas, Sao Paulo, 13020-431, Brazil|Instituto de Pesquisa Clinica em Campinas, Campinas, Sao Paulo, 13060-080, Brazil|Instituto de Estudos e Pesquisas Clinicas do Ceara IEP/CE - Oncology, Fortaleza, 60160-230, Brazil|IPEC-Instituto de Pesquisa Clinica, Sao Paulo, 01223-001, Brazil|CPQuali Pesquisa Clinica Ltda, Sao Paulo, 01228-000, Brazil|MHAT Yuliya Vrevska Byala, Byala, Ruse, 7100, Bulgaria|UMHAT - Kaspela- EOOD, Plovdiv, 4002, Bulgaria|Medical Center Asklepion - Humane Medicine Research EOOD, Sofia, 1303, Bulgaria|Alexandrovska University Hospital, Sofia, 1431, Bulgaria|University of Calgary, Calgary, Alberta, T2N 2T9, Canada|Central Alberta Research Centre, Red Deer, Alberta, T4N 6V7, Canada|Vancouver General Hospital, Vancouver, British Columbia, V5Z 1M9, Canada|Patient research centre, St. John's, Newfoundland and Labrador, A1B 3V6, Canada|South Shore Medical Arts, Bridgewater, Nova Scotia, B4V 3N2, Canada|The Ottawa Hospital, Ottawa, Ontario, K1H 7W9, Canada|Toronto Digestive Disease Associates, Inc., Vaughan, Ontario, L4L 4Y7, Canada|Recherche GCP Research, Montreal, Quebec, H1M 1B1, Canada|Centro Cardiovascular Colombiano Clínica Santa María, Medellin, Antioquia, 050034, Colombia|Rodrigo Botero S.A.S., Medellín, Antioquia, 050030, Colombia|Centro Cardiovascular y de Diabetes, Barranquilla, Atlantico, 080020, Colombia|Fundación del Caribe para la InvestigacionBiomédica-Fundación BIOS, Barranquilla, Atlantico, 080020, Colombia|Asociación Colombiana de Diabetes, Bogotá, Cundinamarca, 111311, Colombia|Healthy Medical Center, Zipaquira, Cundinamarca, 250252, Colombia|Endocare Ltda., Bogotá, Distrito Capital De Bogotá, 111111, Colombia|Medplus Centro de Recuperacion Integral S.A.S., Bogotá, Distrito Capital, 110221, Colombia|Centro de Investigaciones Clínicas IPS CARDIOMET Pereira, Pereira, Risaralda, 660003, Colombia|IPS Centro Medico Julian Coronel S.A, Cali, Valle Del Cauca, 760035, Colombia|Centro Medico Imbanaco de Cali S.A., Cali, Valle Del Cauca, 760042, Colombia|Steno Diabetes Center Copenhagen, Hellerup, Copenhagen, 2900, Denmark|Gastroenheden, Hvidovre hospital, Hvidovre, København, 2605, Denmark|Klinische Forschung Karlsruhe GmbH, Karlsruhe, Baden-Wurttemberg, 76199, Germany|Studienzentrum Schwittay, Böhlen, Saxony, 4564, Germany|Klinische Forschung Dresden GmbH, Dresden, Saxony, 1309, Germany|Clinical Research Hamburg, Hamburg, 22143, Germany|Israelitisches Krankenhaus, Hamburg, 22297, Germany|KRH Klinikum Siloah, Hannover, 30459, Germany|Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger, Heves, H-3300, Hungary|Hetenyi Geza Hospital, Szolnok, Jász-Nagykun-Szolnok, H-5004, Hungary|Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, Zala, H-8900, Hungary|Strázsahegy Gyógyszertár Medicina, Budapest, H1171, Hungary|Szegedi TudomanyegyetemSzent-Gyorgyi Albert Klinikai Kozpont és Altalanos Orvostudomanyi Kar Belgyogyaszati Klinika, Szeged, H-6720, Hungary|Kumudini Devi Diabetes Research Center; Ramdevrao Hospital, Hyderabad, Andhra Pradesh, 500072, India|King George Hospital, Visakhapatnam, Andhra Pradesh, 530002, India|Dr. Jivraj Mehta Smarak Health Foundation Bakeri Medical Research Centre - Gasterentrology, Ahmedabad, Gujarat, 380007, India|Zydus Hospital, Ahmedabad, Gujarat, 380054, India|Lifecare Clinic and Research Centre - Internal Med/Diabetology, Bangalore, Karnataka, 560092, India|Diacon Hospital and research Center - Diabetology, Bengaluru, Karnataka, 359-360, India|Victoria Hospital Bangalore Medical College and Research Institute, Bengaluru, Karnataka, 560002, India|Rajalakshmi Hospital, Bengaluru, Karnataka, 560097, India|Bhatia Hospital, Mumbai, Maharashtra, 400007, India|B. J. Government Medical College and Sassoon General Hospitals, Pune, Maharashtra, 411001, India|Universal Hospital, Pune, Maharashtra, 411011, India|Noble Hospital, Pune, Maharashtra, 411013, India|S R Kalla (SRK) Memorial Gastro & General Hospital, Jaipur, Rajasthan, 302001, India|Marudhar Hospital, Jaipur, Rajasthan, 302012, India|Eternal Hospital - Diabetology, Jaipur, Rajasthan, 302017, India|SMS Hospital, Jaipur, Rajasthan, 302017, India|M.V. Hospital for Diabetes & Diabetes Research Centre, Chennai, Tamil Nadu, 600013, India|Kovai Diabetes Speciality Centre, Coimbatore, Tamil Nadu, 641009, India|Arthur Asirvatham Hospital, Madurai, Tamil Nadu, 625020, India|M V Hospital & Research Centre, Lucknow, Uttar Pradesh, 226003, India|Sir Ganga Ram Hospital (SGRH), Delhi, 110060, India|Vinaya Hospital & Research Centre, Mangalore, 575003, India|Bnei-Zion MC, Haifa, 31948, Israel|Chonbuk National University Hospital, Jeonju, Jeollabuk-Do, 561-712, Korea, Republic of|Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Nowon-gu, 1757, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Kraslava Hospital, Kraslava, Kraslavas Nov., 5601, Latvia|Polana-D, Daugavpils, LV5401, Latvia|Pauls Stradins Clinical University Hospital, Endokrinologijas nodala, Riga, 1002, Latvia|Digestive Diseases Centre GASTRO, Riga, 1006, Latvia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, 5460, Malaysia|Clinical Investigation Centre, Kuala Lumpur, 59100, Malaysia|Clinical Trial Unit, School of Medical Sciences, Health Campus, Hospital Universiti Sains Malaysia, Kubang Kerian, 16150, Malaysia|Hospital Taiping, Taiping, 34000, Malaysia|Mentrials Sa de Cv, Mexico DF, Distrito Federal, 06700, Mexico|Clinicos Asociados BOCM SC, Mexico, Distrito Federal, 03300, Mexico|Centro Especializado en Diabetes, Obesidad y Prevencion de E - Endocrinology, Mexico, Distrito Federal, 11650, Mexico|Centro de Atención e Investigación en Factores de Riesgo Car, Mexico, Distrito Federal, 14000, Mexico|Unidad de Investigacion Clinica Cardiometabolica de Occidente, Guadalajara, Jalisco, 44150, Mexico|Consultorio particular, Guadalajara, Jalisco, 44210, Mexico|Unidad de Investigación Clínica en Medicina S.C/, Guadalajara, Jalisco, 44670, Mexico|Centro de Desarrollo Biomédico S.C.P, Mérida, Yucatán, 97070, Mexico|Centro de Investigacion Cardiometabolica de Aguascalientes SA de CV, Aguascalientes, 20230, Mexico|Hospital Cardiologica Aguascalientes, Aguascalientes, 20230, Mexico|Dioderm Instituto de Investigacion, Durango, 34060, Mexico|CIADEN (Centro de Investigación y Atención de Diabetes, Endocrinología y Nutrición), Durango, 34270, Mexico|Sociedad de Metabolismo y Corazon S.C., Veracruz, 91900, Mexico|West Visayas State University Medical Center, IloIlo City, IloIlo, 5000, Philippines|Cardinal Santos Medical Center, San Juan City, Metro Manila, 1502, Philippines|Manila Doctors Hospital, Ermita, Manila, Metropolitan Manila, 1000, Philippines|San Juan De Dios Educational Foundation, Inc., Pasay, Metropolitan Manila, 1300, Philippines|Ospital ng Makati, Makati City, NCR, 1218, Philippines|Perpetual Succor Hospital, Cebu City, 6000, Philippines|St. Luke's Medical Center, Quezon City, 1100, Philippines|Specjalistyczny Gabinet Neurologiczny Marta Banach, Kraków, Lesser Poland, 30-539, Poland|CenterMed Krakow Ltd, Krakow, Malopolska, 31-530, Poland|Centrum Medyczne Lukamed, Chojnice, 89-600, Poland|Saint-Petersburg City Pokrovskaya Hospital, St-Petersburg, Leningrad Region, 199106, Russian Federation|GUZ Saratov City Clinical Hospital 9, Saratov, Saratov Region, 410030, Russian Federation|Scientific Institute of Clinical and Experimental Lymphology, Novosibirsk, 630117, Russian Federation|Rostov on Don, Rostov on Don, 344019, Russian Federation|National University Hospital, Singapore, 119228, Singapore|Changi General Hospital, Singapore, 529889, Singapore|Singapore General Hospital, Singapore, S169856, Singapore|FARMOVS, Bloemfontein, Free State, 9301, South Africa|Wits Clinical Research, Johannesburg, Gauteng, 2193, South Africa|Synexus Stanza Clinical Research Centre, Pretoria, Gauteng, 0122, South Africa|Watermeyer Clinical Research Site, Pretoria, Val De Grace, 0184, South Africa|Synexus Helderberg Clinical Research Centre, Somerset West, 7130, South Africa|Hospital Universitario Principe de Asturias, Madrid, 28850, Spain|Phramongkutklao Hospital, Bangkok, 10400, Thailand|Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand|Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, 50200, Thailand|State Institution Ukrainian State Research Institute of Medical and Social Problems of Disability of the Ministry of Health of Ukraine, Dnipro, Dnipropetrovs'ka Oblast', 49027, Ukraine|Municipal Institution, City Hospital #7, polyclinic department, c. Zaporizhzhia, Zaporizhzhia, Zaporizhzhia Region, 69600, Ukraine|Chernivtsi Regional Clinical Hospital, Chernivtsi, 58001, Ukraine|Regional Municipal noncommercial Enterprise ""Chernivtsi Regional Endocrinology Center"", Polyclinic department, Higher State Educational Establishment of Ukraine ""Bukovinian State Medical University"", Department of Clinical Immunology, Allergology and Endo, Chernivtsi, 58022, Ukraine|Ivano-Frankivsk National Medical University, Ivano-Frankivsk, 76008, Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, 76018, Ukraine|Municipal nonprofit entity of Kharkiv municipal council, Kharkiv, 61037, Ukraine|Clinical Endocrinology of SI ""V.Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine"", Kharkiv, 61070, Ukraine|Communal Institution Kherson City Clinical Hospital, Kherson, 73000, Ukraine|Kyiv Railway Clinical Hospital No-2 of Branch of Healthcare Center of the PJSC Ukrainian Railway , Endocrynology Department, Kyiv, 3049, Ukraine|Polyclinic of medical services and rehabilitation department of State Joint-Stock Holding Company Artem, day-patient unit, Kyiv, 4050, Ukraine|Odessa Railway Clinical Hospital of Branch of HC JSC Ukrzaliznytsia, Odessa National Medical University, Odesa, 65010, Ukraine|Poltava Regional Clinical Hospital, Poltava, 36011, Ukraine|Private Small-Scale Enterprise Medical Centre Pulse, Vinnytsia, 21001, Ukraine|Vinnytsia Regional Clinical highly specialized Endocrinology Centre, Vinnytsia, 21010, Ukraine|Municipal Institution 6th City Clinical Hospital, Dept of Gastroenterology, Zaporizhzhia, 69035, Ukraine|Biomedical Research Centre, Nottingham, East Midland, NG7 2UH, United Kingdom|MAC Clinical Research Manchester, Manchester, Greater Manchester, M13 9NQ, United Kingdom|Royal Oldham Hospital, Oldham, Lancashire, OL1 2JH, United Kingdom|MAC Clinical Research, Liverpool, Merseyside, L34 1BH, United Kingdom|MAC Research, Exchange House, Cannock, Staffordshire, WS11 0BH, United Kingdom|University Hospitals of North Midlands, Stoke on Trent, Staffordshire, ST6 8DG, United Kingdom|MAC Clinical Research, Monarch House, Leeds, West Yorkshire, LS10 1DU, United Kingdom|MAC Research, Barnsley, S75 3DL, United Kingdom|MAC Clinical Research, Kaman Court, Blackpool, FY2 0JH, United Kingdom|Mid Essex Hospital Services NHS Trust Broomfield Hospital, Chelmsford, CM1 7ET, United Kingdom|MAC Clinical Research, GAC House, Manchester, M13 9NQ, United Kingdom"
NCT02068989,Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02068989,TERMINATED,Stress Hyperglycemia|Diabetes Mellitus Type 2,,Yale University,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Yale New Haven Hospital St. Raphael Campus, New Haven, Connecticut, 06511, United States|Norwalk Hospital, Norwalk, Connecticut, 06850, United States"
NCT00672204,Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00672204,TERMINATED,Type 1 Diabetes Mellitus|Hypoglycemia,BIOLOGICAL: Allogeneic islets of Langerhans transplant|DRUG: Raptiva|DRUG: Sirolimus|DRUG: anti-thymocyte globulin,University of Minnesota,Juvenile Diabetes Research Foundation,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Universtiy of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT03285308,A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01,https://clinicaltrials.gov/study/NCT03285308,TERMINATED,Gastroparesis|Diabetes Mellitus,DRUG: Placebo|DRUG: Relamorelin,Allergan,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35295, United States|Digestive Health Specialist of the South East, Dothan, Alabama, 36305, United States|Avant Research Associates, Huntsville, Alabama, 35801, United States|Synexus Clinical Research US, Inc., Fountain Hills, Arizona, 85268, United States|Central Arizona Medical Associates, Mesa, Arizona, 85206, United States|Phoenix Clinical LLC, Phoenix, Arizona, 85014, United States|Del Sol Research Management, LLC, Tucson, Arizona, 85712, United States|Preferred Research Partners, Inc., Little Rock, Arkansas, 72211, United States|Arkansas Gastorenterology, North Little Rock, Arkansas, 72117, United States|Hope Clinical Research, Canoga Park, California, 91303, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, 92879, United States|Aurora Care Clinic, LLC, Costa Mesa, California, 92627, United States|Citrus Valley Gastroenterology Clinic, Covina, California, 91722, United States|VVCRD Research, Garden Grove, California, 92845, United States|University of California San Diego, La Jolla, California, 92037, United States|Om Research LLC, Lancaster, California, 93534, United States|Clinical Applications Laboratories, Inc., San Diego, California, 92103, United States|Medical Associates Research Group, Inc, San Diego, California, 92123, United States|Synexus Clinical Research, US, Santa Rosa, Santa Rosa, California, 95405, United States|Upland Clinical Research, Upland, California, 91786, United States|Synexus Clinical Research US, Inc., Vista, California, 92083, United States|University of Colorado, Denver, Aurora, Colorado, 80045, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, 80907, United States|Denver Esophageal and Stomach Center, Englewood, Colorado, 80110, United States|Connecticut Clinical Research Foundation, Bristol, Connecticut, 06010, United States|Medical Research Center of Connecticut, LLC, Hamden, Connecticut, 06518, United States|TrialSpark, Inc., Washington, District of Columbia, 20017, United States|Innovative Research of West FL, Inc., Clearwater, Florida, 33756, United States|West Central Gastroenterology, Clearwater, Florida, 33756, United States|American Research Institute, Inc, Cutler Bay, Florida, 33157, United States|Top Medical Research, Cutler Bay, Florida, 33189, United States|Nature Coast Clinical Research, Inverness, Florida, 34452, United States|Cfagi Llc, Maitland, Florida, 32751, United States|Savin Medical Group LLC, Miami Lakes, Florida, 33014, United States|APF Research LLC, Miami, Florida, 33134, United States|AMPM Research Clinic, Miami, Florida, 33169, United States|Advanced Medical Research Institute, Miami, Florida, 33174, United States|Florida Research Center, Inc., Miami, Florida, 33174, United States|Sensible Healthcare, Ocoee, Florida, 34761, United States|Gulf Region Clinical Research Institute, Pensacola, Florida, 32514, United States|University of South Florida, Tampa, Florida, 33606, United States|West Central Gastroenterology, Tampa, Florida, 33626, United States|Summit Clinical Research, LLC, Carnesville, Georgia, 30521, United States|Infinite Clinical Trials, Riverdale, Georgia, 30274, United States|Southwest Gastroenterology, Oak Lawn, Illinois, 60453, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, 47714, United States|Synexus Clinical Research US, Inc., Evansville, Indiana, 47714, United States|Indiana University Health University Hospital, Indianapolis, Indiana, 46202, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|Cotton-O'Neil Clinical Research Center - Digestive Health, Topeka, Kansas, 66606, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Delta Research Partners, Bastrop, Louisiana, 71220, United States|Cronola LLC, Houma, Louisiana, 70360, United States|New Orleans Research Institute - Metropolitan Gastroenterology Associates, Metairie, Louisiana, 70006, United States|Gastro Center of Maryland, Columbia, Maryland, 21045, United States|Frederick Gastroenterology Associates, PA an Elligo Health Research Site, Frederick, Maryland, 21701, United States|Boston VA Healthcare System, West Roxbury, Massachusetts, 02132, United States|Vida Clinical Studies, Dearborn, Michigan, 48124, United States|National Clinical, LLC, Hamtramck, Michigan, 48212, United States|Henry Ford Health System, Novi, Michigan, 48377, United States|Gastroenterology Associates of Western Michigan, Wyoming, Michigan, 49519, United States|MNGI Digestive Health, Coon Rapids, Minnesota, 55446, United States|Synexus Clinical Research US, Inc., Richfield, Minnesota, 55423, United States|Montana Medical Research, Missoula, Montana, 59808, United States|Synexus Clinical Research, Henderson, Nevada, 89052, United States|Excel Clinical Research, Las Vegas, Nevada, 89109, United States|Clinical Research of South Nevada, Las Vegas, Nevada, 89121, United States|Advanced Biomedical Research of America, Las Vegas, Nevada, 89123, United States|Digestive Disease Specialists, Las Vegas, Nevada, 89128, United States|Palm Research Center, Las Vegas, Nevada, 89135, United States|Garden State Endocrinology, Brick, New Jersey, 08723, United States|Synexus Clinical Research US, Inc., Bridgeton, New Jersey, 08302, United States|AGA Clinical Research Associates LLC, Egg Harbor Township, New Jersey, 08234, United States|CHEAR Center, LLC, Bronx, New York, 10455, United States|Long Island Gastrointestinal Research Group LLP, Great Neck, New York, 11023, United States|United Health Services Hospitals, Inc., Johnson City, New York, 13790, United States|Asheville Gastroenterology Associates, Asheville, North Carolina, 28801, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7080, United States|Carolinas Healthcare-Charlotte, Charlotte, North Carolina, 28204, United States|Carolina Digestive Health Associates, Concord, North Carolina, 28025, United States|Cumberland Research Associates, LLC, Fayetteville, North Carolina, 28304, United States|Triad Clinical Trials, Greensboro, North Carolina, 27410, United States|PMG Research Salisbury, Salisbury, North Carolina, 28144, United States|The Center for Clinical Research, Winston-Salem, North Carolina, 27103, United States|Dayton Gastroenterology,Inc., Beavercreek, Ohio, 45440, United States|Endocrinology Research Associates, Inc., Columbus, Ohio, 43201, United States|Hometown Urgent Care and Research, Columbus, Ohio, 43214, United States|Premier Clinical Research d.b.a. STAT Research, Franklin, Ohio, 45005, United States|Family Practice Center of Wadsworth, Inc., Wadsworth, Ohio, 44281, United States|Digestive Disease Specialists Inc, Oklahoma City, Oklahoma, 73112, United States|Memorial Clinical Research, Oklahoma City, Oklahoma, 73120, United States|Northwest Gastroenterology Clinic, LLC, Portland, Oregon, 97210, United States|Family Medical Associates, Research Department, Levittown, Pennsylvania, 19056, United States|Preferred Primary Care Physicians, Inc., Pittsburgh, Pennsylvania, 15236, United States|Montgomery Medical, Inc., Smithfield, Pennsylvania, 15478, United States|Synexus Clinical Research US, Inc., Anderson, South Carolina, 29621, United States|Carolina Medical Research, Clinton, South Carolina, 29325, United States|Gastroenterology Associates, PA, Greenville, South Carolina, 29615, United States|Synexus Clinical Research, Greer, South Carolina, 29650, United States|Quality Medical Research, Nashville, Tennessee, 37211, United States|Avant Research Associates,LLC, Austin, Texas, 78704, United States|Synexus Clinical Research US, Inc., Dallas, Texas, 75234, United States|Amir Ali Hassan, MD, PA, Houston, Texas, 77089, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, 78229, United States|Sagact Pllc, San Antonio, Texas, 78229, United States|Synexus Clinical Research US, Inc., Layton, Utah, 84041, United States|Synexus Clinical Research US, Inc., Murray, Utah, 84123, United States|Advanced Research Institute, Inc., Ogden, Utah, 84405, United States|Advanced Clinical Research, West Jordan, Utah, 84088, United States|Verity Research Inc., Fairfax, Virginia, 22031, United States|Cardinal Internal Medicine, Woodbridge, Virginia, 22192, United States|West Virginia University, Morgantown, West Virginia, 26506, United States|Nepean Hospital, Kingswood, New South Wales, 2747, Australia|Royal Adelaide Hospital - Central Adelaide Local Health Network Incorporated, Adelaide, South Australia, 5000, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|MHAT Yuliya Vrevska Byala, Byala, Ruse, 7100, Bulgaria|UMHAT - Kaspela- EOOD, Plovdiv, 4001, Bulgaria|Medical Center Asklepion - Humane Medicine Research EOOD, Sofia, 1303, Bulgaria|Alexandrovska University Hospital, Sofia, 1431, Bulgaria|CHU Nantes, Nantes Cedex 1, 44093, France|Hopital Charles Nicolle, Rouen Cedex, 76031, France|Kumudini Devi Diabetes Research Center; Ramdevrao Hospital, Hyderabad, Andhra Pradesh, 500072, India|King George Hospital, Visakhapatnam, Andhra Pradesh, 530002, India|Dr. Jivraj Mehta Smarak Health Foundation Bakeri Medical Research Centre - Gasterentrology, Ahmedabad, Gujarat, 380007, India|Victoria Hospital, Bangalore, Karnataka, 560002, India|Life Care Hospital & Research Centre, Bangalore, Karnataka, 560092, India|Diacon Hospital and research Center - Diabetology, Bengaluru, Karnataka, 359-360, India|Rajalakshmi Hospital, Bengaluru, Karnataka, 560097, India|Vinaya Hospital & Research Centre, Mangalore, Karnataka, 575003, India|Bhatia Hospital, Mumbai, Maharashtra, 400007, India|B. J. Government Medical College and Sassoon General Hospitals, Pune, Maharashtra, 411001, India|Universal Hospital, Pune, Maharashtra, 411011, India|Noble Hospital Pvt. Ltd, Pune, Maharashtra, 411013, India|S R Kalla (SRK) Memorial Gastro & General Hospital, Jaipur, Rajasthan, 302001, India|SMS Hospital, Jaipur, Rajasthan, 302004, India|Diabetic Thyroid and Endocrine Centre, Jaipur, Rajasthan, 302006, India|Marudhar Hospital, Jaipur, Rajasthan, 302012, India|Eternal Hospital - Diabetology, Jaipur, Rajasthan, 302017, India|M.V. Hospital for Diabetes & Diabetes Research Centre, Chennai, Tamil Nadu, 600013, India|Kovai Diabetes Speciality Centre, Coimbatore, Tamil Nadu, 641009, India|M V Hospital & Research Centre, Lucknow, Uttar Pradesh, 226003, India|Arthur Asirvatham Hospital, Madurai, 625020, India|Sir Ganga Ram Hospital, New Delhi, 110060, India|Soroka University Medical Center, Beer Sheba, 85025, Israel|Bnai Zion Medical Center, Haifa, 31048, Israel|E. Wolfson Medical Center, Holon, 58100, Israel|Digestive Diseases Institute, Jerusalem, 9103102, Israel|Gastroenterology Institute, Petach Tikva, 49100, Israel|Endocrinology & Diabetes Center, Safed, 13100, Israel|Gastroenterology Institute, Tel Aviv, 64239, Israel|Chonbuk National University Hospital, Jeonju, Jeollabuk-Do, 561-712, Korea, Republic of|Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Nowon-gu, 01757, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Hospital Sultanah Bahiyah, Alor Setar, Kedah, 5460, Malaysia|University Malaya Medical Centre, Kuala Lumpur, 59100, Malaysia|Universiti Sains Malaysia, Kubang Kerian, 16150, Malaysia|Hospital Taiping, Taiping, 34000, Malaysia|Manila Doctors Hospital, Ermita, Manila, 1000, Philippines|San Juan De Dios Educational Foundation, Inc., Pasay, Metro Manila, 1300, Philippines|Cardinal Santos Medical Center, San Juan City, Metro Manila, 1502, Philippines|Ospital ng Makati, Makati City, NCR, 1218, Philippines|Perpetual Succor Hospital, Cebu City, 6000, Philippines|West Visayas State University Medical Center, IloIlo City, 5000, Philippines|St. Luke's Medical Center, Quezon City, 1100, Philippines|Synexus Polska Sp.z o.o., Pomorskie, Gdansk, 80-382, Poland|CenterMed Krakow Ltd, Krakow, Malopolska, 31-530, Poland|Centrum Medyczne Pratia S.A. Warsaw, Poland, Warsaw, Mazowian, 01-868, Poland|Endoskopia Sp. Z O.O., Sopot, Pomorskie, 81-756, Poland|Synexus Polska Sp. z o.o.Oddzial w Poznaniu, Poznan, Poznañ, 60-702, Poland|Wojewodzki Szpital Specjalistyczny w Olsztynie, Olsztyn, Warmia-Mazury, 10-561, Poland|NZOZ Vita Diabetica - Malgorzata Buraczyk, Bialystok, 15-798, Poland|Centrum Medyczne Lukamed, Chojnice, 89-600, Poland|Synexus Polska sp.z.o.o oddzial Czestochowa, Czestochowa, 42-202, Poland|Specjalistyczny Gabinet Neurologiczny Marta Banach, Kraków, 30-539, Poland|Synexus Polska Sp. z o.o. Oddzial w Lodzi, Lodz, 90-127, Poland|Sanitas Centrum Medyczne, Lublin, 20-090, Poland|Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warszawa, Poland|DRS Wroclaw, Wroclaw, 50-381, Poland|Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska, Wroclaw, 51-162, Poland|National University Hospital, Singapore, 119228, Singapore|Changi General Hospital, Singapore, 529889, Singapore|Singapore General Hospital, Singapore, S169856, Singapore|Hospital Universitario Principe de Asturias, Madrid, 28850, Spain|Hospital Universitario De Salamanca, Salamanca, 37007, Spain|Hospital Universitario Virgen del Rocío, Sevilla, 41009, Spain|Phramongkutklao Hospital, Bangkok, 10400, Thailand|Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand|Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, 50200, Thailand|Communal Institution ""Odesa Regional Clinical Hospital"", Out-patient department, Odesa, Odesa Region, 65025, Ukraine|Limited Liability Company ""Medical Center ""Salutem"", Vinnitsa, Vinnyts'ka Oblast', 21050, Ukraine|Municipal Institution City Hospital No. 7, Zaporizhzhia, Zaporizhzhia Region, 69600, Ukraine|Regional municipal institution ""Chernivtsi's regional clinical hospital"", gastroenterological department, Higher state educational establishment of Ukraine ""Bukovinian state medical university"", department of internal medicine and infectious diseases, c.C, Chernivtsi, 58001, Ukraine|Regional Public Organization Chernivtsi Regional Endocrinology Center, Chernivtsi, 58022, Ukraine|State Institution Ukrainian State Research Institute of Medical and Social Problems of Disability of the Ministry of Health of Ukraine, Dnipro, 49027, Ukraine|Ivano-Frankivsk National Medical University, Ivano-Frankivsk, 76008, Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, 76018, Ukraine|Municipal nonprofit entity of Kharkiv municipal council, Kharkiv, 61037, Ukraine|L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine, Kharkiv, 61039, Ukraine|Clinical Endocrinology of SI ""V.Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine"", Kharkiv, 61070, Ukraine|Communal Institution Kherson City Clinical Hospital, Kherson, 73000, Ukraine|Kyiv municipal clinical endocrinological center, Kyiv, 01034, Ukraine|AS Medbud Clinic, Kyiv, 03037, Ukraine|AS PVNZ, Kyiv, 2002, Ukraine|Limited Liability Company ""Medical and Diagnostic Center ""ADONIS Plus"", outpatient department, c. Kyiv, Kyiv, 2002, Ukraine|Kyiv Railway hospital on the railway transport #2 of the branch ""health, Kyiv, 3049, Ukraine|Medical Center Universal Clinic Oberig, Kyiv, 3680, Ukraine|Polyclinic of medical services and rehabilitation department of State Joint-Stock Holding Company Artem, day-patient unit, Kyiv, 4050, Ukraine|Odessa Railway Clinical Hospital of Branch of HC JSC Ukrzaliznytsia, Odessa National Medical University, Odesa, 65010, Ukraine|Poltava Regional Clinical Hospital, Poltava, 36011, Ukraine|Ternopil University Hospital, Ternopil, 46002, Ukraine|Private Small-Scale Enterprise Medical Centre Pulse, Vinnytsia, 21001, Ukraine|Vinnytsia Regional Clinical highly specialized Endocrinology Centre, Vinnytsia, 21010, Ukraine|Municipal nonprofit entity ""Vinnytsia's city clinical hospital #1"", c. Vinnytsia, Vinnytsia, 21029, Ukraine|6th City Clinical Hospital, c. Zaporizhzhia, Zaporizhzhia, 69035, Ukraine"
NCT04084418,Carbohydrates Under Target for Type 1 Diabetes Management,https://clinicaltrials.gov/study/NCT04084418,TERMINATED,Type 1 Diabetes,OTHER: Control Diet|OTHER: VLCHF Diet,McGill University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Institut de recherches cliniques de Montréal, Montréal, Quebec, H2W1R7, Canada"
NCT03152552,A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure,https://clinicaltrials.gov/study/NCT03152552,TERMINATED,Diabetes Mellitus and Heart Failure,DRUG: LIK066|DRUG: Placebo|DRUG: Empagliflozin,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Novartis Investigative Site, Huntsville, Alabama, 35801, United States|Novartis Investigative Site, Carmichael, California, 95608, United States|Novartis Investigative Site, Concord, California, 94520, United States|Novartis Investigative Site, Long Beach, California, 90813, United States|Novartis Investigative Site, Northridge, California, 91325, United States|Novartis Investigative Site, Stockton, California, 95204, United States|Novartis Investigative Site, Colorado Springs, Colorado, 80906, United States|Novartis Investigative Site, Bradenton, Florida, 34209, United States|Novartis Investigative Site, Clearwater, Florida, 33756, United States|Novartis Investigative Site, Delray Beach, Florida, 33446, United States|Novartis Investigative Site, Fort Lauderdale, Florida, 33312, United States|Novartis Investigative Site, Gurnee, Illinois, 60031, United States|Novartis Investigative Site, Bogalusa, Louisiana, 70427, United States|Novartis Investigative Site, Jackson, Mississippi, 39209, United States|Novartis Investigative Site, Saint Louis, Missouri, 63128, United States|Novartis Investigative Site, Omaha, Nebraska, 68114, United States|Novartis Investigative Site, Charleston, South Carolina, 29407, United States|Novartis Investigative Site, Columbia, South Carolina, 29203, United States|Novartis Investigative Site, San Antonio, Texas, 78229, United States|Novartis Investigative Site, Sugar Land, Texas, 77479, United States|Novartis Investigative Site, Tacoma, Washington, 98405, United States|Novartis Investigative Site, Caba, Buenos Aires, 1407, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1056ABJ, Argentina|Novartis Investigative Site, Caba, Capital Federal, C1179AAB, Argentina|Novartis Investigative Site, Buenos Aires, C1120AAC, Argentina|Novartis Investigative Site, Graz, A-8036, Austria|Novartis Investigative Site, Wien, 1090, Austria|Novartis Investigative Site, Wien, 1130, Austria|Novartis Investigative Site, Lennik, Brussels, 1070, Belgium|Novartis Investigative Site, Aalst, 9300, Belgium|Novartis Investigative Site, Bonheiden, 2820, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Liege, 4000, Belgium|Novartis Investigative Site, Sofia, 1233, Bulgaria|Novartis Investigative Site, Sofia, 1309, Bulgaria|Novartis Investigative Site, Sofia, 1431, Bulgaria|Novartis Investigative Site, Sofia, 1709, Bulgaria|Novartis Investigative Site, London, Ontario, N6A 5A5, Canada|Novartis Investigative Site, Toronto, Ontario, M5B 1W8, Canada|Novartis Investigative Site, Montreal, Quebec, H4A 3J1, Canada|Novartis Investigative Site, Sainte Foy, Quebec, G1V 4G5, Canada|Novartis Investigative Site, St-Jerome, Quebec, J7Z 5T3, Canada|Novartis Investigative Site, Quebec, G1V 4G2, Canada|Novartis Investigative Site, Krapinske toplice, 49 217, Croatia|Novartis Investigative Site, Rijeka, 51000, Croatia|Novartis Investigative Site, Zagreb, 10000, Croatia|Novartis Investigative Site, Brandys nad Labem, Czech Republic, 250 01, Czechia|Novartis Investigative Site, Svitavy, Czech Republic, 568 25, Czechia|Novartis Investigative Site, Trebic, Czech Republic, 674 01, Czechia|Novartis Investigative Site, Karvina, 73506, Czechia|Novartis Investigative Site, Kolin, 280 20, Czechia|Novartis Investigative Site, Prague 5, 158 00, Czechia|Novartis Investigative Site, Praha, 12808, Czechia|Novartis Investigative Site, Prerov, 751 52, Czechia|Novartis Investigative Site, Hellerup, 2900, Denmark|Novartis Investigative Site, Svendborg, 5700, Denmark|Novartis Investigative Site, Bad Oeynhausen, 32545, Germany|Novartis Investigative Site, Berlin, 10789, Germany|Novartis Investigative Site, Berlin, 12157, Germany|Novartis Investigative Site, Berlin, 13347, Germany|Novartis Investigative Site, Frankfurt, 60594, Germany|Novartis Investigative Site, Halle, 06120, Germany|Novartis Investigative Site, Hamburg, 20099, Germany|Novartis Investigative Site, Stuttgart, 70378, Germany|Novartis Investigative Site, Budapest, HUN, 1145, Hungary|Novartis Investigative Site, Budapest, 1134, Hungary|Novartis Investigative Site, Szeged, 6720, Hungary|Novartis Investigative Site, Szekszard, 7100, Hungary|Novartis Investigative Site, Wilton, Cork, Ireland|Novartis Investigative Site, County Limerick, V94 F858, Ireland|Novartis Investigative Site, Dublin 4, Ireland|Novartis Investigative Site, Bergamo, BG, 24127, Italy|Novartis Investigative Site, Milano, MI, 20132, Italy|Novartis Investigative Site, San Donato Milanese, MI, 20097, Italy|Novartis Investigative Site, Milano, 20149, Italy|Novartis Investigative Site, Rimini, 47923, Italy|Novartis Investigative Site, Cheongju si, Chungcheongbuk Do, 28644, Korea, Republic of|Novartis Investigative Site, Wonju, Gangwon-Do, 26426, Korea, Republic of|Novartis Investigative Site, Bundang Gu, Gyeonggi Do, 13620, Korea, Republic of|Novartis Investigative Site, Seoul, 03080, Korea, Republic of|Novartis Investigative Site, Durango, 34000, Mexico|Novartis Investigative Site, Alkmaar, 1815 JD, Netherlands|Novartis Investigative Site, Groningen, 9713 GZ, Netherlands|Novartis Investigative Site, Utrecht, 3584 CX, Netherlands|Novartis Investigative Site, Venlo, 5912 BL, Netherlands|Novartis Investigative Site, Loerenskog, NO 1478, Norway|Novartis Investigative Site, Oslo, 0372, Norway|Novartis Investigative Site, Trondheim, 7006, Norway|Novartis Investigative Site, Warszawa, 00-874, Poland|Novartis Investigative Site, Wroclaw, 51-314, Poland|Novartis Investigative Site, Ponce, 00717, Puerto Rico|Novartis Investigative Site, Singapore, 169609, Singapore|Novartis Investigative Site, Bloemfontein, Free State, 9301, South Africa|Novartis Investigative Site, Paarl, Western Cape, 7626, South Africa|Novartis Investigative Site, Worcester, 6850, South Africa|Novartis Investigative Site, Sevilla, Andalucia, 41014, Spain|Novartis Investigative Site, Villamartin, Cadiz, 11650, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46010, Spain|Novartis Investigative Site, Caceres, Extremadura, 10003, Spain|Novartis Investigative Site, Changhua, 50006, Taiwan|Novartis Investigative Site, Taichung, 40447, Taiwan|Novartis Investigative Site, Taipei, 11217, Taiwan|Novartis Investigative Site, Chelmsford, Essex, CM1 7ET, United Kingdom|Novartis Investigative Site, London, GBR, EC1M 6BQ, United Kingdom|Novartis Investigative Site, Sunderland, Tyne And Wear, SR4 7TP, United Kingdom|Novartis Investigative Site, Birmingham, B15 2TH, United Kingdom"
NCT00228891,Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00228891,TERMINATED,"Diabetes Mellitus, With Complications",PROCEDURE: Effect of Pulsatile IV insulin on diabetic neuropathy|PROCEDURE: Effect of Pulsatile IV Insulin on diabetic neuropathy,Florida Atlantic University,Advanced Diabetes Treatment Centers|Global Infusions,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Florida Atlantic University Center for Complex Systems and Brain Sciences, Boca Raton, Florida, 33431, United States"
NCT00376181,"Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus",https://clinicaltrials.gov/study/NCT00376181,TERMINATED,Type 2 Diabetes,DRUG: Pioglitazone and Azilsartan|DRUG: Pioglitazone and Azilsartan|DRUG: Pioglitazone,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Huntsville, Alabama, United States|Tallassee, Alabama, United States|Little Rock, Arkansas, United States|Auburn, California, United States|Bakersfield, California, United States|Buena Park, California, United States|Chula Vista, California, United States|Huntington Park, California, United States|Los Gatos, California, United States|Norwalk, California, United States|Orangevale, California, United States|Sacramento, California, United States|Stockton, California, United States|Deerfield Beach, Florida, United States|Hialeah, Florida, United States|Hollywood, Florida, United States|Jacksonville, Florida, United States|Kissimmee, Florida, United States|Marianna, Florida, United States|Melbourne, Florida, United States|Miami, Florida, United States|Pembroke Pines, Florida, United States|Winter Haven, Florida, United States|Augusta, Georgia, United States|Dunwoody, Georgia, United States|Chicago, Illinois, United States|Bloomington, Indiana, United States|Evansville, Indiana, United States|Shawnee Mission, Kansas, United States|Prince Frederick, Maryland, United States|Livonia, Michigan, United States|St. Clair Shores, Michigan, United States|Las Vegas, Nevada, United States|Trenton, New Jersey, United States|Albany, New York, United States|Johnson City, New York, United States|Staten Island, New York, United States|Charlotte, North Carolina, United States|Salisbury, North Carolina, United States|Winston-Salem, North Carolina, United States|Marion, Ohio, United States|Oklahoma City, Oklahoma, United States|Buckingham, Pennsylvania, United States|Jeannette, Pennsylvania, United States|Mt. Pleasant, South Carolina, United States|Simpsonville, South Carolina, United States|Bristol, Tennessee, United States|New Tazewell, Tennessee, United States|Dallas, Texas, United States|El Paso, Texas, United States|Euless, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|McKinney, Texas, United States|Midland, Texas, United States|North Richland Hills, Texas, United States|San Antonio, Texas, United States|Falls Church, Virginia, United States|Virginia Beach, Virginia, United States|Buenos Aires, Argentina|Cordoba, Argentina|Santa Fe, Argentina|Santiago, Chile|Temuco, Chile|Leon, Guanajuato, Mexico|Zapopan, Jalisco, Mexico|Monterrey, NL, Mexico|Guadalajara, Mexico|Mexico, DF, Mexico|Arequipa, Peru|Lambayeque, Peru|Lima, Peru|Trujillo, Peru"
NCT00547274,Dyslipidemia in Type 2 Diabetes (0767-034),https://clinicaltrials.gov/study/NCT00547274,TERMINATED,"Diabetes Mellitus, Type II|Dyslipidemia",DRUG: MK0767,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00790699,Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port,https://clinicaltrials.gov/study/NCT00790699,TERMINATED,Type 1 Diabetes|Type 2 Diabetes,DEVICE: I-PORT|OTHER: standard injections,"Texas Diabetes & Endocrinology, P.A.","Amylin Pharmaceuticals, LLC.",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Texas Diabetes & Endocrinology, PA, Austin, Texas, 78731, United States"
NCT00287651,Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00287651,TERMINATED,"Diabetes Mellitus, With Complications",PROCEDURE: Pulsatile IV Insulin|PROCEDURE: Effects of Pulsatile IV Insulin on Diabetic Retinopathy|PROCEDURE: Effects of Pulsatile IV Insulin on Diabetic Retinopathy,Florida Atlantic University,Advanced Diabetes Treatment Centers|Global Infusions,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Florida Atlantic University Center for Complex Systems and Brain Sciences, Boca Raton, Florida, 33431, United States"
NCT00891995,Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00891995,TERMINATED,Type 1 Diabetes,DEVICE: Closed loop|DEVICE: Home glucose monitoring|DEVICE: Insulin pump|DEVICE: Continuous glucose monitor,Jaeb Center for Health Research,,ALL,"CHILD, ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Stanford University, Stanford, California, 94305, United States|Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, 80010, United States|Yale University, New Haven, Connecticut, 06519, United States|Indiana University, Indianapolis, Indiana, 46202, United States|Vanderbilt University, Nashville, Tennessee, 37232, United States"
NCT00979394,Evaluation of Diabetes Care at Austrian GPs,https://clinicaltrials.gov/study/NCT00979394,TERMINATED,Type 2 Diabetes,,AstraZeneca,Bristol-Myers Squibb,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT01002339,Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation,https://clinicaltrials.gov/study/NCT01002339,TERMINATED,"Diabetes Mellitus, Adult-Onset",DRUG: Tacrolimus with rapid steroid withdrawal|DRUG: Tacrolimus with steroids minimization|DRUG: CsA with steroid minimization,Armando Torres Ramírez,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Antonio Osuna, Granada, Andalucía, 18014, Spain|Domingo Hernández, Málaga, Andalucía, 29010, Spain|Carmen Díaz Corte, Oviedo, Asturias, 33006, Spain|Carlos Gómez Alamillo, Santander, Cantabria, 39008, Spain|Juan Manuel Díaz, Barcelona, Cataluña, 08025, Spain|Francisco Moreso, Barcelona, Cataluña, 08035, Spain|Francisco Valdés, La Coruña, Galicia, 15006, Spain|Armando Torres Ramírez, La Laguna, S/C De Tenerife, 38320, Spain|Roberto Gallego, Las Palmas de Gran Canaria, 35010, Spain|Luis Pallardo, Valencia, 46017, Spain"
NCT03258281,Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus,https://clinicaltrials.gov/study/NCT03258281,TERMINATED,"Diabetes Mellitus, Type 2|Dyslipidemia Associated With Type II Diabetes Mellitus|Percutaneous Coronary Intervention",DRUG: Evolocumab|DRUG: Placebo,Inova Health Care Services,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Inova Fairfax Hospital, Falls Church, Virginia, 22042, United States"
NCT04962048,The Influence of Pulse-synchronized Negative Pressure on the Dermal Microcirculation,https://clinicaltrials.gov/study/NCT04962048,TERMINATED,Microcirculation|Diabetes,DEVICE: pulse-synchronized negative pressure (PSNP) device|OTHER: Control - no intervention,Orputec,Medical University of Graz|Joanneum Research Forschungsgesellschaft mbH,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Division of Plastic, Aesthetic and Reconstructive Surgery, Graz, Styira, 8036, Austria"
NCT04983979,The ORTIZ Study: Optimising RASi Therapy With SZC,https://clinicaltrials.gov/study/NCT04983979,TERMINATED,"CKD|Diabetes Mellitus, Type 2|Hyperkalemia",DRUG: Sodium Zirconium Cyclosilicate|DRUG: Placebo,Barts & The London NHS Trust,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Kieran Mccafferty, London, Uk, E1 1BB, United Kingdom"
NCT05694741,"A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186",https://clinicaltrials.gov/study/NCT05694741,TERMINATED,Type 2 Diabetes,DRUG: AZD0186|DRUG: Placebo,AstraZeneca,Parexel,ALL,ADULT,PHASE1,INTERVENTIONAL,"Research Site, Glendale, California, 91206, United States"
NCT02416193,Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D),https://clinicaltrials.gov/study/NCT02416193,TERMINATED,Diabetes|Executive Dysfunction,DRUG: Cholecalciferol|DRUG: Cholecalciferol,Loyola University,University of Chicago,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Loyola University Medical Center, Maywood, Illinois, 60153, United States"
NCT05610722,Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1,https://clinicaltrials.gov/study/NCT05610722,TERMINATED,Type 1 Diabetes,DEVICE: DreaMed Endo Digital,Rabin Medical Center,DreaMed Diabetes,ALL,"CHILD, ADULT",,INTERVENTIONAL,"schneider children medical center of Israel, Petach Tikva, 49202, Israel"
NCT01628445,Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin,https://clinicaltrials.gov/study/NCT01628445,TERMINATED,Type 2 Diabetes,DRUG: liraglutide|DRUG: placebo injection,University of Manitoba,Novo Nordisk A/S,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Winnipeg Regional Health Authority Health Sciences Centre Winnipeg Diabetes Research Group, Winnipeg, Manitoba, R3E3P4, Canada"
NCT03419624,The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients,https://clinicaltrials.gov/study/NCT03419624,TERMINATED,"Obesity|Diabetes Mellitus, Type 2","DRUG: Dapagliflozin 10mg|DRUG: Exenatide 2 mg [Bydureon]|DRUG: Placebo Oral Tablet|DRUG: Placebo injection|DRUG: Insulin|DRUG: Metformin, if taken before",Universitätsklinikum Hamburg-Eppendorf,AstraZeneca,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Diabeteszentrum Oldenburg, Oldenburg, Lower Saxony, 23758, Germany|University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany|Diabetologische Schwerpunktpraxis Harburg, Hamburg, 21073, Germany|Gemeinschaftspraxis für Innere Medizin und Diabetologie, Hamburg, 22607, Germany"
NCT01381926,Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist,https://clinicaltrials.gov/study/NCT01381926,TERMINATED,Type 2 Diabetes Mellitus|Bone Remodeling,DRUG: exenatide|DRUG: Saline,University of Alabama at Birmingham,"Amylin Pharmaceuticals, LLC.",FEMALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States"
NCT02671331,Loop Duodenal Switch Surgery in Morbidly Obese Patients,https://clinicaltrials.gov/study/NCT02671331,TERMINATED,Obesity|Type-2 Diabetes Mellitus,PROCEDURE: Loop duodenal switch,Medical College of Wisconsin,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States"
NCT00255645,"G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)",https://clinicaltrials.gov/study/NCT00255645,TERMINATED,Type 2 Diabetes,,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Research Site, Birmingham, Alabama, United States|Research Site, Columbiana, Alabama, United States|Research Site, Mobile, Alabama, United States|Research Site, Chandler, Arizona, United States|Research Site, Mesa, Arizona, United States|Research Site, Phoenix, Arizona, United States|Research Site, Searcy, Arizona, United States|Research Site, Sierra Vista, Arizona, United States|Research Site, Tucson, Arizona, United States|Research Site, Carlisle, Arkansas, United States|Research Site, Jonesboro, Arkansas, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Sherwood, Arkansas, United States|Research Site, Anaheim, California, United States|Research Site, Carmichael, California, United States|Research Site, Chula Vista, California, United States|Research Site, Elk Grove, California, United States|Research Site, Encinitas, California, United States|Research Site, Encino, California, United States|Research Site, Escondido, California, United States|Research Site, Fresno, California, United States|Research Site, Greenbrae, California, United States|Research Site, Huntington Beach, California, United States|Research Site, La Jolla, California, United States|Research Site, Loma Linda, California, United States|Research Site, Long Beach, California, United States|Research Site, Los Angeles, California, United States|Research Site, Mission Viejo, California, United States|Research Site, Northridge, California, United States|Research Site, Orange, California, United States|Research Site, Pasadena, California, United States|Research Site, Redondo Beach, California, United States|Research Site, Riverside, California, United States|Research Site, Sacramento, California, United States|Research Site, San Diego, California, United States|Research Site, Santa Ana, California, United States|Research Site, Santa Monica, California, United States|Research Site, Spring Valley, California, United States|Research Site, Tustin, California, United States|Research Site, Walnut Creek, California, United States|Research Site, West Hills, California, United States|Research Site, Colorado Springs, Colorado, United States|Research Site, Wheat Ridge, Colorado, United States|Research Site, Waterbury, Connecticut, United States|Research Site, Newark, Delaware, United States|Research Site, Washington, District of Columbia, United States|Research Site, Brandon, Florida, United States|Research Site, Clearwater, Florida, United States|Research Site, Cooper City, Florida, United States|Research Site, Delray Beach, Florida, United States|Research Site, Gainesville, Florida, United States|Research Site, Hialeah, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Melbourne, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Ocoee, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Palm Harbor, Florida, United States|Research Site, Plantation, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Augusta, Georgia, United States|Research Site, Brunswick, Georgia, United States|Research Site, Columbus, Georgia, United States|Research Site, Dunwoody, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Boise, Idaho, United States|Research Site, Berwyn, Illinois, United States|Research Site, Chicago Heights, Illinois, United States|Research Site, Chicago, Illinois, United States|Research Site, Elk Grove Village, Illinois, United States|Research Site, Gurnee, Illinois, United States|Research Site, Melrose Park, Illinois, United States|Research Site, North Chicago, Illinois, United States|Research Site, Peoria, Illinois, United States|Research Site, Springfield, Illinois, United States|Research Site, Sterling, Illinois, United States|Research Site, Evansville, Indiana, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Waterloo, Iowa, United States|Research Site, Topeka, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Lexington, Kentucky, United States|Research Site, Louisville, Kentucky, United States|Research Site, Bossier City, Louisiana, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Slidell, Louisiana, United States|Research Site, Baltimore, Maryland, United States|Research Site, Columbia, Maryland, United States|Research Site, Haverhill, Massachusetts, United States|Research Site, Cadillac, Michigan, United States|Research Site, Kalamazoo, Michigan, United States|Research Site, Excelsior Springs, Missouri, United States|Research Site, Richmond Heights, Missouri, United States|Research Site, Rolla, Missouri, United States|Research Site, St Louis, Missouri, United States|Research Site, Omaha, Nebraska, United States|Research Site, Las Vegas, Nevada, United States|Research Site, North Las Vegas, Nevada, United States|Research Site, Pahrump, Nevada, United States|Research Site, Reno, Nevada, United States|Research Site, Dover, New Hampshire, United States|Research Site, Hamilton, New Jersey, United States|Research Site, Pleasantville, New Jersey, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Bronx, New York, United States|Research Site, Brooklyn, New York, United States|Research Site, Flushing, New York, United States|Research Site, Manlius, New York, United States|Research Site, New Hyde Park, New York, United States|Research Site, New York, New York, United States|Research Site, Olean, New York, United States|Research Site, Rochester, New York, United States|Research Site, Staten Island, New York, United States|Research Site, White Plains, New York, United States|Research Site, Asheville, North Carolina, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Wilmington, North Carolina, United States|Research Site, Winston-Salem, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Cleveland, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Dayton, Ohio, United States|Research Site, Kettering, Ohio, United States|Research Site, Toledo, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Tulsa, Oklahoma, United States|Research Site, Medford, Oregon, United States|Research Site, Portland, Oregon, United States|Research Site, Altoona, Pennsylvania, United States|Research Site, Cheswick, Pennsylvania, United States|Research Site, Erie, Pennsylvania, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Reading, Pennsylvania, United States|Research Site, Warminster, Pennsylvania, United States|Research Site, Columbia, South Carolina, United States|Research Site, Greer, South Carolina, United States|Research Site, Simpsonville, South Carolina, United States|Research Site, Memphis, Tennessee, United States|Research Site, Morristown, Tennessee, United States|Research Site, Carrollton, Texas, United States|Research Site, Corpus Christi, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Fort Worth, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Midland, Texas, United States|Research Site, North Richland Hills, Texas, United States|Research Site, Roseland, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Salt Lake City, Utah, United States|Research Site, Burke, Virginia, United States|Research Site, Norfolk, Virginia, United States|Research Site, Richmond, Virginia, United States|Research Site, Virginia Beach, Virginia, United States|Research Site, Bellevue, Washington, United States|Research Site, Gig Harbor, Washington, United States|Research Site, Renton, Washington, United States|Research Site, Seattle, Washington, United States|Research Site, Spokane, Washington, United States|Research Site, Tacoma, Washington, United States|Research Site, Huntington, West Virginia, United States|Research Site, Madison, Wisconsin, United States|Research Site, Menomonee Falls, Wisconsin, United States|Research Site, Milwaukee, Wisconsin, United States|Research Site, Moron, Buenos Aires, Argentina|Research Site, Quilmes, Buenos Aires, Argentina|Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Córdoba, Argentina|Research Site, Rosario, Argentina|Research Site, Salta, Argentina|Research Site, Adelaide, Australia|Research Site, Brisbane, Australia|Research Site, Cairns, Australia|Research Site, Geelong, Australia|Research Site, Melbourne, Australia|Research Site, Perth, Australia|Research Site, Sydney, Australia|Research Site, Tasmania, Australia|Research Site, Antwerpen, Belgium|Research Site, Braine-L'alleud, Belgium|Research Site, Hasselt, Belgium|Research Site, Liege, Belgium|Research Site, Merksem, Belgium|Research Site, Sint-Gillis-Waas, Belgium|Research Site, Steenokkerzeel, Belgium|Research Site, Curitiba, Brazil|Research Site, Fortaleza, Brazil|Research Site, Goiânia, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, São Paulo, Brazil|Research Site, Calgary, Alberta, Canada|Research Site, Edmonton, Alberta, Canada|Research Site, Abbotsford, British Columbia, Canada|Research Site, Coquitlam, British Columbia, Canada|Research Site, Surrey, British Columbia, Canada|Research Site, Vancouver, British Columbia, Canada|Research Site, Winnipeg, Manitoba, Canada|Research Site, Bay Roberts, Newfoundland and Labrador, Canada|Research Site, Mount Pearl, Newfoundland and Labrador, Canada|Research Site, St. John's, Newfoundland and Labrador, Canada|Research Site, Halifax, Nova Scotia, Canada|Research Site, Truro, Nova Scotia, Canada|Research Site, Windzor, Nova Scotia, Canada|Research Site, Bolton, Ontario, Canada|Research Site, Brampton, Ontario, Canada|Research Site, Etobicoke, Ontario, Canada|Research Site, Hamilton, Ontario, Canada|Research Site, Hastings, Ontario, Canada|Research Site, Kingston, Ontario, Canada|Research Site, London, Ontario, Canada|Research Site, Napanee, Ontario, Canada|Research Site, Niagara Falls, Ontario, Canada|Research Site, North York, Ontario, Canada|Research Site, Oshawa, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Scarborough, Ontario, Canada|Research Site, Smith Falls, Ontario, Canada|Research Site, St. Catherines, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Chicoutimi, Quebec, Canada|Research Site, LavaL, Quebec, Canada|Research Site, Longueuil, Quebec, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Sherbrooke, Quebec, Canada|Research Site, Trois-Rivières, Quebec, Canada|Research Site, Brno, Czech Republic|Research Site, Hodonin, Czech Republic|Research Site, Hradec Kralove, Czech Republic|Research Site, Plzen, Czech Republic|Research Site, Praha, Czech Republic|Research Site, Pribram, Czech Republic|Research Site, Semily, Czech Republic|Research Site, Tabor, Czech Republic|Research Site, Usti nad Labem, Czech Republic|Research Site, Paide, Estonia|Research Site, Pärnu, Estonia|Research Site, Tallinn, Estonia|Research Site, Tartu, Estonia|Research Site, Viljandi, Estonia|Research Site, Helsinki, Finland|Research Site, Hämeenlinna, Finland|Research Site, Imatra, Finland|Research Site, Joensuu, Finland|Research Site, Kauniainen, Finland|Research Site, Kokkola, Finland|Research Site, Kouvola, Finland|Research Site, Kuopio, Finland|Research Site, Lahti, Finland|Research Site, Mikkeli, Finland|Research Site, Oulu, Finland|Research Site, Pietarsaari, Finland|Research Site, Pori, Finland|Research Site, Salo, Finland|Research Site, Seinajoki, Finland|Research Site, Tampere, Finland|Research Site, Turku, Finland|Research Site, Vaasa, Finland|Research Site, Vantaa, Finland|Research Site, Belgrade, Former Serbia and Montenegro|Research Site, Ambriere Les Vallees, France|Research Site, Angers, France|Research Site, Beziers, France|Research Site, Briey, France|Research Site, Broglie, France|Research Site, Château Gontier, France|Research Site, Crémeaux, France|Research Site, Fontaine St Martin, France|Research Site, Gan, France|Research Site, Hyeres, France|Research Site, Jarny, France|Research Site, La Garde, France|Research Site, La Seyne Sur Mer, France|Research Site, Lambersat, France|Research Site, Laval, France|Research Site, Le Brusc, France|Research Site, Le Lavandou, France|Research Site, Lille, France|Research Site, Lomme, France|Research Site, Marignane, France|Research Site, Mars da Tour, France|Research Site, Mayenne, France|Research Site, Metz, France|Research Site, Mondelange, France|Research Site, Montbrison, France|Research Site, Montpellier, France|Research Site, Montrevault, France|Research Site, Moutiers, France|Research Site, Nantes, France|Research Site, Paris, France|Research Site, Poitiers, France|Research Site, Roanne, France|Research Site, Roquevaire, France|Research Site, Saint Jean de Luz, France|Research Site, Saint-Cyr, France|Research Site, Six Fours Les Plages, France|Research Site, St Chamond, France|Research Site, Tantonville, France|Research Site, Tierce, France|Research Site, Toulon, France|Research Site, Toulouse, France|Research Site, Aschaffenburg, Germany|Research Site, Beckum, Germany|Research Site, Berlin, Germany|Research Site, Dresden, Germany|Research Site, Duesseldorf, Germany|Research Site, Ehrenberg, Germany|Research Site, Essen, Germany|Research Site, Gelnhausen, Germany|Research Site, Hamburg, Germany|Research Site, Hannover, Germany|Research Site, Heidelberg, Germany|Research Site, Heilbronn, Germany|Research Site, Hermaringen, Germany|Research Site, Künzing, Germany|Research Site, Langen, Germany|Research Site, Mannheim, Germany|Research Site, Marl, Germany|Research Site, Nürberg, Germany|Research Site, Pirna, Germany|Research Site, Rotenburg/Fulda, Germany|Research Site, Athens, Greece|Research Site, Piraeus, Greece|Research Site, Hong Kong, Hong Kong|Research Site, Shatin, N.T., Hong Kong|Research Site, Balatonfüred, Hungary|Research Site, Budapest, Hungary|Research Site, Gy?r, Hungary|Research Site, Kaposvár, Hungary|Research Site, Kecskemét, Hungary|Research Site, Miskolc, Hungary|Research Site, Siófok, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Bangalore, India|Research Site, Hyderabad, India|Research Site, Mumbai, India|Research Site, New Delhi, India|Research Site, Jakarta, Indonesia|Research Site, Malang, Indonesia|Research Site, Ashkelon, Israel|Research Site, Haifa, Israel|Research Site, Holon, Israel|Research Site, Jerusalem, Israel|Research Site, Rishon-Lezion, Israel|Research Site, Tel Aviv, Israel|Research Site, Tel Hashomer, Israel|Research Site, Zefat, Israel|Research Site, Arenzano, Italy|Research Site, Chiavari (GE), Italy|Research Site, Chieri, Italy|Research Site, Firenze, Italy|Research Site, Gubbio (PG), Italy|Research Site, Messina, Italy|Research Site, Milano, Italy|Research Site, Monteccio Emilia, Italy|Research Site, Napoli, Italy|Research Site, Padova, Italy|Research Site, Perugia, Italy|Research Site, Pescara, Italy|Research Site, Piacenza, Italy|Research Site, Pistoia, Italy|Research Site, Reggio Calabria, Italy|Research Site, Reggio Emilia, Italy|Research Site, Roma, Italy|Research Site, Scandiano, Italy|Research Site, Udine, Italy|Research Site, Seoul, Korea, Republic of|Research Site, Suwon, Korea, Republic of|Research Site, Daugavpils, Latvia|Research Site, Jekabpils, Latvia|Research Site, Madona, Latvia|Research Site, Riga, Latvia|Research Site, SIgulda, Latvia|Research Site, Talsi, Latvia|Research Site, Valmiera, Latvia|Research Site, Vilnius, Lithuania|Research Site, Kuala Lumpur, Malaysia|Research Site, Kubang Kerian, Kota Bharu, Malaysia|Research Site, Penang, Malaysia|Research Site, Guadalajara, Jalisco, Mexico|Research Site, México, D.F., Mexico|Research Site, Nuevo León, Monterrey, Mexico|Research Site, Torreon, Mexico|Research Site, Veracruz, Veracruz, Mexico|Research Site, Zapopan , Jalisco, Mexico|Research Site, Beek en Donk, Netherlands|Research Site, Bennebroek, Netherlands|Research Site, Den Haag, Netherlands|Research Site, Deurne, Netherlands|Research Site, Huizen, Netherlands|Research Site, Losser, Netherlands|Research Site, Nijverdal, Netherlands|Research Site, Rijswijk, Netherlands|Research Site, Roelofarendsveen, Netherlands|Research Site, Rotterdam, Netherlands|Research Site, Aurskog, Norway|Research Site, Bergen, Norway|Research Site, Elverum, Norway|Research Site, Enebakk, Norway|Research Site, Fredrikstad, Norway|Research Site, Hamar, Norway|Research Site, Haugesund, Norway|Research Site, Horten, Norway|Research Site, Hønefoss, Norway|Research Site, Inderøy, Norway|Research Site, Kongsberg, Norway|Research Site, Larvik, Norway|Research Site, Lena, Norway|Research Site, Lierskogen, Norway|Research Site, Lysaker, Norway|Research Site, Oslo, Norway|Research Site, Rolvsøy, Norway|Research Site, Rud, Norway|Research Site, Soerumsand, Norway|Research Site, Stavanger, Norway|Research Site, Straume, Norway|Research Site, Trondheim, Norway|Research Site, Ås, Norway|Research Site, Østerås, Norway|Research Site, Cebu City, Philippines|Research Site, Makati, Philippines|Research Site, Manila, Philippines|Research Site, Marikina City, Philippines|Research Site, Pasig City, Philippines|Research Site, Quezon City, Philippines|Research Site, Bialystok, Poland|Research Site, Bydgoszcz, Poland|Research Site, Gdansk, Poland|Research Site, Katowice - Ochojec, Poland|Research Site, Krakow, Poland|Research Site, Lodz, Poland|Research Site, Lublin, Poland|Research Site, Olsztyn, Poland|Research Site, Poznan, Poland|Research Site, P³ock, Poland|Research Site, Radom, Poland|Research Site, Rzeszow, Poland|Research Site, Sopot, Poland|Research Site, Szczecin, Poland|Research Site, Toruñ, Poland|Research Site, Tychy, Poland|Research Site, Warszawa, Poland|Research Site, Wroclaw, Poland|Research Site, Zielona Gora, Poland|Research Site, Almada, Portugal|Research Site, Amadora, Portugal|Research Site, Elvas, Portugal|Research Site, Lisbon, Portugal|Research Site, Portalegre, Portugal|Research Site, Moscow, Russian Federation|Research Site, St. Petersburg, Russian Federation|Research Site, Yaroslavl, Russian Federation|Research Site, Singapore, Singapore|Research Site, Bratislava, Slovakia|Research Site, Dolny Kubin, Slovakia|Research Site, Ilava, Slovakia|Research Site, Kosice, Slovakia|Research Site, Kysucke Nove Mesto, Slovakia|Research Site, Levice, Slovakia|Research Site, Lubochna, Slovakia|Research Site, Lucenec, Slovakia|Research Site, Nitra, Slovakia|Research Site, Nove Zamky, Slovakia|Research Site, Povazska Bystrica, Slovakia|Research Site, Presov, Slovakia|Research Site, Sahy, Slovakia|Research Site, Trencin, Slovakia|Research Site, Trnava, Slovakia|Research Site, Velky Meder, Slovakia|Research Site, Zilina, Slovakia|Research Site, Cape Town, South Africa|Research Site, Chatsworth, South Africa|Research Site, Durban, South Africa|Research Site, Gauteng, South Africa|Research Site, Houghton Gauteng, South Africa|Research Site, Johannesburg, South Africa|Research Site, Pretoria, South Africa|Research Site, Barcelona, Spain|Research Site, Begonte (Lugo), Spain|Research Site, Guissona (Lleida), Spain|Research Site, Madrid, Spain|Research Site, San Sebastian de los Reyes, Spain|Research Site, San Vicente de Raspeig (Alicante), Spain|Research Site, Sevilla, Spain|Research Site, Valencia, Spain|Research Site, Villar del Arzobispo (Valencia), Spain|Research Site, Borås, Sweden|Research Site, Dalby, Sweden|Research Site, Göteborg, Sweden|Research Site, Höganäs, Sweden|Research Site, Malmö, Sweden|Research Site, Mölndal, Sweden|Research Site, Partille, Sweden|Research Site, Skene, Sweden|Research Site, Skrivarp, Sweden|Research Site, Stenungsund, Sweden|Research Site, Uddevalla, Sweden|Research Site, Uppsala, Sweden|Research Site, Vänersborg, Sweden|Research Site, Åmål, Sweden|Research Site, Bern, Switzerland|Research Site, Ilanz, Switzerland|Research Site, Lausanne, Switzerland|Research Site, Monthey, Switzerland|Research Site, Zürich, Switzerland|Research Site, Changhua, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taipei, Taiwan|Research Site, Bangkok, Thailand|Research Site, Aberdeen, United Kingdom|Research Site, Atherstone, United Kingdom|Research Site, Ayr, United Kingdom|Research Site, Bath, United Kingdom|Research Site, Belfast, United Kingdom|Research Site, Berks, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Bolton, United Kingdom|Research Site, Bucks, United Kingdom|Research Site, Cardiff, United Kingdom|Research Site, Co Antrim N Ireland, United Kingdom|Research Site, Co. Wexford, Ireland, United Kingdom|Research Site, Coventry, United Kingdom|Research Site, Dublin, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Edinburgh, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Kent, United Kingdom|Research Site, Leeds, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Northampton, United Kingdom|Research Site, Pembrokeshire, United Kingdom|Research Site, Plymouth, United Kingdom|Research Site, Radstock, United Kingdom|Research Site, Reading, United Kingdom|Research Site, Shrewsbury, United Kingdom|Research Site, Surrey, United Kingdom|Research Site, West Midlands, United Kingdom|Research Site, Wiltshire, United Kingdom|Research Site, Wrexham, United Kingdom|Research Site, Hanoi, Vietnam|Research Site, Ho Chi Minh, Vietnam"
NCT02162004,Continuous Correction,https://clinicaltrials.gov/study/NCT02162004,TERMINATED,Type 1 Diabetes,PROCEDURE: Continuous Correction,Hvidovre University Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hvidovre University Hospital, Hvidovre, 2650, Denmark"
NCT00775541,Hyperglycemia and Oxidative Stress in the Human Brain With Diabetes,https://clinicaltrials.gov/study/NCT00775541,TERMINATED,Type 2 Diabetes,DIETARY_SUPPLEMENT: Vitamin C,"In-Young Choi, Ph.D.",,ALL,ADULT,,INTERVENTIONAL,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States"
NCT01647308,Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01647308,TERMINATED,Type 2 Diabetes,DRUG: ISIS-APOCIIIRX|DRUG: Placebo,"Ionis Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Profil Institute for Clinical Research, Chula Vista, California, 91911, United States"
NCT00478972,Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise,https://clinicaltrials.gov/study/NCT00478972,TERMINATED,Obesity|Diabetes Mellitus Type 2,DRUG: Rimonabant|DRUG: placebo (for Rimonabant)|OTHER: Diet and exercise,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Tokyo, Japan"
NCT00478595,Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug,https://clinicaltrials.gov/study/NCT00478595,TERMINATED,Obesity|Diabetes Mellitus Type 2,DRUG: Rimonabant|DRUG: Placebo (for Rimonabant)|DRUG: Anti-diabetic monotherapy,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Tokyo, Japan"
NCT00965510,SeaCare's Care Coordination for Diabetes Management in a Primary Care Office,https://clinicaltrials.gov/study/NCT00965510,TERMINATED,Type 2 Diabetes,BEHAVIORAL: care coordination,SeaCare Health Services,New Hampshire Charitable Foundation,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Exeter Family Care, Exeter, New Hampshire, 03833, United States"
NCT05552859,Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment,https://clinicaltrials.gov/study/NCT05552859,TERMINATED,Type 2 Diabetes Mellitus|Renal Impairment,DRUG: Insulin glargine 300 U/mL|DRUG: Insulin degludec 100 U/mL,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Yuma Clinical Trials, LLC Site Number: 8400028, Yuma, Arizona, 85364-7110, United States|American Clinical Trials Site Number: 8400014, Buena Park, California, 90620-3800, United States|Clearview Medical Research LLC Site Number: 8400021, Canyon Country, California, 91351-4138, United States|Torrance Clinical Research Institute Site Number: 8400003, Lomita, California, 90717-2101, United States|Center for Endocrinology Diabetes and Metabolic Disorders (CEDMD) - CAR Site Number: 8400026, Santa Clarita, California, 91321-2454, United States|San Fernando Valley Health Institute - ClinEdge - PPDS Site Number: 8400023, Van Nuys, California, 91405-3605, United States|Chase Medical Research LLC Site Number: 8400007, Waterbury, Connecticut, 06708, United States|Innovative Research of West Florida Site Number: 8400016, Clearwater, Florida, 33756-2004, United States|Evolution Clinical Trials Site number: 8400034, Hialeah Gardens, Florida, 33016, United States|Wellness Research Center Inc - Miami Site Number: 8400010, Miami, Florida, 33135-1601, United States|Med Research of Florida, LLC Investigator Site: 8400033, Miami, Florida, 33186, United States|Florida Institute For Clinical Research LLC Site Number: 8400004, Orlando, Florida, 32825, United States|Emory University Site Number: 8400032, Atlanta, Georgia, 30303, United States|Agile Clinical Research Trials, LLC Site Number: 8400001, Atlanta, Georgia, 30328-5532, United States|Centricity Research Site Number: 8400006, Columbus, Georgia, 31904, United States|Georgia Clinical Research Site Number: 8400009, Lawrenceville, Georgia, 30044-5896, United States|Endocrine and Metabolic Consultants Research Center Site Number: 8400031, Rockville, Maryland, 20852, United States|Diabetes, Obesity, Cardiovascular Clinical Specialists (DOCS) Site Number: 8400019, Las Vegas, Nevada, 89113-3628, United States|Mid Hudson Medical Research PLLC Site Number: 8400024, New Windsor, New York, 12553-7754, United States|Lucas Research - Morehead City - HyperCore - PPDS Site Number: 8400008, Morehead City, North Carolina, 28557-3126, United States|Advanced Medical Research Site Number: 8400012, Maumee, Ohio, 43537-1863, United States|Capital Area Research LLC Site Number: 8400029, Newport, Pennsylvania, 17074, United States|Jefferson University Physicians (JUP) Site Number: 8400025, Philadelphia, Pennsylvania, 19107-6810, United States|Holston Medical Group PC Site Number: 8400018, Bristol, Tennessee, 37620-7353, United States|Frontier Medical Center Site Number: 8400035, El Paso, Texas, 79935-4202, United States|Diabetes and Thyroid Center of Fort Worth PLLC Site Number: 8400015, Fort Worth, Texas, 76132-4242, United States|Juno Research, LLC Site Number: 8400017, Houston, Texas, 77054, United States|Reichman and Associates Site Number: 8400013, Houston, Texas, 77074-1691, United States|Texas Institute for Kidney and Endocrine Disorders Site Number: 8400027, Lufkin, Texas, 75904-3163, United States|Northeast Clinical Research of San Antonio LLC Site Number: 8400022, Schertz, Texas, 78154-1403, United States|Consano Clinical Research Site Number: 8400030, Shavano Park, Texas, 78231, United States|David Ramstad Associates Research - IACT - HyperCore - PPDS Site Number: 8400005, Suffolk, Virginia, 23435-3763, United States|Diabetologie MUDr. Tomas Edelsberger Site Number: 2030001, Krnov, Moravskoslezský Kraj, 794 01, Czechia|Agentura Science Pro spol. s.r.o.Site Number: 2030002, Olomouc, Olomoucký Kraj, 779 00, Czechia|Institut Klinicke A Experimentalni Mediciny Site Number: 2030006, Prague, Praha, Hlavní Mesto, 140 21, Czechia|Diacentrum Brandys n. L. Site Number: 2030004, Brandýs Nad Labem-Stará Boleslav, 250 01, Czechia|Diabetologicka, interni a obezitologicka ambulance Site Number: 2030005, Jílové U Prahy, 254 00, Czechia|Fakultni nemocnice Kralovske Vinohrady Site Number: 2030007, Praha, 100 34, Czechia|Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz Site Number: 3480006, Nyíregyháza, Szabolcs-Szatmár-Bereg, 4400, Hungary|Markusovszky Egyetemi Oktatókórház Site Number: 3480001, Szombathely, Vas, 9700, Hungary|Csolnoky Ferenc Korhaz Site Number: 3480005, Balatonfüred, Veszprém, 8230, Hungary|Zala Megyei Szent Rafael Korhaz Site Number: 3480002, Zalaegerszeg, Zala, 8904, Hungary|Magyar Honvédség Egészségügyi Központ Site Number: 3480003, Budapest, 1134, Hungary|Somogy Megyei Kaposi Mór Oktató Kórház Site Number: 3480004, Kaposvár, 7400, Hungary|Regionalna Poradnia Diabetologiczna - Wroclaw Site Number: 6160009, Wroclaw, Dolnoslaskie, 50-127, Poland|Niepubliczny Zaklad Opieki Zdrowotnej Przychodnia Specjalistyczna Medica Site Number: 6160008, Lublin, Lubelskie, 20-538, Poland|KO-MED Centra Kliniczne Sp. z o.o. Site Number: 6160010, Puławy, Lubelskie, 24-100, Poland|KO-MED Centra Kliniczne Sp. z o.o. Site Number: 6160012, Zamość, Lubelskie, 22-400, Poland|Zaklad Opieki Medycznej ""Sanatio"" Sp.z o.o. - Osrodek Leczenia Schorzen Cywilizacyjnych Site Number: 6160016, Kraków, Malopolskie, 31-548, Poland|Prywatny Gabinet Lekarski Centrum Medyczne Diabetika Dorota Mlodawska-Choluj Site Number: 6160015, Radom, Mazowieckie, 26-610, Poland|NBR Polska Site Number: 6160003, Warszawa, Mazowieckie, 00-465, Poland|Centralny Szpital Kliniczny MSW Site Number: 6160005, Warszawa, Mazowieckie, 02-507, Poland|NZOZ Gdanska Poradnia Cukrzycowa Sp. z o.o. Site Number: 6160014, Gdańsk, Pomorskie, 80-858, Poland|NZOZ Specjalistyczny Osrodek Internistyczno-Diabetologiczny Site Number: 6160001, Częstochowa, Slaskie, 42-207, Poland|Specjalistyczna Praktyka Lekarska Site Number: 6160004, Lubliniec, Slaskie, 42-700, Poland|KO-MED Centra Kliniczne Sp. z o.o. Site Number:6160011, Staszów, Swietokrzyskie, 28-200, Poland|Centrum Medyczne OMEDICA Site Number: 6160013, Poznań, Wielkopolskie, 60-111, Poland|Gabinet Lekarski Malgorzata Saryusz-Wolska Site Number: 6160017, Lódz, 90-132, Poland|Praktyka Lekarska Ewa Krzyzagórska Site Number: 6160014, Poznan, 61-655, Poland|Prywatny Gabinet Lekarski, Centrum Medyczne ""Diabetika"" Site Number:6160002, Radom, 26-600, Poland|ETG Skierniewice - PPDS Site Number: 6160006, Skierniewice, Lódzkie, Poland|ETG Lodz Site Number: 6160018, Łódź, 90-302, Poland|Clinical Hospital Centar Zvezdara Site Number: 6880001, Belgrade, 11000, Serbia|University Clinical Center of Serbia - PPDS Site Number: 6880003, Belgrade, 11000, Serbia|University Clinical Center of Serbia - PPDS Site Number: 6880004, Belgrade, 11000, Serbia|University Clinical Center Nis Site Number: 6880002, Niš, 18 000, Serbia|University Clinical Center Nis Site Number: 6880005, Niš, 18 000, Serbia|Health Center Zajecar Site Number: 6880006, Zaječar, 19000, Serbia"
NCT01579136,Do Home Monitors Improve Blood Pressure Control?,https://clinicaltrials.gov/study/NCT01579136,TERMINATED,Hypertension|Diabetes Mellitus,BEHAVIORAL: Home blood pressure monitor,Exempla Saint Joseph Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Caritas Clinic, Exempla Saint Joseph Hospital, Denver, Colorado, 80218, United States"
NCT02632292,EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02632292,TERMINATED,Coronary Artery Disease|Diabetes Mellitus,DEVICE: Absorb GT1|DEVICE: Promus,University of Luebeck,"University Hospital Schleswig-Holstein|Kerckhoff Klinik|Charite University, Berlin, Germany",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Luebeck, Luebeck, 23538, Germany"
NCT00494663,A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00494663,TERMINATED,Type 2 Diabetes,DRUG: DIO-902|DRUG: DIO-902|DRUG: DIO-902|DRUG: DIO-902 placebo|DRUG: DIO-902|DRUG: DIO-902|DRUG: DIO-902|DRUG: DIO-902 placebo,DiObex,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Dr. Terence Hart, Muscle Shoals, Alabama, 35662, United States|Genova Research, Tucson, Arizona, 85741, United States|Research Solutions, Jonesboro, Arkansas, 72401, United States|Arkansas Primary Care Clinic, Little Rock, Arkansas, 72211, United States|Advanced Medical Research, Lakewood, California, 90712, United States|Mills-Peninsula Helath Services, San Mateo, California, 94401, United States|Diabetes Research Goup University of Hawaii at Manoa, Honolulu, Hawaii, 96813, United States|Creighton Diabetes Center, Omaha, Nebraska, 68131, United States|AHS Oklahoma Physician Group, Tulsa, Oklahoma, 74104, United States|Covance Clinical Research Unit - Dr. Andrew Ahmann, Portland, Oregon, 927239, United States|Covance CRU, Austin, Texas, 78752, United States|Diabetes Glandular and Disease Research Associates, San Antonio, Texas, 78229, United States|Flinders Medical Centre, Adelaide, South Australia, Australia|Lyell McEwin Hospital, North Western Adelaide, South Australia, Australia|ECRU, Box Hill, Melbourne, Victoria, Australia|School of Medicine and Pharmacology, Fremantle, Western Australia, 6160, Australia|Keough Institute, Nedands, Western Australia, 6009, Australia|Endocrinology Research Unit, Herston Road, QLD 4029, Australia|Endocrinology Department, St Leonards, NSW 2065, Australia|Royal Melbourn Hospital, Victoria, Australia|Middlemore Hospital, Otahuhu, Auckland, New Zealand|Lipid and Diabetes Research, Christchurch, New Zealand|Waikaito Hospital, Hamilton, New Zealand|Diabetes Centre, Wellington, New Zealand"
NCT03991299,"Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects",https://clinicaltrials.gov/study/NCT03991299,TERMINATED,"Obese|Diabetes Mellitus, Type 2",DRUG: Botox 200 UNT Injection,Vanderbilt University Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Vanderbilt University Medical Center, Nashville, Tennessee, 37232-6602, United States"
NCT02892604,Study the Feasibility of Permanent Use of inControl for the Treatment of Type 1 Diabetes,https://clinicaltrials.gov/study/NCT02892604,TERMINATED,Type 1 Diabetes,DEVICE: insulin pump to inControl AP platform,"University Hospital, Montpellier","MEDBIOMED, Montpellier, France|Jaeb Center for Health Research|University of Virginia",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"UHMontpellier, Montpellier, 34295, France"
NCT00789945,Timing of Insulin Before Meals Everyday,https://clinicaltrials.gov/study/NCT00789945,TERMINATED,Type 1 Diabetes,OTHER: Control|OTHER: Study Arm B,University of New Mexico,American Diabetes Association,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"UNM HSC Diabetes Research and Treatment Center, Albuquerque, New Mexico, 87131, United States|Unm Hsc Gcrc, Albuquerque, New Mexico, 87131, United States"
NCT01834144,The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) Trial,https://clinicaltrials.gov/study/NCT01834144,TERMINATED,Type 1 Diabetes,OTHER: Exercise Training,University of Manitoba,Manitoba Institute of Child Health,ALL,"CHILD, ADULT",,INTERVENTIONAL,"University of Calgary, Calgary, Alberta, T2N 1N4, Canada|University of Alberta, Edmonton, Alberta, T6G 2R3, Canada|Manitoba Institute of Child Health, WInnipeg, Manitoba, R3E 3P4, Canada|McMaster University, Hamilton, Ontario, L8S 4L8, Canada|University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada"
NCT00806585,Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007),https://clinicaltrials.gov/study/NCT00806585,TERMINATED,Type 2 Diabetes Mellitus|Hypertension,DRUG: MK-0736|DRUG: Comparator: Placebo|DRUG: Comparator: HCTZ,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00982293,The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes,https://clinicaltrials.gov/study/NCT00982293,TERMINATED,Type 2 Diabetes,DEVICE: Resonator device|DEVICE: Resonator device - sham,"pico-tesla Magnetic Therapies, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"pico-tesla Magnetic Therapies, Littleton, Colorado, 80120, United States"
NCT02236481,Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes,https://clinicaltrials.gov/study/NCT02236481,TERMINATED,"Diabetes Mellitus, Type 2|Arthritis, Rheumatoid",DRUG: Anakinra|DRUG: TNF alpha inhibitors,Prof. Roberto Giacomelli,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"L'Aquila University, L'Aquila, 67100, Italy"
NCT04892680,Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT04892680,TERMINATED,Type 2 Diabetes,BEHAVIORAL: Online Diabetes Self-Management Education and Support (DSMES) Program,"Omada Health, Inc.",Sutter Health|Palo Alto Medical Foundation,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Palo Alto Medical Foundation Research Institute, Palo Alto, California, 94301, United States"
NCT03228602,Impaired Gustatory Sensory Perception in Obese and Obese Diabetic Persons,https://clinicaltrials.gov/study/NCT03228602,TERMINATED,Obesity|Diabetes,OTHER: Recording of GEP (Gustatory Evoked Potentials),Centre Hospitalier Universitaire Dijon,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"CHU Dijon Bourgogne, Dijon, 21079, France"
NCT01387659,Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations,https://clinicaltrials.gov/study/NCT01387659,TERMINATED,Diabetes|Immunosuppression,PROCEDURE: Gastric emptying test,"The University of Texas Medical Branch, Galveston",Novartis Pharmaceuticals,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Texas Medical Branch, Galveston, Texas, 77555, United States"
NCT02965443,Dapagliflozin + Saxagliptin in a Basal-bolus Insulin Treatment,https://clinicaltrials.gov/study/NCT02965443,TERMINATED,Type 2 Diabetes,DRUG: Dapagliflozin 10 mg + Saxagliptin 5 mg|DRUG: Placebo 1 10 mg + Placebo 2 5 mg,University Hospital Tuebingen,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University Hospital Tübingen, Tübingen, 72076, Germany"
NCT01017965,Impact of Objective Sleep Duration on Blood Glucose Control in Type 1 Diabetes Adult Patients,https://clinicaltrials.gov/study/NCT01017965,TERMINATED,Type 1 Diabetes,DEVICE: Actimeter + blood pressure monitoring,"University Hospital, Grenoble",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Service de Diabétologie du Pr Halimi, CHU, Grenoble Cedex 9, 38043, France"
NCT02526069,An ACT Based Application for Young People With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT02526069,TERMINATED,Type 1 Diabetes,BEHAVIORAL: Acceptance and Commitment Therapy,University of Edinburgh,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"University of Edinburgh, Edinburgh, EH8 9AG, United Kingdom"
NCT00965458,Inducing Remission in Type 1 Diabetes With Alefacept,https://clinicaltrials.gov/study/NCT00965458,TERMINATED,New-onset Type 1 Diabetes Mellitus,BIOLOGICAL: Alefacept|DRUG: Placebo,National Institute of Allergy and Infectious Diseases (NIAID),Immune Tolerance Network (ITN)|Juvenile Diabetes Research Foundation|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"University of Arizona, Tucson, Arizona, 85724, United States|Children's Hospital of Los Angeles, Los Angeles, California, 90027, United States|University of California - San Francisco, San Francisco, California, 94143, United States|Barbara Davis Center for Childhood Diabetes - University of Colorado, Aurora, Colorado, 80045, United States|Emory University, Atlanta, Georgia, 30322, United States|Indiana University, Indianapolis, Indiana, 46202, United States|University of Iowa Hospital & Clinics, Iowa City, Iowa, 52242, United States|University of Maryland, Baltimore, Maryland, 21201, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, 64108, United States|Creighton University, Omaha, Nebraska, 68131, United States|University of North Carolina, Durham, North Carolina, 27713, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Benaroya Research Institute at Virginia Mason, Seattle, Washington, 98101, United States"
NCT02914821,Do Taxes Reduce the Purchasing of Soda?,https://clinicaltrials.gov/study/NCT02914821,TERMINATED,Obesity|Diabetes,BEHAVIORAL: Simulated tax via 3 cent per ounce price increase,Harvard University,,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT00627783,Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00627783,TERMINATED,Type 2 Diabetes,OTHER: a bicycle exercise test,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hopital Louis Pradel, Bron, 69500, France"
NCT01196104,Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler,https://clinicaltrials.gov/study/NCT01196104,TERMINATED,Type 2 Diabetes,DRUG: Technosphere® Insulin Inhalation Powder|DRUG: Insulin Aspart|DRUG: Insulin Glargine,Mannkind Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Coastal Clinical Research Inc, Mobile, Alabama, 36608, United States|Valley Research, Fresno, California, 93720, United States|Health Care Partners Medical Group, Long Beach, California, 90806, United States|Diabetes Research Center, Tustin, California, 92780, United States|Diablo Clinical Research, Walnut Creek, California, 94598, United States|Laureate Clinical Research Group, Atlanta, Georgia, 30308, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|Alta Pharmaceutical Research Center, Dunwoody, Georgia, 30338, United States|John H Stoger Jr Hospital of Cook County, Chicago, Illinois, 60612, United States|LaPorte County Institute for Clinical Research Inc., Michigan City, Indiana, 46360, United States|Radiant Research Inc (Minneapolis), Edina, Minnesota, 55435, United States|Amin Radparvar's Private Practice, St Peters, Missouri, 63376, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|Billings Clinic Research Center, Billings, Montana, 59101, United States|Creighton Diabetes Center, Omaha, Nebraska, 68131, United States|University of New Mexico HCS, Albuquerque, New Mexico, 87131, United States|Winthrop University Hospital, Mineola, New York, 11501, United States|North Shore Diabetes and Endocrine Associates, New Hyde Park, New York, 11042, United States|Endocrine Research Physicians East PA, Greenville, North Carolina, 27834, United States|Your Diabetes Endocrine Nutrition Group, Inc., Mentor, Ohio, 44060, United States|Legacy Clinical Research, Portland, Oregon, 97232, United States|OHSU Diabetes Center Research Oregon Health & Science University, Portland, Oregon, 97239, United States|The Endocrine Clinic, Memphis, Tennessee, 38119, United States|Dallas Diabetes & Endocrine Center, Dallas, Texas, 75230, United States|Baylor Endocrine Center, Dallas, Texas, 75246, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|SAM Clinical Research Center, San Antonio, Texas, 78229, United States|Exodus Healthcare Network, Magna, Utah, 84044, United States|Diabetes Research Center -Fletcher Allen Health Care, South Burlington, Vermont, 05403, United States"
NCT01581736,Molecular Regulation of Muscle Glucose Metabolism,https://clinicaltrials.gov/study/NCT01581736,TERMINATED,Obesity|Type 2 Diabetes Mellitus,DRUG: U100 Humulin|OTHER: Exercise,Mayo Clinic,Arizona State University,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States"
NCT00472953,Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD),https://clinicaltrials.gov/study/NCT00472953,TERMINATED,"Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Chronic Obstructive Pulmonary Disease",DRUG: inhaled human insulin|DRUG: insulin aspart,Novo Nordisk A/S,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novo Nordisk Investigational Site, Buenos Aires, B1636DSU, Argentina|Novo Nordisk Investigational Site, Buenos Aires, C1425AGC, Argentina|Novo Nordisk Investigational Site, Ciudad de Buenos Aires, 1280, Argentina|Novo Nordisk Investigational Site, Chandigarh, Punjab, 160012, India|Novo Nordisk Investigational Site, Vellore, Tamil Nadu, 632004, India|Novo Nordisk Investigational Site, Kolkata, West Bengal, 700020, India|Novo Nordisk Investigational Site, Hyderabad, 600034, India|Novo Nordisk Investigational Site, Mumbai, 400 067, India|Novo Nordisk Investigational Site, Pune, 411011, India|Novo Nordisk Investigational Site, Bucharest, 020475, Romania|Novo Nordisk Investigational Site, Bucharest, 020992, Romania|Novo Nordisk Investigational Site, Kosice, 04190, Slovakia|Novo Nordisk Investigational Site, Lubochna, 03491, Slovakia|Novo Nordisk Investigational Site, Moldava nad Bodvou, 045 01, Slovakia|Novo Nordisk Investigational Site, Zilina, 01001, Slovakia|Novo Nordisk Investigational Site, Zilina, 01207, Slovakia|Novo Nordisk Investigational Site, Changhua, 500, Taiwan|Novo Nordisk Investigational Site, Chiayi City, 600, Taiwan|Novo Nordisk Investigational Site, Taipei, 231, Taiwan|Novo Nordisk Investigational Site, Bangkok, 10330, Thailand|Novo Nordisk Investigational Site, Bangkok, 10700, Thailand|Novo Nordisk Investigational Site, Erzurum, 25240, Turkey|Novo Nordisk Investigational Site, Gaziantep, 27070, Turkey|Novo Nordisk Investigational Site, Istanbul, 34400, Turkey|Novo Nordisk Investigational Site, Istanbul, 34722, Turkey|Novo Nordisk Investigational Site, Istanbul, 34890, Turkey|Novo Nordisk Investigational Site, Kocaeli, 41380, Turkey"
NCT00490893,Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir,https://clinicaltrials.gov/study/NCT00490893,TERMINATED,Diabetes Mellitus|Hypoglycemia,DRUG: Detemir,University Hospital Tuebingen,,ALL,ADULT,PHASE4,INTERVENTIONAL,"University of Tübingen, Medical Department, Tübingen, 72076, Germany"
NCT00252876,GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00252876,TERMINATED,Type 2 Diabetes,DRUG: tesaglitazar,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Birmingham, Alabama, United States|Research Site, Columbiana, Alabama, United States|Research Site, Mobile, Alabama, United States|Research Site, Carlisle, Arkansas, United States|Research Site, Sherwood, Arkansas, United States|Research Site, Chula Vista, California, United States|Research Site, Escondido, California, United States|Research Site, Huntington Beach, California, United States|Research Site, Los Angeles, California, United States|Research Site, Mission Viejo, California, United States|Research Site, Orange, California, United States|Research Site, Pasadena, California, United States|Research Site, Redondo Beach, California, United States|Research Site, Sacramento, California, United States|Research Site, Colorado Springs, Colorado, United States|Research Site, Wheat Ridge, Colorado, United States|Research Site, Clearwater, Florida, United States|Research Site, Gainesville, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Miami, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Brunswick, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Boise, Idaho, United States|Research Site, Evansville, Indiana, United States|Research Site, Witchita, Kansas, United States|Research Site, Bossier City, Louisiana, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Baltimore, Maryland, United States|Research Site, Kalamazoo, Michigan, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Pahrump, Nevada, United States|Research Site, Hamilton, New Jersey, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Bronx, New York, United States|Research Site, New York, New York, United States|Research Site, Rochester, New York, United States|Research Site, White Plains, New York, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Dayton, Ohio, United States|Research Site, Kettering, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Medford, Oregon, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Simpsonville, South Carolina, United States|Research Site, Morristown, Tennessee, United States|Research Site, Corpus Christi, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Burke, Virginia, United States|Research Site, Norfolk, Virginia, United States|Research Site, Richmond, Virginia, United States|Research Site, Tacoma, Washington, United States|Research Site, Menomonee Falls, Wisconsin, United States|Research Site, Milwaukee, Wisconsin, United States|Research Site, Moron, Buenos Aires, Argentina|Research Site, Quilmes, Buenos Aires, Argentina|Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Córdoba, Argentina|Research Site, Rosario, Argentina|Research Site, Salta - Salta, Argentina|Research Site, Adelaide, Australia|Research Site, Brisbane, Australia|Research Site, Cairns, Australia|Research Site, Geelong, Australia|Research Site, Melbourne, Australia|Research Site, Perth, Australia|Research Site, Sydney, Australia|Research Site, Tasmania, Australia|Research Site, Curitiba, Brazil|Research Site, Fortaleza, Brazil|Research Site, Goiânia, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, São Paulo, Brazil|Research Site, Calgary, Alberta, Canada|Research Site, Coquitlam, British Columbia, Canada|Research Site, Surrey, British Columbia, Canada|Research Site, Winnipeg, Manitoba, Canada|Research Site, Bay Roberts, Newfoundland and Labrador, Canada|Research Site, Mount Pearl, Newfoundland and Labrador, Canada|Research Site, St. John's, Newfoundland and Labrador, Canada|Research Site, Bolton, Ontario, Canada|Research Site, Brampton, Ontario, Canada|Research Site, Hamilton, Ontario, Canada|Research Site, Hastings, Ontario, Canada|Research Site, Kingston, Ontario, Canada|Research Site, London, Ontario, Canada|Research Site, Napanee, Ontario, Canada|Research Site, North York, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Smith Falls, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Chomedey-Laval, Quebec, Canada|Research Site, Laval, Quebec, Canada|Research Site, Montréal, Quebec, Canada|Research Site, Sherbrooke, Quebec, Canada|Research Site, Brno, Czech Republic|Research Site, Hodonin, Czech Republic|Research Site, Hradec Kralove, Czech Republic|Research Site, Plzen, Czech Republic|Research Site, Praha 5, Czech Republic|Research Site, Pribram, Czech Republic|Research Site, Semily, Czech Republic|Research Site, Tabor, Czech Republic|Research Site, Usti nad Labem, Czech Republic|Research Site, Paide, Estonia|Research Site, Pärnu, Estonia|Research Site, Tallinn, Estonia|Research Site, Tartu, Estonia|Research Site, Viljandi, Estonia|Research Site, Helsinki, Finland|Research Site, Hämeenlinna, Finland|Research Site, Imatra, Finland|Research Site, Joensuu, Finland|Research Site, Kokkola, Finland|Research Site, Kouvola, Finland|Research Site, Kuopio, Finland|Research Site, Lahti, Finland|Research Site, Mikkeli, Finland|Research Site, Oulu, Finland|Research Site, Pietarsaari, Finland|Research Site, Salo, Finland|Research Site, Seinajoki, Finland|Research Site, Tampere, Finland|Research Site, Turku, Finland|Research Site, Vaasa, Finland|Research Site, Vantaa, Finland|Research Site, Belgrade, Former Serbia and Montenegro|Research Site, Athens, Greece|Research Site, Piraeus, Greece|Research Site, Hong Kong, Hong Kong|Research Site, Balatonfüred, Hungary|Research Site, Budapest, Hungary|Research Site, Győr, Hungary|Research Site, Kaposvár, Hungary|Research Site, Kecskemét, Hungary|Research Site, Miskolc, Hungary|Research Site, Siófok, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Bangalore, India|Research Site, Hyderabad, India|Research Site, Mumbai, India|Research Site, New Delhi, India|Research Site, Jakarta, Indonesia|Research Site, Malang, Indonesia|Research Site, Ashkelon, Israel|Research Site, Haifa, Israel|Research Site, Holon, Israel|Research Site, Jerusalem, Israel|Research Site, Rishon-Lezion, Israel|Research Site, Tel Aviv, Israel|Research Site, Tel Hashomer, Israel|Research Site, Zefat, Israel|Research Site, Arenzano, Italy|Research Site, Chiavari (GE), Italy|Research Site, Chieri, Italy|Research Site, Firenze, Italy|Research Site, Messina, Italy|Research Site, Milano, Italy|Research Site, Monteccio Emilia, Italy|Research Site, Napoli, Italy|Research Site, Padova, Italy|Research Site, Pescara, Italy|Research Site, Piacenza, Italy|Research Site, Pistoia, Italy|Research Site, Reggio Calabria, Italy|Research Site, Reggio Emilia, Italy|Research Site, Roma, Italy|Research Site, Scandiano, Italy|Research Site, Udine, Italy|Research Site, Seoul, Korea, Republic of|Research Site, Suwon, Korea, Republic of|Research Site, Daugavpils, Latvia|Research Site, Jekabpils, Latvia|Research Site, Madona, Latvia|Research Site, Riga, Latvia|Research Site, SIgulda, Latvia|Research Site, Talsi, Latvia|Research Site, Valmiera, Latvia|Research Site, Vilnius, Lithuania|Research Site, Kubang Kerian, Kota Bharu, Malaysia|Research Site, Kuala Lumpur, Malaysia|Research Site, Penang, Malaysia|Research Site, Beek en Donk, Netherlands|Research Site, Bennebroek, Netherlands|Research Site, Den Haag, Netherlands|Research Site, Deurne, Netherlands|Research Site, Huizen, Netherlands|Research Site, Losser, Netherlands|Research Site, Nijverdal, Netherlands|Research Site, Rijswijk, Netherlands|Research Site, Roelofarendsveen, Netherlands|Research Site, Rotterdam, Netherlands|Research Site, Cebu City, Philippines|Research Site, Makati, Philippines|Research Site, Manila, Philippines|Research Site, Marikina City, Philippines|Research Site, Pasig City, Philippines|Research Site, Quezon City, Philippines|Research Site, Katowice, Ochojec, Poland|Research Site, Bialystok, Poland|Research Site, Bydgoszcz, Poland|Research Site, Gdansk, Poland|Research Site, Krakow, Poland|Research Site, Lodz, Poland|Research Site, Olsztyn, Poland|Research Site, Poznan, Poland|Research Site, Radom, Poland|Research Site, Rzeszow, Poland|Research Site, Sopot, Poland|Research Site, Szczecin, Poland|Research Site, Toruñ, Poland|Research Site, Tychy, Poland|Research Site, Warszawa, Poland|Research Site, Wroclaw, Poland|Research Site, Zielona Gora, Poland|Research Site, Almada, Portugal|Research Site, Amadora, Portugal|Research Site, Elvas, Portugal|Research Site, Lisbon, Portugal|Research Site, Portalegre, Portugal|Research Site, Moscow, Russian Federation|Research Site, St. Petersburg, Russian Federation|Research Site, Yaroslavl, Russian Federation|Research Site, Singapore, Singapore|Research Site, Dolny Kubin, Slovakia|Research Site, Levice, Slovakia|Research Site, Lubochna, Slovakia|Research Site, Lucenec, Slovakia|Research Site, Nove Zamky, Slovakia|Research Site, Povazska Bystrica, Slovakia|Research Site, Sahy, Slovakia|Research Site, Trencin, Slovakia|Research Site, Velky Meder, Slovakia|Research Site, Zilina, Slovakia|Research Site, Cape Town, South Africa|Research Site, Chatsworth, South Africa|Research Site, Durban, South Africa|Research Site, Gauteng, South Africa|Research Site, Johannesburg, South Africa|Research Site, Pretoria, South Africa|Research Site, Bern, Switzerland|Research Site, Ilanz, Switzerland|Research Site, Lausanne, Switzerland|Research Site, Monthey, Switzerland|Research Site, Zürich, Switzerland|Research Site, Aberdeen, United Kingdom|Research Site, Atherstone, United Kingdom|Research Site, Ayr, United Kingdom|Research Site, Bath, United Kingdom|Research Site, Belfast, United Kingdom|Research Site, Berks, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Bolton, United Kingdom|Research Site, Bucks, United Kingdom|Research Site, Cardiff, United Kingdom|Research Site, Coventry, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Edinburgh, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Leeds, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Northampton, United Kingdom|Research Site, Plymouth, United Kingdom|Research Site, Radstock, United Kingdom|Research Site, Shrewsbury, United Kingdom|Research Site, Surrey, United Kingdom|Research Site, West Bromwich, United Kingdom|Research Site, Wiltshire, United Kingdom|Research Site, Wrexham, United Kingdom|Research Site, Hanoi, Vietnam|Research Site, Ho Chi Minh, Vietnam"
NCT00569465,N-Acetylcysteine and Arginine Administration in Diabetic Patients,https://clinicaltrials.gov/study/NCT00569465,TERMINATED,Type 2 Diabetes Mellitus|Hypertension,DRUG: Arginine|DRUG: Acetylcysteine|DRUG: Placebo,"University of Turin, Italy",,MALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"""San Giovanni Battista"" Hospital of Turin, Turin, 10126, Italy"
NCT01398995,Managing Insulin Pumps for Exercise (Study 2),https://clinicaltrials.gov/study/NCT01398995,TERMINATED,Type 1 Diabetes,OTHER: Reduction of basal insulin infusion to 50% of normal,Buckinghamshire Healthcare NHS Trust,Animas Corporation,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Wycombe Hospital, High Wycombe, Buckinghamshire, HP11 2TT, United Kingdom"
NCT02409017,A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial,https://clinicaltrials.gov/study/NCT02409017,TERMINATED,Diabetes|Pregnancy,PROCEDURE: Insulin drip,WellSpan Health,,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"WellSpan York Hospital, York, Pennsylvania, 17403, United States"
NCT00666861,Type 2 Diabetes and Exercise - A Pilot Study,https://clinicaltrials.gov/study/NCT00666861,TERMINATED,Type 2 Diabetes,,Bayside Health,"International Diabetes Institute, Australia|Baker Heart Research Institute",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Alfred Hospital, Melbourne, Victoria, 3004, Australia"
NCT00938119,Care China-Diabetes,https://clinicaltrials.gov/study/NCT00938119,TERMINATED,Cardiovascular Disease|Diabetes,,"Johnson & Johnson Medical, China",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Beijing Anzhen Hospital of the Capital University of Medical Science, Beijing, Beijing, 100029, China|General Hospital of Armed Police Forces, Beijing, Beijing, 100039, China|Peking University People's Hospital, Beijing, Beijing, 100044, China|Beijing Tongren Hospital affiliated to Capital Medical University, Beijing, Beijing, 100730, China|Beijing Chaoyang Hospital, Beijing, Beijing, China|Beijing Friendship Hospital, Beijing, Beijing, China|Beijing Hospital, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|Peking University Third Hospital, Beijing, Beijing, China|The General Hospital of the People's Liberation Army, Beijing, Beijing, China|Xuan Wu Hospital Capital Medical University, Beijing, Beijing, China|China-Japan Friendship Hospital, Beijng, Beijing, 100029, China|Zhongshan Hospital Xiamen University, Xiamen, Fujian, China|Lanzhou University First Hospita, Lanzhou, Gansu, China|Peking University, Shenzhen Hospital, Guangdong, Guangdong, China|NanFang Hospital Affiliated to Southern Medical University, Guangzhou, Guangdong, 510515, China|Guangdong General Hospital, Guangzhou, Guangdong, China|The First Affiliated Hospital,Sun Yat-Sen University, Guangzhou, Guangdong, China|Peace Hospital, ShiJiaZhuang, Hebei, 050082, China|The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China|Henan Provincial People's Hospital, Zhengzhou, Henan, 450000, China|Nanjing First Hospital, Nanjing, Jiangsu, China|The Second Affiliated Hospital of Jilin University, Changchun, Jilin, China|The General Hospital of Shenyang Military Command, Shenyang, Liaoning, 110015, China|The First Hospital of China Medical University, Shenyang, Liaoning, China|The Affiliated Hospital Of Medical College Qingdao University, Qingdao, Shandong, China|Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China|Zhongshan Hospital Fudan University, Shanghai, Shanghai, 200032, China|Shanghai Jiaotong University School of Medicine affiliated Renji Hospital, Shanghai, Shanghai, China|Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, 030001, China|The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China|Xijing Hospital, Xian, Shanxi, China|Tian Jin Chest Hospital, Tianjin, Tianjin, China|Tianjin First Center Hospital, Tianjin, Tianjin, China|People's Hospital Of XinJiang Uygur Autonomous Region, Urumuqi, Xinjiang, China|Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, 310009, China|Cardiovascular Institute & Fu Wai Hospital, Beijing, 100037, China|General Hospital of Daqing Oilfield, Da Qing, China|Sir Run Run Shaw Hospital, Hang Zhou, 310016, China|Shandong Provincial Hospital, Jinan, 250021, China|Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, China|Shengjing Hospital of China Medical University, Shen Yang, 110004, China|Teda International Cardiovascular Hospital, Tianjin, China|The Affiliated Hospital of Medical College of Chinese Armed Police Forces, Tianjin, China|The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, 325000, China|The First Hospital of Xian Jiao Tong University, Xi'an, 710061, China"
NCT03071692,Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT),https://clinicaltrials.gov/study/NCT03071692,TERMINATED,Type2 Diabetes|Dyslipidemia,DRUG: K-877|DRUG: Placebo,"Kowa Research Institute, Inc.",Brigham and Women's Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Synexus Clinical Research US, Inc., Birmingham, Alabama, 35211, United States|University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|VA Medical Center - Birmingham, Birmingham, Alabama, 35233, United States|Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, 35235, United States|Fundamental Research, LLC, Gulf Shores, Alabama, 36542, United States|Mobile Heart Specialists, PC, Mobile, Alabama, 36608, United States|Terence T. Hart, MD, Tuscumbia, Alabama, 35674, United States|Synexus Clinical Research US, Inc., Chandler, Arizona, 85224-6279, United States|Synexus Clinical Research US, Inc., Mesa, Arizona, 85206, United States|Arizona Arthritis & Rheumatology Research, PLLC, Peoria, Arizona, 85381, United States|Phoenix Veterans Adminstration Health Care System, Phoenix, Arizona, 85012, United States|Synexus Clinical Research US, Inc., Phoenix, Arizona, 85050, United States|Clinical Research Institute of Arizona, LLC, Surprise, Arizona, 85374, United States|Synexus Clinical Research US, Inc., Tucson, Arizona, 85712, United States|Eclipse Clinical Research, Tucson, Arizona, 85745, United States|Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, 72205, United States|Clinical Research Alliance, Inc, Alhambra, California, 91801, United States|Aurora Care Clinic, Costa Mesa, California, 92627, United States|AMCR Institute, Inc., Escondido, California, 92025, United States|National Institute of Clinical Research, Huntington Beach, California, 92648-1717, United States|VA Loma Linda Healthcare System, Loma Linda, California, 92354, United States|VA Long Beach Healthcare System, Long Beach, California, 90822, United States|Eastside Clinical Research Associates, Los Angeles, California, 90022, United States|VA Greater Los Angeles Healthcare System, Los Angeles, California, 90073, United States|Richard S. Cherlin, MD, Los Gatos, California, 95032, United States|Northridge Clinical Research Inc., Northridge, California, 91324, United States|Palo Alto Division, Palo Alto, California, 94304, United States|Huntington Hospital - Research Department, Pasadena, California, 91105, United States|Rancho Cucamonga Clinical Research, Rancho Cucamonga, California, 91730, United States|MD Strategies Research Centers, San Diego, California, 92119, United States|Alex Harrison, MD Inc., Santa Maria, California, 93454, United States|Santa Rosa Cardiology Medical Group, Inc., Santa Rosa, California, 95404, United States|Blue Coast Cardiology, Vista, California, 92083, United States|Lynn Institute of Denver, Aurora, Colorado, 80012, United States|New West Physicians, PC, Golden, Colorado, 80401, United States|Southwest Family Medicine, Littleton, Colorado, 80127, United States|Chase Medical Research, LLC, Waterbury, Connecticut, 06708, United States|VA Connecticut Healthcare Sys, West Haven, Connecticut, 06516-2770, United States|Cardiology Physicians, PA, Newark, Delaware, 19713, United States|Bay Pines VA Healthcare System, Bay Pines, Florida, 33744, United States|Meridien Research, Bradenton, Florida, 34201, United States|Clinical Research Of Brandon, LLC, Brandon, Florida, 33511, United States|Clearwater Cardiovascular Consultants, Clearwater, Florida, 33756, United States|Daytona Heart Group, Daytona Beach, Florida, 32114, United States|Cohen Medical Research Associates, LLC, Delray Beach, Florida, 33446, United States|Malcom Randall VA Medical Center, Gainesville, Florida, 32608, United States|Pines Clinical Research, Inc., Hollywood, Florida, 33024, United States|Homestead Cardiac & Vein Center, Homestead, Florida, 33030, United States|Westside Center for Clinical Research, Jacksonville, Florida, 32205, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, 32216, United States|Health Awareness, Inc., Jupiter, Florida, 33458, United States|Meridien Research, Lakeland, Florida, 33805, United States|Clearwater Cardiovascular & Interventional Consultants, Largo, Florida, 33777, United States|University of Miami, Miami, Florida, 33136, United States|Advanced Medical Research Institute, Miami, Florida, 33174, United States|Ocala Research Institute, Inc., Ocala, Florida, 34471, United States|Morgan Medical Management & Consultants Inc., Ocala, Florida, 34474, United States|Endocrine Associates of Florida, Ocoee, Florida, 34761, United States|Research Physicians Network Alliance, Orlando, Florida, 32803, United States|Andres Patron, D.O., P.A, Pembroke Pines, Florida, 33026, United States|DBC Research, Corp, Pembroke Pines, Florida, 33029, United States|Langhorne Cardiology Consultants, Inc., Pensacola, Florida, 32501, United States|Clearwater Cardiovascular Consultants, Safety Harbor, Florida, 34695, United States|Professional Health Care of Pinellas, Saint Petersburg, Florida, 33713, United States|James A. Haley VA Medical Center, Tampa, Florida, 33612, United States|Clinical Research of Central Florida, Winter Haven, Florida, 33880, United States|Emory University, Atlanta, Georgia, 30322, United States|Atlanta Heart Specialists, LLC, Cumming, Georgia, 30041, United States|VA Medical Center - Atlanta, Decatur, Georgia, 30033, United States|Alta Pharmaceutical Research Center, Inc., Dunwoody, Georgia, 30338, United States|Atlanta Heart Specialists, LLC, Tucker, Georgia, 30084, United States|Christie Clinic, LLC, Champaign, Illinois, 61822, United States|Apex Medical Research, AMR, Inc., Chicago, Illinois, 60607, United States|Clinical Investigation Specialists, Inc., Gurnee, Illinois, 60031, United States|Edward Hines Jr. VA Hospital, Hines, Illinois, 60141, United States|Advocate Health and Hospitals Corp, Normal, Illinois, 61761, United States|Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois, 60064, United States|Specialty Physicians of Illinois, Olympia Fields, Illinois, 60461, United States|Community Hospital of Anderson and Madison County, Inc., Anderson, Indiana, 46011, United States|Synexus Clinical Research US, Inc., Evansville, Indiana, 47714, United States|Deaconess Clinic, Evansville, Indiana, 47725, United States|VA Medical Center - Indianapolis, Indianapolis, Indiana, 46202, United States|Cardiovascular Research of Northwest Indiana, LLC, Munster, Indiana, 46321, United States|Buynak Clinical Research, Valparaiso, Indiana, 46383, United States|West Broadway Clinic, Council Bluffs, Iowa, 51501, United States|Iowa Diabetes and Endocrinology Research Center, PLC, Des Moines, Iowa, 50314, United States|The Iowa Clinic, PC, West Des Moines, Iowa, 50266, United States|University of Kansas Medical Center Research Institute, Inc., Kansas City, Kansas, 66160, United States|VA Eastern Kansas Health Care, Leavenworth, Kansas, 66048, United States|The Research Group of Lexington, LLC, Lexington, Kentucky, 40503, United States|Robley Rex VA Medical Center, Louisville, Kentucky, 40206, United States|Cambridge Medical Trials, Alexandria, Louisiana, 71301, United States|Cardiovascular Associates Research, LLC, Covington, Louisiana, 70433, United States|Centex Studies Inc., Lake Charles, Louisiana, 70601, United States|Overton Brooks VA Medical Center, Shreveport, Louisiana, 71101, United States|Southern Maine Health Care, Biddeford, Maine, 04005, United States|Baltimore VA medical centre, Baltimore, Maryland, 21201, United States|University of Maryland School of Medicine, Baltimore, Maryland, 21201, United States|Maryland Cardiovascular Specialists, Baltimore, Maryland, 21229, United States|Medstar Health Research Institute, Hyattsville, Maryland, 20782, United States|Delmarva Heart Research Foundation, Inc., Salisbury, Maryland, 21804, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|Pentucket Medical Associates, Haverhill, Massachusetts, 01830, United States|South Shore Internal Medicine Associates, Milton, Massachusetts, 02186, United States|University of Michigan, Ann Arbor, Michigan, 48105, United States|Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, 48105, United States|Northern Pines Health Center, Buckley, Michigan, 49620, United States|Cadillac Clinical Research, LLC, Cadillac, Michigan, 49601, United States|AA MRC LLC Ahmed Arif Medical Research Center, Flint, Michigan, 48504, United States|Sparrow Clinical Research Institute, Lansing, Michigan, 48912, United States|Covenant Medical Center, Inc., Saginaw, Michigan, 48602, United States|Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, 55407, United States|Synexus Clinical Research US, Inc., Richfield, Minnesota, 55432, United States|CentraCare Heart & Vascular, Saint Cloud, Minnesota, 56303-1900, United States|HealthEast Medical Research Institute, Saint Paul, Minnesota, 55102, United States|GV Montgomery VA Medical Center, Jackson, Mississippi, 39216, United States|Kansas City VA Medical Center, Kansas City, Missouri, 64128, United States|Synexus Clinical Research US, Inc., Saint Louis, Missouri, 63141, United States|Kalispell Regional Medical Center dba Glacier View Research Institute, Kalispell, Montana, 59901, United States|VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, 68105, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198-4120, United States|Synexus Clinical Research US, Inc., Papillion, Nebraska, 68046, United States|Synexus Clinical Research US, Inc., Henderson, Nevada, 89052, United States|Red Rock Clinical Research LLC, Las Vegas, Nevada, 89146, United States|VA Sierra Nevada Health Care System, Reno, Nevada, 89502, United States|Southern New Hampshire Diabetes and Endocrinology, Nashua, New Hampshire, 03063, United States|Monmouth Cardiology Associates, Eatontown, New Jersey, 07724, United States|NJ Heart, Linden, New Jersey, 07036, United States|The Valley Hospital, Ridgewood, New Jersey, 07450, United States|Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico, 87108, United States|Endocrine Group, L.L.P., Albany, New York, 12206, United States|Stratton Veterans Affairs Medical Center - Albany, Albany, New York, 12208, United States|Buffalo VA Medical Center, Buffalo, New York, 14215, United States|Winthrop Cardiology Associates, Mineola, New York, 11501, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|SUNY Upstate Medical University, Syracuse, New York, 13210, United States|VA Medical Center - Syracuse, Syracuse, New York, 13210, United States|Randolph Medical Associates, Asheboro, North Carolina, 27203, United States|OnSite Clinical Solutions, LLC, Asheville, North Carolina, 28801, United States|Kernodle Clinic, Inc., Dept. of the Private Diagnostic Clinic, PLLC, Burlington, North Carolina, 27215, United States|Cary Research Group, LLC, Cary, North Carolina, 27518, United States|PMG Research of Cary, LLC, Cary, North Carolina, 27518, United States|Novant Health - Heart and Vascular Institute, Charlotte, North Carolina, 28204, United States|The Presbyterian Hospital, Charlotte, North Carolina, 28204, United States|Focus Clinical Research Solutions, Charlotte, North Carolina, 28277, United States|Medication Management, LLC, Greensboro, North Carolina, 27408, United States|Triad Clinical Trials, LLC, Greensboro, North Carolina, 27410, United States|Clinical Trials of America-NC, LLC, Hickory, North Carolina, 28601, United States|PMG Research of Hickory, LLC, Hickory, North Carolina, 28601, United States|Research Institute of the Carolinas, PLC, Mooresville, North Carolina, 28117, United States|Diabetes and Endocrinology Consultants, Morehead City, North Carolina, 28557, United States|Pinehurst Medical Clinic Inc, Pinehurst, North Carolina, 28374, United States|PMG Research of Raleigh, LLC, Raleigh, North Carolina, 27609, United States|PMG Research of Rocky Mount, LLC, Rocky Mount, North Carolina, 27804, United States|PMG Research of Salisbury, LLC, Salisbury, North Carolina, 28144, United States|Carolina Research Center, Inc., Shelby, North Carolina, 28150-3803, United States|Synexus Clinical Research US, Inc., Akron, Ohio, 44311, United States|OhioHealth Heart & Vascular Physicians (Heartcare, Inc.) - Athens, Athens, Ohio, 45701, United States|Aultman Hospital, Canton, Ohio, 44710, United States|Hometown Urgent Care & Occupational Health, Cincinnati, Ohio, 45215, United States|Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, 45267, United States|Louis Stokes Cleveland Dept of VA Medical Center, Cleveland, Ohio, 44106, United States|Prestige Clinical Research Center, Franklin, Ohio, 45005, United States|Craig S Thompson MD LLC, Marion, Ohio, 43302, United States|Intend Research, Norman, Oklahoma, 73069, United States|Lynn Institute of Norman, Norman, Oklahoma, 73069, United States|Oklahoma City Clinic - Central, Oklahoma City, Oklahoma, 73104, United States|South Oklahoma Heart Research Group, Oklahoma City, Oklahoma, 73135, United States|Heart Clinic of Southern Oregon, Medford, Oregon, 97504, United States|Chambersburg Hospital, Chambersburg, Pennsylvania, 17201, United States|AMH Feasterville Family Health Care Center, Feasterville, Pennsylvania, 19053, United States|Family Medical Associates, Levittown, Pennsylvania, 19056, United States|VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, 15240, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, 15317, United States|Fay West Family Practice, Scottdale, Pennsylvania, 15683, United States|Montgomery Medical Inc., Smithfield, Pennsylvania, 15478, United States|Partners in Clinical Research, Cumberland, Rhode Island, 02864, United States|Ocean State Clinical Research Partners, Lincoln, Rhode Island, 02865, United States|Providence Veteran Administration Medical Center, Providence, Rhode Island, 02908, United States|Synexus Clinical Research US, Inc., Anderson, South Carolina, 29621-2062, United States|Ralph H. Johnson VA Medical Center, Charleston, South Carolina, 29401, United States|Mountain View Clinical Research, Inc., Greer, South Carolina, 29651, United States|Piedmont Research Partners, Indian Land, South Carolina, 29707, United States|Main Street Physician's Care - Waterway, Little River, South Carolina, 29566, United States|Family Medicine of Sayebrook, Myrtle Beach, South Carolina, 29588, United States|Palmetto Research Center, LLC, Spartanburg, South Carolina, 29302, United States|Palmetto Clinical Research, Summerville, South Carolina, 29485, United States|PMG Research of Bristol, LLC, Bristol, Tennessee, 37620, United States|Chattanooga Medical Research, LLC, Chattanooga, Tennessee, 37404, United States|Chattanooga Research and Medicine (CHARM), Chattanooga, Tennessee, 37404, United States|University Diabetes & Endocrine Consultants, Chattanooga, Tennessee, 37411, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee, 37421, United States|Holston Medical Group, P.C., Kingsport, Tennessee, 37660, United States|Metro Knoxville HMA, LLC, Knoxville, Tennessee, 37934, United States|VA Medical Center - Memphis, Memphis, Tennessee, 38104, United States|Tennessee Valley Healthcare System, Nashville, Tennessee, 37232, United States|Central Texas Clinical Research, LLC, Austin, Texas, 78705, United States|Protenium Clinical Research, Dallas, Texas, 75208, United States|VA Medical Center - Dallas, Dallas, Texas, 75216, United States|North Texas Endocrine Center, Dallas, Texas, 75231, United States|Research Institute of Dallas, P.A., Dallas, Texas, 75231, United States|Synexus Clinical Research US, Inc., Dallas, Texas, 75234, United States|Doctors Hospital at Renaissance, Edinburg, Texas, 78539, United States|Texas Health Research & Education Institute, Fort Worth, Texas, 76104, United States|Texas Health Physicians Group, Fort Worth, Texas, 76107, United States|University of North Texas Health Science Center, Fort Worth, Texas, 76107, United States|Diabetes and Thyroid Center of Fort Worth, Fort Worth, Texas, 76132, United States|Rockwood Medical Clinic, Fort Worth, Texas, 76164, United States|East Texas Cardiology PA, Houston, Texas, 77002, United States|Endocrine Associates, LLC, Houston, Texas, 77004, United States|Heights Doctors Clinic, Houston, Texas, 77008, United States|Associates in Medicine, Houston, Texas, 77027, United States|Michael E. DeBakey VA Medical Center, Houston, Texas, 77030, United States|Southwest Clinical Trials, Houston, Texas, 77081, United States|Protenium Clinical Research, Hurst, Texas, 76054, United States|Houston Methodist Research Institute - CCAT Pearland, Pearland, Texas, 77584, United States|Clinical Investigations of Texas, Plano, Texas, 75075, United States|Consano Clinical Research, LLC, San Antonio, Texas, 78205, United States|Sant Antonio Premiere Internal Medicine, San Antonio, Texas, 78220, United States|Briggs Clinical Research, LLC., San Antonio, Texas, 78224, United States|Schnitzler Cardiovascular Consultants (SCC), PLLC, San Antonio, Texas, 78229-3271, United States|Bandera Family Healthcare Research LLC, San Antonio, Texas, 78249, United States|Northeast Clinical Research of San Antonio, Schertz, Texas, 78154, United States|Spring Family Practice Associates, Spring, Texas, 77379, United States|Northwest Houston Heart Center, Tomball, Texas, 77375, United States|Victoria Heart & Vascular Center, Victoria, Texas, 77901, United States|Hillcrest Family Health Clinics, Waco, Texas, 76710, United States|Utah Cardiology, P.C. (Davis), Farmington, Utah, 84025, United States|VA Medical Center, White River Junction, Vermont, 05055, United States|Burke Internal Medicine & Research, Burke, Virginia, 22015, United States|Virginia Endocrinology Research, Chesapeake, Virginia, 23321, United States|Carient Heart and Vascular, Manassas, Virginia, 20109, United States|Clinical Research Partners, LLC, Richmond, Virginia, 23220, United States|McGuire DVA Medical Center, Richmond, Virginia, 23249, United States|Roanoke Heart Institute, Roanoke, Virginia, 24014, United States|Suffolk Multispecialty Research, Suffolk, Virginia, 23435, United States|Corporation Lane Internal Medicine, Virginia Beach, Virginia, 23462, United States|Cardiology Associates of Bellin Health, Green Bay, Wisconsin, 54301, United States|Clinical Investigation Specialists Inc, Kenosha, Wisconsin, 53144, United States|Mayo Clinic Health System, La Crosse, Wisconsin, 54601, United States|Meriter Medical Group, Inc., Madison, Wisconsin, 53713, United States|Zablocki VA Medical Center, Milwaukee, Wisconsin, 53295, United States|Hospital Interzonal General de Agudos Dr Jose Penna, Bahia Blanca, Buenos Aires, 8000, Argentina|Hospital Italiano Regional del Sur, Bahia Blanca, Buenos Aires, B8001HXM, Argentina|Hospital Italiano, Ciudad Autonoma Buenos Aires, Buenos Aires, C1181ACH, Argentina|CICLO, La Plata, Buenos Aires, B1902AGY, Argentina|Centro de Investigaciones Medicas Mar del Plata, Mar del Plata, Buenos Aires, B7600FYK, Argentina|Instituto de Investigaciones Clinicas, Mar del Plata, Buenos Aires, B7600FZ, Argentina|Instituto de Investigaciones Clinicas San Nicolas, San Nicolas, Buenos Aires, B2900DMH, Argentina|Instituto Clinico Metabolico, San Nicolas, Buenos Aires, B2900DPA, Argentina|Clinica Olivos, Vicente Lopez, Buenos Aires, 1602, Argentina|Hospital Sirio Libanes, Caba, Ciudad Autonoma Buenos Aires, C1419GEP, Argentina|Sanatorio Güemes, Ciudad Autonoma de Bs. As., Ciudad Autonoma Buenos Aires, C1180AAX, Argentina|Centro Medico Viamonte SRL, Ciudad Autonoma de Buenos Aires, Ciudad Autonoma Buenos Aires, C1120AAC, Argentina|CEMEDIC - Centro de Especialidades Medicas, Villa Luro, Ciudad Autonoma Buenos Aires, C1440CFD, Argentina|Centro Medico Luquez, San Vicente, Cordoba, X5006CBI, Argentina|Axismed S.R.L.- Clínica Mayo, San Miguel de Tucuman, Tucuman, 4000, Argentina|Consultorio Dr. Litvak Bruno, Ciudad Autonoma Buenos Aires, 1406, Argentina|Fundacion Favaloro, Ciudad Autonoma Buenos Aires, C1093AAS, Argentina|CIPREC, Ciudad Autonoma Buenos Aires, C1119ACN, Argentina|Investigaciones Medicas IMOBA S.R.L, Ciudad Autonoma Buenos Aires, C1179AAB, Argentina|Centro Medico Dra Laura Maffei Investigacion Clinica Aplicada, Ciudad Autonoma Buenos Aires, C1425AGC, Argentina|CEDIC Centro de Investigaciones Clinicas, Ciudad Autonoma Buenos Aires, C1425DES, Argentina|Instituto Cardiovascular Buenos Aires, Ciudad Autonoma Buenos Aires, C1428ART, Argentina|CCBR - Buenos Aires - AR, Ciudad Autonoma Buenos Aires, C1430CKE, Argentina|Inst. Privado de Inv. Clinicas de Cordoba, Cordoba, X5000AAW, Argentina|Instituto Medico DAMIC, Cordoba, X5003DCE, Argentina|Hospital Privado Centro Medico de Cordoba S.A, Cordoba, X5016KEH, Argentina|Clinica del Prado, Cordoba, X5020AAA, Argentina|Instituto de Cardiologia de Corrientes, Corrientes, 3400, Argentina|Prevencion Cardiovascular Salta, Salta, A4400CRC, Argentina|L2IP - Instituto de Pesquisas Clínicas Ltda., Brasília, Distrito Federal, 70200-730, Brazil|Hospital do Coração do Brasil, Brasília, Distrito Federal, 70390903, Brazil|CECAP - Centro de Cardiologia Clínica, Brasília, Distrito Federal, 70710-100, Brazil|Hospital Universitário de Brasília, Brasília, Distrito Federal, 70840-091, Brazil|Clínica de Endocrinologia e Metabologia Ltda., Brasília, Distrito Federal, 71655-175, Brazil|CARDIOINTERV Centro de Pesquisa S/S, Goiânia, Goiás, 74210-050, Brazil|Via Médica, Goiânia, Goiás, 74223-130, Brazil|HC-UFG - Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Goiás, 74605-020, Brazil|Hospital Felício Rocho, Belo Horizonte, Minas Gerais, 30110-060, Brazil|CARDRESEARCH - Cardiologia Assistencial, Belo Horizonte, Minas Gerais, 30150-240, Brazil|Sociedade Hospitalar Angelina Caron, Campina Grande do Sul, Paraná, 83430-000, Brazil|Cline Research Center (Leite PS Consultoria Medica LTDA), Curitiba, Paraná, 80030-480, Brazil|Núcleo de Pesquisa Clínica S/S, Curitiba, Paraná, 80730-150, Brazil|Paraná Medical Research Center, Maringá, Paraná, 87015-000, Brazil|HUJBB-UFPA - Hospital Universitário João de Barros Barreto - Universidade Federal do Pará, Belém, Pará, 66073-000, Brazil|CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda., Rio de Janeiro, Rio Do Janeiro, 22271-100, Brazil|Eurolatino Natal Pesquisas Médicas Ltda., Natal, Rio Grande Do Norte, 59020-500, Brazil|Hospital Universitário, Canoas, Rio Grande Do Sul, 92425-900, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, 99010-080, Brazil|Santa Casa de Misericórdia de Pelotas, Pelotas, Rio Grande Do Sul, 96015-290, Brazil|Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-074, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, 90035-903, Brazil|Centro de Pesquisas em Diabetes Ltda., Porto Alegre, Rio Grande Do Sul, 90430-001, Brazil|Centro de Pesquisa Clínica Maimônides - Maimônides Day Hospital, Porto Alegre, Rio Grande Do Sul, 90480-000, Brazil|Centro de Pesquisa Médica Santa Maria Ltda., Santa Maria, Rio Grande Do Sul, 97015-530, Brazil|Maestri e Kormann Consultoria Medico Científica LTDA, Blumenau, Santa Catarina, 89010-906, Brazil|Loema - Instituto de Pesquisa Clínica, Campinas, Sao Paulo, 13010-001, Brazil|IPCC - Instituto de Pesquisa Clínica de Campinas, Campinas, Sao Paulo, 13060-080, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, São Bernardo do Campo, Sao Paulo, 09780-000, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, Sao Paulo, 15090-000, Brazil|ISPEM - Instituto São José dos Campos em Pesquisas Médicas, São José dos Campos, Sao Paulo, 12243-280, Brazil|CPQuali Pesquisa Clínica Ltda., São Paulo, Sao Paulo, 01228-000, Brazil|CPCLIN - Centro de Pesquisas Clínicas Ltda., São Paulo, Sao Paulo, 01228-200, Brazil|Clínica Paulista de Doenças Cardiovasculares Ltda., São Paulo, Sao Paulo, 01323-000, Brazil|Dr. Consulta, São Paulo, Sao Paulo, 04208-002, Brazil|CEPIC - Centro Paulista de Investigação Clínica e Serviços Médicos, São Paulo, Sao Paulo, 04266-010, Brazil|Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, Sao Paulo, 05403-000, Brazil|Incor - Instituto do Coração - HCFMUSP, São Paulo, Sao Paulo, 05403-000, Brazil|IMC - Instituto de Moléstias Cardiovasculares Tatuí, Tatuí, Sao Paulo, 18270-170, Brazil|Santa Casa de Votuporanga, Votuporanga, Sao Paulo, 15500-003, Brazil|MHAT 'Puls' AD, Blagoevgrad, 2700, Bulgaria|MHAT - Blagoevgrad, EOOD, Blagoevgrad, 2700, Bulgaria|MHAT ""Yuliya Vrevska - Byala"", EOOD, Byala, 7100, Bulgaria|MHAT-Haskovo, AD, Haskovo, 6300, Bulgaria|MHAT ""Higia"", AD - Pazardzhik, Pazardzhik, 4400, Bulgaria|MHAT - Pazardzhik AD, Pazardzhik, 4400, Bulgaria|MHAT ""Sv. Pantaleymon - Pleven"", OOD, Pleven, 5800, Bulgaria|SHATC Pleven EAD, Pleven, 5800, Bulgaria|UMHAT 'Dr. Georgi Stranski', EAD, Pleven, 5800, Bulgaria|UMHAT ""Sv. Georgi"", EAD, Plovdiv, 4000, Bulgaria|UMHAT ""Kaspela"", EOOD, Plovdiv, 4002, Bulgaria|MC Rusemed ltd., Ruse, 7013, Bulgaria|Diagnostic Consultative Center II - Sofia OOD, Sofia, 1040, Bulgaria|Fifth MHAT - Sofia EAD, Sofia, 1233, Bulgaria|NMTH ""Tsar Boris III"", Sofia, 1233, Bulgaria|MHAT - ""National Heart Hospital"" EAD, Sofia, 1309, Bulgaria|MHAT ""Lyulin"", EAD, Sofia, 1336, Bulgaria|Acibadem City Clinic Tokuda Hospital Ead, Sofia, 1407, Bulgaria|MC Start - d-r Todor Dimitrov EOOD, Sofia, 1408, Bulgaria|DCC ""Alexandrovska"", EOOD, Sofia, 1431, Bulgaria|UMHAT ""Alexandrovska"" EAD, Sofia, 1431, Bulgaria|UMHAT 'Tsaritsa Yoanna - ISUL', EAD, Sofia, 1527, Bulgaria|Fourth MHAT - Sofia EAD, Sofia, 1606, Bulgaria|Diagnostic Consultation Center CONVEX EOOD, Sofia, 1680, Bulgaria|Medical Center Kalimat, Sofia, 1680, Bulgaria|UMHAT 'Sveta Anna' AD, Sofia, 1750, Bulgaria|MC ""Synexus - Sofia"", EOOD, Sofia, 1784, Bulgaria|UMHAT ""SofiaMed"", OOD, Sofia, 1797, Bulgaria|MC ""Orfey"", EOOD, Stara Zagora, 6000, Bulgaria|SHATC ""Cardiolife"", OOD, Varna, 9000, Bulgaria|SHATC - Varna, EOOD, Varna, 9002, Bulgaria|MHAT ""Sv. Panteleymon"", AD, Yambol, 8600, Bulgaria|LMC Clinical Research Inc. (Calgary), Calgary, Alberta, T2H 2G4, Canada|ALTA Clinical Research Inc., Edmonton, Alberta, T5A 4L8, Canada|Royal Alexandra Hospital, CK Hui Heart Centre, Edmonton, Alberta, T5H 3V9, Canada|The Bailey Clinic, Red Deer, Alberta, T4N 6V7, Canada|Fraser Clinical Trials Inc., New Westminster, British Columbia, V3L 3W4, Canada|Surrey Memorial Hospital, Surrey, British Columbia, V3V 0C6, Canada|BC Diabetes As Operated by Dr. TG Elliott, Inc., Vancouver, British Columbia, V5Y 3W2, Canada|Discovery Clinical Services Ltd., Victoria, British Columbia, V8T 5G4, Canada|Saint Boniface General Hospital, Winnipeg, Manitoba, R2H 2A6, Canada|Rivergrove Medical Clinic, Winnipeg, Manitoba, R2V 4W3, Canada|Winnipeg Clinic, Winnipeg, Manitoba, R3A 1R9, Canada|Health Sciences Centre, St. John's, Newfoundland and Labrador, NL A1B 3V6, Canada|LMC Clinical Research Inc. (Barrie), Barrie, Ontario, L4N 7L3, Canada|LMC Clinical Research Inc. (Brampton), Brampton, Ontario, L6S 0C9, Canada|Aggarwal and Associates Ltd, Brampton, Ontario, L6T 0G1, Canada|JBN Medical Diagnostic Services Inc., Burlington, Ontario, L7M 4Y1, Canada|LMC Clinical Research dba Manna Research Inc. Burlington North, Burlington, Ontario, L7M 4Y1, Canada|Cambridge Cardiac Care Centre, Cambridge, Ontario, N1R 6V6, Canada|Joanne F. Liutkus Medicine Professional Corporation, Cambridge, Ontario, N1R 7L6, Canada|Saul Vizel Professional Medicine Corporation, Cambridge, Ontario, N1R 7R1, Canada|LMC Clinical Research Inc. (Thornhill), Concord, Ontario, L4K 4M2, Canada|LMC Clinical Research Inc. (Etobicoke), Etobicoke, Ontario, M9R 4E1, Canada|Dawson Road Family Medical Clinic, Guelph, Ontario, N1H 1B1, Canada|LMC Clinical Research Inc. (Ottawa), Nepean, Ontario, K2J 0V2, Canada|LMC Clinical Research Inc. (Oakville), Oakville, Ontario, L6M1M1, Canada|James Cha, MD, Oshawa, Ontario, L1J 2K1, Canada|The Ottawa Hospital - Riverside Campus, Ottawa, Ontario, K1H 7W9, Canada|Kawartha Cardiology Clinical Trials, Peterborough, Ontario, K9J 0B2, Canada|Scarborough Cardiology Research, Scarborough, Ontario, M1E 5E9, Canada|Janik Research, Sudbury, Ontario, P3E 5M4, Canada|Humber River Hospital, Toronto, Ontario, M3M 0B2, Canada|LMC Clinical Research Inc. (Bayview), Toronto, Ontario, M4G 3E8, Canada|St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada|LMC Clinical Research dba Manna Research Inc. Toronto, Toronto, Ontario, M9W 4L6, Canada|Ecogene-21, Chicoutimi, Quebec, G7H 7K9, Canada|ViaCar Recherche Clinique Inc, Greenfield Park, Quebec, J4V 2G8, Canada|Centre de Dépistage et Recherche Cardiovasculaire Rive-Sud, Longueuil, Quebec, J4M 2X1, Canada|Clinique de Cardiologie de Levis, Lévis, Quebec, G6V 4Z5, Canada|LMC Clinical Research dba Manna Research Inc. Mirabel, Mirabel, Quebec, J7J 2K8, Canada|CHUM Hôtel-Dieu, Montreal, Quebec, H2W 1T8, Canada|Applied Medical Informatics Research Inc., Montreal, Quebec, H4A 3T2, Canada|Clinique Santé Cardio MC, Montréal, Quebec, H1T 3Y7, Canada|Recherche Clinique Sigma Inc., Québec, Quebec, G1G 3Y8, Canada|Clinique Médicale St-Louis (Recherche) inc d/b/a/ Centre de Recherche Saint-Louis, Québec, Quebec, G1W 4R4, Canada|ALPHA Recherche Clinique, Québec, Quebec, G3K 2P8, Canada|LMC Clinical Research Inc. (Montreal), Saint-Laurent, Quebec, H4T 1Z9, Canada|Recherche Médicale St-Jérôme Inc., St-Jérôme, Quebec, J7Z 5T3, Canada|Centre Medical des Carrieres, St-Marc-des-Carrieres, Quebec, G0A 4B0, Canada|DIEX Recherche Quebec Inc., Quebec, G1N 4V3, Canada|Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, G1V 4G5, Canada|Clinique des maladies Lipidiques de Quebec, Quebec, G1V 4M6, Canada|Centro de Investigacion Medico Asistencial S.A.S, Barranquilla, 080020, Colombia|IPS Centro Cientifico Asistencial S.A.S, Barranquilla, 080020, Colombia|Dexa Diab Servicios Médicos Limitada., Bogota, 110221, Colombia|Solano y Terront Servicios Médicos Ltda., Bogota, 110221, Colombia|Centro Cardiovascular Aristides Sotomayor Santa Lucia S.A.S. - IPS ASTALUC S.A.S. IPS, Cartagena, 130010, Colombia|Fundación Centro de Investigaciones Biomédicas Riescard, Espinal, 00000, Colombia|Fundación Oftalmológica de Santander - FOSCAL, Floridablanca, 681004, Colombia|Centro de Investigación Clínica CIC, Medellin, 050021, Colombia|Medicentrum Beroun spol. s.r.o., Beroun, 266 01, Czechia|Nemocnice Milosrdnych bratri, Brno, 639 00, Czechia|Fakultni nemocnice u sv. Anny v Brne, Brno, 65691, Czechia|EDUMED s.r.o, Broumov, 550 01, Czechia|Poliklinika Chocen a.s., Chocen, 56501, Czechia|Ordinace pro choroby srdce s.r.o., Chomutov, 430 02, Czechia|MUDr. Jan Hubac s.r.o., Chrudim, 537 01, Czechia|Nemocnice Havlickuv Brod p.o., Havlickuv Brod, 580 22, Czechia|Kardio-Pisova s.r.o., Hradec Kralove, 500 02, Czechia|MUDr. Tomas Edelsberger, Krnov, 794 01, Czechia|EDUMED s.r.o, Nachod, 547 01, Czechia|Agentura Science Pro Spol. s.r.o., Olomouc, 772 00, Czechia|PreventaMed s.r.o., Olomouc, 77900, Czechia|CCR Ostrava s.r.o., Ostrava, 702 00, Czechia|Corintez s.r.o., Prague, 158 00, Czechia|MUDr. Jan KVASNICKA CSc. Angiologie kardiologie a interna, Praha 10, 101 00, Czechia|Nemocnice na Frantisku, Praha 1, 110 00, Czechia|Vseobecna fakultni nemocnice v Praze, Praha 2, 128 00, Czechia|ResTrial s.r.o., Praha 8, 18100, Czechia|Synexus Czech s.r.o., Praha, 120 00, Czechia|MUDr.Eva Mandakova MBA, Rakovnik, 269 01, Czechia|Nemocnice Slany, Slany, 274 01, Czechia|AeskuLab k.s., Teplice, 415 01, Czechia|Kardiologicka ambulance MUDr. Ferkl s.r.o., Trutnov, 541 01, Czechia|Clinical Trials Services s.r.o, Uherske Hradiste, 68601, Czechia|MUDr. Nina Zemkova s.r.o., Uherske Hradiste, 68601, Czechia|Bioclinica, Aalborg, 9000, Denmark|Ålborg Universitets Hospital, Aalborg, 9100, Denmark|Aarhus University Hospital, Aarhus, 8200, Denmark|Bioclinica, Ballerup, 2750, Denmark|Amager-Hvidovre Hospital, Copenhagen S, 2300, Denmark|Sydvestjyds Sygehus Esbjerg, Esbjerg, 6700, Denmark|Amager-Hvidovre Hospital, Glostrup, 2600, Denmark|Herlev og Gentofte Hospital, Hellerup, 2900, Denmark|Herlev og Gentofte Hospital, Herlev, 2730, Denmark|Regionshospitalet Herning-Hospitalsenheden Vest, Herning, 7400, Denmark|Holbæk Sygehus, Holbæk, 4300, Denmark|Sjællands Universitetshospital, Roskilde, 4000, Denmark|OUH, Svendborg, 5700, Denmark|Bioclinica, Vejle, 7100, Denmark|CHU Tours - Hôpital Trousseau, Chambray Les Tours, Indre Et Loire, 37170, France|CHU Nantes - Hopital Nord Laënnec, Nantes cedex 01, Loire Atlantique, 44093, France|Hôpital Bichat - Claude Bernard, Paris cedex 18, Paris, 75877, France|Universitaetsklinikum Freiburg, Freiburg, Baden Wuerttemberg, 79106, Germany|Praxis fuer Praevention und Therapie, Villingen-Schwenningen, Baden Wuerttemberg, 78048, Germany|Gemeinschaftspraxis Dr. Klein/ Minnich, Kuenzing, Bayern, 94550, Germany|Klinikum der Universitaet Muenchen, Muenchen, Bayern, 80336, Germany|Deutsches Herzzentrum Muenchen, Muenchen, Bayern, 80636, Germany|GP Dr. Haggenmiller, PD Dr. Michael Jeserich, Naumburg, Bayern, 90402, Germany|ZKS-Südbrandenburg -center for clinical studies Südbrandenburg GmbH, Elsterwerda, Brandenburg, 04910, Germany|Neurologische Praxis Dr. Schoell & Kollegen, Bad Homburg, Hessen, 61348, Germany|Synexus Clinical Research GmbH, Frankfurt, Hessen, 60313, Germany|ClinPhenomics GmbH & Co KG, Frankfurt, Hessen, 60596, Germany|Klinische Forschung Schwerin GmbH, Schwerin, Mecklenburg Vorpommern, 19055, Germany|Synexus Clinical Research GmbH, Bochum, Nordrhein Westfalen, 44787, Germany|Gemeinschaftspraxis Diabeteszentrum Dortmund Dr.med. Klaus Busch, Dortmund, Nordrhein Westfalen, 44137, Germany|Kardiologische Praxis Gemeinschaftspraxis, Dortmund, Nordrhein Westfalen, 44137, Germany|St. Johannes Hospital, Dortmund, Nordrhein Westfalen, 44137, Germany|Klinikum Bielefeld gem. GmbH, Dortmund, Nordrhein Westfalen, 44139, Germany|Zentrum fuer Praevention und Rehabilitation, Siegen, Nordrhein Westfalen, 57072, Germany|Synexus Clinical Research GmbH, Leipzig, Sachsen, 04103, Germany|Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut, Leipzig, Sachsen, 04249, Germany|Dr. Uwe Böckmann / Birgit Jacobs - Diabeteszentrum Neumünster, Neumünster, Schleswig Holstein, 24534, Germany|RED - Institut GmbH, Oldenburg, Schleswig Holstein, 23758, Germany|Katholisches Krankenhaus ""St. Johann Nepomuk"", Erfurt, Thueringen, 99097, Germany|Diabetespraxis Prenzlauer Allee, Berlin, 10409, Germany|Institut fuer klinische Forschung und Entwicklung Berlin GmbH, Berlin, 10437, Germany|Studienzentrum Rankestrasse, Berlin, 10789, Germany|Synexus Clinical Research GmbH, Berlin, 12627, Germany|Gemeinschaftspraxis fuer innere Medizin und Diabetologie, Hamburg, 22607, Germany|Lausmed Kft., Baja, 6500, Hungary|Principal SMO Kft., Baja, 6500, Hungary|DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured, 8230, Hungary|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Bekescsaba, 5600, Hungary|Belgyogyaszati es Kardiologiai Maganrendelo, Bekescsaba, 5600, Hungary|Clinexpert Kft., Budapest, 1033, Hungary|Synexus Magyarorszag Kft., Budapest, 1036, Hungary|CSALADGYOGYASZ Kft., Budapest, 1083, Hungary|Semmelweis Egyetem, Budapest, 1083, Hungary|Borvo Clinic Kft., Debrecen, 4025, Hungary|Debreceni Egyetem, Debrecen, 4032, Hungary|Meditoll Kft., Godollo, 2100, Hungary|Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaza, Gyula, 5700, Hungary|Synexus Magyarorszag Egeszsegugyi Szolgaltato Kft.- Gyula DRS, Gyula, 5700, Hungary|BKS Research Kft., Hatvan, 3000, Hungary|Z+P MED Egeszsegugyi, Kereskedelmi es Szolgaltato Bt., Kalocsa, 6300, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvar, 7400, Hungary|Selye Janos Korhaz, Komarom, 2900, Hungary|IPR Hungary Kft., Miskolc, 3530, Hungary|Kanizsai Dorottya Korhaz, Nagykanizsa, 8800, Hungary|Medifarma-98 Kft., Nyiregyhaza, 4400, Hungary|BORBANYA PRAXIS Kft., Nyiregyhaza, H-4405, Hungary|Dr. Nagy Laszlo Kardiologiai Maganrendeles, Oroshaza, 5900, Hungary|Da Vinci Maganklinika, Pecs, 7635, Hungary|Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, 8000, Hungary|Tolna Megyei Balassa Janos Korhaz, Szekszard, 7100, Hungary|Csolnoky Ferenc Korhaz, Veszprem, 8200, Hungary|Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, 8900, Hungary|Vijaya Super Speciality Hospital, Nellore, Andhra Pradesh, 524001, India|GNRC Hospital, Guwahati, Assam, 781006, India|Loknayak Hospital, New Delhi, Delhi, 110002, India|Sir Gangaram Hospital, New Delhi, Delhi, 110060, India|Fortis Flight Lieutenant Rajan Dhall Hospital, New Delhi, Delhi, 110070, India|Ahmedabad Bariatrics and Cosmetics Pvt Ltd., Ahmedabad, Gujarat, 380015, India|S. A. L. Hospital & Medical Institute, Ahmedabad, Gujarat, 380054, India|DDMM Heart Institute, Nadiad, Gujarat, 387002, India|Shri B. D. Mehta Mahavir Heart Institute, Surat, Gujarat, 395002, India|BAPS Pramukhswami Hospital, Surat, Gujarat, 395009, India|Sterling Hospital, Vadodara, Gujarat, 390007, India|Rhythm Heart Institute, Vadodara, Gujarat, 391740, India|Medanta The Medicity, Gurgaon, Haryana, 122001, India|Fortis Hospitals Ltd., Bangalore, Karnataka, 560052, India|K.L.E. Society's Dr. Prabhakar Kore Hospital and Medical Research Centre, Belgaum, Karnataka, 590010, India|JSS Hospital, Mysuru, Karnataka, 570004, India|Medical College, Thiruvananthapuram, Kerala, 695 011, India|Meditrina Institute Of Medical Sciences, Nagpur, Maharashtra, 440010, India|Supe Heart & Diabetes Hospital & Research Centre, Nashik, Maharashtra, 422002, India|7-Orange Hospital, Pimpri-Chinchwad, Maharashtra, 411033, India|Shree Multispecialty Hospital, Pune, Maharashtra, 411006, India|King Edward Memorial Hospital Research Centre, Pune, Maharashtra, 411011, India|Aashirwad Hospital, Ulhasnagar, Maharashtra, 421001, India|Institute of Medical Sciences and SUM Hospital, Bhubaneshwar, Orissa, 751003, India|Eternal Heart Care Centre, Jaipur, Rajasthan, 302020, India|SRM Institutes for Medical Sciences, Chennai, Tamilnadu, 600026, India|Institute of Cardiovascular Diseases Madras Medical Mission, Chennai, Tamilnadu, 600037, India|KRM Hospital & Research Centre, Lucknow, Uttar Pradesh, 226010, India|Galaxy Hospital, Varanasi, Uttar Pradesh, 221010, India|IPGMER and SSKM Hospital, Kolkata, West Bengal, 700020, India|Maharaja Agrasen Hospital, Delhi, 110052, India|HaEmek Medical Center, Afula, 18101, Israel|Bnai Zion Medical Center, Haifa, 31048, Israel|Rambam Health Care Center, Haifa, 3109601, Israel|The Lady Davis Carmel Medical Center, Haifa, 34362, Israel|Wolfson Medical Center, Holon, 58100, Israel|Shaare Zedek Medical Center, Jerusalem, 91031, Israel|Hadassah University Hospital - Ein Kerem, Jerusalem, 91120, Israel|Galilee Medical Center, Nahariya, 2210001, Israel|Rabin Medical Center-Beilinson Campus, Petach Tikva, 49100, Israel|Chaim Sheba Medical Center, Ramat-Gan, 52621, Israel|Kaplan Medical Center, Rechovot, 7610001, Israel|Ziv Medical Center, Safed, 13100, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel|Diabetes Medical Center, Tel Aviv, 6937947, Israel|Aichi Medical University Hospital, Nagakute-shi, Aichi-Ken, 480-1195, Japan|JOHAS Chubu Rosai Hospital, Nagoya-shi, Aichi-Ken, 455-8530, Japan|Kojunkai Daido Clinic, Nagoya-shi, Aichi-Ken, 457-8511, Japan|NHO Nagoya Medical Center, Nagoya-shi, Aichi-Ken, 460-0001, Japan|National Center For Geriatrics And Gerontology, Obu-shi, Aichi-Ken, 474-8511, Japan|Fujita Health University Hospital, Toyoake-shi, Aichi-Ken, 470-1192, Japan|Chiba University Hospital, Chiba-shi, Chiba-Ken, 260-8677, Japan|Kioroshikai Chibanishi General Hospital, Matsudo-shi, Chiba-Ken, 270-2251, Japan|Seikeikai New Tokyo Heart Clinic, Matsudo-shi, Chiba-Ken, 271-0077, Japan|Ehime Prefectural Central Hospital, Matsuyama-shi, Ehime-Ken, 790-0024, Japan|Fukuoka University Hospital, Fukuoka-shi, Fukuoka-Ken, 814-0180, Japan|Fukuoka Tokushukai Hospital, Kasuga-shi, Fukuoka-Ken, 816-0864, Japan|Steel Memorial Yawata Hospital, Kitakyushu-shi, Fukuoka-Ken, 805-8508, Japan|NHO Fukuoka Higashi Medical Center, Koga-shi, Fukuoka-Ken, 811-3195, Japan|Chiyukai Fukuoka Shinmizumaki Hospital, Onga-gun, Fukuoka, 807-0051, Japan|Southern Tohoku Medical Clinic, Koriyama-shi, Fukushima-Ken, 963-8052, Japan|Hoshi General Hospital, Koriyama-shi, Fukushima-Ken, 963-8501, Japan|Nakahama Heart Clinic, Fuchu-shi, Hiroshima-Ken, 726-0013, Japan|Nippon Kokan Fukuyama Hospital, Fukuyama-shi, Hiroshima-Ken, 721-0927, Japan|NHO Higashihiroshima Medical Center, Higashihiroshima-shi, Hiroshima-Ken, 739-0041, Japan|Miyanosawa Clinic of Internal Medicine and Cardiology, Sapporo-shi, Hokkaido, 063-0826, Japan|Tanaka Cardiology Clinic, Hitachinaka-shi, Ibaraki-Ken, 312-0032, Japan|Nakakinen Clinic Medical Corporation Kensei-kai, Naka-shi, Ibaraki-Ken, 311-0113, Japan|Public Central Hospital of Matto Ishikawa, Hakusan-shi, Ishikawa-Ken, 924-8588, Japan|NHI Komatsu Municipal Hospital, Komatsu-shi, Ishikawa-Ken, 923-8560, Japan|Kuonkai Kamata Medical Clinic, Morioka-shi, Iwate-Ken, 020-0866, Japan|Iwate Medical University Uchimaru Medical Center Hospital, Morioka-shi, Iwate-Ken, 020-8505, Japan|Josuikai Olive Takamatsu Medical Clinic, Takamatsu-shi, Kagawa-Ken, 760-0076, Japan|Sohken Yamamoto Clinic, Sagamihara-shi, Kanagawa-Ken, 252-0311, Japan|NHO Yokohama Medical Center, Yokohama-shi, Kanagawa-Ken, 245-8575, Japan|Kumamoto University Hospital, Kumamoto-shi, Kumamoto-Ken, 860-8556, Japan|Ryubokai Higashi Diabetes and Cardiovascular Clinic, Tamana-shi, Kumamoto-Ken, 865-0016, Japan|Ijinkai Takeda General Hospital, Kyoto-shi, Kyoto-Fu, 601-1495, Japan|Kyoto University Hospital, Kyoto-shi, Kyoto-Fu, 606-8507, Japan|Rakuwakai Otowa Hospital, Kyoto-shi, Kyoto-Fu, 607-8062, Japan|Sato Hospital, Osaki-shi, Miyagi-Ken, 989-6143, Japan|Tohoku Kosai Hospital, Sendai-shi, Miyagi-Ken, 980-0803, Japan|Sendai Kousei Hospital, Sendai-shi, Miyagi-Ken, 980-0873, Japan|Keiwakai Oita Oka Hospital, Oita-shi, Oita-Ken, 870-0192, Japan|Okayama University Hospital, Okayama-shi, Okayama-Ken, 700-8558, Japan|Okinawa Tokushukai Chubu Tokushukai Hospital, Nakagami-gun, Okinawa-Ken, 901-2393, Japan|Iwasaki Naika Clinic, Higashiosaka-shi, Osaka-Fu, 577-0802, Japan|Takekawa Naika Clinic, Higashiosaka-shi, Osaka-Fu, 577-0803, Japan|Rinku General Medical Center, Izumisano-shi, Osaka-Fu, 598-8577, Japan|Shiraiwa Medical Clinic, Kashiwara-shi, Osaka-Fu, 582-0005, Japan|Tokushukai Kishiwada Tokushukai Hospital, Kishiwada-shi, Osaka-Fu, 596-8522, Japan|Kansai Electric Power Hospital, Osaka-shi, Osaka-Fu, 553-0003, Japan|National Cerebral and Cardiovascular Center, Suita-shi, Osaka-Fu, 564-8565, Japan|Senrichuo Ekimae Clinic, Toyonaka-shi, Osaka-Fu, 560-0082, Japan|IMS Miyoshi General Hospital, Iruma-gun, Saitama-Ken, 354-0041, Japan|Sugiura Clinic, Kawaguchi-shi, Saitama-Ken, 332-0012, Japan|Sanyukai Saino Clinic, Tokorozawa-shi, Saitama-Ken, 359-1141, Japan|NHO Saitama National Hospital, Wako-shi, Saitama-Ken, 351-0102, Japan|Shiga University of Medical Science Hospital, Otsu-shi, Shiga-Ken, 520-2192, Japan|NHO Hamada Medical Center, Hamada-shi, Shimane-Ken, 697-8511, Japan|Jichi Medical University Hospital, Shimotsuke-shi, Tochigi-Ken, 329-0498, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo-To, 113-8431, Japan|Fukuwa Clinic, Chuo-ku, Tokyo-To, 103-0027, Japan|Tokyo-Eki Center-Building Clinic, Chuo-Ku, Tokyo-To, 103-0027, Japan|Nomura Clinic, Itabashi-ku, Tokyo-To, 173-0004, Japan|Hosoda Clinic, Katsushika-ku, Tokyo-To, 124-0021, Japan|Toyukai Yutenji Medical Clinic (Yutenji Naika), Meguro-ku, Tokyo-To, 153-0053, Japan|Shinjuku Research Park Clinic, Shinjuku-ku, Tokyo-To, 169-0073, Japan|Yamaguchi University Hospital, Ube-shi, Yamaguchi-Ken, 755-8505, Japan|Centro de Investigacion Cardiovascular y Metabolica, Tijuana, Baja California Norte, 22500, Mexico|Phytomedicamenta S.A. de C.V., Mexico, Distrito Federal, 03100, Mexico|Health Pharma Professional Research S.A. de C.V., Mexico, Distrito Federal, 03810, Mexico|Centro de Atención e Investigación en Factores de Riesgo Cardiovascular Omega S.C., Mexico, Distrito Federal, 06700, Mexico|Instituto Nacional de Ciencias Médicas y Nutricion Dr. Salvador Zubiran, Mexico, Distrito Federal, 14080, Mexico|Mentrials S.A. de C.V., Mexico, Distrito Federal, 67000, Mexico|Centro de Investigacion Clinica del Pacifico, S.A. de C.V., Acapulco de Juárez, Guerrero, 39670, Mexico|Cardiologia Clinica e Intervencionista, Guadalajara, Jalisco, 44670, Mexico|Centro de Investigacion Medica de Occidente, S.C., Zapopan, Jalisco, 45116, Mexico|Instituto de Diabetes, Obesidad y Nutrición S.C., Cuautla, Morelos, 62746, Mexico|Universidad Autonoma de Nuevo Leon, Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo León, 64460, Mexico|Centro Medico San Francisco, Monterrey, Nuevo León, 64710, Mexico|Unidad Medica para la Salud Integral, San Nicolas de los Garza, Nuevo León, 66465, Mexico|Centro Integral Medico SJR S.C., San Juan del Rio, Queretaro, 76800, Mexico|Centro de Estudios de Investigacion Metabolicos y Cardiovasculares S.C., Madero, Tamaulipas, 89440, Mexico|Centro de Investigacion Cardiometabolica de Aguascalientes S.A de C.V, Aguascalientes, 20230, Mexico|Investigacion En Salud Y Metabolismo S.C., Chihuahua, 31237, Mexico|Sociedad de Metabolismo y Corazon S.C, Veracruz, 91900, Mexico|Noordwest Ziekenhuisgroep, Alkmaar, 1815 JD, Netherlands|Ziekenhuisgroep Twente, Almelo, Almelo, 7609 PP, Netherlands|Meander Medisch Centrum, Amersfoort, 3813 TZ, Netherlands|Ziekenhuis Amstelland, Amstelveen, 1186 AM, Netherlands|BovenlJ Ziekenhuis, Amsterdam, 1034 CS, Netherlands|Amsterdam UMC, Locatie AMC, Amsterdam, 1105 AZ, Netherlands|Gelre ziekenhuizen, locatie Lukas, Apeldoorn, 7334 DZ, Netherlands|Rijnstate, Arnhem, 6815 AD, Netherlands|Haga Ziekenhuis, Den Haag, 2545 AA, Netherlands|Deventer Ziekenhuis, Deventer, 7416 SE, Netherlands|Albert Schweitzer Ziekenhuis, Dordwijk, Dordrecht, 3318 AT, Netherlands|Gelderse Vallei Ziekenhuis, Ede, Ede, 6716 RP, Netherlands|Catharina Ziekenhuis Eindhoven, Eindhoven, 5623 EJ, Netherlands|Spaarne Gasthuis, Hoofddorp, Haarlem, 2035 RC, Netherlands|Zuyderland Medisch Centrum - Heerlen, Heerlen, 6419 PC, Netherlands|Huisartsenpraktijk Gorecht, Hoogezand, 9603 AE, Netherlands|Quality Care Research, Kloosterhaar, 7694 AC, Netherlands|Leids Universitair Medisch Centrum, Leiden, 2333 ZA, Netherlands|Bravis Ziekenhuis, Roosendaal, Roosendaal, 4708 AE, Netherlands|Maasstad Ziekenhuis, Zuider, Rotterdam, 3079 DZ, Netherlands|Ikazia Ziekenhuis, Rotterdam, 3083 AN, Netherlands|Albert Schweitzer Ziekenhuis, Zwijndrecht, Sliedrecht, 3331 LZ, Netherlands|Bernhoven Uden, Uden, 5406 PT, Netherlands|UMC Utrecht, Utrecht, 3508 GA, Netherlands|Diakonessenhuis, Utrecht, Utrecht, 3582 KE, Netherlands|Maxima Medisch Centrum, Veldhoven, 5504 DB, Netherlands|VieCuri Medisch Centrum, Venlo, 5912 BL, Netherlands|NZOZ Centrum Medyczne KERmed, Bydgoszcz, 85-231, Poland|KARDIOMED Janczska Kociwska Ostki PodckaRekrzSp, Elblag, 82-300, Poland|Poradnia Kardiologiczna Jarosław Jurowiecki, Gdansk, 80-286, Poland|Synexus Polska SCM Sp. z o.o. Gdansku, Gdansk, 80-382, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-952, Poland|Indywidualna Specjalistyczna Praktyka Lekarska w Dziedzinie Kardiologii lek. med. Krzysztof Cymerman, Gdynia, 81-157, Poland|Synexus Polska Sp. z o.o. Oddzial w Gdyni, Gdynia, 81-537, Poland|Samodzielny Publiczny Specjalistyczny Szpital Zachodni im. Jana Pawla II, Grodzisk Mazowiecki, 05-825, Poland|Synexus Polska Sp. z o.o. Oddzial w Katowicach, Katowice, 40-040, Poland|Centrum Medyczne Pratia Katowice II, Katowice, 40-084, Poland|SPSK Nr 7 SUM w Katowicach Gornoslaskie CM im. prof. Leszka Gieca, Katowice, 40-635, Poland|Specjalistyczna Poradnia Kardiologiczna i Nadciśnienia Tętniczego, Kielce, 25-525, Poland|Augustyn Monika, Krakow, 30-363, Poland|Krakowskie Centrum Medyczne Sp. z o.o., Krakow, 31-501, Poland|Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi, Lodz, 93-513, Poland|NZOZ ALL-MED Centrum Medyczne Specjalistyczne Gabinety Lekarskie, Lodz, 94-048, Poland|Indywidualna Specjalistyczna Praktyka Lekarska, Lodz, 94-255, Poland|KO-MED Centra Kliniczne Lublin II, Lublin, 20-362, Poland|Clinical Best Solutions, Lublin, 20-709, Poland|NZOZ Twoja Przychodnia, Lublin, 20-857, Poland|NZOZ Osrodek Kardiologii Inwazyjnej -Ikardia, Naleczow, 24-140, Poland|Medicome Sp. z o.o., Oswiecim, 32-600, Poland|Synexus Polska sp. z o.o. Oddzial w Poznaniu, Poznan, 60-702, Poland|Praktyka Lekarska Ewa Krzyzagorska, Poznan, 61-655, Poland|KO-MED Centra Kliniczne Pulawy, Pulawy, 24-100, Poland|NZOZ Przychodnia Specjalistyczna H. Rudzki, A. Wittek, Ruda Slaska, 41-709, Poland|Centrum Medyczne Medyk, Rzeszow, 35-055, Poland|Clinmed Research, Skierniewice, 96-100, Poland|NZOZ Pro-Cordis Sopockie Centrum Bad. Kardiolog., Sopot, 81-717, Poland|NSZOZ Medicus, Sroda Wielkopolska, 63-000, Poland|KO-MED Centra Kliniczne Staszow, Staszow, 28-200, Poland|Indywidualna Specjalistyczna Praktyka Lekarska dr n. med. Agnieszka Karczmarczyk Specjalista Chorob, Szczecin, 71-531, Poland|NBR Polska, Warsaw, 00-465, Poland|Centrum Medyczne Świat Pacjenta, Warszawa, 00-631, Poland|Synexus Polska Sp. z o.o. Oddział w Warszawie, Warszawa, 01-192, Poland|Centrum Zdrowia Tuchow Sp. z o.o., Wierzchosławice, 33-122, Poland|Synexus Polska Sp. z o.o. Oddział we Wroclawiu, Wroclaw, 50-381, Poland|KO-MED Centra Kliniczne Zamosc, Zamosc, 22-400, Poland|VA Medical Center - San Juan, San Juan, 00927-5800, Puerto Rico|S.C. CMI Dr. Pletea Noemi S.R.L, Bacau, 600154, Romania|Cabinet Medical Individual Diabet, Nutritie, Boli Metabolice Dr. Pop Lavinia, Baia Mare, 430222, Romania|S.C Centrul Medical de Diagnostic si Tratament Ambulator Neomed S.R.L, Brasov, 500283, Romania|Institutul de Urgenta pentru Boli Cardiovasculare ""Prof. Dr. C.C. Iliescu"", Bucharest, 022328, Romania|S.C Clinica Medicala Data Plus S.R.L, Bucuresti, 010192, Romania|Spitalul Clinic Colentina, Bucuresti, 020125, Romania|Spitalul Clinic de Urgenta ""Sfantul Pantelimon"", Bucuresti, 021659, Romania|S.C. Health Net S.R.L, Bucuresti, 030088, Romania|S.C Policlinica CCBR S.R.L, Bucuresti, 030463, Romania|CMI Dr. Stolea T. Violeta - Medic specialist diabet zaharat, nutritie si boli metabolice, Bucuresti, 061072, Romania|S.C. Medcon S.R.L., Buzau, 120203, Romania|S.C Grandmed S.R.L, Oradea, 410159, Romania|S.C Pelican Impex S.R.L, Oradea, 410469, Romania|S.C. Bella Praxis S.R.L, Pașcani, 705200, Romania|S.C. Diabmed Dr. Popescu Alexandrina S.R.L, Ploiesti, 100163, Romania|CMI Dr Busegeanu Mihaela Magdalena, Ploiesti, 100342, Romania|S.C Mediab S.R.L, Targu Mures, 540142, Romania|S.C Medicali's S.R.L, Timisoara, 300359, Romania|Spitalul Clinic Judetean de Urgenta ""Pius Brinzeu"", Timisoara, 300723, Romania|SBIH of Arkhangelsk region "" First City Clinical hospital n.a. E. E. Volosevich"", Arkhangelsk, 163001, Russian Federation|TSHI ""Altay Territorial Cardiologocal dispensary"", Barnaul, 656055, Russian Federation|SEIHPE ""Ural SMA of RosZdrav"" b.o. LLC ""City Hospital #41"", Ekaterinburg, 620026, Russian Federation|FSHI ""MSU of MoIA of RF of Kemerovo Region"", Kemerovo, 650000, Russian Federation|FSBI ""Scientific-research Institute for Complex Problems of cardiovascular disease"", Kemerovo, 650002, Russian Federation|NSIH ""Departmental Hospital on Station Kemerovo of OJSC ""Russian Railways"", Kemerovo, 650055, Russian Federation|SAIH ""Kemerovo Regional Clinical Hospital"", Kemerovo, 650066, Russian Federation|TSBIH ""Krasnoyarsk Interdistrict Clinical Hospital of Emergency Medical Care n.a. N.S. Karpovich, Krasnoyarsk, 660062, Russian Federation|SBIH of Moscow ""City Clinical Hospital n.a.Bakhrushinykh"", Moscow, 107 014, Russian Federation|SBHI ""City Polyclinic #2 of Healthcare department of city of Moscow"", Moscow, 117556, Russian Federation|FSBIH ""Central Clinical Hospital of Russian Academy of Sciences"", Moscow, 117593, Russian Federation|FSBI ""Central Clinical Hospital with Polyclinic of the Department for Presidential Affairs of the RF, Moscow, 121359, Russian Federation|SBEI HPE ""Moscow State Medical and Dentistry University n.a. A. I. Evdokimov"" of the MoH of the RF, Moscow, 127473, Russian Federation|SBEI HPE ""Moscow State Medical and Dentistry University n.a. A. I. Evdokimov"" of the MoH of the RF, Moscow, 129301, Russian Federation|Murmansk Regional Clinical Hospital named after Bayandin, Murmansk, 183047, Russian Federation|SBIH of Novosibirsk Region ""Clinical Emergency Hospital #2"", Novosibirsk, 630008, Russian Federation|SBIH of Novosibirsk region ""City Clinical Hospital # 19"", Novosibirsk, 630068, Russian Federation|FSBSI ""Scientific Research Institute of Therapy and Preventive Medicine"", Novosibirsk, 630089, Russian Federation|LLC ""RC Medical"", Novosibirsk, 630091, Russian Federation|BIH of Omsk region ""Clinical Medico-Sanitary Unit # 9, Omsk, 644018, Russian Federation|Llc Ultramed, Omsk, 644024, Russian Federation|SBIH of Perm territory "" City Clinical Hospital # 2 n.a. Fedor Khristoforovich Gral"", Perm, 614068, Russian Federation|State Budgetary Healthcare Institution Clinical Medical Sani, Perm, 614077, Russian Federation|SHI ""Perm Regional Hospital of War Veterans"", Perm, 614097, Russian Federation|City Emergency Hospital #2, Rostov-on-Don, 344068, Russian Federation|CJSC Clinic complex, Saint-Petersburg, 190013, Russian Federation|FSBI North-West Federal Medical Research Center n.a. V.A. Almazov of MoH RF, Saint-Petersburg, 194156, Russian Federation|Saint-Petersburg SBHI ""City outpatient clinic #28"", Saint-Petersburg, 195427, Russian Federation|Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, 197022, Russian Federation|SPb SBIH ""City Pokrovskaya Hospital"", Saint-Petersburg, 199106, Russian Federation|LLC Medical Center Mart, Saint-Petersburg, 199178, Russian Federation|SIH ""Saratov City Clinical Hospital # 2 n.a. V.I. Razumovskiy"", Saratov, 410028, Russian Federation|SPb SBIH ""City Hospital # 40 of Kurortnyi region"", Sestroretsk, 197706, Russian Federation|SPb SBIH ""City Multy-field Hospital # 2"", St. Petersburg, 194354, Russian Federation|LLC ""Institute of Medical Examinations"", St. Petersburg, 196084, Russian Federation|Llc ""Medinet"", St. Petersburg, 197136, Russian Federation|SPb SBIH ""Nikolaevskaya Hospital"", St. Petersburg, 198510, Russian Federation|FSBI ""Research Institute for Cardiology"" of Siberian Branch RAMS, Tomsk, 634012, Russian Federation|SHI ""Regional Clinical Hospital"", Tver, 170036, Russian Federation|SHI Ulyanovsk Reg Clinical Hospital, Ulyanovsk, 432063, Russian Federation|Yaroslavl Regional Clinical Hospital of War Veterans, Yaroslavl, 150047, Russian Federation|Alian s.r.o., Bardejov, 085 01, Slovakia|Thyreomedical s.r.o., Bardejov, 08501, Slovakia|Metabol KLINIK s.r.o., Bratislava, 81108, Slovakia|Galenum, s.r.o., Bratislava, 821 07, Slovakia|DIAFA s.r.o., Bratislava, 82102, Slovakia|Diabet, spol. s.r.o., Bratislava, 82108, Slovakia|Kardiovaskularne centrum, s.r.o., Bratislava, 83101, Slovakia|Kardiologicka, interna a sonograficka amb. Kardio-Sanus, sro, Bratislava, 84108, Slovakia|MEDISPEKTRUM PLUS s.r.o., Bratislava, 85101, Slovakia|MUDr. Vladimir Gergel, s.r.o., Bratislava, 85101, Slovakia|ENDIAMED, s.r.o., Dolny Kubin, 02601, Slovakia|MEDICUS plus s.r.o., Komarno, 94501, Slovakia|Human-Care s.r.o., Kosice, 04001, Slovakia|Sukromna interna a kardiologicka ambulancia, Kosice, 04001, Slovakia|DIA- Kontrol s.r.o., Levice, 93401, Slovakia|CELL B, s.r.o., Levice, 93405, Slovakia|KARDIO 1 s.r.o., Lucenec, 984 39, Slovakia|IN-DIA s.r.o., Lucenec, 98401, Slovakia|MUDr. Zuzana Ochodnicka,, Nitra, 94911, Slovakia|Fakultna nemocnica s poliklinikou Nove Zamky, Nove Zamky, 94002, Slovakia|DIABETOL s.r.o., Presov, 08001, Slovakia|Medispol s.r.o., Presov, 08001, Slovakia|Nemocnica s poliklinikou sv. Barbory Roznava a.s., Roznava, 04801, Slovakia|Peter Farkas MD, s.r.o., Sahy, 93601, Slovakia|Interna SK s.r.o., Svidnik, 08901, Slovakia|Nemocnica arm. generala L. Svobodu Svidnik, a.s.,, Svidnik, 08901, Slovakia|Diabetes centrum, s.r.o., Trencin, 91101, Slovakia|JAL s.r.o., Trnava, 91701, Slovakia|MEDIVASA s.r.o., Zilina, 01001, Slovakia|Cardiology Clinical Research, Alberton, Gauteng, 1449, South Africa|Johese Clinical Research: Unitas, Centurion, Gauteng, 0157, South Africa|Medicross Roodepoort Clinical Research, Johannesburg, Gauteng, 1724, South Africa|Lenasia Clinical Trial Centre, Johannesburg, Gauteng, 1827, South Africa|Wits Clinical Research, Johannesburg, Gauteng, 2013, South Africa|Clinresco Centres (Pty) Ltd, Kempton Park, Gauteng, 1619, South Africa|Synexus SA - Stanza Clinical Research Centre, Mamelodi East, Gauteng, 0122, South Africa|Seeber, M, Pretoria, Gauteng, 0002, South Africa|Emmed Research, Pretoria, Gauteng, 0084, South Africa|Synexus SA Watermeyer Clinical Research Centre, Pretoria, Gauteng, 0184, South Africa|Johese Clinical Research: Midstream, Pretoria, Gauteng, 1692, South Africa|Limpopo Clinical Research Initiative, Thabazimbi, Limpopo, 0380, South Africa|Dr AA Mahomed Medical Centre, Moloto, Mpumalanga, 1022, South Africa|Synexus Helderberg Clinical Research Centre, Cape Town, Western Cape, 7130, South Africa|Corbod Research, Cape Town, Western Cape, 7500, South Africa|Tread Research, Cape Town, Western Cape, 7500, South Africa|Tiervlei Trial Centre, Cape Town, Western Cape, 7530, South Africa|Cape Town Medical Research Centre, Cape Town, Western Cape, 7580, South Africa|Paarl Research Centre, Cape Town, Western Cape, 7646, South Africa|Groote Schuur Hospital Lipid Laboratory, Cape Town, Western Cape, 7925, South Africa|Dr JM Engelbrecht Practice, Somerset West, Western Cape, 7130, South Africa|Helderberg Research Institute, Somerset West, Western Cape, 7130, South Africa|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Virgen del Camino, Sanlucar de Barrameda, Cádiz, 11540, Spain|Hospital Universitario Reina Sofia, Cordoba, Córdoba, 14004, Spain|Complejo Hospitalario Universitario A Coruña, A Coruña, La Coruña, 15006, Spain|Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, La Coruña, 15706, Spain|Hospital Virgen del Mar, Almeria, 04120, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Quironsalud Barcelona, Barcelona, 08023, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Regional Universitario de Malaga, Málaga, 29010, Spain|Nuevas tecnologías en Diabetes y Endocrinología, Sevilla, 41003, Spain|Hospital Quironsalud Infanta Luisa, Sevilla, 41010, Spain|Hospital Universitario Virgen Macarena, Sevilla, 41071, Spain|Cherkasy Regional Cardiological Center, Cherkasy, 18009, Ukraine|CI Cherkasy RH of Cherkasy Regional Council, Cherkasy, 18009, Ukraine|CMI CCH#3 Dep of Ther# w the beds of card profile HSEI of UBSMU, Chernivtsi, 58000, Ukraine|RCI Chernivtsi Regional Endocrinology Center Policlinic Dept SHEI of UBSMU, Chernivtsi, 58022, Ukraine|CI Dnipropetrovsk City Cl Hosp #9 of Dniprop Reg Council SI DMA of MOH of Ukr Ch of Endocrinology, Dnipro, 49000, Ukraine|Medical Center of Limited Liability Company Medical Center Clinic of Family Medicine, Dnipro, 49038, Ukraine|Regional CH Dept of Endocrinology SHEI Ivano-Frankivsk NMU, Ivano-Frankivsk, 76008, Ukraine|CI Ivano-Frankivsk Reg Cl Card Center Dept of Chronic Ischemic Heart Dis SHEI Ivano-Frank NMU, Ivano-Frankivsk, 76018, Ukraine|Ivano-Frankivsk CCH Dept of Therapy #1 SHEI Ivano-Frankivsk NMU, Ivano-Frankivsk, 76018, Ukraine|CHI Kharkiv City Student Hosp Therap dept Nat Pharm Univer, Kharkiv, 61002, Ukraine|CNE Prof. O.O. Shalimov Kharkiv City Clinical Hospital #2 KCC, Kharkiv, 61037, Ukraine|GI L.T.Malaya Therapy National Institute of the NAMS of Ukraine, Kharkiv, 61039, Ukraine|State Institution LT Malaya Inst. of Ther. of AMS of Ukraine, Kharkiv, 61039, Ukraine|Railway Transport Kharkiv CH #1 of Healthcare Center Branch of PJSC Ukr Railway, Kharkiv, 61103, Ukraine|Railway Transport Kharkiv CH#1 of Healthcare Center Branch of PJSC Ukrainian Railway, Kharkiv, 61103, Ukraine|MC Doctor Alex Dept of General Practice-Family Medicine Kharkiv MA of PGE, Kharkiv, 61106, Ukraine|CNE City Clin Hosp #8 of KCC Dept of Therapy Kharkiv MA of PGE of MOHU, Kharkiv, 61176, Ukraine|CI Ye.Ye.Karabelesh Kherson City Clinical Hosp., Kherson, 73000, Ukraine|KCCC of Endocr Dept of General Endocrine Pathology O. O. Bogomolets NMU, Kyiv, 01004, Ukraine|Kyiv CCH #12 Dept of Therapy O.O.Bogomolets NMU, Kyiv, 01103, Ukraine|LLC Treatment and Diagnostic Center Adonis Plus, Kyiv, 02002, Ukraine|MC of PHEI Institute of General Practice - Family Medicine, Kyiv, 02002, Ukraine|Medical Center Blagomed Plus LLC, Kyiv, 02081, Ukraine|Med Center 'Ok!Clinic+' of International Institute of Clinical Trials LLC, Kyiv, 02091, Ukraine|MC of Subsidiary Production Unit Med Scient Pract Union Medbud of PJSc Holding Company Kyivmiskbud, Kyiv, 03037, Ukraine|Kyiv CH on Railway Transport #2 of Branch Center of Healthcare Public Company Ukr Railway, Kyiv, 03049, Ukraine|Med Center of Eurolab LLC Policlinic Outpatient Dept O.O.Bogomolets NMU, Kyiv, 03110, Ukraine|SI National Scientific Centre of Radiation Medicine of NAMSU, Kyiv, 03115, Ukraine|SI NSC M.D. Strazhesko Institute of Cardiology of NAMSU, Kyiv, 03680, Ukraine|SI NSС M.D. Strazhesko Institute of Cardiology of NAMSU, Kyiv, 03680, Ukraine|Department of Medical Services and Rehabilitation of State Joint Stock Holding Company Artem, Kyiv, 04050, Ukraine|Medical Center of Limited Liability Company Medical Center Concilium Medical, Kyiv, 04050, Ukraine|CI of Kyiv RC Regional Clinical Hospital #2, Kyiv, 04053, Ukraine|SI V.P.Komisarenko Institute of E&M of NAMSU, Kyiv, 04114, Ukraine|SI V.P.Komisarenko Institute of Endocrinology and Metabolism of NAMSU, Kyiv, 04114, Ukraine|Lviv Reg St Clin Treatment - Diagnostic Endocrin Center, Dept of Polyclinic, D.Galytskyy Lviv NMU, Lviv, 79010, Ukraine|Lviv Communal 4th City Clinical Hospital, Lviv, 79011, Ukraine|Center of Reconstructive & Restorative Medicine (University Clinic) of Odessa National Medical Uni, Odesa, 65000, Ukraine|CI Sumy City Clinical Hospital #1 Dept of Therapy Sumy SU Med Inst, Sumy, 40021, Ukraine|Ternopil City Municipal Hospital #2 Dept of Gastroenterology Ternopil I.Ya. Gorbachevskyi SMU, Ternopil, 46023, Ukraine|Transcarpathian Regional Clinical Cardiology Dispansery, Uzhgorod, 88014, Ukraine|Private Small Enterprise Medical Center Pulse, Vinnytsia, 21001, Ukraine|Vinnytsia RC Highly Special.Endocr.Center Dept of Therapy #2 M.I. Pyrogov NMU, Vinnytsia, 21010, Ukraine|National Pirogov Memorial Medical University, Vinnytsia, 21018, Ukraine|SRI of Invalid Rehabilitation (EST Complex) of Vinnytsia M.I.Pyrogov NMU MOHU, Vinnytsia, 21029, Ukraine|CI Zapor CCH#10 SI ZMA PGE Ch of therapy clin pharmacol & endocrin, Zaporizhzhia, 69001, Ukraine|CI Central City Hospital #1 of Zhytomyr, Zhytomyr, 10002, Ukraine|Zhytomyr regional clinical hospital n.a. O.F. Gerbachevskyy, Zhytomyr, 10002, Ukraine|Synexus Thames, Reading, Berkshire, RG2 0TG, United Kingdom|Mounts Bay Medical Ltd, Hayle, Cornwall, TR27 5DT, United Kingdom|Oak Tree Surgery, Liskeard, Cornwall, PL14 3XA, United Kingdom|The Alverton Practice, Penzance, Cornwall, TR18 4JH, United Kingdom|Rame Medical Limited, Torpoint, Cornwall, PL11 2TB, United Kingdom|Knowle House Surgery, Plymouth, Devon, PL5 3JB, United Kingdom|Torbay Hospital, Torquay, Devon, TQ2 7AA, United Kingdom|Synexus Clinical Research North Tees, Stockton on Tees, Durham, TS19 8PE, United Kingdom|Broomfield Hospital, Chelmsford, Essex, CM1 7ET, United Kingdom|Barts Hospital, London, Greater London, EC1A 7BE, United Kingdom|Manchester Royal Infirmary, Manchester, Greater Manchester, M13 9WL, United Kingdom|Synexus Manchester Clinical Research Centre, Manchester, Greater Manchester, M15 6SX, United Kingdom|Waterloo Medical Centre, Blackpool, Lancashire, FY4 3AD, United Kingdom|Synexus Lancashire Clinical Research Centre, Chorley, Lancashire, PR7 7NA, United Kingdom|Synexus Merseyside Clinical Research Centre, Liverpool, Merseyside, L22 0LG, United Kingdom|Synexus Hexham General Hospital, Hexham, Northumberland, NE46 1QJ, United Kingdom|Synexus Wales Clinical Research Centre, Cardiff, South Glamorgan, CF15 9SS, United Kingdom|Synexus Scotland Clinical Research Centre, Glasgow, Strathclyde, G20 OSP, United Kingdom|Ninewells Hospital, Dundee, Tayside Region, DD1 9SY, United Kingdom|Synexus Birmingham Clinical Research Centre, Birmingham, West Midlands, B15 2SQ, United Kingdom|Morriston Hospital, Swansea, SA6 6NL, United Kingdom"
NCT02131896,"The Effects of Mediterranean Diet on Remission, Lipid Profile, Weight and Body Composition in Children and Adolescents With Newly Diagnosed Type 1 Diabetes",https://clinicaltrials.gov/study/NCT02131896,TERMINATED,Type 1 Diabetes,OTHER: Interventional arm-Mediterranean diet|OTHER: Control Arm- regular nutritional instructions in accordance with the accepted nutritional guidelines,Rabin Medical Center,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Schneider Children's Medical Center, Petah-Tikva, 49202, Israel"
NCT00395603,Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122),https://clinicaltrials.gov/study/NCT00395603,TERMINATED,Cardiovascular Diseases|Diabetes Mellitus,"DRUG: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks|DRUG: Comparator: atorvastatin / Duration of Treatment: 6 Weeks",Organon and Co,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02680054,Additional Insulin for Fat and Protein in Children With Diabetes Study,https://clinicaltrials.gov/study/NCT02680054,TERMINATED,Type 1 Diabetes,"DRUG: Insulin, Asp(B28)-",Oxford University Hospitals NHS Trust,,ALL,"CHILD, ADULT",PHASE4,INTERVENTIONAL,"Royal Berkshire Hospital, Reading, Berkshire, United Kingdom|Oxford Children's Hospital, John Radcliffe Hospital, Oxford, Oxon, OX3 9DU, United Kingdom"
NCT01937858,The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure,https://clinicaltrials.gov/study/NCT01937858,TERMINATED,Diabetes|Renal Failure,,Reem Mohammad Alamoudi,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT01238224,Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01238224,TERMINATED,Type 2 Diabetes,DRUG: Tadalafil,Vastra Gotaland Region,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"The Wallenberg Laboratory, Dept of Molecular and Clinical Medicine, Sahlgrenska University Hospital, Bruna stråket 16,, Göteborg, SE 413 45, Sweden"
NCT00390975,Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis,https://clinicaltrials.gov/study/NCT00390975,TERMINATED,Gastroparesis|Diabetes,DRUG: Tegaserod,Novartis,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"The University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|The University of Louisville, Louisville, Kentucky, 40292, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States"
NCT05007977,Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT05007977,TERMINATED,Type 1 Diabetes|Hypoglycemia,DRUG: ZT-01 low dose|DRUG: ZT-01 high dose|DRUG: Placebo,Zucara Therapeutics Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"LMC Manna Research, Toronto, Ontario, M4G 3E8, Canada"
NCT00700622,Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks,https://clinicaltrials.gov/study/NCT00700622,TERMINATED,"Diabetes, Type 1",DRUG: Technosphere Insulin|DRUG: Insulin glargine|DRUG: Insulin lispro,Mannkind Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Diabetes/Lipid Management and Research Center, Huntington Beach, California, 92648, United States|The Whittier Institute for Diabetes Clinical Trials, La Jolla, California, 92037, United States|Dorothy L & James E Frank Diabetes Research Institute, San Mateo, California, 94401, United States|Barbara Davis Center for Diabetes Young Adult Clinic, Aurora, Colorado, 80045, United States|University of Miami Diabetes Research Institute, Miami, Florida, 33136, United States|University of Miami School of Medicine, Miami, Florida, 33136, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30309, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, 70112-2699, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|Deaconess Billings Clinic Research Center, Billings, Montana, 59101, United States|Mountain Diabetes & Endocrine Center, Asheville, North Carolina, 28803, United States|Endocrine Research Physicians East PA, Greenville, North Carolina, 27834, United States|Your Diabetes Endocrine Nutrition Group, Inc., Mentor, Ohio, 44060, United States|OHSU Diabetes Center Research Oregon Health & Science University, Portland, Oregon, 97239, United States|AM Diabetes and Endocrinology Center, Barrtlett, Tennessee, 38133, United States|Dallas Diabetes & Endocrine Center, Dallas, Texas, 75230, United States|Baylor Endocrine Center, Dallas, Texas, 75246, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Diabetes Research Center -Fletcher Allen Health Care, South Burlington, Vermont, 05403, United States|Diabetes Care Center, Seattle, Washington, 98105, United States|Centro de Pesquisas em Diabetes Ltda, Porto Alegre, RS, -90035-170, Brazil|CPClin-Centro de Pesquisas Clinicas, Sao Paulo, 01244-030, Brazil"
NCT03660683,Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT03660683,TERMINATED,"Diabetes Mellitus, Type 2|Cardiovascular Diseases",DRUG: Dapagliflozin 10mg|DRUG: Saxagliptin 5mg|DRUG: Placebo Oral Tablet,Sabyasachi Sen,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"The GW Medical Faculty Associates, Washington, District of Columbia, 20037, United States"
NCT00225888,Feasibility Study of Digital Photography and Group Discussion for People With Diabetes,https://clinicaltrials.gov/study/NCT00225888,TERMINATED,Type 2 Diabetes,BEHAVIORAL: Digital Photography of meals/snacks and group discussion,Joslin Diabetes Center,Beth Israel Deaconess Medical Center,ALL,ADULT,,INTERVENTIONAL,"Joslin Diabetes Center, Boston, Massachusetts, 02215, United States"
NCT00699413,Supplements for Controlling Resistance to Insulin,https://clinicaltrials.gov/study/NCT00699413,TERMINATED,"Obesity|Diabetes Mellitus, Type 2",DRUG: nutrition education plus active supplement|DRUG: nutrition education plus inactive supplement,University of Southern California,"InterHealth Nutraceuticals, Inc.",ALL,CHILD,PHASE4,INTERVENTIONAL,"USC - Preventive Medicine, Los Angeles, California, 90033, United States"
NCT00564018,"Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH",https://clinicaltrials.gov/study/NCT00564018,TERMINATED,Type 1 Diabetes,DRUG: Insulin detemir|DRUG: Glargine|DRUG: NPH,University of Texas Southwestern Medical Center,Novo Nordisk A/S,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Children's Medical Center, Dallas, Texas, 75235, United States"
NCT02485132,Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea,https://clinicaltrials.gov/study/NCT02485132,TERMINATED,Type 2 Diabetes,OTHER: Observational,Institut de Recherches Cliniques de Montreal,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"University of Toronto, Toronto, Ontario, M5C2T2, Canada|Institut de recherches cliniques de Montréal, Montreal, Quebec, H2W1R7, Canada"
NCT00428571,Laparoscopic Bariatric Surgery to Treat Type 2 Diabetes in Obese Patients,https://clinicaltrials.gov/study/NCT00428571,TERMINATED,Type 2 Diabetes,PROCEDURE: laparoscopic gastric bypass surgery|PROCEDURE: laparoscopic adjustable gastric banding|PROCEDURE: Intensive Medical Management,Hamilton Health Sciences Corporation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"St. Joseph's Healthcare, Hamilton, Ontario, L8N 4A6, Canada"
NCT02721888,Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism,https://clinicaltrials.gov/study/NCT02721888,TERMINATED,Type 2 Diabetes,DRUG: Liraglutide|DRUG: MRI/ MRS (Magnetic Resonance Imaging /Magnetic Resonance Spectroscopy)|BIOLOGICAL: Blood sample|OTHER: Kinetic substudy (10 patients),Centre Hospitalier Universitaire Dijon,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"CHU de Dijon, Dijon, 21079, France"
NCT00946517,Impaired Family Dynamics Leads to Non Compliance in Type I Diabetes,https://clinicaltrials.gov/study/NCT00946517,TERMINATED,Type 1 Diabetes,OTHER: Questionnaires,Nationwide Children's Hospital,,ALL,"CHILD, ADULT",,OBSERVATIONAL,"Nationwide Children's Hospital, Columbus, Ohio, 43205, United States"
NCT00967642,Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI),https://clinicaltrials.gov/study/NCT00967642,TERMINATED,Diabetes Mellitus|Percutaneous Coronary Intervention,DRUG: Intravenous Insulin,Hospital de Clinicas de Porto Alegre,"Conselho Nacional de Desenvolvimento Científico e Tecnológico|Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil|FIPE",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT00698789,Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00698789,TERMINATED,Type 2 Diabetes,DRUG: INCB019602|DRUG: INCB019602|DRUG: INCB019602|DRUG: INCB019602|DRUG: INCB019602|DRUG: Placebo|DRUG: Metformin,Incyte Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Phoenix, Arizona, 85029, United States|Tucson, Arizona, 85705, United States|Chula Vista, California, 91911, United States|Los Angeles, California, United States|Mission Viejo, California, 92691, United States|Orange, California, 92869, United States|Paramount, California, 90723, United States|San Diego, California, 92117, United States|Santa Ana, California, 92701, United States|Tustin, California, 92780, United States|Colorado Springs, Colorado, 80909, United States|St. Petersburg, Florida, 33709, United States|Shawnee Mission, Kansas, 66216, United States|Shreveport, Louisiana, 71101, United States|Dearborn, Michigan, 48126, United States|St. Louis, Missouri, 63110, United States|Omaha, Nebraska, 68154, United States|Elizabeth, New Jersey, 07202, United States|Charlotte, North Carolina, 28211, United States|Oklahoma City, Oklahoma, 73103, United States|East Providence, Rhode Island, 02914, United States|San Antonio, Texas, 78229, United States"
NCT01079637,Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet,https://clinicaltrials.gov/study/NCT01079637,TERMINATED,Diabetes Mellitus 1 or 2|Midfoot Charcot Neuroarthropathy,PROCEDURE: Surgery with Midfoot Fusion Bolt|PROCEDURE: Cast treatment,AO Clinical Investigation and Publishing Documentation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Dept. of Trauma and Reconstructive Surgery, University of Rostock, Rostock, 18055, Germany"
NCT01550328,Bias Source of Signal in SCOUT DS,https://clinicaltrials.gov/study/NCT01550328,TERMINATED,Type 2 Diabetes,,"VeraLight, Inc.",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"VeraLight, Albuquerque, New Mexico, 87106, United States"
NCT00999856,Investigation of a Sub-Conjunctival Insert,https://clinicaltrials.gov/study/NCT00999856,TERMINATED,Diabetes Care,DEVICE: GOMIS and Photometer|DEVICE: GOMIS and Photometer|DEVICE: GOMIS and Photometer|DEVICE: GOMIS and Photometer|DEVICE: GOMIS and Photometer,EyeSense GmbH,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Diabetes Instiut Heidelberg, Heidelberg, 69115, Germany"
NCT03365531,RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver Disease,https://clinicaltrials.gov/study/NCT03365531,TERMINATED,"NAFLD|Obesity|Diabetes Mellitus, Type 2",OTHER: Alternate Daily Fasting (ADF)|OTHER: Caloric Restriction (CR),University of Florida,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Florida, Gainesville, Florida, 32610, United States"
NCT00729365,PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease),https://clinicaltrials.gov/study/NCT00729365,TERMINATED,Type 1 Diabetes,DRUG: Ramipril|DRUG: Placebo|DRUG: Placebo,Northwestern University,Juvenile Diabetes Research Foundation|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"CHILD, ADULT",PHASE3,INTERVENTIONAL,"University of Florida, Gainesville, Florida, 32611, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|Rush University Medical Center, Endocrinology Section, Chicago, Illinois, 60612, United States|University of Illinois at Chicago, Chicago, Illinois, 60612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Loyola University Chicago, Maywood, Illinois, 60153, United States"
NCT02617160,Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study,https://clinicaltrials.gov/study/NCT02617160,TERMINATED,Type 1 Diabetes,DEVICE: MD-Logic Pump Advisor|OTHER: Control Group,Rabin Medical Center,Novo Nordisk A/S|DreaMed,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Schneider Medical Center, Petach- Tikva, 49202, Israel"
NCT00704197,"""ISIS"" Study of Sex Differences in Characteristics of Adiposity and Metabolism",https://clinicaltrials.gov/study/NCT00704197,TERMINATED,Obesity|Diabetes,,Pennington Biomedical Research Center,"University of Maryland|University of California, San Diego",ALL,ADULT,,OBSERVATIONAL,"Pennington Biomedical Research Center, Baton Rouge, Louisiana, 70808, United States"
NCT00958269,Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment,https://clinicaltrials.gov/study/NCT00958269,TERMINATED,Type 2 Diabetes Mellitus|Renal Impairment,DRUG: dutogliptin|DRUG: dutogliptin|DRUG: placebo|DRUG: sitagliptin|DRUG: sitagliptin,Phenomix,Forest Laboratories,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Phenomix Investigational Site 115, Tempe, Arizona, United States|Phenomix Investigational Site 121, Long Beach, California, United States|Phenomix Investigational Site 110, Lynwood, California, United States|Phenomix Investigational Site 118, Lynwood, California, United States|Phenomix Investigational Site 119, Orange, California, United States|Phenomix Investigational Site 109, Palm Springs, California, United States|Phenomix Investigational Site 122, Whittier, California, United States|Phenomix Investigational Site 112, Lauderdale Lakes, Florida, United States|Phenomix Investigational Site 104, Ocala, Florida, United States|Phenomix Investigational Site 116, Pembroke Pines, Florida, United States|Phenomix Investigational Site 101, Augusta, Georgia, United States|Phenomix Investigational Site 117, Honolulu, Hawaii, United States|Phenomix Investigational Site 102, Baton Rouge, Louisiana, United States|Phenomix Investigational Site 100, Rockville, Maryland, United States|Phenomix Investigational Site 125, Rockville, Maryland, United States|Phenomix Investigational Site 114, Springfield Gardens, New York, United States|Phenomix Investigational Site 120, Winston-Salem, North Carolina, United States|Phenomix Investigational Site 107, Columbia, South Carolina, United States|Phenomix Investigational Site 111, Nashville, Tennessee, United States|Phenomix Investigational Site 103, Fort Worth, Texas, United States|Phenomix Investigational Site 106, Houston, Texas, United States|Phenomix Investigational Site 108, San Antonio, Texas, United States|Phenomix Investigational Site 113, Alexandria, Virginia, United States|Phenomix Investigational Site 208, Kemerovo, Russian Federation|Phenomix Investigational Site 203, Moscow, Russian Federation|Phenomix Investigational Site 204, Moscow, Russian Federation|Phenomix Investigational Site 209, Moscow, Russian Federation|Phenomix Investigational Site 211, Moscow, Russian Federation|Phenomix Investigational Site 205, Novosibirsk, Russian Federation|Phenomix Investigational Site 207, Perm., Russian Federation|Phenomix Investigational Site 206, Petrozavodsk, Russian Federation|Phenomix Investigational Site 200, St. Petersburg, Russian Federation|Phenomix Investigational Site 201, St. Petersburg, Russian Federation|Phenomix Investigational Site 210, St. Petersburg, Russian Federation|Phenomix Investigational Site 212, St. Petersburg, Russian Federation|Phenomix Investigational Site 213, St. Petersburg, Russian Federation|Phenomix Investigational Site 304, Chernivtsi, Ukraine|Phenomix Investigational Site 300, Kyiv, Ukraine|Phenomix Investigational Site 301, Kyiv, Ukraine|Phenomix Investigational Site 306, Kyiv, Ukraine|Phenomix Investigational Site 302, Odesa, Ukraine|Phenomix Investigational Site 303, Vinnytsa, Ukraine|Phenomix Investigational Site 307, Zaporizhzhya, Ukraine"
NCT01644201,"A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics",https://clinicaltrials.gov/study/NCT01644201,TERMINATED,Type II Diabetes Mellitus|Obesity,DIETARY_SUPPLEMENT: PolyGlycopleX® - PGX®|DIETARY_SUPPLEMENT: Rice Flour (placebo),InovoBiologic Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Wharton Medical Clinic and Weight Management Centre, Hamilton, Ontario, Canada"
NCT01954459,Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?,https://clinicaltrials.gov/study/NCT01954459,TERMINATED,Type 1 Diabetes,DEVICE: Insupatch|DEVICE: Continuous glucose sensor,Yale University,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"CHILD, ADULT",EARLY_PHASE1,INTERVENTIONAL,"Yale University School of Medicine, New Haven, Connecticut, 06520, United States"
NCT00261417,Dose Response Study in Japanese Patients,https://clinicaltrials.gov/study/NCT00261417,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Ashino, Japan|Research Site, Fuchu Keijinkai, Japan|Research Site, Fujimino, Japan|Research Site, Hijirino Koike, Japan|Research Site, Houseikai, Japan|Research Site, Hyuga, Japan|Research Site, Iriuchijima, Japan|Research Site, Iwase, Japan|Research Site, Kato, Japan|Research Site, Kawamata, Japan|Research Site, Keishukai Shirakawa, Japan|Research Site, Koga, Japan|Research Site, Kouhoku, Japan|Research Site, Kousei, Japan|Research Site, Kurosawa, Japan|Research Site, Nihonmatu, Japan|Research Site, Oki, Japan|Research Site, Saiseikai Fukuoka, Japan|Research Site, Sapporo, Japan|Research Site, Takamori, Japan"
NCT01898286,Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®,https://clinicaltrials.gov/study/NCT01898286,TERMINATED,Type 1 Diabetes,DRUG: DiaPep277®,Andromeda Biotech Ltd.,,ALL,ADULT,PHASE3,INTERVENTIONAL,"Atlanta Diabetes associates, Atlanta, Georgia, 30318, United States|Henry Ford Medical Centers - New Center One, Detroit, Michigan, 48202, United States|Mountain Diabetes and Endocrine Center, Asheville, North Carolina, 28803, United States"
NCT00366301,The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00366301,TERMINATED,Type 2 Diabetes,DRUG: Insulin glargine injection|DRUG: metformin|DRUG: Placebo pill,Brigham and Women's Hospital,Sanofi,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States"
NCT00332085,Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00332085,TERMINATED,Type 2 Diabetes,DRUG: Chromium Picolinate,Bastyr University,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Bastyr University Campus SPR, Kenmore, Washington, 98036, United States|Bastyr Center for Natural Health, Seattle, Washington, United States"
NCT01785771,A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c,https://clinicaltrials.gov/study/NCT01785771,TERMINATED,Type 2 Diabetes,DRUG: ITCA 650 (exenatide in DUROS),Intarcia Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, 35235, United States|Fundamental Research, Gulf Shores, Alabama, 36542, United States|East Valley Family Physicians, PLC, Chandler, Arizona, 85224, United States|Desert Clinical Research, Mesa, Arizona, 85213, United States|Clinical Research Advantage, Inc., Phoenix, Arizona, 85020, United States|eStudySite, Chula Vista, California, United States|Rocks Medical Research Institute, Inc., Fresno, California, 93721, United States|Rocks Medical Research Institute, Fresno, California, 93721, United States|Long Beach Center for Clinical Research, Long Beach, California, 90807, United States|Saviers Medical Group, Port Hueneme, California, 93041, United States|University Clinical Investigatons, Inc/Diabetes Research Center, Tustin, California, 92780, United States|Diablo Clinical Research, Inc., Walnut Creek, California, 94598, United States|Colorado Springs Health Partners-Briargate, Colorado Springs, Colorado, 80922, United States|Meridien Research, Bradenton, Florida, 34208, United States|East Coast Institute for Research, LLC, Jacksonville, Florida, 32216, United States|New Horizon Research Center, Inc., Miami, Florida, 33175, United States|International Research Assocaites, LLC, Miami, Florida, 33183, United States|Harmony Clinical Research, Inc., North Miami Beach, Florida, 33162, United States|Palm Harbor Medical Associates, Palm Harbor, Florida, 34684, United States|Andres Patron, D.O., P.A., Pembroke Pines, Florida, 33026, United States|Clinical Research of West Florida, Tampa, Florida, 33603, United States|Perimeter Institute for Clinical Research PRIME, Atlanta, Georgia, 30338, United States|Solaris Clinical Research, Meridian, Idaho, 83646, United States|Chicago Research Center, Chicago, Illinois, 60634, United States|American Health Network of Indiana, LLC, Avon, Indiana, 46123, United States|Medisphere Medical Research Center, LLC, Evansville, Indiana, 47714, United States|American Health Network of Indiana, Franklin, Indiana, 46131, United States|American Health Network of Indiana, LLC, Muncie, Indiana, 47304, United States|Bunyan Clinical Research, Valparaiso, Indiana, 46383, United States|Crescent City Clinical Research Center, Metairie, Louisiana, 70006, United States|Palm Research Center, Inc., Las Vegas, Nevada, 89148, United States|PMG Research of Charlotte, LLC, Charlotte, North Carolina, 28209, United States|University of North Carolina at Chapel Hill, Durham, North Carolina, 27713, United States|PMG Research of Salisbury, LLC, Salisbury, North Carolina, 28144, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, 27103, United States|Sentral Clinical Research Services, LLC, Cincinnati, Ohio, 45236, United States|Columbus Clinical Research, Columbus, Ohio, 43213, United States|Prestige Clinical Research, Franklin, Ohio, 45005, United States|Lynn Institute of Norman, Norman, Oklahoma, 73069, United States|Preferred Primary Care Physicians, Uniontown, Pennsylvania, 15401, United States|Greer, South Carolina, 29651, United States|BMG The Endocrine Clinic, Memphis, Tennessee, 38119, United States|Tekton Research, Inc., Austin, Texas, 78745, United States|3rd Coast Research Associates, Corpus Christi, Texas, 78414, United States|Dallas Diabetes and Endocrine Center, Dallas, Texas, 75230, United States|Galena Research, Dallas, Texas, 75251, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Medstar Clinical Research and Associates, Houston, Texas, 77083, United States|Clinical Trials of Texas, Inc., San Angelo, Texas, 78229, United States|Sound Healthcare, Port Orchard, Washington, 98366, United States|Ranier Clinical Research Center, Renton, Washington, 98057, United States"
NCT00255541,GALLANT 4 Tesaglitazar vs. Glibenclamide,https://clinicaltrials.gov/study/NCT00255541,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar|DRUG: Glibenclamide,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Antwerpen, Belgium|Research Site, Braine-L'alleud, Belgium|Research Site, Hasselt, Belgium|Research Site, Liege, Belgium|Research Site, Merksem, Belgium|Research Site, Sint-Gillis-Waas, Belgium|Research Site, Steenokkerzeel, Belgium|Research Site, Shatin, N.T., Hong Kong|Research Site, Balatonfüred, Hungary|Research Site, Budapest, Hungary|Research Site, Kaposvár, Hungary|Research Site, Kecskemét, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Arenzano, Italy|Research Site, Chiavari (GE), Italy|Research Site, Chieri, Italy|Research Site, Gubbio (PG), Italy|Research Site, Milano, Italy|Research Site, Napoli, Italy|Research Site, Padova, Italy|Research Site, Perugia, Italy|Research Site, Piacenza, Italy|Research Site, Reggio Calabria, Italy|Research Site, Reggio Emilia, Italy|Research Site, Rho, Italy|Research Site, Roma, Italy|Research Site, Udine, Italy|Research Site, Kubang Kerian, Kota Bharu, Malaysia|Research Site, Kuala Lampur, Malaysia|Research Site, México, D.f., Mexico|Research Site, Guadalajara, Jalisco, Mexico|Research Site, Zapopan, Jalisco, Mexico|Research Site, Veracruz, Mexico|Research Site, Bergen, Norway|Research Site, Kongsvinger, Norway|Research Site, Lysaker, Norway|Research Site, Oslo, Norway|Research Site, Skedsmokorset, Norway|Research Site, Sørumstand, Norway|Research Site, Trondheim, Norway|Research Site, Ås, Norway|Research Site, Manila, Philippines|Research Site, Pasig City, Philippines|Research Site, Kraków, Poland|Research Site, Lublin, Poland|Research Site, P³ock, Poland|Research Site, Toruñ, Poland|Research Site, Tychy, Poland|Research Site, Warszawa, Poland|Research Site, £ód?, Poland|Research Site, Bratislava, Slovakia|Research Site, Ilava, Slovakia|Research Site, Kosice, Slovakia|Research Site, Kysucke Nove Mesto, Slovakia|Research Site, Lubochna, Slovakia|Research Site, Lucenec, Slovakia|Research Site, Nitra, Slovakia|Research Site, Presov, Slovakia|Research Site, Trnava, Slovakia|Research Site, Cape Town, South Africa|Research Site, Durban, South Africa|Research Site, Houghton Gauteng, South Africa|Research Site, Changhua, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taipei, Taiwan|Research Site, Bangkok, Thailand"
NCT00300105,GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00300105,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Hasselt, Belgium|Research Site, Liege, Belgium|Research Site, Sint-Gillis-Waas, Belgium|Research Site, Steenokkerzeel, Belgium|Research Site, Shatin, Hong Kong|Research Site, Balatonfured, Hungary|Research Site, Budapest, Hungary|Research Site, Kaposvar, Hungary|Research Site, Kecskemet, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Gubbio, Italy|Research Site, Milano, Italy|Research Site, Perugia, Italy|Research Site, Piacenza, Italy|Research Site, Reggio Emilia, Italy|Research Site, Udine, Italy|Research Site, Kubang Kerian, Kelantan, Malaysia|Research Site, Kuala Lumpur, Malaysia|Research Site, Makati City, Philippines|Research Site, Manila, Philippines|Research Site, Pasig City, Philippines|Research Site, Kraków, Poland|Research Site, Lublin, Poland|Research Site, Plock, Poland|Research Site, Torun, Poland|Research Site, Tychy, Poland|Research Site, Warszawa, Poland|Research Site, £ód?, Poland|Research Site, Banská Bystrica, Slovakia|Research Site, Bratislava, Slovakia|Research Site, Ilava, Slovakia|Research Site, Kosice, Slovakia|Research Site, Kysucke Nove Mesto, Slovakia|Research Site, Lubochna, Slovakia|Research Site, Lucenec, Slovakia|Research Site, Nitra, Slovakia|Research Site, Presov, Slovakia|Research Site, Trnava, Slovakia|Research Site, Johannesburg, Gauteng, South Africa|Research Site, Cape Town, South Africa|Research Site, Durban, South Africa|Research Site, Bangkok, Thailand"
NCT00252837,GALLANT 22 Tesaglitazar vs. Placebo,https://clinicaltrials.gov/study/NCT00252837,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar|BEHAVIORAL: Dietary and Lifestyle counseling,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Adelaide, Australia|Research Site, Cairns, Australia|Research Site, Gosford, Australia|Research Site, Keswick, Australia|Research Site, Kippa Ring, Australia|Research Site, Melbourne, Australia|Research Site, Miranda, Australia|Research Site, Nowra, Australia|Research Site, Wollongong, Australia|Research Site, Brno, Czech Republic|Research Site, Hodonin, Czech Republic|Research Site, Hradec Kralove, Czech Republic|Research Site, Plzen, Czech Republic|Research Site, Praha 5, Czech Republic|Research Site, Pribram, Czech Republic|Research Site, Semily, Czech Republic|Research Site, Tabor, Czech Republic|Research Site, Usti nad Labem, Czech Republic|Research Site, Paide, Estonia|Research Site, Pärnu, Estonia|Research Site, Tallinn, Estonia|Research Site, Tartu, Estonia|Research Site, Viljandi, Estonia|Research Site, Belgrade, Former Serbia and Montenegro|Research Site, Angers, France|Research Site, Briollay, France|Research Site, Poitiers, France|Research Site, Saint Benoit, France|Research Site, Saint Ouen, France|Research Site, Toulouse, France|Research Site, Trelaze, France|Research Site, Athens, Greece|Research Site, Piraeus, Greece|Research Site, Balatonfüred, Hungary|Research Site, Budapest, Hungary|Research Site, Kaposvár, Hungary|Research Site, Kecskemét, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Daugavpils, Latvia|Research Site, Jekabpils, Latvia|Research Site, Madona, Latvia|Research Site, Riga, Latvia|Research Site, SIgulda, Latvia|Research Site, Talsi, Latvia|Research Site, Valmiera, Latvia|Research Site, Kaunas, Lithuania|Research Site, Klaipeda, Lithuania|Research Site, Panevezys, Lithuania|Research Site, Vilnius, Lithuania|Research Site, Aurskog, Norway|Research Site, Bergen, Norway|Research Site, Enebakk, Norway|Research Site, Fredrikstad, Norway|Research Site, Haugesund, Norway|Research Site, Hønefoss, Norway|Research Site, Inderøy, Norway|Research Site, Larvik, Norway|Research Site, Lierskogen, Norway|Research Site, Oslo, Norway|Research Site, Rolvsøy, Norway|Research Site, Cebu City, Philippines|Research Site, Pasig City, Philippines|Research Site, Quezon City, Philippines|Research Site, Katowice, Ochojec, Poland|Research Site, Bialystok, Poland|Research Site, Bydgoszcz, Poland|Research Site, Gdansk, Poland|Research Site, Krakow, Poland|Research Site, Lodz, Poland|Research Site, Lublin, Poland|Research Site, Olsztyn, Poland|Research Site, Poznań, Poland|Research Site, Radom, Poland|Research Site, Rzeszow, Poland|Research Site, Sopot, Poland|Research Site, Szczecin, Poland|Research Site, Toruñ, Poland|Research Site, Tychy, Poland|Research Site, Warszawa, Poland|Research Site, Wroclaw, Poland|Research Site, Zabrze, Poland|Research Site, Zielona Gora, Poland|Research Site, Dolny Kubin, Slovakia|Research Site, Levice, Slovakia|Research Site, Lubochna, Slovakia|Research Site, Lucenec, Slovakia|Research Site, Nove Zamky, Slovakia|Research Site, Povazska Bystrica, Slovakia|Research Site, Sahy, Slovakia|Research Site, Trencin, Slovakia|Research Site, Velky Meder, Slovakia|Research Site, Zilina, Slovakia|Research Site, Borås, Sweden|Research Site, Göteborg, Sweden|Research Site, Mölndal, Sweden|Research Site, Partille, Sweden|Research Site, Skene, Sweden|Research Site, Stenungsund, Sweden|Research Site, Uddevalla, Sweden|Research Site, Vänersborg, Sweden|Research Site, Åmål, Sweden"
NCT00252772,GALLANT 2 Tesaglitazar vs. Placebo,https://clinicaltrials.gov/study/NCT00252772,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar|BEHAVIORAL: Dietary and Lifestyle counseling,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Hanko, Finland|Research Site, Helsinki, Finland|Research Site, Imatra, Finland|Research Site, Kokkola, Finland|Research Site, Kuopio, Finland|Research Site, Lahti, Finland|Research Site, Mikkeli, Finland|Research Site, Oulu, Finland|Research Site, Pattijoki, Finland|Research Site, Pietarsaari, Finland|Research Site, Pori, Finland|Research Site, Tampere, Finland|Research Site, Turku, Finland|Research Site, Ödet, Finland"
NCT01460251,OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277,https://clinicaltrials.gov/study/NCT01460251,TERMINATED,Type 1 Diabetes,DRUG: DiaPep277,Rabin Medical Center,,ALL,ADULT,PHASE3,INTERVENTIONAL,"Hadassah Medical Center, Jerusalem, 91120, Israel|Schneider Children's Medical Center, Petah-Tikva, 49202, Israel"
NCT00159211,Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin,https://clinicaltrials.gov/study/NCT00159211,TERMINATED,Type 2 Diabetes,DRUG: UMULINE NPH|DRUG: pioglitazone,Assistance Publique - Hôpitaux de Paris,Laboratoires Takeda,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Sce de Diabétologie, hôpital de la Pitié-salpêtrière, 83bld de l'hôpital, Paris, 75013, France"
NCT03411460,Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System,https://clinicaltrials.gov/study/NCT03411460,TERMINATED,Insulin-Dependent Diabetes,DEVICE: FreeStyle Libre™ system|PROCEDURE: Finger prick,Centre Hospitalier Universitaire de Nīmes,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"CHU Nimes, Nîmes, 30029, France"
NCT00251953,GALLANT 8 Tesaglitazar Add-on to Metformin,https://clinicaltrials.gov/study/NCT00251953,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar|DRUG: Metformin,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Adelaide, Australia|Research Site, Brisbane, Australia|Research Site, Cairns, Australia|Research Site, Geelong, Australia|Research Site, Melbourne, Australia|Research Site, Perth, Australia|Research Site, Sydney, Australia|Research Site, Coquitlam, British Columbia, Canada|Research Site, Winnipeg, Manitoba, Canada|Research Site, St. John's, Newfoundland and Labrador, Canada|Research Site, Etobicoke, Ontario, Canada|Research Site, Hamilton, Ontario, Canada|Research Site, Hastings, Ontario, Canada|Research Site, Kingston, Ontario, Canada|Research Site, North York, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Smith Falls, Ontario, Canada|Research Site, Toronto, Ontario, Canada|Research Site, Chomedey-Laval, Quebec, Canada|Research Site, Laval, Quebec, Canada|Research Site, Montréal, Quebec, Canada|Research Site, Helsinki, Finland|Research Site, Hämeenlinna, Finland|Research Site, Joensuu, Finland|Research Site, Kouvola, Finland|Research Site, Kuopio, Finland|Research Site, Mikkeli, Finland|Research Site, Oulu, Finland|Research Site, Salo, Finland|Research Site, Tampere, Finland|Research Site, Vantaa, Finland|Research Site, Aschaffenburg, Germany|Research Site, Berlin, Germany|Research Site, Essen, Germany|Research Site, Hamburg, Germany|Research Site, Heidelberg, Germany|Research Site, Mannheim, Germany|Research Site, Nürberg, Germany|Research Site, Rotenburg/Fulda, Germany|Research Site, Bangalore, India|Research Site, Hyderabad, India|Research Site, New Delhi, India|Research Site, Arenzano, Italy|Research Site, Chiavari (GE), Italy|Research Site, Chieri, Italy|Research Site, Desio, Italy|Research Site, Firenze, Italy|Research Site, Gubbio, Italy|Research Site, Marsala, Italy|Research Site, Messina, Italy|Research Site, Milano, Italy|Research Site, Monteccio Emilia, Italy|Research Site, Napoli, Italy|Research Site, Padova, Italy|Research Site, Perugia, Italy|Research Site, Pescara, Italy|Research Site, Piacenza, Italy|Research Site, Pistoia, Italy|Research Site, Reggio Calabria, Italy|Research Site, Reggio Emilia, Italy|Research Site, Rho, Italy|Research Site, Roma, Italy|Research Site, Scandiano, Italy|Research Site, Udine, Italy|Research Site, Kubang Kerian, Kota Bharu, Malaysia|Research Site, Kuala Lumpur, Malaysia|Research Site, Cebu City, Philippines|Research Site, Quezon City, Philippines|Research Site, Singapore, Singapore|Research Site, Borås, Sweden|Research Site, Dalby, Sweden|Research Site, Göteborg, Sweden|Research Site, Höganäs, Sweden|Research Site, Kungsör, Sweden|Research Site, Malmö, Sweden|Research Site, Mölndal, Sweden|Research Site, Oskarshamn, Sweden|Research Site, Skene, Sweden|Research Site, Skrivarp, Sweden|Research Site, Stenungsund, Sweden|Research Site, Uppsala, Sweden|Research Site, Ängelholm, Sweden|Research Site, Aberdeen, United Kingdom|Research Site, Aldershot, United Kingdom|Research Site, Atherstone, United Kingdom|Research Site, Barry, United Kingdom|Research Site, Bath, United Kingdom|Research Site, Bexhill-on-Sea, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Bolton, United Kingdom|Research Site, Cardiff, United Kingdom|Research Site, Chippenham, United Kingdom|Research Site, Coventry, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, Edinburgh, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Harrow, United Kingdom|Research Site, Hastings, United Kingdom|Research Site, Leeds, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Plymouth, United Kingdom|Research Site, Radstock, United Kingdom|Research Site, Slough, United Kingdom|Research Site, Swindon, United Kingdom|Research Site, West Midlands, United Kingdom|Research Site, Wrexham, United Kingdom"
NCT00251940,GALLANT 7 Tesaglitazar Add-on to Sulphonylurea,https://clinicaltrials.gov/study/NCT00251940,TERMINATED,Type 2 Diabetes,"DRUG: Tesaglitazar 0.5 or 1 mg|DRUG: Glibenclamide 2.5, 5, 10 or 15 mg",AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Adelaide, Australia|Research Site, Brisbane, Australia|Research Site, Cairns, Australia|Research Site, Geelong, Australia|Research Site, Melbourne, Australia|Research Site, Perth, Australia|Research Site, Sydney, Australia|Research Site, Tasmania, Australia|Research Site, Angers, France|Research Site, Hyeres, France|Research Site, La Garde, France|Research Site, La Seyne Sur Mer, France|Research Site, Laval, France|Research Site, Le Brusc, France|Research Site, Le Lavandou, France|Research Site, Montrevault, France|Research Site, Paris, France|Research Site, Saint-Cyr, France|Research Site, Six Fours Les Plages, France|Research Site, Tierce, France|Research Site, Toulon, France|Research Site, Ashkelon, Israel|Research Site, Haifa, Israel|Research Site, Holon, Israel|Research Site, Jerusalem, Israel|Research Site, Rishon-Lezion, Israel|Research Site, Tel Aviv, Israel|Research Site, Tel Hashomer, Israel|Research Site, Zefat, Israel|Research Site, Seoul, Korea, Republic of|Research Site, Suwon, Korea, Republic of|Research Site, Bergen, Norway|Research Site, Elverum, Norway|Research Site, Enebakk, Norway|Research Site, Fredrikstad, Norway|Research Site, Gamle Fredrikstad, Norway|Research Site, Hamar, Norway|Research Site, Haugesund, Norway|Research Site, Hurdal, Norway|Research Site, Inderøy, Norway|Research Site, Lena, Norway|Research Site, Levanger, Norway|Research Site, Oslo, Norway|Research Site, Rud, Norway|Research Site, Sedsmokorset, Norway|Research Site, Soerumsand, Norway|Research Site, Stavanger, Norway|Research Site, Manila, Philippines|Research Site, Marikina City, Philippines|Research Site, Pasig City, Philippines|Research Site, Cape Town, South Africa|Research Site, Chatsworth, South Africa|Research Site, Gauteng, South Africa|Research Site, Pretoria, South Africa|Research Site, Alzira (Valencia), Spain|Research Site, Barcelona, Spain|Research Site, Guissona (Lleida), Spain|Research Site, Madrid, Spain|Research Site, San Sebastian de los Reyes ( Madrid), Spain|Research Site, San Vicente de Raspeig (Alicante), Spain|Research Site, Valencia, Spain|Research Site, Dublin, Ireland, United Kingdom|Research Site, Aberdeen, United Kingdom|Research Site, Barnsley, United Kingdom|Research Site, Bath, United Kingdom|Research Site, Belfast, United Kingdom|Research Site, Birmingham, United Kingdom|Research Site, Cardiff, United Kingdom|Research Site, Coventry, United Kingdom|Research Site, Dundee, United Kingdom|Research Site, East Sussex, United Kingdom|Research Site, Edinburgh, United Kingdom|Research Site, Glasgow, United Kingdom|Research Site, Leeds, United Kingdom|Research Site, Liverpool, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Shrewsbury, United Kingdom|Research Site, Surrey, United Kingdom|Research Site, West Midlands, United Kingdom|Research Site, Wiltshire, United Kingdom|Research Site, Wrexham, United Kingdom|Research Site, Hanoi, Vietnam|Research Site, Ho Chi Minh, Vietnam"
NCT00430040,Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.,https://clinicaltrials.gov/study/NCT00430040,TERMINATED,"Diabetes Mellitus, Type 2|Hypertension",DRUG: Carvedilol Controlled Release (CR)|DRUG: lisinopril,University at Buffalo,GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Diabetes - Endocrinology Center of Western New York, Buffalo, New York, 14221, United States"
NCT00609154,Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates,https://clinicaltrials.gov/study/NCT00609154,TERMINATED,Type 2 Diabetes,DRUG: glucagon like peptide-1|DIETARY_SUPPLEMENT: glucose control,Albert Einstein College of Medicine,Merck Sharp & Dohme LLC|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Albert Einstein College of Medicinie, Bronx, New York, 10461, United States"
NCT05293340,"Continuous Glucose Monitoring and Hass Avocado Trial (""CHAT"")",https://clinicaltrials.gov/study/NCT05293340,TERMINATED,"Dietary Habits|Diabetes Mellitus, Type 2",DIETARY_SUPPLEMENT: Avocado Vouchers,Sansum Diabetes Research Institute,Hass Avocado Board,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Sansum Diabetes Research Institute, Santa Barbara, California, 93105, United States"
NCT00261352,GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate,https://clinicaltrials.gov/study/NCT00261352,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar|DRUG: Metformin|DRUG: Fenofibrate,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Research Site, Fortaleza, CE, Brazil|Research Site, Goiânia, GO, Brazil|Research Site, Porto Alegre, RS, Brazil|Research Site, Curitiba, Brazil|Research Site, Sao Paulo, Brazil|Research Site, Calgary, Alberta, Canada|Research Site, Surrey, British Columbia, Canada|Research Site, Bay Roberts, Newfoundland and Labrador, Canada|Research Site, Mount Pearl, Newfoundland and Labrador, Canada|Research Site, St. John's, Newfoundland and Labrador, Canada|Research Site, Bolton, Ontario, Canada|Research Site, Brampton, Ontario, Canada|Research Site, Etobicoke, Ontario, Canada|Research Site, Hastings, Ontario, Canada|Research Site, Kingston, Ontario, Canada|Research Site, Kitchener, Ontario, Canada|Research Site, London, Ontario, Canada|Research Site, Mississauga, Ontario, Canada|Research Site, Napanee, Ontario, Canada|Research Site, Newboro, Ontario, Canada|Research Site, Ottawa, Ontario, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Pointe-Claire, Quebec, Canada|Research Site, Sherbrooke, Quebec, Canada|Research Site, Helsinki, Finland|Research Site, Kuopio, Finland|Research Site, Lahti, Finland|Research Site, Mikkeli, Finland|Research Site, Oulu, Finland|Research Site, Porvoo, Finland|Research Site, Savonlinna, Finland|Research Site, Seinäjoki, Finland|Research Site, Suonenjoki, Finland|Research Site, Tampere, Finland|Research Site, Turku, Finland|Research Site, Vaasa, Finland|Research Site, Aix En Provence, France|Research Site, Ambriere Les Vallees, France|Research Site, Beziers, France|Research Site, Briey Cedex, France|Research Site, Broglie, France|Research Site, Chateau Gontier, France|Research Site, Cremeaux, France|Research Site, Falaise, France|Research Site, Fontaine Saint Martin, France|Research Site, Freyming Merlebach, France|Research Site, GAN, France|Research Site, Hyeres, France|Research Site, Jarny, France|Research Site, Jort, France|Research Site, L'aigle, France|Research Site, Lambersart, France|Research Site, Le Lavandou, France|Research Site, Lille, France|Research Site, Lomme Cedex, France|Research Site, Marange Silvange, France|Research Site, Marignane, France|Research Site, Mars La Tour, France|Research Site, Martigues, France|Research Site, Mayenne, France|Research Site, Metz, France|Research Site, Mondelange, France|Research Site, Montbrison, France|Research Site, Montpellier, France|Research Site, Moutiers, France|Research Site, Nantes Cedex 01, France|Research Site, Nantes Cedex 1, France|Research Site, Paris, France|Research Site, Poitiers, France|Research Site, Roanne, France|Research Site, Roquevaire, France|Research Site, Rugles, France|Research Site, Saint Chamond, France|Research Site, Saint Jean de Luz, France|Research Site, Tantonville, France|Research Site, Heidelberg, Baden-Württemberg, Germany|Research Site, Stuttgart, Baden-Württemberg, Germany|Research Site, München, Bayern, Germany|Research Site, Frankfurt, Hessen, Germany|Research Site, Hannover, Niedersachsen, Germany|Research Site, Düsseldorf, Nordrhein-Westfalen, Germany|Research Site, Münster, Nordrhein-Westfalen, Germany|Research Site, Dresden, Sachsen, Germany|Research Site, Aschaffenburg, Germany|Research Site, Beckum, Germany|Research Site, Berlin, Germany|Research Site, Dresden, Germany|Research Site, Düsseldorf, Germany|Research Site, Essen, Germany|Research Site, Gelnhausen, Germany|Research Site, Hannover, Germany|Research Site, Heidelberg, Germany|Research Site, Heilbronn, Germany|Research Site, Künzing, Germany|Research Site, Nürnberg, Germany|Research Site, Pirna, Germany|Research Site, Hong Kong, Hong Kong|Research Site, Shatin, Hong Kong|Research Site, Balatonfüred, Hungary|Research Site, Budapest, Hungary|Research Site, Gy¿r, Hungary|Research Site, Kaposvár, Hungary|Research Site, Kecskemét, Hungary|Research Site, Miskolc, Hungary|Research Site, Siófok, Hungary|Research Site, Székesfehérvár, Hungary|Research Site, Mumbai, Mashatra, India|Research Site, Bangalore, India|Research Site, Delhi, India|Research Site, India, India|Research Site, Jakarta, DKI Jakarta, Indonesia|Research Site, Malang, East Java, Indonesia|Research Site, Kuala Lumpur, Malaysia|Research Site, Penang, Malaysia|Research Site, Petaling Jaya, Malaysia|Research Site, Bergen, Norway|Research Site, Bodø, Norway|Research Site, Elverum, Norway|Research Site, Fredrikstad, Norway|Research Site, Hamar, Norway|Research Site, Oslo, Norway|Research Site, Paradis, Norway|Research Site, Trondheim, Norway|Research Site, Tvedestrand, Norway|Research Site, Cebu City, Philippines|Research Site, Makati City, Philippines|Research Site, Manila, Philippines|Research Site, Almada, Portugal|Research Site, Amadora, Portugal|Research Site, Caldas da Rainha, Portugal|Research Site, Elvas, Portugal|Research Site, Lisboa, Portugal|Research Site, Portalegre, Portugal|Research Site, Moscow, Russian Federation|Research Site, St.Petersburg, Russian Federation|Research Site, Yaroslavl, Russian Federation|Research Site, Singapore, Singapore|Research Site, Cape Town, South Africa|Research Site, Durban, South Africa|Research Site, Johannesburg, South Africa|Research Site, Pretoria, South Africa|Research Site, Bern, Switzerland|Research Site, Chur, Switzerland|Research Site, Ilanz, Switzerland|Research Site, Lausanne, Switzerland|Research Site, Monthey, Switzerland|Research Site, Sion, Switzerland|Research Site, Zürich, Switzerland|Research Site, Yong-Kang City, Tainan County, Taiwan|Research Site, Changhua, Taiwan|Research Site, Taichung, Taiwan|Research Site, Taipei, Taiwan"
NCT03653533,"Evaluation of the Function ""Stop Before Hypoglycemia"" on External Insulin Pump",https://clinicaltrials.gov/study/NCT03653533,TERMINATED,Type I Diabetes,DEVICE: MiniMed™ 640G|DEVICE: Captor CGM Enlite®|DEVICE: SmartGuard®,ARAIR Assistance,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Pole Sante Sud Le Mans, Le Mans, France"
NCT03063229,Energy Balance Following Islet Transplantation,https://clinicaltrials.gov/study/NCT03063229,TERMINATED,Type 1 Diabetes,DEVICE: Accelerometer|OTHER: Anthropomentry|PROCEDURE: Blood tests|DEVICE: BODPOD|PROCEDURE: MRI (Magnetic Resonance Imaging)|OTHER: Food Diary|DEVICE: CGMS (Continuous Glucose Monitoring System)|OTHER: Questionnaire and Hypo Score|PROCEDURE: Mixed Meal Tolerance Test (MMTT)|PROCEDURE: Indirect Calorimetry|DRUG: Doubly Labelled Water|DRUG: Hepatic Mitochondrial Oxidation breath test,University of Edinburgh,NHS Lothian,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Royal Infirmary Edinburgh, Edinburgh, Midlothian, EH16 4SA, United Kingdom"
NCT01247649,Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG,https://clinicaltrials.gov/study/NCT01247649,TERMINATED,Type 1 Diabetes,DEVICE: Physical Logic Continuous Glucose Monitoring System,Rabin Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Schneider Children's Medical center, Petach-Tikva, 49202, Israel"
NCT02655666,Qingdao: Insulin Pump Follow-Up Program,https://clinicaltrials.gov/study/NCT02655666,TERMINATED,Type 1 Diabetes,,Medtronic Diabetes,,ALL,"CHILD, ADULT",,OBSERVATIONAL,"The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"
NCT00925977,Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents,https://clinicaltrials.gov/study/NCT00925977,TERMINATED,Diabetes Type 1,DRUG: insulin Glargine + Insulin Apidra|DRUG: Insulin NPH + Insulin Apidra: Active Comparator,Rabin Medical Center,Sanofi,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Soroka hospital, Bear Sheva, Israel|Rambam Hospital, Haifa, Israel|Health care unit- Jerusalem, Jerusalem, Israel|Schnider children medical center, Petach-Tikva, Israel"
NCT00627471,Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2),https://clinicaltrials.gov/study/NCT00627471,TERMINATED,Type 2 Diabetes,DRUG: Insulin Glargine|DRUG: Insulin Glargine,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Sanofi-aventis administrative office Argentina, Buenos Aires, Argentina"
NCT00263965,ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity,https://clinicaltrials.gov/study/NCT00263965,TERMINATED,Type 2 Diabetes,DRUG: Tesaglitazar|DRUG: Metformin|BEHAVIORAL: Dietary and lifestyle modification counseling,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Helsinki, Finland|Research Site, Pisa, Italy|Research Site, Oxford, United Kingdom"
NCT04678661,My Dose Coach Mobile App to Support Insulin Titration and Maintenance,https://clinicaltrials.gov/study/NCT04678661,TERMINATED,Diabetes Mellitus Type 2 - Insulin-Treated,DEVICE: Smartphone application and web portal|BEHAVIORAL: Standard Insulin Therapy Education,Linda Siminerio,Sanofi,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States"
NCT00515099,Study of Antithymocyte Globulin for Treatment of New-onset T1DM,https://clinicaltrials.gov/study/NCT00515099,TERMINATED,New-onset Type 1 Diabetes Mellitus,DRUG: Antithymocyte globulin|DRUG: Placebo,National Institute of Allergy and Infectious Diseases (NIAID),Immune Tolerance Network (ITN),ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"Children's Hospital/USC School of Medicine, Los Angeles, California, 90027, United States|Children's Hospital and Research Center, Oakland, California, 92609, United States|UCSD/San Diego Children's Hospital, San Diego, California, 92123, United States|Diabetes Center at UCSF, San Francisco, California, 94143, United States|Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, Colorado, 80010, United States|Emory Children's Center, Atlanta, Georgia, 30322, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States"
NCT03174522,The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM,https://clinicaltrials.gov/study/NCT03174522,TERMINATED,"Peripheral Arterial Disease (PAD)|Diabetes Mellitus (DM)|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Cardiovascular Disease|Critical Limb Ischemia (CLI)",DRUG: REX-001|DRUG: Placebo,Ixaka Ltd,Andalusian Network for Design and Translation of Advanced Therapies,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Fakultní nemocnice Ostrava, Ostrava, Czechia|Pécsi Tudományegyetem, PTE-KK I. sz Belgyógyászati Klinika, Pécs, Hungary|Leids Universitair Medisch Centrum, Leiden, Netherlands|Maastricht Universitair Medisch Centrum, Maastricht, Netherlands|Hospital Garcia de Orta, EPE, Almada, Portugal|Centro Hospitalar Lisboa Norte, EPE, Lisboa, Portugal|Centro Hospitalar de São João, Porto, Portugal|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitario Puerta del Mar, Cadiz, Spain|First site: Hospital Universitario Reina Sofía, Córdoba, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Regional Universitario, Málaga, Spain|University Hospital of Wales, Cardiff, United Kingdom"
NCT01652911,A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation,https://clinicaltrials.gov/study/NCT01652911,TERMINATED,Type I Diabetes,DEVICE: Sernova Cell Pouch,University of Alberta,Sernova Corp,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"University of Alberta - Clinical Islet Transplant Program, Edmonton, Alberta, T6G 2C8, Canada"
NCT03111238,The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM,https://clinicaltrials.gov/study/NCT03111238,TERMINATED,"Peripheral Arterial Disease (PAD)|Diabetes Mellitus (DM)|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Cardiovascular Disease|Critical Limb Ischemia (CLI)",DRUG: REX-001|DRUG: Placebo,Ixaka Ltd,Andalusian Network for Design and Translation of Advanced Therapies,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Fakultní nemocnice Ostrava, Ostrava, Czechia|Vitkovicka nemocnice a. s. Vaskularni centrum, Ostrava, Czechia|Klinikum der Goethe-Universität Frankfurt, Frankfurt, Germany|Pécsi Tudományegyetem, PTE-KK I. sz Belgyógyászati Klinika, Pécs, Hungary|Instytut Hematologii i Transfuzjologii, Warsaw, Poland|Centro Hospitalar de São João, Porto, Portugal|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitario Puerta del Mar, Cadiz, Spain|First site: Hospital Universitario Reina Sofía, Córdoba, Spain|Complejo Hospitalario Universitario de Granada, Hospital del Campus de la Salud, Granada, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Universitario Virgen de Valme, Sevilla, Spain"
NCT01530347,Non Invasive Breath Based Acetone-meter- Easy Check,https://clinicaltrials.gov/study/NCT01530347,TERMINATED,Type 1 Diabetes,DEVICE: Easy Check,Rabin Medical Center,,MALE,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Schneider Children's Medical Center, Petah- Tikva, 49202, Israel"
NCT01101269,"Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease",https://clinicaltrials.gov/study/NCT01101269,TERMINATED,Type 2 Diabetes,DRUG: ACEI or ARB|DRUG: Lisinopril,University of Virginia,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Virginia Health System, Charlottesville, Virginia, 22908, United States"
NCT01308437,Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics,https://clinicaltrials.gov/study/NCT01308437,TERMINATED,Type I Diabetes,BIOLOGICAL: Wosulin (N or 70/30 with R)|BIOLOGICAL: Novolin® (N or 70/30 with R),Wockhardt,,ALL,ADULT,PHASE3,INTERVENTIONAL,"University Clinical Investigators, Inc. dba Diabetes Research Center, Tustin, California, 92780, United States|International Research Associates, Hialeah, Florida, 33012, United States|The Center for Diabetes and Endocrine Care, Hollywood, Florida, 33021, United States|Baptist Diabetes Associates, PA, Miami, Florida, 33156, United States|Suncoast Clinical Research, New Port Richey, Florida, 34652, United States|Ormond Medical Arts Pharmaceutical Research Center, Ormond Beach, Florida, 32174, United States|Suncoast Clinical Research, Palm Harbor, Florida, 34684, United States|International Clinical Research - US, LLC, Sanford, Florida, 32771, United States|Cotton-O'Neil Clinical Research Center, Diabetes & Endocrinology, Topeka, Kansas, 66606, United States|Kentucky Diabetes Endocrinology Center, Lexington, Kentucky, 40503, United States|Endocrine & Metabolic Consultants, Rockville, Maryland, 20852, United States|ActivMed Practices and Research, Haverhill, Massachusetts, 01830, United States|Alzohaili Medical Consultants, Dearborn, Michigan, 48124, United States|ActivMed Practices and Research, Rochester, New Hampshire, 03867, United States|University Diabetes & Endocrine Association, Chattanooga, Tennessee, 37411, United States|Sergio Rovner, MD, El Paso, Texas, 79925, United States|Optimum Clinical Research, Inc., Salt Lake City, Utah, 84102, United States|Dr Rakesh Sahay, Hyderabad, Andhra Pradesh, 500012, India|Dia Care - A Complete Diabetes Care Centre, Ahmedabad, Gujrat, 380015, India|Dr Sanjay Kalra, Karnal, Haryana, 132001, India|Dr Mala Dharmalingam, Bangalore, Karnataka, 560003, India|Bangalore Diabetes Hospital, Bangalore, Karnataka, 560052, India|Dr Sharad Pendsey, Nagpur, Maharashtra, 440012, India|Diabetes Thyroid &Endocrine Centre, Jaipur, Rajasthan, 302006, India|Bhandari's Clinic, Jaipur, Rajasthan, 302015, India"
NCT01498614,Psychological Impact in Diabetes: Intervention With Affect School and Basal Body Awareness,https://clinicaltrials.gov/study/NCT01498614,TERMINATED,Diabetes Mellitus|Depression|Alexithymia|Anxiety,BEHAVIORAL: Affect School and Basal body awareness,Lund University,"Landstinget Kronoberg, Sweden",ALL,ADULT,,INTERVENTIONAL,"Landstinget Kronoberg, Vaxjo, Kronoberg, s-35251, Sweden"
NCT03523143,The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes,https://clinicaltrials.gov/study/NCT03523143,TERMINATED,Pregnancy Complications|Gestational Diabetes Mellitus in Pregnancy,OTHER: early screening and intervention|OTHER: standard screening and intervention,National Taiwan University Hospital,,FEMALE,ADULT,,INTERVENTIONAL,"Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100, Taiwan"
NCT00805974,Study of the Relationship Between Sleep Quality and Daytime-Nighttime Variations of Blood Pressure and Plasma Glucose Type I,https://clinicaltrials.gov/study/NCT00805974,TERMINATED,Type 1 Diabetes,BIOLOGICAL: Biological examinations (blood and urinary).,"University Hospital, Grenoble",Pr Mallion Jean-Michel|Pr BAGUET Jean-Philippe|Pr BENHAMOU Pierre-Yves|Pr LEVY Patrick|Dr MOURET Sandrine|Dr ORMEZZANO Olivier|Pr PEPIN Jean-Louis|Dr TAMISIER Renaud,ALL,ADULT,,INTERVENTIONAL,"University Hospital, Grenoble, France"
NCT04964388,Effect of GLP-1 Receptor Agonists on Trabecular Bone Score,https://clinicaltrials.gov/study/NCT04964388,TERMINATED,"Osteoporosis, Postmenopausal|Diabetes Mellitus, Type 2",DRUG: GLP-1 receptor agonist,University of Mississippi Medical Center,,FEMALE,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States"
NCT02303405,Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02303405,TERMINATED,Diabetes Mellitus Type 2 With Hyperglycemia,DRUG: Hydroxychloroquine|DRUG: Pioglitazone,Charles Drew University of Medicine and Science,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Charles Drew University of Medicine and Science, Los Angeles, California, 90059, United States"
NCT02324491,An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02324491,TERMINATED,Obesity|Type 2 Diabetes,DRUG: ZGN-440 for Injectable Suspension|DRUG: ZGN-440 Placebo for Injectable Suspension,"Zafgen, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Royal Prince Alfred Hospital, Camperdown, New South Wales, 2050, Australia|Pendlebury Research, Cardiff, New South Wales, 2285, Australia|Australian Clinical Research Network, Maroubra, New South Wales, 2035, Australia|Royal North Shore Hospital, St. Leonards, New South Wales, 2065, Australia|Illawara Diabetes Service, Wollongong, New South Wales, 2500, Australia|Q-Pharm, Herston, Queensland, 4006, Australia|Ipswich Research Institute, Ipswich, Queensland, 4305, Australia|AusTrials, Sherwood, Queensland, 4075, Australia|CMAX, Adelaide, South Australia, 5000, Australia|Box Hill Hospital, Box Hill, Victoria, 3128, Australia|St. Vincent's Hospital, Fitzroy, Victoria, 3065, Australia|Barwon Health, Geelong, Victoria, 3220, Australia|Austin Health, Heidelberg West, Victoria, 3081, Australia|Emeritus Research, Malvern East, Victoria, 3145, Australia|Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia|Keogh Institute for Medical Research, Nedlands, Western Australia, 6009, Australia"
NCT02015910,Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT02015910,TERMINATED,Type II Diabetes,DRUG: Sitagliptin|DRUG: Placebo,Georgetown University,Merck Sharp & Dohme LLC,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Medstar Georgetown University Hospital, Washington, District of Columbia, 20007, United States"
NCT02548494,Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes,https://clinicaltrials.gov/study/NCT02548494,TERMINATED,"Diabetes Mellitus, Type 1|Diabetic Ketoacidosis",DRUG: Glargine|DRUG: IV insulin|OTHER: Electrolyte Correction|OTHER: Correction of Fluid Loss,Chattanooga-Hamilton County Hospital Authority,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Children's @ Erlanger, Chattanooga, Tennessee, 37403, United States"
NCT01108978,Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease,https://clinicaltrials.gov/study/NCT01108978,TERMINATED,Type 2 Diabetes Mellitus|Cardiovascular Disease|Hypercholesterolemia,DRUG: Placebo|DRUG: Dehypotin,"Nang Kuang Pharmaceutical Co., Ltd.",National Taiwan University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Nang Kuang Pharmaceutical Co., LTD, Tainan, Xinhua Township, 712, Taiwan"
NCT03665350,Insulin Treatment in Diabetic Older People With Heart Failure.,https://clinicaltrials.gov/study/NCT03665350,TERMINATED,"Heart Failure|Diabetes Mellitus, Type 2",DRUG: Insulin,Mario Negri Institute for Pharmacological Research,,ALL,OLDER_ADULT,PHASE2,INTERVENTIONAL,"Ospedale Bolognini di Seriate, Seriate, BG, 24068, Italy|Ospedale Treviglio, Treviglio, BG, 24047, Italy|Ospedale di Passirana, Passirana, MI, 20017, Italy"
NCT04484987,The Effect of Time-Restricted Eating in Cardiometabolic Health,https://clinicaltrials.gov/study/NCT04484987,TERMINATED,Obesity|Pre-diabetes,OTHER: 9 hours daily eating window|OTHER: 15 hours daily eating window,"University of California, Davis",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of California, Davis, Davis, California, 95616-5398, United States"
NCT02532101,Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02532101,TERMINATED,Uncontrolled Insulin-treated Type 2 Diabetes Mellitus,DIETARY_SUPPLEMENT: Oil Palm Phenolics,Universiti Sains Malaysia,"Malaysia Palm Oil Board|Clinical Research Centre, Malaysia",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Seberang Jaya Hospital, Seberang Jaya, Penang, 13700, Malaysia"
NCT02387164,Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies,https://clinicaltrials.gov/study/NCT02387164,TERMINATED,"Diabetes Mellitus, Type 1|Prediabetic State",DRUG: Alum-GAD|DRUG: Vitamin D3,Lund University,Region Skane,ALL,"CHILD, ADULT",PHASE2,INTERVENTIONAL,"Clinical Research Center, Pediatric Endocrinology, Jan Waldenströms gata 35, 60:11, Malmö, 205 02, Sweden"
NCT01336673,Glucophage XR® Observational Study,https://clinicaltrials.gov/study/NCT01336673,TERMINATED,Diabetes Mellitus Type 2|GI Side Effect,,"Merck KGaA, Darmstadt, Germany","Merck Ltd., Thailand",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Faculty of Medicine Vajira Hospital, Bangkok, Thailand"
NCT00718614,Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM),https://clinicaltrials.gov/study/NCT00718614,TERMINATED,"Diabetes Mellitus, Type 1|Diabetic Retinopathy",PROCEDURE: Light will be switched from 0.5µW/cm2/sr to 115µW/cm2/sr.,Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Clinical Pharmacology, Vienna, 1090, Austria"
NCT03490942,Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses,https://clinicaltrials.gov/study/NCT03490942,TERMINATED,"Hypoglycemia Unawareness|Diabetes Mellitus, Type 1",DRUG: Glucagon|DRUG: Placebo,Xeris Pharmaceuticals,Integrated Medical Development,ALL,ADULT,PHASE2,INTERVENTIONAL,"University of Alabama, Birmingham, Birmingham, Alabama, 35294, United States|University of California, San Diego, San Diego, California, 92037, United States|Emory University - Grady Memorial Hospital, Atlanta, Georgia, 30303, United States|Atlanta Diabetes Associates, Atlanta, Georgia, 30318, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States"
NCT04007133,Statin Compliance of Patients With Non-insulin-dependent Diabetes,https://clinicaltrials.gov/study/NCT04007133,TERMINATED,Non-insulin-dependent Diabetes,OTHER: Girerd test,Lille Catholic University,"University Hospital, Lille",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Lille Catholic Hospitals, Lomme, Nord, 59462, France"
NCT00557518,Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria,https://clinicaltrials.gov/study/NCT00557518,TERMINATED,"Diabetes Mellitus, Type 1|Diabetic Nephropathy",DRUG: Alagebrium|DRUG: Placebo,"Synvista Therapeutics, Inc",Juvenile Diabetes Research Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Royal Prince Alfred Hospital, Camperdown, New South Wales, 2050, Australia|International Diabetes Institute, Caulfield, Victoria, 3162, Australia|Dept. of Clinical and Biomedical Science Myers House, Geelong, Victoria, 3220, Australia|Austin Health, Heidelburg, Victoria, 3084, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|Steno Diabetes Center, Gentofte, DK-2820, Denmark"
NCT03521934,Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial),https://clinicaltrials.gov/study/NCT03521934,TERMINATED,Heart Failure|Type 2 Diabetes Mellitus,DRUG: Sotagliflozin|DRUG: Placebo,Lexicon Pharmaceuticals,Sanofi,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8400128, Alexander City, Alabama, 35010, United States|Investigational Site Number 8400109, Cottonwood, Arizona, 86326, United States|Investigational Site Number 8400032, Little Rock, Arkansas, 72205, United States|Investigational Site Number 8400080, Little Rock, Arkansas, 72205, United States|Investigational Site Number 8400075, Bakersfield, California, 93309, United States|Investigational Site Number 8400069, Fresno, California, 93701, United States|Investigational Site Number 8400008, Los Angeles, California, 90024, United States|Investigational Site Number 8400063, Los Angeles, California, 90073, United States|Investigational Site Number 8400127, National City, California, 91950, United States|Investigational Site Number 8400007, Redondo Beach, California, 90277, United States|Investigational Site Number 8400036, Stockton, California, 95204, United States|Investigational Site Number 8400033, Sylmar, California, 91342, United States|Investigational Site Number 8400049, Torrance, California, 90502, United States|Investigational Site Number 8400028, Walnut Creek, California, 94598, United States|Investigational Site Number 8400029, Bridgeport, Connecticut, 06606, United States|Investigational Site Number 8400037, New Haven, Connecticut, 06519, United States|Investigational Site Number 8400046, DeLand, Florida, 32720, United States|Investigational Site Number 8400009, Gainesville, Florida, 32608, United States|Investigational Site Number 8400079, Homestead, Florida, 33033, United States|Investigational Site Number 8400031, Jacksonville, Florida, 32207, United States|Investigational Site Number 8400022, Jacksonville, Florida, 32216, United States|Investigational Site Number 8400098, Lake Mary, Florida, 32746, United States|Investigational Site Number 8400058, Miami Beach, Florida, 33140, United States|Investigational Site Number 8400105, Orlando, Florida, 32806, United States|Investigational Site Number 8400082, Pensacola, Florida, 32504, United States|Investigational Site Number 8400057, Port Charlotte, Florida, 33952, United States|Investigational Site Number 8400006, Sarasota, Florida, 34239, United States|Investigational Site Number 8400035, Tampa, Florida, 33609, United States|Investigational Site Number 8400042, Tampa, Florida, 33612, United States|Investigational Site Number 8400004, Wellington, Florida, 33449, United States|Investigational Site Number 8400073, Atlanta, Georgia, 30322-1020, United States|Investigational Site Number 8400118, Tucker, Georgia, 30084, United States|Investigational Site Number 8400067, Arlington Heights, Illinois, 60005, United States|Investigational Site Number 8400043, Chicago, Illinois, 60637, United States|Investigational Site Number 8400072, Elk Grove Village, Illinois, 60007, United States|Investigational Site Number 8400055, Indianapolis, Indiana, 46060, United States|Investigational Site Number 8400020, Muncie, Indiana, 47303-3400, United States|Investigational Site Number 8400122, Richmond, Indiana, 47374, United States|Investigational Site Number 8400091, Waterloo, Iowa, 50702, United States|Investigational Site Number 8400030, Covington, Louisiana, 70433, United States|Investigational Site Number 8400065, Annapolis, Maryland, 21401, United States|Investigational Site Number 8400012, Boston, Massachusetts, 02118, United States|Investigational Site Number 8400001, Cambridge, Massachusetts, 02135, United States|Investigational Site Number 8400077, Detroit, Michigan, 48202, United States|Investigational Site Number 8400062, Kalamazoo, Michigan, 49009, United States|Investigational Site Number 8400017, Kalamazoo, Michigan, 49048, United States|Investigational Site Number 8400107, Duluth, Minnesota, 55805, United States|Investigational Site Number 8400056, Jackson, Mississippi, 39216, United States|Investigational Site Number 8400019, Columbia, Missouri, 65201, United States|Investigational Site Number 8400103, Lee's Summit, Missouri, 64064, United States|Investigational Site Number 8400132, Grand Island, Nebraska, 68803, United States|Investigational Site Number 8400130, Lincoln, Nebraska, 68506, United States|Investigational Site Number 8400083, Omaha, Nebraska, 68124, United States|Investigational Site Number 8400071, Omaha, Nebraska, 68198, United States|Investigational Site Number 8400015, Ridgewood, New Jersey, 07450-2736, United States|Investigational Site Number 8400050, Voorhees, New Jersey, 08043, United States|Investigational Site Number 8400131, Albuquerque, New Mexico, 87131, United States|Investigational Site Number 8400097, Bronx, New York, 10457, United States|Investigational Site Number 8400061, Bronx, New York, 10468-3904, United States|Investigational Site Number 8400051, Brooklyn, New York, 11203, United States|Investigational Site Number 8400111, Buffalo, New York, 14215, United States|Investigational Site Number 8400045, Greensboro, North Carolina, 27401, United States|Investigational Site Number 8400085, Raleigh, North Carolina, 27610, United States|Investigational Site Number 8400078, Winston-Salem, North Carolina, 27157, United States|Investigational Site Number 8400087, Cincinnati, Ohio, 45220, United States|Investigational Site Number 8400047, Cincinnati, Ohio, 45267, United States|Investigational Site Number 8400095, Maumee, Ohio, 43537, United States|Investigational Site Number 8400099, Toledo, Ohio, 43699, United States|Investigational Site Number 8400121, Zanesville, Ohio, 43701, United States|Investigational Site Number 8400054, Arlington, Oregon, 19001, United States|Investigational Site Number 8400134, Doylestown, Pennsylvania, 18901, United States|Investigational Site Number 8400044, Natrona Heights, Pennsylvania, 15065, United States|Investigational Site Number 8400115, Philadelphia, Pennsylvania, 19104, United States|Investigational Site Number 8400039, Sayre, Pennsylvania, 18840, United States|Investigational Site Number 8400114, Providence, Rhode Island, 02903, United States|Investigational Site Number 8400100, Warwick, Rhode Island, 02886, United States|Investigational Site Number 8400059, Charleston, South Carolina, 29425, United States|Investigational Site Number 8400092, Columbia, South Carolina, 29203, United States|Investigational Site Number 8400104, Greenville, South Carolina, 29605, United States|Investigational Site Number 8400040, Rapid City, South Dakota, 57701, United States|Investigational Site Number 8400088, Greenville, Tennessee, 30000, United States|Investigational Site Number 8400089, Memphis, Tennessee, 38104, United States|Investigational Site Number 8400053, Nashville, Tennessee, 37212, United States|Investigational Site Number 8400041, Brownsville, Texas, 78521, United States|Investigational Site Number 8400074, Dallas, Texas, 75226, United States|Investigational Site Number 8400016, Houston, Texas, 77030, United States|Investigational Site Number 8400123, McKinney, Texas, 75071, United States|Investigational Site Number 8400101, New Braunfels, Texas, 78130, United States|Investigational Site Number 8400066, Victoria, Texas, 77901, United States|Investigational Site Number 8400093, Manassas, Virginia, 20109, United States|Investigational Site Number 8400003, Richmond, Virginia, 23249-0001, United States|Investigational Site Number 8400126, Clarksburg, West Virginia, 26301, United States|Investigational Site Number 8400038, Morgantown, West Virginia, 26506, United States|Investigational Site Number 8400048, Manitowoc, Wisconsin, 54220, United States|Investigational Site Number 0320031, Caba, 1430, Argentina|Investigational Site Number 0320009, Caba, C1093AAS, Argentina|Investigational Site Number 0320016, Capital Federal, 1405, Argentina|Investigational Site Number 0320002, Ciudad De Buenos Aires, C1428DCO, Argentina|Investigational Site Number 0320011, Cordoba, X5000AAX, Argentina|Investigational Site Number 0320010, Cordoba, X5004BAL, Argentina|Investigational Site Number 0320022, Corrientes, 3400, Argentina|Investigational Site Number 0320001, Corrientes, W3400AMZ, Argentina|Investigational Site Number 0320024, Córdoba, 5000, Argentina|Investigational Site Number 0320003, Córdoba, X5000JHQ, Argentina|Investigational Site Number 0320025, Córdoba, X5006IKK, Argentina|Investigational Site Number 0320029, La Plata, B1900AXI, Argentina|Investigational Site Number 0320007, La Plata, B1906ESC, Argentina|Investigational Site Number 0320006, Merlo, B1722COV, Argentina|Investigational Site Number 0320005, Moron, B1708CGU, Argentina|Investigational Site Number 0320012, Olivos, 1638, Argentina|Investigational Site Number 0320023, Quilmes, 1878, Argentina|Investigational Site Number 0320018, Rosario, 2000, Argentina|Investigational Site Number 0320013, Rosario, S2000DSR, Argentina|Investigational Site Number 0320008, Salta, 4400, Argentina|Investigational Site Number 0320020, San Martin, B1685CSQ, Argentina|Investigational Site Number 0320028, San Miguel De Tucuman, T4000IFL, Argentina|Investigational Site Number 0320019, San Miguel De Tucuman, T4000NIL, Argentina|Investigational Site Number 0320017, Santa Fe, S3000EOZ, Argentina|Investigational Site Number 0320015, Santa Fe, S3000FWO, Argentina|Investigational Site Number 0320030, Tucuman, T4000JCU, Argentina|Investigational Site Number 0320004, Villa Belgrano, X5021FPQ, Argentina|Investigational Site Number 0320014, Villa Maria, X5900JKA, Argentina|Investigational Site Number 0360007, Murdoch, 6150, Australia|Investigational Site Number 0360001, Wollongong, 2500, Australia|Investigational Site Number 0400006, Braunau, 5280, Austria|Investigational Site Number 0400002, Feldkirch, 6800, Austria|Investigational Site Number 0400007, Graz, 8036, Austria|Investigational Site Number 0400005, Linz, 4010, Austria|Investigational Site Number 0400004, Salzburg, 5020, Austria|Investigational Site Number 0400003, Wien, 1090, Austria|Investigational Site Number 0400001, Wien, 1160, Austria|Investigational Site Number 0560002, Aalst, 9300, Belgium|Investigational Site Number 0560007, Gent, 9000, Belgium|Investigational Site Number 0560004, Kortrijk, 8500, Belgium|Investigational Site Number 0560001, Leuven, 3000, Belgium|Investigational Site Number 0560003, Liège, 4000, Belgium|Investigational Site Number 0560005, Mol, 2400, Belgium|Investigational Site Number 0560006, Mons, 7000, Belgium|Investigational Site Number 0560008, Roeselare, 8800, Belgium|Investigational Site Number 0760009, Belo Horizonte, 30110-908, Brazil|Investigational Site Number 0760024, Belo Horizonte, 30150-221, Brazil|Investigational Site Number 0760002, Blumenau, 89020-430, Brazil|Investigational Site Number 0760011, Brasilia, 70390-903, Brazil|Investigational Site Number 0760005, Campinas, 13060-080, Brazil|Investigational Site Number 0760006, Campinas, 13092-111, Brazil|Investigational Site Number 0760023, Fortaleza, 60840-285, Brazil|Investigational Site Number 0760018, Goiania, 74210050, Brazil|Investigational Site Number 0760010, Passo Fundo, 99010-180, Brazil|Investigational Site Number 0760003, Porto Alegre, 90020-090, Brazil|Investigational Site Number 0760020, Porto Alegre, 90035 003, Brazil|Investigational Site Number 0760021, Porto Alegre, 90610-000, Brazil|Investigational Site Number 0760007, Porto Alegre, 90620-001, Brazil|Investigational Site Number 0760013, Porto Alegre, 91350-250, Brazil|Investigational Site Number 0760004, Recife, 52051-380, Brazil|Investigational Site Number 0760001, Sao Jose Do Rio Preto, 15090-000, Brazil|Investigational Site Number 0760012, Sao Paulo, 04012-909, Brazil|Investigational Site Number 0760008, Sao Paulo, 05403-000, Brazil|Investigational Site Number 0760017, Votuporanga, 15500-003, Brazil|Investigational Site Number 1240013, Cambridge, N1R 6V6, Canada|Investigational Site Number 1240006, Granby, J2G 1T7, Canada|Investigational Site Number 1240015, Halifax, B3H 3A7, Canada|Investigational Site Number 1240002, Montreal, H1T 1C8, Canada|Investigational Site Number 1240019, Montreal, H3G 1A4, Canada|Investigational Site Number 1240018, Montreal, H4A 3J1, Canada|Investigational Site Number 1240004, Peterborough, K9J 0B2, Canada|Investigational Site Number 1240014, Quebec, G1V 4G5, Canada|Investigational Site Number 1240007, Scarborough, M1B 4Z8, Canada|Investigational Site Number 1240005, Sherbrooke, J1G 2E8, Canada|Investigational Site Number 1240011, Toronto, M5B 1W8, Canada|Investigational Site Number 1240001, Toronto, M5G 2C4, Canada|Investigational Site Number 1240009, Trois-Rivières, G9A 5C5, Canada|Investigational Site Number 1520009, Concepción, Chile|Investigational Site Number 1520011, Santiago, 80004005, Chile|Investigational Site Number 1520006, Santiago, 8053095, Chile|Investigational Site Number 1520003, Santiago, 8380456, Chile|Investigational Site Number 1520004, Santiago, Chile|Investigational Site Number 1520005, Santiago, Chile|Investigational Site Number 1520012, Santiago, Chile|Investigational Site Number 1520013, Santiago, Chile|Investigational Site Number 1520002, Temuco, Chile|Investigational Site Number 1520010, Vina Del Mar, Chile|Investigational Site Number 1520001, Viña Del Mar, Chile|Investigational Site Number 2030001, Brno, 62500, Czechia|Investigational Site Number 2030003, Brno, 63600, Czechia|Investigational Site Number 2030004, Brno, 65691, Czechia|Investigational Site Number 2030014, Kolin 3, 28002, Czechia|Investigational Site Number 2030010, Kromeriz, 76701, Czechia|Investigational Site Number 2030005, Liberec, 46063, Czechia|Investigational Site Number 2030013, Mestec Kralove, 28903, Czechia|Investigational Site Number 2030018, Praha 10, 10100, Czechia|Investigational Site Number 2030002, Praha 2, 12808, Czechia|Investigational Site Number 2030007, Praha 5 - Motol, 15006, Czechia|Investigational Site Number 2030017, Praha 5, 15030, Czechia|Investigational Site Number 2030011, Prerov, 75152, Czechia|Investigational Site Number 2030015, Pribram I, 26101, Czechia|Investigational Site Number 2030006, Slany, 27401, Czechia|Investigational Site Number 2080003, Aarhus N, 8200, Denmark|Investigational Site Number 2080002, Glostrup, 2600, Denmark|Investigational Site Number 2080001, Herlev, 2730, Denmark|Investigational Site Number 2080005, København Nv, 2400, Denmark|Investigational Site Number 2080004, Ålborg, 9100, Denmark|Investigational Site Number 2460004, Espoo, 02740, Finland|Investigational Site Number 2460001, Helsinki, 00029 HUS, Finland|Investigational Site Number 2460002, Jyväskylä, 40620, Finland|Investigational Site Number 2460003, Oulu, 90220, Finland|Investigational Site Number 2460005, Seinäjoki, 60220, Finland|Investigational Site Number 2500009, Chambray Les Tours, 37170, France|Investigational Site Number 2500008, La Tronche, 38700, France|Investigational Site Number 2500004, Le Chesnay, 78150, France|Investigational Site Number 2500002, Le Coudray, 28360, France|Investigational Site Number 2500001, Lille, 59037, France|Investigational Site Number 2500007, Nantes Cedex 1, 44093, France|Investigational Site Number 2500012, Nice Cedex 1, 06002, France|Investigational Site Number 2500003, Paris Cedex 18, 75877, France|Investigational Site Number 2500006, Paris, 75015, France|Investigational Site Number 2500005, Toulouse Cedex 9, 31059, France|Investigational Site Number 2500013, Vandoeuvre-Les-Nancy Cedex, 54511, France|Investigational Site Number 2760020, Bad Nauheim, 61231, Germany|Investigational Site Number 2760016, Bad Oeynhausen, 32545, Germany|Investigational Site Number 2760013, Berlin, 12203, Germany|Investigational Site Number 2760019, Berlin, 13347, Germany|Investigational Site Number 2760001, Berlin, 13353, Germany|Investigational Site Number 2760002, Berlin, 13353, Germany|Investigational Site Number 2760025, Bielefeld, 33604, Germany|Investigational Site Number 2760005, Bonn, 53115, Germany|Investigational Site Number 2760021, Bremen, 28277, Germany|Investigational Site Number 2760035, Coburg, 96450, Germany|Investigational Site Number 2760032, Dortmund, 44137, Germany|Investigational Site Number 2760006, Dortmund, 44379, Germany|Investigational Site Number 2760029, Erfurt, 99097, Germany|Investigational Site Number 2760018, Essen, 45138, Germany|Investigational Site Number 2760033, Frankfurt Am Main, 65929, Germany|Investigational Site Number 2760009, Greifswald, 17475, Germany|Investigational Site Number 2760022, Heidelberg, 69115, Germany|Investigational Site Number 2760031, Heidelberg, 69120, Germany|Investigational Site Number 2760027, Köln, 50733, Germany|Investigational Site Number 2760034, Lahr, 77933, Germany|Investigational Site Number 2760030, Langen, 63225, Germany|Investigational Site Number 2760014, Leverkusen, 51375, Germany|Investigational Site Number 2760036, Limburg, 65549, Germany|Investigational Site Number 2760012, Ludwigshafen, 67063, Germany|Investigational Site Number 2760028, Merseburg, 06217, Germany|Investigational Site Number 2760011, Rotenburg An Der Fulda, 36199, Germany|Investigational Site Number 2760015, Rüsselsheim, 65428, Germany|Investigational Site Number 2760007, Witten, 58455, Germany|Investigational Site Number 2760026, Würzburg, 97080, Germany|Investigational Site Number 3000012, Athens, 11526, Greece|Investigational Site Number 3000004, Athens, 11527, Greece|Investigational Site Number 3000002, Chalkida, 34 100, Greece|Investigational Site Number 3000009, Elefsina, 19600, Greece|Investigational Site Number 3000003, Haidari, 12462, Greece|Investigational Site Number 3000005, Heraklion, 71110, Greece|Investigational Site Number 3000007, Ioannina, 455 00, Greece|Investigational Site Number 3000006, Larissa, 41110, Greece|Investigational Site Number 3000001, N. Ionia, 14233, Greece|Investigational Site Number 3000008, Thessaloniki, 546 36, Greece|Investigational Site Number 3480018, Berettyóújfalu, 4100, Hungary|Investigational Site Number 3480012, Budapest, 1023, Hungary|Investigational Site Number 3480016, Budapest, 1085, Hungary|Investigational Site Number 3480010, Budapest, 1096, Hungary|Investigational Site Number 3480019, Budapest, 1115, Hungary|Investigational Site Number 3480001, Budapest, 1122, Hungary|Investigational Site Number 3480015, Budapest, 1125, Hungary|Investigational Site Number 3480011, Budapest, 1134, Hungary|Investigational Site Number 3480014, Budapest, 1145, Hungary|Investigational Site Number 3480005, Budapest, 1204, Hungary|Investigational Site Number 3480007, Debrecen, 4032, Hungary|Investigational Site Number 3480002, Dombóvár, 7200, Hungary|Investigational Site Number 3480017, Gyula, 5700, Hungary|Investigational Site Number 3480008, Hódmezövásárhely, 6800, Hungary|Investigational Site Number 3480020, Kistarcsa, 2143, Hungary|Investigational Site Number 3480009, Komárom, 2921, Hungary|Investigational Site Number 3480013, Pécs, 7624, Hungary|Investigational Site Number 3480003, Szekesfehervar, 8000, Hungary|Investigational Site Number 3480006, Zalaegerszeg, 8900, Hungary|Investigational Site Number 3760013, Ashkelon, 78278, Israel|Investigational Site Number 3760004, Hadera, 38100, Israel|Investigational Site Number 3760005, Haifa, 31096, Israel|Investigational Site Number 3760006, Jerusalem, 91031, Israel|Investigational Site Number 3760003, Jerusalem, 91120, Israel|Investigational Site Number 3760008, Jerusalem, Israel|Investigational Site Number 3760010, Nahariya, 22100, Israel|Investigational Site Number 3760002, Petah-Tikva, 49100, Israel|Investigational Site Number 3760011, Rehovot, 76100, Israel|Investigational Site Number 3760009, Safed, 13100, Israel|Investigational Site Number 3760001, Tel Aviv, 64239, Israel|Investigational Site Number 3760012, Tiberias, 15208, Israel|Investigational Site Number 3800006, Arzignano (Vi), 36071, Italy|Investigational Site Number 3800011, Brescia, 25123, Italy|Investigational Site Number 3800017, Brescia, 25124, Italy|Investigational Site Number 3800005, Cortona, 52044, Italy|Investigational Site Number 3800009, Ferrara, 44124, Italy|Investigational Site Number 3800020, Gallipoli, 73014, Italy|Investigational Site Number 3800003, Legnago, 37045, Italy|Investigational Site Number 3800023, Milano, 20122, Italy|Investigational Site Number 3800002, Milano, 20138, Italy|Investigational Site Number 3800012, Milano, 20138, Italy|Investigational Site Number 3800008, Milano, 20162, Italy|Investigational Site Number 3800013, Monza, 20052, Italy|Investigational Site Number 3800022, Napoli, 80131, Italy|Investigational Site Number 3800018, Pavia, 27100, Italy|Investigational Site Number 3800004, Perugia, 06132, Italy|Investigational Site Number 3800016, Pozzilli, 86077, Italy|Investigational Site Number 3800014, Rimini, 47900, Italy|Investigational Site Number 3800010, Roma, 00153, Italy|Investigational Site Number 3800021, Roma, 00189, Italy|Investigational Site Number 3800019, Scorrano, 73020, Italy|Investigational Site Number 3800007, Udine, 33100, Italy|Investigational Site Number 4100008, Bucheon-Si, 14754, Korea, Republic of|Investigational Site Number 4100010, Busan, 49267, Korea, Republic of|Investigational Site Number 4100004, Daegu, 42472, Korea, Republic of|Investigational Site Number 4100001, Hwaseong-Si, 18450, Korea, Republic of|Investigational Site Number 4100003, Incheon, 22332, Korea, Republic of|Investigational Site Number 4100005, Seongnam-Si, 13620, Korea, Republic of|Investigational Site Number 4100002, Seoul, 03080, Korea, Republic of|Investigational Site Number 4100007, Seoul, 03722, Korea, Republic of|Investigational Site Number 4100011, Seoul, 05030, Korea, Republic of|Investigational Site Number 4100009, Seoul, 06351, Korea, Republic of|Investigational Site Number 4280004, Daugavpils, LV-5417, Latvia|Investigational Site Number 4280002, Liepaja, LV-3414, Latvia|Investigational Site Number 4280001, Riga, LV-1002, Latvia|Investigational Site Number 4280003, Riga, LV-1038, Latvia|Investigational Site Number 4400002, Kaunas, 50161, Lithuania|Investigational Site Number 4400005, Kaunas, 50161, Lithuania|Investigational Site Number 4400004, Klaipeda, LT-92288, Lithuania|Investigational Site Number 4400006, Siauliai, LT-76231, Lithuania|Investigational Site Number 4400001, Vilnius, 08661, Lithuania|Investigational Site Number 4400003, Vilnius, 08661, Lithuania|Investigational Site Number 5280003, Amsterdam, 1034 CS, Netherlands|Investigational Site Number 5280001, Breda, 4819 EV, Netherlands|Investigational Site Number 5280007, Delft, 2625 AD, Netherlands|Investigational Site Number 5280002, Doetinchem, 7009 BL, Netherlands|Investigational Site Number 5280004, Hertogenbosch, 5223 GZ 's, Netherlands|Investigational Site Number 5280006, Rotterdam, 3045 PM, Netherlands|Investigational Site Number 5280008, Sneek, 8601, Netherlands|Investigational Site Number 5280005, Veldhoven, 5504 DB, Netherlands|Investigational Site Number 5540007, Auckland, 1023, New Zealand|Investigational Site Number 5540006, Christchurch, 8011, New Zealand|Investigational Site Number 5540002, Hamilton, 3204, New Zealand|Investigational Site Number 5540004, Lower Hutt, New Zealand|Investigational Site Number 5540005, New Plymouth, New Zealand|Investigational Site Number 5540003, Rotorua, 3010, New Zealand|Investigational Site Number 6160007, Bialystok, 15-276, Poland|Investigational Site Number 6160017, Gdansk, 80-462, Poland|Investigational Site Number 6160002, Grodzisk Mazowiecki, 05-825, Poland|Investigational Site Number 6160014, Katowice, 40-635, Poland|Investigational Site Number 6160021, Krakow, 30-693, Poland|Investigational Site Number 6160001, Krakow, 31 -202, Poland|Investigational Site Number 6160003, Krakow, 31-501, Poland|Investigational Site Number 6160012, Krakow, Poland|Investigational Site Number 6160011, Leczna, 21-010, Poland|Investigational Site Number 6160016, Lubin, 59-301, Poland|Investigational Site Number 6160005, Miechow, 32-200, Poland|Investigational Site Number 6160022, Poznan, 61-848, Poland|Investigational Site Number 6160006, Torun, 87-100, Poland|Investigational Site Number 6160013, Warszawa, 00-685, Poland|Investigational Site Number 6160004, Warszawa, 03-242, Poland|Investigational Site Number 6160020, Warszawa, 04-073, Poland|Investigational Site Number 6160024, Warszawa, 04-349, Poland|Investigational Site Number 6160008, Warszawa, 04-628, Poland|Investigational Site Number 6160015, Zamosc, 22-400, Poland|Investigational Site Number 6200012, Braga, 4710-243, Portugal|Investigational Site Number 6200001, Coimbra, 3000-075, Portugal|Investigational Site Number 6200011, Guilhufe - Penafiel, 4564-007, Portugal|Investigational Site Number 6200004, Guimarães, 4810-061, Portugal|Investigational Site Number 6200006, Lisboa, 1449-005, Portugal|Investigational Site Number 6200002, Lisboa, 1500-650, Portugal|Investigational Site Number 6200008, Porto, 4099-001, Portugal|Investigational Site Number 6200007, Vila Franca De Xira, 2600-009, Portugal|Investigational Site Number 6200003, Vila Nova Gaia, 4434-502, Portugal|Investigational Site Number 6200005, Vila Real, 5000-508, Portugal|Investigational Site Number 6420014, Arad, 310037, Romania|Investigational Site Number 6420006, Baia Mare, 430031, Romania|Investigational Site Number 6420015, Braila, 810325, Romania|Investigational Site Number 6420013, Bucharest, 010825, Romania|Investigational Site Number 6420019, Bucuresti, 014461, Romania|Investigational Site Number 6420011, Bucuresti, 020125, Romania|Investigational Site Number 6420008, Bucuresti, 022322, Romania|Investigational Site Number 6420007, Bucuresti, 050659, Romania|Investigational Site Number 6420002, Cluj Napoca, 400001, Romania|Investigational Site Number 6420003, Cluj Napoca, 400347, Romania|Investigational Site Number 6420016, Craiova, 200642, Romania|Investigational Site Number 6420005, Oradea, 410169, Romania|Investigational Site Number 6420004, Oradea, 410469, Romania|Investigational Site Number 6420018, Satu Mare, 440156, Romania|Investigational Site Number 6420001, Targu Mures, 540103, Romania|Investigational Site Number 6420012, Tg-Mures, 540136, Romania|Investigational Site Number 6420009, Timisoara, 300079, Romania|Investigational Site Number 6420010, Timisoara, 300723, Romania|Investigational Site Number 6430026, Ivanovo, 153012, Russian Federation|Investigational Site Number 6430023, Kazan, 420087, Russian Federation|Investigational Site Number 6430002, Kemerovo, 650002, Russian Federation|Investigational Site Number 6430006, Kemerovo, 650002, Russian Federation|Investigational Site Number 6430005, Moscow, 109240, Russian Federation|Investigational Site Number 6430004, Moscow, 111539, Russian Federation|Investigational Site Number 6430022, Moscow, 117292, Russian Federation|Investigational Site Number 6430024, Moscow, 119192, Russian Federation|Investigational Site Number 6430001, Moscow, 121552, Russian Federation|Investigational Site Number 6430003, Moscow, 121552, Russian Federation|Investigational Site Number 6430010, Moscow, 121552, Russian Federation|Investigational Site Number 6430018, Nizhniy Novgorod, 603005, Russian Federation|Investigational Site Number 6430013, Rostov-Na-Donu, 344068, Russian Federation|Investigational Site Number 6430011, Saint-Petersburg, 198205, Russian Federation|Investigational Site Number 6430017, Sochi, 354057, Russian Federation|Investigational Site Number 6430025, St-Petersburg, 193312, Russian Federation|Investigational Site Number 6430007, St-Petersburg, 195067, Russian Federation|Investigational Site Number 6430012, St-Petersburg, 197341, Russian Federation|Investigational Site Number 6430009, St-Petersburg, 199106, Russian Federation|Investigational Site Number 6430016, Tomsk, 634012, Russian Federation|Investigational Site Number 7030003, Bratislava 3 - Kramare, 833 05, Slovakia|Investigational Site Number 7030004, Bratislava 37, 833 48, Slovakia|Investigational Site Number 7030001, Bratislava, 813 69, Slovakia|Investigational Site Number 7030010, Brezno, 97742, Slovakia|Investigational Site Number 7030009, Dolny Kubin, 02614, Slovakia|Investigational Site Number 7030002, Kosice, 040 01, Slovakia|Investigational Site Number 7030011, Nitra, 950 01, Slovakia|Investigational Site Number 7030008, Trnava, 91775, Slovakia|Investigational Site Number 7240016, Alicante, 03010, Spain|Investigational Site Number 7240015, Badalona, 08916, Spain|Investigational Site Number 7240020, Hospitalet De Llobregat, 08907, Spain|Investigational Site Number 7240006, La Coruña, 15006, Spain|Investigational Site Number 7240005, Las Palmas De Gran Canaria, 35020, Spain|Investigational Site Number 7240021, Madrid, 28031, Spain|Investigational Site Number 7240008, Madrid, 28040, Spain|Investigational Site Number 7240022, Manises, 46940, Spain|Investigational Site Number 7240007, Murcia, 30120, Spain|Investigational Site Number 7240004, Málaga, 29010, Spain|Investigational Site Number 7240014, Olot, 17800, Spain|Investigational Site Number 7240009, San Sebastián De Los Reyes, 28702, Spain|Investigational Site Number 7240003, Sanlúcar De Barrameda, 11540, Spain|Investigational Site Number 7240001, Sevilla, 41014, Spain|Investigational Site Number 7240019, Sevilla, 41071, Spain|Investigational Site Number 7240012, Valencia, 46010, Spain|Investigational Site Number 7240011, Valencia, 46014, Spain|Investigational Site Number 7240010, Valencia, 46026, Spain|Investigational Site Number 7240002, Villamartín, 11650, Spain|Investigational Site Number 7240013, Zaragoza, 50009, Spain|Investigational Site Number 7240018, Úbeda, 23400, Spain|Investigational Site Number 7520004, Jönköping, 551 85, Sweden|Investigational Site Number 7520002, Malmö, 205 02, Sweden|Investigational Site Number 7520006, Skellefteå, 931 86, Sweden|Investigational Site Number 7520007, Stockholm, 118 83, Sweden|Investigational Site Number 7520008, Stockholm, 14186, Sweden|Investigational Site Number 7520001, Stockholm, 171 76, Sweden|Investigational Site Number 7560001, Basel, 4031, Switzerland|Investigational Site Number 7560003, Lugano, 6900, Switzerland|Investigational Site Number 7920008, Antalya, 07059, Turkey|Investigational Site Number 7920006, Corum, 19200, Turkey|Investigational Site Number 7920005, Eskisehir, 26480, Turkey|Investigational Site Number 7920002, Haseki/ Istanbul, 34034, Turkey|Investigational Site Number 7920011, Istanbul, 34098, Turkey|Investigational Site Number 7920012, Izmir, 35340, Turkey|Investigational Site Number 7920003, Kocaeli, 41300, Turkey|Investigational Site Number 7920004, Mersin, 33169, Turkey|Investigational Site Number 7920001, Sivas, 58140, Turkey|Investigational Site Number 7920010, Trabzon, 61040, Turkey|Investigational Site Number 8260005, Bournemouth, BH7 7DW, United Kingdom|Investigational Site Number 8260010, Bristol, BS10 5NB, United Kingdom|Investigational Site Number 8260008, Chelmsford, CM1 7ET, United Kingdom|Investigational Site Number 8260009, Hull, HU16 5JQ, United Kingdom|Investigational Site Number 8260002, Newcastle, NE1 4LP, United Kingdom|Investigational Site Number 8260001, Oldham, OL1 2JH, United Kingdom|Investigational Site Number 8260003, Swansea, SA6 6NL, United Kingdom|Investigational Site Number 8260006, Swindon, SN3 6BB, United Kingdom|Investigational Site Number 8260004, Torquay, TQ2 7AA, United Kingdom|Investigational Site Number 8260007, York, YO31 8HE, United Kingdom"
NCT00325910,Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study,https://clinicaltrials.gov/study/NCT00325910,TERMINATED,"Diabetes Mellitus, Type 2|Heart Failure, Congestive",DRUG: Metformin,University of Alberta,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Misericordia Hospital, Edmonton, Alberta, T5R 4H5, Canada|University of Alberta Hospital, Edmonton, Alberta, T6G 2B7, Canada"
NCT03081598,"Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome",https://clinicaltrials.gov/study/NCT03081598,TERMINATED,Type 2 Diabetes Mellitus|Metabolic Syndrome,DRUG: PBI-4050|OTHER: Placebo,Liminal BioSciences Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"C-Health, Edmonton, Alberta, Canada|Omnispec Clinical Research, Mirabel, Quebec, Canada|LMC Clinical Research Inc., Barrie, Canada|C-health - C-endo Division, Calgary, Canada|Centre de recherche clinique de Laval, Laval, Canada|Institut de Recherches Cliniques de Montreal (IRCM), Montréal, Canada|LMC Clinical Research Inc., Montréal, Canada|Manna Research, Quebec City, Canada|Synergy Medical Clinic, Sherwood Park, Canada|Manna Research, Toronto, Canada|Manna Research, Vancouver, Canada"
NCT00549757,Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases),https://clinicaltrials.gov/study/NCT00549757,TERMINATED,Type 2 Diabetes Mellitus|Cardiovascular Disease,DRUG: Aliskiren|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novartis Investigative Site, Birmingham, Alabama, 35209, United States|Novartis Investigative Site, Birmingham, Alabama, 35235, United States|Novartis Investigative Site, Huntsville, Alabama, 35801, United States|Novartis Investigative Site, Mobile, Alabama, 36608, United States|Novartis Investigative Site, Mobile, Alabama, 36617, United States|Novartis Investigative Site, Montgomery, Alabama, 36106, United States|Novartis Investigative Site, Muscle Shoals, Alabama, 35662, United States|Novartis Investigative Site, Peoria, Arizona, 85381, United States|Novartis Investigative Site, Phoenix, Arizona, 85032, United States|Novartis Investigative Site, Tucson, Arizona, 85712, United States|Novartis Investigative Site, Tucson, Arizona, 85741, United States|Novartis Investigative Site, Fayetteville, Arkansas, 72703, United States|Novartis Investigative Site, Burlingame, California, 94010, United States|Novartis Investigative Site, Fullerton, California, 92835, United States|Novartis Investigative Site, Huntington Beach, California, 92648, United States|Novartis Investigative Site, Oakland, California, 94609, United States|Novartis Investigative Site, Pasadena, California, 91101, United States|Novartis Investigative Site, Riverside, California, 92501, United States|Novartis Investigative Site, Spring Valley, California, 91978-1522, United States|Novartis Investigative Site, Torrance, California, 90502, United States|Novartis Investigative Site, Walnut Creek, California, 94598, United States|Novartis Investigative Site, Denver, Colorado, 80209, United States|Novartis Investigative Site, Bridgeport, Connecticut, 06610, United States|Novartis Investigative Site, Aventura, Florida, 33180, United States|Novartis Investigative Site, Boca Raton, Florida, 33433, United States|Novartis Investigative Site, Ft. Lauderdale, Florida, 33311, United States|Novartis Investigative Site, Hollywood, Florida, 33021, United States|Novartis Investigative Site, Jacksonville, Florida, 32204, United States|Novartis Investigative Site, Jacksonville, Florida, 32205, United States|Novartis Investigative Site, Jacksonville, Florida, 32209, United States|Novartis Investigative Site, Jacksonville, Florida, 32216, United States|Novartis Investigative Site, Lauderdale Lakes, Florida, 33313, United States|Novartis Investigative Site, Pensacola, Florida, 32504, United States|Novartis Investigative Site, Plantation, Florida, 33324, United States|Novartis Investigative Site, West Palm Beach, Florida, 33401, United States|Novartis Investigative Site, Atlanta, Georgia, 30309, United States|Novartis Investigative Site, Augusta, Georgia, 30904, United States|Novartis Investigative Site, Augusta, Georgia, 30909, United States|Novartis Investigative Site, Cumming, Georgia, 30041, United States|Novartis Investigative Site, Honolulu, Hawaii, 96813, United States|Novartis Investigative Site, Honolulu, Hawaii, 96814, United States|Novartis Investigative Site, Champaign, Illinois, 61820, United States|Novartis Investigative Site, Lake Zurich, Illinois, 60047, United States|Novartis Investigative Site, Peoria, Illinois, 61615, United States|Novartis Investigative Site, Topeka, Kansas, 66606, United States|Novartis Investigative Site, Louisville, Kentucky, 40202, United States|Novartis Investigative Site, Metairie, Louisiana, 70006, United States|Novartis Investigative Site, Slidell, Louisiana, 70458, United States|Novartis Investigative Site, Baltimore, Maryland, 21204, United States|Novartis Investigative Site, Burlington, Massachusetts, 01803, United States|Novartis Investigative Site, Haverhill, Massachusetts, 01830, United States|Novartis Investigative Site, Jamaica Plain, Massachusetts, 02130, United States|Novartis Investigative Site, Natick, Massachusetts, 01760, United States|Novartis Investigative Site, North Dartmouth, Massachusetts, 02747, United States|Novartis Investigative Site, Waltham, Massachusetts, 02154, United States|Novartis Investigative Site, Worcester, Massachusetts, 01609, United States|Novartis Investigative Site, Ann Arbor, Michigan, 48109, United States|Novartis Investigative Site, Detroit, Michigan, 48202, United States|Novartis Investigative Site, Detroit, Michigan, 48236, United States|Novartis Investigative Site, Kalamazoo, Michigan, 49048, United States|Novartis Investigative Site, Livonia, Michigan, 48154, United States|Novartis Investigative Site, Minneapolis, Minnesota, 55404, United States|Novartis Investigative Site, Minneapolis, Minnesota, 55455, United States|Novartis Investigative Site, St. Louis Park, Minnesota, 55416, United States|Novartis Investigative Site, Belzoni, Mississippi, 39038, United States|Novartis Investigative Site, Gulfport, Mississippi, 39501, United States|Novartis Investigative Site, Jackson, Mississippi, 39209, United States|Novartis Investigative Site, Springfield, Missouri, 65807, United States|Novartis Investigative Site, St. Louis, Missouri, 63110-1093, United States|Novartis Investigative Site, St. Louis, Missouri, 63141, United States|Novartis Investigative Site, Fremont, Nebraska, 68025, United States|Novartis Investigative Site, Omaha, Nebraska, 68131, United States|Novartis Investigative Site, Dover, New Hampshire, 03820-2403, United States|Novartis Investigative Site, Princeton Junction, New Jersey, 08550, United States|Novartis Investigative Site, Albuquerque, New Mexico, 87106, United States|Novartis Investigative Site, Albany, New York, 12206, United States|Novartis Investigative Site, Rochester, New York, 14607, United States|Novartis Investigative Site, Cincinnati, Ohio, 45236, United States|Novartis Investigative Site, Cleveland, Ohio, 44115, United States|Novartis Investigative Site, Lyndhurst, Ohio, 44124, United States|Novartis Investigative Site, Norman, Oklahoma, 73069, United States|Novartis Investigative Site, Oklahoma City, Oklahoma, 73112, United States|Novartis Investigative Site, Tulsa, Oklahoma, 74133, United States|Novartis Investigative Site, Allentown, Pennsylvania, 18103, United States|Novartis Investigative Site, Lancaster, Pennsylvania, 17604, United States|Novartis Investigative Site, Lansdale, Pennsylvania, 19446, United States|Novartis Investigative Site, Melrose Park, Pennsylvania, 19027, United States|Novartis Investigative Site, Philadelphia, Pennsylvania, 19138, United States|Novartis Investigative Site, Wyomissing, Pennsylvania, 19610, United States|Novartis Investigative Site, Warwick, Rhode Island, 02886, United States|Novartis Investigative Site, Aiken, South Carolina, 29801, United States|Novartis Investigative Site, Charleston, South Carolina, 29425, United States|Novartis Investigative Site, Columbia, South Carolina, 29201, United States|Novartis Investigative Site, Greenville, South Carolina, 29605, United States|Novartis Investigative Site, Orangeburg, South Carolina, 29115, United States|Novartis Investigative Site, Collierville, Tennessee, 38017, United States|Novartis Investigative Site, Amarillo, Texas, 79106, United States|Novartis Investigative Site, Austin, Texas, 78731, United States|Novartis Investigative Site, Dallas, Texas, 75226, United States|Novartis Investigative Site, Dallas, Texas, 75231, United States|Novartis Investigative Site, Dallas, Texas, 75235, United States|Novartis Investigative Site, Dallas, Texas, 75390, United States|Novartis Investigative Site, Houston, Texas, 77030, United States|Novartis Investigative Site, Irving, Texas, 75039, United States|Novartis Investigative Site, McAllen, Texas, 78501, United States|Novartis Investigative Site, North Richland Hills, Texas, 76180, United States|Novartis Investigative Site, Plano, Texas, 75024, United States|Novartis Investigative Site, San Antonio, Texas, 78207, United States|Novartis Investigative Site, San Antonio, Texas, 78218, United States|Novartis Investigative Site, San Antonio, Texas, 78229-4801, United States|Novartis Investigative Site, Temple, Texas, 76508-0002, United States|Novartis Investigative Site, Bennington, Vermont, 05201, United States|Novartis Investigative Site, Burlington, Vermont, 05401, United States|Novartis Investigative Site, Alexandria, Virginia, 22304-2315, United States|Novartis Investigative Site, Burke, Virginia, 22015, United States|Novartis Investigative Site, Renton, Washington, 98055, United States|Novartis Investigative Site, Charleston, West Virginia, 25301, United States|Novartis Investigative Site, Appleton, Wisconsin, 54911, United States|Novartis Investigative Site, Caba, Buenos Aires, 1428, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1181ACH, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1280AEB, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1408INH, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1416DRJ, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1425AST, Argentina|Novartis Investigative Site, Florida, Buenos Aires, B1602BPD, Argentina|Novartis Investigative Site, Lanus, Buenos Aires, B8000XAV, Argentina|Novartis Investigative Site, Ramos Mejia, Buenos Aires, B1704ETD, Argentina|Novartis Investigative Site, Zarate, Buenos Aires, 2800, Argentina|Novartis Investigative Site, Rosario, Santa Fe, S2000AII, Argentina|Novartis Investigative Site, Rosario, Santa Fe, S2000CXH, Argentina|Novartis Investigative Site, Rosario, Santa Fe, S2000DFD, Argentina|Novartis Investigative Site, Rosario, Santa Fe, S2001ODA, Argentina|Novartis Investigative Site, Rosario, Santa Fe, S200CVD, Argentina|Novartis Investigative Site, Buenos aires, C1120AAC, Argentina|Novartis Investigative Site, Buenos Aires, C1405BCH, Argentina|Novartis Investigative Site, Cordoba, 5000, Argentina|Novartis Investigative Site, Cordoba, X5000AAW, Argentina|Novartis Investigative Site, Cordoba, X5000EVQ, Argentina|Novartis Investigative Site, Cordoba, X5000FGG, Argentina|Novartis Investigative Site, Cordoba, X5000IUG, Argentina|Novartis Investigative Site, Cordoba, X5000JHQ, Argentina|Novartis Investigative Site, Cordoba, X5009BSN, Argentina|Novartis Investigative Site, Cordoba, X5016KEH, Argentina|Novartis Investigative Site, Corrientes, W3400, Argentina|Novartis Investigative Site, Santa Fe, S3000FNF, Argentina|Novartis Investigative Site, Santa Fe, S3000FSO, Argentina|Novartis Investigative Site, Santa Fe, S3000FVA, Argentina|Novartis Investigative Site, Bregenz, A-6900, Austria|Novartis Investigative Site, Feldkirch, 6807, Austria|Novartis Investigative Site, Graz, 8036, Austria|Novartis Investigative Site, Innsbruck, INNSBRUCK, Austria|Novartis Investigative Site, Salzburg, A-5020, Austria|Novartis Investigative Site, Vienna, 1030, Austria|Novartis Investigative Site, Wien, 1090, Austria|Novartis Investigative Site, Wien, A-1130, Austria|Novartis Investigative Site, Wien, A-1220, Austria|Novartis Investigative Site, Bonheiden, 2820, Belgium|Novartis Investigative Site, Brugge, 8000, Belgium|Novartis Investigative Site, Brussel, 9100, Belgium|Novartis Investigative Site, Bruxelles, 1070, Belgium|Novartis Investigative Site, Bruxelles, 1200, Belgium|Novartis Investigative Site, Charleroi, 6000, Belgium|Novartis Investigative Site, De Pinte, 9840, Belgium|Novartis Investigative Site, Edegem, 2650, Belgium|Novartis Investigative Site, Genk, 3600, Belgium|Novartis Investigative Site, Gent, 9000, Belgium|Novartis Investigative Site, Hasselt, 3500, Belgium|Novartis Investigative Site, Kortrijk, 8500, Belgium|Novartis Investigative Site, La Louvière, 7100, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Liege, 4000, Belgium|Novartis Investigative Site, Roeselare, 8800, Belgium|Novartis Investigative Site, Ronse, 9600, Belgium|Novartis Investigative Site, Seraing, 4100, Belgium|Novartis Investigative Site, Sint-Gillis-Waas, 9170, Belgium|Novartis Investigative Site, Turnhout, 2300, Belgium|Novartis Investigative Site, Vilvoorde, 1800, Belgium|Novartis Investigative Site, Willebroek, 2830, Belgium|Novartis Investigative Site, Salvador, BA, 40050-410, Brazil|Novartis Investigative Site, Fortaleza, CE, 60120-021, Brazil|Novartis Investigative Site, Fortaleza, CE, 60430-370, Brazil|Novartis Investigative Site, Vitoria, ES, 29040-091, Brazil|Novartis Investigative Site, Juiz de Fora, MG, 36036-110, Brazil|Novartis Investigative Site, Belem, PA, 66073-000, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 20020-020, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 20551-030, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90020-090, Brazil|Novartis Investigative Site, Campinas, SP, 13060-904, Brazil|Novartis Investigative Site, Campinas, SP, 13083-190, Brazil|Novartis Investigative Site, Marilia, SP, 17519-030, Brazil|Novartis Investigative Site, Santos, SP, 11045-904, Brazil|Novartis Investigative Site, Sao Jose do Rio Preto, SP, 15090-000, Brazil|Novartis Investigative Site, Sorocaba, SP, 18030-210, Brazil|Novartis Investigative Site, São Paulo, SP, 04023-900, Brazil|Novartis Investigative Site, São Paulo, SP, 05403-000, Brazil|Novartis Investigative Site, Edmonton, Alberta, T5J 3N4, Canada|Novartis Investigative Site, Edmonton, Alberta, T5N 3Y6, Canada|Novartis Investigative Site, Vancouver, British Columbia, V6E 1M7, Canada|Novartis Investigative Site, Winnipeg, Manitoba, R2V 4W3, Canada|Novartis Investigative Site, Winnipeg, Manitoba, R3E 3P4, Canada|Novartis Investigative Site, Bay Roberts, Newfoundland and Labrador, A0A 1G0, Canada|Novartis Investigative Site, St. John's, Newfoundland and Labrador, A1E 4J8, Canada|Novartis Investigative Site, Brampton, Ontario, L6Z 4N5, Canada|Novartis Investigative Site, Burlington, Ontario, L7M 4Y1, Canada|Novartis Investigative Site, Cambridge, Ontario, N1R 6V6, Canada|Novartis Investigative Site, Courtice, Ontario, L1E 3C3, Canada|Novartis Investigative Site, Etobicoke, Ontario, M9R 4E1, Canada|Novartis Investigative Site, London, Ontario, N6A 4G5, Canada|Novartis Investigative Site, North Bay, Ontario, P1B 2H3, Canada|Novartis Investigative Site, Oakville, Ontario, L6H 3P1, Canada|Novartis Investigative Site, Oshawa, Ontario, L1J 2K1, Canada|Novartis Investigative Site, Ottawa, Ontario, K1H 7W9, Canada|Novartis Investigative Site, Scarborough, Ontario, M1H 3G4, Canada|Novartis Investigative Site, Thornhill, Ontario, L4J 8L7, Canada|Novartis Investigative Site, Toronto, Ontario, M4G 3E8, Canada|Novartis Investigative Site, Toronto, Ontario, M4N 3M5, Canada|Novartis Investigative Site, Toronto, Ontario, M5C 2T2, Canada|Novartis Investigative Site, Toronto, Ontario, N6G 4X8, Canada|Novartis Investigative Site, Greenfield Park, Quebec, J4V 2H1, Canada|Novartis Investigative Site, Mirabel, Quebec, J7J 2K8, Canada|Novartis Investigative Site, Montreal, Quebec, H1T 2M4, Canada|Novartis Investigative Site, Pointe-Claire, Quebec, H9R 4S3, Canada|Novartis Investigative Site, Québec, Quebec, G1G 3Y8, Canada|Novartis Investigative Site, Sainte-Foy, Quebec, G1V 4G5, Canada|Novartis Investigative Site, Sainte-Foy, Quebec, G1W 4R4, Canada|Novartis Investigative Site, Sherbrooke, Quebec, J1G 5K2, Canada|Novartis Investigative Site, Ste-Foy, Quebec, G1V 4G2, Canada|Novartis Investigative Site, Trois-Rivières, Quebec, G8Z 3R9, Canada|Novartis Investigative Site, Saskatoon, Saskatchewan, S7H 5M3, Canada|Novartis Investigative Site, Ouest-Montreal, H2W1R7, Canada|Novartis Investigative Site, Beijing, Beijing, 100044, China|Novartis Investigative Site, Beijing, Beijing, 100083, China|Novartis Investigative Site, Beijing, Beijing, 100730, China|Novartis Investigative Site, Chongqing, Chongqing, 400016, China|Novartis Investigative Site, Chongqing, Chongqing, China|Novartis Investigative Site, Fuzhou, Fujian, 350025, China|Novartis Investigative Site, Guangzhou, Guangdong, 510180, China|Novartis Investigative Site, Shijiazhuang, Hebei, 050051, China|Novartis Investigative Site, Harbin, Heilongjiang, 150001, China|Novartis Investigative Site, Harbin, Heilongjiang, 150086, China|Novartis Investigative Site, Wuhan, Hubei, 430030, China|Novartis Investigative Site, Changsha City, Hunan, 410011, China|Novartis Investigative Site, Changsha, Hunan, 410008, China|Novartis Investigative Site, Nanjing, Jiangsu, 210006, China|Novartis Investigative Site, Nanjing, Jiangsu, 210008, China|Novartis Investigative Site, Nanjing, Jiangsu, 210009, China|Novartis Investigative Site, Nanjing, Jiangsu, 210029, China|Novartis Investigative Site, Suzhou, Jiangsu, 215004, China|Novartis Investigative Site, Dalian, Liaoning, 116011, China|Novartis Investigative Site, Shenyang, Liaoning, 110003, China|Novartis Investigative Site, Qingdao, Shandong, 266011, China|Novartis Investigative Site, Xi'an, Shanxi, 710032, China|Novartis Investigative Site, Xi'an, Shanxi, 710061, China|Novartis Investigative Site, Chengdu, Sichuan, 610041, China|Novartis Investigative Site, Kunming, Yunnan, 650101, China|Novartis Investigative Site, Hangzhou, Zhejiang, 310003, China|Novartis Investigative Site, Hangzhou, Zhejiang, 310009, China|Novartis Investigative Site, Hangzhou, Zhejiang, 310013, China|Novartis Investigative Site, Hangzhou, Zhejiang, 310016, China|Novartis Investigative Site, Beijing, 100028, China|Novartis Investigative Site, Beijing, 100029, China|Novartis Investigative Site, Beijing, 100034, China|Novartis Investigative Site, Beijing, 100088, China|Novartis Investigative Site, Beijing, 100176, China|Novartis Investigative Site, Beijing, China|Novartis Investigative Site, Chengdu, 610072, China|Novartis Investigative Site, Chongqing, 400038, China|Novartis Investigative Site, Dalian, China|Novartis Investigative Site, Guangzhou, 510000, China|Novartis Investigative Site, Shanghai, 200003, China|Novartis Investigative Site, Shanghai, 200025, China|Novartis Investigative Site, Shanghai, 200031, China|Novartis Investigative Site, Shanghai, 200233, China|Novartis Investigative Site, Tianjin, 300052, China|Novartis Investigative Site, Tianjin, 300142, China|Novartis Investigative Site, Bogotá, Colombia|Novartis Investigative Site, Cali, Colombia|Novartis Investigative Site, Florida Blanca, Colombia|Novartis Investigative Site, Medellín, Colombia|Novartis Investigative Site, Brno-Bohunice, 639 01, Czech Republic|Novartis Investigative Site, Brno, 61300, Czech Republic|Novartis Investigative Site, Ceske Budejovice, 370 87, Czech Republic|Novartis Investigative Site, Ostrava, 702 00, Czech Republic|Novartis Investigative Site, Pardubice, 53002, Czech Republic|Novartis Investigative Site, Pisek, 397 01, Czech Republic|Novartis Investigative Site, Prague 2, 128 02, Czech Republic|Novartis Investigative Site, Prague 2, 128 08, Czech Republic|Novartis Investigative Site, Prague 4 - Krc, 14059, Czech Republic|Novartis Investigative Site, Prague 5 - Motol, 15112, Czech Republic|Novartis Investigative Site, Aalborg, DK-9100, Denmark|Novartis Investigative Site, Copenhagen NV, DK-2400, Denmark|Novartis Investigative Site, Frederiksberg, DK-2000, Denmark|Novartis Investigative Site, Gentofte, DK-2820, Denmark|Novartis Investigative Site, Hillerød, DK-3400, Denmark|Novartis Investigative Site, Hvidovre, 2650, Denmark|Novartis Investigative Site, Roskilde, DK-4000, Denmark|Novartis Investigative Site, Slagelse, DK-4200, Denmark|Novartis Investigative Site, Svendborg, DK-5700, Denmark|Novartis Investigative Site, Århus, DK-8000, Denmark|Novartis Investigative Site, Helsinki, 00250, Finland|Novartis Investigative Site, Hyvinkää, FIN-05850, Finland|Novartis Investigative Site, Kajaani, FIN-87140, Finland|Novartis Investigative Site, Kuopio, FIN-70211, Finland|Novartis Investigative Site, Lohja, FIN-08200, Finland|Novartis Investigative Site, Oulu, 90100, Finland|Novartis Investigative Site, OYS, FIN-90029, Finland|Novartis Investigative Site, Pori, 28120, Finland|Novartis Investigative Site, Tammisaari, 10600, Finland|Novartis Investigative Site, Tampere, 33520, Finland|Novartis Investigative Site, Valkeakoski, 37600, Finland|Novartis Investigative Site, Besancon Cedex, 25030, France|Novartis Investigative Site, Bondy, 93143, France|Novartis Investigative Site, Corbeil Essonnes, 91100, France|Novartis Investigative Site, Grenoble, 38043, France|Novartis Investigative Site, La Rochelle, 17019, France|Novartis Investigative Site, Lagny sur Marne, 77405, France|Novartis Investigative Site, Limoges Cedex, 87042, France|Novartis Investigative Site, Lyon Cedex 03, 69394, France|Novartis Investigative Site, Lyon, 69437, France|Novartis Investigative Site, Paris cedex 18, 75877, France|Novartis Investigative Site, Paris Cedex 4, 75181, France|Novartis Investigative Site, Poitiers Cedex, 86021, France|Novartis Investigative Site, Aschaffenburg, 63739, Germany|Novartis Investigative Site, Aschaffenburg, 63741, Germany|Novartis Investigative Site, Asslar, 35614, Germany|Novartis Investigative Site, Bad Oeynhausen, 32545, Germany|Novartis Investigative Site, Barsinghausen, 30890, Germany|Novartis Investigative Site, Bensheim, 64625, Germany|Novartis Investigative Site, Berlin, 13055, Germany|Novartis Investigative Site, Berlin, 13597, Germany|Novartis Investigative Site, Berlin, 14193, Germany|Novartis Investigative Site, Bonn, 53105, Germany|Novartis Investigative Site, Bottrop, 46242, Germany|Novartis Investigative Site, Bremen, 28277, Germany|Novartis Investigative Site, Bretten, 75015, Germany|Novartis Investigative Site, Cloppenburg, 49661, Germany|Novartis Investigative Site, Dippoldiswalde, 01744, Germany|Novartis Investigative Site, Dresden, 01127, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Duesseldorf, 40210, Germany|Novartis Investigative Site, Essen, 45127, Germany|Novartis Investigative Site, Essen, 45134, Germany|Novartis Investigative Site, Essen, 45138, Germany|Novartis Investigative Site, Fuldatal, 34233, Germany|Novartis Investigative Site, Göttingen, 37075, Germany|Novartis Investigative Site, Hagen, 58095, Germany|Novartis Investigative Site, Hamburg, 22335, Germany|Novartis Investigative Site, Hamburg, 22393, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Heilbronn, 74072, Germany|Novartis Investigative Site, Heilbronn, 74076, Germany|Novartis Investigative Site, Ingelheim, 55218, Germany|Novartis Investigative Site, Jena, 07743, Germany|Novartis Investigative Site, Kassel, 34117, Germany|Novartis Investigative Site, Krefeld, 47798, Germany|Novartis Investigative Site, Magdeburg, 39120, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Messkirch, 88605, Germany|Novartis Investigative Site, Muehldorf am Inn, 84453, Germany|Novartis Investigative Site, Neuwied, 56564, Germany|Novartis Investigative Site, Offenbach, 63065, Germany|Novartis Investigative Site, Rehburg-Loccum, 31547, Germany|Novartis Investigative Site, Riesa, 01587, Germany|Novartis Investigative Site, Schauenburg-Elgershausen, 34270, Germany|Novartis Investigative Site, Schwabenheim, 55270, Germany|Novartis Investigative Site, St. Ingbert - Oberwuerzbach, 66386, Germany|Novartis Investigative Site, Ursensollen, 92289, Germany|Novartis Investigative Site, Wetter, 58300, Germany|Novartis Investigative Site, Wiehl, 51674, Germany|Novartis Investigative Site, Wiesbaden, 65183, Germany|Novartis Investigative Site, Wuerzburg, 97072, Germany|Novartis Investigative Site, Alexandroupolis, GR 68 100, Greece|Novartis Investigative Site, Athens - GR, 10676, Greece|Novartis Investigative Site, Athens, GR 115 21, Greece|Novartis Investigative Site, Athens, GR 115 22, Greece|Novartis Investigative Site, Athens, GR 115 27, Greece|Novartis Investigative Site, Athens, GR 11527, Greece|Novartis Investigative Site, Athens, Greece|Novartis Investigative Site, Ioannina, GR 45500, Greece|Novartis Investigative Site, Patras, 26500, Greece|Novartis Investigative Site, Piraeurs, GR 184 54, Greece|Novartis Investigative Site, Thessaloniki, 57001, Greece|Novartis Investigative Site, Thessaloniki, GR 546 39, Greece|Novartis Investigative Site, Guatemala City, 01001, Guatemala|Novartis Investigative Site, Guatemala City, 01010, Guatemala|Novartis Investigative Site, Guatemala City, 01011, Guatemala|Novartis Investigative Site, Guatemala City, 01015, Guatemala|Novartis Investigative Site, Baja, 6500, Hungary|Novartis Investigative Site, Balatonfured, 8230, Hungary|Novartis Investigative Site, Budapest, 1062, Hungary|Novartis Investigative Site, Budapest, 1083, Hungary|Novartis Investigative Site, Budapest, 1085, Hungary|Novartis Investigative Site, Budapest, 1096, Hungary|Novartis Investigative Site, Budapest, 1115, Hungary|Novartis Investigative Site, Budapest, H-1032, Hungary|Novartis Investigative Site, Debrecen, 4004, Hungary|Novartis Investigative Site, Debrecen, 4032, Hungary|Novartis Investigative Site, Gyula, 5703, Hungary|Novartis Investigative Site, Kaposvar, 7400, Hungary|Novartis Investigative Site, Miskolc, 3526, Hungary|Novartis Investigative Site, Pecs, 7324, Hungary|Novartis Investigative Site, Szeged, 6720, Hungary|Novartis Investigative Site, Zalaegerszeg, 8900, Hungary|Novartis Investigative Site, Hyderabad, Andhra Pradesh, INDIA, 500034, India|Novartis Investigative Site, Hyderabad, Andhra Pradesh, 500001, India|Novartis Investigative Site, Hyderabad, Andhra Pradesh, 500012, India|Novartis Investigative Site, Hyderabad, Andhra Pradesh, 500018, India|Novartis Investigative Site, Ahmedabad, Gujarat, 380014, India|Novartis Investigative Site, Bangalore, Karnataka, 560054, India|Novartis Investigative Site, Banglaore, Karnataka, 560038, India|Novartis Investigative Site, Mangalore, Karnataka, 575001, India|Novartis Investigative Site, Kochi, Kerala, 682 026, India|Novartis Investigative Site, Mumbai, Maharashtra, 400008, India|Novartis Investigative Site, Pune, Maharashtra, 411011, India|Novartis Investigative Site, Pune, Maharashtra, 411030, India|Novartis Investigative Site, Chennai, Tamil Nadu, 600013, India|Novartis Investigative Site, Vellore, Tamil Nadu, 632004, India|Novartis Investigative Site, Bangalore, 560 034, India|Novartis Investigative Site, Chennai, 600010, India|Novartis Investigative Site, Chennai, 600086, India|Novartis Investigative Site, Hyderabad, 500 063, India|Novartis Investigative Site, Kolkota, 700020, India|Novartis Investigative Site, New Delhi, 110 029, India|Novartis Investigative Site, L'Aquila, AQ, 67100, Italy|Novartis Investigative Site, Bergamo, BG, 24128, Italy|Novartis Investigative Site, Belluno, BL, 32100, Italy|Novartis Investigative Site, Bologna, BO, 40138, Italy|Novartis Investigative Site, Campobasso, CB, 86100, Italy|Novartis Investigative Site, Caserta, CE, 81100, Italy|Novartis Investigative Site, Chieti, CH, 66100, Italy|Novartis Investigative Site, Cuneo, CN, 12100, Italy|Novartis Investigative Site, Cosenza, CS, 87100, Italy|Novartis Investigative Site, Catanzaro, CZ, 88100, Italy|Novartis Investigative Site, Cona, FE, 44100, Italy|Novartis Investigative Site, Foggia, FG, 71100, Italy|Novartis Investigative Site, Firenze, FI, 50134, Italy|Novartis Investigative Site, Arenzano, GE, 16011, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Pozzilli, IS, 86077, Italy|Novartis Investigative Site, Lecco, LC, 23900, Italy|Novartis Investigative Site, Monza, MB, 20900, Italy|Novartis Investigative Site, Milano, MI, 20123, Italy|Novartis Investigative Site, Milano, MI, 20132, Italy|Novartis Investigative Site, Milano, MI, 20146, Italy|Novartis Investigative Site, Milano, MI, 20157, Italy|Novartis Investigative Site, Passirana di Rho, MI, 20017, Italy|Novartis Investigative Site, Palermo, PA, 90127, Italy|Novartis Investigative Site, Perugia, PG, 06100, Italy|Novartis Investigative Site, Pisa, PI, 56124, Italy|Novartis Investigative Site, Pisa, PI, 56126, Italy|Novartis Investigative Site, Pordenone, PN, 33170, Italy|Novartis Investigative Site, Parma, PR, 43100, Italy|Novartis Investigative Site, Casorate Primo, PV, 27022, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Stradella, PV, 27049, Italy|Novartis Investigative Site, Ravenna, RA, 48100, Italy|Novartis Investigative Site, Roma, RM, 00122, Italy|Novartis Investigative Site, Roma, RM, 00133, Italy|Novartis Investigative Site, Roma, RM, 00157, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Roma, RM, 00163, Italy|Novartis Investigative Site, Roma, RM, 00186, Italy|Novartis Investigative Site, Roma, RM, 00189, Italy|Novartis Investigative Site, Cava De' Tirreni, SA, 84013, Italy|Novartis Investigative Site, Mercato San Severino, SA, 84085, Italy|Novartis Investigative Site, Salerno, SA, 84125, Italy|Novartis Investigative Site, Siena, SI, 53100, Italy|Novartis Investigative Site, Olbia, SS, 07026, Italy|Novartis Investigative Site, Sassari, SS, 07100, Italy|Novartis Investigative Site, Torino, TO, 10126, Italy|Novartis Investigative Site, Torino, TO, 10128, Italy|Novartis Investigative Site, Torino, TO, 10154, Italy|Novartis Investigative Site, Vittorio Veneto, TV, 31029, Italy|Novartis Investigative Site, San Daniele Del Friuli, UD, 33038, Italy|Novartis Investigative Site, Udine, UD, 33100, Italy|Novartis Investigative Site, Venezia, VE, 30174, Italy|Novartis Investigative Site, Verona, VR, 37126, Italy|Novartis Investigative Site, Isernia, 86170, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Nagoya, Aichi, 451-8511, Japan|Novartis Investigative Site, Nagoya, Aichi, 455-8530, Japan|Novartis Investigative Site, Nagoya, Aichi, 460-0001, Japan|Novartis Investigative Site, Nagoya, Aichi, 462-0802, Japan|Novartis Investigative Site, Nagoya, Aichi, 462-0825, Japan|Novartis Investigative Site, Asahi, Chiba, 289-2511, Japan|Novartis Investigative Site, Kasuga, Fukuoka, 816-0864, Japan|Novartis Investigative Site, Kitakyushu, Fukuoka, 800-0296, Japan|Novartis Investigative Site, Koriyama-city, Fukushima, 963-8851, Japan|Novartis Investigative Site, Asahikawa, Hokkaido, 078-8211, Japan|Novartis Investigative Site, Sapporo-city, Hokkaido, 060-8648, Japan|Novartis Investigative Site, Sapporo, Hokkaido, 003-0023, Japan|Novartis Investigative Site, Sapporo, Hokkaido, 060-0033, Japan|Novartis Investigative Site, Toride-city, Ibaraki, 302-0022, Japan|Novartis Investigative Site, Takamatsu, Kagawa, 7600076, Japan|Novartis Investigative Site, Aira-city, Kagoshima, 899-5431, Japan|Novartis Investigative Site, Isehara-city, Kanagawa, 259-1131, Japan|Novartis Investigative Site, Kawasaki, Kanagawa, 210-0852, Japan|Novartis Investigative Site, Yatsushiro, Kumamoto, 866-8660, Japan|Novartis Investigative Site, Kyoto-city, Kyoto, 612-8555, Japan|Novartis Investigative Site, Kyoto-city, Kyoto, 615-0035, Japan|Novartis Investigative Site, Sendai-city, Miyagi, 980-8574, Japan|Novartis Investigative Site, Suwa, Nagano, 392-8510, Japan|Novartis Investigative Site, Okayama-city, Okayama, 700-8558, Japan|Novartis Investigative Site, Takatsuki-city, Osaka, 569-1096, Japan|Novartis Investigative Site, Toyonaka, Osaka, 561-0871, Japan|Novartis Investigative Site, Yao-city, Osaka, 581-0011, Japan|Novartis Investigative Site, Tokorozawa, Saitama, 351-1151, Japan|Novartis Investigative Site, Ohtsu-city, Shiga, 520-2192, Japan|Novartis Investigative Site, Shimizu, Shizuoka, 411-8611, Japan|Novartis Investigative Site, Bunkyo-ku, Tokyo, 113-8655, Japan|Novartis Investigative Site, Chuo-ku, Tokyo, 103-0002, Japan|Novartis Investigative Site, Takaoka, Toyama, 933-0955, Japan|Novartis Investigative Site, Oita, 870-0039, Japan|Novartis Investigative Site, Oita, 870-0192, Japan|Novartis Investigative Site, Okayama, 701-1192, Japan|Novartis Investigative Site, Ansan, Gyeonggi-do, 425-801, Korea, Republic of|Novartis Investigative Site, Anyang, Gyeonggi-do, 431-070, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 110 744, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 120-752, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 135-710, Korea, Republic of|Novartis Investigative Site, Bundang, Seongnam, 463-707, Korea, Republic of|Novartis Investigative Site, Busan, 602-739, Korea, Republic of|Novartis Investigative Site, Daejeon, 301-747, Korea, Republic of|Novartis Investigative Site, Incheon, 400-712, Korea, Republic of|Novartis Investigative Site, Pusan, 614-735, Korea, Republic of|Novartis Investigative Site, Seoul, 135-720, Korea, Republic of|Novartis Investigative Site, Seoul, 136 705, Korea, Republic of|Novartis Investigative Site, Seoul, 137-701, Korea, Republic of|Novartis Investigative Site, Seoul, 152-703, Korea, Republic of|Novartis Investigative Site, Seoul, 156-707, Korea, Republic of|Novartis Investigative Site, Taegu, 700 - 721, Korea, Republic of|Novartis Investigative Site, Kaunas, 50009, Lithuania|Novartis Investigative Site, Klaipeda, 92304, Lithuania|Novartis Investigative Site, Vilnius, LT-08661, Lithuania|Novartis Investigative Site, Vilnius, Lithuania|Novartis Investigative Site, Alkmaar, 1851 JD, Netherlands|Novartis Investigative Site, Almelo, 7609 PP, Netherlands|Novartis Investigative Site, Amersfoort, 3800 BM, Netherlands|Novartis Investigative Site, Amsterdam, 1061 AE, Netherlands|Novartis Investigative Site, Apeldoorn, 7334 DZ, Netherlands|Novartis Investigative Site, Arnhem, 6815 AD, Netherlands|Novartis Investigative Site, Breda, 4818 CK, Netherlands|Novartis Investigative Site, Delft, 2625 AD, Netherlands|Novartis Investigative Site, Den Helder, 1782 GZ, Netherlands|Novartis Investigative Site, Deventer, 7416 SE, Netherlands|Novartis Investigative Site, Doetinchem, 7009 BL, Netherlands|Novartis Investigative Site, Dordrecht, 3318AT, Netherlands|Novartis Investigative Site, Eindhoven, 5623 EJ, Netherlands|Novartis Investigative Site, Eindhoven, 5631 BM, Netherlands|Novartis Investigative Site, Goes, 4462 RA, Netherlands|Novartis Investigative Site, Groningen, 9713 GZ, Netherlands|Novartis Investigative Site, Heerlen, 6419 PC, Netherlands|Novartis Investigative Site, Hoogeveen, 7909 AA, Netherlands|Novartis Investigative Site, Hoogwoud, 1718 BG, Netherlands|Novartis Investigative Site, Losser, 7581 BV, Netherlands|Novartis Investigative Site, Meppel, 7943 KA, Netherlands|Novartis Investigative Site, Nieuwegein, 3435 CM, Netherlands|Novartis Investigative Site, Oude Pekela, 9665 AR, Netherlands|Novartis Investigative Site, Rotterdam, 3015 CE, Netherlands|Novartis Investigative Site, Rotterdam, 3045 PM, Netherlands|Novartis Investigative Site, Rotterdam, 3083 AN, Netherlands|Novartis Investigative Site, Tiel, 4002 WP, Netherlands|Novartis Investigative Site, Utrecht, 3508 GA, Netherlands|Novartis Investigative Site, Venlo, 5912 BL, Netherlands|Novartis Investigative Site, Woerden, 3443 GG, Netherlands|Novartis Investigative Site, Zwijndrecht, NL-3331 LZ, Netherlands|Novartis Investigative Site, Zwolle, 8025 AB, Netherlands|Novartis Investigative Site, Bergen, 5013, Norway|Novartis Investigative Site, Fredrikstad, 1607, Norway|Novartis Investigative Site, Horten, 3191, Norway|Novartis Investigative Site, Hønefoss, 3515, Norway|Novartis Investigative Site, Oslo, 0160, Norway|Novartis Investigative Site, Skedsmokorset, 2020, Norway|Novartis Investigative Site, Skien, 3722, Norway|Novartis Investigative Site, Spikkestad, 3430, Norway|Novartis Investigative Site, Stavanger, 4011, Norway|Novartis Investigative Site, Svelvik, 3060, Norway|Novartis Investigative Site, Tromsø, NO-9038, Norway|Novartis Investigative Site, Trondheim, NO-7011, Norway|Novartis Investigative Site, Tønsberg, 3103, Norway|Novartis Investigative Site, Bellavista, Lima, Callao 02, Peru|Novartis Investigative Site, Cercado de Lima, Lima, 01, Peru|Novartis Investigative Site, San Borja, Lima, 41, Peru|Novartis Investigative Site, San Isidro, Lima, 27, Peru|Novartis Investigative Site, San Martin de Porres, Lima, 31, Peru|Novartis Investigative Site, Santiago de Surco, Lima, 33, Peru|Novartis Investigative Site, Almada, 2801-951, Portugal|Novartis Investigative Site, Amadora, 2720-276, Portugal|Novartis Investigative Site, Coimbra, 3000-075, Portugal|Novartis Investigative Site, Linda-a-Velha, 2799-523, Portugal|Novartis Investigative Site, Lisboa, 1169-024, Portugal|Novartis Investigative Site, Lisboa, 1250-203, Portugal|Novartis Investigative Site, Lisboa, 1495-005, Portugal|Novartis Investigative Site, Lisboa, 1649-035, Portugal|Novartis Investigative Site, Matosinhos, 4454-509, Portugal|Novartis Investigative Site, Portimão, 8500-388, Portugal|Novartis Investigative Site, Porto, 4200-319, Portugal|Novartis Investigative Site, Santa Maria da Feira, 4520-211, Portugal|Novartis Investigative Site, Santarém, 2000-153, Portugal|Novartis Investigative Site, Ponce, 00716, Puerto Rico|Novartis Investigative Site, Ponce, 00733-1471, Puerto Rico|Novartis Investigative Site, Singapore, 119074, Singapore|Novartis Investigative Site, Singapore, 159964, Singapore|Novartis Investigative Site, Singapore, 168752, Singapore|Novartis Investigative Site, Singapore, 169608, Singapore|Novartis Investigative Site, Singapore, 308433, Singapore|Novartis Investigative Site, Bratislava, Slovak Republic, 826 06, Slovakia|Novartis Investigative Site, Kosice, Slovak Republic, 040 22, Slovakia|Novartis Investigative Site, Zilina, Slovak Republic, 010 01, Slovakia|Novartis Investigative Site, Banksa Bystrica, SK 97 517, Slovakia|Novartis Investigative Site, Bratislava, 811 08, Slovakia|Novartis Investigative Site, Bratislava, 812 72, Slovakia|Novartis Investigative Site, Bratislava, 81369, Slovakia|Novartis Investigative Site, Bratislava, 833 48, Slovakia|Novartis Investigative Site, Bratislava, 851 07, Slovakia|Novartis Investigative Site, Kosice, 040 01, Slovakia|Novartis Investigative Site, Lubochna, SK 03491, Slovakia|Novartis Investigative Site, Lucenec, 98439, Slovakia|Novartis Investigative Site, Martin, 03601, Slovakia|Novartis Investigative Site, Nitra, 949 01, Slovakia|Novartis Investigative Site, Piestany, 921 01, Slovakia|Novartis Investigative Site, Prievidza, 971 01, Slovakia|Novartis Investigative Site, Trstena, 549 16, Slovakia|Novartis Investigative Site, Somerset West, Western Cape, 7130, South Africa|Novartis Investigative Site, Cape Town, 7925, South Africa|Novartis Investigative Site, Durban, 4001, South Africa|Novartis Investigative Site, Durban, 4030, South Africa|Novartis Investigative Site, Durban, 4052, South Africa|Novartis Investigative Site, Durban, 4110, South Africa|Novartis Investigative Site, Gauteng, South Africa|Novartis Investigative Site, Johannesburg, 2196, South Africa|Novartis Investigative Site, Port Elizabeth, 6001, South Africa|Novartis Investigative Site, Pretoria, 0002, South Africa|Novartis Investigative Site, Cadiz, Andalucia, 11010, Spain|Novartis Investigative Site, Granada, Andalucia, 18014, Spain|Novartis Investigative Site, Jerez de La Frontera, Andalucia, 11407, Spain|Novartis Investigative Site, Malaga, Andalucia, 29010, Spain|Novartis Investigative Site, Malaga, Andalucia, 29018, Spain|Novartis Investigative Site, Málaga, Andalucia, 29010, Spain|Novartis Investigative Site, Puerto de Santa Maria, Andalucia, 11500, Spain|Novartis Investigative Site, Sanlúcar de Barrameda, Andalucia, 11540, Spain|Novartis Investigative Site, Sevilla, Andalucia, 41009, Spain|Novartis Investigative Site, Oviedo, Asturias, 33006, Spain|Novartis Investigative Site, Oviedo, Asturias, 33008, Spain|Novartis Investigative Site, Oviedo, Asturias, 33010, Spain|Novartis Investigative Site, Hospitalet de Llobregat, Barcelona, 08907, Spain|Novartis Investigative Site, Sabadell, Barcelona, 08208, Spain|Novartis Investigative Site, Alcazar de San Juan, Castilla la Mancha, 13600, Spain|Novartis Investigative Site, Aranda de Duero, Castilla y Leon, 09400, Spain|Novartis Investigative Site, Miranda de Ebro, Castilla y Leon, 09200, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08025, Spain|Novartis Investigative Site, Barcelona, Cataluña, 08025, Spain|Novartis Investigative Site, Barcelona, Cataluña, 08905, Spain|Novartis Investigative Site, Girona, Cataluña, 17007, Spain|Novartis Investigative Site, La Pobla Llarga, Cataluña, 46670, Spain|Novartis Investigative Site, Llança, Cataluña, 17490, Spain|Novartis Investigative Site, Manresa, Cataluña, 08240, Spain|Novartis Investigative Site, Mollet del Vallés, Cataluña, 08100, Spain|Novartis Investigative Site, Rubi, Cataluña, 08191, Spain|Novartis Investigative Site, Santa Coloma de Gramanet, Cataluña, 08923, Spain|Novartis Investigative Site, Tarrega, Cataluña, 25300, Spain|Novartis Investigative Site, Vic, Cataluña, 08500, Spain|Novartis Investigative Site, Alacuas, Comunidad Valenciana, 46970, Spain|Novartis Investigative Site, Alicante, Comunidad Valenciana, 03004, Spain|Novartis Investigative Site, Alzira, Comunidad Valenciana, 46600, Spain|Novartis Investigative Site, Benidorm, Comunidad Valenciana, 03550, Spain|Novartis Investigative Site, Puerto de Sagunto, Comunidad Valenciana, 46520, Spain|Novartis Investigative Site, Quart de Poblet, Comunidad Valenciana, 46930, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46010, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46011, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46014, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46017, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46019, Spain|Novartis Investigative Site, Xixona, Comunidad Valenciana, 03100, Spain|Novartis Investigative Site, Mérida, Extremadura, 06800, Spain|Novartis Investigative Site, Begonte, Galicia, 27373, Spain|Novartis Investigative Site, Ferrol, Galicia, 15405, Spain|Novartis Investigative Site, La Coruña, Galicia, 15010, Spain|Novartis Investigative Site, Pontevedra, Galicia, 36071, Spain|Novartis Investigative Site, Santiago de Compostela, Galicia, 15706, Spain|Novartis Investigative Site, Vigo, Galicia, 36200, Spain|Novartis Investigative Site, Palma De Mallorca, Islas Baleares, Spain|Novartis Investigative Site, Alcorcón, Madrid, 28922, Spain|Novartis Investigative Site, Arganda del Rey, Madrid, 28500, Spain|Novartis Investigative Site, Civdad Real, Madrid, 13002, Spain|Novartis Investigative Site, Murcia, Madrid, 30007, Spain|Novartis Investigative Site, Plentzia, Pais Vasco, 48620, Spain|Novartis Investigative Site, San Sebastian, Pais Vasco, 20014, Spain|Novartis Investigative Site, Villabona, Pais Vasco, 20150, Spain|Novartis Investigative Site, Zumarraga, Pais Vasco, 20700, Spain|Novartis Investigative Site, Alfaro, Rioja, 26540, Spain|Novartis Investigative Site, Logroño, Rioja, 26005, Spain|Novartis Investigative Site, Hospitalet de Llbregat, 08902, Spain|Novartis Investigative Site, Hospitalet de Llobregat, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Madrid, 28035, Spain|Novartis Investigative Site, Madrid, 28040, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Madrid, 28046, Spain|Novartis Investigative Site, Madrid, 28770, Spain|Novartis Investigative Site, Göteborg, SE-412 55, Sweden|Novartis Investigative Site, Helsingborg, 251 87, Sweden|Novartis Investigative Site, Karlstad, 651 85, Sweden|Novartis Investigative Site, Malmö, 21152, Sweden|Novartis Investigative Site, Rättvik, 79530, Sweden|Novartis Investigative Site, Stenstorp, SE-521 60, Sweden|Novartis Investigative Site, Uppsala, 751 85, Sweden|Novartis Investigative Site, Varberg, s-432 81, Sweden|Novartis Investigative Site, Estavayer-le-Lac, CH, 1470, Switzerland|Novartis Investigative Site, Ascona, Switzerland|Novartis Investigative Site, Bern, 3010, Switzerland|Novartis Investigative Site, Bolligen, 3065, Switzerland|Novartis Investigative Site, Bruderholz, 4101, Switzerland|Novartis Investigative Site, Fribourg, 1700, Switzerland|Novartis Investigative Site, La Chaux-de-Fonds, 2300, Switzerland|Novartis Investigative Site, Lausanne, 1011, Switzerland|Novartis Investigative Site, Lugano, 6900, Switzerland|Novartis Investigative Site, Lugano, 6903, Switzerland|Novartis Investigative Site, Renens, 1020, Switzerland|Novartis Investigative Site, Schaffhausen, 8200, Switzerland|Novartis Investigative Site, St. Gallen, 9007, Switzerland|Novartis Investigative Site, Winterthur, 8400, Switzerland|Novartis Investigative Site, Zuerich, 8091, Switzerland|Novartis Investigative Site, Yungkang, Tainan, 710, Taiwan|Novartis Investigative Site, Changhua, 500, Taiwan|Novartis Investigative Site, Kaohsiung, 807, Taiwan|Novartis Investigative Site, Niaosong Township, 83301, Taiwan|Novartis Investigative Site, Taichung County, Taiwan|Novartis Investigative Site, Taichung, 40705, Taiwan|Novartis Investigative Site, Taichung, Taiwan|Novartis Investigative Site, Taipei, 10002, Taiwan|Novartis Investigative Site, Taipei, 114, Taiwan|Novartis Investigative Site, Taipei, Taiwan|Novartis Investigative Site, Bangkok, 10330, Thailand|Novartis Investigative Site, Bangkok, 10400, Thailand|Novartis Investigative Site, Bangkok, 10700, Thailand|Novartis Investigative Site, Chiang Mai, 50200, Thailand|Novartis Investigative Site, Altunizade, 34662, Turkey|Novartis Investigative Site, Ankara, 06100, Turkey|Novartis Investigative Site, Ankara, 06590, Turkey|Novartis Investigative Site, Gaziantep, 27070, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Izmir, 35340, Turkey|Novartis Investigative Site, Kocaeli, 41380, Turkey|Novartis Investigative Site, High Wycombe, Buckinghamshire, HP11 2TT, United Kingdom|Novartis Investigative Site, Truro, Cornwall, TR1 3LJ, United Kingdom|Novartis Investigative Site, Paignton, Devon, TQ4 5LA, United Kingdom|Novartis Investigative Site, Cornwall, England, PL23 1DT, United Kingdom|Novartis Investigative Site, Welwyn Garden City,, Hertfordshire, AL7 4HQ, United Kingdom|Novartis Investigative Site, Gravesend, Kent, DA1 24JW, United Kingdom|Novartis Investigative Site, Glasgow, Scotland, G12 8TA, United Kingdom|Novartis Investigative Site, East Horsley, Surrey, KT24 6QT, United Kingdom|Novartis Investigative Site, Crawley, West Sussex, RH10 7DX, United Kingdom|Novartis Investigative Site, Bath, BA2 3HT, United Kingdom|Novartis Investigative Site, Cardiff, CF14 4XN, United Kingdom|Novartis Investigative Site, Cardiff, CF5 4AD, United Kingdom|Novartis Investigative Site, Glasgow, G11 6NT, United Kingdom|Novartis Investigative Site, Glasgow, G21 3UW, United Kingdom|Novartis Investigative Site, Irvine, KA12 0AY, United Kingdom|Novartis Investigative Site, Lancashire, FY3 7EN, United Kingdom|Novartis Investigative Site, Lancashire, FY4 3AD, United Kingdom|Novartis Investigative Site, London, NW10 7NS, United Kingdom|Novartis Investigative Site, London, SE1 9RT, United Kingdom|Novartis Investigative Site, London, SW17 0QT, United Kingdom|Novartis Investigative Site, Manchester, M13 9NT, United Kingdom|Novartis Investigative Site, Merseyside, L7 8PX, United Kingdom|Novartis Investigative Site, Rugby, CV21 5 PX, United Kingdom|Novartis Investigative Site, Vale of Glanmorgan, CF63 4AR, United Kingdom|Novartis Investigative Site, Wrexham, LL13 7TD, United Kingdom|Novartis Investigative Site, Caracas, Distrito Capital, 1010, Venezuela|Novartis Investigative Site, Caracas, Distrito Capital, 1020, Venezuela|Novartis Investigative Site, Caracas, Distrito Capital, 1040, Venezuela|Novartis Investigative Site, Caracas, Distrito Capital, 1080-A, Venezuela|Novartis Investigative Site, Caracas, Distrito Capital, 1100, Venezuela|Novartis Investigative Site, Puerto Ordaz, Estado Bolívar, 8050, Venezuela|Novartis Investigative Site, Valencia, Estado Carabobo, 2001, Venezuela|Novartis Investigative Site, Caracas, Estado Miranda, 1060, Venezuela"
NCT00566215,Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study,https://clinicaltrials.gov/study/NCT00566215,TERMINATED,"Diabetes Mellitus, Type 2|Insulin Resistance|Obesity",PROCEDURE: Duodenal exclusion plus omentectomy|PROCEDURE: Duodenal exclusion without omentectomy,"University of Campinas, Brazil",,ALL,ADULT,PHASE1|PHASE2,INTERVENTIONAL,"LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP), Campinas, SP, Brazil"
NCT04567225,Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management,https://clinicaltrials.gov/study/NCT04567225,TERMINATED,Diabetic Ketoacidosis|Type 1 Diabetes|Type 2 Diabetes,DRUG: Early Glargine|DRUG: Late Glargine|OTHER: IV insulin infusion|OTHER: IV fluid and electrolytes replacement,The Cleveland Clinic,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cleveland Clinic Fairview Hospital, Cleveland, Ohio, 44111, United States"
NCT01887067,Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01887067,TERMINATED,"Hypertension, Resistant|Diabetes Mellitus|Renal Denervation Therapy",PROCEDURE: Renal denervation therapy,Pamela Youde Nethersole Eastern Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong"
NCT03102892,Antimicrobial Photodynamic Therapy on Periodontal Treatment and Salivary Status of Type 1 Diabetes Mellitus Patients,https://clinicaltrials.gov/study/NCT03102892,TERMINATED,"Diabetes Mellitus, Type 1|Periodontal Diseases|Periodontal Pocket",PROCEDURE: Scaling root planing|PROCEDURE: Antimicrobial photodynamic therapy,University of Sao Paulo,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Bauru School of Dentistry, Bauru, Sao Paulo, 17012-901, Brazil"
NCT04171648,Effect of Dry Roasted Peanuts and Boiled Peanuts on Glycemic Control,https://clinicaltrials.gov/study/NCT04171648,TERMINATED,Diabetes Mellitus|Glycemic Control,OTHER: Roasted Peanut Treatment|OTHER: Boiled Peanut Treatment,North Carolina State University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"North Carolina State University, Raleigh, North Carolina, 27607, United States"
NCT03132571,Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia,https://clinicaltrials.gov/study/NCT03132571,TERMINATED,"Schizophrenia|Diabetes Mellitus, Type 2|Obesity",DRUG: Naltrexone|DRUG: Bupropion|OTHER: Placebo,Yale University,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Connecticut Mental Health Center, New Haven, Connecticut, 06519, United States"
NCT00870831,Islet Function and Clinical Analyses of Transplant Recipients,https://clinicaltrials.gov/study/NCT00870831,TERMINATED,Type One Diabetes Mellitus,OTHER: OGTT (Oral Glucose Tolerance Test),Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT03591458,Amitriptyline in Treating Hypoglycemia,https://clinicaltrials.gov/study/NCT03591458,TERMINATED,Type1 Diabetes Mellitus|Hypoglycemia Unawareness,DRUG: Amitriptyline|DRUG: Placebo,University of Utah,,ALL,ADULT,PHASE2,INTERVENTIONAL,"University of Utah, Salt Lake City, Utah, 84132, United States"
NCT05341388,The Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT05341388,TERMINATED,Type2 Diabetes|Cognitive Impairment,DIAGNOSTIC_TEST: MOCA cognitive evaluation test|DIAGNOSTIC_TEST: BDNF levels|OTHER: SF-36 test|DIAGNOSTIC_TEST: Geriatric depression test,Goztepe Training and Research Hospital,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Istanbul Medeniyet University Goztepe Research and Training Hospital, Istanbul, Turkey"
NCT00837590,"Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls",https://clinicaltrials.gov/study/NCT00837590,TERMINATED,Pre-diabetes|Obesity,DRUG: Chronic salsalate|DRUG: Acute Salsalate,Indiana University,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Indiana Clinical Research Center, Indianapolis, Indiana, 46202, United States"
NCT03339336,Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy,https://clinicaltrials.gov/study/NCT03339336,TERMINATED,Small Fiber Neuropathy|Diabetes Mellitus,DRUG: BIIB074|DRUG: Placebo,Biogen,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Byala, Bulgaria|UMHAT 'Dr Georgi Stranski' EAD, Pleven, Bulgaria|Research Site, Plovdiv, Bulgaria|Research Site, Sofia, Bulgaria|Vancouver General Hospital, Vancouver, British Columbia, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Research Site, Greenfield Park, Quebec, Canada|Research Site, Montreal, Quebec, Canada|Recherche Médicale St-Jérôme Inc., St-Jerome, Quebec, Canada|Research Site, Kingston, Canada|Research Site, Winnipeg, Canada|Fakultni Nemocnice Brno, Brno, Czechia|Fakultni Nemocnice u sv. Anny v Brne, Brno, Czechia|Research Site, Hradec Kralove, Czechia|Fakultni nemocnice Ostrava, Ostrava-Poruba, Czechia|Nemocnice Pardubickeho kraje a.s. Pardubicka nemocnice, Pardubice, Czechia|Fakultni nemocnice v Motole, Prague, Czechia|Research Site, Aarhus, Denmark|Research Site, Copenhagen, Denmark|Research Site, Herlev, Denmark|OUH, Odense, Denmark|Research Site, Brest, Finistere, France|CHU Saint Etienne - Hôpital Nord, Saint Priest En Jarez, Loire, France|Hopital Salengro - CHRU de Lille, Lille, Nord, France|CHU Clermond Ferrand - Hopital Gabriel Montpied, Clermont Ferrand, Puy De Dome, France|Research Site, Venissieux, Rhone, France|Hôpital Ambroise Paré - Boulogne-Billancourt, Boulogne-Billancourt, France|Research Site, Corbeil-Essonnes, France|Hopital Henri Mondor, Creteil, France|Research Site, Le Creusot, France|Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin Bicêtre, France|CHU Nice - Hôpital de l'Archet 1, Nice, France|Hopital Lariboisiere, Paris, France|Clinical Research, Böblingen, Baden-Württemberg, Germany|Research Site, Aschaffenburg, Bayern, Germany|Research Site, Kuenzing, Bayern, Germany|Clinical Research, Westerstede, Niedersachsen, Germany|Clinical Research, Muenster, Nord Rhein Westfalen, Germany|Gemeinschaftspraxis Diabeteszentrum Dortmund Dr.med. Klaus Busch, Dortmund, Nordrhein Westfalen, Germany|Hausarzt- und Diabetologische Schwerpunktpraxis, Lage, Sachsen Anhalt, Germany|Zentrum fur Klinische Forschung, Bad Homburg, Germany|Gemeinschaftspraxis für Neurologie, Berlin, Germany|Research Site, Essen, Germany|Diabetologische Schwerpunktpraxis Harburg, Hamburg, Germany|Research Site, Mainz, Germany|DKD Helios Klinik Wiesbaden, Wiesbaden, Germany|Research Site, Wurzburg, Germany|Research Site, Athens, Greece|Research Site, Heraklion, Greece|Research Site, Patras, Greece|AHEPA General Hospital of Thessaloniki, Thessaloniki, Greece|Research Site, Baja, Hungary|Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz, Bekescsaba, Hungary|UNO Medical Trials Kft., Budapest, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvar, Hungary|Research Site, Nyiregyhaza, Hungary|Research Site, Pecs, Hungary|Research Site, Szeged, Hungary|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili), Brescia, Italy|Research Site, Genova, Italy|Research Site, Milan, Italy|Azienda Ospedaliero Univeraitaria Pisana, Pisa, Italy|Università Campus Bio-Medico di Roma, Roma, Italy|Research Site, Telese Terme, Italy|Amsterdam UMC, Locatie AMC, Amsterdam, Netherlands|Maastricht UMC+, Maastricht, Netherlands|Research Site, Bydgoszcz, Poland|Research Site, Chorzow, Poland|PRATIA MCM Kraków, Kraków, Poland|Research Site, Lublin, Poland|Research Site, Oswiecim, Poland|Praktyka Lekarska Ewa Krzyzagorska, Poznan, Poland|Research Site, Warszawa, Poland|Regionalna Poradnia Diabetologiczna Zytkiewicz-Jaruga,Stasinska, Wroclaw, Poland|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Research Site, Barcelona, Spain|Hospital Universitario Reina Sofia, Cordoba, Spain|Research Site, La Coruna, Spain|Research Site, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Ospedale Regionale di Lugano, Lugano, Switzerland|Kantonspital St. Gallen, St. Gallen, Switzerland|Research Site, Zurich, Switzerland|Royal Hallamshire Hospital, Sheffield, South Yorkshire, United Kingdom|Clinical Reseach, Bath, United Kingdom|Research Site, Ipswich, United Kingdom|Research Site, Liverpool, United Kingdom|Guy's Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom|St Pancras Clinical Research, London, United Kingdom|The Royal London Hospital, London, United Kingdom|Research Site, Manchester, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Research Site, Swansea, United Kingdom"
NCT01582282,Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects,https://clinicaltrials.gov/study/NCT01582282,TERMINATED,Non-Insulin-dependent Diabetes Mellitus,DIETARY_SUPPLEMENT: placebo|DIETARY_SUPPLEMENT: 3.4 g psyllium BID|DIETARY_SUPPLEMENT: 6.8g psyllium BID,Procter and Gamble,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Miami, Diabetes Unit D-1, Miami, Florida, 33136, United States|International Diabetes Center, Minneapolis, Minnesota, 55416, United States"
NCT03029351,GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT03029351,TERMINATED,Type2 Diabetes|Kidney Diseases,DRUG: Exenatide Extended Release for Inj Susp 2 MG|DRUG: Placebo,University at Buffalo,AstraZeneca,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Diabetes Endocrinology Research Center of WNY, Williamsville, New York, 14221, United States"
NCT04278664,Telemedicine in Pregnant Women With Type 1 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT04278664,TERMINATED,Type 1 Diabetes|Pregnancy in Diabetic,,Ana Braescu,University of Arizona,FEMALE,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT02462421,Pharmacogenetics of SGLT2 Inhibitors,https://clinicaltrials.gov/study/NCT02462421,TERMINATED,Diabetes Mellitus|Gout|Hyperuricemia,DRUG: Canagliflozin,"University of Maryland, Baltimore",National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT03781102,Type 2 Diabetes Prevention in Community Health Care Settings for at Risk Children and Mothers,https://clinicaltrials.gov/study/NCT03781102,TERMINATED,PreDiabetes|Type 2 Diabetes,BEHAVIORAL: 16-Week Diabetes Prevention Program for Mothers and Children,University of Arizona,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"El Rio Community Health Center, Tucson, Arizona, 85701, United States"
NCT04132739,Piloting Diet and Exercise Interventions in Older Hispanics With Diabetes,https://clinicaltrials.gov/study/NCT04132739,TERMINATED,Diabetes|Senior Syndrome|Frailty,BEHAVIORAL: Diet|BEHAVIORAL: Exercise|BEHAVIORAL: Diet and exercise,Florida International University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Dr. Armando Badia Senior Center, Miami, Florida, 33144, United States|Millennium Senior Center, Miami, Florida, 33175, United States|Westwind Senior Center, Miami, Florida, 33193, United States|Victoria Senior Center, Sweetwater, Florida, 33174, United States"
NCT01108263,Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01108263,TERMINATED,Diabetes|Foot Ulcer,DRUG: INTEGRA™ Flowable Matrix (Collagen),Georgetown University,Integra LifeSciences Corporation,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Georgetown University Hospital, Washington, D.C, District of Columbia, 20007, United States"
NCT00209417,Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography,https://clinicaltrials.gov/study/NCT00209417,TERMINATED,Renal Insufficiency|Diabetes Mellitus,DRUG: Iodixanol 320-Arm 1|DRUG: Iopamidol 300-Arm 2,GE Healthcare,"ABX CRO|Examination Management Services Inc.|Covance|Quintiles, Inc.|Averion International Corporation",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"GE Healthcare, Princeton, New Jersey, 08540, United States|GE Healthcare, Amersham, HP7 9LL, United Kingdom"
NCT03020264,Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life,https://clinicaltrials.gov/study/NCT03020264,TERMINATED,Type2 Diabetes|Elderly|Hypoglycemia,DEVICE: glycemic sensor FREESTYLE Libre Pro,Nantes University Hospital,,ALL,OLDER_ADULT,,INTERVENTIONAL,"CHU de Nantes, Nantes, Loire Atlantique, 44000, France|CH d'Ancenis, Ancenis, 44150, France|CHU d'Angers, Angers, 49100, France|Hôpital Sud Francilien, Corbeil-Essonnes, 91106, France|CHRU de Lille, Lille, 59037, France|CHU de Poitiers, Poitiers, 86021, France|CHU de Toulouse, Toulouse, France"
NCT04837989,Effectiveness of the Diabetes Body Project Among Females With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT04837989,TERMINATED,"Feeding and Eating Disorders|Diabetes Mellitus, Type 1|Body Image",BEHAVIORAL: Diabetes Body Project|BEHAVIORAL: Psychoeducation,Oslo University Hospital,The Dam Foundation|Norwegian Diabetes Association,FEMALE,"CHILD, ADULT",,INTERVENTIONAL,"Oslo Unviersity Hospital, Oslo, 0424, Norway"
NCT01765270,Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery,https://clinicaltrials.gov/study/NCT01765270,TERMINATED,Type 2 Diabetes Mellitus|Cardiovascular Disease,DRUG: Saxagliptin|DRUG: Placebo,Duke University,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cardiology, PC, Birmingham, Alabama, 35211, United States|Cardio-Thoracic Surgeons PC, Birmingham, Alabama, 35243, United States|Heart Center Research, LLC, Huntsville, Alabama, 35801, United States|Sparks Regional Medical Center, Fort Smith, Arkansas, 72901, United States|Arkansas Cardiology, PA, Little Rock, Arkansas, 72205, United States|Stanford University Medical Center, Palo Alto, California, 94304, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Duke University Medical Center (DUMC), Durham, North Carolina, 27710, United States|Chippenham Medical Center, Richmond, Virginia, 23225, United States|Charleston Area Medical Center (CAMC), Charleston, West Virginia, 25304, United States"
NCT03605329,Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS,https://clinicaltrials.gov/study/NCT03605329,TERMINATED,"Sleep Apnea, Obstructive|Diabetes Mellitus, Type 1",OTHER: to explore the severity of NAC in case of OSAS,"University Hospital, Montpellier",,ALL,ADULT,,INTERVENTIONAL,"CHU Montpellier, Montpellier, France"
NCT04071626,Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure,https://clinicaltrials.gov/study/NCT04071626,TERMINATED,"Heart Failure, Diastolic|Diabetes Mellitus, Type 2",DRUG: Ertugliflozin 5 mg|DRUG: Placebo oral tablet,University Hospitals Cleveland Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States"
NCT00548522,Pancreatic Islet Mass in Pregnancy in Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00548522,TERMINATED,Type 1 Diabetes|Pregnancy,,University of Alberta,,FEMALE,ADULT,,OBSERVATIONAL,"University of Alberta Hospital, Edmonton, Alberta, T6G 2B7, Canada|University of Alberta, Edmonton, Alberta, T6G 2S2, Canada"
NCT01690572,Drug Eluting Balloon for Prevention of Constrictive Remodeling,https://clinicaltrials.gov/study/NCT01690572,TERMINATED,Coronary Disease|Diabetes Mellitus,"DEVICE: Paclitaxel coated balloon catheter|DEVICE: uncoated balloon catheter ""sprinter legend""",Prof. Dr. med. Christoph Hehrlein,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Cardiology and Angiology I, Heart Center,, Freiburg, Baden-Württemberg, 79106, Germany"
NCT02741050,Primary Care-Based Physical Activity for Diabetic Latinas,https://clinicaltrials.gov/study/NCT02741050,TERMINATED,Diabetes|Sedentary Lifestyle,BEHAVIORAL: Tailored Physical Activity Intervention|BEHAVIORAL: Standard of Care,"University of California, San Diego",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of California, San Diego, La Jolla, California, 92093-0628, United States"
NCT01888796,Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01888796,TERMINATED,Diabetes Mellitus Type 2 (T2DM)|Left Ventricular Diastolic Dysfunction,DRUG: Linagliptin|DRUG: placebo,RWTH Aachen University,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Department of Internal Medicine I, University Hospital, Aachen, 52074, Germany"
NCT00638131,Bosentan Use in Patients With Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT00638131,TERMINATED,Type 2 Diabetes,DRUG: bosentan,Centre hospitalier de l'Université de Montréal (CHUM),Actelion,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"CHUM, Montreal, Quebec, H2L 4M1, Canada"
NCT04026750,Insulin Tolerance Test Study in Patients With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT04026750,TERMINATED,Type 1 Diabetes|Hypoglycemia,DRUG: Pitolisant,High Point Clinical Trials Center,Ferox Therapeutics,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"High Point Clinical Trials Center, High Point, North Carolina, 27265, United States"
NCT04531176,EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial,https://clinicaltrials.gov/study/NCT04531176,TERMINATED,Type 2 Diabetes|Obesity,OTHER: Weight Management Program (WMP)|OTHER: Traditional care|DRUG: Phentermine / Topiramate Extended Release Oral Capsule|DRUG: naltrexone/bupropion extended-release|DRUG: liraglutide 3.0 mg|DRUG: Orlistat,The Cleveland Clinic,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cleveland Clinic, Cleveland, Ohio, 44195, United States"
NCT03169530,Moderate Alcohol and Cardiovascular Health Trial,https://clinicaltrials.gov/study/NCT03169530,TERMINATED,Cardiovascular Diseases|Diabetes,OTHER: Alcohol,Beth Israel Deaconess Medical Center,National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Harvard School of Public Health (HSPH)|Wake Forest University Health Sciences|Julius Center,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Johns Hopkins ProHealth Clinical Research Center, Baltimore, Maryland, 21207, United States|Wake Forest Sticht Center on Aging, Winston-Salem, North Carolina, 27157, United States|Julius Clinical, Zeist, Netherlands|Center for Bioethics and Research, Ibadan, 200001, Nigeria"
NCT05762744,Pharmacogenomics of GLP1 Receptor Agonists,https://clinicaltrials.gov/study/NCT05762744,TERMINATED,Type 2 Diabetes,DRUG: Exenatide Injection|DRUG: Saline injection,"University of Maryland, Baltimore",,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Amish Research Clinic, Lancaster, Pennsylvania, 17602, United States"
NCT04365400,Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes,https://clinicaltrials.gov/study/NCT04365400,TERMINATED,Hypertriglyceridemia|Type 2 Diabetes,DRUG: DS102|DRUG: Placebo,Afimmune,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"US Site 5, Little Rock, Arkansas, 72204, United States|US Site 23, Cerritos, California, 90703, United States|US Site 18, Huntington Park, California, 90255, United States|US Site 19, Los Angeles, California, 90057, United States|US Site 20, Panorama City, California, 91402, United States|US Site 21, Santa Ana, California, 92704, United States|US Site 13, Santa Ana, California, 92705, United States|US Site 15, Adairsville, Georgia, 30103, United States|US Site 35, Ames, Iowa, 50010, United States|US Site 2, Albany, New York, 12203, United States|US Site 25, Hickory, North Carolina, 28601, United States|US Site 11, Morehead City, North Carolina, 28557, United States|US Site 34, Raleigh, North Carolina, 27609, United States|US Site 26, Rocky Mount, North Carolina, 27804, United States|US Site 28, Salisbury, North Carolina, 28144, United States|US Site 32, Statesville, North Carolina, 28625, United States|US Site 27, Wilmington, North Carolina, 28601, United States|US Site 22, Edmond, Oklahoma, 73013, United States|US Site 1, Wyomissing, Pennsylvania, 19610, United States|US Site 3, Yardley, Pennsylvania, 19067, United States|US Site 12, Jackson, Tennessee, 38301, United States|US Site 7, Dallas, Texas, 75231, United States|US Site 8, Fort Worth, Texas, 76107, United States|US Site 14, Fort Worth, Texas, 76164, United States|US Site 24, Houston, Texas, 77036, United States|US Site 30, Houston, Texas, 77061, United States|US Site 6, Houston, Texas, 77079, United States|US Site 33, Houston, Texas, 77099, United States|US Site 29, Missouri City, Texas, 77459, United States|US Site 31, North Richland Hills, Texas, 76180, United States|US Site 10, Waco, Texas, 76708, United States|US Site 17, Winchester, Virginia, 22601, United States|Georgia Site 1, Batumi, Georgia|Georgia Site 2, Kutaisi, Georgia|Georgia Site 3, Kutaisi, Georgia|Georgia Site 4, Tbilisi, Georgia|Germany Site 7, Dresden, Germany|Germany Site 3, Hamburg, Germany|Germany Site 1, Heidelberg, Germany|Germany Site 5, Lübeck, Germany|Israel Site 9, Herzliya, Israel|Israel Site 1, H̱olon, Israel|Israel Site 5, Jerusalem, Israel|Israel Site 6, Jerusalem, Israel|Israel Site 4, Nahariya, Israel|Israel Site 8, Sakhnīn, Israel|Israel Site 2, Tel Aviv, Israel|Israel Site 3, Tel Aviv, Israel|Latvia Site 4, Ogre, Latvia|Latvia Site 1, Riga, Latvia|Latvia Site 2, Riga, Latvia|Latvia Site 3, Riga, Latvia|Switzerland Site 3, Lausanne, Switzerland|Switzerland Site 4, Luzern, Switzerland|Switzerland Site 2, Olten, Switzerland|Switzerland Site 1, Saint Gallen, Switzerland"
NCT00488930,Characteristics of Dendritic Cells Before and After Gastric Banding,https://clinicaltrials.gov/study/NCT00488930,TERMINATED,Morbid Obesity|Hyperglycemia|Diabetes Mellitus,OTHER: Observational,"University of California, San Diego",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"UCSD Medical Center, San Diego, California, 92103, United States"
NCT05393843,"Prevention of Maternal and Fetal Metabolic Complications With Diet and Nutraceutical Supplementation in Pregnant Women Affected by Gestational Diabetes: a Randomized, Double-blind Placebo Controlled Trial.",https://clinicaltrials.gov/study/NCT05393843,TERMINATED,Gestational Diabetes|Oxidative Stress,"DIETARY_SUPPLEMENT: omega-3 fatty acids, anthocyanins and alpha-cyclodextrins|BEHAVIORAL: diet|OTHER: placebo","Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",,FEMALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy"
NCT00559286,Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels,https://clinicaltrials.gov/study/NCT00559286,TERMINATED,Arterial Hypertension|Diabetes Mellitus Type 2 IRC or NIR,DRUG: Telmisartan,RWTH Aachen University,CTCA|Heidelberg University|Bayer,MALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University Hospital, Aachen, NRW, 52074, Germany"
NCT04227769,IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes,https://clinicaltrials.gov/study/NCT04227769,TERMINATED,Diabetes Mellitus Type 2 in Obese|Inflammation|Metabolic Disease|Glucose Metabolism Disorders (Including Diabetes Mellitus),DRUG: Anakinra Prefilled Syringe,"University Hospital, Basel, Switzerland",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University Hospital Basel, Basel, Basel BS, 4031, Switzerland"
NCT01170442,Does Vitamin D Improve Glycemic Control in Type II DM?,https://clinicaltrials.gov/study/NCT01170442,TERMINATED,Diabetes Mellitus|Vitamin D Deficiency,DRUG: vitamin D3 2000 IU|DRUG: vitamin D3 5000 IU|DRUG: Placebo,King Faisal Specialist Hospital & Research Center,,ALL,ADULT,PHASE3,INTERVENTIONAL,"King Faisal Specialist Hospital & Research Center, Riyadh, 11211, Saudi Arabia"
NCT01728116,Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese,https://clinicaltrials.gov/study/NCT01728116,TERMINATED,Type 2 Diabetes|Obesity,DEVICE: EndoBarrier|PROCEDURE: Sham Procedure,Morphic Medical Inc.,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States|Mayo Clinic Arizona, Scottsdale, Arizona, 85259, United States|Little Rock Diagnostic Center (LRDC), Little Rock, Arkansas, 72205, United States|Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States|Stanford University School of Medicine, Stanford, California, 94305, United States|University of Colorado/ Anschutz Health & Wellness Center, Aurora, Colorado, 80045, United States|Emory University, Atlanta, Georgia, 30303, United States|Northwestern University, Chicago, Illinois, 60208, United States|Kentucky Research Group, Louisville, Kentucky, 40218, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, 70112-2699, United States|MedStar Health Research Institute, Hyattsville, Maryland, 20782, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Mayo Clinic Minnesota, Rochester, Minnesota, 55905, United States|Washington University, St Louis, Missouri, 63110, United States|Billings Clinic, Billings, Montana, 59101, United States|Beth Israel Medical Center, New York, New York, 10003, United States|University of North Carolina, Chapel Hill, North Carolina, 27599, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Legacy Research Institute, Portland, Oregon, 97232, United States|Endocrinology Consultants of East Tennessee & Gastrointestinal Associates, Knoxville, Tennessee, 37909, United States|Dallas Diabetes, Dallas, Texas, 75230, United States|UT Southwestern Medical Center, Dallas, Texas, 75390-7170, United States|The Methodist Hospital Research Institute, Houston, Texas, 77030, United States"
NCT01542242,Liraglutide Use in Prader-Willi Syndrome,https://clinicaltrials.gov/study/NCT01542242,TERMINATED,Diabetes Mellitus Type 2|Prader Willi Syndrome,DRUG: Liraglutide,Vancouver General Hospital,Novo Nordisk A/S,MALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Vancouver General Hospital - Diamond Center, Vancouver, British Columbia, V5Z 1M9, Canada"
NCT03072901,Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity,https://clinicaltrials.gov/study/NCT03072901,TERMINATED,Type 2 Diabetes|Obesity,DEVICE: EndoBarrier Gastrointestinal Liner,Morphic Medical Inc.,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT00134264,A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease,https://clinicaltrials.gov/study/NCT00134264,TERMINATED,Coronary Disease|Diabetes Mellitus,DRUG: torcetrapib/atorvastatin|DRUG: atorvastatin,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Alabaster, Alabama, United States|Pfizer Investigational Site, Birmingham, Alabama, United States|Pfizer Investigational Site, Gilbert, Arizona, United States|Pfizer Investigational Site, Phoenix, Arizona, United States|Pfizer Investigational Site, Tucson, Arizona, United States|Pfizer Investigational Site, Fresno, California, United States|Pfizer Investigational Site, Los Angeles, California, United States|Pfizer Investigational Site, Modesto, California, United States|Pfizer Investigational Site, San Diego, California, United States|Pfizer Investigational Site, Santa Rosa, California, United States|Pfizer Investigational Site, Tustin, California, United States|Pfizer Investigational Site, Walnut Creek, California, United States|Pfizer Investigational Site, Denver, Colorado, United States|Pfizer Investigational Site, Longmont, Colorado, United States|Pfizer Investigational Site, Guilford, Connecticut, United States|Pfizer Investigational Site, Hartford, Connecticut, United States|Pfizer Investigational Site, Washington, District of Columbia, United States|Pfizer Investigational Site, Clearwater, Florida, United States|Pfizer Investigational Site, Coral Gables, Florida, United States|Pfizer Investigational Site, Fort Meyers, Florida, United States|Pfizer Investigational Site, Jacksonville Beach, Florida, United States|Pfizer Investigational Site, Jacksonville, Florida, United States|Pfizer Investigational Site, Lakeland, Florida, United States|Pfizer Investigational Site, Orlando, Florida, United States|Pfizer Investigational Site, Pensacola, Florida, United States|Pfizer Investigational Site, Port Charlotte, Florida, United States|Pfizer Investigational Site, Sarasota, Florida, United States|Pfizer Investigational Site, West Palm Beach, Florida, United States|Pfizer Investigational Site, Atlanta, Georgia, United States|Pfizer Investigational Site, Aurora, Illinois, United States|Pfizer Investigational Site, Blue Island, Illinois, United States|Pfizer Investigational Site, Chicago, Illinois, United States|Pfizer Investigational Site, Evansville, Indiana, United States|Pfizer Investigational Site, Fort Wayne, Indiana, United States|Pfizer Investigational Site, Davenport, Iowa, United States|Pfizer Investigational Site, des Moines, Iowa, United States|Pfizer Investigational Site, Iowa City, Iowa, United States|Pfizer Investigational Site, Wichita, Kansas, United States|Pfizer Investigational Site, Witchita, Kansas, United States|Pfizer Investigational Site, Louisville, Kentucky, United States|Pfizer Investigational Site, Baton Rouge, Louisiana, United States|Pfizer Investigational Site, Covington, Louisiana, United States|Pfizer Investigational Site, Marrero, Louisiana, United States|Pfizer Investigational Site, Scarborough, Maine, United States|Pfizer Investigational Site, Baltimore, Maryland, United States|Pfizer Investigational Site, Bel Air, Maryland, United States|Pfizer Investigational Site, Columbia, Maryland, United States|Pfizer Investigational Site, Towson, Maryland, United States|Pfizer Investigational Site, Westminster, Maryland, United States|Pfizer Investigational Site, Abington, Massachusetts, United States|Pfizer Investigational Site, Haverhill, Massachusetts, United States|Pfizer Investigational Site, Natick, Massachusetts, United States|Pfizer Investigational Site, Grand Rapids, Michigan, United States|Pfizer Investigational Site, Minneapolis, Minnesota, United States|Pfizer Investigational Site, St. Paul, Minnesota, United States|Pfizer Investigational Site, St. Louis, Missouri, United States|Pfizer Investigational Site, Billings, Montana, United States|Pfizer Investigational Site, Butte, Montana, United States|Pfizer Investigational Site, Omaha, Nebraska, United States|Pfizer Investigational Site, Papillon, Nebraska, United States|Pfizer Investigational Site, Las Vegas, Nevada, United States|Pfizer Investigational Site, Concord, New Hampshire, United States|Pfizer Investigational Site, Lebanon, New Hampshire, United States|Pfizer Investigational Site, Manchester, New Hampshire, United States|Pfizer Investigational Site, Elmer, New Jersey, United States|Pfizer Investigational Site, Haddon Heights, New Jersey, United States|Pfizer Investigational Site, New Brunswick, New Jersey, United States|Pfizer Investigational Site, Garden City, New York, United States|Pfizer Investigational Site, New Hyde Park, New York, United States|Pfizer Investigational Site, Rochester, New York, United States|Pfizer Investigational Site, Durham, North Carolina, United States|Pfizer Investigational Site, Winston-salem, North Carolina, United States|Pfizer Investigational Site, Cincinnati, Ohio, United States|Pfizer Investigational Site, Cleveland, Ohio, United States|Pfizer Investigational Site, Columbus, Ohio, United States|Pfizer Investigational Site, Mansfield, Ohio, United States|Pfizer Investigational Site, Sandusky, Ohio, United States|Pfizer Investigational Site, Toledo, Ohio, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, United States|Pfizer Investigational Site, Portland, Oregon, United States|Pfizer Investigational Site, Beaver, Pennsylvania, United States|Pfizer Investigational Site, Philadelphia, Pennsylvania, United States|Pfizer Investigational Site, Kingsport, Tennessee, United States|Pfizer Investigational Site, Nashville, Tennessee, United States|Pfizer Investigational Site, Beaumont, Texas, United States|Pfizer Investigational Site, Dallas, Texas, United States|Pfizer Investigational Site, Houston, Texas, United States|Pfizer Investigational Site, Plano, Texas, United States|Pfizer Investigational Site, San Antonio, Texas, United States|Pfizer Investigational Site, Salt Lake City, Utah, United States|Pfizer Investigational Site, Burlington, Vermont, United States|Pfizer Investigational Site, Norfolk, Virginia, United States|Pfizer Investigational Site, Richmond, Virginia, United States|Pfizer Investigational Site, Burien, Washington, United States|Pfizer Investigational Site, Tacoma, Washington, United States|Pfizer Investigational Site, Concord, New South Wales, Australia|Pfizer Investigational Site, East Gosford, New South Wales, Australia|Pfizer Investigational Site, St. Leonards, New South Wales, Australia|Pfizer Investigational Site, Wollongong, New South Wales, Australia|Pfizer Investigational Site, Chermside, Queensland, Australia|Pfizer Investigational Site, Herston, Queensland, Australia|Pfizer Investigational Site, Woolloongabba, Queensland, Australia|Pfizer Investigational Site, Adelaide, South Australia, Australia|Pfizer Investigational Site, Bedford Park, South Australia, Australia|Pfizer Investigational Site, Woodville, South Australia, Australia|Pfizer Investigational Site, Clayton, Victoria, Australia|Pfizer Investigational Site, Fitzroy, Victoria, Australia|Pfizer Investigational Site, Footscray, Victoria, Australia|Pfizer Investigational Site, Heidelberg, Victoria, Australia|Pfizer Investigational Site, Prahran, Victoria, Australia|Pfizer Investigational Site, Fremantle, Western Australia, Australia|Pfizer Investigational Site, Joondalup, Western Australia, Australia|Pfizer Investigational Site, Camperdown, Australia|Pfizer Investigational Site, Darlinghurst, Australia|Pfizer Investigational Site, Geelong, Australia|Pfizer Investigational Site, Launceston, Tas, Australia|Pfizer Investigational Site, Melbourne, Australia|Pfizer Investigational Site, Nedlands, Australia|Pfizer Investigational Site, Perth, Australia|Pfizer Investigational Site, Southport, Australia|Pfizer Investigational Site, Calgary, Alberta, Canada|Pfizer Investigational Site, Vancouver, British Columbia, Canada|Pfizer Investigational Site, Winnipeg, Manitoba, Canada|Pfizer Investigational Site, Halifax, Nova Scotia, Canada|Pfizer Investigational Site, Cornwall, Ontario, Canada|Pfizer Investigational Site, Newmarket, Ontario, Canada|Pfizer Investigational Site, Oshawa, Ontario, Canada|Pfizer Investigational Site, Sarnia, Ontario, Canada|Pfizer Investigational Site, Scarborough, Ontario, Canada|Pfizer Investigational Site, Toronto, Ontario, Canada|Pfizer Investigational Site, Laval, Quebec, Canada|Pfizer Investigational Site, Montreal, Quebec, Canada|Pfizer Investigational Site, Sainte-foy, Quebec, Canada|Pfizer Investigational Site, Sherbrooke, Quebec, Canada|Pfizer Investigational Site, Ste-foy, Quebec, Canada|Pfizer Investigational Site, Saint John's, Canada|Pfizer Investigational Site, Amsterdam, Netherlands|Pfizer Investigational Site, AN Rotterdam, Netherlands|Pfizer Investigational Site, Apeldoorn, Netherlands|Pfizer Investigational Site, Arnhem, Netherlands|Pfizer Investigational Site, Breda, Netherlands|Pfizer Investigational Site, Cappelle aan den IJssel, Netherlands|Pfizer Investigational Site, Delft, Netherlands|Pfizer Investigational Site, Eindhoven, Netherlands|Pfizer Investigational Site, Goes, Netherlands|Pfizer Investigational Site, Gouda, Netherlands|Pfizer Investigational Site, Groningen, Netherlands|Pfizer Investigational Site, Heerlen, Netherlands|Pfizer Investigational Site, Hertogenbosch, Netherlands|Pfizer Investigational Site, Hoorn, Netherlands|Pfizer Investigational Site, Leiden, Netherlands|Pfizer Investigational Site, Maastricht, Netherlands|Pfizer Investigational Site, Nijmegen, Netherlands|Pfizer Investigational Site, Rotterdam, Netherlands|Pfizer Investigational Site, Sittard, Netherlands|Pfizer Investigational Site, Utrecht, Netherlands|Pfizer Investigational Site, Velp, Netherlands|Pfizer Investigational Site, Venlo, Netherlands|Pfizer Investigational Site, Zoetermeer, Netherlands|Pfizer Investigational Site, Sant Coloma de Gramenet, Barcelona, Spain|Pfizer Investigational Site, Terrasa, Barcelona, Spain|Pfizer Investigational Site, Jerez de La Frontera, Cadiz, Spain|Pfizer Investigational Site, Santander, Cantabria, Spain|Pfizer Investigational Site, San Sebastian, Guipuzcoa, Spain|Pfizer Investigational Site, Ferrol, La Coruna, Spain|Pfizer Investigational Site, Santiago De Compostela, La Coruña, Spain|Pfizer Investigational Site, Almeria, Spain|Pfizer Investigational Site, Barcelona, Spain|Pfizer Investigational Site, Ciudad Real, Spain|Pfizer Investigational Site, Granada, Spain|Pfizer Investigational Site, Madrid, Spain|Pfizer Investigational Site, Malaga, Spain|Pfizer Investigational Site, Salamanca, Spain|Pfizer Investigational Site, Sevilla, Spain|Pfizer Investigational Site, Valencia, Spain|Pfizer Investigational Site, Zaragoza, Spain|Pfizer Investigational Site, Borås, Sweden|Pfizer Investigational Site, Eskilstuna, Sweden|Pfizer Investigational Site, Goteborg, Sweden|Pfizer Investigational Site, Göteborg, Sweden|Pfizer Investigational Site, Helsingborg, Sweden|Pfizer Investigational Site, Hässleholm, Sweden|Pfizer Investigational Site, Karlshamn, Sweden|Pfizer Investigational Site, Koping, Sweden|Pfizer Investigational Site, Linköping, Sweden|Pfizer Investigational Site, Lulea, Sweden|Pfizer Investigational Site, Lund, Sweden|Pfizer Investigational Site, Malmo, Sweden|Pfizer Investigational Site, Molndal, Sweden|Pfizer Investigational Site, Norrkoping, Sweden|Pfizer Investigational Site, Ostersund, Sweden|Pfizer Investigational Site, Skelleftea, Sweden|Pfizer Investigational Site, Stockholm, Sweden|Pfizer Investigational Site, Uddevalla, Sweden|Pfizer Investigational Site, Uppsala, Sweden|Pfizer Investigational Site, Vaxjo, Sweden|Pfizer Investigational Site, Västervik, Sweden|Pfizer Investigational Site, Wrexham, Clwyd, United Kingdom|Pfizer Investigational Site, Woolwich, London, United Kingdom|Pfizer Investigational Site, Glasgow, Scotland, United Kingdom|Pfizer Investigational Site, Aberdeen, United Kingdom|Pfizer Investigational Site, Bath, United Kingdom|Pfizer Investigational Site, Birmingham, United Kingdom|Pfizer Investigational Site, Bournemouth, United Kingdom|Pfizer Investigational Site, Brighton, East Sussex, United Kingdom|Pfizer Investigational Site, Bristol, United Kingdom|Pfizer Investigational Site, Cardiff, United Kingdom|Pfizer Investigational Site, Chichester, United Kingdom|Pfizer Investigational Site, Coventry, United Kingdom|Pfizer Investigational Site, Dundee, United Kingdom|Pfizer Investigational Site, Edinburgh, United Kingdom|Pfizer Investigational Site, Exeter, United Kingdom|Pfizer Investigational Site, Glasgow, United Kingdom|Pfizer Investigational Site, Harrow, United Kingdom|Pfizer Investigational Site, Leicester, United Kingdom|Pfizer Investigational Site, Liverpool, United Kingdom|Pfizer Investigational Site, London, United Kingdom|Pfizer Investigational Site, Newcastle-upon-Tyne, United Kingdom|Pfizer Investigational Site, Romford, United Kingdom|Pfizer Investigational Site, Shrewsbury, United Kingdom|Pfizer Investigational Site, Warwick, United Kingdom"
NCT02674893,Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02674893,TERMINATED,Type 2 Diabetes|Overweight,DRUG: Liraglutide|OTHER: Observation alone,Centre Hospitalier Universitaire Dijon,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"CHU de DIJON, Dijon, 21079, France"
NCT02048904,Use of Sitagliptin to Decrease Microalbuminuria,https://clinicaltrials.gov/study/NCT02048904,TERMINATED,Type 2 Diabetes|Microalbuminuria,DRUG: Sitagliptin|DRUG: Placebo,University of Missouri-Columbia,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Missouri-Columbia: Diabetes Center, Columbia, Missouri, 65212, United States"
NCT01349374,Skin Samples of Diabetic Patients and Healthy Volunteers Collection,https://clinicaltrials.gov/study/NCT01349374,TERMINATED,Type 2 Diabetes,OTHER: skin biopsy,Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Centre Hospitalier Sud Francilien, Corbeil Essonnes, 91106, France"
NCT03152084,The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.,https://clinicaltrials.gov/study/NCT03152084,TERMINATED,"Diabetes Mellitus, Type 2|Kidney Function Tests",DRUG: Dapagliflozin,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Research Site, Almelo, 7609 PP, Netherlands|Research Site, Amsterdam, 1081 HV, Netherlands|Research Site, Stockholm, 14186, Sweden|Research Site, Örebro, 70185, Sweden"
NCT02573519,Gastrointestinal Motility Among Diabetes Patients,https://clinicaltrials.gov/study/NCT02573519,TERMINATED,Diabetic Autonomic Neuropathy|Gastrointestinal Motility Disorder|Diabetes Mellitus|Change of Transit or Circulation,RADIATION: 11C Donepezil PET/CT scan|DEVICE: 3D-Transit|DRUG: 3D-Transit during treatment with Pyridostigmine|DEVICE: 3D-Transit after Malone appendicostomy,University of Aarhus,"Novo Nordisk A/S|Svend Faelding Humanitarian Foundation|Copenhagen University Foundation for Medical Students|Hoejmosegaard Foundation|Holger Rabitz og Hustru Doris Mary foedt Phillipps Mindelegat|Lundbeck Foundation|Wilhelm Frank og Angelina Franks Mindelegat|Torben og Alice Frimodts Fond|Fonden til Lægevidenskabens Fremme, A.P. Møller Fonden",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, 8000, Denmark"
NCT00299169,Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes,https://clinicaltrials.gov/study/NCT00299169,TERMINATED,Diabetes|Cardiovascular Disease|Hyperlipidemia,BEHAVIORAL: N of 1 Trials,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"St. Joseph's Health Care London, London, Ontario, N6A 4V2, Canada"
NCT00869414,"Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes",https://clinicaltrials.gov/study/NCT00869414,TERMINATED,Type 1 Diabetes|Hypoglycemia,DRUG: Evening only administration of insulin glargine|DRUG: Morning only administration of insulin glargine|DRUG: split dose insulin glargine,Johns Hopkins University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States"
NCT01238484,Ankle Equinus Contracture Treated With Dynamic Splinting,https://clinicaltrials.gov/study/NCT01238484,TERMINATED,Ankle Equinus|Ankle Contracture|Diabetes Mellitus,OTHER: Standard of care|DEVICE: Dynasplint,"Dynasplint Systems, Inc.",McMurry University,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Atlanta Foot and Leg Clinic, Jonesboro, Georgia, 30236, United States|Lopez Ankle and Foot, Fort Worth, Texas, 76164, United States"
NCT01415271,3-Month Trial Observation of A1c Change,https://clinicaltrials.gov/study/NCT01415271,TERMINATED,Type 2 Diabetes,OTHER: Internet Communication,Endocrine Research Society,,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Endocrine Research Society, Vancouver, British Columbia, V6E 1M7, Canada"
NCT00886366,Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients,https://clinicaltrials.gov/study/NCT00886366,TERMINATED,Type 2 Diabetes,DRUG: AZD6714|DRUG: Placebo|DRUG: AZD6714|DRUG: AZD6714,AstraZeneca,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Research Site, Goteborg, Sweden"
NCT03597035,Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On,https://clinicaltrials.gov/study/NCT03597035,TERMINATED,Type2 Diabetes|Hyperkalemia,DRUG: Spironolactone,University Hospitals Cleveland Medical Center,"Relypsa, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States"
NCT00967837,Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics,https://clinicaltrials.gov/study/NCT00967837,TERMINATED,Wound Healing|Diabetes,PROCEDURE: Pulsatile Intravenous Insulin Therapy,Florida Atlantic University,Advanced Diabetes Treatment Centers,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Florida Atlantic University, Boca Raton, Florida, 33487, United States"
NCT04381429,Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes,https://clinicaltrials.gov/study/NCT04381429,TERMINATED,Cystic Fibrosis-related Diabetes,DRUG: A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)|DRUG: F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid),"University Hospital, Strasbourg, France",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Hôpitaux Universitaires de Strasbourg, Strasbourg, 67091, France"
NCT02858843,The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia,https://clinicaltrials.gov/study/NCT02858843,TERMINATED,Cystic Fibrosis|Diabetes,DRUG: lumacaftor-ivacaftor,Massachusetts General Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT02054650,OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02054650,TERMINATED,Chronic Low Back Pain|Type 2 Diabetes Mellitus,OTHER: Osteopathic Manual Treatment (OMT)|OTHER: Sham OMT,University of North Texas Health Science Center,American Osteopathic Association|Osteopathic Heritage Foundations,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of North Texas Health Science Center, Fort Worth, Texas, 76107, United States"
NCT00241956,Impact of Diabetes and Glucose Control During Rehabilitation After Stroke,https://clinicaltrials.gov/study/NCT00241956,TERMINATED,Cerebrovascular Accident|Diabetes|Hyperglycemia,,Melbourne Health,"National Health and Medical Research Council, Australia",ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"The Royal Melbourne Hospital, Melbourne, Victoria, 3050, Australia"
NCT02077309,Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT02077309,TERMINATED,Diabetes Mellitus Type 2 (T2DM)|Vascular Inflammation|Plaque Morphology,DRUG: Linagliptin|DRUG: Placebo,RWTH Aachen University,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Department of Internal Medicine I, University Hospital, Aachen, 52074, Germany|Cardiovascular Research Institute Maastricht (CARIM), Maastricht, 6229, Netherlands"
NCT01084369,Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism,https://clinicaltrials.gov/study/NCT01084369,TERMINATED,Type 2 Diabetes|Hypogonadism,DRUG: Testosterone,Tameside Hospital NHS Foundation Trust,,MALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Tameside General Hospital, Ashton-under-Lyne, Lancashire, OL6 9RW, United Kingdom|Tameside Hospital NHS Foundatoin Trust, Ashton under Lyne, OL69RW, United Kingdom"
NCT02456051,Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients,https://clinicaltrials.gov/study/NCT02456051,TERMINATED,"Diabetes Mellitus, Adult-Onset|Diabetes Complications|Carcinoma, Pancreatic Ductal|Pancreatic Neoplasm",,University of Roma La Sapienza,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Università Sapienza di Roma, Azienda Ospedaliera Sant'Andrea, Roma, 00100, Italy"
NCT02003872,The Long Term Effect of Adjustable Spaatz 3 Intragastric Balloon on Weight Loss,https://clinicaltrials.gov/study/NCT02003872,TERMINATED,Obesity|Diabetes|Hypertension,DEVICE: Spatz 3 intragastric balloon,Sheba Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Sheba Medical Center, Ramat Gan, 52621, Israel"
NCT01968876,Is a Smartphone Application Effective as an Oral Medication Adherence Aid,https://clinicaltrials.gov/study/NCT01968876,TERMINATED,Hypertension|Diabetes|Dyslipidemia,OTHER: Medication Adherence Smartphone App,University of Arkansas,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,INTERVENTIONAL,"Internal Medicine Clinic North; University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Remedy Drug, Little Rock, Arkansas, 72205, United States|Internal Medicine Clinic West; University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72211, United States"
NCT01944618,forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP),https://clinicaltrials.gov/study/NCT01944618,TERMINATED,Type 2 Diabetes,DRUG: Forxiga,AstraZeneca,Monash University,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Local Institution, Clayton, Victoria, VIC 3168, Australia"
NCT01888133,Adopting a Physically Active Lifestyle Through Organized Walk Events Among Joslin Clinic Patients,https://clinicaltrials.gov/study/NCT01888133,TERMINATED,Diabetes|Physical Activity,BEHAVIORAL: Group Walk|BEHAVIORAL: Individual Walk,Joslin Diabetes Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Joslin Diabetes Center, Boston, Massachusetts, 02215, United States"
NCT01660009,Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans,https://clinicaltrials.gov/study/NCT01660009,TERMINATED,Type 2 Diabetes,OTHER: Glycemic clamping,Medical College of Wisconsin,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States"
NCT03757845,Effects of Mediterranean Diet Intervention in Diabetic Heart Disease,https://clinicaltrials.gov/study/NCT03757845,TERMINATED,Diabetes Complications|Cardiovascular Diseases,OTHER: Mediterranean Diet,MaineHealth,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Maine Medical Center, Portland, Maine, 04102, United States"
NCT01551381,"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects",https://clinicaltrials.gov/study/NCT01551381,TERMINATED,Type 2 Diabetes,DRUG: EV-077|DRUG: Placebo,Evolva SA,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany"
NCT03456271,A Prospective Cohort Study:Forecast Fracture Risk With a Serum Marker of Type 2 Diabetes in Guangzhou Community,https://clinicaltrials.gov/study/NCT03456271,TERMINATED,Type 2 Diabetes Mellitus and Fragility Fractures,OTHER,Zhujiang Hospital,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Baiyun Community Taihe Town, Guangzhou, Guangdong, 510000, China|Guangzhou No.12 People's Hospital, Guangzhou, Guangdong, 510000, China|Haizhu Changgang Community, Guangzhou, Guangdong, 510000, China|Tianhe Community, Guangzhou, Guangdong, 510000, China|Zhujiang Hospital, Guangzhou, Guangdong, 510000, China"
NCT05510245,A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction,https://clinicaltrials.gov/study/NCT05510245,TERMINATED,Type 2 Diabetes|Renal Impairment,DRUG: PF-07081532,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Genesis Clinical Research, LLC, Tampa, Florida, 33603, United States|Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, 55114, United States"
NCT04854135,Continuous Glucose Monitoring Initiation at Hospital Discharge,https://clinicaltrials.gov/study/NCT04854135,TERMINATED,Type 1 Diabetes|Type2 Diabetes|Hyperglycemia|Hypoglycemia|Hypoglycemia Unawareness,DEVICE: CGM4Home,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Barnes Jewish Hospital/ Washington University, Saint Louis, Missouri, 63110, United States"
NCT02541838,Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy,https://clinicaltrials.gov/study/NCT02541838,TERMINATED,Diabetes Complications|Diabetic Neuropathies,OTHER: Muscle power|OTHER: balance perturbation|OTHER: aerobic exercise,"University of Maryland, Baltimore",VA Maryland Health Care System,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Maryland School of Medicine, Baltimore, Maryland, 21201-1082, United States|VA Maryland Health Care System, Baltimore, Maryland, 21201, United States"
NCT00830791,A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02),https://clinicaltrials.gov/study/NCT00830791,TERMINATED,Type 2 Diabetes,DRUG: MK-0941 20 mg|DRUG: MK-0941 5 mg,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,
NCT00758680,A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED),https://clinicaltrials.gov/study/NCT00758680,TERMINATED,Type 2 Diabetes,DRUG: MK-1006|DRUG: Comparator: Placebo comparator,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,
NCT00073034,Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy,https://clinicaltrials.gov/study/NCT00073034,TERMINATED,"Diabetes Mellitus|Diabetic Neuropathy, Painful",DRUG: EAA-090,Wyeth is now a wholly owned subsidiary of Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00371982,Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women,https://clinicaltrials.gov/study/NCT00371982,TERMINATED,Type 2 Diabetes,DRUG: Fish oil (Maxepa),Assistance Publique - Hôpitaux de Paris,"Institut National de la Santé Et de la Recherche Médicale, France",FEMALE,ADULT,,INTERVENTIONAL,"Department of Diabetes-Hotel Dieu Hospital, Paris, 75004, France"
NCT00362765,Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study,https://clinicaltrials.gov/study/NCT00362765,TERMINATED,Type 2 Diabetes|Dyslipidemia,DRUG: Fenofibrate|DRUG: Metformin|DRUG: Placebo,Solvay Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Site 2, Turku, Finland|Site 3, Dublin, Ireland|Site 1, Pisa, Italy"
NCT01351675,Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01351675,TERMINATED,"Renal Insufficiency, Chronic|Diabetes Mellitus, Type 2",DRUG: Placebo|DRUG: Bardoxolone Methyl: 20 mg,"Reata, a wholly owned subsidiary of Biogen",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02524938,Dietary Polyphenols and Glycation in Renal Insufficiency,https://clinicaltrials.gov/study/NCT02524938,TERMINATED,"Diabetes Mellitus, Type 2|Renal Insufficiency, Chronic",DIETARY_SUPPLEMENT: Chlorogenic Acid (CGA) enriched coffee|DIETARY_SUPPLEMENT: Conventional coffee,NHS Greater Glasgow and Clyde,University of Glasgow,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"NHS Greater Glasgow and Clyde, Glasgow, United Kingdom|University of Glasgow, Glasgow, United Kingdom"
NCT01350102,The Relationship of Hemoglobin A1c and Diabetic Wound Healing,https://clinicaltrials.gov/study/NCT01350102,TERMINATED,"Diabetes, Type 1|Diabetes, Type 2|Foot Ulcer, Diabetic",DRUG: Bacitracin|DRUG: AmeriGel®|DIETARY_SUPPLEMENT: Vitamin C,Susan Hassenbein,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States"
NCT00799435,Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure,https://clinicaltrials.gov/study/NCT00799435,TERMINATED,"Diabetes Mellitus, Type 2|Heart Failure, Diastolic",DRUG: Exenatide,Baylor College of Medicine,"National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Baylor College of Medicine, Houston, Texas, 77030, United States"
NCT06800365,Assessing Accuracy of the Freestyle Libre Pro Glucose Monitoring in Patients With Diabetes in a Critical Care Setting,https://clinicaltrials.gov/study/NCT06800365,TERMINATED,Diabetes Mellitus|Critical Illness|Continuous Glucose Monitoring,DEVICE: Sensor,Hennepin Healthcare Research Institute,University of Minnesota,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hennepin Healthcare, Minneapolis, Minnesota, 55415, United States"
NCT03458494,The TCF7L2 Gene: Dietary Prevention of T2DM,https://clinicaltrials.gov/study/NCT03458494,TERMINATED,"Type2 Diabetes|Glucose, High Blood",OTHER: Mediterranean Diet|OTHER: Low-fat diet,Tufts University,Allen Foundation Inc.,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, 02111, United States"
NCT00529204,"Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease",https://clinicaltrials.gov/study/NCT00529204,TERMINATED,Diabetes Complications|Fatty Liver,DRUG: exenatide,"University of California, Davis","Amylin Pharmaceuticals, LLC.|Eli Lilly and Company",ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of California Davis Medical Center, Sacramento, California, 95817, United States"
NCT05525572,Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM),https://clinicaltrials.gov/study/NCT05525572,TERMINATED,Erectile Dysfunction With Diabetes Mellitus,DEVICE: Shockwave Therapy (SWT)|DRUG: Autologous Platelet-Rich Plasma (PRP),University of Miami,,MALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"University of Miami, School of Medicine - Desai Sethi Urology Institute, Miami, Florida, 33136, United States"
NCT00642616,Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease,https://clinicaltrials.gov/study/NCT00642616,TERMINATED,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus|Moderate Chronic Obstructive Pulmonary Disease|Asthma,DRUG: Technosphere® Insulin|DRUG: Usual Care,Mannkind Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Mission Hills, California, 91345, United States|San Diego, California, 92117, United States|Palm Harbor, Florida, 34684, United States|Flint, Michigan, 48504, United States|Morehead City, North Carolina, 28557, United States|Medford, Oregon, 97504, United States|Greenville, South Carolina, 29615, United States|Spartanburg, South Carolina, 29302, United States|Dallas, Texas, 75225, United States|Dallas, Texas, 75231, United States|Federal Way, Washington, 98003, United States|Tacoma, Washington, 98405, United States|Yaroslavl, RUS, 150002, Russian Federation|Kemerovo, RU, 650066, Russian Federation|Moscow, RU, 105120, Russian Federation|St Petersburg, RU, 198013, Russian Federation|St. Petersburg, RU, 191015, Russian Federation|St. Petersburg, RU, 191119, Russian Federation|St. Petersburg, RU, 194354, Russian Federation|Kiev, UA, 04114, Ukraine|Kyiv, UA, 01021, Ukraine"
NCT05352230,Continuous Glucose Monitoring (CGM) in Kidney-Transplanted Adults,https://clinicaltrials.gov/study/NCT05352230,TERMINATED,Diabetes Mellitus|Kidney Transplant; Complications,DEVICE: Free style libre-2,University of Alabama at Birmingham,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"UAB Hospital, Birmingham, Alabama, 35294, United States"
NCT03748433,Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia,https://clinicaltrials.gov/study/NCT03748433,TERMINATED,"Diabetes Mellitus, Type 1|Hypoglycemia Unawareness|Hypoglycemia",DEVICE: Dexcom G6 CGM|DEVICE: Tandem t:slim X2 Insulin Pump,Imperial College London,London Ambulance Service,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Imperial College Clinical Research Facility, London, United Kingdom"
NCT00816010,Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes,https://clinicaltrials.gov/study/NCT00816010,TERMINATED,Type 2 Diabetes Mellitus|Acute Coronary Syndrome,BEHAVIORAL: telephone contact,Chinese University of Hong Kong,"Hospital Authority, Hong Kong",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"5 public hospitals in Hong Kong, Hong Kong, Hong Kong"
NCT01067963,Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease,https://clinicaltrials.gov/study/NCT01067963,TERMINATED,"Diabetes Mellitus, Type 2|Renal Insufficiency, Chronic",BEHAVIORAL: Computer assisted education and motivational interviewing.|BEHAVIORAL: Group talks/social chat,"University of Colorado, Denver",Robert Wood Johnson Foundation|National Center for Research Resources (NCRR),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Colorado Hospital, Aurora, Colorado, 80045, United States|VA Eastern Colorado Hospital, Denver, Colorado, 80220, United States"
NCT04079881,Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT04079881,TERMINATED,"Type 1 Diabetes|Hyperglycemia, Postprandial",DRUG: Insulin,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Washington University in St Louis, Saint Louis, Missouri, 63110, United States"
NCT01150617,Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty,https://clinicaltrials.gov/study/NCT01150617,TERMINATED,Type 2 Diabetes Mellitus|Peripheral Vascular Disease,DRUG: Insulin glargine plus insulin analogues,IRCCS San Raffaele,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cardio-Metabolic and Clinical Trials Unit, San Raffaele Scientific Institute, Milan, 20132, Italy"
NCT03554200,EMPA Acute Heart Failure,https://clinicaltrials.gov/study/NCT03554200,TERMINATED,"Diabetes Mellitus, Type 2|Acute Heart Failure",DRUG: Empagliflozin|DRUG: Placebo,RWTH Aachen University,Boehringer Ingelheim,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Department of Internal Medicine I RWTH Aachen University Hospital, Aachen, NRW, 52074, Germany"
NCT03426423,Diabetes and Smoking Cessation: a Gender-Oriented Study,https://clinicaltrials.gov/study/NCT03426423,TERMINATED,Smoking Cessation|Diabetes Type 2,OTHER: Behavioral smoking cessation intervention|OTHER: Control,Carole Clair,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Center for Primary Care and Public Health, Lausanne, Vaud, 1010, Switzerland"
NCT01549769,Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01549769,TERMINATED,"Renal Insufficiency, Chronic|Diabetes Mellitus, Type 2",DRUG: Bardoxolone Methyl,"Reata, a wholly owned subsidiary of Biogen",,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,
NCT04899271,A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.,https://clinicaltrials.gov/study/NCT04899271,TERMINATED,New-onset Type 1 Diabetes,DRUG: Ladarixin|OTHER: Placebo,Dompé Farmaceutici S.p.A,,ALL,ADULT,PHASE2,INTERVENTIONAL,"University of Colorado School of Medicine - Barbara Davis Center for Childhood Diabetes (BDC) - Specialty Clinic, Aurora, Colorado, 80045, United States|Atlanta Diabetes Associates (ADA), Atlanta, Georgia, 30318, United States|Universitair Ziekenhuis Brussel (UZB), Jette, Belgium|National Center for Diabetes Research LTD, Tbilisi, 48159, Georgia|National Institute of Endocrinology LTD, Tbilisi, 48159, Georgia|Universitaetsklinikum Gessen und Marburg GmbH - Medizinische Klinik und Poliklinik III, Glessen, 35392, Germany|Die Praxis am Ludwigsplatz, Ludwigshafen, 67059, Germany|Institut fuer Diabetes forschung in Muenster (IDFM), Muenster, 48145, Germany|Azienda Ospedaliero-Universitaria Conzorziale Policlinico di Bari, Bari, 70124, Italy|Università degli Studi Magna Graecia di Catanzaro, Azienda Ospedaliero-Universitaria Mater Domini, Catanzaro, 88100, Italy|Universitá degli Studi di Milano - Ospedale Luigi Sacco, Milan, 20157, Italy|Azienda Ospedaliera Universitaria Policlinico ""Paolo Giaccone"", Palermo, 90127, Italy|Università Campus Bio-Medico di Roma (UCBM), Roma, 00128, Italy|""Sapienza"" Università di Roma- Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome, 00161, Italy|Clinical Center of Serbia, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Belgrade, 11000, Serbia|Clinical center Kragujevac, Clinic for internal diseases, Center for endocrinology, diabetes and metabolic diseases, Kragujevac, 34000, Serbia"
NCT01789190,Regular Physical Exercise Extends Honeymoon Phase in Type 1 Diabetes Subjects,https://clinicaltrials.gov/study/NCT01789190,TERMINATED,Type 1 Diabetes|Physical Activity,,University Hospital A Coruña,Universidad Miguel Hernandez de Elche|University of Alicante,ALL,"CHILD, ADULT",,OBSERVATIONAL,"Endocrinology Service of the University Hospital Complex of A Coruña (Spain), A Coruna, Spain"
NCT01155518,Hypogonadism in Young Men With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01155518,TERMINATED,Hypogonadotropic Hypogonadism|Type 2 Diabetes,DRUG: testosterone|DRUG: clomiphene|DRUG: placebo|DRUG: placebo,State University of New York at Buffalo,American Diabetes Association,MALE,ADULT,PHASE2,INTERVENTIONAL,"Millard Fillmore Gates Hospital, Buffalo, New York, 14209, United States"
NCT03184662,Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT03184662,TERMINATED,Type2 Diabetes|Diabetic Kidney Disease,OTHER: HIPA|OTHER: Counseling PA,Poitiers University Hospital,"University Hospital, Bordeaux|University Hospital, Clermont-Ferrand|Centre Hospitalier Universitaire Dijon|Centre Hospitalier Universitaire de Besancon|Hopital Lariboisière|Bichat Hospital|Centre Hospitalier Sud Francilien|University Hospital, Lille|Centre Hospitalier Universitaire de Nice|University Hospital, Caen|University Hospital, Toulouse|University Hospital, Tours|Nantes University Hospital|Groupe Hospitalier Pitie-Salpetriere|Hospices Civils de Lyon|University Hospital, Montpellier|University Hospital, Strasbourg|Central Hospital, Nancy, France|HOSPITAL, CHARTRES|University of Liege",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hospital of Liège, Liège, Belgium|Besançon Hospital, Besançon, France|Bordeaux University Hospital, Bordeaux, 33000, France|Caen University Hospital, Caen, 14033, France|CH Chartres, Chartres, France|Clermont Ferrand University Hospital, Clermont Ferrand, 63000, France|CHG Sud Francilien, Corbeil-Essonnes, 91100, France|CHU Dijon, Dijon, 21000, France|CHU Lille, Lille, 59000, France|Chu de Lyon, Lyon, 69229, France|CHRU, Montpellier, France|CHU Nancy, Nancy, 54000, France|Chu de Nice, Nice, 06003, France|Bichat University Hospital, Paris, 75000, France|La Riboisière Hospital, Paris, 75000, France|Hôpital Pitié Salpétrière, Paris, 75651, France|Poitiers University Hospital, Poitiers, 86000, France|CHU Strasbourg, Strasbourg, 67000, France|CHU Toulouse, Toulouse, 31000, France|CHU de TOURS, Tours, 37044, France"
NCT02586519,Pressure-Sensing Insoles in the Neuropathic Ulcer Treatment Pathway,https://clinicaltrials.gov/study/NCT02586519,TERMINATED,Diabetes|Diabetes Complications|Neuropathy|Peripheral Neuropathy|Diabetic Foot Ulcer,DEVICE: SurroSense Rx System,University of Calgary,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Zivot Limb Preservation Centre- Peter Lougheed Centre, Calgary, Alberta, T1Y 6J4, Canada"
NCT02244164,Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.,https://clinicaltrials.gov/study/NCT02244164,TERMINATED,Type 2 Diabetes|Incretinomimetics|Pancreas,DRUG: Incretinomimetics|DRUG: DPP-4 inhibitors,Erasme University Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Gastroenterology Department Erasme Hospital, Brussels, 1070, Belgium"
NCT01840189,Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes,https://clinicaltrials.gov/study/NCT01840189,TERMINATED,Addison Disease|Type 1 Diabetes,OTHER: Cortef|OTHER: Solu-cortef,Haukeland University Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Haukeland University Hospiatl, Bergen, 5021, Norway"
NCT00458081,Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors,https://clinicaltrials.gov/study/NCT00458081,TERMINATED,"Obesity|Microalbuminuria|Diabetes Mellitus, Type 2|Dyslipidemia",DRUG: Rimonabant|DRUG: Placebo,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Barcelona, Spain"
NCT01204216,Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c,https://clinicaltrials.gov/study/NCT01204216,TERMINATED,Diabetes Mellitus|Impaired Fasting Glucose|Prediabetes,BIOLOGICAL: re-infusion of biotin labeled cells|BIOLOGICAL: Re-infusion of biotin labeled cells|BEHAVIORAL: Diabetes education/diabetes medication adjustment,VA Office of Research and Development,University of Cincinnati,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati, Ohio, 45220, United States"
NCT00701181,Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT00701181,TERMINATED,Diabetic Retinopathy|Diabetes Complications,PROCEDURE: Laser Treatment|DRUG: PF-04523655 high|DRUG: PF-04523655 middle|DRUG: PF-04523655 low,Quark Pharmaceuticals,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Pfizer Investigational Site, Mesa, Arizona, 85210, United States|Pfizer Investigational Site, Meza, Arizona, 85210, United States|Pfizer Investigational Site, Peoria, Arizona, 85381, United States|Pfizer Investigational Site, Phoenix, Arizona, 85014, United States|Pfizer Investigational Site, Phoenix, Arizona, 85016, United States|Pfizer Investigational Site, Mountain View, California, 94040, United States|Pfizer Investigational Site, Lakeland, Florida, 33805, United States|Pfizer Investigational Site, Winter Haven, Florida, 33880, United States|Pfizer Investigational Site, Augusta, Georgia, 30909, United States|Pfizer Investigational Site, Aiea, Hawaii, 96701, United States|Pfizer Investigational Site, Chicago, Illinois, 60637, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46290, United States|Pfizer Investigational Site, New Albany, Indiana, 47150, United States|Pfizer Investigational Site, Baltimore, Maryland, 21287, United States|Pfizer Investigational Site, Boston, Massachusetts, 02111, United States|Pfizer Investigational Site, Boston, Massachusetts, 02215, United States|Pfizer Investigational Site, Henderson, Nevada, 89052, United States|Pfizer Investigational Site, Henderson, Nevada, 89074, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89109, United States|Pfizer Investigational Site, Portsmouth, New Hampshire, 03801, United States|Pfizer Investigational Site, Charlotte, North Carolina, 28210, United States|Pfizer Investigational Site, High Point, North Carolina, 27262, United States|Pfizer Investigational Site, Statesville, North Carolina, 28677, United States|Pfizer Investigational Site, Winston-Salem, North Carolina, 27157, United States|Pfizer Investigational Site, Rapid City, South Dakota, 57701, United States|Pfizer Investigational Site, Corpus Christi, Texas, 78413, United States|Pfizer Investigational Site, Glostrup, 2600, Denmark|Pfizer Investigational Site, Freiburg, 79106, Germany|Pfizer Investigational Site, Leipzig, 04103, Germany|Pfizer Investigational Site, Muenster, 48145, Germany|Pfizer Investigational Site, Bhubaneshwar, Orissa, 751 024, India|Pfizer Investigational Site, Ahmedabad, 380 004, India|Pfizer Investigational Site, Bangalore, 560 085, India|Pfizer Investigational Site, New Delhi, 110 029, India|Pfizer Investigational Site, Kfar Saba, 44281, Israel|Pfizer Investigational Site, Petach - Tikva, 49100, Israel|Pfizer Investigational Site, Tel Aviv, 64239, Israel|Pfizer Investigational Site, Tel Hashomer, 52621, Israel|Pfizer Investigational Site, Zerifin, 70300, Israel|Pfizer Investigational Site, Milano, 20122, Italy|Pfizer Investigational Site, Milano, 20132, Italy|Pfizer Investigational Site, Milano, 20157, Italy|Pfizer Investigational Site, Padova, 35128, Italy|Pfizer Investigational Site, Roma, 00168, Italy|Pfizer Investigational Site, Roma, 00198, Italy|Pfizer Investigational Site, Udine, 33100, Italy|Pfizer Investigational Site, Lima, L27, Peru|Pfizer Investigational Site, Frimley, Camberley, Surrey, GU15 3UW, United Kingdom|Pfizer Investigational Site, Bristol, BS1 2LX, United Kingdom|Pfizer Investigational Site, Bristol, BS2 8HW, United Kingdom|Pfizer Investigational Site, Liverpool, L7 8XP, United Kingdom|Pfizer Investigational Site, Sheffield, S10 2JF, United Kingdom|Pfizer Investigational Site, Southampton, SO16 6YD, United Kingdom"
NCT00207389,A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients,https://clinicaltrials.gov/study/NCT00207389,TERMINATED,Obesity|Type 2 Diabetes Mellitus|Insulin Resistance,,Boston Medical Center,,ALL,ADULT,,OBSERVATIONAL,"Boston University Medical Center, Boston, Massachusetts, 02118, United States"
NCT00775216,Project Diabetes: Prescription for Healthy Living,https://clinicaltrials.gov/study/NCT00775216,TERMINATED,Type 2 Diabetes Mellitus|Exercise|Obesity|Behavioral Research,"BEHAVIORAL: Behavioral counseling plus ""telephone helpline""",Vanderbilt University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States"
NCT01268995,Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation,https://clinicaltrials.gov/study/NCT01268995,TERMINATED,New Onset Diabetes Mellitus After Renal Transplantation,DRUG: Cyclosporine A|DRUG: Tacrolimus,Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Medical University of Vienna/General Hospital, Vienna, A-1090, Austria"
NCT04234867,Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D),https://clinicaltrials.gov/study/NCT04234867,TERMINATED,Type 1 Diabetes|Diabetic Ketoacidosis,DRUG: Dapagliflozin|DRUG: Placebo oral tablet|OTHER: Stress|OTHER: Placebo Stress,Kinderkrankenhaus auf der Bult,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Kinder- und Jugendkrankenhaus AUF DER BULT, Hanover, Lower Saxony, 30173, Germany"
NCT01574365,A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01574365,TERMINATED,Chronic Kidney Disease|Type 2 Diabetes,DRUG: RTA 402,"Kyowa Kirin Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Toride City, Ibaraki, Japan"
NCT01804777,Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01804777,TERMINATED,Proteinuria|Hypertension|Type II Diabetes,DRUG: Amiloride|DRUG: HCTZ,University of New Mexico,"Dialysis Clinic, Inc.|University of Pittsburgh",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,INTERVENTIONAL,"University of New Mexico Hospital; Clinical & Translational Science Center, Albuquerque, New Mexico, 87131, United States"
NCT03462940,Effects of TUDCA on Endothelial Function in Type 2 DM,https://clinicaltrials.gov/study/NCT03462940,TERMINATED,"Diabetes Mellitus, Type 2|Insulin Response|Endothelial Dysfunction",DIETARY_SUPPLEMENT: Tauroursodeoxycholic acid,Boston University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Boston Medical Center, Boston, Massachusetts, 02118, United States"
NCT03958539,Prevention of Primary Foot Ulcers in High-risk Diabetes Patients,https://clinicaltrials.gov/study/NCT03958539,TERMINATED,"Diabetes Mellitus|Foot Ulcer, Diabetic|Primary Prevention",DEVICE: 3D printed insoles for normal footware,Countess of Chester NHS Foundation Trust,University of Liverpool|Staffordshire University,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Countess of Chester NHS Trust, Chester, Cheshire, CH2 1UL, United Kingdom"
NCT00782639,Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients,https://clinicaltrials.gov/study/NCT00782639,TERMINATED,Chronic Renal Impairment|Diabetes Mellitus,DRUG: Iopamidol injection 76%|DRUG: iodixanol,"Bracco Diagnostics, Inc",,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Bracco Diagnostics Inc., Princeton, New Jersey, 08540, United States"
NCT01597531,Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding,https://clinicaltrials.gov/study/NCT01597531,TERMINATED,Type 2 Diabetes|Gastric Banding,DRUG: Liraglutide|DRUG: Orlistat|DRUG: Liraglutide + Orlistat,East Carolina University,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Brody School of Medicine at East Carolina University, Greenville, North Carolina, 28590, United States"
NCT02758899,Diabetes and Glycosylation in Cervical Spondylosis,https://clinicaltrials.gov/study/NCT02758899,TERMINATED,Diabetes|Cervical Myelopathy|Cervical Spondylosis,,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Washington University School of Medicine, Saint Louis, Missouri, 63110, United States"
NCT01390636,Type 1 Diabetes and Eating Disorder Diurnal Glucose Patterns,https://clinicaltrials.gov/study/NCT01390636,TERMINATED,Type I Diabetes Mellitus Without Complication|Eating Disorder,,HealthPartners Institute,Park Nicollet Foundation|Melrose Institute|International Diabetes Center at Park Nicollet,FEMALE,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"Melrose Institute, Minneapolis, Minnesota, 55416, United States"
NCT01173939,Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments,https://clinicaltrials.gov/study/NCT01173939,TERMINATED,Hypercholesterolemia|Type 2 Diabetes|Hypertension,DRUG: Pravastatin|DRUG: Rosuvastatin,Positive Trial Group,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hiramitsu Heart Clinic, Nagoya city, Aichi pref., Japan|Medical Dock&Clinic, Nagoya city, Aichi pref., Japan|Matsuno Medical Clinic, Iyo gun, Ehime pref., Japan|Ishite Matsumoto Naika Junkanki Clinic, Matsuyama city, Ehime pref., Japan|Ehime Medical CO-OP Izumigawa Clinic, Niihama city, Ehime pref., Japan|Tsugawa Internal Medicine Clinic, Echizen city, Fukui pref., Japan|Fukui Chuo Clinic, Fukui city, Fukui pref., Japan|Koshino Clinic, Sakai city, Fukui pref., Japan|Fukuoka University Chikushi Hospital, Chikushino city, Fukuoka pref., Japan|Saiseikai Futsukaichi Hospital, Chikushino city, Fukuoka pref., Japan|Abies Clinic, Fukuoka city, Fukuoka pref., Japan|Hirano Medical Clinic, Fukuoka city, Fukuoka pref., Japan|Naitoh Clinic, Fukuoka city, Fukuoka pref., Japan|Saku Hospital, Fukuoka city, Fukuoka pref., Japan|Fukuoka Tokushukai Medical Center, Kasuga city, Fukuoka pref., Japan|Morizono Naika, Kitakyusyu city, Fukuoka pref., Japan|Kawai Naika Clinic, Gifu city, Gifu pref., Japan|Hiroshima General Hospital of West Japan Railway Company, Hiroshima city, Hiroshima pref., Japan|Hijirigaoka Hospital, Date city, Hokkaido pref., Japan|Kyoaikai Hospital, Hakodate city, Hokkaido pref., Japan|Miyazawa Cardiovascular And Internal Medicine Clinic, Kato-gun, Hokkaido pref., Japan|Jiyugaoka Yamada Clinic, Obihiro city, Hokkaido pref., Japan|Chikama Clinic, Sapporo city, Hokkaido pref., Japan|Hiro Clinic, Sapporo city, Hokkaido pref., Japan|Medical and Radiology Clinic Caress Sapporo Hokko Memorial Hospital, Sapporo city, Hokkaido pref., Japan|Seiwa Memorial Hospital, Sapporo city, Hokkaido pref., Japan|Medical Treatment Corporate Foundation Yubari Kibounomori Yubari City Clinic, Yubari city, Hokkaido pref., Japan|Ino Hospital, Himeji city, Hyogo pref., Japan|Katsuya Clinic, Amagasaki city, Hyogo pref, Japan|Kotani Diabetes Clinic, Kobe city, Hyogo pref, Japan|Shimizu Clinic, Kobe city, Hyogo pref, Japan|Dr. Kodama's Office of Internal Medicine, Nishinomiya city, Hyogo pref, Japan|Koga Hospital, Koga city, Ibaraki pref., Japan|Imura Internal Medicine Clinic, Hakusan city, Ishikawa pref., Japan|Yanagi Medical Clinic, Hakusan city, Ishikawa pref., Japan|Okyozuka Clinic, Ishikawa gun, Ishikawa pref., Japan|Koni Clinic, Kahoku gun, Ishikawa pref., Japan|Murata Clinic, Kahoku gun, Ishikawa pref., Japan|Arai Naika Clinic, Kanazawa city, Ishikawa pref., Japan|Dr. Hayakawa's Family Clinic, Kanazawa city, Ishikawa pref., Japan|Wakasa Medical Clinic, Kanazawa city, Ishikawa pref., Japan|Morita Hospital, Komatsu city, Ishikawa pref., Japan|Kawasaki Family Clinic, Ichinoseki, Iwate pref., Japan|Sugie Clinic, Iwate gun, Iwate pref., Japan|Katsura General Clinic, Morioka city, Iwate pref., Japan|Takamiya General Clinic, Shiwa gun, Iwate pref., Japan|Hayashi Clinic, Marugame city, Kagawa pref., Japan|Otsuka Internal Medicine Clinic, Marugame city, Kagawa pref., Japan|Center for Preventive Medical Treatment, NTT West Takamatsu Hospital, Takamatsu city, Kagawa pref., Japan|Hananomiya Clinic, Takamatsu city, Kagawa pref., Japan|Hasegawa Outpatients Clinic for Cardiovascular Disease, Takamatsu city, Kagawa pref., Japan|Kojima Clinic, Takamatsu city, Kagawa pref., Japan|Matsuoka Clinic, Takamatsu city, Kagawa pref., Japan|Osumi-Kanoya Hospital, Kanoya city, Kagoshima pref., Japan|Yakushima Tokushukai Hospital, Kumage gun, Kagoshima pref., Japan|Nemoto G.I.M. Clinic, Ashigara-kami gun, Kanagawa pref., Japan|Magokoro Internal Medicine and Orthopedic Clinic, Ashigarakami gun, Kanagawa pref., Japan|Kasuya Clinic, Atsugi City, Kanagawa pref., Japan|Kuboshima Clinic, Fujisawa city, Kanagawa pref., Japan|Takahashi Clinic, Fujisawa city, Kanagawa pref., Japan|Akizawa Clinic, Isehara city, Kanagawa pref., Japan|Medical Corp Takeda Clinic, Isehara city, Kanagawa pref., Japan|Hashimoto Clinic, Kamakura city, Kanagawa pref., Japan|Iroden Clinic, Kamakura city, Kanagawa pref., Japan|Kamakura Naika Shinryosyo, Kamakura city, Kanagawa pref., Japan|Shohei Clinic, Kamakura city, Kanagawa pref., Japan|Hatori Medical Clinic, Kawasaki city, Kanagawa pref., Japan|Hirayasu Iin, Kawasaki city, Kanagawa pref., Japan|Kamegaya Medical Clinic, Kawasaki city, Kanagawa pref., Japan|Kirimura Iin, Kawasaki city, Kanagawa pref., Japan|Kojima Clinic, Odawara city, Kanagawa pref., Japan|Hakuai Iin, Sagamihara city, Kanagawa pref., Japan|Sato Clinic, Sagamihara city, Kanagawa pref., Japan|Toshiba Rinkan Hospital, Sagamihara city, Kanagawa pref., Japan|Yamamoto Clinic, Sagamihara city, Kanagawa pref., Japan|Fukumura Clinic, Yokohama city, Kanagawa pref., Japan|Fukushi Clinic, Yokohama city, Kanagawa pref., Japan|International Goodwill Hospital, Yokohama city, Kanagawa pref., Japan|Kikuchi Clinic, Yokohama city, Kanagawa pref., Japan|Matsuo Naika Clinic, Yokohama city, Kanagawa pref., Japan|Miho-cho Cardiovascular Medical Clinic, Yokohama city, Kanagawa pref., Japan|Minamisawa Clinic, Yokohama city, Kanagawa pref., Japan|Miyoshi-Clinic, Yokohama city, Kanagawa pref., Japan|Paula's Clinic, Yokohama city, Kanagawa pref., Japan|Shimokurata Heart Clinic, Yokohama city, Kanagawa pref., Japan|Shinwakai Fukuda Iin, Yokohama city, Kanagawa pref., Japan|Shinyoshida Clinic, Yokohama city, Kanagawa pref., Japan|Suzuki Orthopedic Clinic, Yokohama city, Kanagawa pref., Japan|Yokohama City University Medical Center, Yokohama city, Kanagawa pref., Japan|Yokohama Sotetsu bldg. clinic of internal medicine, Yokohama city, Kanagawa pref., Japan|Hara Clinic, Yokosuka City, Kanagawa pref., Japan|Ueta Medical Clinic, Kochi city, Kochi pref., Japan|Nakayama Cardiovascular Clinic, Amakusa city, Kumamoto pref., Japan|Yamashita Clinic, Amakusa city, Kumamoto pref., Japan|National Health Insurance Central Hospital Aso, Aso city, Kumamoto pref., Japan|Sakanashi Heart Clinic, Aso city, Kumamoto pref., Japan|Koyasako iin, Kamimashiki gun, Kumamoto pref., Japan|Kawaguchi Hospital, Kikuchi city, Kumamoto pref., Japan|Miyamoto Internal Clinic, Kikuchi city, Kumamoto pref., Japan|Doi Cardiovascular Clinic, Kumamoto city, Kumamoto pref., Japan|Doi Naika-ichoka Clinic, Kumamoto city, Kumamoto pref., Japan|Haraguchi Circular&Internal Medical Clinic, Kumamoto city, Kumamoto pref., Japan|Jinnouchi Clinic Diabetes Care Center, Kumamoto city, Kumamoto pref., Japan|Kiyota Junkanki Naika Iin, Kumamoto city, Kumamoto pref., Japan|Maki Cardiovascular Clinic, Kumamoto city, Kumamoto pref., Japan|Nozuhara Clinic, Kumamoto city, Kumamoto pref., Japan|Ootsuka Hospital, Kumamoto city, Kumamoto pref., Japan|Shono Heart Clinic, Kumamoto city, Kumamoto pref., Japan|Suefuji Naika Junkankika, Kumamoto city, Kumamoto pref., Japan|Suizenji Tohya Hospital, Kumamoto city, Kumamoto pref., Japan|Terao Hospital, Kumamoto city, Kumamoto pref., Japan|Yi Medical Clinic, Kumamoto city, Kumamoto pref., Japan|Munakata Clinic, Shimomashiki gun, Kumamoto pref., Japan|Higashi Diabetes and Cardiovascular Clinic, Tamana city, Kumamoto pref., Japan|Yoshimura Jyunnkannkika Naika Iinn, Tamana city, Kumamoto pref., Japan|Universal Shipbuilding Co. Ariake Shipyard Ariake Infirmary, Tamana gun, Kumamoto pref., Japan|Miyagi Clinic Cardiovascular Medicine, Yatsushiro city, Kumamoto pref., Japan|Koide Iin, Kizugawa-city, Kyoto pref., Japan|Sawai medical Clinic, Kyotanabe city, Kyoto pref., Japan|Asamoto Clinic of Internal Medicine, Kyoto city, Kyoto pref., Japan|Gotoh Clinic, Kyoto city, Kyoto pref., Japan|Higashiyama Takeda Hospital, Kyoto city, Kyoto pref., Japan|Isoda Internal Medical Clinic, Kyoto city, Kyoto pref., Japan|Omoto Clinic, Kyoto city, Kyoto pref., Japan|Sakazaki Clinic, Kyoto city, Kyoto pref., Japan|Shinya Clinic, Kyoto city, Kyoto pref., Japan|Takagi Cardiology Clinic, Kyoto city, Kyoto pref., Japan|Takenaka Clinic, Kyoto city, Kyoto pref., Japan|Tegoshi Clinic, Kyoto city, Kyoto pref., Japan|Kimura Naika Clinic, Yosa gun, Kyoto pref., Japan|Shimizu Clinic, Ise city, Mie pref., Japan|Horii Clinic Kiodai, Nabari city, Mie pref., Japan|Yamoto-naika Clinic, Higashi matsushima city, Miyagi pref., Japan|Seisuikai Yoshioka QQ Clinic, Kurokawa gun, Miyagi pref., Japan|Ohtomo Clinic, Tome City, Miyagi pref., Japan|Shimoina Kosei Hospital, Shimoina gun, Nagano pref., Japan|Yokoyama Medical Clinic, Shiojiri city, Nagano pref., Japan|Sato Clinic, Suzaka city, Nagano pref., Japan|Hoshiko Clinic, Nagasaki city, Nagasaki pref., Japan|Shinagawa Clinic, Nagasaki city, Nagasaki pref., Japan|Iryohojin Yamamoto Naika, Nishisonogi gun, Nagasaki pref., Japan|Yamada Clinic, Gojo city, Nara pref., Japan|Uyama Naika Clinic, Ikoma city, Nara pref., Japan|Clinic Jinguumae, Kahihara city, Nara pref., Japan|Kasahara Clinic, Kahihara city, Nara pref., Japan|Sawada Clinic, Kashiba city, Nara pref., Japan|Doi Clinic, Kashihara city, Nara pref., Japan|Medical Corporation Kiriyama Clinic, Kashihara city, Nara pref., Japan|Miyamoto Clinic, Kashihara city, Nara pref., Japan|Oosumi Naika Iin, Kashihara city, Nara pref., Japan|Kondo Clinic Mamigaoka Purified Center, Kitakatsuragi gun, Nara pref., Japan|Matsuoka Clinic, Kitakatsuragi gun, Nara pref., Japan|Nakahori Iin, Kitakatsuragi gun, Nara pref., Japan|Seiwadai Clinic, Kitakatsuragi gun, Nara pref., Japan|Saiseikai Nara Hospital, Nara city, Nara pref., Japan|Takanohara Central Hospital, Nara city, Nara pref., Japan|Takanohara Suzuran-naika, Nara city, Nara pref., Japan|Ote Clinic of Internal Medicine, Sakurai city, Nara pref., Japan|Sakaguchi Clinic, Sakurai city, Nara pref., Japan|Kokuho Central Hospital, Shiki gun, Nara pref., Japan|Makiura Naika, Yamatokoriyama city, Nara pref., Japan|Matsuta Heart Clinic, Yamatokoriyama city, Nara pref., Japan|Nakatani Clinic, Yamatotakada city, Nara pref., Japan|Sano Clinic, Murakami city, Niigata pref., Japan|Kawaguchi Clinic, Nagaoka city, Niigata pref., Japan|Maeda Medical Clinic, Niigata city, Niigata pref., Japan|Watanabe NJ Clinic, Beppu city, Oiat pref., Japan|Hirata Clinic, Oita city, Oiat pref., Japan|Ninomiya Clinic, Oita city, Oiat pref., Japan|Sumi Cardiology Clinic, Oita city, Oiat pref., Japan|Tokumaru Digestive Internal Medicine Clinic, Oita city, Oiat pref., Japan|Tsuzaki Clinic, Oita city, Oiat pref., Japan|Ishida Medical Clinic, Usa city, Oiat pref., Japan|Hachiouji Naika Clinic, Kurashiki city, Okayama pref., Japan|Inada Clinic, Kurashiki city, Okayama pref., Japan|Hisamatsu Medical Clinic, Okayama city, Okayama pref., Japan|Yuhara Naika Clinic, Okayama city, Okayama pref., Japan|Hattori Clinic, Setouchi city, Okayama pref., Japan|Nishimura Clinic, Fujiidera city, Osaka pref., Japan|Ikeda Clinic, Higashiosaka city, Osaka pref., Japan|Ogawa Clinic, Higashiosaka city, Osaka pref., Japan|Taisei Clinic, Hirakata city, Osaka pref., Japan|Ishiga Clinic, Ibaraki city, Osaka pref., Japan|Masuda Clinic, Ibaraki city, Osaka pref., Japan|Kanazawa Clinic, Izumi city, Osaka pref., Japan|Misugi Clinic, Kaizuka city, Osaka pref., Japan|Yoshida Clinic, Kaizuka city, Osaka pref., Japan|Mori Iin, Kishiwada city, Osaka pref., Japan|Medical Corporation Joukokai Teranishi-geka naika, Moriguchi city, Osaka pref., Japan|Iryouhoujin Suisyoukai Murata Hospital, Osaka city, Osaka pref., Japan|Izuoka Clinic, Osaka city, Osaka pref., Japan|Keiju Hospital, Osaka city, Osaka pref., Japan|Kondo Clinic, Osaka city, Osaka pref., Japan|Kubota Clinic, Osaka city, Osaka pref., Japan|Matsushita Medical Clinic, Osaka city, Osaka pref., Japan|Nishizawa Clinic, Osaka city, Osaka pref., Japan|Osaka General Medical Center, Osaka city, Osaka pref., Japan|Senpuku Clinic, Osaka city, Osaka pref., Japan|Tai Internal Medicin Clinic, Osaka city, Osaka pref., Japan|Ueda Clinic, Osaka city, Osaka pref., Japan|Ohta Iin, Sakai city, Osaka pref., Japan|Ban Clinic, Suita city, Osaka pref., Japan|Iryohojin Nogi Naika Iin, Suita city, Osaka pref., Japan|Kobayashi Clinic, Suita city, Osaka pref., Japan|Ichida Internal Clinic, Takaishi city, Osaka pref., Japan|Yada Clinic, Takaishi city, Osaka pref., Japan|Ryo Clinic, Takatsuki city, Osaka pref., Japan|Matsuo Clinic, Yao city, Osaka pref., Japan|Enomoto Clinic, Ageo city, Saitama pref., Japan|Medimo Hanyu Clinic, Hanyu city, Saitama pref., Japan|Hirose Hospital, Kawagoe city, Saitama pref., Japan|Iryohojin Hogi Shinryojo, Kawaguchi city, Saitama pref., Japan|Tokutake Iin, Kawaguchi city, Saitama pref., Japan|Gamo Tenjinbashi Clinic, Koshigaya city, Saitama pref., Japan|Matsumoto Clinic, Koshigaya city, Saitama pref., Japan|Medical Corporation Shibuya Clinic, Kumagaya city, Saitama pref., Japan|Akimoto Clinic, Saitama city, Saitama pref., Japan|Iwatsuki-minami Hospital, Saitama city, Saitama pref., Japan|Suzuhiro Clinic, Saitama city, Saitama pref., Japan|Nashida naika clinic, Tokorozawa City, Saitama pref., Japan|Shizuoka Medical Alliance Shirahama Chuou Clinic, Shimoda city, Shizuoka pref., Japan|Akiyama Clinic, Shizuoka city, Shizuoka pref., Japan|Aoshima Clinic, Shizuoka city, Shizuoka pref., Japan|Eguchi Clinic, Shizuoka city, Shizuoka pref., Japan|Shizuoka Hospital, Shizuoka city, Shizuoka pref., Japan|Ueno Clinic, Yaizu city, Shizuoka pref., Japan|Takahashi Medical Clinic, Ohtawara city, Tochigi pref., Japan|Iryouhoujin Yuukoukai Morioka Naika Shonika, Oyama city, Tochigi pref., Japan|Takada Clinic, Tochigi city, Tochigi pref., Japan|Masuda Naika, Utsunomiya city, Tochigi pref., Japan|Murakami Clinic, Anan city, Tokushima pref., Japan|Fukushima Clinic, Itano gun, Tokushima pref., Japan|Yamamoto Naika Ityoka, Itano gun, Tokushima pref., Japan|Yuki National Health Insurance Hospital Of Minami Town, Kaifu gun, Tokushima pref., Japan|Sekishinkan Hospital, Komatsushima city, Tokushima pref., Japan|Ueta Clinic, Myozai gun, Tokushima pref., Japan|Kensei Uchimachi Clinic, Tokushima city, Tokushima pref., Japan|Kitagawa Naika Ityoka, Tokushima city, Tokushima pref., Japan|Kitasako Clinic, Tokushima city, Tokushima pref., Japan|Limbs Tokushima Clinic, Tokushima city, Tokushima pref., Japan|Matsumura Internal, Gastrointestial Medicine, Tokushima city, Tokushima pref., Japan|Okagawa Clinic, Tokushima city, Tokushima pref., Japan|Yokoi Internal Medicine, Tokushima city, Tokushima pref., Japan|Kimura Internal Medicine Clinic, Yoshinokawa city, Tokushima pref., Japan|Yata Clinic, Yoshinokawa city, Tokushima pref., Japan|Okubo Clinic, Akishima city, Tokyo, Japan|Juntendo University Hospital, Bunkyo ku, Tokyo, Japan|Choei Clinic, Edogawa ku, Tokyo, Japan|Shiraishi Iin, Edogawa ku, Tokyo, Japan|Hattori Clinic, Hachioji city, Tokyo, Japan|Toyoizumi Hospital, Hachioji city, Tokyo, Japan|Utsugidai Tajima Clinic, Hachioji City, Tokyo, Japan|Mochizuki Naika Clinic, Itabashi ku, Tokyo, Japan|Nishio Clinic, Itabashi ku, Tokyo, Japan|Ono Heart Clinic, Koto ku, Tokyo, Japan|Shiba Palace Clinic, Minato-ku, Tokyo, Japan|Kamada Clinic, Mitaka city, Tokyo, Japan|Tenjinmae Clinic, Mitaka city, Tokyo, Japan|Takayama Iin, Mitaka-shi, Tokyo, Japan|Sugawara Clinic, Nerima ku, Tokyo, Japan|Yamada Clinic, Ota-ku, Tokyo, Japan|Matsumura Gastroenterological Clinic, Setagaya ku, Tokyo, Japan|Magari Clinic, Shinjuku ku, Tokyo, Japan|Yotsuya Internal Medicine Clinic, Shinjuku ku, Tokyo, Japan|Yotsuya-Murakami Internal Medicine Clinic, Shinjuku ku, Tokyo, Japan|Obayashi Clinic, Sumida city, Tokyo, Japan|Sumidagawa Clinic, Sumida ku, Tokyo, Japan|ISHII Medical Clinic, Tachikawa-shi, Tokyo, Japan|Takahashi Ko Minako Clinic, Murayama city, Yamagata pref., Japan|Obanazawa City Clinic, Obanazawa city, Yamagata pref., Japan|Okuyama Clinic, Obanazawa city, Yamagata pref., Japan|Sakae Clinic, Obanazawa city, Yamagata pref., Japan|Honma Clinic, Sakata city, Yamagata pref., Japan|Isoda Clinic, Yamagata city, Yamagata pref., Japan|Nihei Clinic, Yamagata city, Yamagata pref., Japan|Shimasaki Clinic, Yamagata city, Yamagata pref., Japan|Yamagata Tokushukai Hospital, Yamagata city, Yamagata pref., Japan|Iwasaki Naika Iin, Iwakuni city, Yamaguchi pref., Japan|Kuwahara Clinic, Iwakuni city, Yamaguchi pref., Japan|Ayame Medical Clinic, Shimonoseki city, Yamaguchi pref., Japan|Johno Clinic, Shimonoseki city, Yamaguchi pref., Japan|Matsuda Medical Clinic, Shimonoseki city, Yamaguchi pref., Japan|Mizumachi Medical Clinic, Shimonoseki city, Yamaguchi pref., Japan|Noda Clinic, Shimonoseki city, Yamaguchi pref., Japan|Fujii Clinic, Ube City, Yamaguchi pref., Japan|Shakaiiryouhoujin Onaka Hospital, Ube City, Yamaguchi pref., Japan|Watada-naika Hospital, Ube city, Yamaguchi pref., Japan|Ouchi Clinic, Yamaguchi city, Yamaguchi pref., Japan|Yoshizaki Clinic, Chuo city, Yamanashi pref., Japan|Takahashi Clinic, Nishi Yatsushiro gun, Yamanashi pref., Japan|Higashikatsura Medical Clinic, Tsuru city, Yamanashi pref., Japan|Fukushi Clinic, Aomori city, Japan|Kashiwagi Clinic, Ayase city, Japan|Hayashi Diabetes Clinic, Chigasaki city, Japan|Uchiyama Clinic, Joetsu city, Japan|Nitta Medical Clinic, Kamiinagun, Japan|Imai Clinic, Kawasaki city, Japan|Tani Clinic, Kitakyusyu City, Japan|Marumo Clinic, Koganei city, Japan|Ihara Clinic, Kyoto city, Japan|Goko-Hospital, Matsudo city, Japan|Satou Clinic, Moka city, Japan|Iino Clinic, Nirasaki city, Japan|Miura Clinic, Osaka City, Japan|Kuroda Iin, Otsuki City, Japan|Sasaki Clinic, Sendai city, Japan|Kamata Clinic of Internal Medicine, Shiki city, Japan|Nishikawa Clinic, Shimoda city, Japan|Satou Iin, Shimoinagun, Japan|Kumagai Clinic, Shinshiro city, Japan|Suzuki Clinic, Toyokawa city, Japan|Benibana Clinic, Yamagata city, Japan|Fujimi Clinic, Yokohama city, Japan|Hongo Clinic, Yokohama city, Japan|Jiyukai Yamada Naika, Yokohama city, Japan|Shonan Ochanomizu Clinic, Yokohama city, Japan|Tani Clinic Internal Medicine, Allergology & Rheumatology, Yokohama city, Japan"
NCT00388388,Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects,https://clinicaltrials.gov/study/NCT00388388,TERMINATED,Pre-hypertension|Pre-diabetes,"DRUG: losartan, hydrochlorothiazide",Sir Mortimer B. Davis - Jewish General Hospital,Merck Frosst Canada Ltd.,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Cardiovascular Prevention Centre, Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada"
NCT01572610,A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01572610,TERMINATED,Chronic Kidney Disease|Type 2 Diabetes,DRUG: RTA 402,"Kyowa Kirin Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Koga city, Ibaraki, Japan"
NCT00138671,A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD,https://clinicaltrials.gov/study/NCT00138671,TERMINATED,Diabetes Mellitus|Chronic Obstructive Pulmonary Disease,DRUG: Subcutaneous Insulin|DRUG: Inhaled Insulin,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Glendale, Arizona, 85306, United States|Pfizer Investigational Site, Peoria, Arizona, 85381, United States|Pfizer Investigational Site, Phoenix, Arizona, 85004, United States|Pfizer Investigational Site, Phoenix, Arizona, 85006, United States|Pfizer Investigational Site, Phoenix, Arizona, 85016, United States|Pfizer Investigational Site, Tucson, Arizona, 85715, United States|Pfizer Investigational Site, Jonesboro, Arkansas, 72401, United States|Pfizer Investigational Site, Searcy, Arkansas, 72143, United States|Pfizer Investigational Site, Berkeley, California, 94705, United States|Pfizer Investigational Site, Fresno, California, 93720, United States|Pfizer Investigational Site, Greenbrae, California, 94904, United States|Pfizer Investigational Site, Huntington Beach, California, 92648, United States|Pfizer Investigational Site, Los Angeles, California, 90073, United States|Pfizer Investigational Site, Riverside, California, 92506, United States|Pfizer Investigational Site, Tustin, California, 92780, United States|Pfizer Investigational Site, Denver, Colorado, 80209, United States|Pfizer Investigational Site, Waterbury, Connecticut, 06708, United States|Pfizer Investigational Site, Chiefland, Florida, 32626, United States|Pfizer Investigational Site, Clearwater, Florida, 33756, United States|Pfizer Investigational Site, Clearwater, Florida, 33765, United States|Pfizer Investigational Site, DeLand, Florida, 32720, United States|Pfizer Investigational Site, Gainesville, Florida, 32608, United States|Pfizer Investigational Site, Lake City, Florida, 32025, United States|Pfizer Investigational Site, Melbourne, Florida, 32901, United States|Pfizer Investigational Site, Miami, Florida, 33144, United States|Pfizer Investigational Site, West Palm Beach, Florida, 33401, United States|Pfizer Investigational Site, Winter Park, Florida, 32789, United States|Pfizer Investigational Site, Decatur, Georgia, 30033, United States|Pfizer Investigational Site, Honolulu, Hawaii, 96813, United States|Pfizer Investigational Site, Honululu, Hawaii, 96814, United States|Pfizer Investigational Site, Chicago, Illinois, 60607, United States|Pfizer Investigational Site, Normal, Illinois, 61761, United States|Pfizer Investigational Site, Evansville, Indiana, 47713-1227, United States|Pfizer Investigational Site, Indianapolis, Indiana, 46250, United States|Pfizer Investigational Site, Des Moines, Iowa, 50314, United States|Pfizer Investigational Site, Wichita, Kansas, 67203, United States|Pfizer Investigational Site, Madisonville, Kentucky, 42431, United States|Pfizer Investigational Site, New Orleans, Louisiana, 70119, United States|Pfizer Investigational Site, Springfield, Massachusetts, 01103, United States|Pfizer Investigational Site, Springfield, Massachusetts, 01107, United States|Pfizer Investigational Site, Waltham, Massachusetts, 02453, United States|Pfizer Investigational Site, Kansas City, Missouri, 64106, United States|Pfizer Investigational Site, St. Louis, Missouri, 63141, United States|Pfizer Investigational Site, Butte, Montana, 59701, United States|Pfizer Investigational Site, Omaha, Nebraska, 68105, United States|Pfizer Investigational Site, Henderson, Nevada, 89015, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89103, United States|Pfizer Investigational Site, Las Vegas, Nevada, 89128, United States|Pfizer Investigational Site, Albany, New York, 12205, United States|Pfizer Investigational Site, Albany, New York, 12206, United States|Pfizer Investigational Site, Cincinnati, Ohio, 45231, United States|Pfizer Investigational Site, Cincinnati, Ohio, 45242, United States|Pfizer Investigational Site, Toledo, Ohio, 43608, United States|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73103, United States|Pfizer Investigational Site, Medford, Oregon, 97504, United States|Pfizer Investigational Site, Portland, Oregon, 97219, United States|Pfizer Investigational Site, Pittsburgh, Pennsylvania, 15243, United States|Pfizer Investigational Site, Spartanburg, South Carolina, 29303, United States|Pfizer Investigational Site, Spartanburg, South Carolina, 29307, United States|Pfizer Investigational Site, Memphis, Tennessee, 38119, United States|Pfizer Investigational Site, Nashville, Tennessee, 37203, United States|Pfizer Investigational Site, Beaumont, Texas, 77701, United States|Pfizer Investigational Site, Beaumont, Texas, 77706, United States|Pfizer Investigational Site, Dallas, Texas, 75231, United States|Pfizer Investigational Site, Houston, Texas, 77030, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, San Antonio, Texas, 78237, United States|Pfizer Investigational Site, Fredericksburg, Virginia, 22401, United States|Pfizer Investigational Site, Fredericksburg, Virginia, 22408, United States|Pfizer Investigational Site, Richmond, Virginia, 23225, United States|Pfizer Investigational Site, Richmond, Virginia, 23229, United States|Pfizer Investigational Site, Richmond, Virginia, 23235, United States|Pfizer Investigational Site, Richmond, Virginia, 23249, United States|Pfizer Investigational Site, Spokane, Washington, 99202, United States|Pfizer Investigational Site, Spokane, Washington, 99204, United States|Pfizer Investigational Site, Huntington, West Virginia, 25701, United States|Pfizer Investigational Site, Madison, Wisconsin, 53705, United States|Pfizer Investigational Site, Porto Alegre, RS, 90035-170, Brazil|Pfizer Investigational Site, Campinas, SP, 13083-900, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 01244-030, Brazil|Pfizer Investigational Site, São Paulo, SP, 04231-030, Brazil|Pfizer Investigational Site, Edmonton, Alberta, T5J 3N4, Canada|Pfizer Investigational Site, Red Deer, Alberta, T4N 6V7, Canada|Pfizer Investigational Site, Burlington, Ontario, L7M 4Y1, Canada|Pfizer Investigational Site, Laval, Quebec, H7T 2P5, Canada|Pfizer Investigational Site, Sherbrooke, Quebec, J1H 5N4, Canada|Pfizer Investigational Site, San Jose, Costa Rica|Pfizer Investigational Site, Neuss, 41460, Germany"
NCT01791465,Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults,https://clinicaltrials.gov/study/NCT01791465,TERMINATED,Human Immunodeficiency Virus Infection|Diabetes Mellitus,DRUG: extended-release exenatide,Vanderbilt University,National Institute of Allergy and Infectious Diseases (NIAID),ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Vanderbilt University, Nashville, Tennessee, 37240, United States"
NCT02407626,Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery,https://clinicaltrials.gov/study/NCT02407626,TERMINATED,Myocardial Ischemia,DRUG: Propofol|DRUG: Sevoflurane,Triemli Hospital,University of Alberta,MALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Triemli City Hospital, Zurich, 8063, Switzerland"
NCT00969956,Time To Complications Occurs in Diabetes,https://clinicaltrials.gov/study/NCT00969956,TERMINATED,Retinopathy|Nephropathy|Diabetic Neuropathy|Vascular Disease|Ischemic Heart Disease,,Karolinska Institutet,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Department of Molecular Medicine and Surgery, Rolf Luft Research centre for Diabetes and Endocrinology, Stockholm, 171 76, Sweden"
NCT00208221,Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes,https://clinicaltrials.gov/study/NCT00208221,TERMINATED,Hypertension|Type 2 Diabetes|Albuminuria,DRUG: ramipril|DRUG: ramipril-telmisartan,Institut de Recherches Cliniques de Montreal,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Institut de Recherches Cliniques de Montreal, Montreal, Quebec, J4X 1J3, Canada"
NCT01368536,Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes,https://clinicaltrials.gov/study/NCT01368536,TERMINATED,Hypertension|Stage 2 Hypertension|Diabetes,DRUG: Valturna|DRUG: Amlodipine|DRUG: Chlorthalidone|DRUG: Placebo of Valturna Tablet|DRUG: Placebo Capsule,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Novartis Investigative Site, Athens, Alabama, 35611, United States|Novartis Investigative Site, Florence, Alabama, 35630, United States|Novartis Investigative Site, Huntsville, Alabama, 35801, United States|Novartis Investigative Site, Montgomery, Alabama, 36106, United States|Novartis Investigative Site, Muscle Shoals, Alabama, 35662, United States|Novartis Investigative Site, Chandler, Arizona, 85224, United States|Novartis Investigative Site, Little Rock, Arkansas, 72204, United States|Novartis Investigative Site, Buena Park, California, 90620, United States|Novartis Investigative Site, Fair Oaks, California, 95628, United States|Novartis Investigative Site, Fresno, California, 93726, United States|Novartis Investigative Site, Healdsburg, California, 95448, United States|Novartis Investigative Site, Los Angeles, California, 90057, United States|Novartis Investigative Site, Orangevale, California, 95662, United States|Novartis Investigative Site, Riverside, California, 92506, United States|Novartis Investigative Site, Roseville, California, 95661, United States|Novartis Investigative Site, Sacramento, California, 95816, United States|Novartis Investigative Site, Santa Ana, California, 92701, United States|Novartis Investigative Site, West Covina, California, 91790, United States|Novartis Investigative Site, Shelton, Connecticut, 06484, United States|Novartis Investigative Site, Fort Lauderdale, Florida, 33306, United States|Novartis Investigative Site, Ft. Lauderdale, Florida, 33308, United States|Novartis Investigative Site, Jupiter, Florida, 33458, United States|Novartis Investigative Site, Lauderdale Lakes, Florida, 33319, United States|Novartis Investigative Site, North Miami Beach, Florida, 33169, United States|Novartis Investigative Site, St. Petersburg, Florida, 33701, United States|Novartis Investigative Site, Tampa, Florida, 33603, United States|Novartis Investigative Site, West Palm Beach, Florida, 33409, United States|Novartis Investigative Site, Augusta, Georgia, 30904, United States|Novartis Investigative Site, Honolulu, Hawaii, 96813, United States|Novartis Investigative Site, Chicago, Illinois, 60607, United States|Novartis Investigative Site, Chicago, Illinois, 60610, United States|Novartis Investigative Site, Chicago, Illinois, 60617, United States|Novartis Investigative Site, Gurnee, Illinois, 60031, United States|Novartis Investigative Site, Lansing, Kansas, 66043, United States|Novartis Investigative Site, Topeka, Kansas, 66606, United States|Novartis Investigative Site, Beltsville, Maine, 20705, United States|Novartis Investigative Site, Waltham, Massachusetts, 02453, United States|Novartis Investigative Site, Wellesley Hills, Massachusetts, 02481-2106, United States|Novartis Investigative Site, Brooklyn Center, Minnesota, 55430-2168, United States|Novartis Investigative Site, Belzoni, Mississippi, 39038, United States|Novartis Investigative Site, Jackson, Mississippi, 39209, United States|Novartis Investigative Site, Picayune, Mississippi, 39466, United States|Novartis Investigative Site, Kansas City, Missouri, 64111, United States|Novartis Investigative Site, Ozark, Missouri, 65721, United States|Novartis Investigative Site, St. Louis, Missouri, 63110-1093, United States|Novartis Investigative Site, St. Louis, Missouri, 63128, United States|Novartis Investigative Site, St. Louis, Missouri, 63141, United States|Novartis Investigative Site, Omaha, Nebraska, 68134, United States|Novartis Investigative Site, Henderson, Nevada, 89014, United States|Novartis Investigative Site, Las Vegas, Nevada, 89119, United States|Novartis Investigative Site, Toms River, New Jersey, 08753, United States|Novartis Investigative Site, Toms River, New Jersey, 08755, United States|Novartis Investigative Site, Trenton, New Jersey, 08629, United States|Novartis Investigative Site, Buffalo, New York, 14209, United States|Novartis Investigative Site, Camillus, New York, 13031, United States|Novartis Investigative Site, Asheboro, North Carolina, 27204, United States|Novartis Investigative Site, Asheville, North Carolina, 28801, United States|Novartis Investigative Site, Greensboro, North Carolina, 27401, United States|Novartis Investigative Site, Greensboro, North Carolina, 27408, United States|Novartis Investigative Site, Shelby, North Carolina, 28150, United States|Novartis Investigative Site, Winston-Salem, North Carolina, 27103, United States|Novartis Investigative Site, Fargo, North Dakota, 58103, United States|Novartis Investigative Site, Cincinnati, Ohio, 45219, United States|Novartis Investigative Site, Cincinnati, Ohio, 45224, United States|Novartis Investigative Site, Columbus, Ohio, 43201, United States|Novartis Investigative Site, Lyndhurst, Ohio, 44124, United States|Novartis Investigative Site, Zanesville, Ohio, 43701, United States|Novartis Investigative Site, Oklahoma City, Oklahoma, 73132-4904, United States|Novartis Investigative Site, Oklahoma City, Oklahoma, 73134, United States|Novartis Investigative Site, Portland, Oregon, 97232, United States|Novartis Investigative Site, Reading, Pennsylvania, 19609, United States|Novartis Investigative Site, Uniontown, Pennsylvania, 15401, United States|Novartis Investigative Site, Wallingford, Pennsylvania, 19086, United States|Novartis Investigative Site, Charleston, South Carolina, 29407, United States|Novartis Investigative Site, Charleston, South Carolina, 29412, United States|Novartis Investigative Site, Easley, South Carolina, 29640, United States|Novartis Investigative Site, Greenville, South Carolina, 29615, United States|Novartis Investigative Site, Mt. Pleasant, South Carolina, 29464, United States|Novartis Investigative Site, Summerville, South Carolina, 29485, United States|Novartis Investigative Site, Varnville, South Carolina, 29944, United States|Novartis Investigative Site, Fayetteville, Tennessee, 33734, United States|Novartis Investigative Site, Arlington, Texas, 76012, United States|Novartis Investigative Site, Austin, Texas, 78728-6904, United States|Novartis Investigative Site, Austin, Texas, 78735, United States|Novartis Investigative Site, Dallas, Texas, 75235, United States|Novartis Investigative Site, Houston, Texas, 77025, United States|Novartis Investigative Site, Houston, Texas, 77074, United States|Novartis Investigative Site, Houston, Texas, 77081, United States|Novartis Investigative Site, Houston, Texas, 77083, United States|Novartis Investigative Site, Lake Jackson, Texas, 77566, United States|Novartis Investigative Site, Pasadena, Texas, 77504, United States|Novartis Investigative Site, Plano, Texas, 75093, United States|Novartis Investigative Site, Richardson, Texas, 75080, United States|Novartis Investigative Site, St. George, Utah, 84790, United States|Novartis Investigative Site, Arlington, Virginia, 22203, United States|Novartis Investigative Site, Carolina, 00983, Puerto Rico|Novartis Investigative Site, San Juan, 00926, Puerto Rico"
NCT00700154,Insulin Infusion Diabetes Ulcer,https://clinicaltrials.gov/study/NCT00700154,TERMINATED,Diabetes Mellitus|Insulin Resistance|Hyperglycemia|Surgery|Ulcers|Infection,PROCEDURE: Insulin infusion,Karolinska Institutet,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Vascular Surgery, Karolinska University Hospital, Stockholm, SE-171 76, Sweden"
NCT02589314,Effect of Periodontal Therapy in the Systemic Status of Individuals With Chronic Periodontitis and Diabetes Type 2,https://clinicaltrials.gov/study/NCT02589314,TERMINATED,Chronic Periodontitis|Diabetes Type 2,DEVICE: Mechanical periodontal therapy|PROCEDURE: nonsurgical periodontal therapy,University of Brasilia,Catholic University of Brasília|Brasilia University Hospital,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Priscilla Farias Naiff, Brasilia, Distrito Federal, 70790-123, Brazil"
NCT00639626,Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD),https://clinicaltrials.gov/study/NCT00639626,TERMINATED,Cystic Fibrosis Related Diabetes,DRUG: insulin detemir [rDNA origin] injection,Nationwide Children's Hospital,Novo Nordisk A/S,ALL,"CHILD, ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Nationwide Children's Hospital, Columbus, Ohio, 43205, United States"
NCT02700048,Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia,https://clinicaltrials.gov/study/NCT02700048,TERMINATED,Hypoglycemia Unawareness|Type 1 Diabetes,DRUG: intra-nasal naloxone|DRUG: Intra-nasal saline,University of Minnesota,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota, 55446, United States"
NCT04530617,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,https://clinicaltrials.gov/study/NCT04530617,TERMINATED,Covid19|Diabetes|Hypertension|Obesity,DRUG: Camostat Mesilate|DRUG: Artemisia Annua Leaf,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, None - Non-US/Canada, 14020, Mexico"
NCT01260246,Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01260246,TERMINATED,Type 2 Diabetes|Nonalcoholic Steatohepatitis,DRUG: sitagliptin|DRUG: placebo,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,The Physicians' Services Incorporated Foundation,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"St. Joseph's Health Care, London, Ontario, N6A 4L6, Canada"
NCT03067480,Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients,https://clinicaltrials.gov/study/NCT03067480,TERMINATED,T2DM (Type 2 Diabetes Mellitus)|Continuous Glucose Monitoring,DEVICE: iPro2 Professional CGM,East Tennessee State University,Medtronic,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"East Tennessee State University, Johnson City, Tennessee, 37614, United States"
NCT01715012,Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts,https://clinicaltrials.gov/study/NCT01715012,TERMINATED,Third Degree Burns|Diabetes,BIOLOGICAL: ST266|DRUG: Saline,"Noveome Biotherapeutics, formerly Stemnion",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"The Burn Unit of the Wexner Medical Center at The Ohio State University., Columbus, Ohio, 43210, United States"
NCT00913393,Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy,https://clinicaltrials.gov/study/NCT00913393,TERMINATED,Type 2 Diabetes Mellitus|Diabetic Nephropathy|Diabetic Kidney Disease,DRUG: FG-3019|DRUG: FG-3019|DRUG: Placebo,FibroGen,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Tempe, Arizona, United States|Buena Park, California, United States|Lakewood, California, United States|Sacramento, California, United States|Walnut Creek, California, United States|Whittier, California, United States|Atlanta, Georgia, United States|Evergreen Park, Illinois, United States|Topeka, Kansas, United States|Wichita, Kansas, United States|Kenner, Louisiana, United States|Springfield, Massachusetts, United States|Saint Clair Shores, Michigan, United States|Lincoln, Nebraska, United States|Omaha, Nebraska, United States|Berlin, New Jersey, United States|Buffalo, New York, United States|Flushing, New York, United States|New York, New York, United States|Greenville, North Carolina, United States|Toledo, Ohio, United States|Chattanooga, Tennessee, United States|Knoxville, Tennessee, United States|Dallas, Texas, United States|Houston, Texas, United States|San Antonio, Texas, United States|Fairfax, Virginia, United States|Spokane, Washington, United States"
NCT04123067,Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke,https://clinicaltrials.gov/study/NCT04123067,TERMINATED,"Stroke, Acute|Hyperglycemia|Diabetes",DRUG: Pioglitazone 45 mg|DRUG: Placebo oral tablet,Milton S. Hershey Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Penn State College of Medicine, Hershey, Pennsylvania, 17033, United States"
NCT01609582,Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease,https://clinicaltrials.gov/study/NCT01609582,TERMINATED,Type 2 Diabetes|Cardiovascular Disease,DRUG: TAK-875|DRUG: TAK-875 Placebo,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Birmingham, Alabama, United States|Dothan, Alabama, United States|Mobile, Alabama, United States|Muscle Shoals, Alabama, United States|Pell City, Alabama, United States|Goodyear, Arizona, United States|Phoenix, Arizona, United States|Tempe, Arizona, United States|Tucson, Arizona, United States|Little Rock, Arkansas, United States|Anaheim, California, United States|El Cajon, California, United States|Fresno, California, United States|Fullerton, California, United States|La Mesa, California, United States|Laguna Hills, California, United States|Los Angeles, California, United States|Mission Hills, California, United States|National City, California, United States|Newport Beach, California, United States|Orange, California, United States|Paramount, California, United States|Pismo Beach, California, United States|Redondo Beach, California, United States|San Diego, California, United States|San Francisco, California, United States|San Franciso, California, United States|Stockton, California, United States|Thousand Oaks, California, United States|Torrance, California, United States|Valley Village, California, United States|Westlake Village, California, United States|Denver, Colorado, United States|Lakewood, Colorado, United States|Bridgeport, Connecticut, United States|Danbury, Connecticut, United States|Seaford, Delaware, United States|Washington, District of Columbia, United States|Boynton Beach, Florida, United States|Brandon, Florida, United States|Chipley, Florida, United States|Clearwater, Florida, United States|Cocoa, Florida, United States|Coral Gables, Florida, United States|Coral Springs, Florida, United States|Crystal River, Florida, United States|Delray Beach, Florida, United States|Hialeah, Florida, United States|Hollywood, Florida, United States|Inverness, Florida, United States|Jacksonville Beach, Florida, United States|Jacksonville, Florida, United States|Melbourne, Florida, United States|Miami, Florida, United States|North Miami Beach, Florida, United States|Ocala, Florida, United States|Oviedo, Florida, United States|Pembroke Pines, Florida, United States|Sarasota, Florida, United States|St. Petersburg, Florida, United States|Tampa, Florida, United States|Trinity, Florida, United States|Vero Bearch, Florida, United States|Atlanta, Georgia, United States|Augusta, Georgia, United States|Calhoun, Georgia, United States|Conyers, Georgia, United States|Cumming, Georgia, United States|Norcross, Georgia, United States|Roswell, Georgia, United States|Suwanee, Georgia, United States|Woodstock, Georgia, United States|Chicago, Illinois, United States|LaGrange, Illinois, United States|Springfield, Illinois, United States|Anderson, Indiana, United States|Avon, Indiana, United States|Elkhart, Indiana, United States|Greenfield, Indiana, United States|Indianapolis, Indiana, United States|Muncie, Indiana, United States|Ames, Iowa, United States|Council Bluffs, Iowa, United States|Waterloo, Iowa, United States|Augusta, Kansas, United States|Hutchinson, Kansas, United States|Newton, Kansas, United States|Topeka, Kansas, United States|Wichita, Kansas, United States|Elizabethtown, Kentucky, United States|Marrero, Louisiana, United States|Monroe, Louisiana, United States|Natchitoches, Louisiana, United States|New Orleans, Louisiana, United States|Sherveport, Louisiana, United States|Portland, Maine, United States|Annapolis, Maryland, United States|Balitmore, Maryland, United States|Baltimore, Maryland, United States|Fall River, Massachusetts, United States|Hyannis, Massachusetts, United States|Natick, Massachusetts, United States|Springfield, Massachusetts, United States|Bay City, Michigan, United States|Cadillac, Michigan, United States|Flint, Michigan, United States|Kalamazoo, Michigan, United States|Mt. Clemens, Michigan, United States|Novi, Michigan, United States|Pontiac, Michigan, United States|Saginaw, Michigan, United States|Troy, Michigan, United States|Baxter, Minnesota, United States|St. Cloud, Minnesota, United States|St. Paul, Minnesota, United States|Columbia, Missouri, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Omaha, Nebraska, United States|Las Vegas, Nevada, United States|Nashua, New Hampshire, United States|Bridgewater, New Jersey, United States|Elizabeth, New Jersey, United States|Haddon Heights, New Jersey, United States|Linden, New Jersey, United States|Mine Hill, New Jersey, United States|Somerset, New Jersey, United States|South Plainfield, New Jersey, United States|Toms Rivers, New Jersey, United States|Albuquerque, New Mexico, United States|Brooklyn, New York, United States|Buffalo, New York, United States|Mineola, New York, United States|New York, New York, United States|Saratoga Springs, New York, United States|Smithtown, New York, United States|Syracuse, New York, United States|Burlington, North Carolina, United States|Calabash, North Carolina, United States|Charlotte, North Carolina, United States|Durham, North Carolina, United States|Greensboro, North Carolina, United States|Hickory, North Carolina, United States|Lenoir, North Carolina, United States|Mooresville, North Carolina, United States|Morganton, North Carolina, United States|Raleigh, North Carolina, United States|Rocky Mount, North Carolina, United States|Winston-Salem, North Carolina, United States|Akron, Ohio, United States|Canton, Ohio, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Fairview Park, Ohio, United States|Gallipolis, Ohio, United States|Kettering, Ohio, United States|Marion, Ohio, United States|Middleburg Heights, Ohio, United States|Perrysburg, Ohio, United States|Springfield, Ohio, United States|Toledo, Ohio, United States|Willoughby Hills, Ohio, United States|Norman, Oklahoma, United States|Oklahoma City, Oklahoma, United States|Tulsa, Oklahoma, United States|Portland, Oregon, United States|Chambersburg, Pennsylvania, United States|Hanleysville, Pennsylvania, United States|Harleysville, Pennsylvania, United States|Levittown, Pennsylvania, United States|Norristown, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Philadelphi, Pennsylvania, United States|Scotland, Pennsylvania, United States|Uniontown, Pennsylvania, United States|East Providence, Rhode Island, United States|Pawtucket, Rhode Island, United States|Columbia, South Carolina, United States|Greer, South Carolina, United States|Laurens, South Carolina, United States|Simpsonville, South Carolina, United States|Bristol, Tennessee, United States|Crossville, Tennessee, United States|Jackson, Tennessee, United States|Kingsport, Tennessee, United States|Nashville, Tennessee, United States|Oak Ridge, Tennessee, United States|Tullahoma, Tennessee, United States|Austin, Texas, United States|Carrollton, Texas, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|Irving, Texas, United States|Katy, Texas, United States|Midland, Texas, United States|Odessa, Texas, United States|Pearland, Texas, United States|San Antonio, Texas, United States|Spring, Texas, United States|Tomball, Texas, United States|Victoria, Texas, United States|Bountiful, Utah, United States|Layton, Utah, United States|Salt Lake City, Utah, United States|Alexandria, Virginia, United States|Danville, Virginia, United States|Falls Church, Virginia, United States|Hampton, Virginia, United States|Manassas, Virginia, United States|Wenatchee, Washington, United States|Huntington, West Virginia, United States|Lewisburg, West Virginia, United States|La Crosse, Wisconsin, United States|Madison, Wisconsin, United States|Milwaukee, Wisconsin, United States|Wauwatosa, Wisconsin, United States|Bahia Blanca, Buenos Aires, Argentina|Haedo, Buenos Aires, Argentina|La Plata, Buenos Aires, Argentina|Loma Hermosa, Buenos Aires, Argentina|Mar del Plata, Buenos Aires, Argentina|Quilmes, Buenos Aires, Argentina|San Nicolas, Buenos Aires, Argentina|Zarate, Buenos Aires, Argentina|Trelew, Chubut, Argentina|Ciudad Autonoma de Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina|Córdoba, Cordoba, Argentina|Villa Cabrera, Cordoba, Argentina|Villa Maria, Cordoba, Argentina|San Salvador de Jujuy, Jujy, Argentina|Godoy Cruz, Mendoza, Argentina|Cipolletti, Rio Negro, Argentina|Rosario, Santa Fe, Argentina|Venado Tuerto, Santa Fe, Argentina|San Miguel de Tucuman, Tucuman, Argentina|Ciudad Autonoma Buenos Aires, Argentina|Cordoba, Argentina|Corrientes, Argentina|Mendoza, Argentina|Rosario, Argentina|Salta, Argentina|Santa Fe, Argentina|Santiago del estero, Argentina|Bruce, Australian Capital Territory, Australia|Canberra, Australian Capital Territory, Australia|Garran, Australian Capital Territory, Australia|Westmead, New South Wales, Australia|Wollongong, New South Wales, Australia|Brisbane, Queensland, Australia|Meadowbrook, Queensland, Australia|Milton, Queensland, Australia|Townsville, Queensland, Australia|Woolloongabba, Queensland, Australia|Adelaide, South Australia, Australia|Daw Park, South Australia, Australia|Elizabeth Vale, South Australia, Australia|Clayton, Victoria, Australia|Fitzroy, Victoria, Australia|Geelong, Victoria, Australia|Melbourne, Victoria, Australia|Sale, Victoria, Australia|Joondalup, Western Australia, Australia|Bruce, Australia|Garran, Australia|Fortaleza, Ceará, Brazil|Brasilia, Distrito Federal, Brazil|Goiania, Goiás, Brazil|Campina Grande do Sul, Paraná, Brazil|Curitiba, Paraná, Brazil|Belem, Pará, Brazil|Recife, Pernambuco, Brazil|Canoas, Rio Grande do Sul, Brazil|Caxias do Sul, Rio Grande do Sul, Brazil|Passo Fundo, Rio Grande do Sul, Brazil|Porto Alegre, Rio Grande do Sul, Brazil|Santa Maria, Rio Grande do Sul, Brazil|Marilia, Sao Paulo, Brazil|São Paulo, Sao Paulo, Brazil|Sao Paulo, Brazil|Blagoevgrad, Bulgaria|Byala, Bulgaria|Kazanlak, Bulgaria|Pazardzhik, Bulgaria|Plovdiv, Bulgaria|Sevlievo, Bulgaria|Sofia, Bulgaria|Stara Zagora, Bulgaria|Varna, Bulgaria|Calgary, Alberta, Canada|Spruce Grove, Alberta, Canada|Victoria, British Columbia, Canada|Winnipeg, Manitoba, Canada|Brampton, Ontario, Canada|Etobicoke, Ontario, Canada|Hamilton, Ontario, Canada|Markham, Ontario, Canada|Oakville, Ontario, Canada|Ottawa, Ontario, Canada|Sudbury, Ontario, Canada|Thornhill, Ontario, Canada|Toronto, Ontario, Canada|Gatineau, Quebec, Canada|Laval, Quebec, Canada|Longueuil, Quebec, Canada|Montreal, Quebec, Canada|Pointe Claire, Quebec, Canada|St-Jérôme, Quebec, Canada|Ville Saint-Laurent, Quebec, Canada|Quebec, Canada|Cakovec, Croatia|Karlovac, Croatia|Koprivnica, Croatia|Krapinske Toplice, Croatia|Osijek, Croatia|Rijeka, Croatia|Sisak, Croatia|Slavonski Brod, Croatia|Split, Croatia|Virovitica, Croatia|Zadar, Croatia|Zagreb, Croatia|Ceske Budejovice, Czech Republic|Chocen, Czech Republic|Jindrichuv Hradec, Czech Republic|Kromeriz, Czech Republic|Marianske Lazne, Czech Republic|Moravsky Krumlov, Czech Republic|Olomouc, Czech Republic|Ostrava - Moravska Ostrava, Czech Republic|Ostrava - Vitkovice, Czech Republic|Ostrava, Czech Republic|Prague 10, Czech Republic|Praha 4 - Krc, Czech Republic|Praha 5, Czech Republic|Slany, Czech Republic|Trutnov, Czech Republic|Usti nad Labem, Czech Republic|Paide, Estonia|Tallinn, Estonia|Tartu, Estonia|Corbeil Essonnes, Essonne, France|Corbeil Essonne, Essonne, France|Pessac, Gironde, France|Nanterre cedex, Hauts de Seine, France|Nantes cedex 01, Loire Atlantique, France|Pierre-Bénite cedex, Rhone, France|Paris, France|Friedrichsthal, Baden Wuerttemberg, Germany|Falkensee, Brandenburg, Germany|Kelkheim, Hessen, Germany|Dortmund, Nordrhein Westfalen, Germany|Essen, Nordrhein Westfalen, Germany|Goch, Nordrhein Westfalen, Germany|Kamp-Lintfort, Nordrhein Westfalen, Germany|Koeln, Nordrhein Westfalen, Germany|Bad Kreuznach, Rheinland Pfalz, Germany|Hohenmoelsen, Sachsen Anhalt, Germany|Dippoldiswalde, Sachsen, Germany|Dresden, Sachsen, Germany|Berlin, Germany|Hamburg, Germany|Hong Kong, Hong Kong|New Territories, Hong Kong|Baja, Hungary|Balatonfured, Hungary|Budaors, Hungary|Budapest, Hungary|Debrecen, Hungary|Eger, Hungary|Godollo, Hungary|Gyula, Hungary|Kecskemet, Hungary|Kistelek, Hungary|Komarom, Hungary|Mako, Hungary|Pecs, Hungary|Szeged, Hungary|Szekszard, Hungary|Szikszo, Hungary|Szombathely, Hungary|Urhida, Hungary|Veszprem, Hungary|Zalaegerszeg, Hungary|Ashkelon, Israel|Beer Sheva, Israel|Beer Yaakov, Israel|Beer-Sheva, Israel|Givataim, Israel|Hadera, Israel|Haifa, Israel|Holon, Israel|Jerusalem, Israel|Kfar-Saba, Israel|Petach Tikva, Israel|Petach Tikwa, Israel|Raanana, Israel|Tel Aviv, Israel|Zefat, Israel|San Donato Milanese, Milano, Italy|Sesto San Giovanni, Milano, Italy|Firenze, Italy|Milano, Italy|Pavia, Italy|Wonju-Si, Gangwon-do, Korea, Republic of|Seongnam-si, Gyeonggi-do, Korea, Republic of|Yangsan-si, Gyeongsangnam-do, Korea, Republic of|Jeonju-si, Jeollabuk-do, Korea, Republic of|Busan, Korea, Republic of|Gyeonggi, Korea, Republic of|Seoul, Korea, Republic of|Daugavpils, Latvia|Jelgava, Latvia|Limbazi, Latvia|Ogre, Latvia|Riga, Latvia|Talsi, Latvia|Valmiera, Latvia|Alytus, Lithuania|Kaunas, Lithuania|Klaipeda, Lithuania|Johor Bahru, Johor, Malaysia|Alor Setar, Kedah, Malaysia|Kota Bahru, Kelantan, Malaysia|Kota Bharu, Kelantan, Malaysia|Lembah Pantai, Kuala Lumpur, Malaysia|Ipoh, Perak, Malaysia|Taiping, Perak, Perak, Malaysia|Taiping, Perak, Malaysia|Petaling Jaya, Selangor, Malaysia|Kelantan, Malaysia|Kuala Lumpur, Malaysia|Melaka, Malaysia|Selangor, Malaysia|Terengganu, Malaysia|Tijuana, Baja California Norte, Mexico|Torreon, Coahuila, Mexico|Cuauhtemoc, Distrito Federal, Mexico|Mexico, Distrito Federal, Mexico|Cuautitlan Izcalli, Estado de Mexico, Mexico|Metepec, Estado de Mexico, Mexico|Acapulco de Juárez, Guerrero, Mexico|Pachuca, Hidalgo, Mexico|Guadalajara, Jalisco, Mexico|Zapopan, Jalisco, Mexico|Morelia, Michoacán, Mexico|Cuernavaca, Morelos, Mexico|Monterrey, Nuevo Le=n, Mexico|Monterrey, Nuevo Leon, Mexico|Monterrey, Nuevo León, Mexico|San Luis Potosi, San Luis Potos, Mexico|Culiacan, Sinaloa, Mexico|Xalapa, Veracruz, Mexico|Merida, Yucatán, Mexico|Aguascalientes, Mexico|Chihuahua, Mexico|Durango, Mexico|Tamaulipas, Mexico|Auckland, New Zealand|Christchurch, New Zealand|Dunedin, New Zealand|Palmerston North, New Zealand|Tauranga, New Zealand|Wellington, New Zealand|Callao, Peru|Cusco, Peru|Huacho, Peru|Ica, Peru|La Libertad, Peru|Lima, Peru|Piura, Peru|Baguio City, Philippines|Cebu City, Philippines|Dasmariñas City, Cavite, Philippines|Davao City, Philippines|Iloilo City, Philippines|Marikina City, Philippines|Quezon City, Philippines|Tarlac, Philippines|Taytay, Philippines|Bialystok, Poland|Gdansk, Poland|Gliwice, Poland|Grodzisk Mazowiecki, Poland|Kamieniec Zabkowicki, Poland|Leczyca, Poland|Lodz, Poland|Lublin, Poland|Oswiecim, Poland|Parczew, Poland|Poznan, Poland|Pulawy, Poland|Radom, Poland|Ruda Slaska, Poland|Rzeszow, Poland|Warszawa, Poland|Wroclaw, Poland|Bacau, Romania|Baia Mare, Romania|Brasov, Romania|Bucuresti, Romania|Galati, Romania|Iasi, Romania|Oradea, Romania|Ploiesti, Romania|Targu Mures, Romania|Timisoara, Romania|Arkhangelsk, Russian Federation|Barnaul, Russian Federation|Kazan, Russian Federation|Kemerovo, Russian Federation|Moscow, Russian Federation|Nizhniy Novgorod, Russian Federation|Novosibirsk, Russian Federation|Pushkin, Russian Federation|Saratov, Russian Federation|St. Petersburg, Russian Federation|Yaroslavl, Russian Federation|Bratislava, Slovakia|Komarno, Slovakia|Kosice, Slovakia|Levice, Slovakia|Lucenec, Slovakia|Martin, Slovakia|Nitra, Slovakia|Nove Mesto nad Vahom, Slovakia|Presov, Slovakia|Sahy, Slovakia|Svidnik, Slovakia|Trencin, Slovakia|Zilina, Slovakia|Port Elizabeth, Eastern Cape, South Africa|Bloemfontein, Free State, South Africa|Johannesburg, Gauteng, South Africa|Kempton Park, Gauteng, South Africa|Krugersdorp, Gauteng, South Africa|Lenasia, Gauteng, South Africa|Pretoria, Gauteng, South Africa|Durban, KwaZulu-Natal, South Africa|Cape Town, Western Cape, South Africa|Stellenbosch, Western Cape, South Africa|Worcester, Western Cape, South Africa|Douliou City, Taiwan|Kaohsiung, Taiwan|New Taipei City, Taiwan|Taichung, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Bangkoknoi, Bangkok, Thailand|Dusit, Bangkok, Thailand|Patumwan, Bangkok, Thailand|Rachathevi, Bangkok, Thailand|Rajtevi, Bangkok, Thailand|Ratchathewi, Bangkok, Thailand|Muang, Chiang Mai, Thailand|Muang, Chiang Rai, Thailand|Muang, Khon Kaen, Thailand|Muang, Nakhon Ratchasima, Thailand|Donetsk, Ukraine|Kharkiv, Ukraine|Kyiv, Ukraine|Lugansk, Ukraine|Mykolayiv, Ukraine|Odesa, Ukraine|Poltava, Ukraine|Simferopol, Ukraine|Ternopil, Ukraine|Vinnycia, Ukraine|Vinnytsia, Ukraine|Zaporizhzhia, Ukraine|Truro, Cornwall, United Kingdom|Exeter, Devon, United Kingdom|Plymouth, Devon, United Kingdom|Torquay, Devon, United Kingdom|Hull, East Riding of Yorkshire, United Kingdom|Bexhill on Sea, East Sussex, United Kingdom|Portsmouth, Hampshire, United Kingdom|Watford, Hertfordshire, United Kingdom|Gillingham, Kent, United Kingdom|Thornton-Cleveleys, Lancashire, United Kingdom|Leicester, Leicestershire, United Kingdom|Liverpool, Merseyside, United Kingdom|Harrow, Middlesex, United Kingdom|Northwood, Middlesex, United Kingdom|Stoke on Trent, Staffordshire, United Kingdom|Swansea, West Glamorgan, United Kingdom|Cardiff, United Kingdom"
NCT01158417,Resveratrol in Type2 Diabetes and Obesity,https://clinicaltrials.gov/study/NCT01158417,TERMINATED,Type 2 Diabetes|Obesity|Insulin Resistance,DRUG: Placebo|DRUG: Resveratrol 40 mg oral three times a day|DRUG: Resveratrol 500 mg oral once daily.,University at Buffalo,Kaleida Health,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Jeanne Hejna, Williamsville, New York, 14221, United States"
NCT00157508,Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy,https://clinicaltrials.gov/study/NCT00157508,TERMINATED,Type 2 Diabetes|Early Nephropathy,DRUG: nitroaspirin,Mario Negri Institute for Pharmacological Research,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Clinical Research Center for Rare Diseases, Ranica, Bergamo, 24020, Italy"
NCT03654586,Effects of Sugary Drink Warning Labels,https://clinicaltrials.gov/study/NCT03654586,TERMINATED,Obesity|Diabetes|Weight Gain,BEHAVIORAL: Sugary drink warning labels,University of Pennsylvania,Drexel University|New York University|University of Connecticut,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Blockley Hall, Philadelphia, Pennsylvania, 19103, United States"
NCT03278236,Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?,https://clinicaltrials.gov/study/NCT03278236,TERMINATED,Type2 Diabetes|Insulin Resistance,BEHAVIORAL: TRF,University of Adelaide,Salk Institute for Biological Studies,MALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Adelaide Medical School, Adelaide, South Australia, 5005, Australia"
NCT01901055,Diabetes-Obstructive Sleep Apnea Treatment Trial,https://clinicaltrials.gov/study/NCT01901055,TERMINATED,Type 2 Diabetes|Obstructive Sleep Apnea,DEVICE: CPAP|DEVICE: Sham-CPAP|BEHAVIORAL: Diabetes Education,Eileen R. Chasens,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"John D. Dingell VAMC, Detroit, Michigan, 48201, United States|Pittsburgh Veterans Administration Medical Center, Pittsburgh, Pennsylvania, 15240, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15261, United States|West Virginia University, Morgantown, West Virginia, 26506, United States"
NCT00907608,A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT00907608,TERMINATED,Diabetes Mellitus|Chronic Kidney Disease|Anemia,DRUG: Darbepoetin alfa,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Prince of Wales Hospital, Hong Kong, China"
NCT05048264,Effect of Corticosteroid Injections on Blood Glucose,https://clinicaltrials.gov/study/NCT05048264,TERMINATED,Diabetes Mellitus|Steroid Diabetes|Shoulder Osteoarthritis|Knee Osteoarthritis|Adhesive Capsulitis|Hip Osteoarthritis,,Duke University,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Duke Sports Science Institute, Durham, North Carolina, 27705, United States"
NCT02650050,Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).,https://clinicaltrials.gov/study/NCT02650050,TERMINATED,Macular Edema|Mellitus Diabetes,RADIATION: Micropulsed laser photocoagulation,Fondation Ophtalmologique Adolphe de Rothschild,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Fondation ophtalmique Adolphe de Rothschild, Paris, 75019, France"
NCT02443753,EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects,https://clinicaltrials.gov/study/NCT02443753,TERMINATED,Obesity|Type 2 Diabetes,DEVICE: EndoBarrier SANS,Morphic Medical Inc.,University of Malaya,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Universiti Malaya Medical Centre, Jalan universiti, Kuala Lumpur, 50603, Malaysia"
NCT02145988,DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease,https://clinicaltrials.gov/study/NCT02145988,TERMINATED,Diabetes|Peripheral Arterial Disease,DRUG: DLBS1033|DRUG: Placebo,Dexa Medica Group,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Department of Internal Medicine, Faculty of Medicine, University of Udayana/Sanglah Hospital, Denpasar, Bali, Indonesia|Department of Internal Medicine, RSUD Wangaya, Denpasar, Bali, Indonesia"
NCT00409461,Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts,https://clinicaltrials.gov/study/NCT00409461,TERMINATED,Islet Transplantation|Type 1 Diabetes,DRUG: ATG-Sirolimus-Tacrolimus,AZ-VUB,"Fund for Scientific Research, Flanders, Belgium|Belgian Government",,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Academisch Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB, Brussels, 1090, Belgium|Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL, Leuven, 3000, Belgium"
NCT01974778,A Role for Brown Adipose Tissue in Postprandial Thermogenesis?,https://clinicaltrials.gov/study/NCT01974778,TERMINATED,Obesity|Diabetes|Cardiovascular Disease,DIETARY_SUPPLEMENT: Meal,Bayside Health,,MALE,ADULT,,INTERVENTIONAL,"Alfred Hospital, Melbourne, Victoria, 3004, Australia"
NCT05647798,Intrapartum Glycemic Control in GDMA2,https://clinicaltrials.gov/study/NCT05647798,TERMINATED,"Pregnancy|Gestational Diabetes Mellitus, Class A2|Neonatal Hypoglycemia",OTHER: Blood sugar check every 2 hours|OTHER: Blood sugar check every 4 hours,Inova Health Care Services,,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Inova Fairfax Medical campus, Falls Church, Virginia, 22042, United States|Inova Health Care Services, Falls Church, Virginia, 22042, United States"
NCT04275479,Diabetes/ Endocrine Surveillance in SDS,https://clinicaltrials.gov/study/NCT04275479,TERMINATED,Shwachman-Diamond Syndrome,DIAGNOSTIC_TEST: Oral Glucose Tolerance Test|OTHER: Modified Oral Glucose Tolerance Test|OTHER: Modified Mixed Meal Tolerance Test|DEVICE: Continuous Glucose Monitor|OTHER: Food Diary|OTHER: Medical History Questionnaires,Washington University School of Medicine,Shwachman Diamond Syndrome Foundation|Barnes-Jewish Hospital,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"Washington University, Saint Louis, Missouri, 63110, United States"
NCT01349114,Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects,https://clinicaltrials.gov/study/NCT01349114,TERMINATED,Diabetes|Pre-hypertension|Hypertension,DRUG: aliskiren 300 mg once daily|DRUG: Placebo/sugar pill,University of Alabama at Birmingham,Novartis,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"UAB, Birmingham, Alabama, 35294, United States"
NCT04101045,Pathogenesis of the Cardiometabolic Risk in Youth With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT04101045,TERMINATED,Type 1 Diabetes|De Novo Lipogenesis,DIAGNOSTIC_TEST: Oral Glucose Tolerance Test,Yale University,Juvenile Diabetes Research Foundation,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Yale University School of Medicine, New Haven, Connecticut, 06511, United States"
NCT06268821,Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland,https://clinicaltrials.gov/study/NCT06268821,TERMINATED,Type 2 Diabetes Treated With Insulin,DEVICE: FreeStyle Libre 2 Flash Glucose Monitoring System,Abbott Diabetes Care,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Pihlajalinna Jämsä, Välikatu 1,, Jämsä, 42100, Finland|Pihlajalinna Koskiklinikka, Hatanpäänvaltatie 1,, Tampere, 33100, Finland"
NCT03526536,Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD,https://clinicaltrials.gov/study/NCT03526536,TERMINATED,End-Stage Renal Disease|Diabetes Mellitus,DRUG: IV Novolin R human insulin,State University of New York - Downstate Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"SUNY Downstate Medical Center, Brooklyn, New York, 11203, United States"
NCT00456105,The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes,https://clinicaltrials.gov/study/NCT00456105,TERMINATED,Type 2 Diabetes|Peripheral Vascular Disease,BEHAVIORAL: Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician|BEHAVIORAL: Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team|BEHAVIORAL: Subjects without diabetes will have their blood glucose levels monitored while in the hospital,University of British Columbia,Novo Nordisk A/S,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of British Columbia Gerontology & Diabetes Research Centre, Vancouver, British Columbia, Canada"
NCT01887691,Sleep Effectiveness and Insulin and Glucose Homeostasis,https://clinicaltrials.gov/study/NCT01887691,TERMINATED,Diabetes|Prediabetic|Prediabetes|Glucose Intolerance,DRUG: eszopiclone,Beth Israel Deaconess Medical Center,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States"
NCT01842282,Amlexanox for Type 2 Diabetes and Obesity,https://clinicaltrials.gov/study/NCT01842282,TERMINATED,Diabetes Mellitus Type 2|Non Alcoholic Fatty Liver Disease|Obesity,DRUG: Amlexanox,University of Michigan,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Michigan, Ann Arbor, Michigan, 48109, United States"
NCT04822740,Evaluation of Continuous Glucose Monitoring in Patients With ACS and Type 2 Diabetes in ICU,https://clinicaltrials.gov/study/NCT04822740,TERMINATED,Acute Coronary Syndrome|Type 2 Diabetes,DEVICE: Control Glucose Monitoring System,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Lariboisière Hospital, Paris, Ile De France, 75475, France"
NCT05063734,A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.,https://clinicaltrials.gov/study/NCT05063734,TERMINATED,Diabetes Mellitus|Diabetic Retinopathy|Diabetic Macular Edema,DRUG: THR-687 dose level 1|DRUG: THR-687 dose level 2|DRUG: THR-687 selected dose level|DRUG: Aflibercept,Oxurion,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Salehi Retina Institute Inc., Huntington Beach, California, 92647, United States|California Eye Specialists Medical Group, Inc., Pasadena, California, 91107, United States|Retinal Consultants Medical Group, Sacramento, California, 95825, United States|Retina Consultants of Southern Colorado, P.C., Colorado Springs, Colorado, 80909, United States|Retina Associates, Ltd, Elmhurst, Illinois, 60126, United States|University Retina and macula Associates, PC, Oak Forest, Illinois, 60452, United States|Cumberland Valley Retina Consultants, Hagerstown, Maryland, 21740, United States|Sierra Eye Associates, Reno, Nevada, 89502, United States|Retina Vitreous Surgeons of Central New York, PC, Liverpool, New York, 13088, United States|Tulsa Retina Consultants, Tulsa, Oklahoma, 74114, United States|Eye Care Specialists, Kingston, Pennsylvania, 18704, United States|Tennessee Retina, PC, Nashville, Tennessee, 37203, United States|Austin Research Center of Retina, Austin, Texas, 78705, United States|Retina Consultants of Texas, Katy, Texas, 77494, United States|Valley Retina Institute, P.A., McAllen, Texas, 78503, United States|Medical Center Ophthalmology Associates, San Antonio, Texas, 78240, United States|Retina Center of Texas, Southlake, Texas, 76092, United States|Strategic Clinical Research Group, Willow Park, Texas, 76087, United States|Eye Clinic Dr Krista Turman, Tallinn, 11314, Estonia|Silmalaser OU, Tallinn, 11412, Estonia|Ganglion Medical Center, Pécs, 7621, Hungary|Szegedi Tudományegyetem, Szeged, 6720, Hungary|Pauls Stradins Clinical University Hospital, Riga, LV-1002, Latvia|Riga East Clinical University Hospital, Riga, LV-1006, Latvia|Vilnius University Hospital Santaros klinikos, Vilnius, LT-08661, Lithuania"
NCT00108485,Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT00108485,TERMINATED,"Diabetes Mellitus, Type 2|Kidney Failure, Chronic|Hyperlipidemia",DRUG: Extended release niacin|OTHER: Placebo,University of Miami,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Univesity of Miami/Diabetes Research Institute, Miami, Florida, 33136, United States"
NCT05071820,Microlearning Application for Diabetes Prevention,https://clinicaltrials.gov/study/NCT05071820,TERMINATED,PreDiabetes|Elevated Blood Sugar,OTHER: Health U mobile application|OTHER: National Diabetes Prevention Program,Stanford University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Stanford Health Care, Palo Alto, California, 94304, United States"
NCT03980236,Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study],https://clinicaltrials.gov/study/NCT03980236,TERMINATED,Type 2 Diabetes Treated With Insulin,DEVICE: Livongo-Insulia Study App,Livongo Health,Voluntis|Evidation Health,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Livongo, Mountain View, California, 94041, United States"
NCT00318214,"Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers",https://clinicaltrials.gov/study/NCT00318214,TERMINATED,"Foot Ulcer, Diabetic|Diabetes Complications",DRUG: MRE0094|DRUG: Vehicle gel,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Associated Foot & Ankle Specialists, LLC, Phoenix, Arizona, 85015, United States|Southern Arizona VA Health Care System, Tucson, Arizona, 85723, United States|Roy O. Kroeker, DPM, Fresno, California, 93710, United States|Innovative Medical Technologies, Los Angeles, California, 90063, United States|Diabetic Foot & Wound Center, Denver, Colorado, 80220, United States|North American Center for Limb Preservation, New Haven, Connecticut, 06515, United States|Karr Foot & Leg Centers, Lakeland, Florida, 33813, United States|University of Miami, Miami, Florida, 33136, United States|Ankle and Foot Specialist of Atlanta, Lithonia, Georgia, 30058, United States|Foot Healthcare Associates, Livonia, Michigan, 48152, United States|Northern Michigan Hospital, Petoskey, Michigan, 49770, United States|Calvary Hospital, Bronx, New York, 10461, United States|North Shore Podiatry Group, Port Jefferson Station, New York, 11776, United States|UNC Wound Care Clinic, Durham, North Carolina, 27713, United States|Eastern Carolina Foot & Ankle Specialists, Greenville, North Carolina, 27834, United States|Lehigh Valley Podiatry Associates, Allentown, Pennsylvania, 18104, United States|Limb Salvage Center, Dallas, Texas, 75231, United States|Southwest Regional Wound Care, Lubbock, Texas, 79410, United States|St. Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States"
NCT01963156,Synchronization to Improve Non-Adherence to Cardiovascular Medications,https://clinicaltrials.gov/study/NCT01963156,TERMINATED,Chronic Disease|Cardiovascular Disease|Diabetes Mellitus,BEHAVIORAL: Prescription synchronization,Brigham and Women's Hospital,CVS Caremark,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"CVS Caremark, Woonsocket, Rhode Island, 02895, United States"
NCT02259634,Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients,https://clinicaltrials.gov/study/NCT02259634,TERMINATED,HIV/AIDS|Diabetes Mellitus|Hypertension|Substance Use,BEHAVIORAL: Patient Navigation,St. Luke's-Roosevelt Hospital Center,Patient-Centered Outcomes Research Institute|Hunter College of The City University of New York,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Mount Sinai St. Luke's, New York, New York, 10025, United States|Hunter College at The City University of New York, New York, New York, 10065, United States"
NCT02409238,Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study,https://clinicaltrials.gov/study/NCT02409238,TERMINATED,"Mild Cognitive Impairment|Insulin Resistance|Diabetes Mellitus, Type 2",DRUG: Metformin|BEHAVIORAL: Intensive Lifestyle Intervention|BEHAVIORAL: Standard LIfestyle Recommendation,SingHealth Polyclinics,"National University of Singapore|Singapore General Hospital|Changi General Hospital|National University Hospital, Singapore|Singapore Clinical Research Institute|Agency for Science, Technology and Research|Khoo Teck Puat Hospital|Duke-NUS Graduate Medical School",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"SingHealth Polyclinics - Marine Parade Polyclinic, Singapore, 440080, Singapore"
NCT02365233,Fatty Liver Study in Patients With Type II Diabetes,https://clinicaltrials.gov/study/NCT02365233,TERMINATED,Type II Diabetes|Nonalcoholic Fatty Liver,DRUG: DPP4 inhibitor|DRUG: Pioglitazone|DRUG: Lantus insulin,"The University of Texas Medical Branch, Galveston",,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Texas Medical Branch -Galveston, Galveston, Texas, 77555, United States"
NCT00555217,VA NEPHRON-D: Diabetes iN Nephropathy Study,https://clinicaltrials.gov/study/NCT00555217,TERMINATED,Kidney Disease|Nephropathy|Type 2 Diabetes,DRUG: losartan|DRUG: lisinopril,US Department of Veterans Affairs,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Carl T. Hayden VA Medical Center, Phoenix, Arizona, 85012, United States|Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock, Little Rock, Arkansas, 72205-5484, United States|VA Medical Center, Loma Linda, Loma Linda, California, 92357, United States|VA Palo Alto Health Care System, Palo Alto, California, 94304-1290, United States|VA Connecticut Health Care System (West Haven), West Haven, Connecticut, 06516, United States|North Florida/South Georgia Veterans Health System, Gainesville, Florida, 32608, United States|VA Medical Center, Miami, Miami, Florida, 33125, United States|James A. Haley Veterans Hospital, Tampa, Tampa, Florida, 33612, United States|Edward Hines, Jr. VA Hospital, Hines, Illinois, 60141-5000, United States|Richard Roudebush VA Medical Center, Indianapolis, Indianapolis, Indiana, 46202-2884, United States|VA Medical Center, Iowa City, Iowa City, Iowa, 52246-2208, United States|VA Maryland Health Care System, Baltimore, Baltimore, Maryland, 21201, United States|VA Medical Center, Minneapolis, Minneapolis, Minnesota, 55417, United States|VA Medical Center, Kansas City MO, Kansas City, Missouri, 64128, United States|VA Medical Center, St Louis, St Louis, Missouri, 63106, United States|VA Medical Center, Omaha, Omaha, Nebraska, 68105-1873, United States|VA New Jersey Health Care System, East Orange, East Orange, New Jersey, 07018, United States|New Mexico VA Health Care System, Albuquerque, Albuquerque, New Mexico, 87108-5153, United States|VA Western New York Healthcare System at Buffalo, Buffalo, New York, 14215, United States|VA Medical Center, Durham, Durham, North Carolina, 27705, United States|VA Medical Center, Cleveland, Cleveland, Ohio, 44106, United States|VA Medical Center, Portland, Portland, Oregon, 97201, United States|VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh, Pennsylvania, 15240, United States|Ralph H Johnson VA Medical Center, Charleston, Charleston, South Carolina, 29401-5799, United States|WJB Dorn Veterans Hospital, Columbia, Columbia, South Carolina, 29209, United States|VA Medical Center, Memphis, Memphis, Tennessee, 38104, United States|VA Medical Center, Nashville, Tennessee, 37212-2637, United States|VA North Texas Health Care System, Dallas, Dallas, Texas, 75216, United States|Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, 23249, United States|Zablocki VA Medical Center, Milwaukee, Milwaukee, Wisconsin, 53295-1000, United States|VA Medical Center, San Juan, San Juan, 00921, Puerto Rico"
NCT04014569,"Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study",https://clinicaltrials.gov/study/NCT04014569,TERMINATED,Type 1 Diabetes|Multiple Daily Injections,DEVICE: MPSA Algorithm,Rabin Medical Center,DreaMed|Harvard University,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Schnider children medical center, Petach-Tikva, Israel"
NCT01756105,Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women,https://clinicaltrials.gov/study/NCT01756105,TERMINATED,Gestational Diabetes|Metformin|Treatment|Oxidative Stress,DRUG: Metformin|DRUG: Rapid acting analog insulin Intermediate acting NPH Insulin,"University Hospital, Strasbourg, France",,FEMALE,ADULT,PHASE2,INTERVENTIONAL,"Hôpitaux Civils de Colmar, Colmar, 68024, France|CHU Dijon,, Dijon, 21030, France|Centre hospitalier de Mulhouse, Mulhouse, 68070, France|CHU de Reims, Reims, 51092, France|Hôpitaux Universitaires de Strasbourg, Strasbourg, 67091, France"
NCT02525263,Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD),https://clinicaltrials.gov/study/NCT02525263,TERMINATED,Chronic Kidney Disease|Type 2 Diabetes,BIOLOGICAL: Neo-Kidney Augment,Prokidney,CTI Clinical Trial and Consulting Services,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of North Carolina- Chapel Hill, Chapel Hill, North Carolina, 27599, United States"
NCT00326196,Coronary Artery Revascularization in Diabetes,https://clinicaltrials.gov/study/NCT00326196,TERMINATED,Coronary Artery Disease,DEVICE: Percutaneous coronary intervention (PCI)|PROCEDURE: Coronary artery bypass graft (CABG),US Department of Veterans Affairs,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"VA Medical Center, Birmingham, Birmingham, Alabama, 35233, United States|Southern Arizona VA Health Care System, Tucson, Tucson, Arizona, 85723, United States|VA Palo Alto Health Care System, Palo Alto, California, 94304-1290, United States|VA San Diego Healthcare System, San Diego, San Diego, California, 92161, United States|VA Medical Center, San Francisco, San Francisco, California, 94121, United States|VA Greater Los Angeles HCS, Sepulveda, Sepulveda, California, 91343, United States|VA Eastern Colorado Health Care System, Denver, Denver, Colorado, 80220, United States|VA Medical Center, DC, Washington, District of Columbia, 20422, United States|VA Medical Center, Miami, Miami, Florida, 33125, United States|James A. Haley Veterans Hospital, Tampa, Tampa, Florida, 33612, United States|Atlanta VA Medical and Rehab Center, Decatur, Decatur, Georgia, 30033, United States|Richard Roudebush VA Medical Center, Indianapolis, Indianapolis, Indiana, 46202-2884, United States|VA Boston Healthcare System, Brockton Campus, Brockton, Massachusetts, 02301, United States|VA Medical Center, Minneapolis, Minneapolis, Minnesota, 55417, United States|New York Harbor HCS, New York, New York, 10010, United States|VA Medical Center, Asheville, Asheville, North Carolina, 28805, United States|VA Medical Center, Durham, Durham, North Carolina, 27705, United States|VA Medical Center, Cleveland, Cleveland, Ohio, 44106, United States|VA Medical Center, Oklahoma City, Oklahoma City, Oklahoma, 73104, United States|Ralph H Johnson VA Medical Center, Charleston, Charleston, South Carolina, 29401-5799, United States|VA Medical Center, Memphis, Memphis, Tennessee, 38104, United States|VA North Texas Health Care System, Dallas, Dallas, Texas, 75216, United States|Michael E. DeBakey VA Medical Center (152), Houston, Texas, 77030, United States|VA South Texas Health Care System, San Antonio, San Antonio, Texas, 78229, United States|VA Puget Sound Health Care System, Seattle, Seattle, Washington, 98108, United States|Zablocki VA Medical Center, Milwaukee, Milwaukee, Wisconsin, 53295-1000, United States"
NCT06067685,Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes,https://clinicaltrials.gov/study/NCT06067685,TERMINATED,Fetal Macrosomia|Obesity Complicating Childbirth|Gestational Diabetes,OTHER: Observation,University of Kansas Medical Center,,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States"
NCT03940300,Farming for Life - Health Impact of Organic Vegetable Prescriptions for Adults Living With or at Risk of Type 2 Diabetes,https://clinicaltrials.gov/study/NCT03940300,TERMINATED,"Diabetes Mellitus, Type 2|Food Supply|Poverty|Minority Health|Obesity",DIETARY_SUPPLEMENT: Fresh organic vegetables,Sansum Diabetes Research Institute,United States Department of Agriculture (USDA),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Sansum Diabetes Research Institute, Santa Barbara, California, 93105, United States"
NCT03281083,Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD),https://clinicaltrials.gov/study/NCT03281083,TERMINATED,"Non-Alcoholic Fatty Liver Disease|Diabetes Mellitus, Type 2",DRUG: Levothyroxine Sodium,Duke-NUS Graduate Medical School,"Singapore Clinical Research Institute|Institute for Human Development and Potential (IHDP), Singapore|Institute of Bioengineering and Bioimaging (IBB)|Tan Tock Seng Hospital|Singapore General Hospital|Ng Teng Fong General Hospital|Changi General Hospital|Khoo Teck Puat Hospital|National University Health System, Singapore",MALE,ADULT,PHASE2,INTERVENTIONAL,
NCT01648218,Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia,https://clinicaltrials.gov/study/NCT01648218,TERMINATED,Post-Transplant Glucocorticoid Induced Diabetes,DRUG: Neutral protamine hagedorn (NPH) insulin|DRUG: Regular human insulin or Insulin Aspart|DRUG: Insulin glargine,Vancouver General Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Vancouver General Hospital - Jim Pattison Pavilion, Vancouver, British Columbia, V5Z 1M9, Canada"
NCT00967798,Prevention of Cystic Fibrosis Diabetes,https://clinicaltrials.gov/study/NCT00967798,TERMINATED,Cystic Fibrosis|Prediabetes,DRUG: Sitagliptin,Emory University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Emory University and Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, 30322, United States|Children's Healthcare of Atlanta at Scottish Rite, Atlanta, Georgia, 30342, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States"
NCT03315143,Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk,https://clinicaltrials.gov/study/NCT03315143,TERMINATED,Heart Failure|Type 2 Diabetes Mellitus|Chronic Kidney Diseases,DRUG: Sotagliflozin|DRUG: Placebo,Lexicon Pharmaceuticals,Sanofi,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Investigational Site Number 8400017, Birmingham, Alabama, 35205, United States|Investigational Site Number 8400096, Sheffield, Alabama, 35660, United States|Investigational Site Number 8400004, Mesa, Arizona, 85206, United States|Investigational Site Number 8400059, Mesa, Arizona, 85210, United States|Investigational Site Number 8400021, Peoria, Arizona, 85381, United States|Investigational Site Number 8400014, Surprise, Arizona, 85374, United States|Investigational Site Number 8400071, Little Rock, Arkansas, 72211, United States|Investigational Site Number 8400039, Beverly Hills, California, 90211, United States|Investigational Site Number 8400042, Concord, California, 94520, United States|Investigational Site Number 8400089, Fresno, California, 93720, United States|Investigational Site Number 8400006, Huntington Park, California, 90255, United States|Investigational Site Number 8400036, Long Beach, California, 90807, United States|Investigational Site Number 8400073, Los Angeles, California, 90017, United States|Investigational Site Number 8400084, Los Angeles, California, 90022-4302, United States|Investigational Site Number 8400035, Los Gatos, California, 95032, United States|Investigational Site Number 8400043, Northridge, California, 91325, United States|Investigational Site Number 8400025, Sacramento, California, 95821, United States|Investigational Site Number 8400018, San Dimas, California, 91713, United States|Investigational Site Number 8400070, Temecula, California, 92591, United States|Investigational Site Number 8400013, Waterbury, Connecticut, 06708, United States|Investigational Site Number 8400095, Bradenton, Florida, 34209, United States|Investigational Site Number 8400090, Clearwater, Florida, 33756, United States|Investigational Site Number 8400121, Clearwater, Florida, 33756, United States|Investigational Site Number 8400049, Cooper City, Florida, 33024, United States|Investigational Site Number 8400092, Hialeah, Florida, 33012, United States|Investigational Site Number 8400026, Hollywood, Florida, 33024, United States|Investigational Site Number 8400134, Jacksonville, Florida, 32204, United States|Investigational Site Number 8400055, Jacksonville, Florida, 32207-4966, United States|Investigational Site Number 8400056, Jacksonville, Florida, 32216, United States|Investigational Site Number 8400031, Jacksonville, Florida, 32277, United States|Investigational Site Number 8400037, Maitland, Florida, 32751, United States|Investigational Site Number 8400078, Miami, Florida, 33126, United States|Investigational Site Number 8400117, Miami, Florida, 33135, United States|Investigational Site Number 8400119, Miami, Florida, 33135, United States|Investigational Site Number 8400118, Miami, Florida, 33165, United States|Investigational Site Number 8400105, Miami, Florida, 33174, United States|Investigational Site Number 8400120, Miami, Florida, 33176, United States|Investigational Site Number 8400088, North Miami Beach, Florida, 33162, United States|Investigational Site Number 8400106, Opa-locka, Florida, 33054, United States|Investigational Site Number 8400063, Ormond Beach, Florida, 32174, United States|Investigational Site Number 8400087, Palm Harbor, Florida, 34684-3609, United States|Investigational Site Number 8400058, Saint Petersburg, Florida, 33713, United States|Investigational Site Number 8400108, Spring Hill, Florida, 34609, United States|Investigational Site Number 8400051, Tampa, Florida, 33624, United States|Investigational Site Number 8400123, Atlanta, Georgia, 30303, United States|Investigational Site Number 8400076, Roswell, Georgia, 30076, United States|Investigational Site Number 8400033, Honolulu, Hawaii, 96814, United States|Investigational Site Number 8400085, Arlington Heights, Illinois, 60005, United States|Investigational Site Number 8400104, Chicago, Illinois, 60611, United States|Investigational Site Number 8400027, Chicago, Illinois, 60612, United States|Investigational Site Number 8400124, Chicago, Illinois, 60612, United States|Investigational Site Number 8400001, Chicago, Illinois, 60616, United States|Investigational Site Number 8400052, Crystal Lake, Illinois, 60012, United States|Investigational Site Number 8400028, Springfield, Illinois, 62711, United States|Investigational Site Number 8400125, Michigan City, Indiana, 46360, United States|Investigational Site Number 8400098, Valparaiso, Indiana, 46383, United States|Investigational Site Number 8400003, Des Moines, Iowa, 50314, United States|Investigational Site Number 8400081, Topeka, Kansas, 66606, United States|Investigational Site Number 8400041, Louisville, Kentucky, 40213, United States|Investigational Site Number 8400080, Bangor, Maine, 04401, United States|Investigational Site Number 8400002, Flint, Michigan, 48504, United States|Investigational Site Number 8400069, Flint, Michigan, 48532-3447, United States|Investigational Site Number 8400016, Troy, Michigan, 48098, United States|Investigational Site Number 8400023, Saint Cloud, Minnesota, 56303, United States|Investigational Site Number 8400066, Kansas City, Missouri, 64111, United States|Investigational Site Number 8400024, Saint Louis, Missouri, 63136, United States|Investigational Site Number 8400130, Washington, Missouri, 63090, United States|Investigational Site Number 8400045, Omaha, Nebraska, 68198-4100, United States|Investigational Site Number 8400009, Las Vegas, Nevada, 89148, United States|Investigational Site Number 8400101, Albany, New York, 12206, United States|Investigational Site Number 8400061, Laurelton, New York, 11413, United States|Investigational Site Number 8400046, New York, New York, 10029-6501, United States|Investigational Site Number 8400112, Rosedale, New York, 11422, United States|Investigational Site Number 8400062, Smithtown, New York, 11787, United States|Investigational Site Number 8400079, Greenville, North Carolina, 27834-5704, United States|Investigational Site Number 8400020, Morehead City, North Carolina, 28557, United States|Investigational Site Number 8400048, Morehead City, North Carolina, 28557, United States|Investigational Site Number 8400010, Morganton, North Carolina, 28655, United States|Investigational Site Number 8400072, Fargo, North Dakota, 58103, United States|Investigational Site Number 8400038, Cincinnati, Ohio, 45219, United States|Investigational Site Number 8400007, Cincinnati, Ohio, 45241, United States|Investigational Site Number 8400015, Columbus, Ohio, 43210, United States|Investigational Site Number 8400113, Lorain, Ohio, 44053, United States|Investigational Site Number 8400011, Mentor, Ohio, 44060, United States|Investigational Site Number 8400109, Bend, Oregon, 97702, United States|Investigational Site Number 8400047, Beaver, Pennsylvania, 15009, United States|Investigational Site Number 8400019, Greensburg, Pennsylvania, 15601, United States|Investigational Site Number 8400097, Indiana, Pennsylvania, 15701-3578, United States|Investigational Site Number 8400032, Levittown, Pennsylvania, 19056-2404, United States|Investigational Site Number 8400053, Philadelphia, Pennsylvania, 19107, United States|Investigational Site Number 8400012, Pittsburgh, Pennsylvania, 15212, United States|Investigational Site Number 8400064, Anderson, South Carolina, 29621, United States|Investigational Site Number 8400030, Greer, South Carolina, 29651, United States|Investigational Site Number 8400029, Myrtle Beach, South Carolina, 29572, United States|Investigational Site Number 8400040, Memphis, Tennessee, 38163, United States|Investigational Site Number 8400114, Arlington, Texas, 76015, United States|Investigational Site Number 8400067, Corpus Christi, Texas, 78814, United States|Investigational Site Number 8400082, Dallas, Texas, 75231, United States|Investigational Site Number 8400022, El Paso, Texas, 79935, United States|Investigational Site Number 8400099, Houston, Texas, 77043, United States|Investigational Site Number 8400103, Houston, Texas, 77070, United States|Investigational Site Number 8400086, Katy, Texas, 77450, United States|Investigational Site Number 8400100, Mesquite, Texas, 75150, United States|Investigational Site Number 8400094, Plano, Texas, 75093, United States|Investigational Site Number 8400116, San Antonio, Texas, 78224, United States|Investigational Site Number 8400091, Waco, Texas, 76710, United States|Investigational Site Number 8400065, Bountiful, Utah, 84010-7717, United States|Investigational Site Number 8400131, Ogden, Utah, 84405, United States|Investigational Site Number 8400093, Bennington, Vermont, 05201, United States|Investigational Site Number 8400060, South Burlington, Vermont, 05403, United States|Investigational Site Number 8400133, Danville, Virginia, 24541-2834, United States|Investigational Site Number 8400054, Fairfax, Virginia, 22039, United States|Investigational Site Number 8400132, Falls Church, Virginia, 22044, United States|Investigational Site Number 8400034, Manassas, Virginia, 20110, United States|Investigational Site Number 8400050, Norfolk, Virginia, 23510, United States|Investigational Site Number 8400044, Richmond, Virginia, 23235, United States|Investigational Site Number 8400111, Richmond, Virginia, 23249, United States|Investigational Site Number 8400083, Federal Way, Washington, 98003, United States|Investigational Site Number 8400068, Spokane, Washington, 99207, United States|Investigational Site Number 0320016, Buenos Aires, Argentina|Investigational Site Number 0320029, Buenos Aires, Argentina|Investigational Site Number 0320017, Caba, 1120, Argentina|Investigational Site Number 0320002, Caba, C1093AAS, Argentina|Investigational Site Number 0320004, Caba, C1118AAE, Argentina|Investigational Site Number 0320018, Caba, C1119ACN, Argentina|Investigational Site Number 0320025, Caba, C1128AAF, Argentina|Investigational Site Number 0320019, Caba, Argentina|Investigational Site Number 0320027, Capital Federal, C1056ABJ, Argentina|Investigational Site Number 0320015, Capital Federal, C1179AAB, Argentina|Investigational Site Number 0320014, Ciudad Autonoma De Bs.As, C1428DCO, Argentina|Investigational Site Number 0320023, Ciudad Autonoma De Buenos Aire, C1204AAD, Argentina|Investigational Site Number 0320009, Ciudadela, B1702BML, Argentina|Investigational Site Number 0320001, Cordoba, X5000AAX, Argentina|Investigational Site Number 0320008, Coronel Suarez, B7540GHD, Argentina|Investigational Site Number 0320011, Corrientes, W3400AMZ, Argentina|Investigational Site Number 0320028, La Plata, B1900AXI, Argentina|Investigational Site Number 0320006, La Plata, B1906ESC, Argentina|Investigational Site Number 0320024, Mar Del Plata, B7600FZN, Argentina|Investigational Site Number 0320003, Mar Del Plata, B7600, Argentina|Investigational Site Number 0320020, Merlo, B1722COV, Argentina|Investigational Site Number 0320007, Ramos Mejia, B1704ETD, Argentina|Investigational Site Number 0320030, Rosario, S2000CVD, Argentina|Investigational Site Number 0320026, Rosario, S2000DEJ, Argentina|Investigational Site Number 0320012, Salta, 4400, Argentina|Investigational Site Number 0320021, San Miguel De Tucuman, T4000ICL, Argentina|Investigational Site Number 0320013, Santa Fe, S3000FWO, Argentina|Investigational Site Number 0320022, Temperley, 1842, Argentina|Investigational Site Number 0320005, Villa Maria, X5900JKA, Argentina|Investigational Site Number 0360014, Adelaide, 5000, Australia|Investigational Site Number 0360004, Box Hill, 3128, Australia|Investigational Site Number 0360015, Elizabeth Vale, 5112, Australia|Investigational Site Number 0360005, Fitzroy, 3065, Australia|Investigational Site Number 0360018, Fremantle, 6160, Australia|Investigational Site Number 0360007, Fullarton, 5063, Australia|Investigational Site Number 0360002, Gosford, 2250, Australia|Investigational Site Number 0360016, Heidelberg, 3081, Australia|Investigational Site Number 0360010, Herston, 4029, Australia|Investigational Site Number 0360009, Liverpool, 2170, Australia|Investigational Site Number 0360017, Melbourne, 3004, Australia|Investigational Site Number 0360001, Merewether, 2291, Australia|Investigational Site Number 0360012, Oaklands Park, 5046, Australia|Investigational Site Number 0360011, Parkville, 3050, Australia|Investigational Site Number 0360008, Redcliffe, 4020, Australia|Investigational Site Number 0360013, Sherwood, 4075, Australia|Investigational Site Number 0360019, St Leonards, 2065, Australia|Investigational Site Number 0360006, Wollongong, 2500, Australia|Investigational Site Number 0560004, Bonheiden, 2820, Belgium|Investigational Site Number 0560005, Gent, 9000, Belgium|Investigational Site Number 0560003, Kortrijk, 8500, Belgium|Investigational Site Number 0560002, La-Louvière, 7100, Belgium|Investigational Site Number 0560001, Leuven, 3000, Belgium|Investigational Site Number 0760017, Blumenau, 89020-430, Brazil|Investigational Site Number 0760015, Brasilia, 70200-730, Brazil|Investigational Site Number 0760026, Brasilia, 70390-903, Brazil|Investigational Site Number 0760008, Campinas, 13015-001, Brazil|Investigational Site Number 0760005, Campinas, 13060-080, Brazil|Investigational Site Number 0760018, Canoas, 92425-900, Brazil|Investigational Site Number 0760019, Curitiba, 80030-110, Brazil|Investigational Site Number 0760011, Curitiba, 80230-130, Brazil|Investigational Site Number 0760007, Curitiba, 80730-150, Brazil|Investigational Site Number 0760010, Fortaleza, 60115-282, Brazil|Investigational Site Number 0760002, Fortaleza, 60170-320, Brazil|Investigational Site Number 0760004, Fortaleza, 60430-350, Brazil|Investigational Site Number 0760014, Passo Fundo, 99010-180, Brazil|Investigational Site Number 0760025, Porto Alegre, 90020-090, Brazil|Investigational Site Number 0760016, Porto Alegre, 90430-001, Brazil|Investigational Site Number 0760024, Recife, 52051-380, Brazil|Investigational Site Number 0760023, Rio De Janeiro, 22271-100, Brazil|Investigational Site Number 0760001, Sao Jose Do Rio Preto, 15090-000, Brazil|Investigational Site Number 0760012, Sao Jose Dos Campos, 12243-280, Brazil|Investigational Site Number 0760020, Sao Paulo, 01228-200, Brazil|Investigational Site Number 0760013, Sao Paulo, 04038-002, Brazil|Investigational Site Number 0760022, Sao Paulo, 04266-010, Brazil|Investigational Site Number 0760006, Sao Paulo, 05403-000, Brazil|Investigational Site Number 0760009, Sao Paulo, 05403-000, Brazil|Investigational Site Number 0760003, São Paulo, 01.228-000, Brazil|Investigational Site Number 0760021, Vitoria, 29055 450, Brazil|Investigational Site Number 1000015, Blagoevgrad, 2700, Bulgaria|Investigational Site Number 1000008, Dobrich, MULTIPROFILE HOSPITA, Bulgaria|Investigational Site Number 1000013, Gabrovo, 5300, Bulgaria|Investigational Site Number 1000003, Plovdiv, 4002, Bulgaria|Investigational Site Number 1000016, Ruse, 7002, Bulgaria|Investigational Site Number 1000014, Silistra, 7500, Bulgaria|Investigational Site Number 1000007, Smolyan, 4700, Bulgaria|Investigational Site Number 1000011, Sofia, 1233, Bulgaria|Investigational Site Number 1000004, Sofia, 1431, Bulgaria|Investigational Site Number 1000006, Sofia, 1431, Bulgaria|Investigational Site Number 1000012, Sofia, 1632, Bulgaria|Investigational Site Number 1000005, Sofia, 1750, Bulgaria|Investigational Site Number 1000017, Sofia, 1784, Bulgaria|Investigational Site Number 1000001, Stara Zagora, 6000, Bulgaria|Investigational Site Number 1000018, Stara Zagora, 6000, Bulgaria|Investigational Site Number 1240002, Brampton, L6S0C6, Canada|Investigational Site Number 1240013, Burlington, L7M 4Y1, Canada|Investigational Site Number 1240021, Calgary, T2T 5C7, Canada|Investigational Site Number 1240005, Calgary, T2V 4J2, Canada|Investigational Site Number 1240029, Concord, L4K 4M2, Canada|Investigational Site Number 1240004, Edmonton, T5A 4L8, Canada|Investigational Site Number 1240010, Edmonton, T6H 2L4, Canada|Investigational Site Number 1240027, Halifax, B3H 2Y9, Canada|Investigational Site Number 1240023, Hamilton, L8N 3Z5, Canada|Investigational Site Number 1240011, London, N6A 4V2, Canada|Investigational Site Number 1240019, Montreal, H1T 1C8, Canada|Investigational Site Number 1240017, Montreal, H4A 2C6, Canada|Investigational Site Number 1240018, Montreal, H4N 2W2, Canada|Investigational Site Number 1240007, Newmarket, L3Y 5G8, Canada|Investigational Site Number 1240026, Oshawa, L1G 2B9, Canada|Investigational Site Number 1240016, Oshawa, L1J 2K1, Canada|Investigational Site Number 1240006, Ottawa, K1H7W9, Canada|Investigational Site Number 1240022, Quebec, G1G 3Z4, Canada|Investigational Site Number 1240025, Quebec, G1V 4G5, Canada|Investigational Site Number 1240014, Quebec, G1V 4W2, Canada|Investigational Site Number 1240003, Quebec, G1W-4R4, Canada|Investigational Site Number 1240034, Saint-Charles-Borromee, J6E 6J2, Canada|Investigational Site Number 1240032, St-Marc-Des-Carrieres, G0A 4B0, Canada|Investigational Site Number 1240033, St. John'S, A1B 3V6, Canada|Investigational Site Number 1240008, Sudbury, P3E 4H5, Canada|Investigational Site Number 1240031, Surrey, V3V 0C6, Canada|Investigational Site Number 1240028, Toronto, M6G 1M2, Canada|Investigational Site Number 1240015, Trois-Rivieres, G8Z 3R9, Canada|Investigational Site Number 1240001, Vancouver, V5Y 3W2, Canada|Investigational Site Number 1240030, Victoria, V8R 1B2, Canada|Investigational Site Number 1520015, Concepción, 4070566, Chile|Investigational Site Number 1520003, Osorno, 5311092, Chile|Investigational Site Number 1520012, Punta Arenas, 6210490, Chile|Investigational Site Number 1520013, Santiago, 7500571, Chile|Investigational Site Number 1520018, Santiago, 7500588, Chile|Investigational Site Number 1520001, Santiago, 7500710, Chile|Investigational Site Number 1520004, Santiago, 7500710, Chile|Investigational Site Number 1520006, Santiago, 7500739, Chile|Investigational Site Number 1520014, Santiago, 7591047, Chile|Investigational Site Number 1520016, Santiago, 7650568, Chile|Investigational Site Number 1520017, Santiago, 7770086, Chile|Investigational Site Number 1520020, Santiago, 7770086, Chile|Investigational Site Number 1520009, Santiago, 8053095, Chile|Investigational Site Number 1520011, Santiago, 8207257, Chile|Investigational Site Number 1520026, Santiago, 833-0024, Chile|Investigational Site Number 1520010, Santiago, 8330336, Chile|Investigational Site Number 1520007, Santiago, 8380456, Chile|Investigational Site Number 1520021, Santiago, 8900132, Chile|Investigational Site Number 1520022, Santiago, 8910131, Chile|Investigational Site Number 1520002, Santiago, Chile|Investigational Site Number 1520024, Talca, Chile|Investigational Site Number 1520019, Temuco, 4781156, Chile|Investigational Site Number 1520025, Temuco, 4781173, Chile|Investigational Site Number 1520005, Temuco, 4813299, Chile|Investigational Site Number 1520008, Viña Del Mar, Chile|Investigational Site Number 1560019, Beijing, 100034, China|Investigational Site Number 1560001, Beijing, 100037, China|Investigational Site Number 1560002, Beijing, 100044, China|Investigational Site Number 1560003, Beijing, 100730, China|Investigational Site Number 1560032, Beijing, 100730, China|Investigational Site Number 1560012, Changchun, 130021, China|Investigational Site Number 1560023, Changchun, 130021, China|Investigational Site Number 1560034, Changchun, 130033, China|Investigational Site Number 1560022, Changsha, 410013, China|Investigational Site Number 1560021, Chengdu, 610041, China|Investigational Site Number 1560018, Dalian, 116011, China|Investigational Site Number 1560010, Dalian, 116033, China|Investigational Site Number 1560007, Guangzhou, 510080, China|Investigational Site Number 1560016, Haikou, 570102, China|Investigational Site Number 1560033, Hengyang, 421001, China|Investigational Site Number 1560038, Hohhot, 010020, China|Investigational Site Number 1560005, Huai'An, 223300, China|Investigational Site Number 1560009, Jinan, 250013, China|Investigational Site Number 1560037, Jining, China|Investigational Site Number 1560031, Nanchang, 330006, China|Investigational Site Number 1560004, Nanjing, 210008, China|Investigational Site Number 1560006, Shanghai, 200120, China|Investigational Site Number 1560036, Shenyang, 110016, China|Investigational Site Number 1560020, Siping, 136000, China|Investigational Site Number 1560025, Suzhou, 215004, China|Investigational Site Number 1560014, Suzhou, 215006, China|Investigational Site Number 1560026, Taizhou, 317000, China|Investigational Site Number 1560028, Tianjin, 300121, China|Investigational Site Number 1560029, Tianjin, 300211, China|Investigational Site Number 1560024, Wuhan, 430033, China|Investigational Site Number 1560027, Xi'An, 710061, China|Investigational Site Number 1560035, Xinxiang, 453000, China|Investigational Site Number 1560008, Zhenjiang, 212001, China|Investigational Site Number 2030012, Brno, 62500, Czechia|Investigational Site Number 2030002, Brno, 63900, Czechia|Investigational Site Number 2030021, Broumov, 550 01, Czechia|Investigational Site Number 2030017, Humpolec, 396 01, Czechia|Investigational Site Number 2030014, Liberec, 46063, Czechia|Investigational Site Number 2030007, Marianske Lazne, 353 01, Czechia|Investigational Site Number 2030015, Mestec Kralove, 28903, Czechia|Investigational Site Number 2030009, Plzen, 301 00, Czechia|Investigational Site Number 2030016, Praha 10, 10800, Czechia|Investigational Site Number 2030019, Praha 1, 11694, Czechia|Investigational Site Number 2030006, Praha 2, 12808, Czechia|Investigational Site Number 2030005, Praha 4, 14021, Czechia|Investigational Site Number 2030011, Praha 6, 16900, Czechia|Investigational Site Number 2030018, Praha 8, 18100, Czechia|Investigational Site Number 2030010, Revnice, 25230, Czechia|Investigational Site Number 2030020, Slany, 27401, Czechia|Investigational Site Number 2030001, Trutnov, 54101, Czechia|Investigational Site Number 2030008, Vsetin, 75501, Czechia|Investigational Site Number 2080003, Aarhus N, 8200, Denmark|Investigational Site Number 2080005, Aarhus N, 8200, Denmark|Investigational Site Number 2080009, Gentofte, 2900, Denmark|Investigational Site Number 2080004, Herlev, 2730, Denmark|Investigational Site Number 2080008, Hvidovre, 2650, Denmark|Investigational Site Number 2080002, København Nv, 2400, Denmark|Investigational Site Number 2080007, Slagelse, 4200, Denmark|Investigational Site Number 2080006, Svendborg, 5700, Denmark|Investigational Site Number 2330003, Tallinn, 10138, Estonia|Investigational Site Number 2330001, Tallinn, 13419, Estonia|Investigational Site Number 2330002, Tartu, 51014, Estonia|Investigational Site Number 2500003, Corbeil-Essonnes, 91106, France|Investigational Site Number 2500002, La Rochelle Cedex, 17019, France|Investigational Site Number 2500001, Paris Cedex 18, 75877, France|Investigational Site Number 2500005, Paris, 75010, France|Investigational Site Number 2500006, Paris, 75018, France|Investigational Site Number 2500004, Toulouse Cedex 9, 31059, France|Investigational Site Number 2500007, Venissieux, 69200, France|Investigational Site Number 2680004, Batumi, 6010, Georgia|Investigational Site Number 2680001, Kutaisi, Georgia|Investigational Site Number 2680007, Tbilisi, 0159, Georgia|Investigational Site Number 2680005, Tbilisi, 102, Georgia|Investigational Site Number 2680003, Tbilisi, 159, Georgia|Investigational Site Number 2680006, Tbilisi, 159, Georgia|Investigational Site Number 2680002, Tbilisi, Georgia|Investigational Site Number 2760008, Berlin, 12351, Germany|Investigational Site Number 2760005, Essen, 45136, Germany|Investigational Site Number 2760001, Freiburg, 79106, Germany|Investigational Site Number 2760007, Hamburg, 22041, Germany|Investigational Site Number 2760002, Kassel, 34121, Germany|Investigational Site Number 2760006, Leipzig, 04103, Germany|Investigational Site Number 2760003, Münster, 48149, Germany|Investigational Site Number 2760009, Oldenburg In Holstein, 23758, Germany|Investigational Site Number 3000001, Athens, 11527, Greece|Investigational Site Number 3000002, Ioannina, 45500, Greece|Investigational Site Number 3000004, Larissa, 41110, Greece|Investigational Site Number 3000003, Pireas, 18454, Greece|Investigational Site Number 3000005, Thessaloniki, 54629, Greece|Investigational Site Number 3200007, Guatemala, 01001, Guatemala|Investigational Site Number 3200013, Guatemala, 01010, Guatemala|Investigational Site Number 3200001, Guatemala, 01014, Guatemala|Investigational Site Number 3200002, Guatemala, 1010, Guatemala|Investigational Site Number 3200009, Guatemala, 1010, Guatemala|Investigational Site Number 3200010, Guatemala, Guatemala|Investigational Site Number 3200006, Quetzaltenango, 09001, Guatemala|Investigational Site Number 3200014, Quetzaltenango, 09001, Guatemala|Investigational Site Number 3200004, Quetzaltenango, 9011, Guatemala|Investigational Site Number 3480017, Budapest, 1027, Hungary|Investigational Site Number 3480004, Budapest, 1042, Hungary|Investigational Site Number 3480011, Budapest, 1096, Hungary|Investigational Site Number 3480001, Budapest, 1122, Hungary|Investigational Site Number 3480010, Budapest, 1125, Hungary|Investigational Site Number 3480012, Budapest, 1134, Hungary|Investigational Site Number 3480016, Budapest, 1145, Hungary|Investigational Site Number 3480018, Budapest, 1204, Hungary|Investigational Site Number 3480006, Békéscsaba, 5600, Hungary|Investigational Site Number 3480002, Debrecen, 4032, Hungary|Investigational Site Number 3480008, Debrecen, 4032, Hungary|Investigational Site Number 3480013, Kaposvár, 7400, Hungary|Investigational Site Number 3480014, Nyíregyháza, 4400, Hungary|Investigational Site Number 3480015, Nyíregyháza, 4400, Hungary|Investigational Site Number 3480003, Szekesfehervar, 8000, Hungary|Investigational Site Number 3480007, Zalaegerszeg, 8900, Hungary|Investigational Site Number 3560025, Ahmedabad, 380060, India|Investigational Site Number 3560040, Aurangabad, 431003, India|Investigational Site Number 3560010, Bangalore, 560 034, India|Investigational Site Number 3560026, Bangalore, 560 054., India|Investigational Site Number 3560005, Belgaum, 590010, India|Investigational Site Number 3560008, Bengaluru, 560017, India|Investigational Site Number 3560022, Chandigarh, 160062, India|Investigational Site Number 3560003, Gurgaon, 122001, India|Investigational Site Number 3560004, Gurgaon, 122001, India|Investigational Site Number 3560018, Hyderabad, 500001, India|Investigational Site Number 3560001, Hyderabad, 500012, India|Investigational Site Number 3560007, Hyderabad, 500063, India|Investigational Site Number 3560002, Jaipur, 302017, India|Investigational Site Number 3560024, Kochi, India|Investigational Site Number 3560016, Kolkata, 700027, India|Investigational Site Number 3560030, Kozhikode, 673008, India|Investigational Site Number 3560006, Ludhiana, 141008, India|Investigational Site Number 3560027, Mangalore, 575002, India|Investigational Site Number 3560028, Mangalore, 575018, India|Investigational Site Number 3560017, Mumbai, India|Investigational Site Number 3560037, Mysore, 570015, India|Investigational Site Number 3560013, Nagpur, 440009, India|Investigational Site Number 3560014, Nagpur, 440010, India|Investigational Site Number 3560021, Nashik, 42003, India|Investigational Site Number 3560041, New Delhi, 110 029, India|Investigational Site Number 3560034, New Delhi, 110002, India|Investigational Site Number 3560019, Pune, 411001, India|Investigational Site Number 3560035, Pune, 411004, India|Investigational Site Number 3560042, Pune, 411004, India|Investigational Site Number 3560038, Pune, 411010, India|Investigational Site Number 3560012, Pune, 411019, India|Investigational Site Number 3560043, Varanasi, 221 005, India|Investigational Site Number 3560020, Vellore, 632004, India|Investigational Site Number 3560015, Wardha, 442004, India|Investigational Site Number 3760008, Beer Sheva, 84101, Israel|Investigational Site Number 3760005, Haifa, 31048, Israel|Investigational Site Number 3760007, Haifa, 31096, Israel|Investigational Site Number 3760001, Jerusalem, 91031, Israel|Investigational Site Number 3760002, Jerusalem, 91120, Israel|Investigational Site Number 3760004, Nahariya, 22100, Israel|Investigational Site Number 3760003, Tel Aviv, 64239, Israel|Investigational Site Number 3760006, Tel Hashomer, 52621, Israel|Investigational Site Number 3800006, Catanzaro, 88100, Italy|Investigational Site Number 3800010, Catanzaro, 88100, Italy|Investigational Site Number 3800009, Chieri, 10023, Italy|Investigational Site Number 3800007, Livorno, 57123, Italy|Investigational Site Number 3800002, Milano, 20132, Italy|Investigational Site Number 3800008, Milano, 20145, Italy|Investigational Site Number 3800005, Orbassano, 10043, Italy|Investigational Site Number 3800011, Ravenna, 48100, Italy|Investigational Site Number 3800004, Roma, 00133, Italy|Investigational Site Number 3800001, Verona, 37126, Italy|Investigational Site Number 4100011, Bucheon-Si, 14647, Korea, Republic of|Investigational Site Number 4100005, Busan, 49201, Korea, Republic of|Investigational Site Number 4100007, Gwangju, 61469, Korea, Republic of|Investigational Site Number 4100001, Incheon, 22332, Korea, Republic of|Investigational Site Number 4100002, Seongnam-Si, 13620, Korea, Republic of|Investigational Site Number 4100003, Seoul, 03080, Korea, Republic of|Investigational Site Number 4100006, Seoul, 03722, Korea, Republic of|Investigational Site Number 4100008, Seoul, 05505, Korea, Republic of|Investigational Site Number 4100004, Seoul, 06351, Korea, Republic of|Investigational Site Number 4100010, Uijeongbu-Si, 11765, Korea, Republic of|Investigational Site Number 4280004, Daugavpils, LV-5417, Latvia|Investigational Site Number 4280002, Liepāja, LV3414, Latvia|Investigational Site Number 4280007, Ogre, LV-5001, Latvia|Investigational Site Number 4280006, Riga, LV-1002, Latvia|Investigational Site Number 4280001, Riga, LV-1011, Latvia|Investigational Site Number 4280005, Riga, LV-1038, Latvia|Investigational Site Number 4280003, Sigulda, LV-2150, Latvia|Investigational Site Number 4400006, Kaunas, 49449, Lithuania|Investigational Site Number 4400003, Kaunas, 51270, Lithuania|Investigational Site Number 4400009, Kaunas, LT-50161, Lithuania|Investigational Site Number 4400008, Kedainiai, LT-57164, Lithuania|Investigational Site Number 4400004, Klaipeda, 92111, Lithuania|Investigational Site Number 4400002, Klaipeda, LT-92304, Lithuania|Investigational Site Number 4400007, Ukmerge, 20184, Lithuania|Investigational Site Number 4400005, Utena, LT-28151, Lithuania|Investigational Site Number 4400001, Vilnius, 08661, Lithuania|Investigational Site Number 4840009, Actopan, 42500, Mexico|Investigational Site Number 4840013, Aguascalientes, 20230, Mexico|Investigational Site Number 4840019, Aguascalientes, 20230, Mexico|Investigational Site Number 4840018, Cdmx, 06760, Mexico|Investigational Site Number 4840005, Celaya, 38000, Mexico|Investigational Site Number 4840002, Cuernavaca, 62250, Mexico|Investigational Site Number 4840025, Distrito Federal, 07760, Mexico|Investigational Site Number 4840007, Durango, 34000, Mexico|Investigational Site Number 4840023, Durango, 34080, Mexico|Investigational Site Number 4840033, Guadalajara, 44150, Mexico|Investigational Site Number 4840024, Guadalajara, 44160, Mexico|Investigational Site Number 4840003, Guadalajara, 44210, Mexico|Investigational Site Number 4840011, Guadalajara, 44210, Mexico|Investigational Site Number 4840027, Guadalajara, 44280, Mexico|Investigational Site Number 4840004, Guadalajara, 44600, Mexico|Investigational Site Number 4840010, Guadalajara, 44650, Mexico|Investigational Site Number 4840030, Guadalajara, Mexico|Investigational Site Number 4840034, Merida, 97070, Mexico|Investigational Site Number 4840021, Monterrey, 64020, Mexico|Investigational Site Number 4840020, Monterrey, 64060, Mexico|Investigational Site Number 4840001, Monterrey, 64460, Mexico|Investigational Site Number 4840028, Mérida, 72129, Mexico|Investigational Site Number 4840014, Queretaro, 76000, Mexico|Investigational Site Number 4840015, Toluca, 50130, Mexico|Investigational Site Number 4840008, Veracruz, 91910, Mexico|Investigational Site Number 4840016, Xalapa, 91193, Mexico|Investigational Site Number 4840026, Zapopan, 45116, Mexico|Investigational Site Number 5280004, Almelo, 7609 PP, Netherlands|Investigational Site Number 5280001, Groningen, 9728 NT, Netherlands|Investigational Site Number 5280003, Hoogeveen, 7909 AA, Netherlands|Investigational Site Number 5280005, Meppel, 7943 KA, Netherlands|Investigational Site Number 5280002, Rotterdam, 3045 PM, Netherlands|Investigational Site Number 5540014, Auckland, 1023, New Zealand|Investigational Site Number 5540006, Birkenhead, 0626, New Zealand|Investigational Site Number 5540009, Birkenhead, 0626, New Zealand|Investigational Site Number 5540002, Christchurch, 8011, New Zealand|Investigational Site Number 5540003, Christchurch, New Zealand|Investigational Site Number 5540012, Christchurch, New Zealand|Investigational Site Number 5540007, Dunedin, 9016, New Zealand|Investigational Site Number 5540016, Hamilton, 3240, New Zealand|Investigational Site Number 5540013, New Plymouth, New Zealand|Investigational Site Number 5540015, Palmerston North, 4414, New Zealand|Investigational Site Number 5540005, Rotorua, 3010, New Zealand|Investigational Site Number 5540010, Takapuna, 1309, New Zealand|Investigational Site Number 5540008, Tauranga, 3001, New Zealand|Investigational Site Number 5540011, Tauranga, 3001, New Zealand|Investigational Site Number 5540004, Wellington, 6021, New Zealand|Investigational Site Number 8070003, Skopje, 1000, North Macedonia|Investigational Site Number 8070005, Struga, 6330, North Macedonia|Investigational Site Number 8070001, Tetovo, 1200, North Macedonia|Investigational Site Number 8070004, Tetovo, 1200, North Macedonia|Investigational Site Number 5780005, Hamar, 2317, Norway|Investigational Site Number 5780001, Hønefoss, 3515, Norway|Investigational Site Number 5780003, Oslo, 0514, Norway|Investigational Site Number 5780002, Oslo, 373, Norway|Investigational Site Number 5780004, Skedsmokorset, 2020, Norway|Investigational Site Number 6040004, Arequipa, Peru|Investigational Site Number 6040006, Callao, CALLAO 02, Peru|Investigational Site Number 6040009, Callao, Peru|Investigational Site Number 6040024, Chancay, Peru|Investigational Site Number 6040005, Chiclayo, Peru|Investigational Site Number 6040010, Cuzco, Peru|Investigational Site Number 6040014, Lima Lima, Lima 01, Peru|Investigational Site Number 6040001, Lima, 09, Peru|Investigational Site Number 6040025, Lima, 15135, Peru|Investigational Site Number 6040016, Lima, LIMA 01, Peru|Investigational Site Number 6040020, Lima, LIMA 14, Peru|Investigational Site Number 6040013, Lima, Lima 17, Peru|Investigational Site Number 6040023, Lima, LIMA 27, Peru|Investigational Site Number 6040007, Lima, Lima 29, Peru|Investigational Site Number 6040019, Lima, LIMA 31, Peru|Investigational Site Number 6040022, Lima, LIMA 32, Peru|Investigational Site Number 6040012, Lima, Lima 41, Peru|Investigational Site Number 6040017, Lima, Peru|Investigational Site Number 6040011, Piura, 20000, Peru|Investigational Site Number 6040002, Trujillo, Peru|Investigational Site Number 6160027, Bialystok, 15-276, Poland|Investigational Site Number 6160011, Bialystok, 15-435, Poland|Investigational Site Number 6160029, Bydgoszcz, 85-079, Poland|Investigational Site Number 6160030, Bydgoszcz, 85-231, Poland|Investigational Site Number 6160006, Bydgoszcz, 85-822, Poland|Investigational Site Number 6160018, Bytom, 41-902, Poland|Investigational Site Number 6160002, Czeladz, 41-250, Poland|Investigational Site Number 6160003, Gdynia, 81-394, Poland|Investigational Site Number 6160005, Gdynia, 81-472, Poland|Investigational Site Number 6160008, Grodzisk Mazowiecki, 05-825, Poland|Investigational Site Number 6160031, Grodzisk Mazowiecki, 05-825, Poland|Investigational Site Number 6160023, Katowice, 40-611, Poland|Investigational Site Number 6160026, Katowice, 40-748, Poland|Investigational Site Number 6160022, Kielce, 25-525, Poland|Investigational Site Number 6160019, Krakow, 31-135, Poland|Investigational Site Number 6160024, Krakow, 31-261, Poland|Investigational Site Number 6160010, Krakow, 31-548, Poland|Investigational Site Number 6160016, Lodz, 90-242, Poland|Investigational Site Number 6160013, Lodz, 91-347, Poland|Investigational Site Number 6160015, Lodz, Poland|Investigational Site Number 6160007, Lublin, 20-044, Poland|Investigational Site Number 6160033, Poznan, 60-589, Poland|Investigational Site Number 6160021, Pulawy, 24-100, Poland|Investigational Site Number 6160028, Staszow, 28-200, Poland|Investigational Site Number 6160020, Torun, 87-100, Poland|Investigational Site Number 6160014, Warszawa, 00-631, Poland|Investigational Site Number 6160025, Warszawa, 02-005, Poland|Investigational Site Number 6160001, Warszawa, 02-097, Poland|Investigational Site Number 6160004, Warszawa, 02-507, Poland|Investigational Site Number 6160012, Wroclaw, 52-416, Poland|Investigational Site Number 6160017, Zabrze, 41-800, Poland|Investigational Site Number 6160032, Zamosc, 22-400, Poland|Investigational Site Number 6200004, Almada, 2801-951, Portugal|Investigational Site Number 6200005, Caldas Da Rainha, 2500-176, Portugal|Investigational Site Number 6200009, Carnaxide, 2790-134, Portugal|Investigational Site Number 6200002, Coimbra, 3000-075, Portugal|Investigational Site Number 6200008, Leiria, 2410-197, Portugal|Investigational Site Number 6200001, Lisboa, 1250, Portugal|Investigational Site Number 6200007, Loures, 2674-514, Portugal|Investigational Site Number 6200003, Porto, 4099-001, Portugal|Investigational Site Number 8400122, San Juan, 00917, Puerto Rico|Investigational Site Number 6420008, Bacau, 600154, Romania|Investigational Site Number 6420005, Baia Mare, Maramures, 430222, Romania|Investigational Site Number 6420009, Brasov, 500097, Romania|Investigational Site Number 6420013, Bucuresti, 010507, Romania|Investigational Site Number 6420014, Bucuresti, 010627, Romania|Investigational Site Number 6420012, Bucuresti, 020475, Romania|Investigational Site Number 6420011, Bucuresti, 022441, Romania|Investigational Site Number 6420002, Craiova, 200349, Romania|Investigational Site Number 6420003, Oradea, 410159, Romania|Investigational Site Number 6420004, Oradea, 410469, Romania|Investigational Site Number 6420010, Ploiesti, 100561, Romania|Investigational Site Number 6420001, Targoviste, Dambovita, 130095, Romania|Investigational Site Number 6420006, Targu Mures, Mures, 540142, Romania|Investigational Site Number 6420007, Targu Mures, Mures, 540142, Romania|Investigational Site Number 6430028, Kaliningrad, 236035, Russian Federation|Investigational Site Number 6430018, Kazan, 420101, Russian Federation|Investigational Site Number 6430001, Kemerovo, 650002, Russian Federation|Investigational Site Number 6430035, Kemerovo, 650070, Russian Federation|Investigational Site Number 6430025, Krasnodar, 350042, Russian Federation|Investigational Site Number 6430040, Krasnodar, 350063, Russian Federation|Investigational Site Number 6430010, Krasnodar, 350086, Russian Federation|Investigational Site Number 6430015, Moscow, 101990, Russian Federation|Investigational Site Number 6430016, Moscow, 101990, Russian Federation|Investigational Site Number 6430046, Moscow, 105554, Russian Federation|Investigational Site Number 6430003, Moscow, 117292, Russian Federation|Investigational Site Number 6430036, Moscow, 119192, Russian Federation|Investigational Site Number 6430005, Moscow, 119991, Russian Federation|Investigational Site Number 6430039, Moscow, 119991, Russian Federation|Investigational Site Number 6430021, Moscow, 121309, Russian Federation|Investigational Site Number 6430002, Moscow, 121374, Russian Federation|Investigational Site Number 6430020, Moscow, 125284, Russian Federation|Investigational Site Number 6430024, Moscow, 127644, Russian Federation|Investigational Site Number 6430033, Nizhniy Novgorod, 603005, Russian Federation|Investigational Site Number 6430037, Novosibirsk, 630005, Russian Federation|Investigational Site Number 6430034, Novosibirsk, 630089, Russian Federation|Investigational Site Number 6430007, Perm, 614077, Russian Federation|Investigational Site Number 6430019, Rostov-Na-Donu, 344068, Russian Federation|Investigational Site Number 6430012, Saint-Petersburg, 192242, Russian Federation|Investigational Site Number 6430044, Saint-Petersburg, 197110, Russian Federation|Investigational Site Number 6430045, Saint-Petersburg, 197110, Russian Federation|Investigational Site Number 6430043, Saint-Petersburg, 198205, Russian Federation|Investigational Site Number 6430009, Saratov, 410028, Russian Federation|Investigational Site Number 6430013, Saratov, 410028, Russian Federation|Investigational Site Number 6430042, Saratov, 410039, Russian Federation|Investigational Site Number 6430026, Sochi, 354057, Russian Federation|Investigational Site Number 6430027, Sochi, 354057, Russian Federation|Investigational Site Number 6430041, St-Petersburg, 193312, Russian Federation|Investigational Site Number 6430006, St-Petersburg, 194044, Russian Federation|Investigational Site Number 6430008, St-Petersburg, 194044, Russian Federation|Investigational Site Number 6430030, St-Petersburg, 194044, Russian Federation|Investigational Site Number 6430014, St-Petersburg, 197341, Russian Federation|Investigational Site Number 6430017, St-Petersburg, 197341, Russian Federation|Investigational Site Number 6430004, St-Petersburg, 199106, Russian Federation|Investigational Site Number 6430011, Tomsk, 634012, Russian Federation|Investigational Site Number 6430038, Tomsk, 634050, Russian Federation|Investigational Site Number 6430032, Tyumen, 625000, Russian Federation|Investigational Site Number 6430023, Vladimir, 600020, Russian Federation|Investigational Site Number 6430022, Vladimir, 600023, Russian Federation|Investigational Site Number 6430031, Yaroslavl, 150002, Russian Federation|Investigational Site Number 6880002, Belgrade, 11000, Serbia|Investigational Site Number 6880003, Belgrade, 11000, Serbia|Investigational Site Number 6880004, Belgrade, 11000, Serbia|Investigational Site Number 6880005, Kragujevac, 34000, Serbia|Investigational Site Number 6880001, Nis, 18000, Serbia|Investigational Site Number 6880006, Nis, 18000, Serbia|Investigational Site Number 6880007, Nis, 18000, Serbia|Investigational Site Number 7030006, Bardejov, 085 01, Slovakia|Investigational Site Number 7030012, Bratislava, 813 69, Slovakia|Investigational Site Number 7030011, Kosice, 040 01, Slovakia|Investigational Site Number 7030001, Lubochna, 034 91, Slovakia|Investigational Site Number 7030008, Lucenec, 984 39, Slovakia|Investigational Site Number 7030009, Lucenec, 98401, Slovakia|Investigational Site Number 7030010, Lucenec, 98401, Slovakia|Investigational Site Number 7030004, Moldava Nad Bodvou, 04525, Slovakia|Investigational Site Number 7030013, Presov, 080 01, Slovakia|Investigational Site Number 7030003, Roznava, 04801, Slovakia|Investigational Site Number 7030002, Sabinov, 083 01, Slovakia|Investigational Site Number 7030007, Svidnik, 089 01, Slovakia|Investigational Site Number 7100005, Brits, 0250, South Africa|Investigational Site Number 7100009, Cape Town, 7530, South Africa|Investigational Site Number 7100006, Cape Town, 7570, South Africa|Investigational Site Number 7100001, Parow, 7500, South Africa|Investigational Site Number 7100012, Pinelands, 7405, South Africa|Investigational Site Number 7100011, Pretoria, 0002, South Africa|Investigational Site Number 7100014, Pretoria, 0083, South Africa|Investigational Site Number 7100008, Pretoria, 0157, South Africa|Investigational Site Number 7100010, Rivonia, 2128, South Africa|Investigational Site Number 7100007, Soweto, 1818, South Africa|Investigational Site Number 7100002, Umkomaas, 4170, South Africa|Investigational Site Number 7100013, Vosloorus, 1475, South Africa|Investigational Site Number 7100003, Western Cape, 7130, South Africa|Investigational Site Number 7240003, Almería, 04120, Spain|Investigational Site Number 7240014, Barcelona, 08035, Spain|Investigational Site Number 7240011, Barcelona, 08041, Spain|Investigational Site Number 7240009, Córdoba, 14004, Spain|Investigational Site Number 7240024, El Puerto De Santa Maria, 11500, Spain|Investigational Site Number 7240016, Granada, 18016, Spain|Investigational Site Number 7240015, La Coruña, 15006, Spain|Investigational Site Number 7240001, Madrid, 28023, Spain|Investigational Site Number 7240019, Madrid, 28034, Spain|Investigational Site Number 7240006, Madrid, 28040, Spain|Investigational Site Number 7240010, Madrid, 28046, Spain|Investigational Site Number 7240020, Madrid, 28046, Spain|Investigational Site Number 7240025, Sabadell, 08208, Spain|Investigational Site Number 7240023, Sanlúcar De Barrameda, 11540, Spain|Investigational Site Number 7240013, Santa Cruz De Tenerife, 38320, Spain|Investigational Site Number 7240007, Santiago De Compostela, 15706, Spain|Investigational Site Number 7240026, Sevilla, 41014, Spain|Investigational Site Number 7240012, Sevilla, 41071, Spain|Investigational Site Number 7240004, Valencia, 46010, Spain|Investigational Site Number 7240002, Vigo, 36312, Spain|Investigational Site Number 7240022, Villamartín, 11650, Spain|Investigational Site Number 7240008, Zaragoza, 50009, Spain|Investigational Site Number 7520007, Falun, 791 82, Sweden|Investigational Site Number 7520005, Lund, 221 85, Sweden|Investigational Site Number 7520004, Mölndal, 43180, Sweden|Investigational Site Number 7520003, Rättvik, 79530, Sweden|Investigational Site Number 7520008, Stockholm, 112 21, Sweden|Investigational Site Number 7520002, Stockholm, 118 83, Sweden|Investigational Site Number 7520006, Stockholm, 14186, Sweden|Investigational Site Number 7520001, Uppsala, 751 85, Sweden|Investigational Site Number 7560001, Olten, 4600, Switzerland|Investigational Site Number 7560002, Zollikerberg, 8125, Switzerland|Investigational Site Number 1580005, Hsinchu, 30071, Taiwan|Investigational Site Number 1580008, Kaohsiung, 807, Taiwan|Investigational Site Number 1580004, Linkou, Taiwan|Investigational Site Number 1580006, Taichung, 40447, Taiwan|Investigational Site Number 1580002, Tainan, 704, Taiwan|Investigational Site Number 1580007, Tainan, 710, Taiwan|Investigational Site Number 1580003, Taipei, 100, Taiwan|Investigational Site Number 1580001, Taipei, 112, Taiwan|Investigational Site Number 7920018, Antalya, 07070, Turkey|Investigational Site Number 7920010, Aydın, 09100, Turkey|Investigational Site Number 7920004, Corum, 19200, Turkey|Investigational Site Number 7920016, Gaziantep, 27310, Turkey|Investigational Site Number 7920011, Istanbul, 34034, Turkey|Investigational Site Number 7920009, Istanbul, 34390, Turkey|Investigational Site Number 7920001, Istanbul, Turkey|Investigational Site Number 7920007, Istanbul, Turkey|Investigational Site Number 7920017, Istanbul, Turkey|Investigational Site Number 7920003, Izmir, 35340, Turkey|Investigational Site Number 7920013, Kayseri, 38039, Turkey|Investigational Site Number 7920014, Kocaeli, 41380, Turkey|Investigational Site Number 7920005, Kutahya, Turkey|Investigational Site Number 7920015, Malatya, Turkey|Investigational Site Number 7920008, Mersin, 33169, Turkey|Investigational Site Number 7920002, Sivas, 58140, Turkey|Investigational Site Number 8040020, Dnipro, 49005, Ukraine|Investigational Site Number 8040006, Dnipro, 49600, Ukraine|Investigational Site Number 8040009, Ivano-Frankivsk, 76000, Ukraine|Investigational Site Number 8040012, Ivano-Frankivsk, 76018, Ukraine|Investigational Site Number 8040021, Kharkiv, 61039, Ukraine|Investigational Site Number 8040011, Kharkiv, 61058, Ukraine|Investigational Site Number 8040008, Kharkiv, 61166, Ukraine|Investigational Site Number 8040002, Kiev, 02091, Ukraine|Investigational Site Number 8040024, Kiev, 02660, Ukraine|Investigational Site Number 8040003, Kyiv, 03049, Ukraine|Investigational Site Number 8040015, Kyiv, 03115, Ukraine|Investigational Site Number 8040019, Kyiv, 04050, Ukraine|Investigational Site Number 8040010, Kyiv, 04114, Ukraine|Investigational Site Number 8040026, Kyiv, Ukraine|Investigational Site Number 8040023, Lutsk, 43005, Ukraine|Investigational Site Number 8040025, Lutsk, 43024, Ukraine|Investigational Site Number 8040022, Lviv, 79011, Ukraine|Investigational Site Number 8040001, Ternopil, 46000, Ukraine|Investigational Site Number 8040016, Vinnitsya, 21018, Ukraine|Investigational Site Number 8040007, Vinnitsya, 21100, Ukraine|Investigational Site Number 8040004, Vinnytsya, 21001, Ukraine|Investigational Site Number 8040018, Zhytomyr, Ukraine|Investigational Site Number 8260003, Belfast, BT12 6BA, United Kingdom|Investigational Site Number 8260007, Chippenham, SN14 6GT, United Kingdom|Investigational Site Number 8260009, Davyhulme, Manchester, M41 5SL, United Kingdom|Investigational Site Number 8260010, Glasgow, G21 3UW, United Kingdom|Investigational Site Number 8260004, Hayle, TR27 5DT, United Kingdom|Investigational Site Number 8260011, Inverness, IV2 3UJ, United Kingdom|Investigational Site Number 8260002, Ipswich, IP4 5PD, United Kingdom|Investigational Site Number 8260006, Maidstone, ME16 9QQ, United Kingdom|Investigational Site Number 8260001, Swansea, SA2 8PP, United Kingdom"
NCT03056014,Antioxidant Use in Diabetes to Reduce Oxidative Stress,https://clinicaltrials.gov/study/NCT03056014,TERMINATED,Ameliorating Oxidative Stress in Type 1 Diabetes,DRUG: N-acetyl cysteine|DIETARY_SUPPLEMENT: omega 6 Fish oil ( PUFA)|DIETARY_SUPPLEMENT: Placebo,"University of Maryland, Baltimore",,FEMALE,ADULT,EARLY_PHASE1,INTERVENTIONAL,"University of Maryland, Baltimore, Baltimore, Maryland, 21201, United States"
NCT04233489,Clinical Interventions to Mitigate Neurodevelopmental Risk,https://clinicaltrials.gov/study/NCT04233489,TERMINATED,"Child Development|Mother-Infant Interaction|Diabetes Mellitus, Gestational",BEHAVIORAL: Family Nurture Intervention (FNI),Columbia University,New York State Psychiatric Institute,ALL,CHILD,,INTERVENTIONAL,"Morgan Stanley Children's Hospital of New York, New York, New York, 10032, United States"
NCT03787511,Chronic Cough and Small Fiber Neuropathy,https://clinicaltrials.gov/study/NCT03787511,TERMINATED,Chronic Cough|Type 2 Diabetes,OTHER: Cough assessment|OTHER: Neurological tests and cardiovascular tests|OTHER: Skin biopsy,"University Hospital, Toulouse",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hôpital Larrey, Toulouse, 31059, France"
NCT01500798,A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01500798,TERMINATED,Chronic Kidney Disease|Type 2 Diabetes,DRUG: 20 mg bardoxolone methyl|DRUG: Placebo,Biogen,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,
NCT00579150,Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy,https://clinicaltrials.gov/study/NCT00579150,TERMINATED,Birth Defects|Type 2 Diabetes|Preterm Birth,,AstraZeneca,,FEMALE,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Research Site, Wilmington, North Carolina, United States"
NCT01083108,Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus,https://clinicaltrials.gov/study/NCT01083108,TERMINATED,Obesity|Bariatric Surgery|Morbid Obesity|Diabetes Mellitus Type 2|Diet Therapy,OTHER: Roux-en-Y Gastric Bypass|OTHER: Caloric Restriction,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),,ALL,ADULT,PHASE2,INTERVENTIONAL,"University of Maryland, Baltimore, Baltimore, Maryland, 21201-1595, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|Vanderbilt University, Nashville, Tennessee, 37232, United States"
NCT06457802,Sit Less Program for Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT06457802,TERMINATED,Type 2 Diabetes|Sedentary Behavior|Sedentary Time|Physical Activity,BEHAVIORAL: Sit Less Program,Vanderbilt University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Vanderbilt University, Nashville, Tennessee, 37240, United States"
NCT03331861,Metformin in Heart Failure Without Diabetes,https://clinicaltrials.gov/study/NCT03331861,TERMINATED,Heart Failure,DRUG: Metformin hydrochloride|DRUG: Placebo,Columbia University,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"New York Hospital - Columbia University Irving Medical Center, New York, New York, 10032, United States"
NCT04083248,Building Self-regulation Capacity in AA T2DM Women: Feasibility of EMI,https://clinicaltrials.gov/study/NCT04083248,TERMINATED,Type 2 Diabetes|Self-regulation,BEHAVIORAL: Feasibility group,University of Illinois at Chicago,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Chicago,FEMALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Illinois at Chicago, College of Nursing, Chicago, Illinois, 60612, United States"
NCT04060745,Glucose Metabolism in Brown Adipose Tissue (BAT) in Young Healthy Men Evaluated by Deuterium Metabolic Imaging (DMI),https://clinicaltrials.gov/study/NCT04060745,TERMINATED,Type2 Diabetes|Obesity|Metabolic Syndrome,OTHER: cooling using a water-perfused vest|OTHER: thermoneutrality,University of Aarhus,Aarhus University Hospital|Steno Diabetes Center Copenhagen,MALE,ADULT,,INTERVENTIONAL,"Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, 8200, Denmark"
NCT01257464,Sitagliptin in Cystic Fibrosis-Related Diabetes,https://clinicaltrials.gov/study/NCT01257464,TERMINATED,Cystic Fibrosis,DRUG: Sitagliptin|DRUG: Placebo,University of British Columbia,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of British Columbia Gerontology & Diabetes Reserach Centre (ViTALITY), Vancouver, British Columbia, V5Z 1L8, Canada"
NCT00220831,Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment,https://clinicaltrials.gov/study/NCT00220831,TERMINATED,Diabetes|Myocardial Infarction|Cardiovascular Disease,DRUG: Natural source Vitamin E 400IU/day,"Technion, Israel Institute of Technology",Clalit Health Services|The Kennedy Leigh Charitable Trust,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Clalit Health Services, Haifa and West Galilee - primary health care clinics, in the north of Israel And the Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel., Haifa, Israel"
NCT02790957,Plerixafor in Diabetic Wound Healing,https://clinicaltrials.gov/study/NCT02790957,TERMINATED,Diabetes|Wounds|Critical Limb Ischemia,DRUG: Plerixafor|DRUG: Placebo,Gian Paolo Fadini,University Hospital Padova,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University Hospital of Padova, Padova, 35128, Italy"
NCT03592355,Virtual Visits at Brigham and Women's Hospital,https://clinicaltrials.gov/study/NCT03592355,TERMINATED,Heart Failure|Hypertension|Diabetes Mellitus|Stroke|BPH|Hyperlipidemia,OTHER: Virtual Visit,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States"
NCT00704652,Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00704652,TERMINATED,Diabetic Retinopathy,,Medical University of Vienna,Amgen,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Departmen of Ophthalmology, Medical Unversity of Vienna, Vienna, 1090, Austria"
NCT02032173,Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase,https://clinicaltrials.gov/study/NCT02032173,TERMINATED,Macular Edema|Macular Degeneration|Diabetes,DRUG: Ranibizumab 0.5mg,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novartis Investigative Site, Bobigny cedex, Seine Saint Denis, 93009, France|Novartis Investigative Site, Bordeaux Cedex, F-33076, France|Novartis Investigative Site, Bordeaux, 33000, France|Novartis Investigative Site, Creteil, 94000, France|Novartis Investigative Site, Le Kremlin Bicetre Cedex, 94275, France|Novartis Investigative Site, Lyon, 69002, France|Novartis Investigative Site, Nice, 06000, France|Novartis Investigative Site, Paris Cedex 19, 75940, France|Novartis Investigative Site, Paris, 75015, France|Novartis Investigative Site, Poitiers, 86021, France"
NCT05281562,Immunonutrition for Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT05281562,TERMINATED,Diabetes Mellitus|Diabetic Peripheral Neuropathy|Diabetic Foot Ulcer,DRUG: Lovaza|DRUG: L-Arginine Powder|DRUG: Vitamin C,Prisma Health-Midlands,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Prisma Health, Columbia, South Carolina, 29203, United States"
NCT01006018,DPP-4 Inhibition and TZD for DM Prevention,https://clinicaltrials.gov/study/NCT01006018,TERMINATED,Prediabetic State,DRUG: Sitagliptin + Pioglitazone PLACEBO|DRUG: Sitagliptin + Pioglitazone|DRUG: PLACEBO,Emory University,Merck Sharp & Dohme LLC,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Grady Memorial Hospital, Atlanta, Georgia, 30303, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States"
NCT02743598,Liraglutide for HIV-associated Neurocognitive Disorder,https://clinicaltrials.gov/study/NCT02743598,TERMINATED,HIV Infection|Diabetes Mellitus Type 2|Obesity|Overweight|Metabolic Syndrome,DRUG: Liraglutide,Temple University,The Comprehensive NeuroAIDS Center (CNAC) at Temple University,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cherie Vaz, Philadelphia, Pennsylvania, 19140, United States"
NCT01599442,Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia,https://clinicaltrials.gov/study/NCT01599442,TERMINATED,Type 2 Diabetes Mellitus|Diabetic Foot|Critical Limb Ischemia,,GWT-TUD GmbH,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Krankenhaus Dresden-Friedrichstadt, Dresden, Sachse, 01076, Germany"
NCT01844037,OneShot Renal Denervation Registry,https://clinicaltrials.gov/study/NCT01844037,TERMINATED,Hypertension|Heart Failure|Diabetes Mellitus|Sleep Apnea,DEVICE: OneShot Ablation System,Medtronic Endovascular,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Hospital San Raffaele, Milano, Italy"
NCT00743327,Androgen Deprivation Therapy Study,https://clinicaltrials.gov/study/NCT00743327,TERMINATED,Hypogonadism|Metabolic Syndrome|Diabetes|Inflammation,DRUG: Pioglitazone,National Institute on Aging (NIA),,MALE,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"NIA Clinical Research Unit located at Harbor Hospital, Baltimore, Maryland, 21225, United States"
NCT00558935,The Effect of Alcohol on ABCA1 Expression and Lipid Metabolism,https://clinicaltrials.gov/study/NCT00558935,TERMINATED,Type 2 Diabetes|Heart Disease,DIETARY_SUPPLEMENT: Red Wine,Bayside Health,,MALE,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Baker Heart Research Institute, Melbourne, Victoria, 3004, Australia"
NCT02563015,Can Correction of Low Vitamin D Status in Infancy Program for a Leaner Body Composition?,https://clinicaltrials.gov/study/NCT02563015,TERMINATED,Healthy|Vitamin D Deficiency|Gestational Diabetes,DIETARY_SUPPLEMENT: cholecalciferol|DIETARY_SUPPLEMENT: Reference 400,McGill University,,ALL,CHILD,,INTERVENTIONAL,"Mary Emily Clinical Nutrition Research Unit, Sainte Anne de Bellevue, Quebec, H9X 2E3, Canada"
NCT00187785,Doctor-Patient Communication in Spanish,https://clinicaltrials.gov/study/NCT00187785,TERMINATED,Upper Respiratory Infection|Hypertension|Diabetes,BEHAVIORAL: Spanish speaker level,"University of California, San Francisco",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"UMC Family Health Center, Fresno, California, 93702, United States"
NCT03542071,Dietary Management of Gestational Diabetes in Obese Pregnant Women,https://clinicaltrials.gov/study/NCT03542071,TERMINATED,"Diabetes, Gestational|Dietary Modification|Tissue Glucose|Body Composition|Birth Weight",OTHER: Carbohydrate restricted diet|OTHER: Plant-protein based diet,Helsinki University Central Hospital,University of Helsinki|Aalto University|Finnish Institute for Health and Welfare|City of Helsinki|UKK Institute,FEMALE,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Helsinki university central hospital, Helsinki, Finland"
NCT00936663,Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation,https://clinicaltrials.gov/study/NCT00936663,TERMINATED,Type 2 Diabetes|End Stage Renal Disease,DRUG: Placebo|DRUG: Sitagliptin,University of Nebraska,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States"
NCT04726163,Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection,https://clinicaltrials.gov/study/NCT04726163,TERMINATED,"Diabetic Patient (Type 1,2, MODY, Secondary) or With Corticosteroid-induced Diabetes Following Initiation of Corticosteroid Treatment",DEVICE: Continuous blind glucose measurement device (Free style Pro),"University Hospital, Strasbourg, France",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hopitaux Universitaires de Strasbourg, Strasbourg, 67091, France"
NCT05504785,DexCom Hospital Study-CGM Directed Insulin Delivery,https://clinicaltrials.gov/study/NCT05504785,TERMINATED,Type 2 Diabetes|Hip Osteoarthritis|Knee Osteoarthritis,DEVICE: DexCom G6 continuous glucose monitor,Thomas Jefferson University,"DexCom, Inc.",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States"
NCT02410005,Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL),https://clinicaltrials.gov/study/NCT02410005,TERMINATED,Diabetic Nephropathies,DIETARY_SUPPLEMENT: Calcitriol|DRUG: Losartan,Weill Cornell Medical College in Qatar,Hamad Medical Corporation|Weill Medical College of Cornell University,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Weill Cornell Medical College, New York, New York, 10021, United States|Weill Cornell Medical College in Qatar, Doha, 24144, Qatar|Hamad Medical Corporation, Doha, Qatar"
NCT03642184,Efficacy and Safety of Empagliflozin in NODAT,https://clinicaltrials.gov/study/NCT03642184,TERMINATED,New Onset Diabetes After Transplant|Kidney Transplant; Complications,DRUG: Empagliflozin|DRUG: Linagliptin,RenJi Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Department of nephrology, endocrinology and kidney transplantation , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200127, China"
NCT02272348,Self-management of Type 1 Diabetes Under Functional Insulin Therapy,https://clinicaltrials.gov/study/NCT02272348,TERMINATED,Type 1 Diabetes|Basal-bolus Multiple-dily Insulin Injections|Insulin Pump (CSII),OTHER: Training course to functional insulin therapy|OTHER: Usual diabetes management.,"University Hospital, Montpellier",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Lapeyronie Hospital - CHU de Montpellier, Montpellier, 34295, France"
NCT01129232,"Diabetes Virus Detection Project, Intervention With GAD-alum",https://clinicaltrials.gov/study/NCT01129232,TERMINATED,"Diabetes, Type I|Enterovirus Infections|Autoimmunity",DRUG: GAD-alum|OTHER: Placebo,Oslo University Hospital,,ALL,ADULT,PHASE2,INTERVENTIONAL,"Endokrinologisk poliklinikk, Oslo Universitetssykehus Aker, Oslo, 0514, Norway"
NCT06119204,"SAFE-LCD Trial, for Insulin-treated Adults Living With Type 2 Diabetes",https://clinicaltrials.gov/study/NCT06119204,TERMINATED,Type 2 Diabetes Treated With Insulin|Diet Habit,OTHER: Oviva programme|OTHER: Usual care,Oviva UK Ltd,"Hull University Teaching Hospitals NHS Trust|University College, London",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hull University Teaching Hospital NHS Trust, Hull, HU3 2JZ, United Kingdom"
NCT01461330,Lifestyle Changes in Patients With Type 2 Diabetes Mellitus and Hypertension,https://clinicaltrials.gov/study/NCT01461330,TERMINATED,Blood Pressure,OTHER: DASH diet plus exercise|OTHER: ADA diet,Hospital de Clinicas de Porto Alegre,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil"
NCT04448262,Bronchial Asthma and Diabetes: Impact on Bronchial Inflammation and Exercise Capacity,https://clinicaltrials.gov/study/NCT04448262,TERMINATED,Asthma|Diabete Type 2,OTHER: data collection,Istituti Clinici Scientifici Maugeri SpA,"Galmarini Hospital, Tradate",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Istituti Clinici Maugeri Pneumologia, Tradate, Lombardia, 21049, Italy"
NCT02885428,Detection no Invasive of a Silent Myocardial Ischemia,https://clinicaltrials.gov/study/NCT02885428,TERMINATED,Silent Myocardial Ischemia|Type 2 Diabetes,DEVICE: echography,"University Hospital, Strasbourg, France",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Les Hôpitaux Universitaires, Strasbourg, 67091, France"
NCT03271580,Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing,https://clinicaltrials.gov/study/NCT03271580,TERMINATED,Wound|Bacterial Infections|Diabetes Mellitus|Infected Ulcer of Skin,DIAGNOSTIC_TEST: Finger prick test for HbA1c measurement|PROCEDURE: Punch Biopsy|OTHER: Vac Sponge Collection|OTHER: Ankle Brachial Index,Indiana University,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"IU Health Methodist Hospital, Indianapolis, Indiana, 46202, United States|Davis Heart and Lung Institute, Columbus, Ohio, 42310, United States|The Ohio State University Hospital East, Columbus, Ohio, 43203, United States|Comprehensive Wound Care Centers, The Ohio State University Hospital, Columbus, Ohio, 43210, United States|Martha Morehouse Medical Plaza, Columbus, Ohio, 43221, United States"
NCT05427916,Closed Incision Negative Pressure Wound Therapy vs. Foam as Post Operative Dressing,https://clinicaltrials.gov/study/NCT05427916,TERMINATED,Diabetes|Morbid Obesity|Lymphedema|Orthopedic Disorder,DEVICE: Avance Solo|OTHER: Optifoam,Icahn School of Medicine at Mount Sinai,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Lauren Rodio, New York, New York, 10019, United States"
NCT04315545,Pregnancy Outcomes and Maternal Insulin Sensitivity,https://clinicaltrials.gov/study/NCT04315545,TERMINATED,"Gestational Diabetes|Other ""Heavy-For-Dates"" Infants|Small for Gestational Age Infant|Diabetes Mellitus, Type 2",DIAGNOSTIC_TEST: meal tolerance test,University Medical Center Groningen,,FEMALE,ADULT,,OBSERVATIONAL,"University Medical Centre Groningen, Groningen, 9713 GZ, Netherlands|Medical Center Leeuwarden, Leeuwarden, 8984 AD, Netherlands"
NCT04909983,An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevices,https://clinicaltrials.gov/study/NCT04909983,TERMINATED,Contact Dermatitis Irritant|Type 1 Diabetes,DEVICE: DPLX-PT1|OTHER: Control arm,Copenhagen University Hospital at Herlev,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Pediatric Department, Herlev Hospital, Herlev, 2730, Denmark"
NCT01803711,Omega 3 FA Supplements as Augmentation in the Treatment of Depression,https://clinicaltrials.gov/study/NCT01803711,TERMINATED,Major Depression|Cancer|Diabetes|Cardiovascular Diseases,DRUG: Desvenlafaxine|DIETARY_SUPPLEMENT: Omega 3 Fatty acids|DRUG: Placebo (for Omega 3 fatty acid supplement),UConn Health,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"University of Connecticut Health Center, Farmington, Connecticut, 06030, United States"
NCT03674957,The Manitoba Personalized Lifestyle Research (TMPLR) Study,https://clinicaltrials.gov/study/NCT03674957,TERMINATED,Diabetes|Cardiovascular Diseases|Chronic Kidney Diseases,,University of Manitoba,Research Manitoba,ALL,ADULT,,OBSERVATIONAL,"University of Manitoba, Winnipeg, Manitoba, R3T 6C5, Canada"
NCT03511521,Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia,https://clinicaltrials.gov/study/NCT03511521,TERMINATED,"Hyperglycemia Steroid-induced|Insulin Resistance, Diabetes",DRUG: NPH Insulin|DRUG: glargine|DRUG: Insulin Aspart,Northwestern University,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States"
NCT03237767,A CFit Study - Acute Exercise,https://clinicaltrials.gov/study/NCT03237767,TERMINATED,Cystic Fibrosis|Cystic Fibrosis-related Diabetes,OTHER: MIE|OTHER: HIIE,University of Portsmouth,"Queen Alexandra Hospital, Portsmouth|University Hospital Southampton NHS Foundation Trust|Loughborough University",ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Sport and Exercise Science, Portsmouth, Hampshire, PO1 2ER, United Kingdom"
NCT01486043,Metformin and Transient Hyperglycemia,https://clinicaltrials.gov/study/NCT01486043,TERMINATED,Acute Lymphoblastic Leukemia|Hyperglycemia|Insulin Resistance|Diabetes Mellitus,DRUG: Metformin,Children's Hospital Los Angeles,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Children's Hospital Los Angeles, Los Angeles, California, 90027, United States"
NCT01947036,T and B Cell Responses in Autoimmune Diseases,https://clinicaltrials.gov/study/NCT01947036,TERMINATED,"Type 1 Diabetes Mellitus|Multiple Sclerosis|Arthritis, Rheumatoid|Crohn's Disease|Psoriasis",,National Institute of Allergy and Infectious Diseases (NIAID),Autoimmunity Centers of Excellence,ALL,"CHILD, ADULT",,OBSERVATIONAL,"Yale University, New Haven, Connecticut, 06511, United States|Emory University, Atlanta, Georgia, 30322, United States|Feinstein Institute for Medical Research, Manhasset, New York, 11030, United States|University of Rochester, Rochester, New York, 14642, United States|Oklahoma Medical Research Foundation, Oklahoma City,, Oklahoma, 73104, United States|Baylor Institute of Immunology Research - Clinical Rheumatology, Dallas, Texas, 75204, United States"
NCT02422446,Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects,https://clinicaltrials.gov/study/NCT02422446,TERMINATED,Type 2 Diabetes|Coronary Artery Disease,DRUG: Icosapent ethyl,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Brigham and Women's Hospital, Boston, Massachusetts, 02120, United States"
NCT03757910,Brain Imaging in the Diabetes Prevention Program Outcomes Study,https://clinicaltrials.gov/study/NCT03757910,TERMINATED,Alzheimer Disease,DRUG: 18F-MK-6240|DRUG: 11C-PIB,José A. Luchsinger,Albert Einstein College of Medicine|George Washington University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,INTERVENTIONAL,"Columbia University Irving Medical Center, New York, New York, 10032, United States"
NCT03840343,Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease,https://clinicaltrials.gov/study/NCT03840343,TERMINATED,"Diabetic Kidney Disease|Diabetic Nephropathies|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Chronic Kidney Disease|Diabetic Nephropathy Type 2|Kidney Failure|Kidney Insufficiency",BIOLOGICAL: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose|BIOLOGICAL: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose,Mayo Clinic,Regenerative Medicine Minnesota,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States"
NCT03455985,Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin,https://clinicaltrials.gov/study/NCT03455985,TERMINATED,"Diabetes Mellitus, Type 2|Patient Discharge|Blood Glucose, Low|Blood Glucose, High",OTHER: Discharge Order Set (DOS)|OTHER: Enhanced Standard Care (ESC),Ohio State University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"The Ohio State University, Columbus, Ohio, 43210, United States"
NCT04134143,Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT04134143,TERMINATED,Diabetes|Diabetic Foot Ulcer|Non-healing Wound,BIOLOGICAL: ExpressGraft-C9T1 Skin Tissue,"Stratatech, a Mallinckrodt Company",,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Titan Clinical Research, Phoenix, Arizona, 85004, United States|Limb Preservation Platform, Inc., Fresno, California, 93710, United States|Center For Clinical Resarch, San Francisco, California, 94115, United States|Center for Advanced Research & Education, Gainesville, Georgia, 30501, United States"
NCT03538015,Carvedilol in Treating Hypoglycemia Unawareness,https://clinicaltrials.gov/study/NCT03538015,TERMINATED,Hypoglycemia Unawareness,DRUG: Carvedilol 3.125 mg|DRUG: Carvedilol 2.5 mg|DRUG: Placebo capsule,"Owen Chan, PhD",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Utah, Salt Lake City, Utah, 84132, United States"
NCT00464061,Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus,https://clinicaltrials.gov/study/NCT00464061,TERMINATED,Sleep Initiation and Maintenance Disorders,DRUG: Volinanserin|DRUG: Placebo,Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, 08807, United States|Sanofi-Aventis Administrative Office, Buenos Aires, Argentina|Sanofi-Aventis Administrative Office, Macquarie Park, Australia|Sanofi-Aventis Administrative Office, Vienna, Austria|Sanofi-Aventis Administrative Office, Diegem, Belgium|Sanofi-Aventis Administrative Office, Sao Paulo, Brazil|Sanofi-Aventis Administrative Office, Laval, Canada|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-Aventis Administrative Office, Santafe de Bogota, Colombia|Sanofi-Aventis Administrative Office, Praha, Czech Republic|Sanofi-Aventis Administrative Office, Berlin, Germany|Anofi-Aventis Administrative Office, Causeway Bay, Hong Kong|Sanofi-Aventis Administrative Office, Mumbai, India|Sanofi-Aventis Administrative Office, Milano, Italy|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Mexico, Mexico|Sanofi-Aventis Administrative Office, Moscow, Russian Federation|Sanofi-Aventis Administrative Office, Singapore, Singapore|Sanofi-Aventis Administrative Office, Midrand, South Africa|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Istanbul, Turkey|Sanofi-Aventis Administrative Office, Guildford, Surrey, United Kingdom"
NCT00084110,Use of Complementary and Alternative Medicine Among Older Mexican Americans,https://clinicaltrials.gov/study/NCT00084110,TERMINATED,Arthritis|Diabetes Mellitus|Fractures|Hypertension|Depression|Urinary Incontinence,,National Center for Complementary and Integrative Health (NCCIH),,ALL,OLDER_ADULT,,OBSERVATIONAL,"Jose A. Loera, Galveston, Texas, 77555-0460, United States"
NCT00068094,The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics,https://clinicaltrials.gov/study/NCT00068094,TERMINATED,Fatty Liver|Hepatic Steatosis|Diabetes Mellitus|Liver Diseases,DRUG: Probiotic-containing powder,National Center for Complementary and Integrative Health (NCCIH),,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Johns Hopkins University, Baltimore, Maryland, 21205, United States"
NCT00171119,"A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril",https://clinicaltrials.gov/study/NCT00171119,TERMINATED,Hypertension|Diabetic Nephropathy,DRUG: valsartan,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Novartis Pharmaceuticals, Basel, Switzerland"
NCT04741074,Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy,https://clinicaltrials.gov/study/NCT04741074,TERMINATED,CKD|Diabetic Kidney Disease|Type 2 Diabetes Mellitus in Obese|Obesity|Severe Obesity,"DRUG: Semaglutide 2 mg/1.5 ml (1.34 mg/ml), prefilled pen-injector for subcutaneous injection solution|DRUG: Placebo 1.5 ml, prefilled pen-injector for subcutaneous injection solution",Geisinger Clinic,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Geisinger Medical Center, Danville, Pennsylvania, 17821, United States|Geisinger Wyoming Valley, Wilkes-Barre, Pennsylvania, 18702, United States"
NCT04028960,IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase,https://clinicaltrials.gov/study/NCT04028960,TERMINATED,Type1diabetes,"DRUG: Regular insulin (Humulin-R), intranasal route|DEVICE: SipNose intranasal device",HealthPartners Institute,International Diabetes Center at Park Nicollet|Juvenile Diabetes Research Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Health Partners Institute dba International Diabetes Center, Minneapolis, Minnesota, 55416, United States"
NCT05033275,Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy,https://clinicaltrials.gov/study/NCT05033275,TERMINATED,Infant of Diabetic Mother|Sacral Agenesis,,University of Missouri-Columbia,,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"MU, Columbia, Missouri, 65201, United States"
NCT05188586,New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED),https://clinicaltrials.gov/study/NCT05188586,TERMINATED,Pancreatic Cancer,OTHER: MRI/Imaging,ClearNote Health,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Headlands Research - Scottsdale - PPDS, Scottsdale, Arizona, 85260-6411, United States|JEM Research Institute - Headlands - PPDS, Atlantis, Florida, 33462-6631, United States|Prisma Health/Endocrinology specialist and Thyroid, Greenville, South Carolina, 29605-4289, United States|Consano Clinical Research, LLC, Shavano Park, Texas, 78231-1281, United States|Manassas Clinical Research Center, Manassas, Virginia, 20110-4421, United States"
NCT00961207,Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients,https://clinicaltrials.gov/study/NCT00961207,TERMINATED,Microalbuminuria|Macroalbuminuric Diabetic Nephropathy|Diabetes|Proteinuria|Albuminuria,DRUG: Aliskiren|DRUG: Aliskiren,Cook County Health,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"John H Stroger Hospital of Cook County, Chicago, Illinois, 60612, United States"
NCT03234387,A CFit Study - Baseline,https://clinicaltrials.gov/study/NCT03234387,TERMINATED,Cystic Fibrosis (CF)|Cystic Fibrosis-related Diabetes,OTHER: No intervention - only assessments.,University of Portsmouth,University Hospital Southampton NHS Foundation Trust|Loughborough University|Queen Alexandra Hospital,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"Department of Sport and Exercise Science, Portsmouth, Hampshire, PO1 2ER, United Kingdom"
NCT03742219,Peru Longitudinal Study,https://clinicaltrials.gov/study/NCT03742219,TERMINATED,Cardiovascular Diseases|Diabetes Mellitus|Hypertension|Dyslipidemias|Overweight and Obesity,BEHAVIORAL: Lifestyle Modification,Ohio University,,ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Ohio University, Athens, Ohio, 45701, United States"
NCT01375166,Coupling of Neural Activity and Retinal Blood Flow in Diabetes,https://clinicaltrials.gov/study/NCT01375166,TERMINATED,Diabetic Retinopathy,,Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Department of Clinical Pharmacology, Vienna, 1090, Austria"
NCT05396443,Telehealth Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes,https://clinicaltrials.gov/study/NCT05396443,TERMINATED,"Obesity, Childhood|Type2Diabetes",BEHAVIORAL: Black Girls for Wellness Telehealth,Weill Medical College of Cornell University,Cornell University|National Institute on Minority Health and Health Disparities (NIMHD),FEMALE,"CHILD, ADULT",,INTERVENTIONAL,"Brooklyn Methodist Hospital, Brooklyn, New York, 11215, United States|Weill Cornell Medicine, New York, New York, 10021, United States"
NCT04279587,Camp Based Multi-component Intervention for Families of Young Children With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT04279587,TERMINATED,Type1diabetes,BEHAVIORAL: Residential camp,University of Texas Southwestern Medical Center,,ALL,CHILD,,INTERVENTIONAL,"Perrin C White, Dallas, Texas, 75230, United States|Children's Medical Center, Dallas, Texas, 75235, United States"
NCT01028846,Central Mechanisms That Regulate Glucose Metabolism in Humans,https://clinicaltrials.gov/study/NCT01028846,TERMINATED,"Type 2 Diabetes|Glucose Metabolism Disorders|Glucose, High Blood",DRUG: Diazoxide|DRUG: Placebo,Meredith Hawkins,National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|American Diabetes Association,ALL,ADULT,PHASE4,INTERVENTIONAL,"Albert Einstein College of Medicine, Bronx, New York, 10461, United States"
NCT03297762,Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes,https://clinicaltrials.gov/study/NCT03297762,TERMINATED,Type1diabetes,BEHAVIORAL: gamification|BEHAVIORAL: Use of Dexcom G5,Stanford University,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Stanford Children's, Stanford, California, 94305, United States"
NCT00325650,Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00325650,TERMINATED,Prediabetic State,DRUG: Rimonabant|DRUG: Placebo (for Rimonabant),Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis, Bridgewater, New Jersey, 08807, United States"
NCT02204527,Supplementation of Vitamin D in Patients With Type 2 Diabetes and Hypertension,https://clinicaltrials.gov/study/NCT02204527,TERMINATED,Hypertension,DIETARY_SUPPLEMENT: supplementation of 100.000 IU of vitamin D3|DIETARY_SUPPLEMENT: placebo pill,Hospital de Clinicas de Porto Alegre,Federal University of Rio Grande do Sul,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"HCPA, Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, 90035903, Brazil"
NCT00565799,A Pilot Study of Metabolic Effects of Omentectomy,https://clinicaltrials.gov/study/NCT00565799,TERMINATED,Patients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2|Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy|Age 18-64 Years,PROCEDURE: Omentectomy|OTHER: No intervention,NYU Langone Health,Washington University School of Medicine,ALL,ADULT,PHASE2,INTERVENTIONAL,"NYU School of Medicine, NY, New York, 10016, United States"
NCT04270604,Biological Sample Collection for Research and Biobanking,https://clinicaltrials.gov/study/NCT04270604,TERMINATED,"Parkinson Disease|Diabetes Mellitus, Type 1|Macular Degeneration|ALS|Cancer|Alzheimer Disease|Huntington Disease",OTHER: Biological sample collection,New York Stem Cell Foundation Research Institute,,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"New York Stem Cell Foundation Research Institute, New York, New York, 10019, United States"
NCT04173117,Feasibility of Low Energy Diet in HFpEF and Type 2 Diabetes,https://clinicaltrials.gov/study/NCT04173117,TERMINATED,Dietary Exposure,DIETARY_SUPPLEMENT: Low energy meal replacement plan (12 weeks),University of Leicester,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Cardiovascular Research Centre (Glenfield Hospital), Leicester, Leicestershire, LE3 9QP, United Kingdom"
NCT06007508,Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis,https://clinicaltrials.gov/study/NCT06007508,TERMINATED,DKA,DRUG: Insulin Glargine,HealthPartners Institute,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Regions Hospital, Saint Paul, Minnesota, 55101, United States"
NCT02665689,Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab,https://clinicaltrials.gov/study/NCT02665689,TERMINATED,"Visual Acuity Reduced Transiently|Macular Edema, Cystoid",DRUG: ranibizumab,Prof. Dr. Antonia M. Joussen,"Charite University, Berlin, Germany",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Department of Ophthalmology, Charite, Berlin, Berlin, 12203, Germany"
NCT04141475,Evaluation of Alpha-Lipoic Acid in Diabetic Cardiomyopathy,https://clinicaltrials.gov/study/NCT04141475,TERMINATED,Diabetic Cardiomyopathies,DIETARY_SUPPLEMENT: Physiomance acide lipoïque gold|DIETARY_SUPPLEMENT: Placebo - Physiomance acide lipoïque gold,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Nice Hospital, Nice, 06000, France"
NCT00880139,Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes,https://clinicaltrials.gov/study/NCT00880139,TERMINATED,Diabetic Retinopathy|Inflammation,"PROCEDURE: Blood sampling|PROCEDURE: Noninvasive measurement of systemic hemodynamics|PROCEDURE: Visual acuity assessment|DEVICE: Blue field entoptic technique (Blue field stimulator, BFS-2050)|PROCEDURE: Ophthalmic examination and fundus photography|DEVICE: Retinal Vessel Analyzer (DVA)|DEVICE: High resolution optical coherence tomography (OCT)",Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria"
NCT02686281,Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02686281,TERMINATED,Healthy,DRUG: GMC-252-L-Lysine|OTHER: Placebo,Genmedica Therapeutics S.L.,Simbec Research,MALE,ADULT,PHASE1,INTERVENTIONAL,"Simbec Research Ltd, Merthyr Tydfil, CF48 4DR, United Kingdom"
NCT00574834,Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00574834,TERMINATED,Metabolic Syndrome,DRUG: Ramipril|DRUG: HCTZ-hydrochlorothiazide|DRUG: Ramipril+HCTZ,"University of Maryland, Baltimore",King Pharmaceuticals is now a wholly owned subsidiary of Pfizer,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,INTERVENTIONAL,"University of Maryland, Baltimore, Baltimore, Maryland, 21201, United States"
NCT04253860,Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy,https://clinicaltrials.gov/study/NCT04253860,TERMINATED,Diabetic Neuropathy Peripheral,DEVICE: Transcutaneous electrical neurostimulation,Centro Universitario de Tonalá,"University of Guadalajara|Diabetes sin Complicaciones S.A de C.V, Mexico",ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"University of Guadalajara, Guadalajara, Jalisco, 45425, Mexico"
NCT03939065,Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management,https://clinicaltrials.gov/study/NCT03939065,TERMINATED,Cystic Fibrosis-related Diabetes|Cystic Fibrosis Pulmonary Exacerbation|Cystic Fibrosis in Children,DEVICE: Sensor Augmented Pump Therapy|DEVICE: Standard of Care with CGM,"University of Colorado, Denver",Cystic Fibrosis Foundation,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Children's Hospital Colorado, University of Colorado Denver, Aurora, Colorado, 80045, United States"
NCT04006392,An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain,https://clinicaltrials.gov/study/NCT04006392,TERMINATED,Diabetic Peripheral Neuropathy,DEVICE: Erchonia FX-635|DEVICE: Placebo Laser,Erchonia Corporation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Arizona Institute of Footcare Physicians, Mesa, Arizona, 85204, United States|Jeffrey Kleis, DPM, Costa Mesa, California, 92626, United States|Hialeah Hospital Medical Plaza, Hialeah, Florida, 33139, United States|Jordan Steinberg, DPM, Florham Park, New Jersey, 07932, United States"
NCT03660189,Two Bag System for Diabetic Ketoacidosis,https://clinicaltrials.gov/study/NCT03660189,TERMINATED,Diabetic Ketoacidosis,OTHER: Two bag system,MetroHealth Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"MetroHealth Medical Center, Cleveland, Ohio, 44109, United States"
NCT02008851,"A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes",https://clinicaltrials.gov/study/NCT02008851,TERMINATED,Chronic Kidney Disease,BIOLOGICAL: Neo-kidney augment,Tengion,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"University of Chicago Medicine, Chicago, Illinois, 60637, United States|LSU Health Care Services, New Orleans, Louisiana, 70112, United States|Brigham & Women's Hospital, Boston, Massachusetts, 02120, United States|UNC Medical Center, Chapel Hill, North Carolina, 27514, United States|Vanderbilt University, Nashville, Tennessee, 37235, United States"
NCT02393573,Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism,https://clinicaltrials.gov/study/NCT02393573,TERMINATED,Pre-Diabetes|Major Lung or Abdominal Surgery|Insulin Resistance,DRUG: Metformin|DRUG: Placebo,McGill University Health Centre/Research Institute of the McGill University Health Centre,Mitacs|Medtronic - MITG,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Montreal General Hospital, Montreal, Quebec, H3G 1A4, Canada"
NCT03066440,Double Blinded Randomized Control Trial of Types of IVF in Children With DKA,https://clinicaltrials.gov/study/NCT03066440,TERMINATED,Diabetic Ketoacidosis,DRUG: Normal saline|DRUG: Lactated Ringers,State University of New York at Buffalo,,ALL,"CHILD, ADULT",PHASE4,INTERVENTIONAL,"John R. Oishei Children's Hospital, Buffalo, New York, 14203, United States"
NCT02048189,Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes,https://clinicaltrials.gov/study/NCT02048189,TERMINATED,Patient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus Strategy,DRUG: LEVEMIR|DRUG: APIDRA,Centre Hospitalier Universitaire Dijon,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"CHU de Besancon, Besancon, 25000, France|CHU de Dijon, Dijon, 21079, France"
NCT01087203,A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy,https://clinicaltrials.gov/study/NCT01087203,TERMINATED,Diabetic Peripheral Neuropathy,BIOLOGICAL: Tanezumab|BIOLOGICAL: placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Alabama Orthopaedic Clinic, Mobile, Alabama, 36608, United States|Coastal Clinical Research, Inc., Mobile, Alabama, 36608, United States|Dedicated Clinical Research, Goodyear, Arizona, 85395, United States|Valley Radiology, Ltd., Goodyear, Arizona, 85395, United States|Dedicated Clinical Research, Litchfield Park, Arizona, 85340, United States|Clinical Trials, Inc., Little Rock, Arkansas, 72205, United States|Anaheim Hills MRI Holdings, Inc, Anaheim Hills, California, 92807, United States|Fullerton Neurology and Headache Center, Fullerton, California, 92835, United States|NervePro Medical Corporation, Irvine, California, 92618, United States|United Medical Imaging Healthcare (X-Ray Only), Irvine, California, 92618, United States|Coordinated Clinical Research, La Jolla, California, 92037, United States|LabCorp (Draw blood only), La Jolla, California, 92037, United States|Alpine Clinical Research Center, Inc, Boulder, Colorado, 80304, United States|JEM Research Institute, Atlantis, Florida, 33462, United States|Medical Specialists of the Palm Beaches, Atlantis, Florida, 33462, United States|Bradenton Research Center, Inc., Bradenton, Florida, 34205, United States|Innovative Research of West Florida, Inc., Clearwater, Florida, 33756, United States|SJS Clinical Research, Inc., Destin, Florida, 32541, United States|White Wilson Medical Center, Fort Walton Beach, Florida, 32547, United States|MD Clinical, Hallandale Beach, Florida, 33009, United States|Laszlo J. Mate, MD, North Palm Beach, Florida, 33408, United States|Palm Beach Neurological Center, Advanced Research Consultants, Inc., Palm Beach Gardens, Florida, 33418, United States|Neurology Clinical Research, Inc., Sunrise, Florida, 33351, United States|Neurology Specialists of Decatur Research Center, Decatur, Georgia, 30033, United States|Neurology Specialists of Decatur, Decatur, Georgia, 30033, United States|Allied Physicians Inc d/b/a Fort Wayne Neurology, Fort Wayne, Indiana, 46805, United States|American Health Network of IN, LLC, Greenfield, Indiana, 46140-2834, United States|Radiology Department, American Health Network, Greenfield, Indiana, 46140-2834, United States|Lee Research Institute, Lenexa, Kansas, 66215, United States|Mid-Atlantic Medical Research Centers, Hollywood, Maryland, 20636, United States|Michigan Head Pain and Neurological Institute, Ann Arbor, Michigan, 48104, United States|Ozarks Community Hospital Christian County Clinic, Nixa, Missouri, 65714, United States|Clinvest/A Division of Banyan Group, Inc., Springfield, Missouri, 65807, United States|Montana Neuroscience Institute Foundation, Missoula, Montana, 59802, United States|Asheville Neurology Specialists, PA, Asheville, North Carolina, 28806, United States|Joel Vandersluis, MD, Dayton, Ohio, 45417, United States|Hometown Urgent Care and Research, Dayton, Ohio, 45432, United States|Neurology and Neuroscience Center of Ohio, Toledo, Ohio, 43623, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, 73112, United States|Mark A. Fisher M.D. -Private Practice, Oklahoma City, Oklahoma, 73112, United States|Westmoreland Neurology Associates, Inc, Greensburg, Pennsylvania, 15601-2234, United States|The Neurology and Pain Clinic, Orangeburg, South Carolina, 29118, United States|Centex Research/Pineloch Medical Center, Houston, Texas, 77062, United States|Paragon Research Center, LLC, San Antonio, Texas, 78205, United States|Innovative Clinical Trials, San Antonio, Texas, 78229, United States|Daniel B. Vine, MD, Salt Lake City, Utah, 84102, United States|Wasatch Clinical Research, Salt Lake City, Utah, 84107, United States|RGL Medical Services, West Jordan, Utah, 84084, United States"
NCT01050218,Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy,https://clinicaltrials.gov/study/NCT01050218,TERMINATED,"Diabetic Neuropathy, Painful",DRUG: Desvenlafaxine Succinate Sustained-Release (DVS SR),Wyeth is now a wholly owned subsidiary of Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00993018,A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy,https://clinicaltrials.gov/study/NCT00993018,TERMINATED,Diabetic Neuropathy,DRUG: JNJ-42160443 (1 mg)|DRUG: JNJ-42160443 (3 mg)|DRUG: JNJ-42160443 (10 mg)|DRUG: Placebo,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Jonesboro, Arkansas, United States|Fresno, California, United States|La Jolla, California, United States|Long Beach, California, United States|Redondo Beach, California, United States|Tustin, California, United States|Walnut Creek, California, United States|Bradenton, Florida, United States|Palm Beach Gardens, Florida, United States|Baltimore, Maryland, United States|Albany, New York, United States|Syracuse, New York, United States|Winston Salem, North Carolina, United States|Winston-Salem, North Carolina, United States|Toledo, Ohio, United States|Tulsa, Oklahoma, United States|Philadelphia, Pennsylvania, United States|Greer, South Carolina, United States|Tullahoma, Tennessee, United States|Austin, Texas, United States|Houston, Texas, United States|Plano, Texas, United States|San Antonio, Texas, United States|Renton, Washington, United States"
NCT00756041,Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy,https://clinicaltrials.gov/study/NCT00756041,TERMINATED,Diabetic Neuropathies,DRUG: TAK-128,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT00625833,"A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.",https://clinicaltrials.gov/study/NCT00625833,TERMINATED,Diabetic Neuropathies,"DRUG: Placebo|DRUG: [S,S]-Reboxetine",Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Pfizer Investigational Site, Anniston, Alabama, 36207, United States|Pfizer Investigational Site, Birmingham, Alabama, 35235, United States|Pfizer Investigational Site, Mission Viejo, California, 92691, United States|Pfizer Investigational Site, Denver, Colorado, 80209, United States|Pfizer Investigational Site, New Britain, Connecticut, 06050, United States|Pfizer Investigational Site, Waterbury, Connecticut, 06708, United States|Pfizer Investigational Site, Tampa, Florida, 33609, United States|Pfizer Investigational Site, Winter Haven, Florida, 33880, United States|Pfizer Investigational Site, Lexington, Kentucky, 40503, United States|Pfizer Investigational Site, Louisville, Kentucky, 40213, United States|Pfizer Investigational Site, North Dartmouth, Massachusetts, 02747, United States|Pfizer Investigational Site, Jackson, Mississippi, 39202, United States|Pfizer Investigational Site, Tupelo, Mississippi, 38801, United States|Pfizer Investigational Site, Marionville, Missouri, 65705, United States|Pfizer Investigational Site, Springfield, Missouri, 65807, United States|Pfizer Investigational Site, Elizabeth, New Jersey, 07207, United States|Pfizer Investigational Site, Hamilton, New Jersey, 08690, United States|Pfizer Investigational Site, Buffalo, New York, 14209, United States|Pfizer Investigational Site, New York, New York, 10021, United States|Pfizer Investigational Site, New York, New York, 10024, United States|Pfizer Investigational Site, Cranston, Rhode Island, 02920, United States|Pfizer Investigational Site, Cumberland, Rhode Island, 02864, United States|Pfizer Investigational Site, Myrtle Beach, South Carolina, 29572, United States|Pfizer Investigational Site, Bartlett, Tennessee, 38133, United States|Pfizer Investigational Site, Beaumont, Texas, 77701, United States|Pfizer Investigational Site, Beaumont, Texas, 77706, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75246, United States|Pfizer Investigational Site, Dallas, Texas, 75390-8858, United States|Pfizer Investigational Site, Houston, Texas, 77079, United States|Pfizer Investigational Site, Houston, Texas, 77081, United States|Pfizer Investigational Site, Milwaukee, Wisconsin, 53209, United States|Pfizer Investigational Site, Brno, 636 00, Czechia|Pfizer Investigational Site, Ceske Budejovice, 370 87, Czechia|Pfizer Investigational Site, Ostrava, 702 00, Czechia|Pfizer Investigational Site, Zlin, 760 01, Czechia|Pfizer Investigational Site, Helsinki, 00290, Finland|Pfizer Investigational Site, Kokkola, 67100, Finland|Pfizer Investigational Site, Lahti, 15110, Finland|Pfizer Investigational Site, Lohja, 08200, Finland|Pfizer Investigational Site, Almere, 1311 RL, Netherlands|Pfizer Investigational Site, Amsterdam, 1105 AZ, Netherlands|Pfizer Investigational Site, Venlo, 5912 BL, Netherlands|Pfizer Investigational Site, Worcester, Cape Town, 6850, South Africa|Pfizer Investigational Site, Bloemfontein, Free State, 9301, South Africa|Pfizer Investigational Site, Ennerdale, Gauteng, 1820, South Africa|Pfizer Investigational Site, Tshwane, Gauteng, 0204, South Africa|Pfizer Investigational Site, Stanger, Kwa- Zulu Natal, 4450, South Africa|Pfizer Investigational Site, Durban, KwaZulu Natal, 4000, South Africa|Pfizer Investigational Site, Cape Town, 7130, South Africa|Pfizer Investigational Site, L'hospitalet de Llobregat, Barcelona, 08907, Spain|Pfizer Investigational Site, Santiago de Compostela, LA Coruña, 15706, Spain|Pfizer Investigational Site, Barcelona, 08035, Spain|Pfizer Investigational Site, Madrid, 28040, Spain|Pfizer Investigational Site, Pontevedra, 36071, Spain|Pfizer Investigational Site, Valencia, 46014, Spain"
NCT00487981,Spinal Cord Stimulation for Painful Diabetic Neuropathy,https://clinicaltrials.gov/study/NCT00487981,TERMINATED,Diabetic Neuropathy|Pain|Peripheral Neuropathy,DEVICE: Precision Spinal Cord Stimulation,Boston Scientific Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Deaconess Pain Management Center, Evansville, Indiana, 47747, United States"
NCT00283842,Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy,https://clinicaltrials.gov/study/NCT00283842,TERMINATED,Diabetic Neuropathies|Pain,DRUG: DVS SR|DRUG: Placebo,Wyeth is now a wholly owned subsidiary of Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Mesa, Arizona, 85210, United States|Peoria, Arizona, 85381, United States|Phoenix, Arizona, 85016, United States|Encino, California, 91316, United States|Newport Beach, California, 92660, United States|Walnut Creek, California, 94598, United States|Pueblo, Colorado, 81001, United States|New Britain, Connecticut, 06050, United States|Stratford, Connecticut, 06615, United States|Waterbury, Connecticut, 06708, United States|Ft. Myers, Florida, 33907, United States|Palm Beach Gardens, Florida, 33418, United States|Pembroke Pines, Florida, 33026, United States|St. Petersburg, Florida, 33709, United States|West Palm Beach, Florida, 33401, United States|Lawrenceville, Georgia, 30045, United States|Roswell, Georgia, 30076, United States|Coeur D'Alene, Idaho, 83814, United States|Chicago, Illinois, 60610, United States|Evansville, Indiana, 47714, United States|Des Moines, Iowa, 50314, United States|Madisonville, Kentucky, 42431, United States|Springfield, Massachusetts, 01199, United States|Ann Arbor, Michigan, 48106, United States|Kansas City, Missouri, 64114, United States|St. Louis, Missouri, 63117, United States|St. Louis, Missouri, 63141, United States|Billings, Montana, 59101, United States|Omaha, Nebraska, 88131, United States|Albany, New York, 12205, United States|Flushing, New York, 11365, United States|New York, New York, 10024, United States|Rochester, New York, 14621, United States|Staten Island, New York, 10312, United States|Fargo, North Dakota, 58104, United States|Cincinnati, Ohio, 45236, United States|Dayton, Ohio, 45432, United States|Toledo, Ohio, 43623, United States|Collegeville, Pennsylvania, 19426, United States|Feasterville, Pennsylvania, 19053, United States|Harleysville, Pennsylvania, 19438, United States|Warwick, Rhode Island, 02886, United States|Austin, Texas, 78705, United States|Dallas, Texas, 75246, United States|San Antonio, Texas, 78229, United States|Midvale, Utah, 84047, United States|Salt Lake City, Utah, 84106, United States|Virginia Beach, Virginia, 23451, United States|Lakewood, Washington, 98499, United States|Tacoma, Washington, 98405, United States|Milwaukee, Wisconsin, 53209, United States"
NCT03635671,Diabetic Retinopathy and Subclinical Signs of Disease Transition,https://clinicaltrials.gov/study/NCT03635671,TERMINATED,Diabetic Retinopathy,DIAGNOSTIC_TEST: Optical Coherence Tomography Angiography,University of British Columbia,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Eye Care Center, Vancouver, British Columbia, V5Z 3N9, Canada"
NCT02136758,Cardiovascular Risk Clinic,https://clinicaltrials.gov/study/NCT02136758,TERMINATED,Cardiovascular Disease|Coronary Artery Disease|Hypertension|Diabetes|Obesity,BEHAVIORAL: CRC lifestyle modification program,Windber Research Institute,Walter Reed National Military Medical Center,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Windber Research Institute, Windber, Pennsylvania, 15963, United States"
NCT01788930,Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients,https://clinicaltrials.gov/study/NCT01788930,TERMINATED,Atherothrombosis|Type 2 Diabetes|Obstructive Sleep Apnea Syndrome,DEVICE: CPAP,"University Hospital, Grenoble",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Grenoble University Hospital, Grenoble, Isere, France"
NCT05268926,TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension,https://clinicaltrials.gov/study/NCT05268926,TERMINATED,Albuminuria,DRUG: Dapagliflozin 10Mg Tab|DRUG: Placebo,University Medical Center Groningen,AstraZeneca,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"UMCG, Groningen, Netherlands"
NCT05464407,High Protein Oral Nutritional Support With Special Nutrients in Patients With Type 2 Diabetes and Foot Ulcer,https://clinicaltrials.gov/study/NCT05464407,TERMINATED,Healing Ulcer,DIETARY_SUPPLEMENT: Cubitan,Aalborg University Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Aalborg University Hospital, Aalborg, 9000, Denmark"
NCT04246619,"Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life",https://clinicaltrials.gov/study/NCT04246619,TERMINATED,Painful Diabetic Peripheral Neuropathy,DRUG: Pregabalin|DRUG: Duloxetine,KRKA,3ARH|INTERBORA|University Medical Centre Maribor,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Opća bolnica Karlovac, Karlovac, Croatia|Clinical Medical Center Osijek, Osijek, Croatia|KB Merkur, Sveučilišna klinika Vuk Vrhovac, Zagreb, Croatia|Klinička bolnica Sveti Duh, Zagreb, Croatia|JZU Univerzitetska klinika za endokrinologija, dijabetes I metabolicki bolesti - Skopje, Skopje, North Macedonia|JZU Univerzitetska klinika za nevrologija, Skopje, North Macedonia|Gabinet Neurologiczny, prof. Adam Stępień, Warszawa, Poland|Poradnia neurologiczna, Centrum terapii dzieci i Dorosłych FIMEDICA Sp. z o.o., Warszawa, Poland|Klinički centar Srbije, Belgrade, Serbia|Klinički centar Niš, Niš, Serbia|Klinički centar Vojvodine, Novi Sad, Serbia|Zdravstveni dom Koper, Koper, 6000, Slovenia|Clemenz Marjetka - Nevrološka Ordinacija, Ljubljana, 1000, Slovenia"
NCT03297294,Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN),https://clinicaltrials.gov/study/NCT03297294,TERMINATED,Painful Diabetic Neuropathy,DRUG: EMA401|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Novartis Investigative Site, Broadmeadow, New South Wales, 2292, Australia|Novartis Investigative Site, Orange, New South Wales, 2800, Australia|Novartis Investigative Site, Adelaide, South Australia, 5000, Australia|Novartis Investigative Site, Heidelberg Heights, Victoria, 3081, Australia|Novartis Investigative Site, Graz, A-8036, Austria|Novartis Investigative Site, Klagenfurt, 9020, Austria|Novartis Investigative Site, Wien, A-1090, Austria|Novartis Investigative Site, Edegem, 2650, Belgium|Novartis Investigative Site, Liege, 4000, Belgium|Novartis Investigative Site, Pellenberg, 3212, Belgium|Novartis Investigative Site, Sofia, Sofia-Grad, 1336, Bulgaria|Novartis Investigative Site, Sofia, 1000, Bulgaria|Novartis Investigative Site, Sofia, 1407, Bulgaria|Novartis Investigative Site, Sofia, 1431, Bulgaria|Novartis Investigative Site, Ontario, CAN, L4J 1W3, Canada|Novartis Investigative Site, Thornhill, Ontario, L4J 8L7, Canada|Novartis Investigative Site, Toronto, Ontario, M4G 3E8, Canada|Novartis Investigative Site, Laval, Quebec, H7T 2P5, Canada|Novartis Investigative Site, Aarhus, 8000, Denmark|Novartis Investigative Site, Gentofte, DK 2820, Denmark|Novartis Investigative Site, Odense C, DK 5000, Denmark|Novartis Investigative Site, Tampere, FIN-33520, Finland|Novartis Investigative Site, Boulogne Billancourt, 92104, France|Novartis Investigative Site, Bielefeld, D 33647, Germany|Novartis Investigative Site, Duesseldorf, 40225, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Halle (Saale), 06120, Germany|Novartis Investigative Site, Kassel, Germany|Novartis Investigative Site, Kiel, 24119, Germany|Novartis Investigative Site, Leipzig, 04109, Germany|Novartis Investigative Site, Wiesbaden, 65191, Germany|Novartis Investigative Site, Debrecen, HUN, 4032, Hungary|Novartis Investigative Site, Esztergom, HUN, 2500, Hungary|Novartis Investigative Site, Szeged, HUN, 6720, Hungary|Novartis Investigative Site, Balatonfured, 8230, Hungary|Novartis Investigative Site, Budapest, 1085, Hungary|Novartis Investigative Site, Budapest, 1089, Hungary|Novartis Investigative Site, Kistarcsa, 2143, Hungary|Novartis Investigative Site, Pecs, 7632, Hungary|Novartis Investigative Site, Szeged, 6725, Hungary|Novartis Investigative Site, Oslo, 0450, Norway|Novartis Investigative Site, Krakow, POL, 31 505, Poland|Novartis Investigative Site, Bialystok, 15-351, Poland|Novartis Investigative Site, Warszawa, 00 144, Poland|Novartis Investigative Site, Caldas da Rainha, 2500 176, Portugal|Novartis Investigative Site, Lisboa, 1250 203, Portugal|Novartis Investigative Site, Matosinhos, 4454 509, Portugal|Novartis Investigative Site, Porto, 4200 319, Portugal|Novartis Investigative Site, Viana do Castelo, 4901858, Portugal|Novartis Investigative Site, Vila Nova de Gaia, 4434 502, Portugal|Novartis Investigative Site, Lucenec, Slovak Republic, 98401, Slovakia|Novartis Investigative Site, Bratislava, 83305, Slovakia|Novartis Investigative Site, Bratislava, 85101, Slovakia|Novartis Investigative Site, Presov, 080 01, Slovakia|Novartis Investigative Site, Presov, 08001, Slovakia|Novartis Investigative Site, Sevilla, Andalucia, 41014, Spain|Novartis Investigative Site, Madrid, 28222, Spain|Novartis Investigative Site, Bradford, West Yorkshire, BD9 6RJ, United Kingdom|Novartis Investigative Site, Bath, BA1 3NG, United Kingdom|Novartis Investigative Site, Bournemouth, BH7 7DW, United Kingdom|Novartis Investigative Site, Edinburgh, EH4 2XU, United Kingdom|Novartis Investigative Site, London, SE1 7EH, United Kingdom|Novartis Investigative Site, Middlesborough, TS4 3BW, United Kingdom|Novartis Investigative Site, Oldham, OL1 2JH, United Kingdom"
NCT01591902,Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®,https://clinicaltrials.gov/study/NCT01591902,TERMINATED,Diabetic Retinopathy|HIV,DRUG: Tesamorelin|DRUG: Placebo-Control,Theratechnologies,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Southwest Center for HIV/AIDS, Phoenix, Arizona, 85004, United States|Spectrum Medical Group, Phoenix, Arizona, 85012, United States|5P21 Rand Schrader Clinic, Los Angeles, California, 90033, United States|University of California CARE Clinic, Los Angeles, Los Angeles, California, 90035, United States|Palmtree Clinical Research, Inc., Palm Springs, California, 92262, United States|UCSD Antiviral Research Center, San Diego, California, 92103, United States|VAMC, Infectious Disease Section 111W, San Francisco, California, 94121, United States|Capital Medical Associates, PC, Washington, District of Columbia, 20036, United States|Gary J. Richmond, M.D., PA, Fort Lauderdale, Florida, 33316, United States|Orange County Health Department, Orlando, Florida, 32809, United States|Triple O Research Institute, West Palm Beach, Florida, 33401, United States|Rowan Tree Medical , P.A., Wilton Manors, Florida, 33305, United States|Be Well Medical Center, P.C., Berkley, Michigan, 48072-3436, United States|Southampton Clinical Research, Inc d.b.a. Central West Clinical Research, Saint Louis, Missouri, 63108, United States|Southampton Healthcare, Inc., Saint Louis, Missouri, 63139, United States|South Jersey Infectious Disease, Somers Point, New Jersey, 08244, United States|Harold Hamm Diabetes Center at the University of Oklahoma, Oklahoma City, Oklahoma, 73104, United States|Fanno Creek Clinic, LLC, Portland, Oregon, 97219, United States|Central Texas Clinical Research, Austin, Texas, 78705, United States|St. Hope Foundation, Inc., Bellaire, Texas, 77401, United States|Dallas VA Medical Center, Dallas, Texas, 75216, United States|UT Southwestern Medical Center, Atten: HIV Research Unit, Dallas, Texas, 75235, United States|Research Access Network, Houston, Texas, 77098, United States|Virginia Mason Medical Center, Seattle, Washington, 98112, United States"
NCT05066230,A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR),https://clinicaltrials.gov/study/NCT05066230,TERMINATED,Non-proliferative Diabetic Retinopathy,DRUG: KSI-301|OTHER: Sham injection,Kodiak Sciences Inc,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Retinal Research Institute, LLC, Phoenix, Arizona, 85014, United States|Retina Vitreous Associates, Beverly Hills, California, 90211, United States|Retina Consultants of Orange County, Fullerton, California, 92835, United States|Retina Consultants of Southern California, Redlands, California, 92374, United States|Retinal Consultants Medical Group Inc, Sacramento, California, 95825, United States|California Retina Consultants - Santa Maria, Santa Maria, California, 93454, United States|Connecticut Eye Consultants, Danbury, Connecticut, 06810, United States|Retina Group of New England, Waterford, Connecticut, 06385, United States|The Macula Center/ Blue Ocean Clinical Research, Clearwater, Florida, 33761, United States|Retina Group of Florida, Fort Lauderdale, Florida, 33308, United States|Florida Eye Associates, Melbourne, Florida, 32901, United States|Med Eye Associates, Miami, Florida, 33143, United States|Florida Retina Institute, Orlando, Florida, 32806, United States|Center for Retina & Macular Disease, Winter Haven, Florida, 33880, United States|Southeast Retina Center, Augusta, Georgia, 30909, United States|Retina Specialists of Idaho, Boise, Idaho, 83713, United States|University of Chicago, Chicago, Illinois, 60637, United States|Springfield Clinic LLP, Springfield, Illinois, 62703, United States|Retina Associates PA, Lenexa, Kansas, 66215, United States|Cumberland Valley Retina Consultants PC, Hagerstown, Maryland, 21740, United States|Foundation for Vision Research, Grand Rapids, Michigan, 49525, United States|Sierra Eye Associates, Reno, Nevada, 89502, United States|Envision Ocular LLC, Bloomfield, New Jersey, 07003, United States|Long Island Vitreoretinal Consultants, Hauppauge, New York, 11788, United States|Ophthalmic Consultants of Long Island, Oceanside, New York, 11572, United States|Graystone Eye, Hickory, North Carolina, 28603-2588, United States|Cascade Medical Research Institute, Eugene, Oregon, 97401, United States|MidAtlantic Retina, Bethlehem, Pennsylvania, 18017-9412, United States|Charleston Neurosciences Institute, Beaufort, South Carolina, 29902, United States|Charleston Neuroscience Center, Charleston, South Carolina, 29414, United States|Southeastern Retina Associates PC, Knoxville, Tennessee, 37909, United States|Charles Retina Institute, Memphis, Tennessee, 38119-4823, United States|Tennessee Retina PC, Nashville, Tennessee, 37203, United States|Retina Research Institute of Texas, Abilene, Texas, 79606, United States|Panhandle Eye Group, LLP, Amarillo, Texas, 79106, United States|Austin Retina Associates, Austin, Texas, 78705, United States|Retina Consultants of Texas (Houston), Bellaire, Texas, 77401, United States|Star Vision Consultants, Burleson, Texas, 76028, United States|Retina Consultants of Texas (Katy), Katy, Texas, 77494, United States|Texas Retina Associates, Plano, Texas, 75075, United States|Austin Retina Associates (Round Rock), Round Rock, Texas, 78681, United States|Medical Center Ophthalmology Associates, San Antonio, Texas, 78240, United States|Retina Consultants of San Antonio, San Antonio, Texas, 78240, United States|Retina Consultants of Texas - (Woodlands), The Woodlands, Texas, 77384, United States|Piedmont Eye Center, Lynchburg, Virginia, 24502, United States|Spokane Eye, Spokane, Washington, 99204, United States|OFTEX s.r.o., Pardubice, Pardubický Kraj, 530 02, Czechia|Axon Clinical, s.r.o., Praha 5, 15 0 00, Czechia|Pauls Stradins Clinical University Hospital, Riga, LV-1002, Latvia|Latvian American Eye Center, Rīga, LV-1009, Latvia|Warszawski Szpital Okulistyczny, Warszawa, Mazowieckie, 01-258, Poland|Optimum Profesorskie Centrum Okulistyki, Gdansk, Pomorskie, 80-952, Poland|Oftalmika Sp. z o.o., Bydgoszcz, 85-631, Poland|Emanuelli Research & Development Center LLC, Arecibo, 00612, Puerto Rico|Fakultna nemocnica s poliklinikou F. D. Roosevelta, Banska Bystrica, 975 17, Slovakia|Fakultna nemocnica Trencin, Trencin, 911 71, Slovakia|Hospital Universitario de Bellvitge, L'hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Universitari General de Catalunya - Grupo Quironsalud, Sant Cugat del Valles, Barcelona, 08195, Spain|Hospital Universitario Puerta de Hierro - Majadahonda, Madrid, Majadanonda, 28220, Spain|Hospital Clinico Universitario Lozano Blesa, Zaragoza, 50001, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50006, Spain"
NCT05038020,A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI),https://clinicaltrials.gov/study/NCT05038020,TERMINATED,Diabetic Retinopathy,DRUG: AKST4290|DRUG: Placebo,"Alkahest, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Site 132, Phoenix, Arizona, 85021, United States|Site 136, Phoenix, Arizona, 85053, United States|Site 123, Glendale, California, 91203, United States|Site 121, Huntington Beach, California, 92647, United States|Site 116, Clearwater, Florida, 33761, United States|Site 117, Sarasota, Florida, 34239, United States|Site 118, Winter Haven, Florida, 33880, United States|Site 120, Oak Forest, Illinois, 60452, United States|Site 133, Beaufort, South Carolina, 29902, United States|Site 127, Ladson, South Carolina, 29456, United States|Site 122, Arlington, Texas, 76012, United States|Site 130, Bellaire, Texas, 77401, United States|Site 126, Harlingen, Texas, 78550, United States|Site 134, Houston, Texas, 77025, United States|Site 129, Katy, Texas, 77494, United States|Site 128, San Antonio, Texas, 78240, United States|Site 125, Salt Lake City, Utah, 84107, United States"
NCT03230266,Root Cause Determination of Catheter Obstructions,https://clinicaltrials.gov/study/NCT03230266,TERMINATED,Type1diabetes,PROCEDURE: Collection of intra-peritoneal catheters for insulin infusion,"University Hospital, Montpellier",Juvenile Diabetes Research Foundation,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Montpellier University Hospital, Montpellier, 34295, France"
NCT02372578,Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy,https://clinicaltrials.gov/study/NCT02372578,TERMINATED,Painful Diabetic Peripheral Neuropathy (PDPN),DRUG: ASP3662|DRUG: pregabalin|DRUG: ASP3662 placebo|DRUG: pregabalin placebo,"Astellas Pharma Global Development, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Site US10001, Anniston, Alabama, 36207, United States|Site US10039, Phoenix, Arizona, 85023, United States|Site US10054, Fresno, California, 93720, United States|Site US10020, Lomita, California, 90717, United States|Site US10047, Santa Monica, California, 90404, United States|Site US10017, Tustin, California, 92780, United States|Site US10055, Walnut Creek, California, 94598, United States|Site US10053, Fairfield, Connecticut, 06824, United States|Site US10005, Boynton Beach, Florida, 33436, United States|Site US10023, Bradenton, Florida, 34205, United States|Site US10018, Clearwater, Florida, 33765, United States|Site US10019, DeLand, Florida, 32720, United States|Site US10004, Homestead, Florida, 33030, United States|Site US10042, Jacksonville, Florida, 32256, United States|Site US10007, Jupiter, Florida, 33458, United States|Site US10041, Miami Lakes, Florida, 33014, United States|Site US10046, Orlando, Florida, 32806, United States|Site US10008, Ormond Beach, Florida, 32174, United States|Site US10003, Oviedo, Florida, 32765, United States|Site US10049, The Villages, Florida, 32162, United States|Site US10009, Aurora, Illinois, 60506, United States|Site US10036, Chicago, Illinois, 60624, United States|Site US10025, Evansville, Indiana, 47714, United States|Site US10064, Metairie, Louisiana, 70006, United States|Site US10051, Boston, Massachusetts, 02115, United States|Site US10026, New Bedford, Massachusetts, 02740-2133, United States|Site US10063, Quincy, Massachusetts, 02169, United States|Site US10043, Hazelwood, Missouri, 63042, United States|Site US10013, Kettering, Ohio, 45429, United States|Site US10014, Duncansville, Pennsylvania, 16635, United States|Site US10015, Greer, South Carolina, 29651, United States|Site US10034, Austin, Texas, 78731, United States|Site US10040, Houston, Texas, 77030, United States|Site US10032, San Antonio, Texas, 78218, United States|Site US10031, San Antonio, Texas, 78228, United States|Site US10033, Salt Lake City, Utah, 84107, United States|Site US10045, Renton, Washington, 98057, United States"
NCT01880372,The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT01880372,TERMINATED,Moderate Non-proliferative Diabetic Retinopathy,DIETARY_SUPPLEMENT: Alpha Lipoic Acid,Ferris State University,Retina Specialists of Michigan,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Ferris State University, Big Rapids, Michigan, 49307, United States|Retina Specialists of Michigan, Grand Rapids, Michigan, 49525, United States"
NCT04387448,"A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease",https://clinicaltrials.gov/study/NCT04387448,TERMINATED,"Kidney Diseases|Diabetic Nephropathies|Glomerulosclerosis, Focal Segmental|Nephrosis, Lipoid|Urologic Diseases|Diabetes Complications|Diabetes Mellitus|Endocrine System Diseases|Glomerulonephritis|Nephritis|Nephrosis",DRUG: GFB-887|DRUG: Placebo,"Goldfinch Bio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Alabama at Birmingham, Birmingham, Alabama, 35392, United States|Aventiv Research - Phoenix, Mesa, Arizona, 85210-6041, United States|Arizona Kidney Disease & Hypertension Centers (AKDHC), Scottsdale, Arizona, 85258, United States|Academic Medical Research Institute (AMRI), Glendale, California, 90022, United States|Amicis Research Center, Granada Hills, California, 91344, United States|Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States|Amicis Research Center, Northridge, California, 91324, United States|Valley Renal Medical Group, Northridge, California, 91324, United States|Respire Research - Palm Springs, Palm Springs, California, 92262, United States|Dr. Malvin Yan Inc., S. Gate, California, 90280, United States|North American Research Institute, San Dimas, California, 91773, United States|Valiance Clinical Research - Tarzana, Tarzana, California, 91356, United States|Amicis Research Center, Vacaville, California, 95687, United States|DaVita Mojave Sage Dialysis, Victorville, California, 92395-8322, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States|Colorado Kidney Care (Denver Nephrology), Denver, Colorado, 80230, United States|Western Nephrology - Westminster, Wheat Ridge, Colorado, 80033, United States|DaVita Hartford North, Hartford, Connecticut, 06112, United States|Nephrology Associationes, P.A., Newark, Delaware, 19713, United States|Prohealth Research Center - Doral, Doral, Florida, 33166, United States|Clinical Site Partners Leesburg, LLC, Leesburg, Florida, 34748, United States|Premier Clinical Research Institute, Miami, Florida, 33122, United States|Kidney & Hypertension Specialists of Miami, Miami, Florida, 33150, United States|Avanza Medical Research Center, Pensacola, Florida, 32503, United States|Coastal Nephrology Associates Research Center, LLC, Port Charlotte, Florida, 33952, United States|Florida Premier Research Institute - Clay Street, Winter Park, Florida, 32789, United States|Masters of Clinical Research, Inc., Augusta, Georgia, 30909, United States|Inova Clinical Trials and Research Center, Tyrone, Georgia, 30290, United States|Boise Kidney and Hypertension Institute, Meridian, Idaho, 83642, United States|Research by Design, LLC, Chicago, Illinois, 60643, United States|Adventist Health Partners, Hinsdale, Illinois, 60521, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|University of Iowa College of Public Health, Iowa City, Iowa, 52242, United States|My Kidney Center, LLC, Manhattan, Kansas, 66502, United States|Louisiana Kidney Update, LLC, Lafayette, Louisiana, 70506, United States|Louisiana State University Health Sciences Center - School of Medicine - New Orleans, New Orleans, Louisiana, 70112, United States|University of Maryland Medical Center, Baltimore, Maryland, 21201, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Renal and Transplant Associates of New England, PC, Springfield, Massachusetts, 01107, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Wayne State University School of Medicine, Detroit, Michigan, 48201, United States|St. Clair Nephrology, Roseville, Michigan, 48066, United States|DaVita Clinical Research, Edina, Minnesota, 55435, United States|University of Minnesota - Center for Pediatric Obesity Medicine, Minneapolis, Minnesota, 55414, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Nephrology & Hypertension Associates Ltd, Tupelo, Mississippi, 38801, United States|Clinical Research Consultants, Kansas City, Missouri, 64111, United States|DaVita Pelican Point Dialysis, Las Vegas, Nevada, 89129, United States|Sierra Nevada Nephrology Consultants, Reno, Nevada, 89511, United States|Mount Sinai Medical Center, New York, New York, 10029, United States|Columbia University Medical Center, New York, New York, 10032, United States|Eastern Nephrology Associates PLLC, New Bern, North Carolina, 28562, United States|Akron Nephrology Associates, Inc., Akron, Ohio, 44302, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, 43210, United States|Northeast Clinical Research Center, Bethlehem, Pennsylvania, 18017, United States|Rhode Island Hospital, East Providence, Rhode Island, 02915, United States|South Carolina Nephrology and Hypertension, Orangeburg, South Carolina, 29118, United States|Southeast Renal Research Institute, Chattanooga, Tennessee, 37404, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Texas Tech University Health Sciences Center - Amarillo, Amarillo, Texas, 79106, United States|Arlington Nephrology, PC, Arlington, Texas, 76015, United States|Conroe Willis Medical Research, Conroe, Texas, 77304, United States|Renal Disease Research Institute, Dallas, Texas, 75235, United States|El Paso Kidney Specialists, PA, El Paso, Texas, 79935, United States|Xpress Trials LLC, Houston, Texas, 77036, United States|Prolato Clinical Research Center, Houston, Texas, 77054, United States|North Texas Kidney Disease Association, Lewisville, Texas, 75057-6039, United States|Clinical Advancement Center, PLLC, San Antonio, Texas, 78212, United States|San Antonio Kidney Disease Center Physicians Group, PLLC, San Antonio, Texas, 78258, United States|Clear Lake Specialties, Webster, Texas, 77598, United States|Utah Kidney Research Institute, Salt Lake City, Utah, 84115, United States|Tidewater Kidney Specialists - Riverview, Norfolk, Virginia, 23502, United States|Providence Medical Research Center, Spokane, Washington, 99204, United States"
NCT03777956,The Effect of Lacosamide in Peripheral Neuropathic Pain,https://clinicaltrials.gov/study/NCT03777956,TERMINATED,"Neuropathic Pain|Neuropathy;Peripheral|Neuropathy, Painful|Neuropathy, Diabetic|Neuropathy",DRUG: Lacosamide|DRUG: Placebo,Danish Pain Research Center,Odense University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Danish Pain Research Center, Aarhus University Hospital, Aarhus, 8200, Denmark"
NCT01063868,"A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)",https://clinicaltrials.gov/study/NCT01063868,TERMINATED,"Diabetic Neuropathy, Painful|Diabetic Polyneuropathy",DRUG: Tapentadol extended release (ER)|DRUG: Oxycodone controlled release (CR),"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",Grünenthal GmbH,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Mesa, Arizona, United States|Tucson, Arizona, United States|Fruitland Park, Florida, United States|New Port Richey, Florida, United States|Oviedo, Florida, United States|Tampa, Florida, United States|Libertyville, Illinois, United States|Franklin, Indiana, United States|Paducah, Kentucky, United States|Wellesley Hills, Massachusetts, United States|Albuquerque, New Mexico, United States|New York, New York, United States|Greenville, North Carolina, United States|Hickory, North Carolina, United States|Wilmington, North Carolina, United States|Winston Salem, North Carolina, United States|Kettering, Ohio, United States|Tulsa, Oklahoma, United States|Greer, South Carolina, United States|Dallas, Texas, United States|Odessa, Texas, United States|San Antonio, Texas, United States|Virginia Beach, Virginia, United States"
NCT01056315,A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y,https://clinicaltrials.gov/study/NCT01056315,TERMINATED,Painful Diabetic Neuropathy,DRUG: GRT3938Y|DRUG: Placebo,Grünenthal GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Site 127, Fairhope, Alabama, United States|Site 130, Homewood, Alabama, United States|Site 112, Tucson, Arizona, United States|Site 129, Escondido, California, United States|Site 209, Fullerton, California, United States|Site 135, Long Beach, California, United States|Site 202, Northridge, California, United States|Site 208, Northridge, California, United States|Site 219, Northridge, California, United States|Site 203, San Francisco, California, United States|Site 116, Santa Ana, California, United States|Site 118, Santa Ana, California, United States|Site 121, Santa Ana, California, United States|Site 133, Santa Ana, California, United States|Site 126, Vista, California, United States|Site 214, Vista, California, United States|Site 201, Waterbury, Connecticut, United States|Site 136, Deerfield Beach, Florida, United States|Site 137, Deerfield Beach, Florida, United States|Site 140, Deerfield Beach, Florida, United States|Site 216, Deerfield Beach, Florida, United States|Site 217, Deerfield Beach, Florida, United States|Site 218, Deerfield Beach, Florida, United States|Site 117, Fort Myers, Florida, United States|Site 124, Jacksonville, Florida, United States|Site 228, Jupiter, Florida, United States|Site 101, Orlando, Florida, United States|Site 226, Orlando, Florida, United States|Site 206, Sarasota, Florida, United States|Site 212, West Palm Beach, Florida, United States|Site 142, Atlanta, Georgia, United States|Site 128, Chicago, Illinois, United States|Site 223, Chicago, Illinois, United States|Site 114, Leawood, Kansas, United States|Site 102, Paducah, Kentucky, United States|Site 211, Baltimore, Maryland, United States|Site 108, East Bridgewater, Massachusetts, United States|Site 113, Las Vegas, Nevada, United States|Site 122, Princeton, New Jersey, United States|Site 230, New York, New York, United States|Site 109, Rochester, New York, United States|Site 225, Asheville, North Carolina, United States|Site 115, High Point, North Carolina, United States|Site 227, Canton, Ohio, United States|Site 233, Cincinnati, Ohio, United States|Site 111, Toledo, Ohio, United States|Site 125, Toledo, Ohio, United States|Site 104, Philadelphia, Pennsylvania, United States|Site 106, Philadelphia, Pennsylvania, United States|Site 205, Philadelphia, Pennsylvania, United States|Site 105, Austin, Texas, United States|Site 213, Corpus Christi, Texas, United States|Site 110, Houston, Texas, United States|Site 123, Houston, Texas, United States|Site 204, Houston, Texas, United States|Site 210, Houston, Texas, United States|Site 231, Houston, Texas, United States|Site 131, San Antonio, Texas, United States|Site 215, San Antonio, Texas, United States|Site 221, San Antonio, Texas, United States|Site 139, Provo, Utah, United States"
NCT03242031,Medico-economic Comparison Between Treatment with Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT03242031,TERMINATED,Diabetic Retinopathy,PROCEDURE: monospot panretinal photocoagulation|PROCEDURE: multispot panretinal photocoagulation,Centre Hospitalier Universitaire Dijon,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"CHU dijon Bourgogne, Dijon, 21079, France"
NCT02735369,A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR,https://clinicaltrials.gov/study/NCT02735369,TERMINATED,Proliferative Diabetic Retinopathy (PDR),DRUG: 2% OC-10X|DRUG: Placebo Comparator,"OcuCure Therapeutics, Inc.",Semler Research Center Pvt. Ltd.,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Bangladesh Eye Hospital, Dhaka, 1205, Bangladesh"
NCT00820807,Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes,https://clinicaltrials.gov/study/NCT00820807,TERMINATED,Insulin Resistance,OTHER: Novel dietary fiber|OTHER: Novel dietary fiber|OTHER: Placebo,Cargill,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Louisville Metabolic and Atherosclerosis Research Center (LMARC), Louisville, Kentucky, 40213, United States"
NCT05951270,Glucose Homeostasis and Apple Polyphenols,https://clinicaltrials.gov/study/NCT05951270,TERMINATED,PreDiabetes|Impaired Glucose Tolerance|Glucose Metabolism Disorders,DIETARY_SUPPLEMENT: Apple Polyphenols|OTHER: Control,Maastricht University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Villa Flora, Venlo, Limburg, 5928 SZ, Netherlands"
NCT01737957,Safety and Efficacy of Low-Fluence PRP for PDR,https://clinicaltrials.gov/study/NCT01737957,TERMINATED,Proliferative Diabetic Retinopathy,DEVICE: Low-fluence PRP with 532nm green LASER|DEVICE: Full-Fluence PRP with 532nm LASER,Asociación para Evitar la Ceguera en México,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Asociación Para Evitar la Ceguera en México, Mexico City, DF, 04030, Mexico"
NCT01589029,A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP),https://clinicaltrials.gov/study/NCT01589029,TERMINATED,Proliferative Diabetic Retinopathy,DRUG: CANAKINUMAB (ILARIS®),PD Dr. med. Stephan Michels,"Novartis|University Hospital, Zürich",ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Department of Ophthalmology, Triemli Hospital Zurich, Zurich, 8063, Switzerland"
NCT04082000,Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy,https://clinicaltrials.gov/study/NCT04082000,TERMINATED,Diabetic Neuropathy,DRUG: BOL-DP-o-04|DRUG: Placebo,Breath of Life International Pharma Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Wolfson Medical Center, H̱olon, 58100, Israel"
NCT01488877,A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT01488877,TERMINATED,Type 2 Diabetic Nephropathy,DRUG: PF-03882845|DRUG: PF-03882845|DRUG: PF-03882845|DRUG: Spironolactone|OTHER: placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Pfizer Investigational Site, Chula Vista, California, 91911, United States|Pfizer Investigational Site, San Diego, California, 92123, United States|Pfizer Investigational Site, DeLand, Florida, 32720, United States|Pfizer Investigational Site, Miami, Florida, 33169, United States|Pfizer Investigational Site, Kalamazoo, Michigan, 49007, United States|Pfizer Investigational Site, New York, New York, 10019, United States"
NCT02080741,Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile,https://clinicaltrials.gov/study/NCT02080741,TERMINATED,Patients With Type 1 or Type 2 Diabetes|Patients With a Type A or B Behaviour Profile,OTHER: Blood sample of 12 ml,Centre Hospitalier Universitaire Dijon,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"CHU de DIJON, Dijon, 21079, France"
NCT01023698,Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters,https://clinicaltrials.gov/study/NCT01023698,TERMINATED,Neovascular,PROCEDURE: laser photocoagulation,Asociación para Evitar la Ceguera en México,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT00802269,Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.,https://clinicaltrials.gov/study/NCT00802269,TERMINATED,Proliferative Diabetic Retinopathy,PROCEDURE: Retinal laser photocoagulation,Asociación para Evitar la Ceguera en México,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Asociacion para Evitar la Ceguera en Mexico, Mexico City, DF, 04030, Mexico"
NCT00767884,Effect of Panretinal Photocoagulation on Optic Nerve Head Topography,https://clinicaltrials.gov/study/NCT00767884,TERMINATED,Diabetic Retinopathy,,University of Nebraska,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"UNMC Truhlsen Eye Institute, Omaha, Nebraska, 68105, United States|University of Nebraska Medical Center Eye Clinic, Omaha, Nebraska, 68198-5540, United States"
NCT01510847,The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM),https://clinicaltrials.gov/study/NCT01510847,TERMINATED,"Assess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events.",DRUG: Andriol Testocaps,Singapore Clinical Research Institute,Singapore General Hospital|Duke-NUS Graduate Medical School,MALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Camry Medical Centre, Singapore, 310095, Singapore|Frontier Medical Associates (Ubi) Pte Ltd, Singapore, 400305, Singapore|Everhealth Medical Centre, Singapore, 530540, Singapore|Frontier Medical Associates (Buangkok Cresent) Pte Ltd, Singapore, 530982, Singapore|Frontier Medical Associates (AMK) Pte Ltd, Singapore, 560163, Singapore|EJ Tan Clinic & Surgery, Singapore, 600104, Singapore|Everhealth Family Clinic & Surgery, Singapore, 640762, Singapore|Bukit Batok Medical Clinic, Singapore, 650207, Singapore|Princeton Family Clinic Pte Ltd, Singapore, 670445, Singapore|The Edinburgh Clinic, Singapore, 680306, Singapore|Frontier Medical Associates (Woodlands) Pte Ltd, Singapore, 732899, Singapore|Frontier Medical Associates (Yishun) Pte Ltd, Singapore, 760654, Singapore"
NCT00664183,A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects,https://clinicaltrials.gov/study/NCT00664183,TERMINATED,Diabetic Retinopathy,DRUG: Vitreosolve,"Vitreoretinal Technologies, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Phoenix, Arizona, United States|Beverly Hills, California, United States|Santa Ana, California, United States|Gainesville, Florida, United States|Lakeland, Florida, United States|Indianapolis, Indiana, United States|New Albany, Indiana, United States|Asheville, North Carolina, United States|McAllen, Texas, United States|Silverdale, Washington, United States|LVPEI, Bhubhneshwar, India|Sankara Nethralaya, Chennai, India|Aravind, Coimbatore, India|AIIMS, Delhi, India|LVPEI, Hyderabad, India|Aravind, Madurai, India|Aravind, Pondicherry, India"
NCT05686421,Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations,https://clinicaltrials.gov/study/NCT05686421,TERMINATED,"Age-Related Macular Degeneration|Diabetic Retinopathy|Central Serous Chorioretinopathy|Glaucoma|Glaucoma, Suspect|Eye Diseases",DEVICE: OCT Imaging Using Device N|DEVICE: OCT Imaging Using Device C,NYU Langone Health,National Eye Institute (NEI),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"NYU Langone Health, New York, New York, 10017, United States"
NCT00600262,Intravitreal Bevacizumab for Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT00600262,TERMINATED,Severe Nonproliferative|Proliferative Diabetic Retinopathy|Active Photocoagulated Diabetic Retinopathy,DRUG: intravitreal bevacizumab,Asociación para Evitar la Ceguera en México,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,"Elizabeth Reyna Castelan, Mexico City, 04030, Mexico"
NCT00563628,Changes in Macular Thickness After Patterns Scan Laser,https://clinicaltrials.gov/study/NCT00563628,TERMINATED,Non Proliferative Diabetic Retinopathy|Proliferative Diabetic Retinopathy,DEVICE: Panretinal photocoagulation with PASCAL system,Asociación para Evitar la Ceguera en México,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Asociaciòn para Evitar la Ceguera en Mèxico, Mexico, DF, 04030, Mexico"
NCT00563043,Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment,https://clinicaltrials.gov/study/NCT00563043,TERMINATED,Non Proliferative Diabetic Retinopathy|Proliferative Diabetic Retinopathy,PROCEDURE: PASCAL laser treatment,Asociación para Evitar la Ceguera en México,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Asociaciòn para Evitar la Ceguera en Mèxico, Mèxico, DF, 04030, Mexico"
NCT05412264,Step Up For Health Study: A Pedometer and Website Intervention in Those With Prediabetes,https://clinicaltrials.gov/study/NCT05412264,TERMINATED,Prediabetes|Impaired Glucose Tolerance,BEHAVIORAL: Website intervention,University of Alberta,Athabasca University|Alberta Health services,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Alberta Health Services, Nutrition Services, Edmonton, Alberta, T1B 0E1, Canada"
NCT00248157,Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT00248157,TERMINATED,Diabetic Retinopathy,DRUG: Octreotide acetate in microspheres,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00248131,Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT00248131,TERMINATED,Diabetic Retinopathy,DRUG: Octreotide acetate in microspheres,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00211406,Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg),https://clinicaltrials.gov/study/NCT00211406,TERMINATED,Diabetic Retinopathy,DRUG: Anecortave Acetate Sterile Suspension (15 mg),"Manhattan Eye, Ear & Throat Hospital",Alcon Research,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Manhattan Eye, Ear & Throat Hospital, New York, New York, 10021, United States"
NCT00170742,Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.,https://clinicaltrials.gov/study/NCT00170742,TERMINATED,Proliferative Diabetic Retinopathy,"DRUG: Octreotide, 30 mg i.m. LAR formulation",Novartis,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Novartis, Basel, Switzerland"
NCT02798393,Efficacy of Near Infrared Phototherapy in Type 2 Diabetic Neuropathy,https://clinicaltrials.gov/study/NCT02798393,TERMINATED,Neuropathy,OTHER: Infrared Phototherapy|OTHER: Sham,"Healthlight, LLC","Clin-Assist, LLC|Midwest Medical Research",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Midwest Medical Research, Topeka, Kansas, 66604, United States"
NCT04838431,A First Trimester Prediction Model for Large for Gestational Age Infants: a Preliminary Study,https://clinicaltrials.gov/study/NCT04838431,TERMINATED,"Large for Gestational Age Baby|Macrosomia, Fetal",OTHER: Blood sample and ultrasound at first trimester,University of Modena and Reggio Emilia,,FEMALE,ADULT,,OBSERVATIONAL,"University Hospital of Modena, Modena, 41124, Italy"
NCT05338125,Electrophysiology of the Human Pituitary Gland,https://clinicaltrials.gov/study/NCT05338125,TERMINATED,Pituitary Adenoma|Pituitary Tumor|Diabetes Insipidus Cranial Type|Endocrine; Deficiency,PROCEDURE: Micro-electrode measurement,Leiden University Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Leiden University Medical Center, Leiden, 2333ZA, Netherlands"
NCT05838755,A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain,https://clinicaltrials.gov/study/NCT05838755,TERMINATED,Pain,DRUG: GSK3858279|DRUG: Placebo,GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"GSK Investigational Site, Anniston, Alabama, 36207, United States|GSK Investigational Site, Surprise, Arizona, 85378, United States|GSK Investigational Site, Cerritos, California, 90703, United States|GSK Investigational Site, Lomita, California, 90717, United States|GSK Investigational Site, Largo, Florida, 33777, United States|GSK Investigational Site, Miami, Florida, 33135, United States|GSK Investigational Site, Miami, Florida, 33175, United States|GSK Investigational Site, West Palm Beach, Florida, 33401, United States|GSK Investigational Site, Decatur, Georgia, 30030, United States|GSK Investigational Site, Chicago, Illinois, 60611, United States|GSK Investigational Site, Waltham, Massachusetts, 02451, United States|GSK Investigational Site, Williamsville, New York, 14221, United States|GSK Investigational Site, Huntersville, North Carolina, 28078, United States|GSK Investigational Site, Lancaster, South Carolina, 29720, United States|GSK Investigational Site, Cypress, Texas, 77429, United States|GSK Investigational Site, DeSoto, Texas, 75154, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, McAllen, Texas, 78501, United States|GSK Investigational Site, Bellevue, Washington, 98007, United States|GSK Investigational Site, New Westminster, British Columbia, V3L 3W4, Canada|GSK Investigational Site, Vancouver, British Columbia, V5Y 3W2, Canada|GSK Investigational Site, Winnipeg, Manitoba, R3C 0N2, Canada|GSK Investigational Site, Toronto, Ontario, L6S 0C6, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2C4, Canada|GSK Investigational Site, Beijing, 100032, China|GSK Investigational Site, Guangzhou, 510000, China|GSK Investigational Site, Harbin, 150001, China|GSK Investigational Site, Luoyang, 471003, China|GSK Investigational Site, Shanghai, 200032, China|GSK Investigational Site, Wuhan, 430030, China|GSK Investigational Site, Yueyang, 414000, China|GSK Investigational Site, Corbeil-Essonnes, 91100, France|GSK Investigational Site, Mulhouse, 68100, France|GSK Investigational Site, Bad Homburg, 61348, Germany|GSK Investigational Site, Mainz, 55128, Germany|GSK Investigational Site, Muenster, 48145, Germany|GSK Investigational Site, Wallerfing, 94574, Germany|GSK Investigational Site, Chiba, 260-0804, Japan|GSK Investigational Site, Fukuoka, 807-8556, Japan|GSK Investigational Site, Gunma, 370-3573, Japan|GSK Investigational Site, Hokkaido, 060-0061, Japan|GSK Investigational Site, Ibaraki, 300-0028, Japan|GSK Investigational Site, Kanagawa, 211-8533, Japan|GSK Investigational Site, Osaka, 565-0853, Japan|GSK Investigational Site, Tochigi, 321-0204, Japan|GSK Investigational Site, Tochigi, 321-0974, Japan|GSK Investigational Site, Tochigi, 322-8550, Japan|GSK Investigational Site, Tokyo, 103-0027, Japan|GSK Investigational Site, Tokyo, 104-0031, Japan|GSK Investigational Site, Tokyo, 143-0015, Japan|GSK Investigational Site, Tokyo, 160-0008, Japan|GSK Investigational Site, Bucheon, 422711, Korea, Republic of|GSK Investigational Site, Daejeon, 35233, Korea, Republic of|GSK Investigational Site, Seoul, 120-752, Korea, Republic of|GSK Investigational Site, Seoul, 136-705, Korea, Republic of|GSK Investigational Site, Seoul, 137-701, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Czestochowa, 42-217, Poland|GSK Investigational Site, Gdynia, 81-338, Poland|GSK Investigational Site, Katowice, 40-081, Poland|GSK Investigational Site, Katowice, 40-282, Poland|GSK Investigational Site, Katowice, 40-648, Poland|GSK Investigational Site, Katowice, 40-749, Poland|GSK Investigational Site, Skorzewo, 60-185, Poland|GSK Investigational Site, Sochaczew, 96-500, Poland|GSK Investigational Site, Warszawa, 02-117, Poland|GSK Investigational Site, Cape Town, 7530, South Africa|GSK Investigational Site, Johannesburg, 2196, South Africa|GSK Investigational Site, Pretoria, 0184, South Africa|GSK Investigational Site, Somerset West, 7130, South Africa|GSK Investigational Site, Stanger, 4450, South Africa|GSK Investigational Site, A CoruNa, 15006, Spain|GSK Investigational Site, Barcelona, 08023, Spain|GSK Investigational Site, Malaga, 29010, Spain|GSK Investigational Site, Palma de Mallorca, 07120, Spain|GSK Investigational Site, San SebastiAn De Los Rey, 28702, Spain|GSK Investigational Site, Torrevieja Alicante, 3186, Spain|GSK Investigational Site, Cannock, WS11 0BN, United Kingdom|GSK Investigational Site, Liverpool, L9 7AL, United Kingdom|GSK Investigational Site, Teesside, TS17 6EW, United Kingdom|GSK Investigational Site, West Yorkshire, LS10 1DU, United Kingdom"
NCT01760356,Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients,https://clinicaltrials.gov/study/NCT01760356,TERMINATED,End Stage Liver Disease|Rejection|Infection|Malignancy|Toxicity|Diabetes,,UDA Centro Nacional Hepato-Bilio-Pancreático,"INSERM UMR-S850, Limoges, France|University Hospital, Limoges|PEDECIBA, Uruguay|Universidad de la Republica|ANII (Agencia Nacional de Investigación e Innovación), Uruguay|Scientific Cooperation Service, French Embassy, Uruguay|Hospital Central de las Fuerzas Armadas, Uruguay|ECOS Sud Program France-Uruguay|National Center for Liver Transplantation, Uruguay",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"National Center for Liver Transplantation and Liver Diseases Department, Hospital Central de las Fuerzas Armadas, Montevideo, 11600, Uruguay"
NCT02984813,Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT02984813,TERMINATED,Open-angle Glaucoma|Diabetic Retinopathy,DRUG: GlaucoHealth|DRUG: GlaucoSelect|DRUG: Placebo,The New York Eye & Ear Infirmary,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"New York Eye and Ear Infirmary of Mount Sinai, New York, New York, 10003, United States"
NCT00508430,ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy,https://clinicaltrials.gov/study/NCT00508430,TERMINATED,Diabetic Neuropathies,DRUG: ASP8825|DRUG: Placebo,Astellas Pharma Inc,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Chubu, Japan|Chugoku, Japan|Hokkaido, Japan|Kansai, Japan|Kanto, Japan|Kyusyu, Japan|Shikoku, Japan|Touhoku, Japan"
NCT00505947,Treatment of Refractory Diabetic Macular Edema With Infliximab,https://clinicaltrials.gov/study/NCT00505947,TERMINATED,Diabetic Macular Edema|Visual Acuity|Diabetic Retinopathy,DRUG: infliximab|DRUG: placebo,University of Athens,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Medical School, University of Athens, Athens, 11527, Greece|University of Athens, Athens, 11527, Greece"
NCT03068286,iCBT for Long-term Conditions in IAPT,https://clinicaltrials.gov/study/NCT03068286,TERMINATED,Diabetes|Chronic Pain|COPD|CHD - Coronary Heart Disease|Depression|Anxiety,BEHAVIORAL: Space in Diabetes|BEHAVIORAL: Space in COPD|BEHAVIORAL: Space in Chronic Pain,Derek Richards,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Barnet, Enfield, and harringey Mental Health Trust, Enfield, EN2 0JB, United Kingdom"
NCT00597545,Effect of Raised CBF During CEA on Cognition in DM Patients,https://clinicaltrials.gov/study/NCT00597545,TERMINATED,Carotid Artery Disease|Carotid Artery Stenosis|Diabetes|Cognitive Dysfunction,PROCEDURE: Carotid endarterectomy|DEVICE: Shunt,Columbia University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Columbia University, Department of Anesthesiology, New York, New York, 10032, United States"
NCT00004407,Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy,https://clinicaltrials.gov/study/NCT00004407,TERMINATED,Diabetic Neuropathies,DRUG: immune globulin,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT01752985,Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease,https://clinicaltrials.gov/study/NCT01752985,TERMINATED,Diabetic Kidney Disease,DRUG: BMS-813160|DRUG: Placebo matching with BMS-813160,Bristol-Myers Squibb,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Uab Hospital, Birmingham, Alabama, 35294, United States|Univ Of Al At Birmingham, Birmingham, Alabama, 35294, United States|Akdhc Medical Research Services Llc, Phoenix, Arizona, 85012, United States|Academic Medical Research Institute, Los Angeles, California, 90022, United States|Ucla, Los Angeles, California, 90025, United States|Providence Clinical Research, North Hollywood, California, 91606, United States|Diabetes Medical Center Of California, Northridge, California, 91325, United States|Diablo Clinical Research, Inc., Walnut Creek, California, 94598, United States|George Washington University Medical Faculty Associates, Washington, District of Columbia, 20037, United States|All Medical Research, Llc, Cooper City, Florida, 33024, United States|International Research Associates, Llc, Hialeah, Florida, 33012, United States|Genesis Clinical Research, Inc., Tampa, Florida, 33614, United States|Emory University School Of Medicine, Atlanta, Georgia, 30303, United States|Endocrine Research Solutions, Inc., Roswell, Georgia, 30076, United States|John H. Stroger, Jr. Hospital Of Cook County, Chicago, Illinois, 60612, United States|Research By Design, Llc, Evergreen Park, Illinois, 60805, United States|St Louis Center Clinl Res, Saint Louis, Missouri, 63128, United States|St. Louis Center For Clinical Research, Saint Louis, Missouri, 63128, United States|Va Nebraska-Western Iowa Health Care System (Nwihcs), Omaha, Nebraska, 68105, United States|Southern Nh Diab And Endo, Nashua, New Hampshire, 03063, United States|Premier Research, Inc., Trenton, New Jersey, 08611, United States|Albany Medical College, Albany, New York, 12206, United States|The Endocrine Group Llp, Albany, New York, 12206, United States|Nephrology Associates, Flushing, New York, 11355, United States|Medispect Medical Research, Llc, Boone, North Carolina, 28607, United States|Metrolina Internal Medicine, Charlotte, North Carolina, 28204, United States|Duke University, Durham, North Carolina, 27705, United States|Ohio State University Medical Center, Columbus, Ohio, 43210, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, 43210, United States|Paramount Medical Research & Consulting, Llc, Middleburg Heights, Ohio, 44130, United States|Physician Research, Inc., Zanesville, Ohio, 43701, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|Piedmont Health Grp, Llc-Twr Pt Res Ctr, Hodges, South Carolina, 29653, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232-1371, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Doctors Hospital At Renaissance, Edinburg, Texas, 78539, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, 78234-6200, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, 78234, United States|Northeast Clinical Research Of San Antonio, Llc, Schertz, Texas, 78154, United States|Burke Internal Medicine And Research, Burke, Virginia, 22015, United States|Virginia Endocrinology Research, Chesapeake, Virginia, 23321, United States|Manassas Clinical Research Center, Manassas, Virginia, 20110, United States|Mcguire Va Medical Center, Richmond, Virginia, 23249, United States|Health Sciences Centre Diabetes Research Centre, Winnipeg, Manitoba, R3A 1R9, Canada|Eastern Health Sciences Center, St. John's, Newfoundland and Labrador, A1B 3V6, Canada|Aggarwal And Associates, Brampton, Ontario, L6T 0G1, Canada|Clinical Research Solutions, Inc, Kitchener, Ontario, N2H 5Z8, Canada|Lmc Diabetes & Endocrinology (Thornhill), Thornhill, Ontario, L4J 8L7, Canada|Lmc Diabetes & Endocrinology (Bayview), Toronto, Ontario, M4G 3E8, Canada|Centre De Recherche Clinique De Laval, Laval, Quebec, H7T 2P5, Canada|Recherche Gcp Research, Montreal, Quebec, H2R 1V6, Canada|Local Institution, Montreal, Quebec, H3T 1E2, Canada|Local Institution, Frederiksberg, 2000, Denmark|Local Institution, Gentofte, 2820, Denmark|Local Institution, Hillerod, 3400, Denmark|Local Institution, Holstebro, 7500, Denmark|Local Institution, Amiens Cedex 1, 80054, France|Local Institution, Grenoble Cedex 9, F38043, France|Local Institution, Nantes Cedex 1, 44093, France|Local Institution, Paris, 75877, France|Local Institution, Poitiers Cedex, 86021, France|Local Institution, Tours Cedex 09, 37044, France"
NCT02207712,Noctura400 Treatment for Diabetic Retinopathy (CANDLE),https://clinicaltrials.gov/study/NCT02207712,TERMINATED,Diabetic Macular Oedema,DEVICE: Noctura 400 Eye Mask|DRUG: Ranibizumab,PolyPhotonix Medical,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Royal Berkshire NHS Foundation Trust, Reading, Berkshire, RG1 5AN, United Kingdom|Hitchingbrooke Healthcare NHS Trust, Huntingdon, Cambridgeshire, PE29 6NT, United Kingdom|Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, Cambridgeshire, PE3 9GZ, United Kingdom|South Tees Hospitals NHS Foundation Trust, Middlesbrough, Cleveland, TS4 3BW, United Kingdom|Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, TR1 3LJ, United Kingdom|Colchester Hospital University NHS Foundation Trust, Colchester, Essex, CO4 5JL, United Kingdom|Glouchestershire Hospitals NHS Foundation Trust, Cheltenham, Glouchestershire, GL53 7AG, United Kingdom|Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, Hampshire, RG24 9NA, United Kingdom|North Lincolnshire and Goole NHS Trust, Scunthorpe, Lincolnshire, DN15 7BH, United Kingdom|James Paget University Hospital NHS Foundation Trust, Great Yarmouth, Norfolk, NR31 6LA, United Kingdom|Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney, Norwich Norfolk, NR4 7UY, United Kingdom|Oxford Radcliffe Hospitals NHS Trust, Headington, Oxford Oxfordshire, 0X3 9DU, United Kingdom|Yeovil District Hospital NHS Foundation Trust, Yeovil, Somerset, BA21 4AT, United Kingdom|Ashford & St Peters Hospitals NHS Foundation Trust, Chertsey, Surrey, KT16 0PZ, United Kingdom|Royal Surrey County Hospital, Guildford, Surrey, GU2 7XX, United Kingdom|Mid Yorkshire Hospitals NHS Trust, Wakefield, West Yorkshire, WF1 4EE, United Kingdom|Great Western Hospital, Swindon, Wiltshire, SN3 6BB, United Kingdom|Plymouth Hospitals NHS Trust, Plymouth, PL6 8DH, United Kingdom"
NCT03755934,Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy,https://clinicaltrials.gov/study/NCT03755934,TERMINATED,Painful Diabetic Neuropathy,DRUG: MEDI7352|OTHER: Placebo,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Gentofte, 2820, Denmark|Research Site, Balatonfüred, 8230, Hungary|Research Site, Budapest, 1036, Hungary|Research Site, Bydgoszcz, 85-065, Poland|Research Site, Gdańsk, 80-382, Poland|Research Site, Katowice, 40-040, Poland|Research Site, Katowice, 40-282, Poland|Research Site, Kraków, 30-534, Poland|Research Site, Lublin, 20-093, Poland|Research Site, Lublin, 20064, Poland|Research Site, Olsztyn, 10117, Poland|Research Site, Poznań, 60-702, Poland|Research Site, Sochaczew, 96-500, Poland|Research Site, Toruń, 87100, Poland|Research Site, Warszawa, 01-192, Poland|Research Site, Warszawa, 01144, Poland|Research Site, Wrocław, 53-413, Poland|Research Site, Bucuresti, 011025, Romania|Research Site, Calarasi, 917080, Romania|Research Site, Craiova, 200505, Romania|Research Site, Galati, 800291, Romania|Research Site, Targu-Mures, 540142, Romania|Research Site, Barnsley, S75 3DL, United Kingdom|Research Site, Blackpool, FY2 0JH, United Kingdom|Research Site, Cannock, WS11 0BN, United Kingdom|Research Site, Cardiff, CF14 4XW, United Kingdom|Research Site, Leeds, LS10 1DU, United Kingdom|Research Site, London, NW10 7EW, United Kingdom|Research Site, Manchester, M13 9NQ, United Kingdom|Research Site, Prescot, L34 1BH, United Kingdom|Research Site, Stockton-on-Tees, TS17 6EW, United Kingdom"
NCT03720080,The OpenAPS_ShadowMode Study,https://clinicaltrials.gov/study/NCT03720080,TERMINATED,Type1diabetes,DEVICE: OpenAPS,"Insel Gruppe AG, University Hospital Bern",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern, Bern, 3010, Switzerland"
NCT00939276,Macular Edema Incidence/Severity Reduction With Nevanac,https://clinicaltrials.gov/study/NCT00939276,TERMINATED,Diabetic Retinopathy,"DRUG: Nepafenac ophthalmic suspension, 0.1% (NEVANAC®)|DRUG: Nepafenac ophthalmic suspension vehicle",Alcon Research,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, 76134, United States"
NCT05895552,A Phase 2 Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain (CYPRESS),https://clinicaltrials.gov/study/NCT05895552,TERMINATED,Diabetic Peripheral Neuropathic Pain,DRUG: RTA 901|DRUG: RTA 901-Matching Placebo,"Reata, a wholly owned subsidiary of Biogen",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Centricity Research Phoenix Multispecialty, Mesa, Arizona, 85206, United States|Arizona Research Center, Phoenix, Arizona, 85053, United States|Hope Clinical Research, Inc., Canoga Park, California, 91303, United States|Valley Research - Trials, Fresno, California, 93720, United States|Clinical Research Institute, Los Angeles, California, 90048, United States|Acclaim Clinical Research, San Diego, California, 92120, United States|Optimus Medical Group, San Francisco, California, 94102, United States|PIH Health Whittier Hospital, Whittier, California, 90606, United States|Denver Endocrinology Diabetes and Thyroid Center PC, Englewood, Colorado, 80113, United States|Paradigm Clinical Research, Wheat Ridge, Colorado, 80033, United States|Innovative Research of West Florida, Inc., Clearwater, Florida, 33756, United States|Clinical Research of West Florida Inc, Clearwater, Florida, 33765, United States|East Coast Institute for Research, LLC, Jacksonville, Florida, 32204, United States|Multi Specialty Research Associates, LLC, Lake City, Florida, 32055, United States|3 Sync LLC, Lake Worth, Florida, 33460, United States|Floridian Clinical Research, Miami Lakes, Florida, 33016, United States|Finlay Medical Research, Miami, Florida, 33126, United States|New Horizon Research Center, Miami, Florida, 33165, United States|IMA Clinical Research, PC, Saint Petersburg, Florida, 33709, United States|3 Sync LLC, Sunrise, Florida, 33013, United States|Genesis Clinical Research, Tampa, Florida, 33603, United States|Clinical Research of West Florida, Inc., Tampa, Florida, 33606, United States|Baycare Clinical Research, Tampa, Florida, 33607, United States|VICIS Clinical Research, Tampa, Florida, 33615, United States|Clinical Site Partners, Orlando, Winter Park, Florida, 32789, United States|Conquest Research, LLC, Winter Park, Florida, 32789, United States|Agile Clinical Research Trials, LLC, Atlanta, Georgia, 30328, United States|East Coast Institute for Research, LLC, Canton, Georgia, 30114, United States|Centricity Research Columbus Endocrinology, Columbus, Georgia, 31904, United States|East Coast Institute for Research, LLC, Macon, Georgia, 31210, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61606, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, 47714, United States|Integrated Clinical Trial Services, Inc., West Des Moines, Iowa, 50265, United States|Tandem Clinical Research, Marrero, Louisiana, 70072, United States|Tandem Clinical Research, Metairie, Louisiana, 70006, United States|Boston Clinical Trials, LLC, Boston, Massachusetts, 02131, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|ActivMed Practices & Research, LLC, Methuen, Massachusetts, 01844, United States|Revival Research Institute, LLC., Sterling Heights, Michigan, 48126, United States|Clinical Research Consultants, LLC, Kansas City, Missouri, 64111, United States|StudyMetrix Research, Saint Peters, Missouri, 63303, United States|Velocity Clinical Research, Inc., Lincoln, Nebraska, 68510, United States|Velocity Clinical Research, Inc., Norfolk, Nebraska, 68510, United States|Las Vegas Endocrinology, Henderson, Nevada, 89074, United States|Jubilee Clinical Research Inc, Las Vegas, Nevada, 89106, United States|Excel Clinical Research, Las Vegas, Nevada, 89109, United States|ActivMed Practices & Research, LLC, Portsmouth, New Hampshire, 03801, United States|Columbia University, New York, New York, 10032, United States|Richmond Behavioral Associates, Staten Island, New York, 10314, United States|Carolina Institute for Clinical Research, LLC, Fayetteville, North Carolina, 28303, United States|Diabetes & Endocrinology Associates of Stark County, Inc., Canton, Ohio, 44718, United States|Velocity Clinical Research, Cincinnati, Cincinnati, Ohio, 45242, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Remington-Davis, Inc., Columbus, Ohio, 43215, United States|Meta Medical Research Institute, Dayton, Ohio, 45432, United States|Velocity Clinical Research, Providence, East Greenwich, Rhode Island, 68510, United States|Notus Clinical Research, Charleston, South Carolina, 29414, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee, 37421, United States|Trinity Clinical Research LLC, Tullahoma, Tennessee, 37388, United States|FutureSearch Trials of Neurology, Austin, Texas, 78731, United States|REX Clinical Trials, LLC, Beaumont, Texas, 77701, United States|Zenos Clinical Research, Dallas, Texas, 75230, United States|Care United Research, LLC, Forney, Texas, 75126, United States|Diabetes and Thyroid Center of Fort Worth, Fort Worth, Texas, 76053, United States|Nerve and Muscle Center of Texas, Houston, Texas, 77030, United States|Biopharma Informatic, LLC, Houston, Texas, 77043, United States|Endocrine IPS, PLLC, Houston, Texas, 77079, United States|Amir A Hassan, MD, PA, Houston, Texas, 77089, United States|3 Sync LLC, Kingwood, Texas, 77339, United States|Epic Clinical Research, Lewisville, Texas, 75057, United States|Shadow Creek Medical Clinic, Pearland, Texas, 77584, United States|Diabetes & Glandular Disease Clinic, P.A., San Antonio, Texas, 78229, United States|VIP Trials, San Antonio, Texas, 78230, United States|Velocity Clinical Research, Salt Lake City, West Jordan, Utah, 84088, United States|Rainier Clinical Research Center, Renton, Washington, 98057, United States"
NCT01722474,Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness.,https://clinicaltrials.gov/study/NCT01722474,TERMINATED,Healthy|Diabetes Type 2|Obesity|Coronary Artery Disease|Peripheral Arterial Disease,DEVICE: ASI Device,University of Manitoba,St. Boniface Hospital|Arterial Stiffness Incorporated,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"St. Boniface General Hospital - Asper Clinical Research Institute, Winnipeg, Manitoba, R2H 2A6, Canada"
NCT05333055,Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT05333055,TERMINATED,Diabetic Retinopathy|Diabetic Macular Edema|Other Retinal Disorders,,Greater Houston Retina Research,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Retina Consultants of Texas, Bellaire, Texas, 77401, United States|Retina Consultants of Texas, Katy, Texas, 77494, United States|Retina Consultants of Texas, The Woodlands, Texas, 77384, United States"
NCT04707157,Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain,https://clinicaltrials.gov/study/NCT04707157,TERMINATED,Diabetic Peripheral Neuropathic Pain,DRUG: LY3556050|DRUG: Placebo,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Synexus- Chandler, Chandler, Arizona, 85224, United States|Synexus Clinical Research - Glendale, Glendale, Arizona, 85306, United States|Alliance for Multispecialty Research - Clinical Research Consortium, Tempe, Arizona, 85281, United States|Artemis Institute for Clinical Research, Riverside, California, 92503, United States|Artemis Institute for Clinical Research, San Diego, California, 92103, United States|CMR of Greater New Haven, Hamden, Connecticut, 06517, United States|VIN-Julie Schwartzbard, Aventura, Florida, 33180, United States|Clinical Research of South Florida, Coral Gables, Florida, 33134, United States|Suncoast Research Group, Miami, Florida, 33135, United States|University of Miami Don Suffer Clinical Research Building, Miami, Florida, 33136, United States|New Horizon Research Center, Miami, Florida, 33165, United States|Renstar Medical Research, Ocala, Florida, 34470, United States|Synexus Clinical Research US, Inc - Orlando, Orlando, Florida, 32806, United States|Synexus Clinical Research US, Inc., Pinellas Park, Florida, 33781, United States|Gold Coast Research, Plantation, Florida, 33317, United States|Synexus Clinical Research US, Inc - Orlando, The Villages, Florida, 32162, United States|Rocky Mountain Clinical Research, Idaho Falls, Idaho, 83404, United States|Synexus Clinical Research US, Inc., Chicago, Illinois, 60602, United States|Northwestern University, Chicago, Illinois, 60611, United States|NorthShore University HealthSystem, Skokie, Illinois, 60077, United States|Boston Clinical Trials, Boston, Massachusetts, 02131, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|ActivMed Practices and Research, Methuen, Massachusetts, 01844, United States|MedVadis Research Corporation, Waltham, Massachusetts, 02451, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|StudyMetrix Research, Saint Peters, Missouri, 63303, United States|Clinvest Research LLC, Springfield, Missouri, 65807, United States|Synexus - Cincinnati, Cincinnati, Ohio, 45236, United States|META Medical Research Institute, Dayton, Ohio, 45432, United States|Altoona Center For Clinical Research, Duncansville, Pennsylvania, 16635, United States|FutureSearch Trials, Austin, Texas, 78731, United States|Cedar Health Research, Dallas, Texas, 75251, United States|Synexus - US, San Antonio, Texas, 78229, United States|Northwest Clinical Research Center, Bellevue, Washington, 98007, United States|Rainier Clinical Research Center, Renton, Washington, 98057, United States|Ponce Medical School Foundation Inc., Ponce, 00716, Puerto Rico|Latin Clinical Trial Center, San Juan, 00909, Puerto Rico"
NCT01168258,Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT01168258,TERMINATED,Diabetic Retinopathy|Diabetic Macular Edema,,National Eye Institute (NEI),,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT03345901,PROMINENT-Eye Ancillary Study (Protocol AD),https://clinicaltrials.gov/study/NCT03345901,TERMINATED,Diabetic Retinopathy|Diabetic Macular Edema,DRUG: Pemafibrate|DRUG: Placebo,Jaeb Center for Health Research,"Kowa Company, Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Arizona Retina and Vitreous Consultants, Phoenix, Arizona, 85021, United States|Retinal Diagnostic Center, Campbell, California, 95008, United States|Macula & Retina Institute, Glendale, California, 91203, United States|Atlantis Eye Care, Huntington Beach, California, 92647, United States|Loma Linda University Health Care, Department of Ophthalmology, Loma Linda, California, 92354, United States|South Coast Retina Center, Long Beach, California, 90807, United States|Northern California Retina Vitreous Associates, Mountain View, California, 94040, United States|Retinal Consultants of Southern California Medical Group, Inc., Westlake Village, California, 91361, United States|National Ophthalmic Research Institute, Fort Myers, Florida, 33912, United States|University of Florida College of Med., Department of Ophthalmology, Jacksonville Health Science Cent, Jacksonville, Florida, 32209, United States|Florida Retina Consultants, Lakeland, Florida, 33805, United States|Retina Macula Specialists of Miami, Miami, Florida, 33126, United States|Florida Retina Institute, Orlando, Florida, 32806, United States|Southeast Eye Institute, P.A. dba Eye Associates of Pinellas, Pinellas Park, Florida, 33782, United States|Sarasota Retina Institute, Sarasota, Florida, 34239, United States|Emory Eye Center, Atlanta, Georgia, 30322-1013, United States|Emory Eye Center, Atlanta, Georgia, 30322, United States|Southeast Retina Center, P.C., Augusta, Georgia, 30909, United States|Thomas Eye Group, Sandy Springs, Georgia, 30328, United States|Northwestern Medical Faculty Foundation, Chicago, Illinois, 60611-2987, United States|Northwestern Medical Faculty Foundation, Chicago, Illinois, 60611, United States|University of Illinois at Chicago Medical Center, Chicago, Illinois, 60612, United States|NorthShore University HealthSystem, Glenview, Illinois, 60026, United States|Illinois Retina Associates, S.C., Oak Park, Illinois, 60304, United States|John-Kenyon American Eye Institute, New Albany, Indiana, 47150, United States|Wolfe Eye Clinic, West Des Moines, Iowa, 50266, United States|Mid-America Retina Consultants, P.A., Overland Park, Kansas, 66211, United States|Retina Associates, P.A., Shawnee Mission, Kansas, 66204, United States|Retina and Vitreous Associates of Kentucky, Lexington, Kentucky, 40509, United States|Eye Associates of Northeast Louisiana dba Haik Humble Eye Center, West Monroe, Louisiana, 71291-4452, United States|Eye Associates of Northeast Louisiana dba Haik Humble Eye Center, West Monroe, Louisiana, 71291, United States|Elman Retina Group, P.A., Baltimore, Maryland, 21237, United States|Wilmer Eye Institute at Johns Hopkins, Baltimore, Maryland, 21287, United States|Valley Eye Physicians and Surgeons, Ayer, Massachusetts, 01432, United States|Ophthalmic Consultants of Boston, Boston, Massachusetts, 02114, United States|Joslin Diabetes Center, Boston, Massachusetts, 02215, United States|Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, 48105, United States|Henry Ford Health System, Dept of Ophthalmology and Eye Care Services, Detroit, Michigan, 48202-2689, United States|Henry Ford Health System, Dept of Ophthalmology and Eye Care Services, Detroit, Michigan, 48202, United States|Vitreo-Retinal Associates, Grand Rapids, Michigan, 49546, United States|Retina Center, PA, Minneapolis, Minnesota, 34239, United States|Retina Center, PA, Minneapolis, Minnesota, 55404, United States|The Retina Institute, Saint Louis, Missouri, 63128, United States|Eye Associates of New Mexico, Albuquerque, New Mexico, 87109-5857, United States|Eye Associates of New Mexico, Albuquerque, New Mexico, 87109, United States|MaculaCare, New York, New York, 10021, United States|Retina Associates of Western New York, Rochester, New York, 14620, United States|Retina-Vitreous Surgeons of Central New York, PC, Syracuse, New York, 13224, United States|Western Carolina Clinical Research, LLC, Asheville, North Carolina, 28803, United States|Kittner Eye Center, Chapel Hill, North Carolina, 27517-8923, United States|Kittner Eye Center, Chapel Hill, North Carolina, 27517, United States|Charlotte Eye, Ear, Nose and Throat Assoc., PA, Charlotte, North Carolina, 28210, United States|Retina Vitreous Center, Edmond, Oklahoma, 73103, United States|Dean A. McGee Eye Institute, Oklahoma City, Oklahoma, 73104, United States|Retina Vitreous Consultants, Monroeville, Pennsylvania, 15146, United States|Southeastern Retina Associates, Chattanooga, Tennessee, 37421, United States|Southeastern Retina Associates, P.C., Knoxville, Tennessee, 37909, United States|Retina Research Center, Austin, Texas, 78705, United States|Robert E. Torti, MD, PA dba Retina Specialists, DeSoto, Texas, 75115-2011, United States|Valley Retina Institute, DeSoto, Texas, 75115, United States|Retina Center of Texas, Grapevine, Texas, 76051, United States|Baylor Eye Physicians and Surgeons, Houston, Texas, 77030-4101, United States|Baylor Eye Physicians and Surgeons, Houston, Texas, 77030, United States|Retina Consultants of Houston, PA, Houston, Texas, 77030, United States|Valley Retina Institute, McAllen, Texas, 78503, United States|Medical Center Ophthalmology Associates, San Antonio, Texas, 78240, United States|Retinal Consultants of San Antonio, San Antonio, Texas, 78240, United States|Retina Institute of Virginia, Richmond, Virginia, 23235, United States|University of Wisconsin-Madison, Dept of Ophthalmology/Retina Service, Madison, Wisconsin, 53705, United States|UBC/VCHA Eye Care Centre, Vancouver, British Columbia, V5Z 3N9, Canada|University Health Network - Toronto Western Hospital, Toronto, M5T 2S8, Canada"
NCT01858532,Study Of Diabetic Nephropathy With Atrasentan,https://clinicaltrials.gov/study/NCT01858532,TERMINATED,Diabetic Nephropathy,DRUG: Atrasentan|DRUG: Placebo,AbbVie,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02681809,A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR,https://clinicaltrials.gov/study/NCT02681809,TERMINATED,Diabetic Retinopathy|Posterior Vitreous Detachment|Disease Progression,DRUG: ocriplasmin 0.0625mg|DRUG: ocriplasmin 0.125mg|DRUG: Sham injection,ThromboGenics,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Phoenix, Arizona, 85021, United States|Campbell, California, 95008, United States|Irvine, California, 92697, United States|Loma Linda, California, 92354, United States|Santa Ana, California, 92705, United States|Rapid City, South Dakota, 57701, United States|McAllen, Texas, 78503, United States|San Antonio, Texas, 78240, United States|Charlottesville, Virginia, 22903, United States|Brno, 625 00, Czechia|Hradec Kralove, 500 05, Czechia|Olomouc, 779 00, Czechia|Pardubice, 530 02, Czechia|Praha 10, 100 34, Czechia|Praha 4, 140 00, Czechia|Zlin, 760 01, Czechia|Paris, 75475, France|Munchen, Bayern, 80336, Germany|Darmstadt, Hessen, 64297, Germany|Leipzig, Sachsen, 04103, Germany|Debrecen, Hajdú-Bihar, 4032, Hungary|Budapest, 1062, Hungary|Budapest, 1083, Hungary|Budapest, 1106, Hungary|Budapest, 1133, Hungary|Szombathely, 9700, Hungary|Be'er Sheva', 84101, Israel|Petah Tiqva, 4941492, Israel|Rehovot, 7610001, Israel|Tel Aviv, 6423906, Israel|Milan, 20132, Italy|Barcelona, 08195, Spain|Barcelona, 8025, Spain|Girona, 17007, Spain|Valladolid, 47012, Spain|Frimley, Surrey, GU16 7UJ, United Kingdom|London, EC1V 2PD, United Kingdom|London, SE5 9RS, United Kingdom"
NCT02826655,Adaptive Optics for Ophthalmic Technologies,https://clinicaltrials.gov/study/NCT02826655,TERMINATED,Diabetic Retinopathy|Diabetic Macular Edema,DEVICE: WF-AO-OCT,Duke University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Duke Eye Center, Durham, North Carolina, 27710, United States"
NCT01830348,Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01830348,TERMINATED,Diabetic Foot Ulcers,DRUG: DSC127|DRUG: placebo vehicle gel,Integra LifeSciences Corporation,Integrium,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"WILMAX Clinical Research Inc, Mobile, Alabama, 36680, United States|Center for Clinical Research, Fair Oaks, California, 95628, United States|Roy O Kroeker, DPM, Inc, Fresno, California, 93710, United States|Foot and Ankle Clinic, Los Angeles, California, 90010, United States|Brian O'Carroll, DPM, Inc., Pismo Beach, California, 93449, United States|UCLA Medical Center - Olive View, Sylmar, California, 91342, United States|Orange County Research Center, Tustin, California, 92780, United States|Advanced Research Institute of Miami, Homestead, Florida, 33030, United States|UF Health Orthopaedic Surgery Clinic, Jacksonville, Florida, 32209, United States|GF Professional Research, Miami Lakes, Florida, 33016, United States|Miami Dade Medical Research Institute, Miami, Florida, 33176, United States|Barry University Clinical Research, North Miami Beach, Florida, 33013, United States|Professional Health Care of Pinellas, Saint Petersburg, Florida, 33713, United States|Memorial Medical Group, Granger, Indiana, 46530, United States|LaPorte Medical Group, LaPorte, Indiana, 46350, United States|Boston University Medical Center, Boston, Massachusetts, 02118, United States|East Carolina Foot and Ankle Specialists, Greenville, North Carolina, 27834, United States|Clinical Research Center, Eugene, Oregon, 97401, United States|Center for Clinical Research, Portland, Oregon, 97232, United States|Carolina Musculoskeletel Institute, Aiken, South Carolina, 29801, United States|ClinSearch, LLC, Chattanooga, Tennessee, 37421, United States|Dallas VA Medical Center, Dallas, Texas, 75216, United States|Fort Worth Diagnostic Clinic, Fort Worth, Texas, 76104, United States|Endeavor Clinical Trials, San Antonio, Texas, 78229, United States|Professional Education and Research Institute, Roanoke, Virginia, 24016, United States"
NCT03550443,A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study,https://clinicaltrials.gov/study/NCT03550443,TERMINATED,Diabetic Kidney Disease,DRUG: Bardoxolone methyl|DRUG: Placebo,"Kyowa Kirin Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Japan Community Health care Organization Sendai Hospital, Sendai, Miyagi, 981-3281, Japan"
NCT02156336,Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP),https://clinicaltrials.gov/study/NCT02156336,TERMINATED,Diabetic Peripheral Neuropathic Pain,DRUG: Ranolazine|DRUG: Placebo,Horizons International Peripheral Group,Gilead Sciences,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cardiology Associates, Fairhope, Alabama, 36532, United States|Cardiovascular Institute of the South, Houma, Louisiana, 70361, United States|Cardiovascular Institute of the South, Lafayette, Louisiana, 70503, United States"
NCT04371978,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,https://clinicaltrials.gov/study/NCT04371978,TERMINATED,"COVID 19|Coronavirus|Diabetes Mellitus, Type 2|Diabetes Mellitus|Glucose Metabolism Disorders|Metabolic Disease|Endocrine System Diseases|Dipeptidyl-Peptidase IV Inhibitors|Linagliptin|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Hypoglycemic Agents|Respiratory Tract Diseases|Incretins|Hormones",DRUG: Linagliptin 5 MG,Rabin Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Shamir Medical Center, Be'er Ya'aqov, Israel|Rabin Medical Center, Beilinson Campus, Petah tikva, Israel|Rabin Medical Center, Hasharon Campus, Petah tikva, Israel"
NCT00361868,Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI,https://clinicaltrials.gov/study/NCT00361868,TERMINATED,Dyslipidemia|Glucose Metabolism Disorder,DRUG: fenofibrate (F) + metformin (M) hydrochloride fixed combination|DRUG: Rosiglitazone,Solvay Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Site105, Pula, Croatia|Site102, Rijeka, Croatia|Site103, Split, Croatia|Site104, Varazdin, Croatia|Site100, Zagreb, Croatia|Site101, Zagreb, Croatia|Site 205, Jyväskylä, Finland|Site 206, Kokkola, Finland|Site 208, Laukaa, Finland|Site 207, Oulu, Finland|Site 303, Bassens, France|Site 307, Bordeaux, France|Site 305, Murs Erigne, France|Site 302, Seysses, France|Site 304, Strasbourg, France|Site 301, Thouars, France|Site 306, Vihiers, France|Site 405, Berlin, Germany|Site 410, Borna, Germany|Site 403, Bretten, Germany|Site 402, Dresden, Germany|Site 404, Frankfurt, Germany|Site 400, Freiburg, Germany|Site 401, Hannover, Germany|Site 409, Ilvesheim, Germany|Site 411, Ilvesheim, Germany|Site 407, Leipzig, Germany|Site 406, Rodgau, Germany|Site 413, Rotenburg, Germany|Site 408, Schwerin, Germany|Site 412, Villingen-Schwenningen, Germany|Site 509, Almere, Netherlands|Site 502, Breda, Netherlands|Site 503, Eindhoven, Netherlands|Site 504, Groningen, Netherlands|Site 505, Leiden, Netherlands|Site 506, Nijmegen, Netherlands|Site 500, Rotterdam, Netherlands|Site 507, Velp, Netherlands|Site 508, Zoetermeer, Netherlands|Site 610, Bialystok, Poland|Site 606, Elblag, Poland|Site 608, Gdansk, Poland|Site 600, Lodz, Poland|Site 605, Otolinska, Poland|Site 604, Radom, Poland|Site 613, Starogard Gdanski, Poland|Site 601, Warszawa, Poland|Site 607, Warszawa, Poland|Site 612, Warszawa, Poland|Site 602, Wroclaw, Poland|Site 603, Wroclaw, Poland|Site 704, Brasov, Romania|Site 701, Bucharest, Romania|Site 703, Bucharest, Romania|Site 700, Cluj-Napoca, Romania|Site 702, Iasi, Romania|Site 705, Targu-Mures, Romania|Site 807, Kharkiv, Ukraine|Site 811, Kharkiv, Ukraine|Site 812, Kharkiv, Ukraine|Site 800, Kiev, Ukraine|Site 803, Kiev, Ukraine|Site 808, Kiev, Ukraine|Site 809, Kiev, Ukraine|Site 810, Kiev, Ukraine|Site 813, Kiev, Ukraine|Site 805, Lviv, Ukraine|Site 804, Odessa, Ukraine|Site 802, Vinnitsa, Ukraine"
NCT03734887,Social Engagement Strategies to Improve Medication Adherence,https://clinicaltrials.gov/study/NCT03734887,TERMINATED,Diabetes|Atherosclerosis Cardiovascular Disease|Congestive Heart Failure|Poor Medication Adherence,BEHAVIORAL: Social Network Feedback|BEHAVIORAL: Private Feedback,"University of California, Los Angeles",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"UCLA Division Of General Internal Medicine, Los Angeles, California, 90024, United States"
NCT02156843,Pyridorin in Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT02156843,TERMINATED,Diabetic Nephropathy|Diabetic Kidney Disease,DRUG: Pyridorin|DRUG: Placebo,"NephroGenex, Inc.","Collaborative Study Group (CSG)|Medpace, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"CSG Investigational Site (#157), Birmingham, Alabama, 35294, United States|CSG Investigational Site (#130), Phoenix, Arizona, 85012, United States|CSG Investigational Site (#150), Phoenix, Arizona, 85054, United States|CSG Investigational Site (#145), Prescott, Arizona, 86301, United States|CSG Investigational Site (#142), Tucson, Arizona, 85745, United States|CSG Investigational Site (#160), Los Angeles, California, 90048, United States|CSG Investigational Site (#143), Riverside, California, 92505, United States|CSG Investigational Site (#159), Roseville, California, 95661, United States|CSG Investigational Site (#153), Arvada, Colorado, 80002, United States|CSG Investigational Site (#118), Aurora, Colorado, 80045, United States|CSG Investigational Site (#120), Westminster, Colorado, 80031, United States|CSG Investigational Site (#158), Waterbury, Connecticut, 06708, United States|CSG Investigational Site (#156), Columbus, Georgia, 31901, United States|CSG Investigational Site (#113), Chicago, Illinois, 60607, United States|CSG Investigational Site (#102), Michigan City, Indiana, 46360, United States|CSG Investigational Site (#115), New Orleans, Louisiana, 70112, United States|CSG Investigational Site (#147), Greenbelt, Maryland, 20770, United States|CSG Investigational Site (#117), Boston, Massachusetts, 02111, United States|CSG Investigational Site (#114), Springfield, Massachusetts, 01107, United States|CSG Investigational Site (#111), Detroit, Michigan, 48202, United States|CSG Investigational Site (#134), Pontiac, Michigan, 48341, United States|CSG Investigational Site (#162), Kansas City, Missouri, 64111, United States|CSG Investigational Site (#152), Kansas City, Missouri, 64128, United States|CSG Investigational Site (#141), Las Vegas, Nevada, 89115, United States|CSG Investigational Site (#128), Buffalo, New York, 14215, United States|CSG Investigational Site (#136), Northport, New York, 11768, United States|CSG Investigational Site (#154), West Nyack, New York, 10994, United States|CSG Investigational Site (#108), Asheville, North Carolina, 28801, United States|CSG Investigational Site (#116), Charlotte, North Carolina, 28207, United States|CSG Investigational Site (#125), Durham, North Carolina, 27710, United States|CSG Investigational Site (#155), New Bern, North Carolina, 28562, United States|CSG Investigational Site (#127), Winston-Salem, North Carolina, 27157, United States|CSG Investigational Site (#124), Cincinnati, Ohio, 45267, United States|CSG Investigational Site (#151), Cleveland, Ohio, 44106, United States|CSG Investigational Site (#123), Cleveland, Ohio, 44195, United States|CSG Investigational Site (#106), Columbus, Ohio, 43210, United States|CSG Investigational Site (#148), Parma Heights, Ohio, 44130, United States|CSG Investigational Site (#101), Philadelphia, Pennsylvania, 19104, United States|CSG Investigational Site (#149), Pittsburgh, Pennsylvania, 15240, United States|CSG Investigational Site (#146), Providence, Rhode Island, 02903, United States|CSG Investigational Site (#131), Chattanooga, Tennessee, 37408, United States|CSG Investigational Site (#105), Nashville, Tennessee, 37205, United States|CSG Investigational Site (#119), Dallas, Texas, 75390, United States|CSG Investigational Site (#139), Houston, Texas, 77004, United States|CSG Investigational Site (#133), Houston, Texas, 77076, United States|CSG Investigational Site (#109), Midland, Texas, 79707, United States|CSG Investigational Site (#132), Salt Lake City, Utah, 84112, United States|CSG Investigational Site (#107), Burlington, Vermont, 05401, United States|CSG Investigational Site (#129), Charlottesville, Virginia, 22908, United States|CSG Investigational Site (#137), Fairfax, Virginia, 22030, United States|CSG Investigational Site (#103), Fairfax, Virginia, 22033, United States|CSG Investigational Site (#104), Hampton, Virginia, 23666, United States|CSG Investigational Site (#144), Richmond, Virginia, 23249, United States|CSG Investigational Site (#121), Spokane, Washington, 99204, United States|CSG Investigational Site (#122), Milwaukee, Wisconsin, 53295, United States|CSG Investigational Site (#205), Camperdown, New South Wales, 2050, Australia|CSG Investigational Site (#201), Gosford, New South Wales, 2250, Australia|CSG Investigational Site (#206), Liverpool, New South Wales, 2170, Australia|CSG Investigational Site (#208), St. Leonards, New South Wales, 2065, Australia|CSG Investigative Site (#204), Adelaide, South Australia, 5000, Australia|CSG Investigational Site (#207), Footscray, Victoria, 2011, Australia|CSG Investigational Site (#200), Reservoir, Victoria, 3073, Australia|CSG Investigational Site (#202), Richmond, Victoria, 3121, Australia|CSG Investigational Site (#209), Parkville, 3050, Australia|CSG Investigational Site (#757), Plovdiv, Bulgaria|CSG Investigational Site (# 750), Sofia, Bulgaria|CSG Investigational Site (# 755), Sofia, Bulgaria|CSG Investigational Site (# 756), Sofia, Bulgaria|CSG Investigational Site (#751), Sofia, Bulgaria|CSG Investigational Site (#752), Sofia, Bulgaria|CSG Investigational Site (#753), Sofia, Bulgaria|CSG Investigational Site (#754), Stara Zagora, Bulgaria|CSG Investigational Site (#801), Grenoble, Cedex, 38043, France|CSG Investigational Site (#802), Paris, Cedex, 75877, France|CSG Investigational Site (#800), Boulogne Sur Mer, 62321, France|CSG Investigational Site (#803), Colmar, 68024, France|CSG Investigational Site (#806), Montpellier, 34295, France|CSG Investigational Site (#804), Rhone, 69310, France|CSG Investigational Site (#805), Valenciennes, 59322, France|CSG Investigational Site (#709), Aschaffenburg, 63739, Germany|CSG Investigative Site (#702), Berlin, 10249, Germany|CSG Investigational Site (#706), Elsterwerda, 04910, Germany|CSG Investigational Site (#703), Heidelberg, 69115, Germany|CSG Investigational Site (#707), Herzberg, 04916, Germany|CSG Investigational Site (#701), Hoyerswerda, 02977, Germany|CSG Investigational Site (#708), Mainz, 55116, Germany|CSG Investigational Site (#700), Munchen, 81675, Germany|CSG Investigational Site (#400), Hong Kong, Hong Kong|CSG Investigational Site (#402), Kwai Chung, Hong Kong|CSG Investigational Site (#401), Sha Tin, Hong Kong|CSG Investigational Site (#501), Balatonfuered, 8230, Hungary|CSG Investigational Site (#509), Budapest, 1032, Hungary|CSG Investigational Site (#513), Budapest, 1036, Hungary|CSG Investigational Site (#505), Budapest, 1096, Hungary|CSG Investigational Site (#507), Debrecen, 4032, Hungary|CSG Investigational Site (#508), Gyula, 5701, Hungary|CSG Investigational Site (#502), Hatvan, 3000, Hungary|CSG Investigational Site (#504), Kaposvar, 7400, Hungary|CSG Investigational Site (#510), Kisvarda, 4600, Hungary|CSG Investigational Site (#506), Pecs, 7623, Hungary|CSG Investigational Site (#514), Szekesfehervar, 8000, Hungary|CSG Investigational Site (#500), Szikszo, 3800, Hungary|CSG Investigational Site (#503), Zalaegerszeg, 8900, Hungary|CSG Investigational Site (#308), Safed, Zefad, 13100, Israel|CSG Investigational Site (#307), Ashkelon, 78278, Israel|CSG Investigational Site (#313), Beer Sheva, 84101, Israel|CSG Investigational Site (#300), Haifa, 31096, Israel|CSG Investigational Site (#304), Holon, 58100, Israel|CSG Investigational Site (#306), Jerusalem, 91120, Israel|CSG Investigational Site (#314), Jerusalem, 93106, Israel|CSG Investigational Site (#309), Kfar Saba, 44281, Israel|CSG Investigational Site (#302), Nahariya, 22100, Israel|CSG Investigational Site (#312), Petah Tikva, 49100, Israel|CSG Investigational Site (#315), Poriya, 15208, Israel|CSG Investigational Site (#311), Rishon Le-Zion, 75650, Israel|CSG Investigational Site (#305), Tel Aviv, 62039, Israel|CSG Investigational Site (#303), Tel Aviv, Israel|CSG Investigational Site (#310), Tel Hasomer, 52621, Israel|CSG Investigational Site (#301), Zerifin, 70300, Israel|CSG Investigational Site (# 850), Phoenix, Mauritius|CSG Investigational Site (#651), Bydgoszcz, Poland|CSG Investigational Site (#655), Chojnice, Poland|CSG Investigational Site (#653), Kielce, Poland|CSG Investigational Site (#657), Nowy Sacz, Poland|CSG Investigational Site (#652), Poznan, Poland|CSG Investigational Site (#656), Poznan, Poland|CSG Investigational Site (#112), Rio Piedras, 00935, Puerto Rico|CSG Investigational Site (#110), San Juan, 00918, Puerto Rico|CSG Investigational Site (#135), Toa Baja, 00949, Puerto Rico|CSG Investigational Site (#601), San Sebastian de los Reyes, Madrid, 28702, Spain|CSG Investigational Site (#605), Barcelona, 08003, Spain|CSG Investigational Site (#606), Barcelona, 08022, Spain|CSG Investigational Site (#603), Barcelona, 08025, Spain|CSG Investigational Site (#604), Barcelona, 08907, Spain|CSG Investigational Site (#600), Girona, 17007, Spain|CSG Investigational Site (# 607), Lleida, 25198, Spain|CSG Investigational Site (#602), Valencia, 46017, Spain"
NCT06181227,A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT06181227,TERMINATED,Diabetic Macular Edema|Diabetic Retinopathy,DRUG: AVD-104,"Aviceda Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Erie Retina Research, Erie, Pennsylvania, 16507, United States|Texas Retina Associates, Dallas, Texas, 75231, United States|West Texas Retina Consultants, Wichita Falls, Texas, 76309, United States"
NCT01213888,Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT01213888,TERMINATED,Diabetic Retinopathy,DRUG: Trientine Hydrochloride|DRUG: Oral placebo capsules,University of British Columbia,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Eye Care Centre - Vancouver Coastal Health, Vancouver, British Columbia, V5Z 3N9, Canada"
NCT01129960,Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain,https://clinicaltrials.gov/study/NCT01129960,TERMINATED,Painful Diabetic Neuropathy,DRUG: Eslicarbazepine acetate (BIA 2-093)|DRUG: Placebo,Bial - Portela C S.A.,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"BIAL - Portela & Cª, S.A., S. Mamede do Coronado, 4045-457, Portugal"
NCT00668785,Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II),https://clinicaltrials.gov/study/NCT00668785,TERMINATED,Proliferative Diabetic Retinopathy|Macular Edema,DRUG: ranibizumab,"Jumper, J. Michael, M.D.","Genentech, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"West Coast Retina Medical Group Inc., San Francisco, California, 94107, United States"
NCT04831606,Blue Light Photobiomodulation Therapy on Neuroischemic Patients,https://clinicaltrials.gov/study/NCT04831606,TERMINATED,Diabetic Foot Ulcer,PROCEDURE: debridement|DEVICE: Offloading|DEVICE: Advanced dressing|DEVICE: Blue Light Photobiomodulation,Emoled,Ospedale San Donato|University of Pisa,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"San Donato Hospital, Arezzo, 52100, Italy"
NCT00619983,"Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy",https://clinicaltrials.gov/study/NCT00619983,TERMINATED,Diabetic Neuropathic Pain|Chronic Low Back Pain,DRUG: donepezil|DRUG: duloxetine|DRUG: donepezil 2.5 mg and duloxetine 30mg|DRUG: placebo|DRUG: gabapentin,Wake Forest University,National Institute of Neurological Disorders and Stroke (NINDS),ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States"
NCT01113801,A Study in Participants With Diabetic Kidney Disease,https://clinicaltrials.gov/study/NCT01113801,TERMINATED,Diabetic Kidney Disease|Diabetic Nephropathy|Diabetic Glomerulosclerosis,DRUG: LY2382770|DRUG: Placebo,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Phoenix, Arizona, 85012, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Inglewood, California, 90301, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Los Angeles, California, 90073, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Northridge, California, 91324, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Denver, Colorado, 80220, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Port Charlotte, Florida, 33952, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tampa, Florida, 33614, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Atlanta, Georgia, 30342, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Idaho Falls, Idaho, 83404, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Wichita, Kansas, 67214, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kenner, Louisiana, 70065, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Rockville, Maryland, 20852, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kansas City, Missouri, 64128, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Omaha, Nebraska, 68131, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chapel Hill, North Carolina, 27599, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Charlotte, North Carolina, 28207, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Durham, North Carolina, 27705, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Greenville, North Carolina, 27834, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Winston-Salem, North Carolina, 27157, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Beachwood, Ohio, 44122, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bend, Oregon, 97701, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Providence, Rhode Island, 02903, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Orangeburg, South Carolina, 29118, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas, Texas, 75390, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lufkin, Texas, 75904, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Saint George, Utah, 84770, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Suffolk, Virginia, 23435, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Milwaukee, Wisconsin, 53295, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Camperdown, New South Wales, 2050, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Concord, New South Wales, 2139, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gosford, New South Wales, 2250, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Liverpool, New South Wales, 2170, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Adelaide, South Australia, 5000, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Launceston, Tasmania, 7250, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Box Hill, Victoria, 3128, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fitzroy, Victoria, 3065, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, Victoria, 3084, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Melbourne, Victoria, 3004, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Parkville, Victoria, 3050, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Reservoir, Victoria, 3073, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nedlands, Western Australia, 6009, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cesky Krumlov, 381 27, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Decin, 405 99, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Jilemnice, 514 15, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Liberec, 460 63, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ostrava, 703 84, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Prague, 181 02, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tabor, 390 02, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Teplice, 415 01, Czechia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Grenoble, 38043, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lyon, 69437, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nanterre Cedex, 92014, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Valenciennes, 59322, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Vandoeuvre Les Nancy, 54511, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Baja, 6500, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Balatonfured, 8230, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Budapest, 1096, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gyongyos, 3200, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gyor, 9023, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kaposvar, 7400, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nagykanizsa, 8800, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Szeged, 6720, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Szigetvar, 7900, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Zalaegerszeg, 8900, Hungary|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ashkelon, 78278, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hadera, 38100, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Haifa, 31096, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Holon, 58100, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Jerusalem, 91120, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kfar Saba, 44281, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nahariya, 22100, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Rehovot, 76100, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Safed, 13110, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tel Aviv, 64239, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tel Hashomer, 52621, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Zerifin, 70300, Israel|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cidra, 00739, Puerto Rico|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Rio Piedras, 000935, Puerto Rico"
NCT04991350,Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT04991350,TERMINATED,Diabetic Macular Edema|Macular Ischemia|Diabetic Retinopathy|Vascular Endothelial Growth Factor Overexpression,DRUG: Intravitreal ranibizumab|DRUG: Intravitreal bevacizumab,Cairo University,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Cairo University, Cairo, 11956, Egypt"
NCT03555656,Repeated Educational Intervention for the Prevention of Diabetic Foot Ulcers in High-risk Patients,https://clinicaltrials.gov/study/NCT03555656,TERMINATED,Diabetic Foot,BEHAVIORAL: Repeated intervention|BEHAVIORAL: Single session,Azienda Ospedaliero-Universitaria Careggi,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Diabetologia AOU Careggi, Florence, 50134, Italy"
NCT03509870,Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds,https://clinicaltrials.gov/study/NCT03509870,TERMINATED,Diabetic Foot Ulcer,BIOLOGICAL: mesenchymal stromal cells,Steno Diabetes Center Copenhagen,Leiden University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Steno Diabetes Center Copenhagen, Gentofte, 2820, Denmark"
NCT00001310,Tissue Studies of Human Eye Diseases,https://clinicaltrials.gov/study/NCT00001310,TERMINATED,Retinal Disease|Corneal Disease|Diabetic Retinopathy|Uveitis|Age-Related Macular Degeneration,,National Eye Institute (NEI),,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT05092620,Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials,https://clinicaltrials.gov/study/NCT05092620,TERMINATED,Diabetic Foot Ulcer,,University of Michigan,"Indiana University|University of Miami|University of California, San Francisco|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Stanford University",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Stanford University, Palo Alto, California, 94305, United States|University of California, San Francisco, San Francisco, California, 94143, United States|University of Miami, Miami, Florida, 33126, United States|Indiana University, Indianapolis, Indiana, 46202, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States"
NCT01849965,Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01849965,TERMINATED,Diabetic Foot Ulcers,"DRUG: DSC127|DRUG: placebo vehicle gel|DRUG: Standard of Care gel, Aquasite",Integra LifeSciences Corporation,Integrium,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"East Valley Foot and Ankle Specialist, Mesa, Arizona, 85206, United States|Arizona Burn Center Maricopa Medical Center, Phoenix, Arizona, 85008, United States|Associated Foot & Ankle Specialists, PC, Phoenix, Arizona, 85015, United States|Ledesma Foot and Ankle, Phoenix, Arizona, 85032, United States|Precision Trials, Phoenix, Arizona, 85032, United States|Center for Clinical Research, Inc., Castro Valley, California, 94546, United States|Reliance Institute of Clinical Research, Chino, California, 91710, United States|Vladimir Zeetser, DPM, Encino, California, 91316, United States|Innovative Medical Technologies, LLC, Los Angeles, California, 90063, United States|Samuel Merritt University, California School of Podiatric Medicine, Oakland, California, 94609, United States|Center for Clinical Research, Inc., San Francisco, California, 94115, United States|The Diabetic Foot and Wound Center, Denver, Colorado, 80220, United States|Orthopedic Research Associates, Boynton Beach, Florida, 33472, United States|Invesclinic, LLC, Fort Lauderdale, Florida, 33308, United States|Research in Miami, Inc., Hialeah, Florida, 33013, United States|River City Clinical Research, Jacksonville, Florida, 32207, United States|New Phase Clincal Trials, Inc., Miami Beach, Florida, 33140, United States|Advanced Pharma CR, LLC, Miami, Florida, 33136, United States|University of Miami, Miami, Florida, 33136, United States|Phoenix Medical Research, Miami, Florida, 33165, United States|Bluegrass Foot Center c/o Research Concierge, LLC, Owensboro, Kentucky, 42303, United States|Grace Research, Shreveport, Louisiana, 71101, United States|American Center for Clinical Trials, Southfield, Michigan, 48034, United States|Dr. Vincent Giacalone, Emerson, New Jersey, 07630, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, 27533, United States|O'Malley Foot and Ankle, Wilmington, North Carolina, 24801, United States|Regional Infectious Disease & Infusion Center Inc., Lima, Ohio, 45801, United States|Paddington Testing Clinic, Philadelphia, Pennsylvania, 19103, United States|Martin Foot & Ankle, York, Pennsylvania, 17403, United States|North Texas Podiatric Medicine & Surgery, Dallas, Texas, 75231, United States|Bone and Joint Institute, Fort Worth, Texas, 76104, United States|Houston Foot & Ankle Specialists, Houston, Texas, 77074, United States|Redwood Health Center, Salt Lake City, Utah, 84119, United States|The Mayer Institute, Hamilton, Ontario, L8R 2R3, Canada|Lawson Health Research Institute, London, Ontario, N6C 5J1, Canada|Xceed Clinical, Whitby, Ontario, L1N 2L1, Canada|Centre Podiatrique et Soins des Plaies, Boucherville, Quebec, J4B 5E4, Canada|Centre de recherche du CHUS, Sherbrooke, Quebec, J1H 5N4, Canada|Centro de Curacion de Heridas del Caribe, Inc., Aguadilla, 00603, Puerto Rico|Office of Renier D. Gonzalez-Cruz, MD, Juana Diaz, 00795, Puerto Rico|Clinical Research Puerto Rico, San Juan, 00909, Puerto Rico|Wound and Ulcer Care Clinic, San Juan, 00918, Puerto Rico|GCT - Mercantile Clinical Trial Centre - Primecure Clinic, Port Elizabeth, Eastern Cape, 6020, South Africa|Iatros International, Bloemfontein, Free State, 9301, South Africa|Josha Research, Bloemfontein, Free State, 9301, South Africa|Worthwhile Clinical Trials, Benoni, Gauteng, 1500, South Africa|Dr Lakha's Consulting Rooms, Johannesburg, Gauteng, 1829, South Africa|Newtown Clincal Research Centre, Newtown, Gauteng, 2113, South Africa|Sunninghill Hospital, Sunninghill, Gauteng, 2157, South Africa|Synapta Clinical Research Centre, Durban, KwaZulu Natal, 4001, South Africa|Flamco Clinical Trials, Durban, KwaZulu Natal, 4092, South Africa|Brookedale Clinical Research Centre, Phoenix, KwaZulu Natal, 4068, South Africa|Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, Western Cape, 7530, South Africa|Tread Research, Parow, Western Cape, 7505, South Africa|Boland Ethical Research Group, Worcester, Western Cape, 6850, South Africa|Randles Road Medical Centre, Durban, ZwaZulu Natal, 4091, South Africa"
NCT02503527,Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin Therapy,https://clinicaltrials.gov/study/NCT02503527,TERMINATED,Aneurysmal Subarachnoid Hemorrhage,OTHER: Diben 1.5 kcal HP|OTHER: Fresubin HP Energy Fibre (1.5 kcal),Fresenius Kabi,OE Clinical Trial Center (KKS) Universität Innsbruck|International Medical Research - Partner GmbH|dsh statistical services GmbH,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Universitätsklinikum Innsbruck, Innsbruck, 6020, Austria"
NCT01014884,Coventry Outcomes Study of Seniors (COSS): A Comparative Effectiveness Study to Evaluate the Effect of a Multidisciplinary Team's Intervention on the Incidence of Nonelective Hospitalizations in a Medicare Population,https://clinicaltrials.gov/study/NCT01014884,TERMINATED,Heart Failure|Chronic Obstructive Pulmonary Disease|Cardiovascular Disease|Diabetes|Osteoporosis,OTHER: Multidisciplinary team interventions|OTHER: Multidisciplinary team bimonthly visits either in person or via telephone.|OTHER: Usual case management and pharmacy management as provided by the health Plan and the pharmacy benefit manager,"Medco Health Solutions, Inc.","Coventry Health Care, Inc.",ALL,OLDER_ADULT,,INTERVENTIONAL,"Kansas City, Missouri, United States|St. Louis, Missouri, United States"
NCT01328561,Oxytocin and Arginine Vasopressin in Pain Relief,https://clinicaltrials.gov/study/NCT01328561,TERMINATED,Placebo Analgesia,,National Institute of Mental Health (NIMH),,ALL,ADULT,,OBSERVATIONAL,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT00089557,An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain,https://clinicaltrials.gov/study/NCT00089557,TERMINATED,Herpes Zoster|Neuralgia|Pain|HIV Infections|Peripheral Nervous System Diseases|Diabetic Neuropathies|Diabetes Mellitus|Polyneuropathies,DRUG: Capsaicin Dermal Patch,NeurogesX,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,
NCT01657318,Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers,https://clinicaltrials.gov/study/NCT01657318,TERMINATED,Ulcer|Skin Ulcer|Leg Ulcer|Diabetic Foot,OTHER: Olivamine containing wound care products,De La Salle University Medical Center,Pinnaclife Inc.,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"De La Salle University Medical Center, Dasmariñas, Cavite, 4114, Philippines"
NCT06053047,Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration,https://clinicaltrials.gov/study/NCT06053047,TERMINATED,Diabetic Foot,DEVICE: Bluedrop Monitoring Service (BMS),Bluedrop Medical Limited,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Duke Clinical Research Institute, Durham, North Carolina, 27701, United States"
NCT05372809,"Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs",https://clinicaltrials.gov/study/NCT05372809,TERMINATED,Diabetic Foot,BIOLOGICAL: SkinTE|OTHER: Control,PolarityTE,Alira Health,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Limb Preservation Platform, INC, Fresno, California, 93710, United States|LA Foot and Ankle Clinic, Los Angeles, California, 900010, United States|Royal Research, Corp, Hollywood, Florida, 33021, United States|Barry University Clinical Research, Tamarac, Florida, 33321, United States|Gateway Clinical Trials, O'Fallon, Illinois, 62269, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|Mount Sinai West, New York, New York, 10019, United States|Northwell Health, New York, New York, 11042, United States|VA North Texas Health Care System, Dallas, Texas, 75216, United States|University of Texas Southwestern Wound Care Clinic, Dallas, Texas, 75390, United States|Futuro Clinical Trials, LLC, McAllen, Texas, 78501, United States|Baylor Scott & White Research Institute - Plano, Plano, Texas, 75204, United States|Foot and Ankle Institute, Saint George, Utah, 84770, United States"
NCT05276401,Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer,https://clinicaltrials.gov/study/NCT05276401,TERMINATED,Chronic Diabetic Foot Ulcers,DRUG: 5% Bisphosphocin Topical Gel|DRUG: Placebo Topical Gel|DRUG: 10% Bisphosphocin Topical Gel,Lakewood-Amedex Inc,Professional Education and Research Institute|PrimeVigilance,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"NEA Baptist Clinic, Jonesboro, Arkansas, 72405, United States|Limb Preservation Platform, Inc., Fresno, California, 93710, United States|Doctors Research Network, South Miami, Florida, 33143, United States|ACM Global Laboratories, Rochester, New York, 14624, United States|Futuro Clinical Trials, LLC, McAllen, Texas, 78501, United States"
NCT05362474,Targeting Leukotrienes in Kidney Disease,https://clinicaltrials.gov/study/NCT05362474,TERMINATED,Diabetic Kidney Disease,DRUG: Montelukast,"University of Colorado, Denver",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"University of Colorado, Aurora, Colorado, 80045, United States"
NCT05315908,COVID-19 Testing in Underserved and Vulnerable Populations,https://clinicaltrials.gov/study/NCT05315908,TERMINATED,"Heart Failure|Coronary Artery Disease|Cancer|Chronic Kidney Diseases|COPD|Obesity|Sickle Cell Disease|Diabetes Mellitus, Type 2",OTHER: Community outreach method,Jesse Nodora,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of California, San Diego, La Jolla, California, 92093, United States"
NCT02950181,Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients,https://clinicaltrials.gov/study/NCT02950181,TERMINATED,Stroke|Diabetic Ketoacidosis|Increased Intracranial Pressures|Altered Mental Status,DEVICE: NIRS,Arkansas Children's Hospital Research Institute,,ALL,"CHILD, ADULT",,INTERVENTIONAL,"Arkansas Children's Hospital, Little Rock, Arkansas, 72202, United States"
NCT05506215,Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT05506215,TERMINATED,Diabetic Foot|Chronic Foot Ulcer|Wound Healing|Foot Ulcer,DEVICE: SynPath Acellular Dermal Matrix plus Off-loading Device|DEVICE: Wound Dressing composed of 90% collagen and 10% Alginate plus Off-loading Device,PolyNovo Biomaterials Pty Ltd.,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Center for Clinical Research, Castro Valley, California, 94546, United States|Limb Preservation Platform, Inc, Fresno, California, 93710, United States|ILD Research Center, Vista, California, 92083, United States|Barry University Clinical Research, Tamarac, Florida, 33321, United States|Lower Extremity Institute for Research and Therapy, LLC, Youngstown, Ohio, 44512, United States|JPS Health Network, Fort Worth, Texas, 76104, United States|Foot and Ankle Specialists of Mid-Atlantic, LLC, Salem, Virginia, 24153, United States"
NCT03048227,Can Continuous Glucose Measurements Help Diabetic Patients Treated With an Implantated Pump?,https://clinicaltrials.gov/study/NCT03048227,TERMINATED,Type1diabetes,DEVICE: Continuous Glucose Measurement (CGM),"University Hospital, Montpellier",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Chu de Nancy, Nancy, Vandoeuvre-les-nancy, 54500, France|CHU de Bordeaux, Bordeaux, 33078, France|CH Sud Francilien, Corbeil-essonnes, 91100, France|CHU de Dijon, Dijon, 77908, France|CHRU de Lille, Lille, 59037, France|AP - Hôpitaux de Marseille, Marseille, 13005, France|UHMontpellier, Montpellier, 34295, France|AP - Hôpitaux de Paris, Paris, 75014, France|CHRU de Strasbourg, Strasbourg, 67091, France|Chu de Toulouse, Toulouse, 31059, France"
NCT04838600,A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv®,https://clinicaltrials.gov/study/NCT04838600,TERMINATED,Chronic Leg Ulcer|Chronic Diabetic Foot Ulcer,DEVICE: ChloraSolv,RLS Global,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Vårdcentralen Tunafors, Eskilstuna, Sweden|Capio Lundby Sjukhus, Gothenburg, Sweden|Carlanderska Hospital, Göteborg, Sweden|Wästerläkarna, Göteborg, Sweden|Wetterhälsan Munksjöstaden, Jönköping, Sweden|Orthopedic Clinic Mölndal Hospital, Mölndal, Sweden|Framtidens vårdavdelning, Trelleborg, Sweden"
NCT00130312,Effect of Sulodexide in Overt Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT00130312,TERMINATED,Diabetic Nephropathy,DRUG: Sulodexide|DRUG: Placebo,Keryx Biopharmaceuticals,Collaborative Study Group (CSG),ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian clinics, Rush University Medical Center, Chicago, Illinois, 60612, United States|The Collaborative Study Group, Clinical Coordinating Center for the Pacific Region, Monash Medical Center, Melbourne, Victoria, 3168, Australia|The Collaborative Study Group, Clinical Coordinating Center for European Clinics, University of Groningen, Groningen, 9713 AV, Netherlands"
NCT04709419,Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds,https://clinicaltrials.gov/study/NCT04709419,TERMINATED,Diabetic Foot Ulcer,DEVICE: Celliant Diabetic Medical Socks|DEVICE: Control (placebo) Medical Socks,University of Texas Southwestern Medical Center,"Hologenix, LLC",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"UT Southwestern Medical Center at Dallas, Dallas, Texas, 75390, United States"
NCT04178525,Clinical Trial Evaluating the Safety and Efficacy of the Use of Chitosan Gel in Patients With Chronic Wounds,https://clinicaltrials.gov/study/NCT04178525,TERMINATED,Diabetic Foot Ulcer,DEVICE: ChitoCare gel|DEVICE: Placebo gel,Primex ehf,Vizera d.o.o.|University of Ljubljana,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University Clinic Vuk Vrhovac, Zagreb, 10000, Croatia|General Hospital Celje, Celje, 3000, Slovenia|Clinic Golnik - Diabetic Clinic Kranj, Kranj, 4000, Slovenia|University Hospital Center Ljubljana, Ljubljana, 1000, Slovenia|General Hospital Murska Sobota, Murska Sobota, 9000, Slovenia"
NCT03997526,3C Patch® Medicare Claims Study,https://clinicaltrials.gov/study/NCT03997526,TERMINATED,Diabetic Foot Ulcer,DEVICE: 3C Patch,Reapplix,,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"Mayo Clinic, Phoenix, Arizona, 84054, United States|Natchitoches Regional Medical Center, Natchitoches, Louisiana, 27514, United States|Opelousas General Hospital Wound Center, Opelousas, Louisiana, 70570, United States|Southeast Wound Care and Hyperbaric Medical Center, Cape Girardeau, Missouri, 63703, United States|Regional One Physician Specialists, Poplar Bluff, Missouri, 63901, United States|UNC Chapel Hill, Chapel Hill, North Carolina, 27514, United States"
NCT03872089,Transient Thermal Behavior and Diabetic Foot,https://clinicaltrials.gov/study/NCT03872089,TERMINATED,Diabetic Patients Type 1 and 2|Podologic Grade From 0 to 3,OTHER: Infrared Thermography,"University Hospital, Montpellier",Université Montpellier,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"CHU Montpellier - Lapeyronie hospital, Montpellier, 34295, France"
NCT03933956,Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN),https://clinicaltrials.gov/study/NCT03933956,TERMINATED,Diabetic Nephropathies,DRUG: Empagliflozin 10 MG,Singapore General Hospital,Duke-NUS Graduate Medical School,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Singapore General Hospital, Singapore, 169608, Singapore"
NCT02499185,Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients,https://clinicaltrials.gov/study/NCT02499185,TERMINATED,Acute Kidney Injury|Arterial Hypertension|Obesity|Cardio Vascular Disease|Diabetes Mellitus|Chronic Liver Disease|Hypercholesterolemia,DEVICE: Nephro Check Test|OTHER: serum creatinine measurement,Universitair Ziekenhuis Brussel,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Universitair Ziekenhuis Brussel, Jette, Brussels, 1090, Belgium"
NCT03654989,Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers,https://clinicaltrials.gov/study/NCT03654989,TERMINATED,Diabetic Foot Ulcer,DRUG: Treprostinil iontophoresis|DEVICE: Remodulin® placebo iontophoresis,"University Hospital, Grenoble",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"CHU Grenoble Alpes, Grenoble, France"
NCT03712046,Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis,https://clinicaltrials.gov/study/NCT03712046,TERMINATED,Diabetic Foot Infection,DIAGNOSTIC_TEST: 18F-FDG PET-CT,Centre hospitalier de l'Université de Montréal (CHUM),,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"CHUM, Montréal, Quebec, Canada"
NCT03708029,Efficacy of Human Placental Graft in Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT03708029,TERMINATED,Diabetic Foot,OTHER: Revita Allograft,StimLabs,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Gulf Coast Podiatry, Pensacola, Florida, 32503, United States|Louisiana Foot and Ankle Specialists, Lake Charles, Louisiana, 70605, United States|Crozer/Keystone Health System, Center for Wound Healing, Springfield, Pennsylvania, 19064, United States"
NCT00387101,Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT00387101,TERMINATED,Diabetic Foot Ulcer,DEVICE: Dermal - Living Skin Replacement (Dermal - LSR),ApoPharma,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Southern Arizona Veterans Administration Health Care System, 3601 S. 6th Avenue (2-112), Tuscon, Arizona, 85723, United States|Veterans Affairs Northern Health Care System, Sacramento VA Medical Center at Mather, Mather, California, 95655, United States|San Diego Research Center 4452 Park Boulevard Suite 210, San Diego, San Diego, California, 92116, United States|Doctors Research Network, South Miami, Florida, 33143, United States|Weil Foot and Ankle Institute, Des Plaines, Illinois, 60016, United States|Hines VA Hospital, Hines, Illinois, 60141, United States|National Center for Lower Limb Preservation, Niles, Illinois, 60714, United States|Foot Care Vascular and Endovascular Specialists of Boston Medical Center, Boston, Massachusetts, 02118, United States|Joslin-Beth Israel Deaconess Foot Center, Division of Podiatry, 185 Pilgrim Road, Boston, Massachusetts, 02215, United States|North Shore Diabetic and Endocrine Associates, New Hyde Park, New York, 11042, United States|The Learner Research Centre, Department of Orthopaedic Surgery. The Cleveland Clinic Foundation, 9500 Euclid Ave. A40, Cleveland, Ohio, 44195, United States|Center for Advanced Wound Care, Reading, Pennsylvania, 19601, United States"
NCT03640988,The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs,https://clinicaltrials.gov/study/NCT03640988,TERMINATED,Diabetic Foot Ulcer,DEVICE: dermaPACE,"SANUWAVE, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University Hospital, Newark, New Jersey, 07103, United States"
NCT03186560,"Speckle Study: In Arterial, Mixed and Diabetic Foot Ulcers",https://clinicaltrials.gov/study/NCT03186560,TERMINATED,Leg Ulcer,DEVICE: gekoTM,Firstkind Ltd,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Glenfield Hospital, Leicester, LE3 9QP, United Kingdom|Aneurin Bevan Local Health Board, Newport, NP18 3XG, United Kingdom|Welsh wound Innovation Centre, Wales, cf72 8ux, United Kingdom"
NCT03204149,Evaluation of Safety of Low Level Laser Device Treatment in Chronic Wounds,https://clinicaltrials.gov/study/NCT03204149,TERMINATED,Diabetic Foot Ulcer,DEVICE: MC-8XL low level laser device and Standard wound care|DEVICE: Sham laser device and Standard wound care,Medical Coherence LLC,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Northern District Trauma & Wound Clinics Division, Maccabi Health Care Services, Haifa, Israel"
NCT00462202,"Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong",https://clinicaltrials.gov/study/NCT00462202,TERMINATED,Diabetic Nephropathy,DRUG: sulodexide,Keryx Biopharmaceuticals,Collaborative Study Group (CSG),ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Monash Medical Center, Melbourne, Victoria, 3168, Australia"
NCT02875704,"Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy",https://clinicaltrials.gov/study/NCT02875704,TERMINATED,Stargardt Disease|Diabetic Retinopathy|Macular Degeneration (Age Related),OTHER: Anterior Chamber (AC) Tap,Johns Hopkins University,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Wilmer Eye Institute, Baltimore, Maryland, 21287, United States"
NCT04910763,"Prediabetes, Exercise, and Appetite Regulation",https://clinicaltrials.gov/study/NCT04910763,TERMINATED,PreDiabetes|Appetitive Behavior,BEHAVIORAL: Resistance Exercise,University of Utah,,ALL,ADULT,,INTERVENTIONAL,"University of Utah, Salt Lake City, Utah, 84112, United States"
NCT02036528,Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT02036528,TERMINATED,Diabetic Foot Ulcers,DRUG: Gentamicin Topical Gel|DRUG: Ciprofloxacin|DRUG: Doxycycline,"Royer Biomedical, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Georgetown University Hospital Center, Washington, District of Columbia, 20007, United States|GF Professional Research, Corp., Miami Lakes, Florida, 33016, United States|Florida Medical Center & Research, Inc., Miami, Florida, 33142, United States|Advanced Foot and Ankle Institute of Georgia LLC, Smyrna, Georgia, 30080, United States|Union Memorial Hospital, Baltimore, Maryland, 21218, United States|Detroit Clinical Research Center, PC, Farmington Hills, Michigan, 48334, United States|Utah Valley Medical Center, Provo, Utah, 84604, United States"
NCT02510885,SD-OCT Angiography,https://clinicaltrials.gov/study/NCT02510885,TERMINATED,Neovascular Age-related Macular Degeneration|Age-related Macular Degeneration|Diabetic Retinopathy|Retinal Vein Occlusion|Diabetic Macular Edema,DEVICE: AngioVue SD-OCT,Duke University,Optovue,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Duke Eye Center, Durham, North Carolina, 27710, United States"
NCT02585622,NEPHSTROM for Diabetic Kidney Disease,https://clinicaltrials.gov/study/NCT02585622,TERMINATED,Diabetic Kidney Disease,BIOLOGICAL: Mesenchymal Stromal Cells|OTHER: Placebo,Mario Negri Institute for Pharmacological Research,"Leiden University Medical Center|Papa Giovanni XXIII Hospital|Istituto Di Ricerche Farmacologiche Mario Negri|Belfast Health and Social Care Trust|National University of Ireland, Galway, Ireland|University Hospital Birmingham, NHS Foundation Trust, Hospital, Birmingham, UK|NHS Blood and Transplant",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"National University of ireland - Galway University Hospital -Regenerative Medicine Institute, Galway, Ireland|ASST - Papa Giovanni XXIII - U.O. Nefrologia e Dialisi/ Mario Negri Institute for Pharmacological Research - Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Bergamo, BG, 24027, Italy|Belfast Health and Social Care Trust - Belfast City Hospital, Belfast, United Kingdom|University Hospital Birmingham NHS Foundation Trust - Queen Elizabeth Medical Centre, Birmingham, United Kingdom"
NCT02313428,Topical Oxygen Therapy for Diabetic Wounds,https://clinicaltrials.gov/study/NCT02313428,TERMINATED,Diabetic Foot Ulcers|Wound,DEVICE: Topical Oxygen Chamber for Extremities,Indiana University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"IU Health Methodist Hospital, Indianapolis, Indiana, 46202, United States"
NCT02166294,NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT02166294,TERMINATED,"Foot Ulcer, Diabetic",OTHER: NEOX® CORD 1K|PROCEDURE: Standard of Care (Pressure Bandage),"Amniox Medical, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Arizona, Tucson, Arizona, 85724, United States|Center for Clinical Research, Inc., Castro Valley, California, 94115, United States|Ankle and Foot Centers of Georgia, Newnan, Georgia, 30265, United States"
NCT02181621,A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs,https://clinicaltrials.gov/study/NCT02181621,TERMINATED,Diabetic Foot Ulcer,DEVICE: Iodosorb|DEVICE: Solosite gel,"Smith & Nephew, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"St Lukes Roosevelt Hospital, New York, New York, 10019, United States"
NCT01966380,"Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia",https://clinicaltrials.gov/study/NCT01966380,TERMINATED,Leg Ulcer|Diabetic Foot Ulcer|Pressure Ulcer,DEVICE: Leia,Molnlycke Health Care AB,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Sahlgrenska clinical trial center, Göteborg, 41346, Sweden"
NCT02667327,A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer,https://clinicaltrials.gov/study/NCT02667327,TERMINATED,Diabetic Foot Ulcers,DRUG: Granexin gel|OTHER: Vehicle gel,"Xequel Bio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"New Hope Podiatry Group, Inc., Los Angeles, California, 90063, United States|Integral - Clinical Trials Solutions, Doral, Florida, 33126, United States|Direct Helpers Research Center, Hialeah, Florida, 33012, United States|Nirvana Research Center, Miami, Florida, 33193, United States|Acclaim Bone & Joint, Fort Worth, Texas, 76104, United States|Futuro Clinical Trials, LLC, McAllen, Texas, 78501, United States|Centre podiatrique et soins des plaies, Boucherville, Quebec, J4B 5E4, Canada|Clinexpert Kft. - Kaszasdulo utca 5., Budapest, 1033, Hungary|Strazsahegy Medicina Bt., Zrinyi utca 226, Budapest, 1171, Hungary|Shrey Hospital Pvt Ltd, Ahmedabad, Gujarat, 380009, India|Parul Sevashram Hospitals, Ahmedabad, Gujarat, 390020, India|Anand Multispecialty Hospital, Vadodara, Gujarat, 390016, India|Convenient Hospitals Ltd., CHL - Hospitals, Indore, Madhya Pradesh, 452008, India|KLEs Dr. Prabakar Kore Hospital and Medical Research Center, Belgaum, India|Peoples College of Medical Science and Research Centre, Bhopal, India|Marwari Hospital and Research Centre, Guwahati, India|Surakshaka MultiSpecialty and Diabetes Hospital, Hyderabad, India|KRM Hospital and Research Center, Lucknow, India|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India|Fortis Hospital, Mohali, India|K R Hospital and Research Institute, Mysore, India|Supe Heart and Diabetes Hospital and Research Centre, Nashik, India|Batra Hospital and Medical Research Center, New Delhi, India|Aman Hospital and Research Centre, Vadodara, India|Anu Hospitals, Kovelamudivara Street, Vijayawada, India|Instytut Medycyny Wsi - oddz diabetologii ul. Jaczewskiego 2, 20-090 Lublin, Poland, Lublin, Jaczewskiego, 20-090, Poland|NZOZ MED ART. Poradnie Specjalistyczne Ks. Wladyslawa 27, 44-240 Zory, Poland, Zory, Wladyslawa 27, 44-240, Poland|Lubuskie Centrum Diabetologii UI., Budziszynek, Zielon, 20 65-945, Poland|MIKOMED Sp. z o.o. ul., Łódź ., Łódź .Pługowa, 51 94-238, Poland"
NCT06037369,The Short Message-based Customized Standardized,https://clinicaltrials.gov/study/NCT06037369,TERMINATED,Diabetic Foot Ulcer,BEHAVIORAL: customized standardized educational program sent by LINE software.,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Chang Gung Memorial Hospital, Taoyuan City, Taiwan"
NCT00761176,A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT00761176,TERMINATED,Diabetic Foot Ulcers,DEVICE: The Provant Therapy System,"Regenesis Biomedical, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Winston - Salem Outpatient Clinic, Winston - Salem, North Carolina, 27103, United States"
NCT01608776,RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs,https://clinicaltrials.gov/study/NCT01608776,TERMINATED,Diabetic Foot Ulcer,DEVICE: MIST Therapy|OTHER: SOC - Standard of Care,"Celleration, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Georgetown University Hospital, Washington, District of Columbia, 20007, United States"
NCT00658957,Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer,https://clinicaltrials.gov/study/NCT00658957,TERMINATED,Diabetic Foot Ulcer,DRUG: gentamicin-collagen sponge|DRUG: placebo collagen sponge,Innocoll,Premier Research Group plc,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Chesapeake Foot and Ankle Center, Pasadena, Maryland, 21122, United States"
NCT04286529,"Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons",https://clinicaltrials.gov/study/NCT04286529,TERMINATED,Pre-Diabetic,DRUG: Calcitriol capsules|DRUG: Oral Placebo,Mayo Clinic,,ALL,ADULT,PHASE1,INTERVENTIONAL,"Mayo Clinic, Rochester, Minnesota, 55905, United States"
NCT05666570,The Avelle® Negative Pressure Wound Therapy System on Chronic Wounds,https://clinicaltrials.gov/study/NCT05666570,TERMINATED,Diabetic Foot Ulcer|Venous Leg Ulcer,DEVICE: Avelle NPWT,ConvaTec Inc.,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Convatec Medical Care, Bogota, Cundinamarca, 11001000, Colombia"
NCT01549964,Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT01549964,TERMINATED,Glycemic Control,DRUG: Fasiglifam (TAK-875)|DRUG: Sitagliptin|DRUG: Placebo,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Muscle Shoals, Alabama, United States|Mesa, Arizona, United States|Peoria, Arizona, United States|Phoenix, Arizona, United States|Chula Vista, California, United States|El Cajon, California, United States|La Mesa, California, United States|Laguna Hills, California, United States|National City, California, United States|Paramount, California, United States|San Diego, California, United States|Stockton, California, United States|Tustin, California, United States|West Hills, California, United States|Trumbull, Connecticut, United States|Coral Gables, Florida, United States|Jacksonville, Florida, United States|Miami, Florida, United States|New Port Richey, Florida, United States|Ocala, Florida, United States|West Palm Beach, Florida, United States|Meridian, Idaho, United States|Chicago, Illinois, United States|Greenfield, Indiana, United States|Muncie, Indiana, United States|Lexington, Kentucky, United States|Owensboro, Kentucky, United States|Hyattsville, Maryland, United States|Troy, Michigan, United States|Picayune, Mississippi, United States|St. Louis, Missouri, United States|Haddon Heights, New Jersey, United States|Rosedale, New York, United States|Calabash, North Carolina, United States|Charlotte, North Carolina, United States|Monroe, North Carolina, United States|Morehead City, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Dayton, Ohio, United States|Norman, Oklahoma, United States|Lancaster, Pennsylvania, United States|Levittown, Pennsylvania, United States|Spartanburg, South Carolina, United States|Crossville, Tennessee, United States|Memphis, Tennessee, United States|Carrollton, Texas, United States|Houston, Texas, United States|Irving, Texas, United States|Katy, Texas, United States|McKinney, Texas, United States|Plano, Texas, United States|San Antonio, Texas, United States|Spring, Texas, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Richmond, Virginia, United States|Camperdown, New South Wales, Australia|Maroubra, New South Wales, Australia|Redcliffe, Queensland, Australia|Adelaide, South Australia, Australia|Daw Park, South Australia, Australia|Box Hill, Victoria, Australia|Fitzroy, Victoria, Australia|Melbourne, Victoria, Australia|Byala, Bulgaria|Kazanlak, Bulgaria|Plovdiv, Bulgaria|Sofia, Bulgaria|Cakovec, Croatia|Karlovac, Croatia|Krapinske Toplice, Croatia|Rijeka, Croatia|Slavonski Brod, Croatia|Split, Croatia|Zadar, Croatia|Zagreb, Croatia|Beroun, Czech Republic|Brno, Czech Republic|Havlickuv Brod, Czech Republic|Kladno, Czech Republic|Kromeriz, Czech Republic|Mlada Boleslav, Czech Republic|Ostrava - Moravska Ostrava, Czech Republic|Ostrava, Czech Republic|Pardubice, Czech Republic|Pisek, Czech Republic|Plzen, Czech Republic|Praha 11, Czech Republic|Praha 2, Czech Republic|Praha 5, Czech Republic|Praha 6, Czech Republic|Praha 8, Czech Republic|Usti nad Labem, Czech Republic|Baja, Hungary|Balatonfured, Hungary|Budaors, Hungary|Budapest, Hungary|Debrecen, Hungary|Eger, Hungary|Godollo, Hungary|Gyongyos, Hungary|Gyula, Hungary|Hodmezovasarhely, Hungary|Kecskemet, Hungary|Kistelek, Hungary|Kisvarda, Hungary|Komarom, Hungary|Mohacs, Hungary|Nyiregyhaza, Hungary|Pecs, Hungary|Szeged, Hungary|Szekszard, Hungary|Szikszo, Hungary|Szolnok, Hungary|Szombathely, Hungary|Urhida, Hungary|Veszprem, Hungary|Zalaegerszeg, Hungary|Sesto San Giovanni, Milano, Italy|Firenze, Italy|Milano, Italy|Pavia, Italy|Goyang-si, Gyeonggi-do, Korea, Republic of|Seongnam-Si, Gyeonggi-do, Korea, Republic of|Incheon, Korea, Republic of|Seoul, Korea, Republic of|Johor Bahru, Johor, Malaysia|Alor Setar, Kedah, Malaysia|Kota Bharu, Kelantan, Malaysia|Cheras, Kuala Lumpur, Malaysia|Lembah Pantai, Kuala Lumpur, Malaysia|Petaling Jaya, Selangor, Malaysia|Kelantan, Malaysia|Kuala Lumpur, Malaysia|Banska Bystrica, Slovakia|Bardejov, Slovakia|Bratislava, Slovakia|Kosice - Saca, Slovakia|Kosice, Slovakia|Levice, Slovakia|Lucenec, Slovakia|Moldava nad Bodvou, Slovakia|Nitra, Slovakia|Pezinok, Slovakia|Presov, Slovakia|Prievidza, Slovakia|Sahy, Slovakia|Stropkov, Slovakia|Sturovo, Slovakia|Svidnik, Slovakia|Trebisov, Slovakia|Trencin, Slovakia|Zilina, Slovakia|Patumwan, Bangkok, Thailand|Rachathevi, Bangkok, Thailand|Rajtevi, Bangkok, Thailand|Ratchathewi, Bangkok, Thailand|Muang, Chiang Mai, Thailand|Muang, Nakhon Ratchasima, Thailand|Hatyai, Songkhla, Thailand|Bangkok, Thailand|Khon Kaen, Thailand"
NCT05608187,Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT05608187,TERMINATED,Wound Heal|Wound Healing Disturbance of|Wound Healing Disorder|Wound Healing Delayed|Diabetic Foot Ulcer|Diabetic Foot Ulcer Mixed,BIOLOGICAL: ILP100-Topical (emilimogene sigulactibac) 5x10^7 CFU/cm^2|BIOLOGICAL: ILP100-Topical (emilimogene sigulactibac) 1x10^9 CFU/cm^2|BIOLOGICAL: Placebo,Ilya Pharma,European Commission,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Department of Endocrinology, Skåne University Hospital, Lund, 221 85, Sweden|Clinical Diabetes Research Unit at Uppsala University Hospital, Uppsala, Sweden"
NCT01199783,Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment,https://clinicaltrials.gov/study/NCT01199783,TERMINATED,Diabetic Foot,DRUG: Daptomycin|DRUG: Vancomycin,Ruhr University of Bochum,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Herz- und Diabeteszentrum, Bad Oeynhausen, 32545, Germany"
NCT05494450,"An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds",https://clinicaltrials.gov/study/NCT05494450,TERMINATED,Pressure Ulcer|Diabetic Foot Ulcer|Venous Leg Ulcer,DEVICE: ExufiberAG+,Molnlycke Health Care AB,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Center for Clinical Research, San Francisco, California, 94115, United States|Sycamore Wound Care and Hyperbaric Center, Miamisburg, Ohio, 45342, United States"
NCT05438251,"Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)",https://clinicaltrials.gov/study/NCT05438251,TERMINATED,Diabetic Foot Ulcer (DFU),DRUG: Fespixon Cream,"Oneness Biotech Co., Ltd.",China Medical University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"China Medical University Hospital, Taichung, 40447, Taiwan"
NCT00762138,The AutoloGel™ Post-Market Surveillance (TAPS) Program,https://clinicaltrials.gov/study/NCT00762138,TERMINATED,Wounds|Leg Ulcers|Pressure Ulcers|Diabetic Foot Ulcers,DEVICE: AutoloGel System,Cytomedix,CTI Clinical Trial and Consulting Services,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Aiyan Diabetes Center, Augusta, Georgia, 30809, United States|Providence Wound Institute, El Paso, Texas, 79902, United States"
NCT00837096,A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds,https://clinicaltrials.gov/study/NCT00837096,TERMINATED,Diabetic Amputation Foot Wound,DEVICE: V.A.C. Therapy|DEVICE: Moist wound therapy (MWT),"KCI USA, Inc",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT00823225,Urokinase Therapy in Patients With Diabetic Foot Syndrome,https://clinicaltrials.gov/study/NCT00823225,TERMINATED,Diabetic Foot|Arterial Occlusive Disease|Ischemia,PROCEDURE: standard therapy|DRUG: Urokinase,medac GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Franziskus Krankenhaus, Berlin, Germany|Klinikum Dortmund Nord GmbH, Dortmund, Germany|Krankenhaus Dresden-Neustadt, Dresden, Germany|Universitätsklinik, Dresden, Germany|Weißeritztal-Kliniken GmbH, Freital, Germany|Klinikum Karlsbad Langensteinbach, Karlsbad, Germany"
NCT04962139,Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT04962139,TERMINATED,Chronic Diabetic Foot Ulcers,DRUG: ON101 Cream|OTHER: Vehicle Cream,"Oneness Biotech Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Oneness Investigational Site, Mesa, Arizona, 85206, United States|Oneness Investigational Site, Carlsbad, California, 92009, United States|Oneness Investigational Site, Castro Valley, California, 94546, United States|Oneness Investigational Site, Fresno, California, 93710, United States|Oneness Investigational Site, San Francisco, California, 94117, United States|Oneness Investigational Site, Sylmar, California, 91342, United States|Oneness Investigational Site, Miami Lakes, Florida, 33016, United States|Oneness Investigational Site, Miami, Florida, 33165, United States|Oneness Investigational Site, North Miami Beach, Florida, 33321, United States|Oneness Investigational Site, Mount Prospect, Illinois, 60056, United States|Oneness Investigational Site, O'Fallon, Illinois, 62269, United States|Oneness Investigational Site, Springfield, Illinois, 62704, United States|Oneness Investigational Site, Dallas, Texas, 75251, United States|Oneness Investigational Site, McAllen, Texas, 78501, United States"
NCT04927702,Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU),https://clinicaltrials.gov/study/NCT04927702,TERMINATED,Diabetic Foot Ulcer|Venous Leg Ulcer,DEVICE: Synthetic Hybrid-Scale Fiber Matrix|DEVICE: Standard of Care|DEVICE: Living Cellular Skin Substitute,"Acera Surgical, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"ILD Research Center, Vista, California, 92083, United States|University of Florida - Jacksonville, Jacksonville, Florida, 32209, United States|Barry University, Miami Beach, Florida, 33169, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|Gundersen Health System, La Crosse, Wisconsin, 54601, United States"
NCT00605189,A Trial Examining Cellular Energetics Related to Various Wound Treatment Therapies,https://clinicaltrials.gov/study/NCT00605189,TERMINATED,Diabetic Foot Ulcers,DEVICE: Powered Suction Pump (VAC Freedom)|DEVICE: Powered Suction Pump|DEVICE: MWT,"KCI USA, Inc",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"The Ohio State University Medical Center, Columbus, Ohio, 43210, United States|University of Texas Health Science Center San Antonio, San Antonio, Texas, 78229, United States"
NCT00672451,Rhubarb and Angiotensin Converting Enzyme Inhibitor,https://clinicaltrials.gov/study/NCT00672451,TERMINATED,Diabetic Kidney Disease,DIETARY_SUPPLEMENT: rhubarb extract|DIETARY_SUPPLEMENT: placebo,Wake Forest University,National Center for Complementary and Integrative Health (NCCIH),ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Wake Forest University Heath Sciences, Winston-Salem, North Carolina, 27157, United States"
NCT00512538,Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT00512538,TERMINATED,Diabetic Foot,DEVICE: Bi-layered cell therapy (Apligraf),Organogenesis,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00399425,Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients,https://clinicaltrials.gov/study/NCT00399425,TERMINATED,"Foot Ulcer, Diabetic|Diabetic Angiopathies",DRUG: bemiparin (low molecular weight heparin),Spanish National Health System,Carlos III Health Institute|Rovi Pharmaceuticals Laboratories,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,INTERVENTIONAL,
NCT00448526,Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT00448526,TERMINATED,Diabetic Nephropathies,BEHAVIORAL: low protein diet,Kanazawa Medical University,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT04634838,Efficacy of Wound Dressings With Copper Oxide,https://clinicaltrials.gov/study/NCT04634838,TERMINATED,Pressure Ulcer|Diabetic Foot Ulcer,DEVICE: MedCu Antibacterial Wound Dressings with Copper Oxide,MedCu Technologies Ltd.,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Loewenstein Rehabilitation Center, Ra'anana, Israel"
NCT04577183,"A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in Elderly Population in Specialized Nursing Facilities Using RD1",https://clinicaltrials.gov/study/NCT04577183,TERMINATED,Diabetic Foot Ulcer|Pressure Ulcer|Venous Leg Ulcer|Trauma Injury|Skin Tear|Chronic Ulcer,DEVICE: RD1 System,RedDress Ltd.,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Sunnyview Nursing & Rehabilitation Center, Butler, Pennsylvania, 16001, United States"
NCT00316537,Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT00316537,TERMINATED,Diabetic Foot Ulcers,DRUG: ATG002 (study drug),CoMentis,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"SeniorCare, Alabama Geriatric Specialists, Homewood, Alabama, 35209, United States|Hope Research Institute, Phoenix, Arizona, 85050, United States|Southern Arizona VA Health Care System, Tucson, Arizona, 85723, United States|Center for Clinical Research, Castro Valley, California, 94546, United States|University of San Diego Wound Treatment and Research Center, San Diego, California, 92103, United States|University of Miami, Miami, Florida, 33136, United States|Ankle and Foot Specialists of Atlanta, Lithonia, Georgia, 30058, United States|Crossroads Research, Inc., Owings Mills, Maryland, 21117, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|NewBridge Medical Research, Warren, Pennsylvania, 16365, United States|Central Washington Podiatry Service, Yakima, Washington, 98902, United States|Aurora Health Care / Lukes Medical Center, Milwaukee, Wisconsin, 53215, United States"
NCT00171600,Antialbuminuric Effects of Valsartan and Lisinopril,https://clinicaltrials.gov/study/NCT00171600,TERMINATED,Hypertension|Early Diabetic Nephropathy,"DRUG: VALSARTAN, VALSARTAN PLUS HCTZ, LISINOPRIL, LISINOPRIL PLUS HCTZ",Novartis,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Novartis Pharmaceuticals, Basel, Switzerland"
NCT05199090,"Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM",https://clinicaltrials.gov/study/NCT05199090,TERMINATED,Obesity,DRUG: MBL949|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,ADULT,PHASE2,INTERVENTIONAL,"Novartis Investigative Site, Miami, Florida, 33135, United States|Novartis Investigative Site, Morehead City, North Carolina, 28557, United States|Novartis Investigative Site, Knoxville, Tennessee, 37920, United States|Novartis Investigative Site, Dallas, Texas, 75230, United States"
NCT00065559,Treatment of Diabetic Nephropathy,https://clinicaltrials.gov/study/NCT00065559,TERMINATED,Diabetic Nephropathy,DRUG: celecoxib,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois, 60612, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States"
NCT04240574,Debritom - Micro Water Jet Technology and Wound Healing,https://clinicaltrials.gov/study/NCT04240574,TERMINATED,Diabetic Foot Ulcer|Non-healing Wound|Non-Healing Ulcer of Skin|Venous Leg Ulcer|Venous Ulcer,DEVICE: Debritom,Stephanie Wu,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Rosalind Franklin University Health Clinics, North Chicago, Illinois, 60064, United States"
NCT04186377,Application of S26E for Diabetic Foot Ulcer Healing,https://clinicaltrials.gov/study/NCT04186377,TERMINATED,Diabetic Foot|Neuropathic Foot Ulcer|Chronic Diabetic Ulcer of Left Foot (Diagnosis)|Chronic Diabetic Foot Ulcer of Right Foot,OTHER: Standard-of-care for neuropathic/neuroischemic diabetic foot ulcers|DRUG: S26E,National and Kapodistrian University of Athens,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Diabetes Clinical Research Laboratory, 1st Department of Propaedeutic Internal Medicine, Athens, 11527, Greece"
NCT02631148,Effects of Melatonin Supplementation on Renal Physiology in a Habitual Sleep Restricted Population.,https://clinicaltrials.gov/study/NCT02631148,TERMINATED,Obesity|Prediabetic State,DRUG: Melatonin|DRUG: Placebo,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States"
NCT00391196,"A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients",https://clinicaltrials.gov/study/NCT00391196,TERMINATED,Obesity,"DRUG: Placebo|DRUG: CP-945,598|DRUG: CP-945,598 Treatment B",Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Pfizer Investigational Site, Birmingham, Alabama, 35233, United States|Pfizer Investigational Site, Birmingham, Alabama, 35294, United States|Pfizer Investigational Site, Huntsville, Alabama, 35801, United States|Pfizer Investigational Site, Mobile, Alabama, 36608, United States|Pfizer Investigational Site, Chandler, Arizona, 85224, United States|Pfizer Investigational Site, Mesa, Arizona, 85213, United States|Pfizer Investigational Site, Phoenix, Arizona, 85014, United States|Pfizer Investigational Site, Fresno, California, 93720, United States|Pfizer Investigational Site, Palm Springs, California, 92262, United States|Pfizer Investigational Site, Tustin, California, 92780, United States|Pfizer Investigational Site, Walnut Creek, California, 94598, United States|Pfizer Investigational Site, New Britain, Connecticut, 06050, United States|Pfizer Investigational Site, Washington, District of Columbia, 20003-4393, United States|Pfizer Investigational Site, Orlando, Florida, 32809, United States|Pfizer Investigational Site, West Palm Beach, Florida, 33401, United States|Pfizer Investigational Site, Honolulu, Hawaii, 96814, United States|Pfizer Investigational Site, Gurnee, Illinois, 60031, United States|Pfizer Investigational Site, Madisonville, Kentucky, 42431, United States|Pfizer Investigational Site, Baton Rouge, Louisiana, 70808, United States|Pfizer Investigational Site, Metairie, Louisiana, 70002, United States|Pfizer Investigational Site, Auburn, Maine, 04210, United States|Pfizer Investigational Site, Scarborough, Maine, 04074, United States|Pfizer Investigational Site, Baltimore, Maryland, 21204, United States|Pfizer Investigational Site, Bay City, Michigan, 48706, United States|Pfizer Investigational Site, Troy, Michigan, 48098, United States|Pfizer Investigational Site, Edina, Minnesota, 55435, United States|Pfizer Investigational Site, Jefferson City, Missouri, 65109, United States|Pfizer Investigational Site, Albuquerque, New Mexico, 87108, United States|Pfizer Investigational Site, Buffalo, New York, 14209, United States|Pfizer Investigational Site, New York, New York, 10025, United States|Pfizer Investigational Site, Greenville, North Carolina, 27834, United States|Pfizer Investigational Site, Beaver, Pennsylvania, 15009, United States|Pfizer Investigational Site, Cumberland, Rhode Island, 02864, United States|Pfizer Investigational Site, Pawtucket, Rhode Island, 02860, United States|Pfizer Investigational Site, Greer, South Carolina, 29651, United States|Pfizer Investigational Site, Bristol, Tennessee, 37620, United States|Pfizer Investigational Site, Nashville, Tennessee, 37203, United States|Pfizer Investigational Site, Dallas, Texas, 75230, United States|Pfizer Investigational Site, Dallas, Texas, 75246, United States|Pfizer Investigational Site, San Antonio, Texas, 78229, United States|Pfizer Investigational Site, San Antonio, Texas, 78237, United States|Pfizer Investigational Site, Renton, Washington, 98057, United States|Pfizer Investigational Site, Morgantown, West Virginia, 26506-9136, United States|Pfizer Investigational Site, Buenos Aires, C1034ACO, Argentina|Pfizer Investigational Site, Buenos Aires, C1405CWB, Argentina|Pfizer Investigational Site, Buenos Aires, C1426ABP, Argentina|Pfizer Investigational Site, Garran, Australian Capital Territory, 2605, Australia|Pfizer Investigational Site, Wollongong, New South Wales, 2500, Australia|Pfizer Investigational Site, Adelaide, South Australia, 5000, Australia|Pfizer Investigational Site, Box Hill, Victoria, 3128, Australia|Pfizer Investigational Site, Nedlands, Western Australia, 6009, Australia|Pfizer Investigational Site, Curitiba, PR, 80030-110, Brazil|Pfizer Investigational Site, Porto Alegre, RS, 90035-170, Brazil|Pfizer Investigational Site, São Paulo, SP, 01221-020, Brazil|Pfizer Investigational Site, São Paulo, SP, 01244-030, Brazil|Pfizer Investigational Site, São Paulo, SP, 04025-011, Brazil|Pfizer Investigational Site, São Paulo, SP, 05403-000, Brazil|Pfizer Investigational Site, Red Deer, Alberta, T4N 6V7, Canada|Pfizer Investigational Site, Coquitlam, British Columbia, V3K 3P4, Canada|Pfizer Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|Pfizer Investigational Site, Thornhill, Ontario, L4J 8L7, Canada|Pfizer Investigational Site, Charlottetown, Prince Edward Island, C1E 1J7, Canada|Pfizer Investigational Site, L'Ancienne-Lorette, Quebec, G2E 2X1, Canada|Pfizer Investigational Site, Saint-Marc-des-Carrières, Quebec, G0A 4B0, Canada|Pfizer Investigational Site, Breclav, 690 02, Czech Republic|Pfizer Investigational Site, Ceske Budejovice, 370 87, Czech Republic|Pfizer Investigational Site, Olomouc, 772 00, Czech Republic|Pfizer Investigational Site, Praha 2, 128 08, Czech Republic|Pfizer Investigational Site, Praha 4 - Krc, 140 21, Czech Republic|Pfizer Investigational Site, Berlin, 13125, Germany|Pfizer Investigational Site, Dresden, 01219, Germany|Pfizer Investigational Site, Duesseldorf, 40225, Germany|Pfizer Investigational Site, Hamburg, 20253, Germany|Pfizer Investigational Site, Leipzig, 04103, Germany|Pfizer Investigational Site, Mittweida, 09648, Germany|Pfizer Investigational Site, Tampico, Cd. Madero, 89109, Mexico|Pfizer Investigational Site, Mexico, DF, 11850, Mexico|Pfizer Investigational Site, Guadalajara, Jalisco, 44340, Mexico|Pfizer Investigational Site, Monterrey, Nuevo León, 64460, Mexico|Pfizer Investigational Site, Banska Bystrica, 975 17, Slovakia|Pfizer Investigational Site, Bratislava, 813 69, Slovakia|Pfizer Investigational Site, Lubochna, 034 91, Slovakia|Pfizer Investigational Site, Nitra, 950 01, Slovakia|Pfizer Investigational Site, Goteborg, 413 45, Sweden|Pfizer Investigational Site, Huddinge, 141 86, Sweden|Pfizer Investigational Site, Edinburgh, Lothian, EH4 2XU, United Kingdom|Pfizer Investigational Site, Bath, Somerset, BA1 3NG, United Kingdom|Pfizer Investigational Site, Coventry, CV2 2DX, United Kingdom|Pfizer Investigational Site, Dumfries, DG1 4AP, United Kingdom|Pfizer Investigational Site, Dundee, DD1 9SY, United Kingdom|Pfizer Investigational Site, Luton, LU4 0DZ, United Kingdom"
NCT00329862,Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy,https://clinicaltrials.gov/study/NCT00329862,TERMINATED,Morbid Obesity|Obstructive Sleep Apnea|Hypertension|Urinary Incontinence|Hypertriglyceridemia|Diabetes|Hypercholesterolemia,PROCEDURE: Laparoscopic Truncal Vagotomy,"Central Carolina Surgery, PA","EndoVx, Inc.",ALL,ADULT,,INTERVENTIONAL,
NCT05095038,The Effect of Appethyl® vs Placebo on Human Health (Appethyl),https://clinicaltrials.gov/study/NCT05095038,TERMINATED,Overweight and Obesity|PreDiabetes,DIETARY_SUPPLEMENT: Appethyl®|DIETARY_SUPPLEMENT: Placebo,University of Copenhagen,"Greenleaf Medical AB, Lund, Sweden|Lund University",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Copenhagen, Frederiksberg, DK, 1958, Denmark"
NCT00576667,An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes,https://clinicaltrials.gov/study/NCT00576667,TERMINATED,Fatty Liver,DRUG: Rimonabant|DRUG: Placebo (for Rimonabant),Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, 08807, United States|Sanofi-Aventis Administrative Office, Buenos Aires, Argentina|Sanofi-Aventis Administrative Office, Cove, New South Wales, Australia|Sanofi-Aventis Administrative Office, Diegem, Belgium|Sanofi-Aventis Administrative Office, Sao Paulo, Brazil|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-Aventis Administrative Office, Shangai, China|Sanofi-Aventis Administrative Office, Santafe de Bogota, Colombia|Sanofi-Aventis Administrative Office, Zagreb, Croatia|Sanofi-Aventis Administrative Office, Paris, France|Sanofi-Aventis Administrative Office, Berlin, Germany|Sanofi-Aventis Administrative Office, Budapest, Hungary|Sanofi-Aventis Administrative Office, Milan, Italy|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Mexico, Mexico|Sanofi-Aventis Administrative Office, Makati City, Philippines|Sanofi-Aventis Administrative Office, Warszawa, Poland|Sanofi-Aventis Administrative Office, Porto Salvo, Portugal|Sanofi-Aventis Administrative Office, Puerto Rico, Puerto Rico|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Geneva, Switzerland|Sanofi-Aventis Administrative Office, Taipei, Taiwan|Sanofi-Aventis Administrative Office, Guildford, Surrey, United Kingdom"
NCT01133600,Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens,https://clinicaltrials.gov/study/NCT01133600,TERMINATED,Diabetic Foot,DRUG: Cubicin|DRUG: Vancomycin,"Clinical Alliance for Research & Education - Infectious Diseases, LLC.","Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Clinical Alliance for Research & Education, Infectious Diseases, LlC, Annandale, Virginia, 22003, United States|Infuscience, Annandale, Virginia, 22003, United States"
NCT03517111,The Impact of a Parenting Intervention on Latino Youth Health Behaviors,https://clinicaltrials.gov/study/NCT03517111,TERMINATED,Diet Modification|Substance Use Disorders|Diabetes Mellitus Risk|Cardiovascular Risk Factor|Lifestyle Risk Reduction|Parenting,BEHAVIORAL: Nutrition/substance use prevention|BEHAVIORAL: Substance use prevention only|BEHAVIORAL: Academic success program,Arizona State University,National Institute on Minority Health and Health Disparities (NIMHD),ALL,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Arizona State University, Phoenix, Arizona, 85004, United States"
NCT02936115,TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT02936115,TERMINATED,Diabetic Foot Ulcers,OTHER: TruSkin®|OTHER: Wound Cover,Osiris Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Florida, Florida, United States|Illinois, Illinois, United States|Michigan, Michigan, United States|Texas, Texas, United States|Virginia, Virginia, United States"
NCT02785198,Passive Training as a Treatment for Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT02785198,TERMINATED,Diabetic Foot Ulcers,DEVICE: Passive knee extensor machine,Herlev Hospital,University of Copenhagen,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Herlev Hospital, Herlev, Capital Region Of Denmark, 2730, Denmark"
NCT02571738,Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT02571738,TERMINATED,Chronic Diabetic Foot Ulcers,BIOLOGICAL: CHAM|OTHER: Control,Osiris Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"SAVAHCS, Tucson, Arizona, 85723, United States|ILD Research Center, Carlsbad, California, 92009, United States|Center for Clinical Research, Castro Valley, California, 94546, United States|Center for Clinical Research, San Francisco, California, 94115, United States|Stanford University, Stanford, California, 94305, United States|MedStar Georgetown University Hospital, Washington, D.C., District of Columbia, 20007, United States|Barry University Clinical Research, North Miami Beach, Florida, 33169, United States|SSH, South Weymouth, Massachusetts, 02190, United States|Ocean County Foot & Ankle Surgical Associates, Toms River, New Jersey, 08753, United States|NSLIJHS, Lake Success, New York, 11042, United States|UNC, Chapel Hill, North Carolina, 27599, United States|Duke University, Durham, North Carolina, 27710, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|University Orthopedics, Altoona, Pennsylvania, 16602, United States|Temple University, Philadelphia, Pennsylvania, 19107, United States|Spartanburg Regional Healthcare System, Spartanburg, South Carolina, 29303, United States|North Texas Podiatric Medicine and Surgery Associates, Dallas, Texas, 75231, United States|Texas Gulf Coast Medical Group, Webster, Texas, 77598, United States"
NCT02563522,Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers,https://clinicaltrials.gov/study/NCT02563522,TERMINATED,"Foot Ulcer, Diabetic",GENETIC: Engensis (VM202)|DRUG: Placebo,"Helixmith Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Central Research Associates, Inc., Birmingham, Alabama, 35205, United States|Arizona Research Center, Phoenix, Arizona, 85053, United States|University of Arizona, Tucson, Arizona, 85724, United States|NEA Baptist, Jonesboro, Arkansas, 72401, United States|Sacramento Foot and Ankle, Carmichael, California, 95608, United States|Bay Area Foot and Ankle, Castro Valley, California, 94546, United States|VA Long Beach Healthcare System, Long Beach, California, 90822, United States|USC Keck School of Medicine, Los Angeles, California, 90033, United States|Foot and Ankle Clinic, Los Angeles, California, 90057, United States|Center for Clinical Research Inc., San Francisco, California, 94115, United States|Olive View-UCLA Education & Research Institute, Sylmar, California, 91342, United States|LCC Medical Research Institute, Miami, Florida, 33126, United States|Miami Dade Medical Research Institute, LLC, Miami, Florida, 33176, United States|Northwestern University, Chicago, Illinois, 60611, United States|UMASS Memorial Med Center, Worcester, Massachusetts, 01655, United States|Saint Louis University, Saint Louis, Missouri, 63110, United States|Advanced Foot & Ankle Center, Las Vegas, Nevada, 89119, United States|Oregon Foot and Ankle Center, Eugene, Oregon, 97401, United States|MedResearch, Inc, El Paso, Texas, 79932, United States|Acclaim Bone & Joint Institute, Fort Worth, Texas, 76107, United States|Texas Heart Institute, Houston, Texas, 77030, United States|Futuro Clinical Trials, McAllen, Texas, 78501, United States"
NCT01539811,Diabetic Foot Infection Antibiotic Study,https://clinicaltrials.gov/study/NCT01539811,TERMINATED,Diabetic Foot Infections,PROCEDURE: Surgical incision and drainage of diabetic foot infection|DRUG: Short course antibiotics|DRUG: Long course antibiotics,Prisma Health-Upstate,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Greenville Hospital System University Medical Center, Greenville, South Carolina, 29605, United States"
NCT02202668,Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT02202668,TERMINATED,Diabetic Foot Ulcer,DEVICE: TRS,University of Michigan,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Michigan, Ann Arbor, Michigan, 48109, United States"
NCT04235621,"A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)",https://clinicaltrials.gov/study/NCT04235621,TERMINATED,"Glomerulosclerosis, Focal Segmental|Minimal Change Disease|Diabetic Nephropathies",OTHER: FSGS/TR-MCD|OTHER: Diabetic Nephropathy (DN),"Goldfinch Bio, Inc.",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Aventiv Research - Phoenix, Mesa, Arizona, 85210-6041, United States|Glendale Adventist Medical Center, Glendale, California, 91206, United States|DaVita Mojave Sage Dialysis, Victorville, California, 92395-8322, United States|Colorado Kidney Care, Denver, Colorado, 80230-7200, United States|Renal and Transplant Associates of New England, PC, Springfield, Massachusetts, 01107-1369, United States|St. Clair Nephrology, Roseville, Michigan, 48066, United States|DaVita Clinical Research, Minneapolis, Minnesota, 55404-1212, United States|Clinical Research Consultants, Kansas City, Missouri, 64111, United States|DaVita Pelican Point Dialysis, Las Vegas, Nevada, 89129-6201, United States|High Desert Nephrology, Gallup, New Mexico, 87301-5655, United States|Akron Nephrology Associates, Inc., Akron, Ohio, 44302-1715, United States|Southeast Renal Research Institute, Chattanooga, Tennessee, 37404-2743, United States|Arlington Nephrology, PC, Arlington, Texas, 76015, United States|North Texas Kidney Disease Association, Lewisville, Texas, 75057-6039, United States|South Texas Renal Care Group (Downtown), San Antonio, Texas, 78207, United States|San Antonio Kidney Disease Center Physicians Group (Wurzbach Road), San Antonio, Texas, 78229-3809, United States|South Texas Renal Care Group (Westover Hills), San Antonio, Texas, 78251-1230, United States|San Antonio Kidney Disease Center Physicians Group (Carnoustie Drive), San Antonio, Texas, 78258-4800, United States"
NCT01858545,A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01858545,TERMINATED,"Foot Ulcer, Diabetic",DEVICE: MatriStem|DEVICE: Cellular Dermal Replacement Tissue,Integra LifeSciences Corporation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Carl t. Hayden Phoenix VA Medical Center, Phoenix, Arizona, 85012, United States|Associated Foot & Ankle Specialists, PC, Phoenix, Arizona, 85015, United States|Center for Clinical Research Inc., Castro Valley, California, 94546, United States|Valley Vascular Surgery Associates, Fresno, California, 93720, United States|Denver VA Medical Center, Denver, Colorado, 80220, United States|Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|Advanced Research Institute of Miami, Homestead, Florida, 33030, United States|NewPhase Clinical Trials, Corp., Miami Beach, Florida, 33140, United States|Professional Health Care of Pinellas, Saint Petersburg, Florida, 33713, United States"
NCT01840085,"Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use",https://clinicaltrials.gov/study/NCT01840085,TERMINATED,Diabetic Foot Ulcer,DRUG: 0.03% DSC127 topical gel,Integra LifeSciences Corporation,Integrium,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"WILMAX Clinical Research, Mobile, Alabama, 36608, United States|Reliance Institute of Clinical Research, Chino, California, 91710, United States|Roy O. Kroeker, DMP, Inc., Fresno, California, 93710, United States|Limb Preservation Platform (LPP), Fresno, California, 93720, United States|Foot and Ankle Clinic, Los Angeles, California, 90010, United States|Center for Clinical Research, Inc., San Francisco, California, 94115, United States|Olive View - UCLA Medical Center, Sylmar, California, 91342, United States|Orange County Research Center, Tustin, California, 92780, United States|Advanced Research Institute of Miami, Homestead, Florida, 33030, United States|UF Health Orthopaedic Surgery Clinic, Jacksonville, Florida, 32209, United States|GF Professional Research, Miami Lakes, Florida, 33016, United States|Phoenix Medical Research, LLC, Miami, Florida, 33165, United States|Miami Dade Medical Research Institute, Miami, Florida, 33176, United States|Barry University Clinical Research, North Miami Beach, Florida, 33169, United States|Professional Health Care of Pinellas, Saint Petersburg, Florida, 33713, United States|Eastern Carolina Foot & Ankle Specialists, Greenville, North Carolina, 27834, United States|O'Malley Foot and Ankle, Wilmington, North Carolina, 28411, United States|Martin Foot & Ankle, York, Pennsylvania, 17402, United States|Carolina Musculoskeletal Institute, Aiken, South Carolina, 29801, United States|Endeavor Clinical Trials, San Antonio, Texas, 78229, United States|Professional Education and Research Institute, Roanoke, Virginia, 24016, United States"
NCT01816672,Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.,https://clinicaltrials.gov/study/NCT01816672,TERMINATED,Diabetic Foot Ulcer,DEVICE: AutoloGel|OTHER: Usual and Customary Care,Cytomedix,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Forest General Hospital, Hattiesburg, Mississippi, 39401, United States"
NCT01816633,Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01816633,TERMINATED,Diabetic Foot Ulcers,DEVICE: AutoloGel,Cytomedix,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Arcadia, California, 91007, United States|HyperBarxs at Northside Forsyth, Cumming, Georgia, United States"
NCT00308646,Instrument Development of Screening Prediabetes Patients,https://clinicaltrials.gov/study/NCT00308646,TERMINATED,Prediabetic State,,China Medical University Hospital,"National Science Council, Taiwan",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT01729286,Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix,https://clinicaltrials.gov/study/NCT01729286,TERMINATED,"Foot Ulcer, Diabetic",DEVICE: PriMatrix Moist Wound Therapy|OTHER: Standard of Care Moist Wound Therapy,Integra LifeSciences Corporation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Southern California, Los Angeles, California, 90033, United States|Foot and Ankle Clinic, Los Angeles, California, 90057, United States|Advanced Research Institute of Miami, Miami, Florida, 33030, United States|Advanced Foot & Ankle Specialists, Tampa, Florida, 33606, United States|Joseph M. Still Research Foundation, Augusta, Georgia, 30909, United States|American Health Network, Carmel, Indiana, 46032, United States|Foot & Andle Center of Mooresville, Mooresville, Indiana, 46158, United States|Imperial Health, Lake Charles, Louisiana, 70601, United States|Kansas City Vascular, North Kansas City, Missouri, 64116, United States|St. Anthony's Medical Center, St. Louis, Missouri, 63128, United States|North Shore Long Island Jewish Comprehensive Wound Healing Center, Lake Success, New York, 11042, United States|Wake Forest University, Winston-Salem, North Carolina, 27157, United States|Fairfield Medical Center, Lancaster, Ohio, 43130, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States|University of Tennessee, Memphis, Tennessee, 38103, United States|Centro Podiatrico del Norte, Arecibo, 00612, Puerto Rico|Renier Gonzalez-Cruz, Juana Diaz, 00795, Puerto Rico|VA Carribean Healthcare System, San Juan, 00921, Puerto Rico"
NCT01531517,Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01531517,TERMINATED,Diabetic Foot Ulcer,DRUG: Royal Jelly and Panthenol (PedyPhar® Ointment)|DRUG: Panthenol Ointment,European Egyptian Pharmaceutical Industries,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Alexandria University Hospitals, Alexandria, Egypt|Cairo University Hospitals, Alexandria, Egypt"
NCT04051229,Exercise Training and Metabolic Flexibility in Prediabetes,https://clinicaltrials.gov/study/NCT04051229,TERMINATED,PreDiabetes|Sedentary Lifestyle,BEHAVIORAL: 6-week exercise training program|BEHAVIORAL: Standardized isoenergetic high fat diet,Wake Forest University Health Sciences,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Health and Exercise Science Clinical Research Center, Winston-Salem, North Carolina, 27105, United States|Wake Forest Baptist Medical Center Clinical Research Unit, Winston-Salem, North Carolina, 27157, United States"
NCT01270633,A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01270633,TERMINATED,"Foot Ulcer, Diabetic",DEVICE: PriMatrix|OTHER: Standard of Care,Integra LifeSciences Corporation,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"HyperbaRXs, Cumming, Georgia, 30041, United States|Covenant Medical Center, Saginaw, Michigan, 48602, United States|Professional Hospital, Guaynabo, 00717, Puerto Rico|Dr. Pila Metropolitan Hospital Wound Healing Center, Ponce, 00717, Puerto Rico|Caribbean Clinical Trials, San Juan, 00918, Puerto Rico|Doctors' Center Hospital of San Juan, San Juan, 00918, Puerto Rico|Wound and Ulcer Care Clinic of San Juan, San Juan, 00918, Puerto Rico|Wilma N. Vazquez Hospital, Vega Baja, 00694, Puerto Rico"
NCT01013792,A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT01013792,TERMINATED,"Foot Ulcer, Diabetic",DEVICE: Wound Dressing|DEVICE: Wound Dressing,Solventum US LLC,3M,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Terry Treadwell, MD, Montgomery, Alabama, 36111, United States|Alex Reyzelman, DPM, Castro Valley, California, 94546, United States|Wyatt Payne, MD, Bay Pines, Florida, 33744, United States|Vickie Driver, DPM, Boston, Massachusetts, 02118, United States|William Marston, MD, Chapel Hill, North Carolina, 27599, United States|Joseph Boykin, MD, Richmond, Virginia, 23220, United States"
NCT00958711,The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer,https://clinicaltrials.gov/study/NCT00958711,TERMINATED,Diabetic Foot Ulcers,DEVICE: Unite Biomatrix|OTHER: Saline and Gauze,Baxter Healthcare Corporation,Synovis Surgical Innovations,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of California - San Diego, San Diego, California, 92103, United States|University of Miami, Miller School of Medicine, Miami, Florida, 33136, United States|Aiyan Diabetes Center, Evans, Georgia, 30809, United States|Foot & Ankle Associates of Central Illinois, LLC, Springfield, Illinois, 62704, United States|Eastern Carolina Foot and Ankle, Greenville, North Carolina, 27834, United States|Foot and Ankle East, Greenville, North Carolina, 27834, United States|Carolina East Family Medicine, Greenville, North Carolina, 27858, United States|Family Foot & Ankle Physicians, Greenville, North Carolina, 27858, United States|Comprehensive Wound Care Thoracic & Vascular Associates of Kinston P.A., Kinston, North Carolina, 28504, United States|The Foot & Ankle Associates of North Carolina, PLLC, Rocky Mount, North Carolina, 27804, United States|Martin Foot and Ankle, York, Pennsylvania, 17403, United States"
NCT00820703,The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT00820703,TERMINATED,Diabetic Foot Ulcer,DRUG: Nexagon®|DRUG: Nexagon® vehicle,"OcuNexus Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Middlemore Hospital, Auckland, New Zealand"
NCT00434538,BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT00434538,TERMINATED,Diabetic Foot Ulcer,DEVICE: BST-DermOn,BioSyntech Canada Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Foothills Medical Center Col Belcher Hospital, Calgary, Alberta, T2N 2T9, Canada|Surrey Memorial Hospital Fraser Health Authority, Surrey, British Columbia, V3V 2K1, Canada|Infection Control Unit, Infectious Diseases and Medical Microbiology, University of Manitoba Health Sciences Centre, Winnipeg, Manitoba, R3A 1R9, Canada|Dermadvance Research, Winnipeg, Manitoba, R3C 1R4, Canada|James Paton Memorial Hospital, Gander, Newfoundland and Labrador, A1V 1P7, Canada|Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, B3H 3A7, Canada|Riverside Professional Centre, Sydney River, Nova Scotia, B1S 3N1, Canada|The Mayer Institute, Hamilton, Ontario, L8R 2R3, Canada|Wassay Gezhig Na Nahn Dah We Igamig, Kenora, Ontario, P9N 1Y9, Canada|Parkwood Hospital, London, Ontario, N6C 5J1, Canada|Dermatology Clinic, Mississauga, Ontario, L4Y1A6, Canada|EntraLogix Clinical Group, Newmarket, Ontario, L3Y 2R2, Canada|St Michael's Hospital, Toronto, Ontario, M5C 1R8, Canada|Dermatology Daycare and Wound Healing Clinic, Toronto, Ontario, M5S 1B5, Canada|Centre podiatrique, Boucherville, Quebec, J4B 5E4, Canada|Clinique de dermatologie Giard & Toscano, 500 Greber #110, Gatineau, Quebec, J8T 7W3, Canada|Centre de Recherche Clinique de Laval, Laval, Quebec, H7T 2P5, Canada|CHAU-Hôtel-Dieu de Lévis, Département de médecine de jour- 5ème étage, Clinique des plaies complexes, Levis, Quebec, G6V 3Z1, Canada|CHUM - Hotel Dieu, Montreal, Quebec, H2W 1T8, Canada|St-Jerome Medical Research Inc., St-Jerome, Quebec, J7Z 5T3, Canada"
NCT03083600,Effect of Protein Hydrolysates on HbA1c Levels in Pre-diabetics,https://clinicaltrials.gov/study/NCT03083600,TERMINATED,PreDiabetes,DIETARY_SUPPLEMENT: Plant-based Protein Hydrolysate 1|DIETARY_SUPPLEMENT: Plant-based Protein Hydrolysate 2|DIETARY_SUPPLEMENT: Placebo,Atlantia Food Clinical Trials,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Atlantia Food Clinical Trials, University College Cork, Cork, Munster, T12 H2TK, Ireland"
NCT00368693,Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers,https://clinicaltrials.gov/study/NCT00368693,TERMINATED,Diabetic Foot Ulcer,DEVICE: Dermal - Living Skin Replacement (Dermal-LSR),"University of California, Davis",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"VA Medical Center, Mather, California, 95655, United States|University of California, Davis Medical Center Department of Dermatology, Sacramento, California, 95816, United States"
NCT05961163,Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study,https://clinicaltrials.gov/study/NCT05961163,TERMINATED,"Coronary Disease|Myocardial Infarction|Heart Failure|Arrhythmias, Cardiac|Peripheral Artery Disease|Stroke|Ischemic Attack, Transient|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Pulmonary Disease, Chronic Obstructive|Asthma|Renal Insufficiency|Depressive Disorder|Anxiety Disorders|Schizophrenia|Peripheral Nervous System Diseases",,Universitätsklinikum Hamburg-Eppendorf,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany"
NCT00034788,A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX,https://clinicaltrials.gov/study/NCT00034788,TERMINATED,Foot Ulcer|Diabetic Foot|Skin Ulcer|Diabetic Neuropathies,DRUG: Becaplermin,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT02188823,Examining the Effects of Diet on Health in Prediabetes With an Online Program,https://clinicaltrials.gov/study/NCT02188823,TERMINATED,Prediabetes,BEHAVIORAL: Low carbohydrate diet,"University of California, San Francisco",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of California, San Francisco, San Francisco, California, 94115, United States"
NCT05897372,Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study,https://clinicaltrials.gov/study/NCT05897372,TERMINATED,Diabetic Kidney Disease,"DRUG: ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib",Iain Bressendorff,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Department of Nephrology, Herlev and Gentofte Hospital, Herlev, 2730, Denmark"
NCT03479242,Diabetic Foot Ulcer Recurrence: Pilot Study,https://clinicaltrials.gov/study/NCT03479242,TERMINATED,Diabetic Foot|Ulcer Foot,OTHER: no interventions,Indiana University,Stanford University,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"IU Health Methodist Hospital, Indianapolis, Indiana, 46202, United States"
NCT01941277,Effect of Exercise on Insulin Resistance,https://clinicaltrials.gov/study/NCT01941277,TERMINATED,Prediabetic State,BEHAVIORAL: Current Recommendations Exercise Group|BEHAVIORAL: Intensive Exercise Group,Alere San Diego,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Manchester University, Manchester, M23 9QZ, United Kingdom|Move Lab, Newcastle upon Tyne, NE1 7RU, United Kingdom"
NCT02071979,Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds,https://clinicaltrials.gov/study/NCT02071979,TERMINATED,Diabetic Foot Ulcers|Venous Ulcers|Pressure Ulcers,DEVICE: Autologous PRP Gel|DEVICE: Autologous PRP Injections|DEVICE: Autologous PRP Gel plus PRP Injections|PROCEDURE: Standard Wound Care,"Arteriocyte, Inc.",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Good Samaritan Wound Care Center, Bakersfield, California, 93313, United States|Sunnyside Foot and Ankle, Idaho Falls, Idaho, 83404, United States|Wound Care Center, Englewood Hospital and Medical Center, Englewood, New Jersey, 07631, United States|Comprehensive Wound Healing Center and Hyperbarics, Lake Success, New York, 11042, United States|Total Foot Care, Cleveland, Ohio, 44107, United States|Heritage Valley Health System, Beaver, Pennsylvania, 15009, United States"
NCT04078854,The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention,https://clinicaltrials.gov/study/NCT04078854,TERMINATED,"Diabetic Ulcers on Both Feet|Amputation; Traumatic, Limb|Sexual Dysfunction|Diabetic Foot Ulcer Ischemic",BEHAVIORAL: Diabetes education,Montefiore Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Montefiore Medical Center, Bronx, New York, 10467, United States"
NCT01909908,ECM and Blood Components for Wound Healing,https://clinicaltrials.gov/study/NCT01909908,TERMINATED,"Ulcer|Venous Ulcer|Foot Ulcer, Diabetic",DEVICE: ECM|BIOLOGICAL: Blood Products|DEVICE: ECM in Blood Products,Cook Group Incorporated,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Health Sciences Centre, Winnipeg, Manitoba, R3A 1R9, Canada"
NCT01717937,Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging,https://clinicaltrials.gov/study/NCT01717937,TERMINATED,Age-related Macular Degeneration|Diabetic Retinopathy|Hypertensive Retinopathy|Retinal Vein Occlusion|Retinal Artery Occlusion,PROCEDURE: Phase variance optical coherence tomography (PV-OCT),"University of California, San Francisco",,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"University of California, San Francisco, San Francisco, California, 94118, United States"
NCT03794752,Visual Enhancement Device in Low Vision Patients,https://clinicaltrials.gov/study/NCT03794752,TERMINATED,"Macular Degeneration, Age-Related|Diabetic Retinopathy",DEVICE: Head-Mounted Visual Enhancement Device,University of Texas Southwestern Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,
NCT00577148,An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes,https://clinicaltrials.gov/study/NCT00577148,TERMINATED,Fatty Liver,DRUG: Rimonabant|DRUG: Placebo (for Rimonabant),Sanofi,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, 08807, United States|Sanofi-Aventis Administrative Office, Buenos Aires, Argentina|Sanofi-Aventis Administrative Office, Cove, New South Wales, Australia|Sanofi-Aventis Administrative Office, Diegem, Belgium|Sanofi-Aventis Administrative Office, Sao Paulo, Brazil|Sanofi-Aventis Administrative Office, Santiago, Chile|Sanofi-Aventis Administrative Office, Shangai, China|Sanofi-Aventis Administrative Office, Santafe de Bogota, Colombia|Sanofi-Aventis Administrative Office, Zagreb, Croatia|Sanofi-Aventis Administrative Office, Paris, France|Sanofi-Aventis Administrative Office, Berlin, Germany|Sanofi-Aventis Administrative Office, Budapest, Hungary|Sanofi-Aventis Administrative Office, Milan, Italy|Sanofi-Aventis Administrative Office, Kuala Lumpur, Malaysia|Sanofi-Aventis Administrative Office, Mexico, Mexico|Sanofi-Aventis Administrative Office, Makati City, Philippines|Sanofi-Aventis Administrative Office, Warszawa, Poland|Sanofi-Aventis Administrative Office, Porto Salvo, Portugal|Sanofi-Aventis Administrative Office, Puerto Rico, Puerto Rico|Sanofi-Aventis Administrative Office, Bucuresti, Romania|Sanofi-Aventis Administrative Office, Barcelona, Spain|Sanofi-Aventis Administrative Office, Geneva, Switzerland|Sanofi-Aventis Administrative Office, Taipei, Taiwan|Sanofi-Aventis Administrative Office, Guildford, Surrey, United Kingdom"
NCT00211471,Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).,https://clinicaltrials.gov/study/NCT00211471,TERMINATED,Severe Diabetic Retinopathy|Central Retinal Vein Occlusion|Chronic Inflammation|Infectious Diseases,DRUG: anecortave acetate,"Manhattan Eye, Ear & Throat Hospital",Alcon Research,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Manhattan Eye, Ear & Throat Hospital, New York, New York, 10021, United States"
NCT02264288,Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease,https://clinicaltrials.gov/study/NCT02264288,TERMINATED,Peripheral Arterial Disease|Diabetic Foot,BIOLOGICAL: 3 x 10^6 cells|BIOLOGICAL: 10 x 10^6 cells|BIOLOGICAL: 30 x 10^6 cells|OTHER: Placebo,Celularity Incorporated,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Cardiology PC, Birmingham, Alabama, 35211, United States|TFi Medical, Mobile, Alabama, 36608, United States|East Valley Foot and Ankle Specialist, Mesa, Arizona, 85206, United States|Carl T. Hayden Veterans Affairs Medical Center, Phoenix, Arizona, 85012, United States|Arizona Arthritis and Rheumatology Research, PLLC, Phoenix, Arizona, 85023, United States|Aung Foothealth Clinics and Advanced Wound Care Center, Tucson, Arizona, 85710, United States|Northeast Arkansas Baptist Clinic, Jonesboro, Arkansas, 72401, United States|Jeffrey A Klemes DPM, Beverly Hills, California, 90211, United States|Center for Clinical Research Inc., Castro Valley, California, 94546-5306, United States|Reliance Clinical Research, Chino, California, 91710, United States|Limb Preservation Platform, INC., Fresno, California, 93720, United States|Foot and Ankle Clinic, Los Angeles, California, 90010, United States|UCLA, Los Angeles, California, 90095, United States|VA Palo Alto Health Care System, Palo Alto, California, 94304, United States|Stanford University, Stanford, California, 94035-5821, United States|Georgetown University Medical Center Lombardi Cancer Center, Washington, District of Columbia, 20007-2197, United States|Clinical Research of West Florida Inc - Clearwater, Clearwater, Florida, 33765, United States|Barry University, Fort Lauderdale, Florida, 33321, United States|Florida Research Network, LLC, Gainesville, Florida, 32605, United States|The Research Center, Hialeah, Florida, 33012, United States|University of Florida, Jacksonville, Florida, 32209, United States|Solutions Through Advanced Research Inc., Jacksonville, Florida, 32258, United States|GF Professional Research Group Corporation, Miami Lakes, Florida, 33016, United States|University of Miami, Miami, Florida, 33136, United States|Well Pharma Medical Research Corporation, Miami, Florida, 33143, United States|Med-Care Research Inc, North Miami Beach, Florida, 33162, United States|Podiatry 1st, Belleville, Illinois, 62226, United States|University of Illinois at Chicago Cancer Center, Chicago, Illinois, 60612, United States|Weill Foot & Ankle Institute, Des Plaines, Illinois, 60016, United States|Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, 60064, United States|Southern Illinois University, Springfield, Illinois, 62702, United States|Foot and Ankle Center of Illinois, Springfield, Illinois, 62704, United States|CGH Medical Center Main Clinic, Sterling, Illinois, 61081, United States|Hamilton Foot Care, Baltimore, Maryland, 21214, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, 21215, United States|Northwest Hospital, Randallstown, Maryland, 21133, United States|Revive Research Institute, Sterling Heights, Michigan, 48313, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, 07631, United States|Office of Michael J. De Marco, DPM, Tinton Falls, New Jersey, 07724, United States|Ocean City Foot and Ankle Assoc, Toms River, New Jersey, 08753, United States|Animas Foot and Ankle, Gallup, New Mexico, 87301, United States|Office of Gerard J. Furst, DPM, PLLC, East Setauket, New York, 11733, United States|Syracuse VA Medical Center, Syracuse, New York, 13210, United States|UNC Hospitals University of North Carolina, Chapel Hill, North Carolina, 27599-7010, United States|Clinical Research Associates of Central Pennsylvania, Duncansville, Pennsylvania, 16635, United States|University of Pennsylvania Health Systems, Philadelphia, Pennsylvania, 19104, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390-9068, United States|Premier Vein and Vascular Center, Houston, Texas, 77084, United States|Complete Family Foot Care - McAllen Office, McAllen, Texas, 78501-2930, United States|Endeavor Clinical Trials PA, San Antonio, Texas, 78229, United States|SAM Clinical Research Center, San Antonio, Texas, 78229, United States|Advanced Foot & Ankle Center, Salt Lake City, Utah, 84102, United States|Carilion Clinic, Roanoke, Virginia, 24013, United States|1Foot 2Foot Centre for Foot & Ankle Care PC, Suffolk, Virginia, 23434, United States|Milwaukee Foot & Ankle Specialists, Wauwatosa, Wisconsin, 53226, United States"
NCT05694169,A Study of Participants With Chronic Kidney Disease Previously Treated With REACT,https://clinicaltrials.gov/study/NCT05694169,TERMINATED,Diabetic Kidney Disease|CAKUT|Chronic Kidney Diseases,BIOLOGICAL: Renal Autologous Cell Therapy (REACT),Prokidney,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Boise kidney and Hypertension Institute, Boise, Idaho, 83642, United States"
NCT00120328,"To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy",https://clinicaltrials.gov/study/NCT00120328,TERMINATED,Diabetic Nephropathy,DRUG: SPP301,Speedel Pharma Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Dr. Mark Warren, Greenville, North Carolina, 27834, United States"
NCT01129557,"Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease",https://clinicaltrials.gov/study/NCT01129557,TERMINATED,"Proteinuric Kidney Disease|Diabetic Nephropathy|Hypertensive Nephrosclerosis|IgA Nephropathy|Focal Segmental Glomerulosclerosis|Glomerulopathy (Obesity-associated)|Glomerulonephritis, Membranous",DRUG: Aliskiren|DRUG: Valsartan,Columbia University,Novartis Pharmaceuticals,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Columbia University Medical Center, New York, New York, 10032, United States"
NCT00458497,Effect of Holofiber Socks and Bedding on Pain and Quality of Sleep in Subjects With Chronic Foot Pain,https://clinicaltrials.gov/study/NCT00458497,TERMINATED,Diabetic Neuropathy|Arthritis|Peripheral Arterial Disease|Plantar Fasciitis,DEVICE: Holofiber fabric|DEVICE: PET fabric,Southern California Institute for Research and Education,"Hologenix, LLC",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"VA Long Beach Healthcare System, Long Beach, California, 90822, United States"
NCT04123093,Safety and Efficacy of the Noxsano Wound Care Bandage,https://clinicaltrials.gov/study/NCT04123093,TERMINATED,"Wound Heal|Peripheral Artery Disease|Ulcer, Leg|Ulcer Foot|Diabetic Foot Ulcer|Arterial Insufficiency",DEVICE: Noxsano Bandage (Healthy Volunteers)|DEVICE: Noxsano Bandage (Wound Care),OhioHealth,"Noxsano, Inc.",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"OhioHealth, Columbus, Ohio, 43214, United States"
NCT01977417,Inflammation Inhibition in Prediabetic Humans,https://clinicaltrials.gov/study/NCT01977417,TERMINATED,Prediabetes|Obese,DRUG: Salsalate|DRUG: Placebo,Gary L. Pierce,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"University of Iowa, Iowa City, Iowa, 52240, United States"
NCT01322256,PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot,https://clinicaltrials.gov/study/NCT01322256,TERMINATED,Diabetic Foot|Osteoarthritis,PROCEDURE: Bone scintigraphy|PROCEDURE: Leukoscan|PROCEDURE: PET / CT|PROCEDURE: Bone biopsy|BIOLOGICAL: Bloodwork,Centre Hospitalier Universitaire de Nīmes,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Centre Hospitalier Universitaire de Nîmes, Nîmes Cedex 09, Gard, 30029, France|CHU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi, Le Grau du Roi, 30240, France"
NCT03844646,Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes,https://clinicaltrials.gov/study/NCT03844646,TERMINATED,Weight Loss|PreDiabetes,DEVICE: CGM|OTHER: Dietitian,Stanford University,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Stanford, Stanford, California, 94305, United States"
NCT04939038,Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease,https://clinicaltrials.gov/study/NCT04939038,TERMINATED,Diabetic Foot Ulcer,PROCEDURE: Revascularization|PROCEDURE: Standard wound care,"Insel Gruppe AG, University Hospital Bern",University of Bern|Swiss National Science Foundation,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Clinic for Angiology, University of Basel, Basel, Switzerland|University Clinic for Angiology, University Hospital Inselspital, Berne, Bern, 3010, Switzerland|Angiologie, Luzerner Kantonsspital, Lucerne, Switzerland|Clinic for Vascular Surgery, Kantonsspital St. Gallen, Saint Gallen, Switzerland"
NCT04839575,Study of Latiglutenase in T1D/CD Patients,https://clinicaltrials.gov/study/NCT04839575,TERMINATED,Celiac Disease,DRUG: Latiglutenase|DRUG: Placebo,Entero Therapeutics,"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Immunogenics, LLC",ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Stanford University, Palo Alto, California, 94306, United States"
NCT05070741,Heat Shock Therapy to Improve Mitochondrial Function in Neuropathy,https://clinicaltrials.gov/study/NCT05070741,TERMINATED,PreDiabetes|Neuropathy,BEHAVIORAL: Heat Therapy,University of Kansas Medical Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States"
NCT03191201,A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.,https://clinicaltrials.gov/study/NCT03191201,TERMINATED,"Iron-deficiency|Iron Toxicity|Glucose Metabolism Disorders (Including Diabetes Mellitus)|Metabolic Side Effects of Drugs|Metabolic Disorder, Glucose|Safety Issues",DRUG: Ferric Carboxymaltose|DRUG: 0.9% sodium chloride solution,Prof Gérard WAEBER,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland|Centre Hospitalier Universitaire Vaudois|University of Lausanne",FEMALE,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Policlinique Médicale Universitaire, Lausanne, Vaud, 1011, Switzerland"
NCT01764919,[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection,https://clinicaltrials.gov/study/NCT01764919,TERMINATED,Diabetic Foot Infection,RADIATION: [124I]FIAU,"BioMed Valley Discoveries, Inc",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"The University of Arizona, Tucson, Arizona, 85724, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States"
NCT01425424,"Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study",https://clinicaltrials.gov/study/NCT01425424,TERMINATED,Prediabetes|Prehypertension,OTHER: Vitamin D supplementation,Pennington Biomedical Research Center,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Physicians Care Center, Baton Rouge, Louisiana, 70806, United States|Bradley L. Meek, MD, Internal Medicine at Hennessy, Baton Rouge, Louisiana, 70808, United States|Pennington Biomedical Research Center, Baton Rouge, Louisiana, 70808, United States|Metabolic Clinic Women's Hospital, Baton Rouge, Louisiana, 70809, United States|Egan Wellness Clinic/AntiAging & Skin Care Spa, Covington, Louisiana, 70433, United States|Amarica Family Practice Office (Second Location), Durham, North Carolina, 27704, United States|Amarica Family Practice Office (First Location), Roxboro, North Carolina, 27573, United States"
NCT04124354,Influence of Exercise on the Gut Microbiome of Overweight and Obese Adults With Prediabetes,https://clinicaltrials.gov/study/NCT04124354,TERMINATED,PreDiabetes,BEHAVIORAL: Physical Activity,University of Minnesota,,ALL,ADULT,,INTERVENTIONAL,"Epidemiology Clinical Research Center, Minneapolis, Minnesota, 55455, United States"
NCT01664637,Diabetic Gastroparesis Efficacy/Safety Study of TZP-102,https://clinicaltrials.gov/study/NCT01664637,TERMINATED,Diabetic Gastroparesis,DRUG: 10 mg TZP-102|DRUG: Placebo,"Tranzyme, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Tranzyme Investigational Site, Huntsville, Alabama, 35801, United States|Tranzyme Investigational Site, Tucson, Arizona, 85710, United States|Tranzyme Investigational Site, North Little Rock, Arkansas, 72117, United States|Tranzyme Investigational Site, Long Beach, California, 90822, United States|Tranzyme Investigational Site, Ventura, California, 93003, United States|Tranzyme Investigational Site, Hialeah, Florida, 33016, United States|Tranzyme Investigational Site, Inverness, Florida, 34452, United States|Tranzyme Investigational Site, Jacksonville, Florida, 32256, United States|Tranzyme Investigational Site, Miami, Florida, 33144, United States|Tranzyme Investigational Site, Miami, Florida, 33183, United States|Tranzyme Investigational Site, New Smyrna Beach, Florida, 32168, United States|Tranzyme Investigational Site, Anderson, Indiana, 46106, United States|Tranzyme Investigational Site, Indianapolis, Indiana, 46202, United States|Tranzyme Investigational Site, Kansas City, Kansas, 66160, United States|Tranzyme Investigational Site, Monroe, Louisiana, 71201, United States|Tranzyme Investigational Site, Boston, Massachusetts, 02215, United States|Tranzyme Investigational Site, Mexico, Missouri, 65265, United States|Tranzyme Investigational Site, Raleigh, North Carolina, 27612, United States|Tranzyme Investigational Site, Salisbury, North Carolina, 28144, United States|Tranzyme Investigational Site, Winston-Salem, North Carolina, 27103, United States|Tranzyme Investigational Site, Oklahoma City, Oklahoma, 73104, United States|Tranzyme Investigational Site, Portland, Oregon, 97210, United States|Tranzyme Investigational Site, El Paso, Texas, 79905, United States|Tranzyme Investigational Site, Bialystok, 15732, Poland|Tranzyme Investigational Site, Bialystok, 15950, Poland|Tranzyme Investigational Site, Bydgoszcz, 85094, Poland|Tranzyme Investigational Site, Kielce, 25035, Poland|Tranzyme Investigational Site, Krakow, 31530, Poland|Tranzyme Investigational Site, Lodz, 90251, Poland|Tranzyme Investigational Site, Lublin, 20090, Poland|Tranzyme Investigational Site, Lublin, 20607, Poland|Tranzyme Investigational Site, Olsztyn, 10561, Poland|Tranzyme Investigational Site, Rzeszow, 35073, Poland|Tranzyme Investigational Site, Warsaw, 02097, Poland|Tranzyme Investigational Site, Zgierz, 95100, Poland"
NCT00587132,Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma,https://clinicaltrials.gov/study/NCT00587132,TERMINATED,Pancreatic Cancer,DRUG: Synthetic Human Secretin,Mayo Clinic,"ChiRhoClin, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"Mayo Clinic, Rochester, Minnesota, 55905, United States"
NCT01136746,Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin,https://clinicaltrials.gov/study/NCT01136746,TERMINATED,Hyperglycemia,DRUG: Human regular insulin|DRUG: Insulin lispro|DRUG: Insulin glargine,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, Alabama, 35294, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Jacksonville, Florida, 32209, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miami, Florida, 33136, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Weston, Florida, 33331, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Atlanta, Georgia, 30312, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Topeka, Kansas, 66604, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hazard, Kentucky, 41701, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bangor, Maine, 04401, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kansas City, Missouri, 64111, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cleveland, Ohio, 44106, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Charleston, South Carolina, 29425, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Memphis, Tennessee, 38104, United States"
NCT00768040,Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT00768040,TERMINATED,Diabetic Macular Edema,DRUG: Aliskiren|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Retinal Consultants of Arizona, Phoenix, Arizona, United States|Retina-Vitreous Associates, Los Angeles, California, United States|National Ophthalmic Research Institute, Fort Myers, Florida, United States|Georgia Retina, Atlanta, Georgia, United States|Elman Retina Group, Baltimore, Maryland, United States|Joslin Clinic, Boston, Massachusetts, MA, United States|Vitreo-Retinal Associates, Grand Rapids, Michigan, United States|Charlotte Eye, Ear, Nose and Throat Associate, Charlotte, North Carolina, NC, United States|Retina-Associates of Cleveland, Inc, Beachwood, Ohio, United States|Retinal Consultants of Houston, Houston, Texas, TX, United States|Novartis Investigative Site, Arhus, Denmark|Novartis Investigative Site, Copenhagen, Denmark"
NCT01573897,Impact of Sleep Apnea on Diabetic Foot Wound.,https://clinicaltrials.gov/study/NCT01573897,TERMINATED,Diabetic Foot|Sleep Apnea,,AGIR à Dom,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Diabetes and Endocrinology Unit, Grenoble University Hospital, Grenoble, 38043, France"
NCT02844907,Regulation of Insulin Secretion by the GLP-1 Receptor,https://clinicaltrials.gov/study/NCT02844907,TERMINATED,Insulin Secretion,DRUG: Exendin (9-39)|DRUG: Dexamethasone|OTHER: Hyperglycemic Clamp,VA Office of Research and Development,Durham VA Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Durham VA Medical Center, Durham, NC, Durham, North Carolina, 27705, United States"
NCT01638585,Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia,https://clinicaltrials.gov/study/NCT01638585,TERMINATED,Diabetic Foot|Critical Limb Ischemia,DRUG: urokinase,GWT-TUD GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Diabetes Klinik, Bad Mergentheim, 97980, Germany|Vivantes Klinikum im Friedrichshain, Berlin, 10249, Germany|Ev. KH Königin Elisabeth Herzberge, Berlin, 10365, Germany|Martin-Luther-Krankenhaus, Berlin, 14193, Germany|Klinikum Bielefeld gGmbH, Bielefeld, 33602, Germany|Stiftungsklinikum Mittelrhein, Boppard, 56154, Germany|Klinikum Chemnitz gGmbH, Chemnitz, 09113, Germany|Klinikum Dortmund gGmbH, Dortmund, 44145, Germany|Städtisches Krankenhaus DD-Neustadt, Dresden, 01129, Germany|Krankenhaus Dresden-Friedrichstadt, Dresden, 01307, Germany|Uniklinikum ""Carl Gustav Carus"" der TU Dresden, Dresden, 01307, Germany|Weißeritztal Kliniken GmbH, Freital, 01705, Germany|Asklepios Westklinikum, Hamburg, 22559, Germany|Universitätsklinikum Leipzig AöR, Leipzig, 04103, Germany|HELIOS Krankenhaus, Leisnig, 04703, Germany|Klinikum Westfalen/Klinikum am Park, Lünen, 44536, Germany|Klinikum Stuttgart, Bürgerhospital, Stuttgart, 70191, Germany|KH der Barmherzigen Brüder, Trier, 54292, Germany"
NCT00935766,Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries,https://clinicaltrials.gov/study/NCT00935766,TERMINATED,Metabolic Diseases|Endocrine System Diseases|Heart Disease|Vascular Diseases|Diabetes|Cardiovascular Disease|Glucose Metabolism Disorders|Hypertension,DRUG: Omega-3|DRUG: Placebo,Denver Health and Hospital Authority,"National Heart, Lung, and Blood Institute (NHLBI)|GlaxoSmithKline",ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Denver Health and Hospital Authority, Denver, Colorado, 80204, United States"
NCT04330079,Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease,https://clinicaltrials.gov/study/NCT04330079,TERMINATED,Coronary Artery Disease|Prediabetic State,DRUG: Dapagliflozin 10mg|OTHER: Lifestyle modification,"CHEOL WHAN LEE, M.D., Ph.D",,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Asan Medical Center, Seoul, Korea, Republic of"
NCT02308735,Fatty Acid Ethyl Esters in Meconium of Infants of Diabetic Mothers: a Pilot Trial,https://clinicaltrials.gov/study/NCT02308735,TERMINATED,Infants of Diabetic Mothers,OTHER: N/A - No intervention,University of Oklahoma,,ALL,"CHILD, ADULT",,OBSERVATIONAL,"Children's Hospital of Oklahoma, Oklahoma City, Oklahoma, 73104, United States"
NCT04154579,"Arts & Health Education to Improve Health, Resilience, and Well-Being",https://clinicaltrials.gov/study/NCT04154579,TERMINATED,Hypertension|Diabetes|Obesity|COPD|CHF|High Cholesterol|Asthma|Chronic Pain|Multiple Sclerosis|Depression|Anxiety|Heart Diseases|Stroke,BEHAVIORAL: HeRe We Arts|BEHAVIORAL: HeRe We Ed,Lisa Gallagher,"National Endowment for the Arts, United States|Cuyahoga Arts and Culture|The Cleveland Clinic",ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Cleveland Clinic Euclid Hospital, Euclid, Ohio, 44119, United States"
NCT00313547,High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients,https://clinicaltrials.gov/study/NCT00313547,TERMINATED,Hypertension,DRUG: Quinapril 40 mg|DRUG: Quinapril 10 mg and amlodipine 5 mg,Montreal Heart Institute,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Montreal Heart Institute, Montreal, Quebec, H1T 1C8, Canada"
NCT01450787,Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics,https://clinicaltrials.gov/study/NCT01450787,TERMINATED,Dry Eyes,,"COA Research Foundation, INC",Allergan,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Columbus Ophthalmalogy Associates, Columbus, Ohio, 43213, United States"
NCT00634868,Treatment of Wounds Utilizing Light,https://clinicaltrials.gov/study/NCT00634868,TERMINATED,Diabetic Ulcer,OTHER: Qray light therapy device|DEVICE: Qray light therapy device-Sham,QRay Ltd.,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Soroka Medical Center, Beer Seva, Israel"
NCT00142974,Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy,https://clinicaltrials.gov/study/NCT00142974,TERMINATED,Diabetic Gastropathy,DRUG: Tegaserod,Novartis,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Novartis, Basel, 4056, Switzerland"
NCT02168816,Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis,https://clinicaltrials.gov/study/NCT02168816,TERMINATED,Osteomyelitis,DRUG: Intravenous Antibacterial Agent|DRUG: Oral Antibacterial Agent,Loyola University,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Loyola University Medical Center, Maywood, Illinois, 60153, United States"
NCT01177709,Metformin for Weight Loss in Schizophrenia,https://clinicaltrials.gov/study/NCT01177709,TERMINATED,Schizophrenia|Obesity,DRUG: Metformin,Nathan Kline Institute for Psychiatric Research,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Manhatan Psychiatric Center, New York, New York, 10035, United States"
NCT00651378,Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708),https://clinicaltrials.gov/study/NCT00651378,TERMINATED,Hypercholesterolemia|Atherosclerosis|Coronary Artery Disease,DRUG: Rosuvastatin|DRUG: Ezetimibe + Atorvastatin|DRUG: Double Atorvastatin,Organon and Co,Merck Sharp & Dohme LLC,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT01994291,"A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema",https://clinicaltrials.gov/study/NCT01994291,TERMINATED,"Macular Edema, Diabetic",DRUG: Ranibizumab|DRUG: Placebo|DRUG: PF-04634817|DRUG: Masked Sham Therapy,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Retina Research Institute, LLC, Phoenix, Arizona, 85014, United States|Retinal Consultants of Arizona, Phoenix, Arizona, 85014, United States|Sunny View Medical Center, Phoenix, Arizona, 85018, United States|Premier Research Group Limited, Phoenix, Arizona, 85027, United States|Retina Centers, P.C., Tucson, Arizona, 85704, United States|Retina Institute of California, Arcadia, California, 91007, United States|Retina Vitreous Associates Medical Group, Beverly Hills, California, 90211, United States|Retinal Diagnostic Center, Campbell, California, 95008, United States|Retina Associates of Orange County, Laguna Hills, California, 92653, United States|Southern California Desert Retina Consultants, Palm Desert, California, 92211, United States|American Institute of Research (Administrative Only), Whittier, California, 90603, United States|New England Retina Associates, New London, Connecticut, 06320, United States|Bascom Palmer Eye Institute, Miami, Florida, 33136, United States|Fort Lauderdale Eye Institute, Plantation, Florida, 33324, United States|Center for Retina and Macular Disease, Winter Haven, Florida, 33880, United States|Southeast Retina Center, PC, Augusta, Georgia, 30909, United States|Midwest Eye Institute, Indianapolis, Indiana, 46290, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|TLC Eyecare & Laser Center, Jackson, Michigan, 49202, United States|Wm Beaumont Medical Office Building, Royal Oak, Michigan, 48073, United States|Charlotte Eye Ear Nose and Throat Associates PA, Charlotte, North Carolina, 28210, United States|Retina Associates of Cleveland, Inc., Cleveland, Ohio, 44122, United States|Retina Associates of Cleveland, Youngstown, Ohio, 44505, United States|Dean McGee Eye Institute, Oklahoma City, Oklahoma, 73104, United States|University of Oklahoma -OU Physicians, Oklahoma City, Oklahoma, 73104, United States|Retina Vitreous Consultants, Pittsburgh, Pennsylvania, 15213, United States|Associates in Ophthalmology Ltd, West Mifflin, Pennsylvania, 15122, United States|Black Hills Regional Eye Institute, Rapid City, South Dakota, 57701, United States|Brain B.Berger,MD,PA, Austin, Texas, 78705, United States|Retina Research Center, Austin, Texas, 78705, United States|Retina Consultants of Houston, PA, Houston, Texas, 77030, United States|Medical Center Ophthalmology Associates, San Antonio, Texas, 78240, United States|Rocky Mountain Retina Consultants, Salt Lake City, Utah, 84107, United States|MC Comac Medical, Sofia, 1612, Bulgaria|Fakultní nemocnice Hradec Králové, Ocni klinika, Hradec Kralove, 500 05, Czech Republic|Fakultní nemocnice Hradec Králové, Nemocnicni lekarna, Hradec Kralove, 50005, Czech Republic|Fakultni nemocnice Ostrava, lekarna, Ostrava - Poruba, 70852, Czech Republic|Fakultni nemocnice Ostrava, Ocni klinika, Ostrava - Poruba, 70852, Czech Republic|Fakultni nemocnice Kralovske Vinohrady, Oftalmologicka klinika, Praha 10, 10034, Czech Republic|Fakultni nemocnice Kralovske Vinohrady, Ustavni lekarna, Praha 10, 10034, Czech Republic|Universitätsklinikum Regensburg, Regensburg, Bavaria, 93053, Germany|Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, 12200, Germany|Universitaetsmedizin Goettingen, Goettingen, 37075, Germany|Universitatsmedizin Mainz, Mainz, 55131, Germany|Augenärzte am St. Franziskus-Hospital, Muenster, 48145, Germany|Universitaetsklinikum Muenster, Muenster, 48159, Germany|Knappschaftsklinikum GmbH, Sulzbach, Saar, 66280, Germany|Universitatsklinikum Tubingen, Tubingen, 72076, Germany|Semmelweis Egyetem, Szemészeti Klinika, Budapest, 1083, Hungary|Bajcsy-Zsilinszky Korhaz, Szemeszet, Budapest, 1106, Hungary|Budapest Retina Associates Kft., Budapest, 1133, Hungary|Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Szemklinika, Debrecen, 4032, Hungary|Ganglion Orvosi Kozpont, Pecs, 7621, Hungary|Csolnoky Ferenc Korhaz, Szemeszeti Osztaly, Veszprem, 8200, Hungary|Hadassah Medical Organization, Hadassah Medical Center, Ein Karem, Jerusalem, 91120, Israel|Meir Medical Center, Kfar Saba, 44281, Israel|Rabin Medical Center, Beilinson Hospital, Petah Tikva, 49100, Israel|Kaplan Medical Center, Rehovot, 76100, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel|Spitalul Clinic Republican, Chisinau, MD-2025, Moldova, Republic of|Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza Radeckiego We Wrocławiu, Klinika Okulistyki, Wroclaw, 50-367, Poland|Med Life SA, Sectia Oftalmologie, Bucuresti, 010719, Romania|Institutul National de Diabet, Nutritie si Boli Metabolice ""N.C.Paulescu"", Bucuresti, 020475, Romania"
NCT01468376,GLU-xx Formulations in Individuals With Impaired Glucose Tolerance,https://clinicaltrials.gov/study/NCT01468376,TERMINATED,Impaired Glucose Tolerance,DIETARY_SUPPLEMENT: GLU-01|DIETARY_SUPPLEMENT: GLU-02|DIETARY_SUPPLEMENT: GLU-03|DIETARY_SUPPLEMENT: GLU-04|DIETARY_SUPPLEMENT: GLU-05|DIETARY_SUPPLEMENT: GLU-06,Afexa Life Sciences Inc,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Staywell Research LLC, Northridge, California, 91325, United States"
NCT01255163,A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease,https://clinicaltrials.gov/study/NCT01255163,TERMINATED,Alzheimer's Disease|Mild Cognitive Impairment,DRUG: Exendin-4 SC|DRUG: Placebo SC,National Institute on Aging (NIA),,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"National Institute on Aging, Clinical Research Unit, Baltimore, Maryland, 21224, United States"
NCT00487162,The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality,https://clinicaltrials.gov/study/NCT00487162,TERMINATED,Hyperglycemia,PROCEDURE: intensive glycemic control|DRUG: conventional glycemic control,University of Medicine and Dentistry of New Jersey,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"University Hospital, Newark, New Jersey, 07107, United States"
NCT02700555,Surveillance of Metabolic Parameters in Patients With Colorectal Cancer,https://clinicaltrials.gov/study/NCT02700555,TERMINATED,Colorectal Cancer,,Kangbuk Samsung Hospital,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Kangbuk Samsung Hospital, Seoul, 110-746, Korea, Republic of"
NCT02496780,The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients,https://clinicaltrials.gov/study/NCT02496780,TERMINATED,Cystic Fibrosis,DRUG: novolog insulin|DRUG: levemir insulin|DRUG: placebo,University of Minnesota,,ALL,"CHILD, ADULT",PHASE2|PHASE3,INTERVENTIONAL,"University of Minnesota, Minneapolis, Minnesota, 55455, United States|Children's Hospitals and Clinics of Minnesota, Saint Paul, Minnesota, United States"
NCT00394303,Tight Intra-Operative Glucose Control During Coronary Artery Bypass Surgery,https://clinicaltrials.gov/study/NCT00394303,TERMINATED,Coronary Artery Bypass,DRUG: Intraoperative continuous insulin infusion|OTHER: Control,Rabin Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"Rabin Medical Center, Beilinson Hospital, Petah Tikvah, 49100, Israel"
NCT00853944,Effect of Sitagliptin on Graft Function Following Islet Transplantation,https://clinicaltrials.gov/study/NCT00853944,TERMINATED,Islet Transplantation,DRUG: sitagliptin,University of British Columbia,Merck Sharp & Dohme LLC,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Vancouver General Hospital, Vancouver, British Columbia, Canada"
NCT04492722,A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease,https://clinicaltrials.gov/study/NCT04492722,TERMINATED,Chronic Kidney Disease,DRUG: AZD5718|DRUG: Dapagliflozin 10 mg|DRUG: Placebo,AstraZeneca,Parexel|George Clinical Pty Ltd,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"Research Site, Canoga Park, California, 91303, United States|Research Site, La Mesa, California, 91942, United States|Research Site, San Carlos, California, 94070, United States|Research Site, San Francisco, California, 94110, United States|Research Site, Victorville, California, 92392, United States|Research Site, Denver, Colorado, 80045, United States|Research Site, Jacksonville, Florida, 32216, United States|Research Site, Winter Haven, Florida, 33880, United States|Research Site, Columbus, Georgia, 31904, United States|Research Site, Roseville, Michigan, 48066, United States|Research Site, Hazelwood, Missouri, 63042, United States|Research Site, Fresh Meadows, New York, 11365, United States|Research Site, Great Neck, New York, 11021, United States|Research Site, Jamaica, New York, 11432, United States|Research Site, Blue Ash, Ohio, 45242, United States|Research Site, East Providence, Rhode Island, 02914, United States|Research Site, Memphis, Tennessee, 38104-2127, United States|Research Site, Austin, Texas, 78738, United States|Research Site, Houston, Texas, 77099, United States|Research Site, Pearland, Texas, 77584, United States|Research Site, San Antonio, Texas, 78215, United States|Research Site, Schertz, Texas, 78154, United States|Research Site, Bahia Blanca, B8109, Argentina|Research Site, Buenos Aires, 1280, Argentina|Research Site, Cordoba, 5000, Argentina|Research Site, Cordoba, X5016KEH, Argentina|Research Site, Cordoba, X5016KET, Argentina|Research Site, Junín, 6000, Argentina|Research Site, Mar del Plata, B7600, Argentina|Research Site, Belem, 66073-005, Brazil|Research Site, Brasilia, 71625-175, Brazil|Research Site, Curitiba, 80215-901, Brazil|Research Site, Fortaleza, 60430-375, Brazil|Research Site, Meireles, 60160-230, Brazil|Research Site, Porto Alegre, 90035-074, Brazil|Research Site, Porto Alegre, 90430-001, Brazil|Research Site, Santo Andre, 09090-790, Brazil|Research Site, Sao Paulo, 05403-9000, Brazil|Research Site, São Paulo, 01323-020, Brazil|Research Site, São Paulo, 05016-090, Brazil|Research Site, Aschaffenburg, 63739, Germany|Research Site, Berlin, 13509, Germany|Research Site, Essen, 45136, Germany|Research Site, Trier, 54292, Germany|Research Site, Balatonfüred, 8230, Hungary|Research Site, Budapest, 1083, Hungary|Research Site, Budapest, 1115, Hungary|Research Site, Debrecen, 4032, Hungary|Research Site, Szentes, 6600, Hungary|Research Site, Szigetvár, 7900, Hungary|Research Site, Afula, 1834111, Israel|Research Site, Ashdod, 7747629, Israel|Research Site, Ashkelon, 78306, Israel|Research Site, Haifa, 34362, Israel|Research Site, Jerusalem, 91031, Israel|Research Site, Ageo, 362-8588, Japan|Research Site, Asahikawa-shi, 070-8530, Japan|Research Site, Chiba-shi, 261-0004, Japan|Research Site, Hiroshima, 732-0057, Japan|Research Site, Kasugai-shi, 486-8510, Japan|Research Site, Kitakyushu, 805-8508, Japan|Research Site, Koga-shi, 306-0041, Japan|Research Site, Kyoto-shi, 604-8845, Japan|Research Site, Mito-shi, 311-4198, Japan|Research Site, Morioka-shi, 020-0066, Japan|Research Site, Osaka-shi, 530-0005, Japan|Research Site, Osaka-shi, 558-8558, Japan|Research Site, Osaka, 553-0003, Japan|Research Site, Sashima-gun, 306-0433, Japan|Research Site, Shizuoka-shi, 420-8630, Japan|Research Site, Toride-shi, 302-0022, Japan|Research Site, Yokohama-shi, 234-0054, Japan|Research Site, Yokohama-shi, 236-0004, Japan|Research Site, Yokohama-shi, 247-8581, Japan|Research Site, Kota Kinabalu, 88586, Malaysia|Research Site, Kuala Lumpur, 50586, Malaysia|Research Site, Kuala Lumpur, 56000, Malaysia|Research Site, Kuala Lumpur, 59100, Malaysia|Research Site, Malacca, 78300, Malaysia|Research Site, Seremban, 70300, Malaysia|Research Site, Seri Manjung, 32040, Malaysia|Research Site, Sibu, 96000, Malaysia|Research Site, Bialystok, 15-375, Poland|Research Site, Białystok, 15-435, Poland|Research Site, Kraków, 31-559, Poland|Research Site, Oswiecim, 32-600, Poland|Research Site, Rzeszow, 35-055, Poland|Research Site, Łódź, 92-213, Poland|Research Site, Kaohsiung City, 82445, Taiwan|Research Site, Kaohsiung, 833, Taiwan|Research Site, Keelung, 20448, Taiwan|Research Site, New Taipei City, 23148, Taiwan|Research Site, Taichung, 40443, Taiwan|Research Site, Taichung, 40705, Taiwan|Research Site, Taichung, 433, Taiwan|Research Site, Taipei 112, Taiwan|Research Site, Taipei, 100, Taiwan|Research Site, Taipei, 116, Taiwan|Research Site, Dnipro, 49005, Ukraine|Research Site, Dnipro, 49038, Ukraine|Research Site, Ivano-Frankivsk, 76000, Ukraine|Research Site, Ivano-Frankivsk, 76014, Ukraine|Research Site, Kyiv, 02125, Ukraine|Research Site, Kyiv, 03049, Ukraine|Research Site, Kyiv, 1004, Ukraine|Research Site, Lviv, 79010, Ukraine|Research Site, Uzhhorod, 88018, Ukraine|Research Site, Vinnytsia, 21001, Ukraine|Research Site, Vinnytsia, 21010, Ukraine|Research Site, Zaporizhzhia, 69600, Ukraine|Research Site, Zhytomyr, 10002, Ukraine"
NCT00651014,Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405),https://clinicaltrials.gov/study/NCT00651014,TERMINATED,Hypercholesterolemia|Atherosclerosis,DRUG: Ezetimibe|DRUG: Placebo,Organon and Co,Merck Frosst Canada Ltd.,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT00438321,Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome,https://clinicaltrials.gov/study/NCT00438321,TERMINATED,Metabolic Syndrome,DRUG: Zoladex|DRUG: Testosterone gel|DRUG: Anastrozole Pill|OTHER: Placebo,Massachusetts General Hospital,National Institutes of Health (NIH)|American Diabetes Association,MALE,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States"
NCT00231621,A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia,https://clinicaltrials.gov/study/NCT00231621,TERMINATED,Obesity|Hyperlipidemia|Hypertriglyceridemia,DRUG: topiramate,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,
NCT00169624,Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin,https://clinicaltrials.gov/study/NCT00169624,TERMINATED,Coronary and Peripheral Endothelial Dysfunction,DRUG: Metformin|DRUG: Gliclazide,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Laurent SEBBAG, Lyon, 69677, France"
NCT02803489,Evaluation of the Performance of an e-Health System,https://clinicaltrials.gov/study/NCT02803489,TERMINATED,Chronic Diseases,DEVICE: medical device intervention,Air Liquide Santé International,Inferential,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Cabinet Privé de Cardiologie - 2, rue jean jaurès, Annecy, 74000, France|Cabinet Privé de Pneumologie - 7 rue gabriel de mortillet, Annecy, 74000, France|Centre Hospitalier d'Annecy Genevois - service cardiologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy, PRINGY Cedex, 74374, France|Centre Hospitalier d'Annecy Genevois - service pneumologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy, Pringy cedex, 74374, France|Cabinet privé de pneumologie - 28 avenue de Genève, Saint Julien en Genevois, 74160, France|cabinet privé de médecine générale - 18, rue Louis Haase, Thones, 74230, France"
NCT01837069,Risk Factor Control Before Orthopedic Surgery,https://clinicaltrials.gov/study/NCT01837069,TERMINATED,Osteoarthritis|Cardiovascular Disease,DRUG: Metoprolol|DRUG: Lisinopril|DRUG: Atorvastatin|BEHAVIORAL: Lifestyle counseling,NYU Langone Health,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,"NYU Hospital for Joint Diseases, New York, New York, 10003, United States"
NCT01601704,Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study),https://clinicaltrials.gov/study/NCT01601704,TERMINATED,Obesity|Overweight,DRUG: NB32|DRUG: PBO|BEHAVIORAL: Weight Management Program,"Orexigen Therapeutics, Inc",,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Birmingham, Alabama, United States|Dothan, Alabama, United States|Mobile, Alabama, United States|Scottsboro, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Peoria, Arizona, United States|Phoenix, Arizona, United States|Scottsdale, Arizona, United States|Tucson, Arizona, United States|Tuscson, Arizona, United States|Little Rock, Arkansas, United States|Anaheim, California, United States|Carmichael, California, United States|Escondido, California, United States|Fresno, California, United States|Harbor City, California, United States|Huntington Beach, California, United States|La Jolla, California, United States|Lomita, California, United States|Los Angeles, California, United States|Paramount, California, United States|Pasadena, California, United States|Riverside, California, United States|Sacramento, California, United States|Santa Rosa, California, United States|Spring Valley, California, United States|Thousand Oaks, California, United States|Torrance, California, United States|West Hills, California, United States|Colorado Springs, Colorado, United States|Denver, Colorado, United States|Golden, Colorado, United States|Wheat Ridge, Colorado, United States|Norwalk, Connecticut, United States|Stamford, Connecticut, United States|Wilmington, Delaware, United States|Washington, District of Columbia, United States|Boynton Beach, Florida, United States|Brooksville, Florida, United States|Clearwater, Florida, United States|Deland, Florida, United States|Delray Beach, Florida, United States|Gainesville, Florida, United States|Jacksonville Beach, Florida, United States|Jacksonville, Florida, United States|Melbourne, Florida, United States|Miami, Florida, United States|New Port Richey, Florida, United States|New Smyrna Beach, Florida, United States|Oakland Park, Florida, United States|Orlando, Florida, United States|Palm Harbor, Florida, United States|Pembroke Pines, Florida, United States|Pensacola, Florida, United States|Pinellas Park, Florida, United States|Saint Petersburg, Florida, United States|Vero beach, Florida, United States|Wellington, Florida, United States|Winter Haven, Florida, United States|Atlanta, Georgia, United States|Austell, Georgia, United States|Columbus, Georgia, United States|Lawrenceville, Georgia, United States|Riverdale, Georgia, United States|Savannah, Georgia, United States|Stockbridge, Georgia, United States|Honolulu, Hawaii, United States|Meridian, Idaho, United States|Chicago, Illinois, United States|Gurnee, Illinois, United States|Melrose Park, Illinois, United States|Bloomington, Indiana, United States|Brownsburg, Indiana, United States|Elwood, Indiana, United States|Evansville, Indiana, United States|Hammond, Indiana, United States|South Bend, Indiana, United States|Valparaiso, Indiana, United States|Ames, Iowa, United States|Council Bluffs, Iowa, United States|Des Moines, Iowa, United States|West Des Moines, Iowa, United States|Overland Park, Kansas, United States|Wichita, Kansas, United States|Crestview Hills, Kentucky, United States|Louisville, Kentucky, United States|Mount Sterling, Kentucky, United States|Alexandria, Louisiana, United States|Baton Rouge, Louisiana, United States|Monroe, Louisiana, United States|Natchitoches, Louisiana, United States|Auburn, Maine, United States|Bangor, Maine, United States|Baltimore, Maryland, United States|Columbia, Maryland, United States|Elkridge, Maryland, United States|Lutherville, Maryland, United States|Salisbury, Maryland, United States|Boston, Massachusetts, United States|Brockton, Massachusetts, United States|Fall River, Massachusetts, United States|Haverhill, Massachusetts, United States|Methuen, Massachusetts, United States|Bingham Farms, Michigan, United States|Dearbon, Michigan, United States|Kalamazoo, Michigan, United States|Midland, Michigan, United States|Saginaw, Michigan, United States|Southfield, Michigan, United States|Stevensville, Michigan, United States|Edina, Minnesota, United States|Rochester, Minnesota, United States|Jackson, Mississippi, United States|Olive Branch, Mississippi, United States|Tupelo, Mississippi, United States|Saint Louis, Missouri, United States|Butte, Montana, United States|Missoula, Montana, United States|Fremont, Nebraska, United States|Grand Island, Nebraska, United States|Omaha, Nebraska, United States|Henderson, Nevada, United States|Las Vegas, Nevada, United States|Reno, Nevada, United States|Sparks, Nevada, United States|Belvidere, New Jersey, United States|Edison, New Jersey, United States|Elizabeth, New Jersey, United States|Elmer, New Jersey, United States|Linden, New Jersey, United States|Ridgewood, New Jersey, United States|Albuquerque, New Mexico, United States|Bronx, New York, United States|Endwell, New York, United States|New Hyde Park, New York, United States|New York, New York, United States|Staten Island, New York, United States|Syracuse, New York, United States|Williamsville, New York, United States|Cary, North Carolina, United States|Charlotte, North Carolina, United States|Durham, North Carolina, United States|Elizabeth City, North Carolina, United States|Greensboro, North Carolina, United States|Greenville, North Carolina, United States|Hickory, North Carolina, United States|Morganton, North Carolina, United States|Raleigh, North Carolina, United States|Salisbury, North Carolina, United States|Wilmington, North Carolina, United States|Winston-Salem, North Carolina, United States|Akron, Ohio, United States|Beachwood, Ohio, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Delaware, Ohio, United States|Kettering, Ohio, United States|Marion, Ohio, United States|Mentor, Ohio, United States|Willoughby Hills, Ohio, United States|Oklahoma City, Oklahoma, United States|Medford, Oregon, United States|Portland, Oregon, United States|Altoona, Pennsylvania, United States|Bensalem, Pennsylvania, United States|Danville, Pennsylvania, United States|Duncansville, Pennsylvania, United States|Ephrata, Pennsylvania, United States|Jersey Shore, Pennsylvania, United States|Lancaster, Pennsylvania, United States|Lansdale, Pennsylvania, United States|Norristown, Pennsylvania, United States|Scottdale, Pennsylvania, United States|Sellersville, Pennsylvania, United States|State College, Pennsylvania, United States|West Reading, Pennsylvania, United States|Wilkes-Barre, Pennsylvania, United States|Anderson, South Carolina, United States|Charleston, South Carolina, United States|Columbia, South Carolina, United States|Greenville, South Carolina, United States|Greer, South Carolina, United States|Hodges, South Carolina, United States|Laurens, South Carolina, United States|Mount Pleasant, South Carolina, United States|Rapid City, South Dakota, United States|Bristol, Tennessee, United States|Chattanooga, Tennessee, United States|Germantown, Tennessee, United States|Jackson, Tennessee, United States|Kingsport, Tennessee, United States|Knoxville, Tennessee, United States|Memphis, Tennessee, United States|Beaumont, Texas, United States|Corpus Christi, Texas, United States|Dallas, Texas, United States|Houston, Texas, United States|Hurst, Texas, United States|Lake Jackson, Texas, United States|McKinney, Texas, United States|San Antonio, Texas, United States|Schertz, Texas, United States|Tomball, Texas, United States|Waco, Texas, United States|Bountiful, Utah, United States|Draper, Utah, United States|Murray, Utah, United States|Ogden, Utah, United States|Orem, Utah, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Alexandria, Virginia, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Winchester, Virginia, United States|Seattle, Washington, United States|Spokane, Washington, United States|Tacoma, Washington, United States|Walla Walla, Washington, United States|Green Bay, Wisconsin, United States|Kenosha, Wisconsin, United States|Madison, Wisconsin, United States"
NCT01633710,Multicentre Study to Investigate the Performance of the Padd Device in the Assessment of Peripheral Arterial Disease,https://clinicaltrials.gov/study/NCT01633710,TERMINATED,Peripheral Arterial Disease,,"University Hospitals, Leicester",,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"University of Leicester, Leicester, Leicestershire, LE1 6TP, United Kingdom|Royal Free Hospital, London, NW3 2QG, United Kingdom"
NCT01530789,Paramedical Consultation in Telemedicine,https://clinicaltrials.gov/study/NCT01530789,TERMINATED,Type 1 Diabetic,,Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète,,ALL,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,
NCT00884819,Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome,https://clinicaltrials.gov/study/NCT00884819,TERMINATED,Polycystic Ovary Syndrome,DRUG: Fenofibrate|OTHER: Placebo,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,,FEMALE,ADULT,,INTERVENTIONAL,"St. Joseph's Health Care, London, Ontario, N6A 4L6, Canada"
NCT00427986,Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema,https://clinicaltrials.gov/study/NCT00427986,TERMINATED,Diabetic Macular Oedema,"DRUG: Galactose, intravenous","Glostrup University Hospital, Copenhagen",,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Nordre Ringvej 57,, Glostrup, DK-2600, Denmark"
NCT00150085,Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion,https://clinicaltrials.gov/study/NCT00150085,TERMINATED,Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients,DRUG: cyclosporine micro-emulsion,Novartis,,ALL,"ADULT, OLDER_ADULT",PHASE4,INTERVENTIONAL,
NCT00099723,The Effect of a Probiotic on Hepatic Steatosis,https://clinicaltrials.gov/study/NCT00099723,TERMINATED,Fatty Liver,DRUG: VSL#3,VSL Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1,INTERVENTIONAL,"Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States"
NCT01515059,Analysing Differences in Glycaemic Control Immediately Post Obesity SurgEry (The ADIPOSE Study),https://clinicaltrials.gov/study/NCT01515059,TERMINATED,Obesity,,University of Leicester,"University Hospitals, Leicester",ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Leicester Diabetes Centre, Leicester, Leicestershire, LE5 4PW, United Kingdom"
NCT00871312,Evaluation of Topical Wound Oxygen (two2) Therapy,https://clinicaltrials.gov/study/NCT00871312,TERMINATED,Diabetic Ulcer,DEVICE: Topical wound oxygen therapy|DEVICE: Topical wound oxygen Placebo,AOTI Ltd.,,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"AOTI Clinic, Buffalo, New York, 14214, United States|Community Dermatology & Wound Healing Clinic, Mississauga, Ontario, L4Y 1A6, Canada|Wound Care Clinic, St. Catherines, Ontario, L2R2P7, Canada"
NCT00477191,Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis,https://clinicaltrials.gov/study/NCT00477191,TERMINATED,Psoriasis|Metabolic Syndrome|Hyperlipidemia|Obesity|Hypertension,DRUG: Etanercept,Massachusetts General Hospital,Amgen,ALL,"ADULT, OLDER_ADULT",,INTERVENTIONAL,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States"
NCT00267839,Effect of Exercise on Risk-factors of Elderly Women,https://clinicaltrials.gov/study/NCT00267839,TERMINATED,Atrophy,"BEHAVIORAL: physical exercise, wellness",University of Erlangen-Nürnberg Medical School,Behinderten- und Versehrten-Sportverband Bayern e.V.|Netzwerk Knochengesundheit e.V.|Kassenärztliche Vereinigung Bayern|Siemens-Betriebskrankenkasse,FEMALE,OLDER_ADULT,PHASE3,INTERVENTIONAL,"Institute of Medical Physics University of Erlangen-Nurnberg, Erlangen, 91052, Germany|Institute of Medical Physics, Erlangen, 91052, Germany"
NCT04611152,"A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)",https://clinicaltrials.gov/study/NCT04611152,TERMINATED,Diabetic Macular Edema,DRUG: KSI-301|DRUG: Aflibercept|OTHER: Sham Procedure,Kodiak Sciences Inc,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"UCSD Jacobs Retina Center, La Jolla, California, 92037, United States|Retina Consultants of Southern California, Redlands, California, 92374, United States|California Retina Consultants, Santa Maria, California, 93454, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, 90502, United States|Colorado Retina Associates PC, Lakewood, Colorado, 80228, United States|Conneticut Eye Consultants, Danbury, Connecticut, 06810, United States|Retina Group of Florida, Boca Raton, Florida, 33431, United States|Blue Ocean Clinical Research, Clearwater, Florida, 33761, United States|Vitreo Retinal Associates, Gainesville, Florida, 32607, United States|Florida Retina Consultants, Lakeland, Florida, 33805, United States|Florida Eye Associates, Melbourne, Florida, 32901, United States|Florida Retina Institute, Orlando, Florida, 32806, United States|Retina Specialty Institute, Pensacola, Florida, 32503, United States|Retina Associates of Florida, Tampa, Florida, 33609, United States|Retina Vitreous Associates of Florida, Tampa, Florida, 33617, United States|Center for Retina & Macular Disease, Winter Haven, Florida, 33880, United States|Springfield Clinic LLP, Springfield, Illinois, 62703, United States|Wolfe Eye Clinic, West Des Moines, Iowa, 50266, United States|Retina Associates PA, Lenexa, Kansas, 66215, United States|Vitreo Retinal Consultants and Surgeons, Wichita, Kansas, 67214, United States|Retina Associates of Kentucky, Lexington, Kentucky, 40509, United States|Cumberland Valley Retina Consultants PC, Hagerstown, Maryland, 21740, United States|Ophthalmic Consultants of Boston, Boston, Massachusetts, 02114, United States|Foundation for Vision Research, Grand Rapids, Michigan, 49525, United States|The Retina Center of New Jersey, Bloomfield, New Jersey, 07017, United States|NJ Retina, Teaneck, New Jersey, 07605, United States|Charlotte Eye Ear Nose & Throat Associates, P.A., Charlotte, North Carolina, 28210, United States|Retina Northwest, Portland, Oregon, 97210, United States|Cascade Medical Research Institute, Springfield, Oregon, 97477, United States|MidAtlantic Retina, Philadelphia, Pennsylvania, 19107, United States|Retina Research of Beaufort, Beaufort, South Carolina, 29902, United States|Charleston Neuroscience Institute - West Ashley, Charleston, South Carolina, 29414, United States|Pametto Retina Center, Florence, South Carolina, 29501, United States|Charleston Neuroscience Institute, Ladson, South Carolina, 29456, United States|Palmetto Retina Center, West Columbia, South Carolina, 29169, United States|Black Hills Regional Eye Institute, Rapid City, South Dakota, 57701, United States|Charles Retina Institute, Germantown, Tennessee, 38138, United States|Tennessee Retina PC, Nashville, Tennessee, 37203, United States|Southwest Retina Specialists, Amarillo, Texas, 79106, United States|Texas Retina Associates, Arlington, Texas, 76012, United States|Austin Retina Associates, Austin, Texas, 78705, United States|Star Retina, Burleson, Texas, 76028, United States|Retina Consultants of Texas, Houston, Texas, 77030, United States|Retina Consultants of San Antonio, San Antonio, Texas, 78240, United States|Strategic Clinical Research Group, LLC, Willow Park, Texas, 76087, United States|Piedmont Eye Center, Lynchburg, Virginia, 24502, United States|Retina Center Northwest, Silverdale, Washington, 98383, United States|Spokane Eye, Spokane, Washington, 99204, United States|Universitätsklinikum Freiburg, Freiburg, Baden-Württemberg, 79106, Germany|Universitätsklinikum Regensburg, Regensburg, Bayern, 93053, Germany|Dietrich Bonhoeffer Klinikum Neubrandenburg, Neubrandenburg, Mecklenburg-Vorpommern, 17036, Germany|St. Elisabeth Krankenhaus, Köln, Nordrhein-Westfalen, 50935, Germany|St Franziskus Hospital, Münster, Nordrhein-Westfalen, 48145, Germany|Jahn Ferenc Dél-Pesti Kórház és Rendelointézet, Budapest, 1214, Hungary|Ganglion Medical Center, Pécs, 7621, Hungary|Fondazione PTV Policlinico Tor Vergata, Roma, 00133, Italy|Signes Ozolinas Doctor Praxis In Ophthalmology, Jelgava, LV-3001, Latvia|Pauls Stradins Clinical University Hospital, Riga, LV-1002, Latvia|Riga Eastern Clinical University Hospital Clinic Bikernieki, Riga, LV-1006, Latvia|Latvian American Eye Center, Riga, LV-1009, Latvia|Emanuelli Research & Development Center LLC, Arecibo, 00612, Puerto Rico|Fakultna nemocnica s poliklinikou F. D. Roosevelta, Banská Bystrica, 974 01, Slovakia|Univerzitna nemocnica Bratislava, Bratislava, 826 06, Slovakia|Uvea Klinika, S.R.O., Martin, 036 01, Slovakia|Nemocnica s poliklinikou Trebisov a.s. Ocne oddelenie - jednonova zdravotna starostlivost, Trebišov, 075 01, Slovakia|Fakultna nemocnica Trencin, Trencín, 911 01, Slovakia|Fakultna nemocnica s poliklinikou Zilina, Žilina, 012 07, Slovakia|Hospital dos de Maig, Barcelona, 08025, Spain|Hospital Clinic de Barcelona, Barcelona, 08028, Spain|Hospital Universitari General de Catalunya - Grupo Quironsalud, Barcelona, 08195, Spain|Hospital Universitario Puerta de Hierro - Majadahonda, Madrid, 28222, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, 46026, Spain|Hospital Universitario Rio Hortega, Valladolid, 47012, Spain|Hospital Clinico Universitario Lozano Blesa, Zaragoza, 50009, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain"
NCT04603937,"A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)",https://clinicaltrials.gov/study/NCT04603937,TERMINATED,Diabetic Macular Edema,DRUG: KSI-301|DRUG: Aflibercept|OTHER: Sham Procedure,Kodiak Sciences Inc,,ALL,"ADULT, OLDER_ADULT",PHASE3,INTERVENTIONAL,"Retinal Research Institute, LLC, Phoenix, Arizona, 85014, United States|Retina Vitreous Associates, Beverly Hills, California, 90211, United States|Retina Consultants of Orange County, Fullerton, California, 92835, United States|Northern California Retina Vitreous Associates, Mountain View, California, 94040, United States|Retina Consultants of San Diego, Poway, California, 92064, United States|Retinal Consultants Medical Group Inc, Sacramento, California, 95825, United States|Retina Group of New England, Waterford, Connecticut, 06385, United States|Florida Eye Microsurgical Institute, Boynton Beach, Florida, 33426, United States|Rand Eye Institute, Deerfield Beach, Florida, 33064, United States|National Ophthalmic Research Institute, Fort Myers, Florida, 33912, United States|Fort Lauderdale Eye Institute, Plantation, Florida, 33324, United States|Retina Vitreous Associates of Florida, Saint Petersburg, Florida, 33703, United States|Southern Vitreoretinal Associates, Tallahassee, Florida, 32308, United States|Southeast Retina Center, Augusta, Georgia, 30909, United States|Georgia Retina, P.C., Marietta, Georgia, 30060, United States|Retina Consultants of Hawaii, Inc, 'Aiea, Hawaii, 96701, United States|Retina Specialists of Idaho, Boise, Idaho, 83713, United States|Talley Eye, Evansville, Indiana, 47710, United States|Maine Eye Center, Portland, Maine, 04101, United States|Associated Retinal Consultants PC, Royal Oak, Michigan, 48073, United States|Vitreoretinal Surgery PA, Minneapolis, Minnesota, 55435, United States|Retina Consultants of NV, Henderson, Nevada, 89052, United States|Sierra Eye Associates, Reno, Nevada, 89502, United States|Vitreo Retinal Consultants, Hauppauge, New York, 11788, United States|Retina-Vitreous Surgeons of Central NY, Liverpool, New York, 13088, United States|Ophthalmic Consultants of Long Island, Oceanside, New York, 11572, United States|Retina Associates of Western NY, Rochester, New York, 14620, United States|Asheville Eye Associates, Asheville, North Carolina, 28803, United States|Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, Ohio, 44195, United States|Retina Consultants, LLC, Salem, Oregon, 97302, United States|Southeastern Retina Associates PC, Knoxville, Tennessee, 37922, United States|Retina Research Institute of Texas, Abilene, Texas, 79606, United States|Austin Research Center for Retina, Austin, Texas, 78705, United States|Texas Retina Associates, Fort Worth, Texas, 76108, United States|Retina Consultants of Houston-(Katy), Katy, Texas, 77494, United States|Texas Retina Associates, Plano, Texas, 75075, United States|Austin Retina Associates (Round Rock), Round Rock, Texas, 78681, United States|Medical Center Ophthalmology Associates, San Antonio, Texas, 78240, United States|Retina Consultants of Houston - (Woodlands), The Woodlands, Texas, 77384, United States|Retina Institute of Virginia, Richmond, Virginia, 23235, United States|OFTEX s.r.o., Pardubice, 53002, Czechia|Vseobecna Fakultni, Praha, 128 08, Czechia|Lekarna BENU, Praha, 150 00, Czechia|CHRU Dijon Complexe Du Bocage, Dijon, Côte-d'Or, 21079, France|Hôpital de La Croix Rousse, Lyon, Rhône, 69317, France|Centre Hospitalier Intercommunal de Créteil, Créteil, 94000, France|Centre Paradis Monticelli, Marseille, 13008, France|Hôpital Lariboisière - Service Pharmacie , Essais cliniques - Aude Jacob, Paris, 75 010, France|Fondation Rothschild, Paris, 75019, France|Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz , Josa Andras Oktatókórház, Nyíregyháza, Szabolcs-Szatmár-Bereg, H-4400, Hungary|Semmelweis Egyetem, Budapest, 1085, Hungary|Bajcsy-Zsilinszky Korhaz es Rendelointezet, Budapest, 1106, Hungary|Budapest Retina Associates Kft, Budapest, 1133, Hungary|Bnai Zion, Haifa, 31048, Israel|Rambam MC, Haifa, 31096, Israel|Hadassah University Hospital, Jerusalem, 91120, Israel|Meir MC, Kfar Saba, 44281, Israel|Rabin Medical Center, Petach Tikva, 49100, Israel|Kaplan MC, Rehovot, 76100, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel|Assuta HaShalom, Tel Aviv, 6789140, Israel|Shamir Medical Center Assaf Harofeh, Tzrifin, 70300, Israel|Fondazione Policlinico Universitario A Gemelli, Roma, Lazio, 00168, Italy|Ospedale San Raffaele S.r.l. - PPDS, Milano, Lombardia, 20132, Italy|AOU dell'Università degli Studi della Campania Luigi Vanvitelli, Naples, 80131, Italy|Optimum Profesorskie Centrum Okulistyki, Gdansk, Pomorskie, 80-809, Poland|Uniwersyteckie Centrum Kliniczne Im. Prof. K. Gibinskiego Slaskiego Uniwersytetu Medycznego w Katowi, Katowice, Slaskie, 40-514, Poland|Oftalmika Sp. z o.o., Bydgoszcz, 85-631, Poland|Dr Nowosielska Okulistyka i Chirurgia Oka, Warszawa, 01-249, Poland|Specjalistyczny Szpital im. Alfreda Sokolowskiego, Wałbrzych, 58-309, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu, Wrocław, 50-556, Poland|Emanuelli Research & Development Center LLC, Arecibo, 00612, Puerto Rico"
NCT02001051,Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism,https://clinicaltrials.gov/study/NCT02001051,TERMINATED,Subclinical Hypercortisolism|Cushing Syndrome|Adrenal Neoplasm,PROCEDURE: Adrenalectomy|OTHER: Observation,National Cancer Institute (NCI),Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Clinical Center Office of the Associates Director for Radiologic&Imaging Sciences,ALL,"ADULT, OLDER_ADULT",PHASE2,INTERVENTIONAL,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States"
NCT04891315,Measuring sVAP-1 as a Predictor of Pregnancy Problems,https://clinicaltrials.gov/study/NCT04891315,TERMINATED,Pregnancy Complications,DIAGNOSTIC_TEST: Blood test for soluble VAP-1 (sVAP-1).,University of Leicester,,FEMALE,"CHILD, ADULT, OLDER_ADULT",,OBSERVATIONAL,"Leicester Royal Infirmary, Leicester, United Kingdom"
NCT02077179,Health Improvement After Pregnancy (HIP) Program Randomized Control Trial,https://clinicaltrials.gov/study/NCT02077179,TERMINATED,Metabolic Cardiovascular Syndrome,BEHAVIORAL: HIP Program,Queen's University,,FEMALE,"CHILD, ADULT, OLDER_ADULT",,INTERVENTIONAL,"Queen's Unviersity, Kingston, Ontario, K7L 2V7, Canada"
NCT05622981,Pediatric Obesity Management Study,https://clinicaltrials.gov/study/NCT05622981,TERMINATED,"Obesity, Childhood|Behavior, Eating",BEHAVIORAL: Age-specific educational materials and monitoring,William Beaumont Hospitals,,ALL,CHILD,,INTERVENTIONAL,"Beaumont Health System, Royal Oak, Michigan, 48073, United States"
NCT04697758,Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema,https://clinicaltrials.gov/study/NCT04697758,TERMINATED,Diabetic Macular Edema (DME),DRUG: AXT107 0.1 mg|DRUG: AXT107 0.25 mg|DRUG: AXT107 0.5 mg,"AsclepiX Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,INTERVENTIONAL,"AsclepiX Investigative Site, Gilbert, Arizona, 85053, United States|AsclepiX Investigative Site, Los Angeles, California, 90211, United States|AsclepiX Investigative Site, Saint Petersburg, Florida, 33711, United States|AsclepiX Investigative Site, Boston, Massachusetts, 02114, United States|AsclepiX Investigative Site, Reno, Nevada, 89502, United States|AsclepiX Investigative Site, Eugene, Oregon, 97401, United States|AsclepiX Investigative Site, Philadelphia, Pennsylvania, 19107, United States|AsclepiX Investigative Site, Abilene, Texas, 79606, United States|AsclepiX Investigative Site, McAllen, Texas, 78550, United States|AsclepiX Investigative Site, The Woodlands, Texas, 77384, United States"
NCT01475565,Insulin Resistance Before and During Pregnancy in Women With Polycystic Ovary Syndrome,https://clinicaltrials.gov/study/NCT01475565,TERMINATED,Polycystic Ovary Syndrome|Insulin Resistance|Insulin Sensitivity|Obesity|Pregnancy,,Virginia Commonwealth University,National Institute on Minority Health and Health Disparities (NIMHD),FEMALE,ADULT,,OBSERVATIONAL,"Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298-5051, United States"
NCT01892917,BIOFLOW-III Hungary Satellite Registry,https://clinicaltrials.gov/study/NCT01892917,TERMINATED,Coronary Artery Disease|Myocardial Ischemia,,Biotronik Hungária Kft.,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Állami Szívkórház (State Hospital for cardiology of Balatonfüred), Balatonfüred, 8231, Hungary|Gottsegen György Országos Kardiológiai Intézet (Gottsegen György Hungarian Institute of Cardiology), Budapest, 1096, Hungary|Bajcsy-Zsilinszky Kórház (Bajcsy-Zsilinszky Hospital), Budapest, 1106, Hungary|SE ÁOK Kardiológiai Központ (Semmelweis University, Heart Center), Budapest, 1122, Hungary|DEOEC, Kardiológiai Intézet ( Institute of Cardiology, University of Debrecen), Debrecen, 4012, Hungary|Kaposi Mór Oktató Kórház, Kardiológia (Kaposi Mór Teaching Hospital, Cardiology), Kaposvár, 7400, Hungary|Jósa András Kórház, Kardiológia (Jósa András Hospital, Department of Cardiology), Nyíregyháza, 4400, Hungary|PTE ÁOK Szívcentrum (University of Pécs, Faculty of Medicine, Heart Institute), Pécs, 7624, Hungary|Szentgyörgyi Albert Tudomány Egyetem, ÁOK, Kardiológia (University of Szeged, Albert Szent-Györgyi Clinical Center, Faculty Of Medicine, Second Department of Medicine and Cardiology Centre), Szeged, 6720, Hungary|Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház, Kardiológia-Hemodinamika (Jász-Nagykun-Szolnok County, Hetényi Géza Hospital, Cardiology, Haemodynamics), Szolnok, 5004, Hungary|Vas Megyei Markusovszky Kórház Zrt (Vas County, Markusovszky Hospital), Szombathely, 9400, Hungary|Fejér Megyei Szent György Kórház (Fejér County Szent György Hospital), Székesfehérvár, 8001, Hungary|Zala Megyei Kórház, Kardiológia (Zala County Hospital, Cardiology), Zalaegerszeg, 8900, Hungary"
NCT01593059,BIOFLOW-III Romania Satellite Registry,https://clinicaltrials.gov/study/NCT01593059,TERMINATED,Coronary Artery Disease|Myocardial Ischemia,,Biotronik Vertriebs-GmbH,,ALL,"ADULT, OLDER_ADULT",,OBSERVATIONAL,"Cardiovascular Diseases Institute CC Iliescu, Bucharest, Romania|University Hospital Bucharest, Bucharest, Romania|County Emergency Hospital, Cluj Napoca, Romania|Country Hospital, Targu Mures, 540136, Romania"
